(lp1
(dp2
S'cdsr_refcode'
p3
VSTD-Dimson-1986_x0023_
p4
sS'pmc_id'
p5
S'PMC1778127'
p6
sS'cdsr_filename'
p7
VCD002112 v. 6.0 Desmopressin for nocturnal enuresis in children.rm5
p8
sS'pm_filename'
p9
V3539030.xml
p10
sa(dp11
g3
VSTD-Aladjem-1982
p12
sg5
S'PMC1627511'
p13
sg7
g8
sg9
V7039520.xml
p14
sa(dp15
g3
VSTD-Fjellestad-1987_x0023_
p16
sg5
S'PMC1779260'
p17
sg7
g8
sg9
V3307643.xml
p18
sa(dp19
g3
VSTD-Wille-1986
p20
sg5
S'PMC1777552'
p21
sg7
g8
sg9
V3513716.xml
p22
sa(dp23
g3
VSTD-Dearlove-1983
p24
sg5
S'PMC1548276'
p25
sg7
VCD003019 v. 7.0 Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in child.rm5
p26
sg9
V6407644.xml
p27
sa(dp28
g3
VSTD-Kass-1989
p29
sg5
S'PMC1298559'
p30
sg7
VCD003167 v. 5.0 Medical interventions for primary open angle glaucoma and ocular hypertension.rm5
p31
sg9
V2562546.xml
p32
sa(dp33
g3
VSTD-Geyer-1988
p34
sg5
S'PMC1041616'
p35
sg7
g31
sg9
V3067745.xml
p36
sa(dp37
g3
VSTD-Watson-2001
p38
sg5
S'PMC1724066'
p39
sg7
g31
sg9
V11466256.xml
p40
sa(dp41
g3
VSTD-Hobbs-1996
p42
sg5
S'PMC2352974'
p43
sg7
VCD000560 v. 11.0 Psychological debriefing for preventing post traumatic stress disorder (PTSD).rm5
p44
sg9
V8973231.xml
p45
sa(dp46
g3
VSTD-Mozambique-1986
p47
sg5
S'PMC2491050'
p48
sg7
VCD000016 v. 10.0 Amodiaquine for treating malaria.rm5
p49
sg9
V3293827.xml
p50
sa(dp51
g3
VSTD-China-1986
p52
sg5
S'PMC2491139'
p53
sg7
g49
sg9
V3048759.xml
p54
sa(dp55
g3
VSTD-Lammers-1986a
p56
sg5
S'PMC1401187'
p57
sg7
VCD002992 v. 11.0 Cardioselective beta-blockers for reversible airway disease.rm5
p58
sg9
V2878680.xml
p59
sa(dp60
g3
VSTD-Benson-1978
p61
sg5
S'PMC1429350'
p62
sg7
g58
sg9
V26371.xml
p63
sa(dp64
g3
VSTD-Skinner-1975b
p65
sg5
S'PMC1402628'
p66
sg7
g58
sg9
V786353.xml
p67
sa(dp68
g3
VSTD-Chen-2011
p69
sg5
S'PMC3167410'
p70
sg7
VCD008987 v. 2.0 Surgical interventions for treating radial head fractures in adults.rm5
p71
sg9
V20680272.xml
p72
sa(dp73
g3
VSTD-Ruan-2009
p74
sg5
S'PMC2899229'
p75
sg7
g71
sg9
V17938924.xml
p76
sa(dp77
g3
VSTD-Fugere-1983
p78
sg5
S'PMC1875263'
p79
sg7
VCD007482 v. 3.0 Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.rm5
p80
sg9
V6344970.xml
p81
sa(dp82
g3
VSTD-Humphreys-2010
p83
sg5
S'PMC2924332'
p84
sg7
VCD009987 v. 2.4 Decentralising HIV treatment in lower- and middle-income countries.rm5
p85
sg9
V20687955.xml
p86
sa(dp87
g3
VSTD-Fatti-2010
p88
sg5
S'PMC2943483'
p89
sg7
g85
sg9
V20877631.xml
p90
sa(dp91
g3
VSTD-Jaffar-2009
p92
sg5
S'PMC2806484'
p93
sg7
g85
sg9
V19939445.xml
p94
sa(dp95
g3
VSTD-Vickers-2004
p96
sg5
S'PMC381326'
p97
sg7
VCD001218 v. 8.0 Acupuncture for migraine prophylaxis.rm5
p98
sg9
V15023828.xml
p99
sa(dp100
g3
VSTD-Shepherd-1956
p101
sg5
S'PMC497211'
p102
sg7
VCD000284 v. 13.5 Chlorpromazine versus placebo for schizophrenia.rm5
p103
sg9
V13357965.xml
p104
sa(dp105
g3
VSTD-Harbarth-1999
p106
sg5
S'PMC89288'
p107
sg7
VCD006216 v. 5.0 Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.rm5
p108
sg9
V10348762.xml
p109
sa(dp110
g3
VSTD-Trivedi-2003
p111
sg5
S'PMC150177'
p112
sg7
VCD007146 v. 8.0 Interventions for preventing falls in older people living in the community.rm5
p113
sg9
V12609940.xml
p114
sa(dp115
g3
VSTD-Lannin-2007
p116
sg5
S'PMC1832184'
p117
sg7
g113
sg9
V17355644.xml
p118
sa(dp119
g3
VSTD-Spink-2011
p120
sg5
S'PMC3116775'
p121
sg7
g113
sg9
V21680622.xml
p122
sa(dp123
g3
VSTD-Robertson-2001a
p124
sg5
S'PMC30094'
p125
sg7
g113
sg9
V11264206.xml
p126
sa(dp127
g3
VSTD-Carpenter-1990
p128
sg5
S'PMC1662856'
p129
sg7
g113
sg9
V2354297.xml
p130
sa(dp131
g3
VSTD-Campbell-2005
p132
sg5
S'PMC1246082'
p133
sg7
g113
sg9
V16183652.xml
p134
sa(dp135
g3
VSTD-Harwood-2005
p136
sg5
S'PMC1772474'
p137
sg7
g113
sg9
V15615747.xml
p138
sa(dp139
g3
VSTD-Van-Rossum-1993
p140
sg5
S'PMC1678489'
p141
sg7
g113
sg9
V8343668.xml
p142
sa(dp143
g3
VSTD-Van-Haastregt-2000
p144
sg5
S'PMC27508'
p145
sg7
g113
sg9
V11039967.xml
p146
sa(dp147
g3
VSTD-Wagner-1994
p148
sg5
S'PMC1615188'
p149
sg7
g113
sg9
V7977921.xml
p150
sa(dp151
g3
VSTD-Carter-2002
p152
sg5
S'PMC134175'
p153
sg7
g113
sg9
V12403738.xml
p154
sa(dp155
g3
VSTD-Campbell-1997
p156
sg5
S'PMC2127698'
p157
sg7
g113
sg9
V9366737.xml
p158
sa(dp159
g3
VSTD-Haran-2010
p160
sg5
S'PMC2876235'
p161
sg7
g113
sg9
V20501583.xml
p162
sa(dp163
g3
VSTD-Conroy-2010
p164
sg5
S'PMC2956530'
p165
sg7
g113
sg9
V20823124.xml
p166
sa(dp167
g3
VSTD-Dangour-2011
p168
sg5
S'PMC3079648'
p169
sg7
g113
sg9
V21526229.xml
p170
sa(dp171
g3
VSTD-Vetter-1992
p172
sg5
S'PMC1882829'
p173
sg7
g113
sg9
V1392755.xml
p174
sa(dp175
g3
VSTD-Logan-2010
p176
sg5
S'PMC2868162'
p177
sg7
g113
sg9
V20460331.xml
p178
sa(dp179
g3
VSTD-Porthouse-2005
p180
sg5
S'PMC557150'
p181
sg7
g113
sg9
V15860827.xml
p182
sa(dp183
g3
VSTD-Hogan-2001
p184
sg5
S'PMC81411'
p185
sg7
g113
sg9
V11563205.xml
p186
sa(dp187
g3
VSTD-Steinberg-2000
p188
sg5
S'PMC1731645'
p189
sg7
g113
sg9
V10746118.xml
p190
sa(dp191
g3
VSTD-Weber-2008
p192
sg5
S'PMC2359523'
p193
sg7
g113
sg9
V18373136.xml
p194
sa(dp195
g3
VSTD-Liu_x002d_Ambrose-2004
p196
sg5
S'PMC3344816'
p197
sg7
g113
sg9
V15086643.xml
p198
sa(dp199
g3
VSTD-Scurr-1985
p200
sg5
S'PMC2498276'
p201
sg7
VCD001732 v. 7.0 Injection sclerotherapy for varicose veins.rm5
p202
sg9
V3883876.xml
p203
sa(dp204
g3
VSTD-Shouler-1989
p205
sg5
S'PMC2499037'
p206
sg7
g202
sg9
V2690721.xml
p207
sa(dp208
g3
VSTD-Asilian-2003
p209
sg5
S'PMC2572463'
p210
sg7
VCD005067 v. 6.0 Interventions for Old World cutaneous leishmaniasis.rm5
p211
sg9
V12856053.xml
p212
sa(dp213
g3
VSTD-Nilforoushzadeh-2007
p214
sg5
S'PMC1891315'
p215
sg7
g211
sg9
V17466071.xml
p216
sa(dp217
g3
VSTD-Dybul-2001
p218
sg5
S'PMC65000'
p219
sg7
VCD005482 v. 4.0 Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.rm5
p220
sg9
V11734634.xml
p221
sa(dp222
g3
VSTD-Papasavvas-2004
p223
sg5
S'PMC539050'
p224
sg7
g220
sg9
V15630469.xml
p225
sa(dp226
g3
VSTD-Hance-2001
p227
sg5
S'PMC114364'
p228
sg7
g220
sg9
V11413308.xml
p229
sa(dp230
g3
VSTD-Ortiz-2001
p231
sg5
S'PMC60863'
p232
sg7
g220
sg9
V11687611.xml
p233
sa(dp234
g3
VSTD-Oxenius-2002a
p235
sg5
S'PMC129766'
p236
sg7
g220
sg9
V12370434.xml
p237
sa(dp238
g3
VSTD-Oxenius-2002
p239
sg5
S'PMC136545'
p240
sg7
g220
sg9
V12239291.xml
p241
sa(dp242
g3
VSTD-Imbasciati-1985
p243
sg5
S'PMC1417455'
p244
sg7
VCD001537 v. 7.0 Interventions for minimal change disease in adults with nephrotic syndrome.rm5
p245
sg9
V3933645.xml
p246
sa(dp247
g3
VSTD-Coggins-1985
p248
sg5
S'PMC2279687'
p249
sg7
g245
sg9
V3915841.xml
p250
sa(dp251
g3
VSTD-B_x00f8_-1999
p252
sg5
S'PMC27740'
p253
sg7
VCD002114 v. 10.0 Weighted vaginal cones for urinary incontinence.rm5
p254
sg9
V10024253.xml
p255
sa(dp256
g3
VSTD-Chisholm-2001
p257
sg5
S'PMC1718812'
p258
sg7
VCD006484 v. 4.0 Influenza vaccination in children being treated with chemotherapy for cancer.rm5
p259
sg9
V11369567.xml
p260
sa(dp261
g3
VSTD-Lyon-1998
p262
sg5
S'PMC1720741'
p263
sg7
VCD004338 v. 7.0 Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants.rm5
p264
sg9
V9536833.xml
p265
sa(dp266
g3
VSTD-Warley-1965
p267
sg5
S'PMC1845333'
p268
sg7
VCD003489 v. 5.2 Malaria chemoprophylaxis in sickle cell disease.rm5
p269
sg9
V14305376.xml
p270
sa(dp271
g3
VSTD-Norway
p272
sg5
S'PMC1678377'
p273
sg7
VCD007058 v. 3.0 Ultrasound for fetal assessment in early pregnancy.rm5
p274
sg9
V7688253.xml
p275
sa(dp276
g3
VSTD-Taitz-1986
p277
sg5
S'PMC1777784'
p278
sg7
VCD002240 v. 6.0 Behavioural and cognitive interventions with or without other treatments for the management of faeca.rm5
p279
sg9
V3717993.xml
p280
sa(dp281
g3
VSTD-Nolan-1998
p282
sg5
S'PMC1717674'
p283
sg7
g279
sg9
V9797593.xml
p284
sa(dp285
g3
VSTD-van-der-Plas-1996a
p286
sg5
S'PMC1511777'
p287
sg7
g279
sg9
V8957948.xml
p288
sa(dp289
g3
VSTD-Hager-1996
p290
sg5
S'PMC2364471'
p291
sg7
VCD005458 v. 6.0 Antibiotics for mastitis in breastfeeding women.rm5
p292
sg9
V18476075.xml
p293
sa(dp294
g3
VSTD-Gilboa_x002d_Schechtman-2010
p295
sg5
S'PMC2945239'
p296
sg7
VCD006726 v. 4.0 Psychological therapies for the treatment of post-traumatic stress disorder in children and adolesce.rm5
p297
sg9
V20855048.xml
p298
sa(dp299
g3
VSTD-Catani-2009
p300
sg5
S'PMC2685130'
p301
sg7
g297
sg9
V19439099.xml
p302
sa(dp303
g3
VSTD-Krasnik-1990
p304
sg5
S'PMC1663335'
p305
sg7
VCD002215 v. 4.0 Capitation salary fee-for-service and mixed systems of payment effects on the behaviour of primar.rm5
p306
sg9
V2390552.xml
p307
sa(dp308
g3
VSTD-Hutchison-1996
p309
sg5
S'PMC1487544'
p310
sg7
g306
sg9
V8603321.xml
p311
sa(dp312
g3
VSTD-Bredin-1999
p313
sg5
S'PMC27809'
p314
sg7
VCD004282 v. 7.0 Non-invasive interventions for improving well-being and quality of life in patients with lung cancer.rm5
p315
sg9
V10102851.xml
p316
sa(dp317
g3
VSTD-Wilkie-2010
p318
sg5
S'PMC3644582'
p319
sg7
g315
sg9
V20164474.xml
p320
sa(dp321
g3
VSTD-Moore-2002
p322
sg5
S'PMC133453'
p323
sg7
g315
sg9
V12433764.xml
p324
sa(dp325
g3
VSTD-Allen-2008
p326
sg5
S'PMC2664509'
p327
sg7
VCD007617 v. 4.0 Interventions for supporting informal caregivers of patients in the terminal phase of a disease.rm5
p328
sg9
V18788966.xml
p329
sa(dp330
g3
VSTD-Addington_x002d_Hall-1992
p331
sg5
S'PMC1883850'
p332
sg7
g328
sg9
V1483075.xml
p333
sa(dp334
g3
VSTD-Radwan-2008
p335
sg5
S'PMC2551723'
p336
sg7
VCD003525 v. 7.0 Surgery for lateral elbow pain.rm5
p337
sg9
V17551726.xml
p338
sa(dp339
g3
VSTD-Paschalidis-2006
p340
sg5
S'PMC1860748'
p341
sg7
VCD004981 v. 4.0 Treatment for femoral pseudoaneurysms.rm5
p342
sg9
V16415194.xml
p343
sa(dp344
g3
VSTD-Connett-1994a
p345
sg5
S'PMC1029734'
p346
sg7
VCD002178 v. 6.0 Early emergency department treatment of acute asthma with systemic corticosteroids.rm5
p347
sg9
V8135557.xml
p348
sa(dp349
g3
VSTD-Connett-1994b
p350
sg5
S'PMC1029734'
p351
sg7
g347
sg9
V8135557.xml
p352
sa(dp353
g3
VSTD-Druss-2010
p354
sg5
S'PMC3775666'
p355
sg7
VCD008567 v. 5.0 General physical health advice for people with serious mental illness.rm5
p356
sg9
V20008945.xml
p357
sa(dp358
g3
VSTD-Mosforth-1958
p359
sg5
S'PMC2026410'
p360
sg7
VCD006283 v. 4.0 Physical therapy for Bell's palsy (idiopathic facial paralysis).rm5
p361
sg9
V13572865.xml
p362
sa(dp363
g3
VSTD-Marigold-2005
p364
sg5
S'PMC3226796'
p365
sg7
VCD008728 v. 2.0 Interventions for preventing falls in people after stroke.rm5
p366
sg9
V15743283.xml
p367
sa(dp368
g3
VSTD-Haran-2010
p369
sg5
S'PMC2876235'
p370
sg7
g366
sg9
V20501583.xml
p371
sa(dp372
g3
VSTD-Parras-1995
p373
sg5
S'PMC162505'
p374
sg7
VCD003340 v. 7.0 Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization.rm5
p375
sg9
V7695302.xml
p376
sa(dp377
g3
VSTD-Harbarth-1999
p378
sg5
S'PMC89288'
p379
sg7
g375
sg9
V10348762.xml
p380
sa(dp381
g3
VSTD-Elliott-2005
p382
sg5
S'PMC1352364'
p383
sg7
VCD005547 v. 5.0 Effect of administration of antihelminthics for soil transmitted helminths during pregnancy.rm5
p384
sg9
V16371154.xml
p385
sa(dp386
g3
VSTD-Davies-2000
p387
sg5
S'PMC27532'
p388
sg7
VCD003573 v. 8.6 Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.rm5
p389
sg9
V11082090.xml
p390
sa(dp391
g3
VSTD-Ojoo-2002
p392
sg5
S'PMC1746235'
p393
sg7
g389
sg9
V11828049.xml
p394
sa(dp395
g3
VSTD-Cotton-2000
p396
sg5
S'PMC1745631'
p397
sg7
g389
sg9
V11050257.xml
p398
sa(dp399
g3
VSTD-Skwarska-2000
p400
sg5
S'PMC1745644'
p401
sg7
g389
sg9
V11050258.xml
p402
sa(dp403
g3
VSTD-Gleeson-1983
p404
sg5
S'PMC1875644'
p405
sg7
VCD001751 v. 6.2 Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.rm5
p406
sg9
V6351994.xml
p407
sa(dp408
g3
VSTD-Changulani-2007
p409
sg5
S'PMC2267584'
p410
sg7
VCD005959 v. 3.0 Dynamic compression plating versus locked intramedullary nailing for humeral shaft fractures in adul.rm5
p411
sg9
V16900354.xml
p412
sa(dp413
g3
VSTD-Bergmann-1995
p414
sg5
S'PMC2549556'
p415
sg7
VCD006706 v. 2.0 Interventions for the prevention and treatment of herpes simplex virus in patients being treated for.rm5
p416
sg9
V7767151.xml
p417
sa(dp418
g3
VSTD-Selby-1989
p419
sg5
S'PMC2247066'
p420
sg7
g416
sg9
V2539180.xml
p421
sa(dp422
g3
VSTD-Anderson-1984
p423
sg5
S'PMC1976928'
p424
sg7
g416
sg9
V6378236.xml
p425
sa(dp426
g3
VSTD-Bubley-1989
p427
sg5
S'PMC284246'
p428
sg7
g416
sg9
V2669626.xml
p429
sa(dp430
g3
VSTD-Barile_x002d_Fabris-2005
p431
sg5
S'PMC1755456'
p432
sg7
VCD002265 v. 9.0 Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lup.rm5
p433
sg9
V15769918.xml
p434
sa(dp435
g3
VSTD-Foshee-1998
p436
sg5
S'PMC1508378'
p437
sg7
VCD004534 v. 5.2 Educational and skills-based interventions for preventing relationship and dating violence in adoles.rm5
p438
sg9
V9584032.xml
p439
sa(dp440
g3
VSTD-Trinder-2006
p441
sg5
S'PMC1471967'
p442
sg7
VCD003518 v. 8.0 Expectant care versus surgical treatment for miscarriage.rm5
p443
sg9
V16707509.xml
p444
sa(dp445
g3
VSTD-Noyes-1998
p446
sg5
S'PMC1784814'
p447
sg7
VCD008726 v. 1.0 Different classes of antibiotics given to women routinely for preventing infection at caesarean sect.rm5
p448
sg9
V9894177.xml
p449
sa(dp450
g3
VSTD-Clarke-1998
p451
sg5
S'PMC1756722'
p452
sg7
VMR000008 v. 7.0 Methods to increase response to postal and electronic questionnaires.rm5
p453
sg9
V9764257.xml
p454
sa(dp455
g3
VSTD-Finsen-2006
p456
sg5
S'PMC1459867'
p457
sg7
g453
sg9
V16646970.xml
p458
sa(dp459
g3
VSTD-Cockayne-2005
p460
sg5
S'PMC1280926'
p461
sg7
g453
sg9
V16250910.xml
p462
sa(dp463
g3
VSTD-Sallis-1984
p464
sg5
S'PMC1651776'
p465
sg7
g453
sg9
V6465406.xml
p466
sa(dp467
g3
VSTD-Campbell-1990
p468
sg5
S'PMC1060602'
p469
sg7
g453
sg9
V2348155.xml
p470
sa(dp471
g3
VSTD-Junghans-2005
p472
sg5
S'PMC1261191'
p473
sg7
g453
sg9
V16157604.xml
p474
sa(dp475
g3
VSTD-Deehan-1997
p476
sg5
S'PMC1312912'
p477
sg7
g453
sg9
V9101691.xml
p478
sa(dp479
g3
VSTD-Etter-1998b
p480
sg5
S'PMC1756667'
p481
sg7
g453
sg9
V9578862.xml
p482
sa(dp483
g3
VSTD-Roberts-1993
p484
sg5
S'PMC1059805'
p485
sg7
g453
sg9
V8228774.xml
p486
sa(dp487
g3
VSTD-Leigh-Brown-1997
p488
sg5
S'PMC1060522'
p489
sg7
g453
sg9
V9328560.xml
p490
sa(dp491
g3
VSTD-Morrison-2003
p492
sg5
S'PMC1732498'
p493
sg7
g453
sg9
V12821704.xml
p494
sa(dp495
g3
VSTD-Clark-2001
p496
sg5
S'PMC1731952'
p497
sg7
g453
sg9
V11449019.xml
p498
sa(dp499
g3
VSTD-Sloan-1997
p500
sg5
S'PMC2127714'
p501
sg7
g453
sg9
V9374887.xml
p502
sa(dp503
g3
VSTD-Roberts-2000
p504
sg5
S'PMC1731530'
p505
sg7
g453
sg9
V10692967.xml
p506
sa(dp507
g3
VSTD-Roberts-2004
p508
sg5
S'PMC534094'
p509
sg7
g453
sg9
V15533256.xml
p510
sa(dp511
g3
VSTD-McKenzie_x002d_McHarg-2005
p512
sg5
S'PMC1190172'
p513
sg7
g453
sg9
V16091137.xml
p514
sa(dp515
g3
VSTD-Salim-Silva-2002
p516
sg5
S'PMC1732073'
p517
sg7
g453
sg9
V11812810.xml
p518
sa(dp519
g3
VSTD-Mortagy-1985
p520
sg5
S'PMC1052430'
p521
sg7
g453
sg9
V4009104.xml
p522
sa(dp523
g3
VSTD-Salvesen-1992
p524
sg5
S'PMC1059502'
p525
sg7
g453
sg9
V1573369.xml
p526
sa(dp527
g3
VSTD-Barker-1996
p528
sg5
S'PMC1060390'
p529
sg7
g453
sg9
V9039392.xml
p530
sa(dp531
g3
VSTD-Peters-1998
p532
sg5
S'PMC1756664'
p533
sg7
g453
sg9
V9578863.xml
p534
sa(dp535
g3
VSTD-Mullner-1982
p536
sg5
S'PMC1424368'
p537
sg7
g453
sg9
V7122824.xml
p538
sa(dp539
g3
VSTD-Shaw-2001
p540
sg5
S'PMC1089193'
p541
sg7
g453
sg9
V11221822.xml
p542
sa(dp543
g3
VSTD-Shah-2001
p544
sg5
S'PMC1313955'
p545
sg7
g453
sg9
V11255905.xml
p546
sa(dp547
g3
VSTD-Kenyon-2005
p548
sg5
S'PMC1201139'
p549
sg7
g453
sg9
V16109160.xml
p550
sa(dp551
g3
VSTD-Tambor-1993
p552
sg5
S'PMC1694880'
p553
sg7
g453
sg9
V8238685.xml
p554
sa(dp555
g3
VSTD-Marsh-1999
p556
sg5
S'PMC1730548'
p557
sg7
g453
sg9
V10628925.xml
p558
sa(dp559
g3
VSTD-Maheux-1989b
p560
sg5
S'PMC1349512'
p561
sg7
g453
sg9
V2705601.xml
p562
sa(dp563
g3
VSTD-Maheux-1989a
p564
sg5
S'PMC1349512'
p565
sg7
g453
sg9
V2705601.xml
p566
sa(dp567
g3
VSTD-Br_x00f8_gger-2007
p568
sg5
S'PMC2270416'
p569
sg7
g453
sg9
V18174120.xml
p570
sa(dp571
g3
VSTD-Lavelle-2008
p572
sg5
S'PMC2427026'
p573
sg7
g453
sg9
V18507819.xml
p574
sa(dp575
g3
VSTD-Harrison-2004
p576
sg5
S'PMC534787'
p577
sg7
g453
sg9
V15537429.xml
p578
sa(dp579
g3
VSTD-Paul-2005
p580
sg5
S'PMC1732979'
p581
sg7
g453
sg9
V16286502.xml
p582
sa(dp583
g3
VSTD-Moses-2004
p584
sg5
S'PMC449720'
p585
sg7
g453
sg9
V15222889.xml
p586
sa(dp587
g3
VSTD-Windsor-1992
p588
sg5
S'PMC1059500'
p589
sg7
g453
sg9
V1573368.xml
p590
sa(dp591
g3
VSTD-Clark-TJ-2001
p592
sg5
S'PMC64502'
p593
sg7
g453
sg9
V11782286.xml
p594
sa(dp595
g3
VSTD-Slesnick-2005
p596
sg5
S'PMC1933523'
p597
sg7
VCD007501 v. 2.0 Interventions to modify sexual risk behaviours for preventing HIV in homeless youth.rm5
p598
sg9
V15878048.xml
p599
sa(dp600
g3
VSTD-Slesnick-2008
p601
sg5
S'PMC2430633'
p602
sg7
g598
sg9
V17940861.xml
p603
sa(dp604
g3
VSTD-Kochiadakis-2000
p605
sg5
S'PMC1760955'
p606
sg7
VCD005049 v. 5.0 Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.rm5
p607
sg9
V10956284.xml
p608
sa(dp609
g3
VSTD-Sodermark-1975
p610
sg5
S'PMC482826'
p611
sg7
g607
sg9
V1093559.xml
p612
sa(dp613
g3
VSTD-Hillestad-1971
p614
sg5
S'PMC487206'
p615
sg7
g607
sg9
V4934041.xml
p616
sa(dp617
g3
VSTD-Byrne_x002d_Quinn-1970
p618
sg5
S'PMC487336'
p619
sg7
g607
sg9
V4911757.xml
p620
sa(dp621
g3
VSTD-A-ba_x002d_bai_x002d_ke_x002d_re-2011
p622
sg5
S'PMC3070018'
p623
sg7
VCD004322 v. 6.0 Phlebotonics for haemorrhoids.rm5
p624
sg9
V21472103.xml
p625
sa(dp626
g3
VSTD-Body-2004
p627
sg5
S'PMC2409647'
p628
sg7
VCD003474 v. 15.3 Bisphosphonates and other bone agents for breast cancer.rm5
p629
sg9
V15026791.xml
p630
sa(dp631
g3
VSTD-Hershman-2008
p632
sg5
S'PMC2653138'
p633
sg7
g629
sg9
V18711172.xml
p634
sa(dp635
g3
VSTD-Sutton-1988
p636
sg5
S'PMC461097'
p637
sg7
VCD008351 v. 2.3 Airway clearance techniques for bronchiectasis.rm5
p638
sg9
V3353875.xml
p639
sa(dp640
g3
VSTD-Schnelle-1983
p641
sg5
S'PMC1307878'
p642
sg7
VCD002113 v. 5.0 Prompted voiding for the management of urinary incontinence in adults.rm5
p643
sg9
V6885672.xml
p644
sa(dp645
g3
VSTD-Dougados-2005
p646
sg5
S'PMC1755199'
p647
sg7
VCD002047 v. 9.2 Leflunomide for the treatment of rheumatoid arthritis.rm5
p648
sg9
V15271770.xml
p649
sa(dp650
g3
VSTD-Scott-2001
p651
sg5
S'PMC1753377'
p652
sg7
g648
sg9
V11557646.xml
p653
sa(dp654
g3
VSTD-Jenkinson-1988
p655
sg5
S'PMC1833935'
p656
sg7
VCD001005 v. 3.0 Limited (information only) patient education programs for adults with asthma.rm5
p657
sg9
V3416147.xml
p658
sa(dp659
g3
VSTD-Moldofsky-1979
p660
sg5
S'PMC1819150'
p661
sg7
g657
sg9
V436049.xml
p662
sa(dp663
g3
VSTD-Hagel-2006
p664
sg5
S'PMC2586783'
p665
sg7
VCD005401 v. 8.0 Bicycle helmet legislation for the uptake of helmet use and prevention of head injuries.rm5
p666
sg9
V16887950.xml
p667
sa(dp668
g3
VSTD-Swan-2010
p669
sg5
S'PMC2879135'
p670
sg7
VCD009670 v. 3.0 Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.rm5
p671
sg9
V20409497.xml
p672
sa(dp673
g3
VSTD-Aveyard-2007
p674
sg5
S'PMC2094265'
p675
sg7
g671
sg9
V17483139.xml
p676
sa(dp677
g3
VSTD-Williams-2010
p678
sg5
S'PMC2859987'
p679
sg7
g671
sg9
V20363089.xml
p680
sa(dp681
g3
VSTD-Reid-1999
p682
sg5
S'PMC1230362'
p683
sg7
g671
sg9
V10373999.xml
p684
sa(dp685
g3
VSTD-Gariti-2009
p686
sg5
S'PMC2778325'
p687
sg7
g671
sg9
V19339135.xml
p688
sa(dp689
g3
VSTD-Ellerbeck-2009
p690
sg5
S'PMC2825176'
p691
sg7
g671
sg9
V19349629.xml
p692
sa(dp693
g3
VSTD-Lando-1997
p694
sg5
S'PMC1381132'
p695
sg7
g671
sg9
V9357351.xml
p696
sa(dp697
g3
VSTD-Hollis-2007
p698
sg5
S'PMC2598511'
p699
sg7
g671
sg9
V18048633.xml
p700
sa(dp701
g3
VSTD-Wu-2009
p702
sg5
S'PMC2784492'
p703
sg7
g671
sg9
V19915080.xml
p704
sa(dp705
g3
VSTD-Lloyd_x002d_Richardson-2009
p706
sg5
S'PMC2763031'
p707
sg7
g671
sg9
V19719796.xml
p708
sa(dp709
g3
VSTD-Hall-2009
p710
sg5
S'PMC2718733'
p711
sg7
g671
sg9
V19392908.xml
p712
sa(dp713
g3
VSTD-Hovell-2003
p714
sg5
S'PMC1448065'
p715
sg7
VCD003974 v. 5.0 Placebo interventions for all clinical conditions.rm5
p716
sg9
V14600055.xml
p717
sa(dp718
g3
VSTD-Robinson-2001
p719
sg5
S'PMC1760991'
p720
sg7
g716
sg9
V11423594.xml
p721
sa(dp722
g3
VSTD-Tarrier-1998
p723
sg5
S'PMC28621'
p724
sg7
g716
sg9
V9685273.xml
p725
sa(dp726
g3
VSTD-Thomas-1987
p727
sg5
S'PMC1246362'
p728
sg7
g716
sg9
V3109581.xml
p729
sa(dp730
g3
VSTD-Thomas-2002b
p731
sg5
S'PMC128377'
p732
sg7
g716
sg9
V12364304.xml
p733
sa(dp734
g3
VSTD-Thomas-2002a
p735
sg5
S'PMC128377'
p736
sg7
g716
sg9
V12364304.xml
p737
sa(dp738
g3
VSTD-Melchart-2005
p739
sg5
S'PMC1184247'
p740
sg7
g716
sg9
V16055451.xml
p741
sa(dp742
g3
VSTD-Foster-2007
p743
sg5
S'PMC1962890'
p744
sg7
g716
sg9
V17699546.xml
p745
sa(dp746
g3
VSTD-Conn-1986
p747
sg5
S'PMC2498376'
p748
sg7
g716
sg9
V3538985.xml
p749
sa(dp750
g3
VSTD-Carbajal-1999
p751
sg5
S'PMC28282'
p752
sg7
g716
sg9
V10574854.xml
p753
sa(dp754
g3
VSTD-Carlson-2007
p755
sg5
S'PMC1955332'
p756
sg7
VCD006858 v. 2.9 Personal assistance for children and adolescents (0-18) with intellectual impairments.rm5
p757
sg9
V17244293.xml
p758
sa(dp759
g3
VSTD-Ziboh-2004
p760
sg5
S'PMC2275406'
p761
sg7
VCD005989 v. 4.0 Herbal interventions for chronic asthma in adults and children.rm5
p762
sg9
V15154607.xml
p763
sa(dp764
g3
VSTD-Hederos-1996
p765
sg5
S'PMC1511801'
p766
sg7
g762
sg9
V9014601.xml
p767
sa(dp768
g3
VSTD-Lincoln-2002
p769
sg5
S'PMC1737698'
p770
sg7
VCD004431 v. 5.0 Psychological interventions for multiple sclerosis.rm5
p771
sg9
V11784832.xml
p772
sa(dp773
g3
VSTD-Quist_x002d_Paulsen-2003
p774
sg5
S'PMC286243'
p775
sg7
VCD006886 v. 2.0 Psychosocial interventions for smoking cessation in patients with coronary heart disease.rm5
p776
sg9
V14644967.xml
p777
sa(dp778
g3
VSTD-Carlsson-1997
p779
sg5
S'PMC484693'
p780
sg7
g776
sg9
V9093045.xml
p781
sa(dp782
g3
VSTD-Hajek-2002
p783
sg5
S'PMC64504'
p784
sg7
g776
sg9
V11786452.xml
p785
sa(dp786
g3
VSTD-Thomas-1987
p787
sg5
S'PMC1246283'
p788
sg7
VCD000155 v. 9.0 Ovulation suppression for endometriosis for women with subfertility.rm5
p789
sg9
V3107721.xml
p790
sa(dp791
g3
VSTD-Flach-2000
p792
sg5
S'PMC1298216'
p793
sg7
VCD003738 v. 6.0 Interventions for preventing posterior capsule opacification.rm5
p794
sg9
V11190013.xml
p795
sa(dp796
g3
VSTD-Hayashi-2004
p797
sg5
S'PMC1771981'
p798
sg7
g794
sg9
V14736768.xml
p799
sa(dp800
g3
VSTD-Nejima-2004
p801
sg5
S'PMC1772204'
p802
sg7
g794
sg9
V15148204.xml
p803
sa(dp804
g3
VSTD-Rabsilber-2007
p805
sg5
S'PMC1955631'
p806
sg7
g794
sg9
V17202203.xml
p807
sa(dp808
g3
VSTD-Laurell-2002
p809
sg5
S'PMC1771439'
p810
sg7
g794
sg9
V12446370.xml
p811
sa(dp812
g3
VSTD-Zemaitiene-2007
p813
sg5
S'PMC1954737'
p814
sg7
g794
sg9
V17124239.xml
p815
sa(dp816
g3
VSTD-Mullany-2006
p817
sg5
S'PMC2367116'
p818
sg7
VCD008635 v. 2.3 Umbilical cord antiseptics for preventing sepsis and death among newborns.rm5
p819
sg9
V16546539.xml
p820
sa(dp821
g3
VSTD-Arad-1981
p822
sg5
S'PMC1627396'
p823
sg7
g819
sg9
V7030227.xml
p824
sa(dp825
g3
VSTD-Duan-2000
p826
sg5
S'PMC1447636'
p827
sg7
VCD006903 v. 3.0 Peer support telephone calls for improving health.rm5
p828
sg9
V10983211.xml
p829
sa(dp830
g3
VSTD-Dennis-2002a
p831
sg5
S'PMC99222'
p832
sg7
g828
sg9
V11800243.xml
p833
sa(dp834
g3
VSTD-Mackenzie-1991
p835
sg5
S'PMC1295464'
p836
sg7
VCD002192 v. 10.0 Premedication for anxiety in adult day surgery.rm5
p837
sg9
V1744867.xml
p838
sa(dp839
g3
VSTD-Majowski-1991
p840
sg5
S'PMC2499479'
p841
sg7
VCD001888 v. 10.0 Cell salvage for minimising perioperative allogeneic blood transfusion.rm5
p842
sg9
V1759769.xml
p843
sa(dp844
g3
VSTD-Zacharopoulos-2007
p845
sg5
S'PMC2267590'
p846
sg7
g842
sg9
V16810542.xml
p847
sa(dp848
g3
VSTD-McGill-2002
p849
sg5
S'PMC113763'
p850
sg7
g842
sg9
V12039820.xml
p851
sa(dp852
g3
VSTD-Altinel-2007
p853
sg5
S'PMC2266671'
p854
sg7
g842
sg9
V17115155.xml
p855
sa(dp856
g3
VSTD-Abuzakuk-2007
p857
sg5
S'PMC2267563'
p858
sg7
g842
sg9
V16761149.xml
p859
sa(dp860
g3
VSTD-Peters-1999
p861
sg5
S'PMC1727665'
p862
sg7
VCD004060 v. 8.0 Treatment for Barrett's oesophagus.rm5
p863
sg9
V10486353.xml
p864
sa(dp865
g3
VSTD-Hage-2004
p866
sg5
S'PMC1774080'
p867
sg7
g863
sg9
V15138203.xml
p868
sa(dp869
g3
VSTD-Ackroyd-2000
p870
sg5
S'PMC1728096'
p871
sg7
g863
sg9
V11034574.xml
p872
sa(dp873
g3
VSTD-Heath-2007
p874
sg5
S'PMC3755596'
p875
sg7
g863
sg9
V17405999.xml
p876
sa(dp877
g3
VSTD-Sharma-2006
p878
sg5
S'PMC1860010'
p879
sg7
g863
sg9
V16905695.xml
p880
sa(dp881
g3
VSTD-Parrilla-2003
p882
sg5
S'PMC1514316'
p883
sg7
g863
sg9
V12616111.xml
p884
sa(dp885
g3
VSTD-Thorne-2008
p886
sg5
S'PMC2671217'
p887
sg7
VCD006605 v. 5.0 Long-term opioid management for chronic noncancer pain.rm5
p888
sg9
V18443671.xml
p889
sa(dp890
g3
VSTD-Barlow-2007
p891
sg5
S'PMC2111288'
p892
sg7
VCD003543 v. 10.0 Interventions to improve antibiotic prescribing practices for hospital inpatients.rm5
p893
sg9
V16928714.xml
p894
sa(dp895
g3
VSTD-Doern-1994
p896
sg5
S'PMC263786'
p897
sg7
g893
sg9
V7929770.xml
p898
sa(dp899
g3
VSTD-Fridkin-2002
p900
sg5
S'PMC3369588'
p901
sg7
g893
sg9
V12095438.xml
p902
sa(dp903
g3
VSTD-Trenholme-1989
p904
sg5
S'PMC267554'
p905
sg7
g893
sg9
V2473995.xml
p906
sa(dp907
g3
VSTD-Salama-1996
p908
sg5
S'PMC3327382'
p909
sg7
g893
sg9
V22514426.xml
p910
sa(dp911
g3
VSTD-Wyatt-1998
p912
sg5
S'PMC28686'
p913
sg7
g893
sg9
V9774287.xml
p914
sa(dp915
g3
VSTD-Kumana-2001
p916
sg5
S'PMC2014574'
p917
sg7
g893
sg9
V11678786.xml
p918
sa(dp919
g3
VSTD-Shojania-1998
p920
sg5
S'PMC61335'
p921
sg7
g893
sg9
V9824802.xml
p922
sa(dp923
g3
VSTD-D_x0027_Souza-1991
p924
sg5
S'PMC1792889'
p925
sg7
VCD004848 v. 16.0 Common antiepileptic drugs in pregnancy in women with epilepsy.rm5
p926
sg9
V2025009.xml
p927
sa(dp928
g3
VSTD-Ornoy-1996
p929
sg5
S'PMC1511819'
p930
sg7
g926
sg9
V9014606.xml
p931
sa(dp932
g3
VSTD-Luabeya-2007
p933
sg5
S'PMC1891438'
p934
sg7
VCD003650 v. 8.0 Micronutrient supplementation in children and adults with HIV infection.rm5
p935
sg9
V17593956.xml
p936
sa(dp937
g3
VSTD-Arpadi-2009
p938
sg5
S'PMC3110671'
p939
sg7
g935
sg9
V19117833.xml
p940
sa(dp941
g3
VSTD-Kupka-2008
p942
sg5
S'PMC2474659'
p943
sg7
g935
sg9
V18541571.xml
p944
sa(dp945
g3
VSTD-Coutsoudis-1995
p946
sg5
S'PMC1615817'
p947
sg7
g935
sg9
V7625499.xml
p948
sa(dp949
g3
VSTD-Villamor-2008
p950
sg5
S'PMC2564793'
p951
sg7
g935
sg9
V18471061.xml
p952
sa(dp953
g3
VSTD-Del-Romero-2010
p954
sg5
S'PMC2871073'
p955
sg7
VCD009153 v. 5.0 Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.rm5
p956
sg9
V20472675.xml
p957
sa(dp958
g3
VSTD-Donnell-2010
p959
sg5
S'PMC2922041'
p960
sg7
g956
sg9
V20537376.xml
p961
sa(dp962
g3
VSTD-Reynolds-2011
p963
sg5
S'PMC3261071'
p964
sg7
g956
sg9
V21160416.xml
p965
sa(dp966
g3
VSTD-Chrystyn-1988
p967
sg5
S'PMC1835250'
p968
sg7
VCD003902 v. 5.0 Oral theophylline for chronic obstructive pulmonary disease.rm5
p969
sg9
V3147048.xml
p970
sa(dp971
g3
VSTD-Fink-1994
p972
sg5
S'PMC475365'
p973
sg7
g969
sg9
V8202902.xml
p974
sa(dp975
g3
VSTD-Aarsland-2002a
p976
sg5
S'PMC1737925'
p977
sg7
VCD006504 v. 4.0 Cholinesterase inhibitors for dementia with Lewy bodies Parkinson's disease dementia and cognitive .rm5
p978
sg9
V12023410.xml
p979
sa(dp980
g3
VSTD-Ravina-2005
p981
sg5
S'PMC1739697'
p982
sg7
g978
sg9
V15965198.xml
p983
sa(dp984
g3
VSTD-Morris-1977
p985
sg5
S'PMC1605162'
p986
sg7
VCD000305 v. 8.0 Heparin low molecular weight heparin and physical methods for preventing deep vein thrombosis and p.rm5
p987
sg9
V843794.xml
p988
sa(dp989
g3
VSTD-Eskander-1997
p990
sg5
S'PMC3617695'
p991
sg7
g987
sg9
V9349964.xml
p992
sa(dp993
g3
VSTD-Walson-2008
p994
sg5
S'PMC2637615'
p995
sg7
VCD006419 v. 4.0 Deworming helminth co-infected individuals for delaying HIV disease progression.rm5
p996
sg9
V18670219.xml
p997
sa(dp998
g3
VSTD-Johnston-2000
p999
sg5
S'PMC1730673'
p1000
sg7
VCD004334 v. 5.0 Interventions for promoting booster seat use in four to eight year olds travelling in motor vehicles.rm5
p1001
sg9
V11144634.xml
p1002
sa(dp1003
g3
VSTD-Kark-1982a
p1004
sg5
S'PMC1052206'
p1005
sg7
VCD004181 v. 6.0 Immunoglobulins for preventing hepatitis A.rm5
p1006
sg9
V6754845.xml
p1007
sa(dp1008
g3
VSTD-Hely-1994
p1009
sg5
S'PMC1073071'
p1010
sg7
VCD002258 v. 4.0 Bromocriptine versus levodopa in early Parkinson's disease.rm5
p1011
sg9
V8057111.xml
p1012
sa(dp1013
g3
VSTD-Cohen-2004
p1014
sg5
S'PMC1755108'
p1015
sg7
VCD005121 v. 3.0 Anakinra for rheumatoid arthritis.rm5
p1016
sg9
V15082469.xml
p1017
sa(dp1018
g3
VSTD-Brugha-1996
p1019
sg5
S'PMC2486871'
p1020
sg7
VCD008145 v. 2.2 Interventions for improving coverage of child immunization in low- and middle-income countries.rm5
p1021
sg9
V9002332.xml
p1022
sa(dp1023
g3
VSTD-Dey-1999
p1024
sg5
S'PMC1313349'
p1025
sg7
VCD004305 v. 8.4 Healthcare financing systems for increasing the use of tobacco dependence treatment.rm5
p1026
sg9
V10326267.xml
p1027
sa(dp1028
g3
VSTD-Schauffler-2001
p1029
sg5
S'PMC1747566'
p1030
sg7
g1026
sg9
V11387540.xml
p1031
sa(dp1032
g3
VSTD-Joyce-2008
p1033
sg5
S'PMC2614005'
p1034
sg7
g1026
sg9
V18783459.xml
p1035
sa(dp1036
g3
VSTD-Twardella-2007
p1037
sg5
S'PMC2598437'
p1038
sg7
g1026
sg9
V17297068.xml
p1039
sa(dp1040
g3
VSTD-Tan-1994
p1041
sg5
S'PMC1364731'
p1042
sg7
VCD000561 v. 13.0 Antidepressants versus placebo for the depressed elderly.rm5
p1043
sg9
V8018452.xml
p1044
sa(dp1045
g3
VSTD-Maryland
p1046
sg5
S'PMC1508998'
p1047
sg7
VCD004168 v. 3.0 Alcohol ignition interlock programmes for reducing drink driving recidivism.rm5
p1048
sg9
V10553391.xml
p1049
sa(dp1050
g3
VSTD-Tonwe_x002d_Gold-2007
p1051
sg5
S'PMC1949842'
p1052
sg7
VCD008440 v. 2.0 Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.rm5
p1053
sg9
V17713983.xml
p1054
sa(dp1055
g3
VSTD-Lehman-2008
p1056
sg5
S'PMC2765916'
p1057
sg7
g1053
sg9
V18614871.xml
p1058
sa(dp1059
g3
VSTD-Bae-2008
p1060
sg5
S'PMC2664540'
p1061
sg7
g1053
sg9
V18670224.xml
p1062
sa(dp1063
g3
VSTD-Tsifetaki-2003
p1064
sg5
S'PMC1754388'
p1065
sg7
VCD006775 v. 5.2 Punctal occlusion for dry eye syndrome.rm5
p1066
sg9
V14644860.xml
p1067
sa(dp1068
g3
VSTD-Conde-2009
p1069
sg5
S'PMC2866651'
p1070
sg7
VCD004795 v. 6.0 Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).rm5
p1071
sg9
V19345831.xml
p1072
sa(dp1073
g3
VSTD-Bhasin-2000_x0028_i_x0029__x002d_no-e
p1074
sg5
S'PMC3173037'
p1075
sg7
VCD005483 v. 3.0 Anabolic steroids for the treatment of weight loss in HIV-infected individuals.rm5
p1076
sg9
V10683055.xml
p1077
sa(dp1078
g3
VSTD-Weinstein-2006
p1079
sg5
S'PMC2562254'
p1080
sg7
VCD001350 v. 9.4 Surgical interventions for lumbar disc prolapse.rm5
p1081
sg9
V17119141.xml
p1082
sa(dp1083
g3
VSTD-Krugluger-2000
p1084
sg5
S'PMC3619876'
p1085
sg7
g1081
sg9
V10990391.xml
p1086
sa(dp1087
g3
VSTD-Domenge-2000
p1088
sg5
S'PMC2363468'
p1089
sg7
VCD006386 v. 4.0 Interventions for the treatment of oral cavity and oropharyngeal cancer chemotherapy.rm5
p1090
sg9
V11189100.xml
p1091
sa(dp1092
g3
VSTD-Chauhan-2008
p1093
sg5
S'PMC2583266'
p1094
sg7
g1090
sg9
V19357741.xml
p1095
sa(dp1096
g3
VSTD-UKHAN-2010
p1097
sg5
S'PMC2806549'
p1098
sg7
g1090
sg9
V19875337.xml
p1099
sa(dp1100
g3
VSTD-Coyle-2001
p1101
sg5
S'PMC1913682'
p1102
sg7
VCD007006 v. 2.1 Abstinence-plus programs for HIV infection prevention in high-income countries.rm5
p1103
sg9
V11889277.xml
p1104
sa(dp1105
g3
VSTD-Coyle-2004
p1106
sg5
S'PMC1448347'
p1107
sg7
g1103
sg9
V15117710.xml
p1108
sa(dp1109
g3
VSTD-Villarruel-2006
p1110
sg5
S'PMC3034476'
p1111
sg7
g1103
sg9
V16894074.xml
p1112
sa(dp1113
g3
VSTD-Harvey_x002d_Berino-2010
p1114
sg5
S'PMC3101104'
p1115
sg7
VCD007675 v. 2.0 Interactive computer-based interventions for weight loss or weight maintenance in overweight or obes.rm5
p1116
sg9
V20478333.xml
p1117
sa(dp1118
g3
VSTD-Bennett-2010
p1119
sg5
S'PMC3710670'
p1120
sg7
g1116
sg9
V19696764.xml
p1121
sa(dp1122
g3
VSTD-Wilkinson-1995
p1123
sg5
S'PMC1239372'
p1124
sg7
VCD007612 v. 2.0 Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica.rm5
p1125
sg9
V7546872.xml
p1126
sa(dp1127
g3
VSTD-Gilbert-1985
p1128
sg5
S'PMC1417150'
p1129
sg7
g1125
sg9
V2931153.xml
p1130
sa(dp1131
g3
VSTD-Lenssen-2008
p1132
sg5
S'PMC2386789'
p1133
sg7
VCD008207 v. 2.0 Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty.rm5
p1134
sg9
V18442423.xml
p1135
sa(dp1136
g3
VSTD-Johnson-1992
p1137
sg5
S'PMC2497687'
p1138
sg7
g1134
sg9
V1471839.xml
p1139
sa(dp1140
g3
VSTD-UK-Trial-1991
p1141
sg5
S'PMC1590363'
p1142
sg7
VCD001402 v. 10.0 Newborn screening for cystic fibrosis.rm5
p1143
sg9
V1996888.xml
p1144
sa(dp1145
g3
VSTD-Luger-2008
p1146
sg5
S'PMC2790732'
p1147
sg7
VCD005028 v. 6.0 Topical treatments for chronic plaque psoriasis.rm5
p1148
sg9
V18787325.xml
p1149
sa(dp1150
g3
VSTD-Kosgei-2011
p1151
sg5
S'PMC3779789'
p1152
sg7
VCD010243 v. 3.0 Behavioral interventions for improving contraceptive use among women living with HIV.rm5
p1153
sg9
V21963940.xml
p1154
sa(dp1155
g3
VSTD-Allen-1993
p1156
sg5
S'PMC1694707'
p1157
sg7
g1153
sg9
V8484453.xml
p1158
sa(dp1159
g3
VSTD-Sorensen-1996
p1160
sg5
S'PMC1380434'
p1161
sg7
VCD003440 v. 10.6 Workplace interventions for smoking cessation.rm5
p1162
sg9
V8669517.xml
p1163
sa(dp1164
g3
VSTD-Sorensen-1998
p1165
sg5
S'PMC1508574'
p1166
sg7
g1162
sg9
V9807537.xml
p1167
sa(dp1168
g3
VSTD-Lang-2000
p1169
sg5
S'PMC1731676'
p1170
sg7
g1162
sg9
V10814655.xml
p1171
sa(dp1172
g3
VSTD-Rodriguez-2003
p1173
sg5
S'PMC1740534'
p1174
sg7
g1162
sg9
V12709522.xml
p1175
sa(dp1176
g3
VSTD-Cambien-1981
p1177
sg5
S'PMC1052130'
p1178
sg7
g1162
sg9
V7299342.xml
p1179
sa(dp1180
g3
VSTD-Gomel-1993a
p1181
sg5
S'PMC1694995'
p1182
sg7
g1162
sg9
V8362997.xml
p1183
sa(dp1184
g3
VSTD-Sutton-1987
p1185
sg5
S'PMC1647001'
p1186
sg7
g1162
sg9
V3303976.xml
p1187
sa(dp1188
g3
VSTD-Hennrikus-2002
p1189
sg5
S'PMC1447056'
p1190
sg7
g1162
sg9
V11818305.xml
p1191
sa(dp1192
g3
VSTD-Glasgow-1995
p1193
sg5
S'PMC1615302'
p1194
sg7
g1162
sg9
V7856780.xml
p1195
sa(dp1196
g3
VSTD-Malott-1984
p1197
sg5
S'PMC1307970'
p1198
sg7
g1162
sg9
V6441794.xml
p1199
sa(dp1200
g3
VSTD-Shaw-2003
p1201
sg5
S'PMC139930'
p1202
sg7
VCD005465 v. 7.10 Interventions for preventing falls in older people in care facilities and hospitals.rm5
p1203
sg9
V12521968.xml
p1204
sa(dp1205
g3
VSTD-Kerse-2008
p1206
sg5
S'PMC2565754'
p1207
sg7
g1203
sg9
V18845605.xml
p1208
sa(dp1209
g3
VSTD-Lapane-2011
p1210
sg5
S'PMC3157676'
p1211
sg7
g1203
sg9
V21649623.xml
p1212
sa(dp1213
g3
VSTD-Crotty-2004b
p1214
sg5
S'PMC415557'
p1215
sg7
g1203
sg9
V15066200.xml
p1216
sa(dp1217
g3
VSTD-Cumming-2008
p1218
sg5
S'PMC2287238'
p1219
sg7
g1203
sg9
V18332052.xml
p1220
sa(dp1221
g3
VSTD-Haines-2004
p1222
sg5
S'PMC381222'
p1223
sg7
g1203
sg9
V15031238.xml
p1224
sa(dp1225
g3
VSTD-Dykes-2010
p1226
sg5
S'PMC3107709'
p1227
sg7
g1203
sg9
V21045097.xml
p1228
sa(dp1229
g3
VSTD-Stenvall-2007
p1230
sg5
S'PMC1766476'
p1231
sg7
g1203
sg9
V17061151.xml
p1232
sa(dp1233
g3
VSTD-Li-2006
p1234
sg5
S'PMC1764949'
p1235
sg7
VCD006806 v. 4.2 Peri-operative glycaemic control regimens for preventing surgical site infections in adults.rm5
p1236
sg9
V17215967.xml
p1237
sa(dp1238
g3
VSTD-Hay-1999
p1239
sg5
S'PMC28251'
p1240
sg7
VCD003686 v. 7.0 Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults.rm5
p1241
sg9
V10514160.xml
p1242
sa(dp1243
g3
VSTD-Huang-1988
p1244
sg5
S'PMC2491139'
p1245
sg7
VCD000386 v. 9.0 Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for treating uncomplicated malari.rm5
p1246
sg9
V3048759.xml
p1247
sa(dp1248
g3
VSTD-Schapira-1988
p1249
sg5
S'PMC2491050'
p1250
sg7
g1246
sg9
V3293827.xml
p1251
sa(dp1252
g3
VSTD-Basco-2002
p1253
sg5
S'PMC2567565'
p1254
sg7
g1246
sg9
V12163917.xml
p1255
sa(dp1256
g3
VSTD-CPPRG-1999
p1257
sg5
S'PMC2762610'
p1258
sg7
VCD004606 v. 6.0 School-based secondary prevention programmes for preventing violence.rm5
p1259
sg9
V10535230.xml
p1260
sa(dp1261
g3
VSTD-White-2003
p1262
sg5
S'PMC1746635'
p1263
sg7
VCD000353 v. 9.0 Homeopathy for chronic asthma.rm5
p1264
sg9
V12668794.xml
p1265
sa(dp1266
g3
VSTD-Yamamura-1997
p1267
sg5
S'PMC163989'
p1268
sg7
VCD003038 v. 9.2 Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeni.rm5
p1269
sg9
V9257745.xml
p1270
sa(dp1271
g3
VSTD-Cornelissen-1992
p1272
sg5
S'PMC189424'
p1273
sg7
g1269
sg9
V1503442.xml
p1274
sa(dp1275
g3
VSTD-Gribble-1983
p1276
sg5
S'PMC185330'
p1277
sg7
g1269
sg9
V6357076.xml
p1278
sa(dp1279
g3
VSTD-Piccart-1984
p1280
sg5
S'PMC180041'
p1281
sg7
g1269
sg9
V6524903.xml
p1282
sa(dp1283
g3
VSTD-Cometta-1996
p1284
sg5
S'PMC163274'
p1285
sg7
g1269
sg9
V8723449.xml
p1286
sa(dp1287
g3
VSTD-Sinclair-1998
p1288
sg5
S'PMC1763872'
p1289
sg7
VCD003698 v. 6.2 Community pharmacy personnel interventions for smoking cessation.rm5
p1290
sg9
V9825420.xml
p1291
sa(dp1292
g3
VSTD-DIAS_x002d_2
p1293
sg5
S'PMC2730486'
p1294
sg7
VCD000514 v. 6.0 Thrombolysis (different doses routes of administration and agents) for acute ischaemic stroke.rm5
p1295
sg9
V19097942.xml
p1296
sa(dp1297
g3
VSTD-TNK_x002d_S2B
p1298
sg5
S'PMC2860601'
p1299
sg7
g1295
sg9
V20185783.xml
p1300
sa(dp1301
g3
VSTD-Stiell-2008
p1302
sg5
S'PMC2292763'
p1303
sg7
VCD003109 v. 6.0 Advanced trauma life support training for ambulance crews.rm5
p1304
sg9
V18427089.xml
p1305
sa(dp1306
g3
VSTD-Ernst-1997
p1307
sg5
S'PMC1304430'
p1308
sg7
VCD005364 v. 9.0 Topical anaesthetics for repair of dermal laceration.rm5
p1309
sg9
V9291744.xml
p1310
sa(dp1311
g3
VSTD-Kendall-1996
p1312
sg5
S'PMC1342653'
p1313
sg7
g1309
sg9
V8653235.xml
p1314
sa(dp1315
g3
VSTD-Johnson-2005
p1316
sg5
S'PMC1215550'
p1317
sg7
VCD001087 v. 13.4 Crisis intervention for people with severe mental illnesses.rm5
p1318
sg9
V16103032.xml
p1319
sa(dp1320
g3
VSTD-Ebenbichler-1998
p1321
sg5
S'PMC28476'
p1322
sg7
VCD009601 v. 2.0 Therapeutic ultrasound for carpal tunnel syndrome.rm5
p1323
sg9
V9529407.xml
p1324
sa(dp1325
g3
VSTD-Hobbs-2005
p1326
sg5
S'PMC1952508'
p1327
sg7
VCD009586 v. 2.0 Effectiveness of systematic screening for the detection of atrial fibrillation.rm5
p1328
sg9
V17673732.xml
p1329
sa(dp1330
g3
VSTD-Hermiz-2002
p1331
sg5
S'PMC130059'
p1332
sg7
VCD000994 v. 9.4 Home care by outreach nursing for chronic obstructive pulmonary disease.rm5
p1333
sg9
V12399344.xml
p1334
sa(dp1335
g3
VSTD-Littlejohns-1991
p1336
sg5
S'PMC463273'
p1337
sg7
g1333
sg9
V1926024.xml
p1338
sa(dp1339
g3
VSTD-Scanlon-1992
p1340
sg5
S'PMC1590510'
p1341
sg7
VCD000273 v. 8.0 Caffeine versus theophylline for apnea in preterm infants.rm5
p1342
sg9
V1586184.xml
p1343
sa(dp1344
g3
VSTD-Morrell-1986
p1345
sg5
S'PMC1339978'
p1346
sg7
VCD003540 v. 5.0 Effects of interventions aimed at changing the length of primary care physicians' consultation.rm5
p1347
sg9
V3083919.xml
p1348
sa(dp1349
g3
VSTD-Ridsdale-1989
p1350
sg5
S'PMC1712205'
p1351
sg7
g1347
sg9
V2558202.xml
p1352
sa(dp1353
g3
VSTD-Wilson-1992
p1354
sg5
S'PMC1881485'
p1355
sg7
g1347
sg9
V1739798.xml
p1356
sa(dp1357
g3
VSTD-Sandborn-2007b
p1358
sg5
S'PMC2701613'
p1359
sg7
VCD006893 v. 3.2 Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.rm5
p1360
sg9
V17299059.xml
p1361
sa(dp1362
g3
VSTD-Sandborn-2004
p1363
sg5
S'PMC1774244'
p1364
sg7
g1360
sg9
V15361500.xml
p1365
sa(dp1366
g3
VSTD-Konrad-1992
p1367
sg5
S'PMC1004758'
p1368
sg7
VCD003010 v. 8.0 Traction for low-back pain with or without sciatica.rm5
p1369
sg9
V1535495.xml
p1370
sa(dp1371
g3
VSTD-Gilson-1993
p1372
sg5
S'PMC1022221'
p1373
sg7
VCD006971 v. 2.0 Intracervical prostaglandins for induction of labour.rm5
p1374
sg9
V8212680.xml
p1375
sa(dp1376
g3
VSTD-WISDOM-2007
p1377
sg5
S'PMC1939792'
p1378
sg7
VCD004143 v. 6.0 Long term hormone therapy for perimenopausal and postmenopausal women.rm5
p1379
sg9
V17626056.xml
p1380
sa(dp1381
g3
VSTD-EPHT-2006
p1382
sg5
S'PMC2330032'
p1383
sg7
g1379
sg9
V18366766.xml
p1384
sa(dp1385
g3
VSTD-O_x0027_Neill-1996
p1386
sg5
S'PMC1060285'
p1387
sg7
VCD009849 v. 2.3 Steroidal contraceptives and bone fractures in women evidence from observational studies.rm5
p1388
sg9
V8935460.xml
p1389
sa(dp1390
g3
VSTD-Arkinstall-1989
p1391
sg5
S'PMC1268755'
p1392
sg7
VCD003868 v. 11.0 Oral morphine for cancer pain.rm5
p1393
sg9
V2645988.xml
p1394
sa(dp1395
g3
VSTD-Lauretti-2003
p1396
sg5
S'PMC2376845'
p1397
sg7
g1393
sg9
V14647133.xml
p1398
sa(dp1399
g3
VSTD-Melzack-1979
p1400
sg5
S'PMC1818901'
p1401
sg7
g1393
sg9
V376079.xml
p1402
sa(dp1403
g3
VSTD-Cant-1986
p1404
sg5
S'PMC1341170'
p1405
sg7
VCD000133 v. 7.0 Maternal dietary antigen avoidance during pregnancy or lactation or both for preventing or treatin.rm5
p1406
sg9
V3089466.xml
p1407
sa(dp1408
g3
VSTD-Smith-1998
p1409
sg5
S'PMC1717450'
p1410
sg7
VCD001507 v. 12.0 Tyrosine supplementation for phenylketonuria.rm5
p1411
sg9
V9579151.xml
p1412
sa(dp1413
g3
VSTD-Dahl_x002d_Jorgensen-1986
p1414
sg5
S'PMC1341978'
p1415
sg7
VCD007543 v. 2.2 Enhanced glucose control for preventing and treating diabetic neuropathy.rm5
p1416
sg9
V3096429.xml
p1417
sa(dp1418
g3
VSTD-Campos-2007
p1419
sg5
S'PMC3476141'
p1420
sg7
VCD000255 v. 8.0 Antithrombotic drugs for carotid artery dissection.rm5
p1421
sg9
V17563840.xml
p1422
sa(dp1423
g3
VSTD-Eljamel-1990
p1424
sg5
S'PMC488052'
p1425
sg7
g1421
sg9
V2351965.xml
p1426
sa(dp1427
g3
VSTD-Dougados-1988_x0028_4.6mg_x002f_kg_x002f_d_x0029_
p1428
sg5
S'PMC1003464'
p1429
sg7
VCD007893 v. 2.0 Effect of cyclosporine on blood pressure.rm5
p1430
sg9
V3281603.xml
p1431
sa(dp1432
g3
VSTD-Swan-2010
p1433
sg5
S'PMC2879135'
p1434
sg7
VCD006103 v. 12.0 Nicotine receptor partial agonists for smoking cessation.rm5
p1435
sg9
V20409497.xml
p1436
sa(dp1437
g3
VSTD-Rennard-2011
p1438
sg5
S'PMC3281242'
p1439
sg7
g1435
sg9
V22080588.xml
p1440
sa(dp1441
g3
VSTD-van-der-Schans-1991
p1442
sg5
S'PMC463090'
p1443
sg7
VCD001401 v. 10.0 Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.rm5
p1444
sg9
V2038733.xml
p1445
sa(dp1446
g3
VSTD-Avasthi-2001
p1447
sg5
S'PMC2956152'
p1448
sg7
VCD001359 v. 12.0 Olanzapine for schizophrenia.rm5
p1449
sg9
V21407865.xml
p1450
sa(dp1451
g3
VSTD-Williams-1985
p1452
sg5
S'PMC1040623'
p1453
sg7
VCD001861 v. 7.5 Interventions for recurrent corneal erosions.rm5
p1454
sg9
V3873960.xml
p1455
sa(dp1456
g3
VSTD-CITT-2005a
p1457
sg5
S'PMC1772876'
p1458
sg7
VCD006768 v. 4.0 Non-surgical interventions for convergence insufficiency.rm5
p1459
sg9
V16170124.xml
p1460
sa(dp1461
g3
VSTD-CITT-2008
p1462
sg5
S'PMC2779032'
p1463
sg7
g1459
sg9
V18852411.xml
p1464
sa(dp1465
g3
VSTD-Becker-2010
p1466
sg5
S'PMC2888216'
p1467
sg7
VCD008653 v. 2.0 Febuxostat for treating chronic gout.rm5
p1468
sg9
V20370912.xml
p1469
sa(dp1470
g3
VSTD-UK-Trial-1997
p1471
sg5
S'PMC1717269'
p1472
sg7
VCD001915 v. 11.2 Inhaled corticosteroids for cystic fibrosis.rm5
p1473
sg9
V9301350.xml
p1474
sa(dp1475
g3
VSTD-Seymour-1996
p1476
sg5
S'PMC2042618'
p1477
sg7
VCD004487 v. 6.0 Paracetamol for pain relief after surgical removal of lower wisdom teeth.rm5
p1478
sg9
V8799525.xml
p1479
sa(dp1480
g3
VSTD-Roberts-2006
p1481
sg5
S'PMC1828217'
p1482
sg7
VCD005110 v. 4.0 Hypnotherapy for treatment of irritable bowel syndrome.rm5
p1483
sg9
V16464325.xml
p1484
sa(dp1485
g3
VSTD-Sugaya-2010
p1486
sg5
S'PMC2876358'
p1487
sg7
VCD002744 v. 10.0 Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).rm5
p1488
sg9
V20368393.xml
p1489
sa(dp1490
g3
VSTD-Barer-1988-propanolol
p1491
sg5
S'PMC2545364'
p1492
sg7
VCD002839 v. 6.0 Vasoactive drugs for acute stroke.rm5
p1493
sg9
V3126956.xml
p1494
sa(dp1495
g3
VSTD-Barer-1988_x002f_50-mg
p1496
sg5
S'PMC2545364'
p1497
sg7
g1493
sg9
V3126956.xml
p1498
sa(dp1499
g3
VSTD-Barer-1988_x002f_80-mg
p1500
sg5
S'PMC2545364'
p1501
sg7
g1493
sg9
V3126956.xml
p1502
sa(dp1503
g3
VSTD-Barer-1988-atenolol
p1504
sg5
S'PMC2545364'
p1505
sg7
g1493
sg9
V3126956.xml
p1506
sa(dp1507
g3
VSTD-Carbajal-2003
p1508
sg5
S'PMC139493'
p1509
sg7
VCD006275 v. 11.0 Non-pharmacological management of infant and young child procedural pain.rm5
p1510
sg9
V12511452.xml
p1511
sa(dp1512
g3
VSTD-Kostandy-2008
p1513
sg5
S'PMC2647362'
p1514
sg7
g1510
sg9
V18513662.xml
p1515
sa(dp1516
g3
VSTD-Curtis-2007
p1517
sg5
S'PMC1950500'
p1518
sg7
g1510
sg9
V17640375.xml
p1519
sa(dp1520
g3
VSTD-Carbajal-1999
p1521
sg5
S'PMC28282'
p1522
sg7
g1510
sg9
V10574854.xml
p1523
sa(dp1524
g3
VSTD-Elserafy-2009
p1525
sg5
S'PMC2813645'
p1526
sg7
g1510
sg9
V19448377.xml
p1527
sa(dp1528
g3
VSTD-Whitelaw-1988
p1529
sg5
S'PMC1779160'
p1530
sg7
VCD002771 v. 6.0 Kangaroo mother care to reduce morbidity and mortality in low birthweight infants.rm5
p1531
sg9
V3060024.xml
p1532
sa(dp1533
g3
VSTD-Neu-2010
p1534
sg5
S'PMC2935695'
p1535
sg7
g1531
sg9
V20629927.xml
p1536
sa(dp1537
g3
VSTD-Spooner-1993
p1538
sg5
S'PMC2379872'
p1539
sg7
VCD003219 v. 9.0 Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome.rm5
p1540
sg9
V8219859.xml
p1541
sa(dp1542
g3
VSTD-Ebenbichler-1998
p1543
sg5
S'PMC28476'
p1544
sg7
g1540
sg9
V9529407.xml
p1545
sa(dp1546
g3
VSTD-Hui-2001
p1547
sg5
S'PMC1753810'
p1548
sg7
g1540
sg9
V11482310.xml
p1549
sa(dp1550
g3
VSTD-Jones-1994
p1551
sg5
S'PMC475231'
p1552
sg7
VCD001385 v. 8.0 Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contai.rm5
p1553
sg9
V7974313.xml
p1554
sa(dp1555
g3
VSTD-Taylor-1998
p1556
sg5
S'PMC1745306'
p1557
sg7
g1553
sg9
V10319056.xml
p1558
sa(dp1559
g3
VSTD-Newnham-1995
p1560
sg5
S'PMC1021218'
p1561
sg7
g1553
sg9
V7597661.xml
p1562
sa(dp1563
g3
VSTD-Booth-1993
p1564
sg5
S'PMC464894'
p1565
sg7
g1553
sg9
V8296255.xml
p1566
sa(dp1567
g3
VSTD-Berry-1974
p1568
sg5
S'PMC1006318'
p1569
sg7
VCD000189 v. 12.0 Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid.rm5
p1570
sg9
V4613287.xml
p1571
sa(dp1572
g3
VSTD-Kirwan-2004
p1573
sg5
S'PMC1755023'
p1574
sg7
g1570
sg9
V15140776.xml
p1575
sa(dp1576
g3
VSTD-Jasani-1968
p1577
sg5
S'PMC1031152'
p1578
sg7
g1570
sg9
V4283768.xml
p1579
sa(dp1580
g3
VSTD-Boardman-1967
p1581
sg5
S'PMC1748911'
p1582
sg7
g1570
sg9
V4861386.xml
p1583
sa(dp1584
g3
VSTD-Carmichael-1990
p1585
sg5
S'PMC1042200'
p1586
sg7
VCD005430 v. 4.0 Topical corticosteroids as adjunctive therapy for bacterial keratitis.rm5
p1587
sg9
V2203467.xml
p1588
sa(dp1589
g3
VSTD-London-1999
p1590
sg5
S'PMC2127677'
p1591
sg7
VCD000443 v. 7.0 Services for reducing duration of hospital care for acute stroke patients.rm5
p1592
sg9
V9366727.xml
p1593
sa(dp1594
g3
VSTD-Griffiths-2005
p1595
sg5
S'PMC1570787'
p1596
sg7
VCD005108 v. 4.0 Self-management education programmes by lay leaders for people with chronic conditions.rm5
p1597
sg9
V16281998.xml
p1598
sa(dp1599
g3
VSTD-Fu-2003
p1600
sg5
S'PMC2572423'
p1601
sg7
g1597
sg9
V12764513.xml
p1602
sa(dp1603
g3
VSTD-Buszewicz-2006
p1604
sg5
S'PMC1626290'
p1605
sg7
g1597
sg9
V17040926.xml
p1606
sa(dp1607
g3
VSTD-Kennedy-2007
p1608
sg5
S'PMC2652924'
p1609
sg7
g1597
sg9
V17325405.xml
p1610
sa(dp1611
g3
VSTD-Nieuwboer-2007
p1612
sg5
S'PMC2077658'
p1613
sg7
VCD002817 v. 10.2 Physiotherapy versus placebo or no intervention in Parkinson's disease.rm5
p1614
sg9
V17229744.xml
p1615
sa(dp1616
g3
VSTD-Hackney-2009
p1617
sg5
S'PMC2783812'
p1618
sg7
g1614
sg9
V19329350.xml
p1619
sa(dp1620
g3
VSTD-Ashburn-2007
p1621
sg5
S'PMC2117667'
p1622
sg7
g1614
sg9
V17119004.xml
p1623
sa(dp1624
g3
VSTD-Fisher-2008
p1625
sg5
S'PMC2989816'
p1626
sg7
g1614
sg9
V18534554.xml
p1627
sa(dp1628
g3
VSTD-Hingson-1996
p1629
sg5
S'PMC1380396'
p1630
sg7
VCD005242 v. 4.4 Increased police patrols for preventing alcohol-impaired driving.rm5
p1631
sg9
V8659651.xml
p1632
sa(dp1633
g3
VSTD-Black-2002
p1634
sg5
S'PMC1743616'
p1635
sg7
VCD009401 v. 3.3 Interventions to improve the use of systematic reviews in decision-making by health system managers.rm5
p1636
sg9
V12448802.xml
p1637
sa(dp1638
g3
VSTD-Dobbins-2009
p1639
sg5
S'PMC2936828'
p1640
sg7
g1636
sg9
V19775439.xml
p1641
sa(dp1642
g3
VSTD-Mason-2001
p1643
sg5
S'PMC59683'
p1644
sg7
g1636
sg9
V11701573.xml
p1645
sa(dp1646
g3
VSTD-Wyatt-1998
p1647
sg5
S'PMC28686'
p1648
sg7
g1636
sg9
V9774287.xml
p1649
sa(dp1650
g3
VSTD-Jones-2001
p1651
sg5
S'PMC1721311'
p1652
sg7
VCD006170 v. 4.2 Methods of milk expression for lactating women.rm5
p1653
sg9
V11517200.xml
p1654
sa(dp1655
g3
VSTD-Moorcroft-2004
p1656
sg5
S'PMC1746905'
p1657
sg7
VCD002768 v. 11.0 Physical training for cystic fibrosis.rm5
p1658
sg9
V15563708.xml
p1659
sa(dp1660
g3
VSTD-Tchivileva-et-al-2010
p1661
sg5
S'PMC2876724'
p1662
sg7
VCD004715 v. 6.0 Pharmacological interventions for pain in patients with temporomandibular disorders.rm5
p1663
sg9
V20216107.xml
p1664
sa(dp1665
g3
VSTD-Vaezi-1999
p1666
sg5
S'PMC1727388'
p1667
sg7
VCD005046 v. 9.0 Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasi.rm5
p1668
sg9
V9895383.xml
p1669
sa(dp1670
g3
VSTD-Sinclair-1979
p1671
sg5
S'PMC1597640'
p1672
sg7
VCD003566 v. 5.0 Cardioselective beta-blockers for chronic obstructive pulmonary disease.rm5
p1673
sg9
V369647.xml
p1674
sa(dp1675
g3
VSTD-Lammers-1985a
p1676
sg5
S'PMC1400701'
p1677
sg7
g1673
sg9
V4041341.xml
p1678
sa(dp1679
g3
VSTD-Perks-1978
p1680
sg5
S'PMC1429247'
p1681
sg7
g1673
sg9
V339932.xml
p1682
sa(dp1683
g3
VSTD-Macquin_x002d_Mavier-1988
p1684
sg5
S'PMC1386540'
p1685
sg7
g1673
sg9
V2902873.xml
p1686
sa(dp1687
g3
VSTD-Prabhu-2010
p1688
sg5
S'PMC2827594'
p1689
sg7
VCD005279 v. 5.0 Ultrasound use for the placement of haemodialysis catheters.rm5
p1690
sg9
V19965532.xml
p1691
sa(dp1692
g3
VSTD-Marteau-1998
p1693
sg5
S'PMC1727004'
p1694
sg7
VCD004118 v. 4.0 Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p1695
sg9
V9536943.xml
p1696
sa(dp1697
g3
VSTD-Deluze-1992
p1698
sg5
S'PMC1883744'
p1699
sg7
VCD007070 v. 3.5 Acupuncture for treating fibromyalgia.rm5
p1700
sg9
V1477566.xml
p1701
sa(dp1702
g3
VSTD-Harris-2009
p1703
sg5
S'PMC2757074'
p1704
sg7
g1700
sg9
V19501658.xml
p1705
sa(dp1706
g3
VSTD-Bauman-2001
p1707
sg5
S'PMC1446646'
p1708
sg7
VCD004493 v. 8.2 Family-based programmes for preventing smoking by children and adolescents.rm5
p1709
sg9
V11291373.xml
p1710
sa(dp1711
g3
VSTD-Schinke-2004
p1712
sg5
S'PMC2795165'
p1713
sg7
g1709
sg9
V15376818.xml
p1714
sa(dp1715
g3
VSTD-Nutbeam-1993
p1716
sg5
S'PMC1676653'
p1717
sg7
g1709
sg9
V8435601.xml
p1718
sa(dp1719
g3
VSTD-Jackson-2006
p1720
sg5
S'PMC1759106'
p1721
sg7
g1709
sg9
V12612363.xml
p1722
sa(dp1723
g3
VSTD-Trenkwalder-2004b
p1724
sg5
S'PMC1757460'
p1725
sg7
VCD006009 v. 4.0 Dopamine agonists for the treatment of restless legs syndrome.rm5
p1726
sg9
V14707315.xml
p1727
sa(dp1728
g3
VSTD-Zhang-2011
p1729
sg5
S'PMC3193968'
p1730
sg7
VCD000434 v. 11.2 Interventions for treating proximal humeral fractures in adults.rm5
p1731
sg9
V21387176.xml
p1732
sa(dp1733
g3
VSTD-Scott-1983
p1734
sg5
S'PMC1027296'
p1735
sg7
VCD002814 v. 9.26 Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.rm5
p1736
sg9
V6842217.xml
p1737
sa(dp1738
g3
VSTD-Lieberman-1992
p1739
sg5
S'PMC463751'
p1740
sg7
VCD000436 v. 7.0 Dietary sodium manipulation and asthma.rm5
p1741
sg9
V1609379.xml
p1742
sa(dp1743
g3
VSTD-Burney-1989
p1744
sg5
S'PMC461661'
p1745
sg7
g1741
sg9
V2928987.xml
p1746
sa(dp1747
g3
VSTD-Carey-1993
p1748
sg5
S'PMC464652'
p1749
sg7
g1741
sg9
V8153919.xml
p1750
sa(dp1751
g3
VSTD-Brusasco-2003
p1752
sg5
S'PMC1746668'
p1753
sg7
VCD009157 v. 4.0 Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.rm5
p1754
sg9
V12728159.xml
p1755
sa(dp1756
g3
VSTD-Rutten_x002d_van-Molken-2007
p1757
sg5
S'PMC1913175'
p1758
sg7
g1754
sg9
V17370096.xml
p1759
sa(dp1760
g3
VSTD-Vandenburg-1994
p1761
sg5
S'PMC1364758'
p1762
sg7
VCD003823 v. 7.0 Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hyper.rm5
p1763
sg9
V8198936.xml
p1764
sa(dp1765
g3
VSTD-Gomez-1989
p1766
sg5
S'PMC1379991'
p1767
sg7
g1763
sg9
V2556172.xml
p1768
sa(dp1769
g3
VSTD-Scholze-1998
p1770
sg5
S'PMC1873536'
p1771
sg7
g1763
sg9
V9643623.xml
p1772
sa(dp1773
g3
VSTD-Kayanakis-1987
p1774
sg5
S'PMC1386051'
p1775
sg7
g1763
sg9
V3555588.xml
p1776
sa(dp1777
g3
VSTD-Holland-2003
p1778
sg5
S'PMC1746478'
p1779
sg7
VCD002769 v. 11.0 Non-invasive ventilation for cystic fibrosis.rm5
p1780
sg9
V14514944.xml
p1781
sa(dp1782
g3
VSTD-Springer-1987
p1783
sg5
S'PMC1778496'
p1784
sg7
VCD003530 v. 4.0 Beclomethasone versus budesonide for chronic asthma.rm5
p1785
sg9
V3662586.xml
p1786
sa(dp1787
g3
VSTD-Field-1982
p1788
sg5
S'PMC1628026'
p1789
sg7
g1785
sg9
V6756319.xml
p1790
sa(dp1791
g3
VSTD-Ebden-1986
p1792
sg5
S'PMC460512'
p1793
sg7
g1785
sg9
V3547757.xml
p1794
sa(dp1795
g3
VSTD-Gent_x002d_AMI-1968
p1796
sg5
S'PMC1912602'
p1797
sg7
VCD001820 v. 8.0 Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.rm5
p1798
sg9
V4879059.xml
p1799
sa(dp1800
g3
VSTD-MacDonald-1989
p1801
sg5
S'PMC172499'
p1802
sg7
VCD007933 v. 2.2 Genital ulcer disease treatment for reducing sexual acquisition of HIV.rm5
p1803
sg9
V2502065.xml
p1804
sa(dp1805
g3
VSTD-Balasubramanian-2006
p1806
sg5
S'PMC1856614'
p1807
sg7
VMR000030 v. 3.0 Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised.rm5
p1808
sg9
V17060756.xml
p1809
sa(dp1810
g3
VSTD-Ethgen-2009
p1811
sg5
S'PMC2679061'
p1812
sg7
g1808
sg9
V19358717.xml
p1813
sa(dp1814
g3
VSTD-Yu-2010
p1815
sg5
S'PMC2886040'
p1816
sg7
g1808
sg9
V20482769.xml
p1817
sa(dp1818
g3
VSTD-Hopewell-2010
p1819
sg5
S'PMC2844941'
p1820
sg7
g1808
sg9
V20332510.xml
p1821
sa(dp1822
g3
VSTD-Partsinevelou-2009
p1823
sg5
S'PMC2788535'
p1824
sg7
g1808
sg9
V19930576.xml
p1825
sa(dp1826
g3
VSTD-Prady-2008
p1827
sg5
S'PMC2216683'
p1828
sg7
g1808
sg9
V18270568.xml
p1829
sa(dp1830
g3
VSTD-Hewitt-2005
p1831
sg5
S'PMC557225'
p1832
sg7
g1808
sg9
V15760970.xml
p1833
sa(dp1834
g3
VSTD-Thoma-2006
p1835
sg5
S'PMC2686052'
p1836
sg7
g1808
sg9
V19554136.xml
p1837
sa(dp1838
g3
VSTD-Han-2008
p1839
sg5
S'PMC3489160'
p1840
sg7
g1808
sg9
V19070681.xml
p1841
sa(dp1842
g3
VSTD-Montan_x00e9_-2010
p1843
sg5
S'PMC2822812'
p1844
sg7
g1808
sg9
V20067642.xml
p1845
sa(dp1846
g3
VSTD-Lipman-2005
p1847
sg5
S'PMC1316160'
p1848
sg7
VCD002020 v. 11.2 Group-based parent training programmes for improving parental psychosocial health.rm5
p1849
sg9
V16293780.xml
p1850
sa(dp1851
g3
VSTD-Patterson-2002
p1852
sg5
S'PMC1755810'
p1853
sg7
g1849
sg9
V12456542.xml
p1854
sa(dp1855
g3
VSTD-Hiscock-2008
p1856
sg5
S'PMC2234515'
p1857
sg7
g1849
sg9
V18244958.xml
p1858
sa(dp1859
g3
VSTD-Senkus_x002d_Konefka-2005
p1860
sg5
S'PMC2361948'
p1861
sg7
VCD002143 v. 12.0 Palliative radiotherapy regimens for non-small cell lung cancer.rm5
p1862
sg9
V15770205.xml
p1863
sa(dp1864
g3
VSTD-MRC-1992
p1865
sg5
S'PMC1977779'
p1866
sg7
g1862
sg9
V1377484.xml
p1867
sa(dp1868
g3
VSTD-Charlton-1990
p1869
sg5
S'PMC1664498'
p1870
sg7
VCD005306 v. 3.1 Written action plans for asthma in children.rm5
p1871
sg9
V2148702.xml
p1872
sa(dp1873
g3
VSTD-Detry-1994
p1874
sg5
S'PMC1364760'
p1875
sg7
VCD003614 v. 5.2 Trimetazidine for stable angina.rm5
p1876
sg9
V8198938.xml
p1877
sa(dp1878
g3
VSTD-Manchanda-1997
p1879
sg5
S'PMC1892273'
p1880
sg7
g1876
sg9
V9404250.xml
p1881
sa(dp1882
g3
VSTD-Frankel-2010
p1883
sg5
S'PMC2890979'
p1884
sg7
VCD008511 v. 3.0 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).rm5
p1885
sg9
V20058059.xml
p1886
sa(dp1887
g3
VSTD-Brown-2001
p1888
sg5
S'PMC2375236'
p1889
sg7
VCD003267 v. 6.2 Interventions for providers to promote a patient-centred approach in clinical consultations.rm5
p1890
sg9
V11720460.xml
p1891
sa(dp1892
g3
VSTD-Ho-2008
p1893
sg5
S'PMC3149814'
p1894
sg7
g1890
sg9
V18777429.xml
p1895
sa(dp1896
g3
VSTD-Kennedy-2004
p1897
sg5
S'PMC1774266'
p1898
sg7
g1890
sg9
V15479685.xml
p1899
sa(dp1900
g3
VSTD-Harmsen-2005
p1901
sg5
S'PMC1463156'
p1902
sg7
g1890
sg9
V15904552.xml
p1903
sa(dp1904
g3
VSTD-Longo-2006
p1905
sg5
S'PMC1821413'
p1906
sg7
g1890
sg9
V16438813.xml
p1907
sa(dp1908
g3
VSTD-Krones-2008
p1909
sg5
S'PMC2384995'
p1910
sg7
g1890
sg9
V18474884.xml
p1911
sa(dp1912
g3
VSTD-Glasgow-2004
p1913
sg5
S'PMC1492587'
p1914
sg7
g1890
sg9
V15610326.xml
p1915
sa(dp1916
g3
VSTD-McLean-2004
p1917
sg5
S'PMC1326066'
p1918
sg7
g1890
sg9
V15353051.xml
p1919
sa(dp1920
g3
VSTD-Stewart-2007
p1921
sg5
S'PMC2000315'
p1922
sg7
g1890
sg9
V17893379.xml
p1923
sa(dp1924
g3
VSTD-Hobma-2006
p1925
sg5
S'PMC1874521'
p1926
sg7
g1890
sg9
V16882375.xml
p1927
sa(dp1928
g3
VSTD-Kinmonth-1998
p1929
sg5
S'PMC28704'
p1930
sg7
g1890
sg9
V9794859.xml
p1931
sa(dp1932
g3
VSTD-Smith-2006
p1933
sg5
S'PMC1924714'
p1934
sg7
g1890
sg9
V16808764.xml
p1935
sa(dp1936
g3
VSTD-Howe-1996
p1937
sg5
S'PMC1239692'
p1938
sg7
g1890
sg9
V8776911.xml
p1939
sa(dp1940
g3
VSTD-Woodfine-2011
p1941
sg5
S'PMC3207090'
p1942
sg7
VCD007825 v. 8.0 Collaboration between local health and local government agencies for health improvement.rm5
p1943
sg9
V22054336.xml
p1944
sa(dp1945
g3
VSTD-Florence-2011
p1946
sg5
S'PMC3116927'
p1947
sg7
g1943
sg9
V21680632.xml
p1948
sa(dp1949
g3
VSTD-Hawkey-2001
p1950
sg5
S'PMC1728427'
p1951
sg7
VCD005415 v. 9.0 Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bl.rm5
p1952
sg9
V11511559.xml
p1953
sa(dp1954
g3
VSTD-Karat-1970
p1955
sg5
S'PMC1699291'
p1956
sg7
VCD006949 v. 5.0 Interventions for erythema nodosum leprosum.rm5
p1957
sg9
V4904935.xml
p1958
sa(dp1959
g3
VSTD-Iyer-1971
p1960
sg5
S'PMC2427977'
p1961
sg7
g1957
sg9
V4947831.xml
p1962
sa(dp1963
g3
VSTD-Tejedor-1998
p1964
sg5
S'PMC1722471'
p1965
sg7
VCD006499 v. 4.0 Botulinum toxin for the treatment of strabismus.rm5
p1966
sg9
V9613374.xml
p1967
sa(dp1968
g3
VSTD-Tejedor-1999
p1969
sg5
S'PMC1723128'
p1970
sg7
g1966
sg9
V10381663.xml
p1971
sa(dp1972
g3
VSTD-Leroi-2005
p1973
sg5
S'PMC1409867'
p1974
sg7
VCD004464 v. 6.0 Sacral nerve stimulation for faecal incontinence and constipation in adults.rm5
p1975
sg9
V16244539.xml
p1976
sa(dp1977
g3
VSTD-Likosky-1991
p1978
sg5
S'PMC1014677'
p1979
sg7
VCD002819 v. 6.0 Cyclophosphamide for multiple sclerosis.rm5
p1980
sg9
V1783915.xml
p1981
sa(dp1982
g3
VSTD-Padmanabhan-2007
p1983
sg5
S'PMC1964741'
p1984
sg7
VCD007705 v. 2.0 Perioperative transversus abdominis plane (TAP) blocks for analgesia after abdominal surgery.rm5
p1985
sg9
V17394704.xml
p1986
sa(dp1987
g3
VSTD-Keitz-2001
p1988
sg5
S'PMC1495270'
p1989
sg7
VCD003938 v. 6.0 Provider training and experience for people living with HIVAIDS.rm5
p1990
sg9
V11556937.xml
p1991
sa(dp1992
g3
VSTD-Landon-2003
p1993
sg5
S'PMC1494839'
p1994
sg7
g1990
sg9
V12709089.xml
p1995
sa(dp1996
g3
VSTD-Shaw-1993
p1997
sg5
S'PMC1029588'
p1998
sg7
VCD002773 v. 4.0 Neuromuscular paralysis for newborn infants receiving mechanical ventilation.rm5
p1999
sg9
V8285749.xml
p2000
sa(dp2001
g3
VSTD-ENGAGE-2009
p2002
sg5
S'PMC2777786'
p2003
sg7
VCD009577 v. 2.0 Long-acting FSH versus daily FSH for women undergoing assisted reproduction.rm5
p2004
sg9
V19684043.xml
p2005
sa(dp2006
g3
VSTD-Bergh-2002
p2007
sg5
S'PMC123167'
p2008
sg7
VCD003909 v. 12.0 Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa.rm5
p2009
sg9
V12082182.xml
p2010
sa(dp2011
g3
VSTD-Bachar-1999
p2012
sg5
S'PMC3330539'
p2013
sg7
g2009
sg9
V10079459.xml
p2014
sa(dp2015
g3
VSTD-Lahteenmaki-1998
p2016
sg5
S'PMC28513'
p2017
sg7
VCD002126 v. 5.2 Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.rm5
p2018
sg9
V9552948.xml
p2019
sa(dp2020
g3
VSTD-Pozzilli-2002
p2021
sg5
S'PMC1738043'
p2022
sg7
VCD006036 v. 5.0 Multidisciplinary rehabilitation for adults with multiple sclerosis.rm5
p2023
sg9
V12185154.xml
p2024
sa(dp2025
g3
VSTD-Craig-2003
p2026
sg5
S'PMC1738635'
p2027
sg7
g2023
sg9
V12933923.xml
p2028
sa(dp2029
g3
VSTD-Tamblyn-2003
p2030
sg5
S'PMC191278'
p2031
sg7
VCD001096 v. 6.0 The effects of on-screen point of care computer reminders on processes and outcomes of care.rm5
p2032
sg9
V12975221.xml
p2033
sa(dp2034
g3
VSTD-Hicks-2008
p2035
sg5
S'PMC2359515'
p2036
sg7
g2032
sg9
V18373141.xml
p2037
sa(dp2038
g3
VSTD-Kenealy-2005
p2039
sg5
S'PMC1490216'
p2040
sg7
g2032
sg9
V16191138.xml
p2041
sa(dp2042
g3
VSTD-Tierney-2003
p2043
sg5
S'PMC1494965'
p2044
sg7
g2032
sg9
V14687254.xml
p2045
sa(dp2046
g3
VSTD-Flottorp-2002
p2047
sg5
S'PMC117890'
p2048
sg7
g2032
sg9
V12183309.xml
p2049
sa(dp2050
g3
VSTD-Tierney-2005
p2051
sg5
S'PMC1361152'
p2052
sg7
g2032
sg9
V15762903.xml
p2053
sa(dp2054
g3
VSTD-Sequist-2005
p2055
sg5
S'PMC1174888'
p2056
sg7
g2032
sg9
V15802479.xml
p2057
sa(dp2058
g3
VSTD-Overhage-1997
p2059
sg5
S'PMC61254'
p2060
sg7
g2032
sg9
V9292842.xml
p2061
sa(dp2062
g3
VSTD-Judge-2006
p2063
sg5
S'PMC1513672'
p2064
sg7
g2032
sg9
V16622171.xml
p2065
sa(dp2066
g3
VSTD-Abdelmassih-2005
p2067
sg5
S'PMC3455286'
p2068
sg7
VCD003719 v. 7.0 Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in I.rm5
p2069
sg9
V16021858.xml
p2070
sa(dp2071
g3
VSTD-Farrag-2008
p2072
sg5
S'PMC2582096'
p2073
sg7
g2069
sg9
V18925430.xml
p2074
sa(dp2075
g3
VSTD-Cowley-1994
p2076
sg5
S'PMC1025506'
p2077
sg7
VCD002230 v. 5.0 Phosphodiesterase III inhibitors for heart failure.rm5
p2078
sg9
V7946771.xml
p2079
sa(dp2080
g3
VSTD-PICO-1996
p2081
sg5
S'PMC484511'
p2082
sg7
g2078
sg9
V8868980.xml
p2083
sa(dp2084
g3
VSTD-Verheij-1994
p2085
sg5
S'PMC1238988'
p2086
sg7
VCD000245 v. 16.0 Antibiotics for acute bronchitis.rm5
p2087
sg9
V8790652.xml
p2088
sa(dp2089
g3
VSTD-Million-1981
p2090
sg5
S'PMC1000779'
p2091
sg7
VCD001823 v. 10.0 Lumbar supports for prevention and treatment of low back pain.rm5
p2092
sg9
V6458250.xml
p2093
sa(dp2094
g3
VSTD-CALBG-9712
p2095
sg5
S'PMC3084002'
p2096
sg7
VCD008079 v. 2.0 Rituximab ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia.rm5
p2097
sg9
V21321292.xml
p2098
sa(dp2099
g3
VSTD-Rojas-de-Arias-1999
p2100
sg5
S'PMC2557652'
p2101
sg7
VCD008657 v. 3.0 Housing improvements for health and associated socio-economic outcomes.rm5
p2102
sg9
V10327712.xml
p2103
sa(dp2104
g3
VSTD-Howden_x002d_Chapman-2007
p2105
sg5
S'PMC1808149'
p2106
sg7
g2102
sg9
V17324975.xml
p2107
sa(dp2108
g3
VSTD-Wilner-1960
p2109
sg5
S'PMC1373218'
p2110
sg7
g2102
sg9
V13845013.xml
p2111
sa(dp2112
g3
VSTD-CHARISMA-2011
p2113
sg5
S'PMC3207090'
p2114
sg7
g2102
sg9
V22054336.xml
p2115
sa(dp2116
g3
VSTD-Breysse-2011
p2117
sg5
S'PMC3072905'
p2118
sg7
g2102
sg9
V21563714.xml
p2119
sa(dp2120
g3
VSTD-Howden_x002d_Chapman-2008
p2121
sg5
S'PMC2658826'
p2122
sg7
g2102
sg9
V18812366.xml
p2123
sa(dp2124
g3
VSTD-Thomson-2007
p2125
sg5
S'PMC2652910'
p2126
sg7
g2102
sg9
V17325397.xml
p2127
sa(dp2128
g3
VSTD-Barton-2007
p2129
sg5
S'PMC2659999'
p2130
sg7
g2102
sg9
V17699530.xml
p2131
sa(dp2132
g3
VSTD-Manary-2004
p2133
sg5
S'PMC1719944'
p2134
sg7
VCD009000 v. 2.2 Ready-to-use therapeutic food for home-based treatment of severe acute malnutrition in children from.rm5
p2135
sg9
V15155403.xml
p2136
sa(dp2137
g3
VSTD-Oakley-2010
p2138
sg5
S'PMC2981006'
p2139
sg7
g2135
sg9
V20980648.xml
p2140
sa(dp2141
g3
VSTD-Neumark-2007
p2142
sg5
S'PMC3379776'
p2143
sg7
VCD000219 v. 16.0 Antibiotics for acute otitis media in children.rm5
p2144
sg9
V17846935.xml
p2145
sa(dp2146
g3
VSTD-Burke-1991
p2147
sg5
S'PMC1670875'
p2148
sg7
g2144
sg9
V1912887.xml
p2149
sa(dp2150
g3
VSTD-Le-Saux-2005
p2151
sg5
S'PMC545757'
p2152
sg7
g2144
sg9
V15684116.xml
p2153
sa(dp2154
g3
VSTD-Laxdal-1970
p2155
sg5
S'PMC1946394'
p2156
sg7
g2144
sg9
V4190002.xml
p2157
sa(dp2158
g3
VSTD-Appelman-1991
p2159
sg5
S'PMC1671677'
p2160
sg7
g2144
sg9
V1773154.xml
p2161
sa(dp2162
g3
VSTD-Little-2001
p2163
sg5
S'PMC26576'
p2164
sg7
g2144
sg9
V11159657.xml
p2165
sa(dp2166
g3
VSTD-Damoiseaux-2000
p2167
sg5
S'PMC27282'
p2168
sg7
g2144
sg9
V10657332.xml
p2169
sa(dp2170
g3
VSTD-Hoberman-2011
p2171
sg5
S'PMC3042231'
p2172
sg7
g2144
sg9
V21226576.xml
p2173
sa(dp2174
g3
VSTD-Nishimoto-2007-_x0028_SAMURAI_x0029_
p2175
sg5
S'PMC1955155'
p2176
sg7
VCD008331 v. 2.0 Tocilizumab for rheumatoid arthritis.rm5
p2177
sg9
V17485422.xml
p2178
sa(dp2179
g3
VSTD-Nishimoto-2009-_x0028_SATORI_x0029_
p2180
sg5
S'PMC2638601'
p2181
sg7
g2177
sg9
V18979150.xml
p2182
sa(dp2183
g3
VSTD-Driver-2011-age-matched
p2184
sg5
S'PMC3023971'
p2185
sg7
VCD008454 v. 2.0 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease evidence .rm5
p2186
sg9
V21252104.xml
p2187
sa(dp2188
g3
VSTD-Gao-2011
p2189
sg5
S'PMC3059148'
p2190
sg7
g2186
sg9
V21368281.xml
p2191
sa(dp2192
g3
VSTD-Driver-2011-age_x002b_-matched
p2193
sg5
S'PMC3023971'
p2194
sg7
g2186
sg9
V21252104.xml
p2195
sa(dp2196
g3
VSTD-Siriwardena-2002
p2197
sg5
S'PMC1314414'
p2198
sg7
VCD005188 v. 6.0 Interventions to increase influenza vaccination rates of those 60 years and older in the community.rm5
p2199
sg9
V12236277.xml
p2200
sa(dp2201
g3
VSTD-Baker-1998
p2202
sg5
S'PMC1496989'
p2203
sg7
g2199
sg9
V9686713.xml
p2204
sa(dp2205
g3
VSTD-Dalby-2000
p2206
sg5
S'PMC1231166'
p2207
sg7
g2199
sg9
V10701382.xml
p2208
sa(dp2209
g3
VSTD-Hull-2002
p2210
sg5
S'PMC1314410'
p2211
sg7
g2199
sg9
V12236273.xml
p2212
sa(dp2213
g3
VSTD-Arthur-2002
p2214
sg5
S'PMC1314411'
p2215
sg7
g2199
sg9
V12236274.xml
p2216
sa(dp2217
g3
VSTD-Lukasik-1987
p2218
sg5
S'PMC2218648'
p2219
sg7
g2199
sg9
V21263970.xml
p2220
sa(dp2221
g3
VSTD-Black-1993
p2222
sg5
S'PMC1694928'
p2223
sg7
g2199
sg9
V8259810.xml
p2224
sa(dp2225
g3
VSTD-Lemelin-2001
p2226
sg5
S'PMC80870'
p2227
sg7
g2199
sg9
V11276541.xml
p2228
sa(dp2229
g3
VSTD-McDowell-1986
p2230
sg5
S'PMC1491283'
p2231
sg7
g2199
sg9
V3093045.xml
p2232
sa(dp2233
g3
VSTD-Clayton-1999
p2234
sg5
S'PMC1508682'
p2235
sg7
g2199
sg9
V10432913.xml
p2236
sa(dp2237
g3
VSTD-Kerse-1999
p2238
sg5
S'PMC28221'
p2239
sg7
g2199
sg9
V10480825.xml
p2240
sa(dp2241
g3
VSTD-Mullooly-1987
p2242
sg5
S'PMC1647052'
p2243
sg7
g2199
sg9
V3565663.xml
p2244
sa(dp2245
g3
VSTD-Hogg-1998
p2246
sg5
S'PMC2277568'
p2247
sg7
g2199
sg9
V9481466.xml
p2248
sa(dp2249
g3
VSTD-Change-of-Heart--1999
p2250
sg5
S'PMC28246'
p2251
sg7
VCD001561 v. 10.0 Multiple risk factor interventions for primary prevention of coronary heart disease.rm5
p2252
sg9
V10514155.xml
p2253
sa(dp2254
g3
VSTD-Abingdon-1990
p2255
sg5
S'PMC1371239'
p2256
sg7
g2252
sg9
V2115348.xml
p2257
sa(dp2258
g3
VSTD-Johns-Hopkins
p2259
sg5
S'PMC1650522'
p2260
sg7
g2252
sg9
V6849473.xml
p2261
sa(dp2262
g3
VSTD-CELL-Study-1995
p2263
sg5
S'PMC2549500'
p2264
sg7
g2252
sg9
V7742677.xml
p2265
sa(dp2266
g3
VSTD-OXCHECK-1994
p2267
sg5
S'PMC2539253'
p2268
sg7
g2252
sg9
V8124120.xml
p2269
sa(dp2270
g3
VSTD-Okayama-2004
p2271
sg5
S'PMC2723573'
p2272
sg7
g2252
sg9
V21432327.xml
p2273
sa(dp2274
g3
VSTD-Toobert-_x0028_MLP_x0029_-2005
p2275
sg5
S'PMC1557654'
p2276
sg7
g2252
sg9
V15823786.xml
p2277
sa(dp2278
g3
VSTD-Take-Heart-1995
p2279
sg5
S'PMC1615302'
p2280
sg7
g2252
sg9
V7856780.xml
p2281
sa(dp2282
g3
VSTD-Desjardins-1986
p2283
sg5
S'PMC2175477'
p2284
sg7
VCD001547 v. 6.2 Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults.rm5
p2285
sg9
V3461726.xml
p2286
sa(dp2287
g3
VSTD-Collins-1978
p2288
sg5
S'PMC1608676'
p2289
sg7
VCD000175 v. 8.0 Prophylactic intravenous preloading for regional analgesia in labour.rm5
p2290
sg9
V719463.xml
p2291
sa(dp2292
g3
VSTD-Nikolaus-2003
p2293
sg5
S'PMC1773804'
p2294
sg7
VCD006790 v. 3.0 Type I interferons for induction of remission in ulcerative colitis.rm5
p2295
sg9
V12912859.xml
p2296
sa(dp2297
g3
VSTD-Tilg-2003
p2298
sg5
S'PMC1773891'
p2299
sg7
g2295
sg9
V14633951.xml
p2300
sa(dp2301
g3
VSTD-Burton-2006
p2302
sg5
S'PMC3216418'
p2303
sg7
VCD003189 v. 13.2 Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.rm5
p2304
sg9
V16508640.xml
p2305
sa(dp2306
g3
VSTD-Thomson-2007
p2307
sg5
S'PMC2083581'
p2308
sg7
VCD009118 v. 2.0 Osmotic and stimulant laxatives for the management of childhood constipation.rm5
p2309
sg9
V17626140.xml
p2310
sa(dp2311
g3
VSTD-Rafati-2011
p2312
sg5
S'PMC3232099'
p2313
sg7
g2309
sg9
V22615652.xml
p2314
sa(dp2315
g3
VSTD-Voskujl-2004
p2316
sg5
S'PMC1774276'
p2317
sg7
g2309
sg9
V15479678.xml
p2318
sa(dp2319
g3
VSTD-Goldstein-2003
p2320
sg5
S'PMC1746667'
p2321
sg7
VCD001001 v. 8.0 Lung volume reduction surgery for diffuse emphysema.rm5
p2322
sg9
V12728160.xml
p2323
sa(dp2324
g3
VSTD-West-1999
p2325
sg5
S'PMC27760'
p2326
sg7
VCD008666 v. 3.0 Vitamin A supplementation during pregnancy for maternal and newborn outcomes.rm5
p2327
sg9
V10037634.xml
p2328
sa(dp2329
g3
VSTD-LEADER
p2330
sg5
S'PMC133451'
p2331
sg7
VCD000123 v. 8.0 Lipid-lowering for peripheral arterial disease of the lower limb.rm5
p2332
sg9
V12433762.xml
p2333
sa(dp2334
g3
VSTD-Teo-2011
p2335
sg5
S'PMC3187313'
p2336
sg7
VCD009593 v. 3.3 Xpert MTBRIF assay for pulmonary tuberculosis and rifampicin resistance in adults.rm5
p2337
sg9
V21865419.xml
p2338
sa(dp2339
g3
VSTD-Boehme-2010d
p2340
sg5
S'PMC2947799'
p2341
sg7
g2337
sg9
V20825313.xml
p2342
sa(dp2343
g3
VSTD-Boehme-2010e
p2344
sg5
S'PMC2947799'
p2345
sg7
g2337
sg9
V20825313.xml
p2346
sa(dp2347
g3
VSTD-Miller-2011
p2348
sg5
S'PMC3187315'
p2349
sg7
g2337
sg9
V21849695.xml
p2350
sa(dp2351
g3
VSTD-Boehme-2010a
p2352
sg5
S'PMC2947799'
p2353
sg7
g2337
sg9
V20825313.xml
p2354
sa(dp2355
g3
VSTD-Boehme-2010b
p2356
sg5
S'PMC2947799'
p2357
sg7
g2337
sg9
V20825313.xml
p2358
sa(dp2359
g3
VSTD-Boehme-2010c
p2360
sg5
S'PMC2947799'
p2361
sg7
g2337
sg9
V20825313.xml
p2362
sa(dp2363
g3
VSTD-Helb-2010
p2364
sg5
S'PMC2812290'
p2365
sg7
g2337
sg9
V19864480.xml
p2366
sa(dp2367
g3
VSTD-Rachow-2011
p2368
sg5
S'PMC3126807'
p2369
sg7
g2337
sg9
V21738575.xml
p2370
sa(dp2371
g3
VSTD-Friedrich-2011
p2372
sg5
S'PMC3147741'
p2373
sg7
g2337
sg9
V21653771.xml
p2374
sa(dp2375
g3
VSTD-Marlowe-2011
p2376
sg5
S'PMC3122817'
p2377
sg7
g2337
sg9
V21289151.xml
p2378
sa(dp2379
g3
VSTD-Scott-2011
p2380
sg5
S'PMC3144192'
p2381
sg7
g2337
sg9
V21814495.xml
p2382
sa(dp2383
g3
VSTD-Boehme-2011f
p2384
sg5
S'PMC3085933'
p2385
sg7
g2337
sg9
V21507477.xml
p2386
sa(dp2387
g3
VSTD-Boehme-2011e
p2388
sg5
S'PMC3085933'
p2389
sg7
g2337
sg9
V21507477.xml
p2390
sa(dp2391
g3
VSTD-Boehme-2011d
p2392
sg5
S'PMC3085933'
p2393
sg7
g2337
sg9
V21507477.xml
p2394
sa(dp2395
g3
VSTD-Boehme-2011c
p2396
sg5
S'PMC3085933'
p2397
sg7
g2337
sg9
V21507477.xml
p2398
sa(dp2399
g3
VSTD-Boehme-2011b
p2400
sg5
S'PMC3085933'
p2401
sg7
g2337
sg9
V21507477.xml
p2402
sa(dp2403
g3
VSTD-Boehme-2011a
p2404
sg5
S'PMC3085933'
p2405
sg7
g2337
sg9
V21507477.xml
p2406
sa(dp2407
g3
VSTD-Ioannidis-2011
p2408
sg5
S'PMC3147726'
p2409
sg7
g2337
sg9
V21677069.xml
p2410
sa(dp2411
g3
VSTD-Moure-2011
p2412
sg5
S'PMC3067676'
p2413
sg7
g2337
sg9
V21191053.xml
p2414
sa(dp2415
g3
VSTD-Lawn-2011
p2416
sg5
S'PMC3144215'
p2417
sg7
g2337
sg9
V21818180.xml
p2418
sa(dp2419
g3
VSTD-Zeka-2011
p2420
sg5
S'PMC3232962'
p2421
sg7
g2337
sg9
V21956978.xml
p2422
sa(dp2423
g3
VSTD-Silverberg-1977
p2424
sg5
S'PMC1605638'
p2425
sg7
VCD008320 v. 3.0 Pharmacological interventions for pruritus in adult palliative care patients.rm5
p2426
sg9
V322794.xml
p2427
sa(dp2428
g3
VSTD-Duncan-1984
p2429
sg5
S'PMC1442057'
p2430
sg7
g2426
sg9
V6145483.xml
p2431
sa(dp2432
g3
VSTD-Williams-1981
p2433
sg5
S'PMC1675841'
p2434
sg7
VCD002988 v. 6.5 Intravenous beta2-agonists for acute asthma in the emergency department.rm5
p2435
sg9
V1106817.xml
p2436
sa(dp2437
g3
VSTD-Williams-1975
p2438
sg5
S'PMC471658'
p2439
sg7
g2435
sg9
V7031975.xml
p2440
sa(dp2441
g3
VSTD-Hambleton-1979
p2442
sg5
S'PMC1545558'
p2443
sg7
g2435
sg9
V383024.xml
p2444
sa(dp2445
g3
VSTD-Femi_x002d_Pearse-2-1977
p2446
sg5
S'PMC1605098'
p2447
sg7
g2435
sg9
V319876.xml
p2448
sa(dp2449
g3
VSTD-Femi_x002d_Pearse-1-1977
p2450
sg5
S'PMC1605098'
p2451
sg7
g2435
sg9
V319876.xml
p2452
sa(dp2453
g3
VSTD-Bloomfield-1979
p2454
sg5
S'PMC1598545'
p2455
sg7
g2435
sg9
V373852.xml
p2456
sa(dp2457
g3
VSTD-Lawford-1978
p2458
sg5
S'PMC1602586'
p2459
sg7
g2435
sg9
V339993.xml
p2460
sa(dp2461
g3
VSTD-McLaughlin-2005
p2462
sg5
S'PMC1490273'
p2463
sg7
VCD008012 v. 3.0 Psychological and pharmacological interventions for depression in patients with coronary artery dise.rm5
p2464
sg9
V16423095.xml
p2465
sa(dp2466
g3
VSTD-Garly-2006
p2467
sg5
S'PMC1702442'
p2468
sg7
VCD001477 v. 11.0 Antibiotics for preventing complications in children with measles.rm5
p2469
sg9
V17060336.xml
p2470
sa(dp2471
g3
VSTD-Malcolm-2002
p2472
sg5
S'PMC1495040'
p2473
sg7
VCD005064 v. 9.0 Anticonvulsants for alcohol withdrawal.rm5
p2474
sg9
V12047731.xml
p2475
sa(dp2476
g3
VSTD-Innes-2002
p2477
sg5
S'PMC1758800'
p2478
sg7
VCD001115 v. 9.0 Continuous versus intermittent beta-agonists for acute asthma.rm5
p2479
sg9
V12454298.xml
p2480
sa(dp2481
g3
VSTD-Pakasi-2010
p2482
sg5
S'PMC2957385'
p2483
sg7
VCD006086 v. 4.2 Nutritional supplements for people being treated for active tuberculosis.rm5
p2484
sg9
V20920186.xml
p2485
sa(dp2486
g3
VSTD-Villamor-2008
p2487
sg5
S'PMC2564793'
p2488
sg7
g2484
sg9
V18471061.xml
p2489
sa(dp2490
g3
VSTD-Martins-2009
p2491
sg5
S'PMC2767482'
p2492
sg7
g2484
sg9
V19858174.xml
p2493
sa(dp2494
g3
VSTD-Rieder-1987
p2495
sg5
S'PMC1491956'
p2496
sg7
VCD005365 v. 3.0 Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts.rm5
p2497
sg9
V3552176.xml
p2498
sa(dp2499
g3
VSTD-Johansson-2008
p2500
sg5
S'PMC2607225'
p2501
sg7
VCD007064 v. 4.6 Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed.rm5
p2502
sg9
V19018255.xml
p2503
sa(dp2504
g3
VSTD-Moynihan-1998
p2505
sg5
S'PMC2665582'
p2506
sg7
g2502
sg9
V9492666.xml
p2507
sa(dp2508
g3
VSTD-Parker-2009
p2509
sg5
S'PMC2716938'
p2510
sg7
g2502
sg9
V19349551.xml
p2511
sa(dp2512
g3
VSTD-Ogawa-2008
p2513
sg5
S'PMC2390947'
p2514
sg7
VCD008834 v. 3.0 Antiplatelet agents for chronic kidney disease.rm5
p2515
sg9
V18235151.xml
p2516
sa(dp2517
g3
VSTD-Ghorbani-2009
p2518
sg5
S'PMC2847809'
p2519
sg7
g2515
sg9
V20368925.xml
p2520
sa(dp2521
g3
VSTD-Kraft-2009
p2522
sg5
S'PMC2574639'
p2523
sg7
VCD002059 v. 6.0 Opiate treatment for opiate withdrawal in newborn infants.rm5
p2524
sg9
V18694901.xml
p2525
sa(dp2526
g3
VSTD-Jackson-2004
p2527
sg5
S'PMC1721707'
p2528
sg7
g2524
sg9
V15210660.xml
p2529
sa(dp2530
g3
VSTD-Eriksen-1997
p2531
sg5
S'PMC2364551'
p2532
sg7
VCD004070 v. 8.0 Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group.rm5
p2533
sg9
V18476153.xml
p2534
sa(dp2535
g3
VSTD-PUNE
p2536
sg5
S'PMC1771720'
p2537
sg7
VCD001323 v. 7.2 Surgical interventions for age-related cataract.rm5
p2538
sg9
V12770957.xml
p2539
sa(dp2540
g3
VSTD-OCTET
p2541
sg5
S'PMC1041029'
p2542
sg7
g2538
sg9
V2872913.xml
p2543
sa(dp2544
g3
VSTD-Waddell-2004
p2545
sg5
S'PMC1772160'
p2546
sg7
g2538
sg9
V15148202.xml
p2547
sa(dp2548
g3
VSTD-Van-den-Ende-1996
p2549
sg5
S'PMC1010314'
p2550
sg7
VCD006853 v. 3.0 Dynamic exercise programs (aerobic capacity andor muscle strength training) in patients with rheuma.rm5
p2551
sg9
V8976635.xml
p2552
sa(dp2553
g3
VSTD-Yeo-2000
p2554
sg5
S'PMC1421155'
p2555
sg7
VCD008370 v. 5.0 Somatostatin analogues for pancreatic surgery.rm5
p2556
sg9
V10973392.xml
p2557
sa(dp2558
g3
VSTD-Katsourakis-2010
p2559
sg5
S'PMC3108665'
p2560
sg7
g2556
sg9
V21694864.xml
p2561
sa(dp2562
g3
VSTD-Westphal-2003
p2563
sg5
S'PMC1920672'
p2564
sg7
VCD007294 v. 4.2 Chemotherapy wafers for high grade glioma.rm5
p2565
sg9
V12672279.xml
p2566
sa(dp2567
g3
VSTD-Cornuz-2008
p2568
sg5
S'PMC2432028'
p2569
sg7
VCD007072 v. 4.0 Nicotine vaccines for smoking cessation.rm5
p2570
sg9
V18575629.xml
p2571
sa(dp2572
g3
VSTD-Jones-1995
p2573
sg5
S'PMC474903'
p2574
sg7
VCD001117 v. 7.0 Self-management education and regular practitioner review for adults with asthma.rm5
p2575
sg9
V7570436.xml
p2576
sa(dp2577
g3
VSTD-Lahdensuo-1996
p2578
sg5
S'PMC2350456'
p2579
sg7
g2575
sg9
V8605463.xml
p2580
sa(dp2581
g3
VSTD-Yoon-1993
p2582
sg5
S'PMC464888'
p2583
sg7
g2575
sg9
V8296253.xml
p2584
sa(dp2585
g3
VSTD-Moudgil-2000
p2586
sg5
S'PMC1745690'
p2587
sg7
g2575
sg9
V10679534.xml
p2588
sa(dp2589
g3
VSTD-Allen-1995
p2590
sg5
S'PMC474644'
p2591
sg7
g2575
sg9
V7570406.xml
p2592
sa(dp2593
g3
VSTD-Abdulwadud-1999
p2594
sg5
S'PMC1745497'
p2595
sg7
g2575
sg9
V10335002.xml
p2596
sa(dp2597
g3
VSTD-Garret-1994
p2598
sg5
S'PMC475232'
p2599
sg7
g2575
sg9
V7974314.xml
p2600
sa(dp2601
g3
VSTD-Kennedy-1997
p2602
sg5
S'PMC1720640'
p2603
sg7
VCD000122 v. 8.0 Early light reduction for preventing retinopathy of prematurity in very low birth weight infants.rm5
p2604
sg9
V9175946.xml
p2605
sa(dp2606
g3
VSTD-Llewellyn-1970
p2607
sg5
S'PMC1647632'
p2608
sg7
VCD002770 v. 8.0 Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease.rm5
p2609
sg9
V5506931.xml
p2610
sa(dp2611
g3
VSTD-Murdock-1970
p2612
sg5
S'PMC1647512'
p2613
sg7
g2609
sg9
V4920541.xml
p2614
sa(dp2615
g3
VSTD-Corbett-1989
p2616
sg5
S'PMC2498882'
p2617
sg7
VCD001486 v. 9.0 Surgery for varicose veins use of tourniquet.rm5
p2618
sg9
V2647025.xml
p2619
sa(dp2620
g3
VSTD-Sykes-2000
p2621
sg5
S'PMC2503503'
p2622
sg7
g2618
sg9
V10932665.xml
p2623
sa(dp2624
g3
VSTD-Thompson-1990
p2625
sg5
S'PMC2499114'
p2626
sg7
g2618
sg9
V2185680.xml
p2627
sa(dp2628
g3
VSTD-Hirsch-1979
p2629
sg5
S'PMC1597797'
p2630
sg7
VCD000384 v. 7.0 Length of hospitalisation for people with severe mental illness.rm5
p2631
sg9
V427401.xml
p2632
sa(dp2633
g3
VSTD-Gitlin-2010
p2634
sg5
S'PMC2955191'
p2635
sg7
VCD006929 v. 4.0 Functional analysis-based interventions for challenging behaviour in dementia.rm5
p2636
sg9
V20662955.xml
p2637
sa(dp2638
g3
VSTD-Burgio-2003
p2639
sg5
S'PMC2579272'
p2640
sg7
g2636
sg9
V12937335.xml
p2641
sa(dp2642
g3
VSTD-Fossey-2006
p2643
sg5
S'PMC1420717'
p2644
sg7
g2636
sg9
V16543297.xml
p2645
sa(dp2646
g3
VSTD-Nacul-1997
p2647
sg5
S'PMC2127384'
p2648
sg7
VCD003700 v. 11.3 Vitamin A for non-measles pneumonia in children.rm5
p2649
sg9
V9329303.xml
p2650
sa(dp2651
g3
VSTD-Morino-2006
p2652
sg5
S'PMC1856631'
p2653
sg7
VCD007683 v. 3.2 Laparoscopy for the management of acute lower abdominal pain in women of childbearing age.rm5
p2654
sg9
V17122613.xml
p2655
sa(dp2656
g3
VSTD-Katkhouda-2005
p2657
sg5
S'PMC1357752'
p2658
sg7
VCD001546 v. 7.0 Laparoscopic versus open surgery for suspected appendicitis.rm5
p2659
sg9
V16135930.xml
p2660
sa(dp2661
g3
VSTD-Martin-1995
p2662
sg5
S'PMC1234801'
p2663
sg7
g2659
sg9
V7677456.xml
p2664
sa(dp2665
g3
VSTD-Frazee-1994
p2666
sg5
S'PMC1243232'
p2667
sg7
g2659
sg9
V8203983.xml
p2668
sa(dp2669
g3
VSTD-Ricca-2007
p2670
sg5
S'PMC3015793'
p2671
sg7
g2659
sg9
V17663093.xml
p2672
sa(dp2673
g3
VSTD-O_x0027_Dwyer-1992
p2674
sg5
S'PMC2399524'
p2675
sg7
VCD004788 v. 7.0 Small-incision versus open cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
p2676
sg9
V1461854.xml
p2677
sa(dp2678
g3
VSTD-Van-Overmeire-1997
p2679
sg5
S'PMC1720646'
p2680
sg7
VCD003481 v. 9.0 Ibuprofen for the treatment of patent ductus arteriosus in preterm andor low birth weight infants.rm5
p2681
sg9
V9175948.xml
p2682
sa(dp2683
g3
VSTD-Wu-2006
p2684
sg5
S'PMC1448924'
p2685
sg7
VCD008085 v. 1.6 Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver re.rm5
p2686
sg9
V16432349.xml
p2687
sa(dp2688
g3
VSTD-Ataoglu-2003
p2689
sg5
S'PMC3055095'
p2690
sg7
VCD005331 v. 4.0 Psychosocial interventions for conversion disorder.rm5
p2691
sg9
V12923337.xml
p2692
sa(dp2693
g3
VSTD-Durand-2003
p2694
sg5
S'PMC1314596'
p2695
sg7
VCD000562 v. 15.0 Psychological treatments for bulimia nervosa and binging.rm5
p2696
sg9
V12830564.xml
p2697
sa(dp2698
g3
VSTD-Burton-2006
p2699
sg5
S'PMC1618764'
p2700
sg7
g2696
sg9
V16458252.xml
p2701
sa(dp2702
g3
VSTD-Bachar-1999
p2703
sg5
S'PMC3330539'
p2704
sg7
g2696
sg9
V10079459.xml
p2705
sa(dp2706
g3
VSTD-Mowat-1970
p2707
sg5
S'PMC1700846'
p2708
sg7
VCD007396 v. 4.0 Parenteral opioids for maternal pain management in labour.rm5
p2709
sg9
V4913784.xml
p2710
sa(dp2711
g3
VSTD-Hidalgo-1997
p2712
sg5
S'PMC163876'
p2713
sg7
VCD004386 v. 7.2 Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemother.rm5
p2714
sg9
V9145895.xml
p2715
sa(dp2716
g3
VSTD-Liang-1990
p2717
sg5
S'PMC171559'
p2718
sg7
g2714
sg9
V2327768.xml
p2719
sa(dp2720
g3
VSTD-Kern-1994b
p2721
sg5
S'PMC284481'
p2722
sg7
g2714
sg9
V8203838.xml
p2723
sa(dp2724
g3
VSTD-Broun-1994
p2725
sg5
S'PMC284500'
p2726
sg7
g2714
sg9
V8203857.xml
p2727
sa(dp2728
g3
VSTD-Bender-1979
p2729
sg5
S'PMC352683'
p2730
sg7
g2714
sg9
V464573.xml
p2731
sa(dp2732
g3
VSTD-Hargadon-1981
p2733
sg5
S'PMC181762'
p2734
sg7
g2714
sg9
V6275778.xml
p2735
sa(dp2736
g3
VSTD-Ford-1998
p2737
sg5
S'PMC105612'
p2738
sg7
g2714
sg9
V9624484.xml
p2739
sa(dp2740
g3
VSTD-Quist_x002d_Paulsen-2003
p2741
sg5
S'PMC286243'
p2742
sg7
VCD001837 v. 12.4 Interventions for smoking cessation in hospitalised patients.rm5
p2743
sg9
V14644967.xml
p2744
sa(dp2745
g3
VSTD-Hajek-2002
p2746
sg5
S'PMC64504'
p2747
sg7
g2743
sg9
V11786452.xml
p2748
sa(dp2749
g3
VSTD-Smith-2009
p2750
sg5
S'PMC2696525'
p2751
sg7
g2743
sg9
V19546455.xml
p2752
sa(dp2753
g3
VSTD-Molyneux-2003
p2754
sg5
S'PMC1746718'
p2755
sg7
g2743
sg9
V12775857.xml
p2756
sa(dp2757
g3
VSTD-Deshpande-1986
p2758
sg5
S'PMC1340908'
p2759
sg7
VCD000195 v. 8.0 Corticosteroids for preventing relapse following acute exacerbations of asthma.rm5
p2760
sg9
V3089439.xml
p2761
sa(dp2762
g3
VSTD-Mimura-2004
p2763
sg5
S'PMC1773918'
p2764
sg7
VCD001176 v. 5.0 Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative coli.rm5
p2765
sg9
V14684584.xml
p2766
sa(dp2767
g3
VSTD-Ettinger-2009
p2768
sg5
S'PMC2627861'
p2769
sg7
VCD007079 v. 2.0 Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy.rm5
p2770
sg9
V19165383.xml
p2771
sa(dp2772
g3
VSTD-England-2000
p2773
sg5
S'PMC1727856'
p2774
sg7
VCD004200 v. 10.0 Palliative biliary stents for obstructing pancreatic carcinoma.rm5
p2775
sg9
V10673303.xml
p2776
sa(dp2777
g3
VSTD-Andersen-1989
p2778
sg5
S'PMC1434171'
p2779
sg7
g2775
sg9
V2475392.xml
p2780
sa(dp2781
g3
VSTD-Isayama-2004
p2782
sg5
S'PMC1774024'
p2783
sg7
g2775
sg9
V15082593.xml
p2784
sa(dp2785
g3
VSTD-Agthe-2009
p2786
sg5
S'PMC2746902'
p2787
sg7
VCD002053 v. 5.0 Sedatives for opiate withdrawal in newborn infants.rm5
p2788
sg9
V19398463.xml
p2789
sa(dp2790
g3
VSTD-Yeboah_x002d_Antwi-2010
p2791
sg5
S'PMC2943441'
p2792
sg7
VCD009527 v. 2.0 Home- or community-based programmes for treating malaria.rm5
p2793
sg9
V20877714.xml
p2794
sa(dp2795
g3
VSTD-Kouyate-2008
p2796
sg5
S'PMC2287184'
p2797
sg7
g2793
sg9
V18364043.xml
p2798
sa(dp2799
g3
VSTD-Delacollette-1996
p2800
sg5
S'PMC2486885'
p2801
sg7
g2793
sg9
V8823965.xml
p2802
sa(dp2803
g3
VSTD-Mubi-2011
p2804
sg5
S'PMC3130036'
p2805
sg7
g2793
sg9
V21750697.xml
p2806
sa(dp2807
g3
VSTD-Kangwana-2011
p2808
sg5
S'PMC3104978'
p2809
sg7
g2793
sg9
V21655317.xml
p2810
sa(dp2811
g3
VSTD-Eriksen-2010
p2812
sg5
S'PMC3052812'
p2813
sg7
g2793
sg9
V21416034.xml
p2814
sa(dp2815
g3
VSTD-Sperber-1989
p2816
sg5
S'PMC1807791'
p2817
sg7
VCD006362 v. 8.0 Non-steroidal anti-inflammatory drugs for the common cold.rm5
p2818
sg9
V2557947.xml
p2819
sa(dp2820
g3
VSTD-Amsterdam-2009
p2821
sg5
S'PMC3600411'
p2822
sg7
VCD007244 v. 4.0 Black cohosh (Cimicifuga spp.) for menopausal symptoms.rm5
p2823
sg9
V19745648.xml
p2824
sa(dp2825
g3
VSTD-Geller--2009
p2826
sg5
S'PMC2783540'
p2827
sg7
g2823
sg9
V19609225.xml
p2828
sa(dp2829
g3
VSTD-Pelz-2001
p2830
sg5
S'PMC1421284'
p2831
sg7
VCD004920 v. 7.0 Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.rm5
p2832
sg9
V11303137.xml
p2833
sa(dp2834
g3
VSTD-Matijevic-2006
p2835
sg5
S'PMC2080361'
p2836
sg7
VCD003927 v. 7.3 Oral betamimetics for maintenance therapy after threatened preterm labour.rm5
p2837
sg9
V16489694.xml
p2838
sa(dp2839
g3
VSTD-Barratt-1994
p2840
sg5
S'PMC1615036'
p2841
sg7
VCD001366 v. 5.2 Dietary advice given by a dietitian versus other health professional or self-help resources to reduc.rm5
p2842
sg9
V8179048.xml
p2843
sa(dp2844
g3
VSTD-Neil-1995
p2845
sg5
S'PMC2548942'
p2846
sg7
g2842
sg9
V7888933.xml
p2847
sa(dp2848
g3
VSTD-Gosselin-1996
p2849
sg5
S'PMC2146929'
p2850
sg7
g2842
sg9
V8974552.xml
p2851
sa(dp2852
g3
VSTD-Joyce-1992
p2853
sg5
S'PMC2497688'
p2854
sg7
VCD004651 v. 6.0 Oral water soluble contrast for the management of adhesive small bowel obstruction.rm5
p2855
sg9
V1306666.xml
p2856
sa(dp2857
g3
VSTD-Neighbors-2006
p2858
sg5
S'PMC2474672'
p2859
sg7
VCD006748 v. 4.0 Social norms interventions to reduce alcohol misuse in University or College students.rm5
p2860
sg9
V17014274.xml
p2861
sa(dp2862
g3
VSTD-Carey--2006
p2863
sg5
S'PMC2442891'
p2864
sg7
g2860
sg9
V17032098.xml
p2865
sa(dp2866
g3
VSTD-Lewis-2007b
p2867
sg5
S'PMC2969166'
p2868
sg7
g2860
sg9
V17658695.xml
p2869
sa(dp2870
g3
VSTD-Lewis-2007a
p2871
sg5
S'PMC2459320'
p2872
sg7
g2860
sg9
V17286341.xml
p2873
sa(dp2874
g3
VSTD-Baer-2001
p2875
sg5
S'PMC1446766'
p2876
sg7
g2860
sg9
V11499124.xml
p2877
sa(dp2878
g3
VSTD-Lewis-2007a_x002c_-Female
p2879
sg5
S'PMC2459320'
p2880
sg7
g2860
sg9
V17286341.xml
p2881
sa(dp2882
g3
VSTD-Borsari-2005
p2883
sg5
S'PMC2663045'
p2884
sg7
g2860
sg9
V16187809.xml
p2885
sa(dp2886
g3
VSTD-Lewis-2007a_x002c_-Male
p2887
sg5
S'PMC2459320'
p2888
sg7
g2860
sg9
V17286341.xml
p2889
sa(dp2890
g3
VSTD-Finer-1992
p2891
sg5
S'PMC1293638'
p2892
sg7
VCD003344 v. 5.0 Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy .rm5
p2893
sg9
V1433118.xml
p2894
sa(dp2895
g3
VSTD-Cone-1985
p2896
sg5
S'PMC176304'
p2897
sg7
g2893
sg9
V3899005.xml
p2898
sa(dp2899
g3
VSTD-Bergeron-1988
p2900
sg5
S'PMC172383'
p2901
sg7
g2893
sg9
V3056255.xml
p2902
sa(dp2903
g3
VSTD-Coppens-1983
p2904
sg5
S'PMC184612'
p2905
sg7
g2893
sg9
V6550482.xml
p2906
sa(dp2907
g3
VSTD-Dupont-2000
p2908
sg5
S'PMC90009'
p2909
sg7
g2893
sg9
V10898671.xml
p2910
sa(dp2911
g3
VSTD-Cometta-1994
p2912
sg5
S'PMC188203'
p2913
sg7
g2893
sg9
V8092830.xml
p2914
sa(dp2915
g3
VSTD-Piccart-1984
p2916
sg5
S'PMC180041'
p2917
sg7
g2893
sg9
V6524903.xml
p2918
sa(dp2919
g3
VSTD-Jaspers-1998
p2920
sg5
S'PMC105786'
p2921
sg7
g2893
sg9
V9593156.xml
p2922
sa(dp2923
g3
VSTD-Links-1988
p2924
sg5
S'PMC1033016'
p2925
sg7
VCD005045 v. 4.0 Treatment for periodic paralysis.rm5
p2926
sg9
V3066848.xml
p2927
sa(dp2928
g3
VSTD-Frennesson-1995
p2929
sg5
S'PMC1722362'
p2930
sg7
VCD006537 v. 3.4 Laser treatment of drusen to prevent progression to advanced age-related macular degeneration.rm5
p2931
sg9
V9924306.xml
p2932
sa(dp2933
g3
VSTD-Wang-2009
p2934
sg5
S'PMC2667658'
p2935
sg7
VCD009350 v. 2.0 Dietary flavonoid for preventing colorectal neoplasms.rm5
p2936
sg9
V19158208.xml
p2937
sa(dp2938
g3
VSTD-Akhter-2009
p2939
sg5
S'PMC2695684'
p2940
sg7
g2936
sg9
V19417743.xml
p2941
sa(dp2942
g3
VSTD-Bobe-2008
p2943
sg5
S'PMC2517243'
p2944
sg7
g2936
sg9
V18559549.xml
p2945
sa(dp2946
g3
VSTD-Cutler-2008
p2947
sg5
S'PMC2572165'
p2948
sg7
g2936
sg9
V18491403.xml
p2949
sa(dp2950
g3
VSTD-Albers-2005
p2951
sg5
S'PMC1350988'
p2952
sg7
VCD006672 v. 4.2 Perineal techniques during the second stage of labour for reducing perineal trauma.rm5
p2953
sg9
V16154062.xml
p2954
sa(dp2955
g3
VSTD-Stamp-2001
p2956
sg5
S'PMC31922'
p2957
sg7
g2953
sg9
V11375230.xml
p2958
sa(dp2959
g3
VSTD-Greenough-1989
p2960
sg5
S'PMC1792547'
p2961
sg7
VCD004503 v. 3.0 Long versus short inspiratory times in neonates receiving mechanical ventilation.rm5
p2962
sg9
V2505689.xml
p2963
sa(dp2964
g3
VSTD-Gravie--2005
p2965
sg5
S'PMC1357701'
p2966
sg7
VCD005393 v. 6.2 Stapled versus conventional surgery for hemorrhoids.rm5
p2967
sg9
V15973098.xml
p2968
sa(dp2969
g3
VSTD-Channabasavanna-1987
p2970
sg5
S'PMC3172444'
p2971
sg7
VCD002923 v. 11.0 Penfluridol for schizophrenia.rm5
p2972
sg9
V21927264.xml
p2973
sa(dp2974
g3
VSTD-Van-Praag-1971
p2975
sg5
S'PMC1799991'
p2976
sg7
g2972
sg9
V4943034.xml
p2977
sa(dp2978
g3
VSTD-Carmichael-1978
p2979
sg5
S'PMC1607388'
p2980
sg7
VCD002879 v. 5.0 Beclomethasone at different doses for chronic asthma.rm5
p2981
sg9
V359091.xml
p2982
sa(dp2983
g3
VSTD-Smith-1986
p2984
sg5
S'PMC460555'
p2985
sg7
g2981
sg9
V3296296.xml
p2986
sa(dp2987
g3
VSTD-Wolthers-1993
p2988
sg5
S'PMC1029340'
p2989
sg7
g2981
sg9
V8323338.xml
p2990
sa(dp2991
g3
VSTD-Pandya-2005
p2992
sg5
S'PMC1627210'
p2993
sg7
VCD004923 v. 7.0 Non-hormonal interventions for hot flushes in women with a history of breast cancer.rm5
p2994
sg9
V16139656.xml
p2995
sa(dp2996
g3
VSTD-Steenstra-2006
p2997
sg5
S'PMC2077992'
p2998
sg7
VCD001822 v. 11.1 Physical conditioning programs for improving work outcomes in workers with back pain.rm5
p2999
sg9
V16847036.xml
p3000
sa(dp3001
g3
VSTD-Silva-2001
p3002
sg5
S'PMC80627'
p3003
sg7
VCD005544 v. 3.0 Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalis.rm5
p3004
sg9
V11202662.xml
p3005
sa(dp3006
g3
VSTD-Kretschmer-1990
p3007
sg5
S'PMC64503'
p3008
sg7
VCD001458 v. 5.0 Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy.rm5
p3009
sg9
V11786451.xml
p3010
sa(dp3011
g3
VSTD-Abul_x002d_Ainine-2002
p3012
sg5
S'PMC1719150'
p3013
sg7
VCD003123 v. 11.0 Epinephrine for bronchiolitis.rm5
p3014
sg9
V11919104.xml
p3015
sa(dp3016
g3
VSTD-Begg-1989
p3017
sg5
S'PMC1379894'
p3018
sg7
VCD002894 v. 6.0 Computerized advice on drug dosage to improve prescribing practice.rm5
p3019
sg9
V2775618.xml
p3020
sa(dp3021
g3
VSTD-Vadher-1997
p3022
sg5
S'PMC2126598'
p3023
sg7
g3019
sg9
V9154031.xml
p3024
sa(dp3025
g3
VSTD-Champion-2007
p3026
sg5
S'PMC1858664'
p3027
sg7
VCD001865 v. 8.4 Personalised risk communication for informed decision making about taking screening tests.rm5
p3028
sg9
V17196358.xml
p3029
sa(dp3030
g3
VSTD-Sequist-2011
p3031
sg5
S'PMC3169179'
p3032
sg7
g3028
sg9
V21149743.xml
p3033
sa(dp3034
g3
VSTD-Bodurtha-2009
p3035
sg5
S'PMC2945922'
p3036
sg7
g3028
sg9
V19105686.xml
p3037
sa(dp3038
g3
VSTD-Smith-2010
p3039
sg5
S'PMC2965151'
p3040
sg7
g3028
sg9
V20978060.xml
p3041
sa(dp3042
g3
VSTD-Rawl-2008
p3043
sg5
S'PMC2492833'
p3044
sg7
g3028
sg9
V18308500.xml
p3045
sa(dp3046
g3
VSTD-Manne-2009
p3047
sg5
S'PMC2707254'
p3048
sg7
g3028
sg9
V19418107.xml
p3049
sa(dp3050
g3
VSTD-Hutchison-1998
p3051
sg5
S'PMC28524'
p3052
sg7
g3028
sg9
V9552998.xml
p3053
sa(dp3054
g3
VSTD-Schwartz-1999
p3055
sg5
S'PMC1508646'
p3056
sg7
g3028
sg9
V10358689.xml
p3057
sa(dp3058
g3
VSTD-Steckelberg-2011
p3059
sg5
S'PMC3106362'
p3060
sg7
g3028
sg9
V21636633.xml
p3061
sa(dp3062
g3
VSTD-Skinner-1994
p3063
sg5
S'PMC1614921'
p3064
sg7
g3028
sg9
V8279610.xml
p3065
sa(dp3066
g3
VSTD-Manne-2010
p3067
sg5
S'PMC3058834'
p3068
sg7
g3028
sg9
V21090893.xml
p3069
sa(dp3070
g3
VSTD-Vadillo_x002d_Ortega-2011
p3071
sg5
S'PMC3100912'
p3072
sg7
VCD004905 v. 7.3 Multiple-micronutrient supplementation for women during pregnancy.rm5
p3073
sg9
V21596735.xml
p3074
sa(dp3075
g3
VSTD-Christian-2003
p3076
sg5
S'PMC151518'
p3077
sg7
g3073
sg9
V12637400.xml
p3078
sa(dp3079
g3
VSTD-Zeng-2008
p3080
sg5
S'PMC2577799'
p3081
sg7
g3073
sg9
V18996930.xml
p3082
sa(dp3083
g3
VSTD-Stabile-1988
p3084
sg5
S'PMC1778825'
p3085
sg7
VCD000361 v. 10.0 Intravenous immunoglobulin for preventing infection in preterm andor low birth weight infants.rm5
p3086
sg9
V3284483.xml
p3087
sa(dp3088
g3
VSTD-Fry-2003
p3089
sg5
S'PMC2376929'
p3090
sg7
VCD003721 v. 7.2 Cancer genetic risk assessment for individuals at risk of familial breast cancer.rm5
p3091
sg9
V12915873.xml
p3092
sa(dp3093
g3
VSTD-Young-2006
p3094
sg5
S'PMC2360713'
p3095
sg7
g3091
sg9
V17047645.xml
p3096
sa(dp3097
g3
VSTD-Ng-1977
p3098
sg5
S'PMC2496657'
p3099
sg7
VCD003558 v. 5.0 Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma.rm5
p3100
sg9
V407559.xml
p3101
sa(dp3102
g3
VSTD-Hofmeyr-1986
p3103
sg5
S'PMC460551'
p3104
sg7
VCD007862 v. 4.2 Active cycle of breathing technique for cystic fibrosis.rm5
p3105
sg9
V3296295.xml
p3106
sa(dp3107
g3
VSTD-Miller-1995
p3108
sg5
S'PMC473916'
p3109
sg7
g3105
sg9
V7701456.xml
p3110
sa(dp3111
g3
VSTD-Holland-2003
p3112
sg5
S'PMC1746478'
p3113
sg7
g3105
sg9
V14514944.xml
p3114
sa(dp3115
g3
VSTD-Osman-2008
p3116
sg5
S'PMC2922723'
p3117
sg7
g3105
sg9
V19703826.xml
p3118
sa(dp3119
g3
VSTD-Mooney-2009
p3120
sg5
S'PMC2742691'
p3121
sg7
VCD007380 v. 4.0 Efficacy of Psychostimulant Drugs for Cocaine Dependence.rm5
p3122
sg9
V19058926.xml
p3123
sa(dp3124
g3
VSTD-Pazirandeh-2007
p3125
sg5
S'PMC3202978'
p3126
sg7
VCD007605 v. 2.2 Nutritional interventions for liver-transplanted patients.rm5
p3127
sg9
V17947609.xml
p3128
sa(dp3129
g3
VSTD-Smith-1989
p3130
sg5
S'PMC172623'
p3131
sg7
VCD007022 v. 3.0 Teicoplanin versus vancomycin for proven or suspected infection.rm5
p3132
sg9
V2529814.xml
p3133
sa(dp3134
g3
VSTD-MMD_x002d_009-1992
p3135
sg5
S'PMC244945'
p3136
sg7
g3132
sg9
V1826594.xml
p3137
sa(dp3138
g3
VSTD-Menichetti-1994
p3139
sg5
S'PMC284681'
p3140
sg7
g3132
sg9
V7811016.xml
p3141
sa(dp3142
g3
VSTD-Nelson-1985
p3143
sg5
S'PMC2148530'
p3144
sg7
VCD007357 v. 4.0 Single dose oral etodolac for acute postoperative pain in adults.rm5
p3145
sg9
V2934008.xml
p3146
sa(dp3147
g3
VSTD-Marlowe-2007
p3148
sg5
S'PMC1885231'
p3149
sg7
VCD007668 v. 2.0 Psychological interventions for antisocial personality disorder.rm5
p3150
sg9
V17071020.xml
p3151
sa(dp3152
g3
VSTD-Havens-2007
p3153
sg5
S'PMC2231639'
p3154
sg7
g3150
sg9
V17334939.xml
p3155
sa(dp3156
g3
VSTD-Neufeld-2008
p3157
sg5
S'PMC2193670'
p3158
sg7
g3150
sg9
V17574801.xml
p3159
sa(dp3160
g3
VSTD-McLellan-1989
p3161
sg5
S'PMC2429442'
p3162
sg7
VCD000194 v. 9.0 Spironolactone versus placebo or in combination with steroids for hirsutism andor acne.rm5
p3163
sg9
V2690044.xml
p3164
sa(dp3165
g3
VSTD-Wiener-1977b
p3166
sg5
S'PMC1631362'
p3167
sg7
VCD003483 v. 6.3 Naloxone for opiate-exposed newborn infants.rm5
p3168
sg9
V884446.xml
p3169
sa(dp3170
g3
VSTD-Wiener-1977a
p3171
sg5
S'PMC1631408'
p3172
sg7
g3168
sg9
V328108.xml
p3173
sa(dp3174
g3
VSTD-Evans-1976
p3175
sg5
S'PMC1689462'
p3176
sg7
g3168
sg9
V990784.xml
p3177
sa(dp3178
g3
VSTD-Brice-1979a
p3179
sg5
S'PMC1545576'
p3180
sg7
g3168
sg9
V383023.xml
p3181
sa(dp3182
g3
VSTD-Bradford
p3183
sg5
S'PMC2351368'
p3184
sg7
VCD005066 v. 6.0 Stroke liaison workers for stroke patients and carers an individual patient data meta-analysis.rm5
p3185
sg9
V8664717.xml
p3186
sa(dp3187
g3
VSTD-Edinburgh
p3188
sg5
S'PMC2126479'
p3189
sg7
g3185
sg9
V9133884.xml
p3190
sa(dp3191
g3
VSTD-Aukett-1986
p3192
sg5
S'PMC1778027'
p3193
sg7
VCD001444 v. 6.4 Iron therapy for improving psychomotor development and cognitive function in children under the age .rm5
p3194
sg9
V2429622.xml
p3195
sa(dp3196
g3
VSTD-Ataoglu-2003
p3197
sg5
S'PMC3055095'
p3198
sg7
VCD006370 v. 5.0 Behavioural treatments for non-epileptic attack disorder.rm5
p3199
sg9
V12923337.xml
p3200
sa(dp3201
g3
VSTD-Dellinger-2007
p3202
sg5
S'PMC1877078'
p3203
sg7
VCD002941 v. 8.0 Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.rm5
p3204
sg9
V17457158.xml
p3205
sa(dp3206
g3
VSTD-Pepin-2000
p3207
sg5
S'PMC2560627'
p3208
sg7
VCD006201 v. 5.0 Chemotherapy for second-stage Human African trypanosomiasis.rm5
p3209
sg9
V11143188.xml
p3210
sa(dp3211
g3
VSTD-Priotto-2006
p3212
sg5
S'PMC1687208'
p3213
sg7
g3209
sg9
V17160135.xml
p3214
sa(dp3215
g3
VSTD-Benn-2008
p3216
sg5
S'PMC2432170'
p3217
sg7
VCD006980 v. 5.0 Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in.rm5
p3218
sg9
V18558641.xml
p3219
sa(dp3220
g3
VSTD-Rahmathullah-2003
p3221
sg5
S'PMC167159'
p3222
sg7
g3218
sg9
V12896935.xml
p3223
sa(dp3224
g3
VSTD-Benn-2010
p3225
sg5
S'PMC2835853'
p3226
sg7
g3218
sg9
V20215360.xml
p3227
sa(dp3228
g3
VSTD-Lewindon-1998
p3229
sg5
S'PMC1717567'
p3230
sg7
VCD008411 v. 4.0 Sweet-tasting solutions for needle-related procedural pain in infants one month to one year of age.rm5
p3231
sg9
V9659093.xml
p3232
sa(dp3233
g3
VSTD-Dowrick-1995
p3234
sg5
S'PMC2551186'
p3235
sg7
VCD002792 v. 8.0 Screening and case finding instruments for depression.rm5
p3236
sg9
V7496238.xml
p3237
sa(dp3238
g3
VSTD-Whooley-2000
p3239
sg5
S'PMC1495458'
p3240
sg7
g3236
sg9
V10840264.xml
p3241
sa(dp3242
g3
VSTD-Robinson-2008
p3243
sg5
S'PMC2743160'
p3244
sg7
VCD009286 v. 2.5 Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.rm5
p3245
sg9
V18505948.xml
p3246
sa(dp3247
g3
VSTD-Louie-2009
p3248
sg5
S'PMC2612138'
p3249
sg7
VCD004610 v. 8.0 Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.rm5
p3250
sg9
V18955525.xml
p3251
sa(dp3252
g3
VSTD-Keighley-1978
p3253
sg5
S'PMC1609009'
p3254
sg7
g3250
sg9
V367509.xml
p3255
sa(dp3256
g3
VSTD-de-Lalla-1992
p3257
sg5
S'PMC245474'
p3258
sg7
g3250
sg9
V1444298.xml
p3259
sa(dp3260
g3
VSTD-Selli-2002
p3261
sg5
S'PMC1769701'
p3262
sg7
VCD006019 v. 5.0 Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.rm5
p3263
sg9
V12101195.xml
p3264
sa(dp3265
g3
VSTD-Dugmore-1999
p3266
sg5
S'PMC1729018'
p3267
sg7
VCD001800 v. 13.0 Exercise-based cardiac rehabilitation for coronary heart disease.rm5
p3268
sg9
V10092561.xml
p3269
sa(dp3270
g3
VSTD-Bethell-1990
p3271
sg5
S'PMC1224812'
p3272
sg7
g3268
sg9
V2271343.xml
p3273
sa(dp3274
g3
VSTD-Lohmander-1996
p3275
sg5
S'PMC1010204'
p3276
sg7
VCD005321 v. 3.0 Viscosupplementation for the treatment of osteoarthritis of the knee.rm5
p3277
sg9
V8774159.xml
p3278
sa(dp3279
g3
VSTD-Pham-2004
p3280
sg5
S'PMC1754857'
p3281
sg7
g3277
sg9
V15331394.xml
p3282
sa(dp3283
g3
VSTD-Henderson-1994
p3284
sg5
S'PMC1005394'
p3285
sg7
g3277
sg9
V7944639.xml
p3286
sa(dp3287
g3
VSTD-Muirhead-2006
p3288
sg5
S'PMC1828262'
p3289
sg7
VCD001141 v. 9.4 Support for healthy breastfeeding mothers with healthy term babies.rm5
p3290
sg9
V16536959.xml
p3291
sa(dp3292
g3
VSTD-Su-2007
p3293
sg5
S'PMC1989016'
p3294
sg7
g3290
sg9
V17670909.xml
p3295
sa(dp3296
g3
VSTD-Ellis-1984
p3297
sg5
S'PMC2153583'
p3298
sg7
g3290
sg9
V21278959.xml
p3299
sa(dp3300
g3
VSTD-Graffy-2004
p3301
sg5
S'PMC313903'
p3302
sg7
g3290
sg9
V14703543.xml
p3303
sa(dp3304
g3
VSTD-Jones-1985
p3305
sg5
S'PMC1777420'
p3306
sg7
g3290
sg9
V4037866.xml
p3307
sa(dp3308
g3
VSTD-Morrell-2000
p3309
sg5
S'PMC27472'
p3310
sg7
g3290
sg9
V10977833.xml
p3311
sa(dp3312
g3
VSTD-Ransjo_x002d_Arvidson-1998
p3313
sg5
S'PMC1756723'
p3314
sg7
g3290
sg9
V9764260.xml
p3315
sa(dp3316
g3
VSTD-Froozani-1999
p3317
sg5
S'PMC2557680'
p3318
sg7
g3290
sg9
V10361754.xml
p3319
sa(dp3320
g3
VSTD-Hoddinott-2009
p3321
sg5
S'PMC2635594'
p3322
sg7
g3290
sg9
V19181729.xml
p3323
sa(dp3324
g3
VSTD-Pugh-2007
p3325
sg5
S'PMC2818063'
p3326
sg7
g3290
sg9
V19854119.xml
p3327
sa(dp3328
g3
VSTD-Dennis-2002
p3329
sg5
S'PMC99222'
p3330
sg7
g3290
sg9
V11800243.xml
p3331
sa(dp3332
g3
VSTD-Flores-1989
p3333
sg5
S'PMC267349'
p3334
sg7
VCD002848 v. 8.3 Rotavirus vaccine for preventing diarrhoea.rm5
p3335
sg9
V2541168.xml
p3336
sa(dp3337
g3
VSTD-Flores-1993
p3338
sg5
S'PMC265775'
p3339
sg7
g3335
sg9
V8408569.xml
p3340
sa(dp3341
g3
VSTD-Linhares-1996
p3342
sg5
S'PMC2486862'
p3343
sg7
g3335
sg9
V9002329.xml
p3344
sa(dp3345
g3
VSTD-Perez_x002d_Schael-1990c
p3346
sg5
S'PMC269661'
p3347
sg7
g3335
sg9
V2157737.xml
p3348
sa(dp3349
g3
VSTD-Corbett-2006
p3350
sg5
S'PMC1483908'
p3351
sg7
VCD005274 v. 5.2 Interventions to reduce risky sexual behaviour for preventing HIV infection in workers in occupation.rm5
p3352
sg9
V16796402.xml
p3353
sa(dp3354
g3
VSTD-Bing-2008
p3355
sg5
S'PMC2822543'
p3356
sg7
g3352
sg9
V18324469.xml
p3357
sa(dp3358
g3
VSTD-Essien-2010
p3359
sg5
S'PMC3059739'
p3360
sg7
g3352
sg9
V21106284.xml
p3361
sa(dp3362
g3
VSTD-Bourchier-1997
p3363
sg5
S'PMC1720650'
p3364
sg7
VCD003662 v. 6.0 Corticosteroids for treating hypotension in preterm infants.rm5
p3365
sg9
V9175947.xml
p3366
sa(dp3367
g3
VSTD-Coskun-2011
p3368
sg5
S'PMC3109380'
p3369
sg7
VCD004829 v. 5.2 Pain relief for women undergoing oocyte retrieval for assisted reproduction.rm5
p3370
sg9
V21789385.xml
p3371
sa(dp3372
g3
VSTD-Evans-1976
p3373
sg5
S'PMC2129830'
p3374
sg7
VCD001269 v. 13.0 Vaccines for preventing influenza in healthy adults.rm5
p3375
sg9
V1069813.xml
p3376
sa(dp3377
g3
VSTD-Waldman-1969a
p3378
sg5
S'PMC2427722'
p3379
sg7
g3375
sg9
V4908340.xml
p3380
sa(dp3381
g3
VSTD-Forsyth-1967
p3382
sg5
S'PMC2130402'
p3383
sg7
g3375
sg9
V5235254.xml
p3384
sa(dp3385
g3
VSTD-Waldman-1969c
p3386
sg5
S'PMC2427722'
p3387
sg7
g3375
sg9
V4908340.xml
p3388
sa(dp3389
g3
VSTD-Waldman-1969b
p3390
sg5
S'PMC2427722'
p3391
sg7
g3375
sg9
V4908340.xml
p3392
sa(dp3393
g3
VSTD-Waldman-1969d
p3394
sg5
S'PMC2427722'
p3395
sg7
g3375
sg9
V4908340.xml
p3396
sa(dp3397
g3
VSTD-Beran-2009a
p3398
sg5
S'PMC2639595'
p3399
sg7
g3375
sg9
V19149900.xml
p3400
sa(dp3401
g3
VSTD-Rocchi-1979b
p3402
sg5
S'PMC2130165'
p3403
sg7
g3375
sg9
V512351.xml
p3404
sa(dp3405
g3
VSTD-Rocchi-1979a
p3406
sg5
S'PMC2130165'
p3407
sg7
g3375
sg9
V512351.xml
p3408
sa(dp3409
g3
VSTD-Goodeve-1983
p3410
sg5
S'PMC2134195'
p3411
sg7
g3375
sg9
V6822725.xml
p3412
sa(dp3413
g3
VSTD-Spencer-1977
p3414
sg5
S'PMC274660'
p3415
sg7
g3375
sg9
V328526.xml
p3416
sa(dp3417
g3
VSTD-Smith-1980
p3418
sg5
S'PMC1344856'
p3419
sg7
VCD004539 v. 5.0 Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults.rm5
p3420
sg9
V6996625.xml
p3421
sa(dp3422
g3
VSTD-Cohn-2000
p3423
sg5
S'PMC1421138'
p3424
sg7
g3420
sg9
V10903605.xml
p3425
sa(dp3426
g3
VSTD-Gozenbach-1987
p3427
sg5
S'PMC1492722'
p3428
sg7
g3420
sg9
V3548611.xml
p3429
sa(dp3430
g3
VSTD-Solomkin-2001
p3431
sg5
S'PMC1421170'
p3432
sg7
g3420
sg9
V11141229.xml
p3433
sa(dp3434
g3
VSTD-Jaccard-1998
p3435
sg5
S'PMC105974'
p3436
sg7
g3420
sg9
V9797234.xml
p3437
sa(dp3438
g3
VSTD-Brismar-1992
p3439
sg5
S'PMC245542'
p3440
sg7
g3420
sg9
V1336347.xml
p3441
sa(dp3442
g3
VSTD-Dupont-2000
p3443
sg5
S'PMC90009'
p3444
sg7
g3420
sg9
V10898671.xml
p3445
sa(dp3446
g3
VSTD-Walker-1993
p3447
sg5
S'PMC1242749'
p3448
sg7
g3420
sg9
V8439209.xml
p3449
sa(dp3450
g3
VSTD-Berne-1987
p3451
sg5
S'PMC1492815'
p3452
sg7
g3420
sg9
V3545106.xml
p3453
sa(dp3454
g3
VSTD-Kiarie-2003
p3455
sg5
S'PMC3387271'
p3456
sg7
VCD003510 v. 8.0 Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.rm5
p3457
sg9
V12478070.xml
p3458
sa(dp3459
g3
VSTD-Chung-2005
p3460
sg5
S'PMC3381340'
p3461
sg7
g3457
sg9
V16103773.xml
p3462
sa(dp3463
g3
VSTD-Chung-2008
p3464
sg5
S'PMC2859833'
p3465
sg7
g3457
sg9
V18839781.xml
p3466
sa(dp3467
g3
VSTD-Mma-Bana
p3468
sg5
S'PMC2999916'
p3469
sg7
g3457
sg9
V20554983.xml
p3470
sa(dp3471
g3
VSTD-APN-2008
p3472
sg5
S'PMC2730636'
p3473
sg7
VCD003594 v. 12.0 Interventions for idiopathic steroid-resistant nephrotic syndrome in children.rm5
p3474
sg9
V18481113.xml
p3475
sa(dp3476
g3
VSTD-SCHILLING1991
p3477
sg5
S'PMC1580245'
p3478
sg7
VCD007192 v. 3.0 Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in dr.rm5
p3479
sg9
V1905051.xml
p3480
sa(dp3481
g3
VSTD-WECHSBERG2004
p3482
sg5
S'PMC1448416'
p3483
sg7
g3479
sg9
V15226138.xml
p3484
sa(dp3485
g3
VSTD-Mikami-2010
p3486
sg5
S'PMC2903643'
p3487
sg7
VCD003018 v. 6.2 Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5.rm5
p3488
sg9
V20339911.xml
p3489
sa(dp3490
g3
VSTD-Surratt-2010
p3491
sg5
S'PMC2879022'
p3492
sg7
VCD006045 v. 4.0 Behavioral interventions to reduce the transmission of HIV infection among sex workers and their cli.rm5
p3493
sg9
V20391059.xml
p3494
sa(dp3495
g3
VSTD-Pettinati-2008-arm-a
p3496
sg5
S'PMC2374760'
p3497
sg7
VCD007024 v. 3.0 Disulfiram for the treatment of cocaine dependence.rm5
p3498
sg9
V18079068.xml
p3499
sa(dp3500
g3
VSTD-Pettinati-2008-arm-b
p3501
sg5
S'PMC2374760'
p3502
sg7
g3498
sg9
V18079068.xml
p3503
sa(dp3504
g3
VSTD-Clarke-2009
p3505
sg5
S'PMC2727290'
p3506
sg7
VCD007415 v. 4.18 Temozolomide for high grade glioma.rm5
p3507
sg9
V19506159.xml
p3508
sa(dp3509
g3
VSTD-Ye-2009
p3510
sg5
S'PMC2654939'
p3511
sg7
VCD001750 v. 8.20 Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.rm5
p3512
sg9
V19225876.xml
p3513
sa(dp3514
g3
VSTD-Kurzawa-2008
p3515
sg5
S'PMC2582126'
p3516
sg7
g3512
sg9
V18802744.xml
p3517
sa(dp3518
g3
VSTD-Jacobson-2010
p3519
sg5
S'PMC2856743'
p3520
sg7
VCD008439 v. 3.0 Monoclonal CCR5 antibody for treatment of people with HIV infection.rm5
p3521
sg9
V20377413.xml
p3522
sa(dp3523
g3
VSTD-Cade-2000
p3524
sg5
S'PMC1718208'
p3525
sg7
VCD004878 v. 10.0 Glucocorticoids for acute viral bronchiolitis in infants and young children.rm5
p3526
sg9
V10648365.xml
p3527
sa(dp3528
g3
VSTD-Gustafson-2001
p3529
sg5
S'PMC1495237'
p3530
sg7
VCD004274 v. 5.0 Interactive Health Communication Applications for people with chronic disease.rm5
p3531
sg9
V11520380.xml
p3532
sa(dp3533
g3
VSTD-Shegog-2001
p3534
sg5
S'PMC134591'
p3535
sg7
g3531
sg9
V11141512.xml
p3536
sa(dp3537
g3
VSTD-Dragone-2002
p3538
sg5
S'PMC3307387'
p3539
sg7
g3531
sg9
V11932129.xml
p3540
sa(dp3541
g3
VSTD-Mahoney-2002
p3542
sg5
S'PMC346625'
p3543
sg7
g3531
sg9
V12087119.xml
p3544
sa(dp3545
g3
VSTD-Burke-1996
p3546
sg5
S'PMC472647'
p3547
sg7
VCD003274 v. 4.0 Budesonide versus placebo for chronic asthma in children and adults.rm5
p3548
sg9
V8977599.xml
p3549
sa(dp3550
g3
VSTD-Henriksen-1985
p3551
sg5
S'PMC1416830'
p3552
sg7
g3548
sg9
V3926141.xml
p3553
sa(dp3554
g3
VSTD-Gleeson-1988
p3555
sg5
S'PMC1834236'
p3556
sg7
g3548
sg9
V3044506.xml
p3557
sa(dp3558
g3
VSTD-Lorentzson-1990
p3559
sg5
S'PMC462715'
p3560
sg7
g3548
sg9
V1978947.xml
p3561
sa(dp3562
g3
VSTD-Varkey-2011
p3563
sg5
S'PMC3236524'
p3564
sg7
VCD010610 v. 1.2 Topiramate for the prophylaxis of episodic migraine in adults.rm5
p3565
sg9
V21890526.xml
p3566
sa(dp3567
g3
VSTD-Bahadoran-2010
p3568
sg5
S'PMC3208940'
p3569
sg7
VCD007426 v. 3.0 Relaxation therapy for preventing and treating preterm labour.rm5
p3570
sg9
V22069407.xml
p3571
sa(dp3572
g3
VSTD-Hughes-2010
p3573
sg5
S'PMC2930079'
p3574
sg7
VCD008033 v. 3.2 Reduction versus abrupt cessation in smokers who want to quit.rm5
p3575
sg9
V20537810.xml
p3576
sa(dp3577
g3
VSTD-Williams-1988
p3578
sg5
S'PMC1778891'
p3579
sg7
VCD008243 v. 4.0 Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosis.rm5
p3580
sg9
V3389899.xml
p3581
sa(dp3582
g3
VSTD-Lau-1996
p3583
sg5
S'PMC1235333'
p3584
sg7
VCD004778 v. 7.0 Laparoscopic repair for perforated peptic ulcer disease.rm5
p3585
sg9
V8757375.xml
p3586
sa(dp3587
g3
VSTD-Bertleff-2009
p3588
sg5
S'PMC2691927'
p3589
sg7
g3585
sg9
V19430829.xml
p3590
sa(dp3591
g3
VSTD-Siu-2002
p3592
sg5
S'PMC1422436'
p3593
sg7
g3585
sg9
V11882751.xml
p3594
sa(dp3595
g3
VSTD-Levens-2009
p3596
sg5
S'PMC2745125'
p3597
sg7
VCD004634 v. 4.0 Follicular flushing during oocyte retrieval in assisted reproductive techniques.rm5
p3598
sg9
V18675970.xml
p3599
sa(dp3600
g3
VSTD-Vogel-2004
p3601
sg5
S'PMC332712'
p3602
sg7
VCD001535 v. 8.0 Antibiotic duration for treating uncomplicated symptomatic lower urinary tract infections in elderl.rm5
p3603
sg9
V14970093.xml
p3604
sa(dp3605
g3
VSTD-Raz-1996
p3606
sg5
S'PMC163499'
p3607
sg7
g3603
sg9
V8878607.xml
p3608
sa(dp3609
g3
VSTD-Dow-1984
p3610
sg5
S'PMC1440107'
p3611
sg7
VCD002849 v. 11.0 Anxiolytics for smoking cessation.rm5
p3612
sg9
V6384510.xml
p3613
sa(dp3614
g3
VSTD-Trienekens-1989
p3615
sg5
S'PMC1838181'
p3616
sg7
VCD004682 v. 7.0 Duration of antibacterial treatment for uncomplicated urinary tract infection in women.rm5
p3617
sg9
V2513939.xml
p3618
sa(dp3619
g3
VSTD-Hooton-1991
p3620
sg5
S'PMC245194'
p3621
sg7
g3617
sg9
V1929311.xml
p3622
sa(dp3623
g3
VSTD-Trienekens-1993
p3624
sg5
S'PMC2379759'
p3625
sg7
g3617
sg9
V8471899.xml
p3626
sa(dp3627
g3
VSTD-Rapoport-1981
p3628
sg5
S'PMC1507721'
p3629
sg7
g3617
sg9
V6794832.xml
p3630
sa(dp3631
g3
VSTD-Jones-1993
p3632
sg5
S'PMC1055149'
p3633
sg7
VCD005471 v. 5.0 Interventions to improve outpatient referrals from primary care to secondary care.rm5
p3634
sg9
V10132454.xml
p3635
sa(dp3636
g3
VSTD-Banait-2000
p3637
sg5
S'PMC1314507'
p3638
sg7
g3634
sg9
V12817353.xml
p3639
sa(dp3640
g3
VSTD-Coulter-1993
p3641
sg5
S'PMC1676519'
p3642
sg7
g3634
sg9
V8461728.xml
p3643
sa(dp3644
g3
VSTD-Bridgman-2005
p3645
sg5
S'PMC1464070'
p3646
sg7
g3634
sg9
V16176738.xml
p3647
sa(dp3648
g3
VSTD-Emslie-1993
p3649
sg5
S'PMC1678278'
p3650
sg7
g3634
sg9
V8280213.xml
p3651
sa(dp3652
g3
VSTD-Morrison-2001
p3653
sg5
S'PMC31924'
p3654
sg7
g3634
sg9
V11375232.xml
p3655
sa(dp3656
g3
VSTD-O_x0027_Cathain-1995
p3657
sg5
S'PMC1239296'
p3658
sg7
g3634
sg9
V7612338.xml
p3659
sa(dp3660
g3
VSTD-Kammerling-1996
p3661
sg5
S'PMC2351139'
p3662
sg7
g3634
sg9
V8646099.xml
p3663
sa(dp3664
g3
VSTD-Brox-1993
p3665
sg5
S'PMC1679023'
p3666
sg7
VCD005619 v. 3.0 Surgery for rotator cuff disease.rm5
p3667
sg9
V8241852.xml
p3668
sa(dp3669
g3
VSTD-Rost-2004
p3670
sg5
S'PMC1350979'
p3671
sg7
VCD006237 v. 4.0 Interventions to improve occupational health in depressed people.rm5
p3672
sg9
V15550800.xml
p3673
sa(dp3674
g3
VSTD-Strozzi-2007
p3675
sg5
S'PMC2080548'
p3676
sg7
VCD004587 v. 4.0 Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.rm5
p3677
sg9
V17589978.xml
p3678
sa(dp3679
g3
VSTD-Hatlebakk-1999
p3680
sg5
S'PMC28208'
p3681
sg7
VCD002095 v. 12.0 Short-term treatment with proton pump inhibitors H2-receptor antagonists and prokinetics for gastro.rm5
p3682
sg9
V10463897.xml
p3683
sa(dp3684
g3
VSTD-Bardhan-1999
p3685
sg5
S'PMC27748'
p3686
sg7
g3682
sg9
V10024259.xml
p3687
sa(dp3688
g3
VSTD-Wynn-2007
p3689
sg5
S'PMC2716219'
p3690
sg7
VCD006654 v. 6.0 Olanzapine versus other atypical antipsychotics for schizophrenia.rm5
p3691
sg9
V17662577.xml
p3692
sa(dp3693
g3
VSTD-Explore-2004_x002a_
p3694
sg5
S'PMC1447873'
p3695
sg7
VCD001230 v. 3.2 Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with m.rm5
p3696
sg9
V12773358.xml
p3697
sa(dp3698
g3
VSTD-R_x002d_B-2004-phone_x0040_
p3699
sg5
S'PMC2843590'
p3700
sg7
g3696
sg9
V15385902.xml
p3701
sa(dp3702
g3
VSTD-Rotheram_x002d_Borus-2001_x0040_
p3703
sg5
S'PMC1446609'
p3704
sg7
g3696
sg9
V11236404.xml
p3705
sa(dp3706
g3
VSTD-CDC-ACDP-1999_x0040_
p3707
sg5
S'PMC1508588'
p3708
sg7
g3696
sg9
V10076482.xml
p3709
sa(dp3710
g3
VSTD-R_x002d_B-2004-in-person_x0040_
p3711
sg5
S'PMC2843590'
p3712
sg7
g3696
sg9
V15385902.xml
p3713
sa(dp3714
g3
VSTD-Kelly-1991
p3715
sg5
S'PMC1404968'
p3716
sg7
g3696
sg9
V1990853.xml
p3717
sa(dp3718
g3
VSTD-Imrie-2001_x002a__x0040_
p3719
sg5
S'PMC32307'
p3720
sg7
g3696
sg9
V11408300.xml
p3721
sa(dp3722
g3
VSTD-Coates-1989_x0040_
p3723
sg5
S'PMC1349674'
p3724
sg7
g3696
sg9
V2735479.xml
p3725
sa(dp3726
g3
VSTD-Kegeles-1996_x0040_
p3727
sg5
S'PMC1380625'
p3728
sg7
g3696
sg9
V8712273.xml
p3729
sa(dp3730
g3
VSTD-Chen-2009
p3731
sg5
S'PMC2666722'
p3732
sg7
VCD006207 v. 9.1 Physical interventions to interrupt or reduce the spread of respiratory viruses.rm5
p3733
sg9
V19284644.xml
p3734
sa(dp3735
g3
VSTD-Cowling-2008
p3736
sg5
S'PMC2364646'
p3737
sg7
g3733
sg9
V18461182.xml
p3738
sa(dp3739
g3
VSTD-Teleman-2004
p3740
sg5
S'PMC2870165'
p3741
sg7
g3733
sg9
V15473141.xml
p3742
sa(dp3743
g3
VSTD-Larson-2010
p3744
sg5
S'PMC2821845'
p3745
sg7
g3733
sg9
V20297744.xml
p3746
sa(dp3747
g3
VSTD-Wu-2004
p3748
sg5
S'PMC3322931'
p3749
sg7
g3733
sg9
V15030685.xml
p3750
sa(dp3751
g3
VSTD-MacIntyre-2009
p3752
sg5
S'PMC2662657'
p3753
sg7
g3733
sg9
V19193267.xml
p3754
sa(dp3755
g3
VSTD-Lau-2004a
p3756
sg5
S'PMC3323085'
p3757
sg7
g3733
sg9
V15200846.xml
p3758
sa(dp3759
g3
VSTD-Isaacs-1991
p3760
sg5
S'PMC1792812'
p3761
sg7
g3733
sg9
V2001109.xml
p3762
sa(dp3763
g3
VSTD-Cowling-2010
p3764
sg5
S'PMC3152767'
p3765
sg7
g3733
sg9
V20353566.xml
p3766
sa(dp3767
g3
VSTD-Turner-2004b
p3768
sg5
S'PMC434190'
p3769
sg7
g3733
sg9
V15215114.xml
p3770
sa(dp3771
g3
VSTD-Turner-2004a
p3772
sg5
S'PMC434190'
p3773
sg7
g3733
sg9
V15215114.xml
p3774
sa(dp3775
g3
VSTD-Li-2010
p3776
sg5
S'PMC2849689'
p3777
sg7
VCD005016 v. 7.0 High-flux versus low-flux membranes for end-stage kidney disease.rm5
p3778
sg9
V20203165.xml
p3779
sa(dp3780
g3
VSTD-MPO-2009
p3781
sg5
S'PMC2653681'
p3782
sg7
g3778
sg9
V19092122.xml
p3783
sa(dp3784
g3
VSTD-Hickson-2007
p3785
sg5
S'PMC1914504'
p3786
sg7
VCD006095 v. 3.0 Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.rm5
p3787
sg9
V17604300.xml
p3788
sa(dp3789
g3
VSTD-Psaradellis-2010
p3790
sg5
S'PMC3278944'
p3791
sg7
g3787
sg9
V22371721.xml
p3792
sa(dp3793
g3
VSTD-Beausoleil-2007
p3794
sg5
S'PMC2658588'
p3795
sg7
g3787
sg9
V18026577.xml
p3796
sa(dp3797
g3
VSTD-de-Wit-1999
p3798
sg5
S'PMC1420944'
p3799
sg7
VCD003641 v. 10.0 Surgery for obesity.rm5
p3800
sg9
V10615935.xml
p3801
sa(dp3802
g3
VSTD-Nguyen-2006
p3803
sg5
S'PMC1422019'
p3804
sg7
g3800
sg9
V11524581.xml
p3805
sa(dp3806
g3
VSTD-Sugerman-1987
p3807
sg5
S'PMC1493086'
p3808
sg7
g3800
sg9
V3296971.xml
p3809
sa(dp3810
g3
VSTD-Lujan-2004
p3811
sg5
S'PMC1356246'
p3812
sg7
g3800
sg9
V15024302.xml
p3813
sa(dp3814
g3
VSTD-Morino-2003
p3815
sg5
S'PMC1356165'
p3816
sg7
g3800
sg9
V14631220.xml
p3817
sa(dp3818
g3
VSTD-Kupka-2008
p3819
sg5
S'PMC2474659'
p3820
sg7
VCD009755 v. 1.0 Micronutrient supplementation in pregnant women with HIV infection.rm5
p3821
sg9
V18541571.xml
p3822
sa(dp3823
g3
VSTD-Kawai-2010
p3824
sg5
S'PMC2806894'
p3825
sg7
g3821
sg9
V19939985.xml
p3826
sa(dp3827
g3
VSTD-Harris-1984
p3828
sg5
S'PMC2573581'
p3829
sg7
VCD003539 v. 7.0 Interventions to improve antibiotic prescribing practices in ambulatory care.rm5
p3830
sg9
V6726669.xml
p3831
sa(dp3832
g3
VSTD-Little-2001
p3833
sg5
S'PMC26576'
p3834
sg7
g3830
sg9
V11159657.xml
p3835
sa(dp3836
g3
VSTD-McConnell-1982
p3837
sg5
S'PMC1274191'
p3838
sg7
g3830
sg9
V6891147.xml
p3839
sa(dp3840
g3
VSTD-Dowell-2001
p3841
sg5
S'PMC1313951'
p3842
sg7
g3830
sg9
V11255901.xml
p3843
sa(dp3844
g3
VSTD-O_x0027_Connell-1999
p3845
sg5
S'PMC27749'
p3846
sg7
g3830
sg9
V10024260.xml
p3847
sa(dp3848
g3
VSTD-Ilett-2000
p3849
sg5
S'PMC2014897'
p3850
sg7
g3830
sg9
V10671912.xml
p3851
sa(dp3852
g3
VSTD-Hux-1999
p3853
sg5
S'PMC1230539'
p3854
sg7
g3830
sg9
V10478162.xml
p3855
sa(dp3856
g3
VSTD-Lagerlov-2000
p3857
sg5
S'PMC1743532'
p3858
sg7
g3830
sg9
V10980076.xml
p3859
sa(dp3860
g3
VSTD-Stewart-2000
p3861
sg5
S'PMC2144801'
p3862
sg7
g3830
sg9
V10790817.xml
p3863
sa(dp3864
g3
VSTD-Flottorp-2002
p3865
sg5
S'PMC117890'
p3866
sg7
g3830
sg9
V12183309.xml
p3867
sa(dp3868
g3
VSTD-Macfarlane-2002
p3869
sg5
S'PMC64506'
p3870
sg7
g3830
sg9
V11786454.xml
p3871
sa(dp3872
g3
VSTD-Dacre1989
p3873
sg5
S'PMC1003749'
p3874
sg7
VCD004258 v. 7.0 Physiotherapy interventions for shoulder pain.rm5
p3875
sg9
V2712613.xml
p3876
sa(dp3877
g3
VSTD-Winters-1997_x002f_9
p3878
sg5
S'PMC27885'
p3879
sg7
g3875
sg9
V10334751.xml
p3880
sa(dp3881
g3
VSTD-Bulgen-1984
p3882
sg5
S'PMC1001344'
p3883
sg7
g3875
sg9
V6742895.xml
p3884
sa(dp3885
g3
VSTD-Atzpodien-2002
p3886
sg5
S'PMC2375173'
p3887
sg7
VCD005413 v. 4.0 Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.rm5
p3888
sg9
V11870502.xml
p3889
sa(dp3890
g3
VSTD-Johnston-1998
p3891
sg5
S'PMC2150174'
p3892
sg7
g3888
sg9
V9579834.xml
p3893
sa(dp3894
g3
VSTD-Christensen-2001
p3895
sg5
S'PMC3620612'
p3896
sg7
VCD003324 v. 10.0 Rehabilitation for distal radial fractures in adults.rm5
p3897
sg9
V11374267.xml
p3898
sa(dp3899
g3
VSTD-Seabrook-2005
p3900
sg5
S'PMC2722618'
p3901
sg7
VCD005230 v. 4.8 Complementary and miscellaneous interventions for nocturnal enuresis in children.rm5
p3902
sg9
V19668674.xml
p3903
sa(dp3904
g3
VSTD-McKendry-1975
p3905
sg5
S'PMC1956570'
p3906
sg7
g3902
sg9
V1192312.xml
p3907
sa(dp3908
g3
VSTD-Izbicki-1998
p3909
sg5
S'PMC1191184'
p3910
sg7
VCD004699 v. 7.0 Surgery for local and locally advanced non-small cell lung cancer.rm5
p3911
sg9
V9445122.xml
p3912
sa(dp3913
g3
VSTD-Shepherd-1998
p3914
sg5
S'PMC2063048'
p3915
sg7
g3911
sg9
V9744511.xml
p3916
sa(dp3917
g3
VSTD-Lin-2005
p3918
sg5
S'PMC1550679'
p3919
sg7
VCD007978 v. 3.0 Email for clinical communication between patientscaregivers and healthcare professionals.rm5
p3920
sg9
V16236699.xml
p3921
sa(dp3922
g3
VSTD-Ross-2004
p3923
sg5
S'PMC1550594'
p3924
sg7
g3920
sg9
V15249261.xml
p3925
sa(dp3926
g3
VSTD-Katz-2003
p3927
sg5
S'PMC1494914'
p3928
sg7
g3920
sg9
V12950483.xml
p3929
sa(dp3930
g3
VSTD-Sahota-2001
p3931
sg5
S'PMC59380'
p3932
sg7
VCD001871 v. 13.12 Interventions for preventing obesity in children.rm5
p3933
sg9
V11691758.xml
p3934
sa(dp3935
g3
VSTD-Gentile-2009
p3936
sg5
S'PMC2758893'
p3937
sg7
g3933
sg9
V19765270.xml
p3938
sa(dp3939
g3
VSTD-Donnelly-2009
p3940
sg5
S'PMC2766439'
p3941
sg7
g3933
sg9
V19665037.xml
p3942
sa(dp3943
g3
VSTD-Webber-2008
p3944
sg5
S'PMC2275165'
p3945
sg7
g3933
sg9
V18312804.xml
p3946
sa(dp3947
g3
VSTD-Reilly-2006
p3948
sg5
S'PMC1647320'
p3949
sg7
g3933
sg9
V17028105.xml
p3950
sa(dp3951
g3
VSTD-Pate-2005
p3952
sg5
S'PMC1449401'
p3953
sg7
g3933
sg9
V16118370.xml
p3954
sa(dp3955
g3
VSTD-Lazaar-2007
p3956
sg5
S'PMC2040215'
p3957
sg7
g3933
sg9
V17718785.xml
p3958
sa(dp3959
g3
VSTD-New-York-1971
p3960
sg5
S'PMC1067443'
p3961
sg7
VCD009009 v. 3.0 General health checks in adults for reducing morbidity and mortality from disease.rm5
p3962
sg9
V4569090.xml
p3963
sa(dp3964
g3
VSTD-Tamblyn-2003
p3965
sg5
S'PMC191278'
p3966
sg7
VCD008165 v. 2.0 Interventions to improve the appropriate use of polypharmacy for older people.rm5
p3967
sg9
V12975221.xml
p3968
sa(dp3969
g3
VSTD-Freelander-1984
p3970
sg5
S'PMC1441767'
p3971
sg7
VCD000052 v. 12.3 Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.rm5
p3972
sg9
V6428582.xml
p3973
sa(dp3974
g3
VSTD-Parkin-1995
p3975
sg5
S'PMC1511081'
p3976
sg7
g3972
sg9
V7741574.xml
p3977
sa(dp3978
g3
VSTD-Lin-1995
p3979
sg5
S'PMC1511067'
p3980
sg7
g3972
sg9
V7741566.xml
p3981
sa(dp3982
g3
VSTD-Dewar-1999
p3983
sg5
S'PMC1717926'
p3984
sg7
g3972
sg9
V10208945.xml
p3985
sa(dp3986
g3
VSTD-Hakim-2000
p3987
sg5
S'PMC1760932'
p3988
sg7
VCD000526 v. 7.2 Interventions for treating tuberculous pericarditis.rm5
p3989
sg9
V10908256.xml
p3990
sa(dp3991
g3
VSTD-Woodruff-2003
p3992
sg5
S'PMC3673685'
p3993
sg7
VCD006188 v. 3.0 Surgical interventions for the rheumatoid shoulder.rm5
p3994
sg9
V12582801.xml
p3995
sa(dp3996
g3
VSTD-Rosenberg-2007
p3997
sg5
S'PMC1964758'
p3998
sg7
g3994
sg9
V17683577.xml
p3999
sa(dp4000
g3
VSTD-Nuki-1973
p4001
sg5
S'PMC1006142'
p4002
sg7
VCD003113 v. 7.0 Opioid therapy for treating rheumatoid arthritis pain.rm5
p4003
sg9
V4584572.xml
p4004
sa(dp4005
g3
VSTD-Egsmose-1965
p4006
sg5
S'PMC2475854'
p4007
sg7
VCD001363 v. 7.0 Isoniazid for preventing tuberculosis in non-HIV infected persons.rm5
p4008
sg9
V5321762.xml
p4009
sa(dp4010
g3
VSTD-Zucherman-2004
p4011
sg5
S'PMC3468027'
p4012
sg7
VCD001352 v. 7.8 Surgery for degenerative lumbar spondylosis.rm5
p4013
sg9
V14685830.xml
p4014
sa(dp4015
g3
VSTD-Madan-2003
p4016
sg5
S'PMC3467791'
p4017
sg7
g4013
sg9
V12955608.xml
p4018
sa(dp4019
g3
VSTD-Griffiths-2004
p4020
sg5
S'PMC314511'
p4021
sg7
VCD000409 v. 7.0 Educational outreach visits effects on professional practice and health care outcomes.rm5
p4022
sg9
V14718266.xml
p4023
sa(dp4024
g3
VSTD-Siriwardena-2002
p4025
sg5
S'PMC1314414'
p4026
sg7
g4022
sg9
V12236277.xml
p4027
sa(dp4028
g3
VSTD-Kerse--1999
p4029
sg5
S'PMC28221'
p4030
sg7
g4022
sg9
V10480825.xml
p4031
sa(dp4032
g3
VSTD-Crotty-2004
p4033
sg5
S'PMC415557'
p4034
sg7
g4022
sg9
V15066200.xml
p4035
sa(dp4036
g3
VSTD-McConnell-1982
p4037
sg5
S'PMC1274191'
p4038
sg7
g4022
sg9
V6891147.xml
p4039
sa(dp4040
g3
VSTD-Newton_x002d_Syms-1992
p4041
sg5
S'PMC1381201'
p4042
sg7
g4022
sg9
V1540493.xml
p4043
sa(dp4044
g3
VSTD-Fretheim-2006
p4045
sg5
S'PMC1472698'
p4046
sg7
g4022
sg9
V16737349.xml
p4047
sa(dp4048
g3
VSTD-Borgiel-1999
p4049
sg5
S'PMC1230705'
p4050
sg7
g4022
sg9
V10551192.xml
p4051
sa(dp4052
g3
VSTD-Dey-2004
p4053
sg5
S'PMC1314775'
p4054
sg7
g4022
sg9
V14965404.xml
p4055
sa(dp4056
g3
VSTD-Cockburn--1992
p4057
sg5
S'PMC1881508'
p4058
sg7
g4022
sg9
V1571645.xml
p4059
sa(dp4060
g3
VSTD-Freemantle-2000
p4061
sg5
S'PMC2014899'
p4062
sg7
g4022
sg9
V10671913.xml
p4063
sa(dp4064
g3
VSTD-Martin-2004
p4065
sg5
S'PMC315525'
p4066
sg7
g4022
sg9
V14734433.xml
p4067
sa(dp4068
g3
VSTD-vanden-Hombergh-1999
p4069
sg5
S'PMC2483655'
p4070
sg7
g4022
sg9
V10847872.xml
p4071
sa(dp4072
g3
VSTD-Kaner-1999
p4073
sg5
S'PMC1313496'
p4074
sg7
g4022
sg9
V10756610.xml
p4075
sa(dp4076
g3
VSTD-Putnam-1985
p4077
sg5
S'PMC1346180'
p4078
sg7
g4022
sg9
V3986727.xml
p4079
sa(dp4080
g3
VSTD-Lemelin-2001
p4081
sg5
S'PMC80870'
p4082
sg7
g4022
sg9
V11276541.xml
p4083
sa(dp4084
g3
VSTD-Frijling-2003
p4085
sg5
S'PMC1743704'
p4086
sg7
g4022
sg9
V12792007.xml
p4087
sa(dp4088
g3
VSTD-Loeb-2005
p4089
sg5
S'PMC1226247'
p4090
sg7
g4022
sg9
V16150741.xml
p4091
sa(dp4092
g3
VSTD-Fender-1999
p4093
sg5
S'PMC27863'
p4094
sg7
g4022
sg9
V10231255.xml
p4095
sa(dp4096
g3
VSTD-Premaratne-1999
p4097
sg5
S'PMC27864'
p4098
sg7
g4022
sg9
V10231256.xml
p4099
sa(dp4100
g3
VSTD-Freemantle-2002
p4101
sg5
S'PMC1314269'
p4102
sg7
g4022
sg9
V11942445.xml
p4103
sa(dp4104
g3
VSTD-Feder-1995
p4105
sg5
S'PMC2543702'
p4106
sg7
g4022
sg9
V8520339.xml
p4107
sa(dp4108
g3
VSTD-Modell-1998
p4109
sg5
S'PMC28672'
p4110
sg7
g4022
sg9
V9740569.xml
p4111
sa(dp4112
g3
VSTD-Ilett-2000
p4113
sg5
S'PMC2014897'
p4114
sg7
g4022
sg9
V10671912.xml
p4115
sa(dp4116
g3
VSTD-Wyatt-1998
p4117
sg5
S'PMC28686'
p4118
sg7
g4022
sg9
V9774287.xml
p4119
sa(dp4120
g3
VSTD-Chang-1998
p4121
sg5
S'PMC1717639'
p4122
sg7
VCD005373 v. 6.0 Inhaled beta2-agonists for non-specific chronic cough in children.rm5
p4123
sg9
V9771244.xml
p4124
sa(dp4125
g3
VSTD-Galarza-1995
p4126
sg5
S'PMC1021356'
p4127
sg7
VCD001876 v. 8.0 Corticosteroids for tuberculous pleurisy.rm5
p4128
sg9
V8553306.xml
p4129
sa(dp4130
g3
VSTD-Gaziano-2009
p4131
sg5
S'PMC2774210'
p4132
sg7
VCD002141 v. 10.0 Drugs for preventing lung cancer in healthy people.rm5
p4133
sg9
V19066368.xml
p4134
sa(dp4135
g3
VSTD-Lin-2009
p4136
sg5
S'PMC2615459'
p4137
sg7
g4133
sg9
V19116389.xml
p4138
sa(dp4139
g3
VSTD-Lippman-2009
p4140
sg5
S'PMC3682779'
p4141
sg7
g4133
sg9
V19066370.xml
p4142
sa(dp4143
g3
VSTD-Darouiche-2005
p4144
sg5
S'PMC1357724'
p4145
sg7
VCD007878 v. 4.0 Catheter impregnation coating or bonding for reducing central venous catheter-related infections in.rm5
p4146
sg9
V16041209.xml
p4147
sa(dp4148
g3
VSTD-Sherertz-1996
p4149
sg5
S'PMC163461'
p4150
sg7
g4146
sg9
V8878569.xml
p4151
sa(dp4152
g3
VSTD-Bong-2003
p4153
sg5
S'PMC1770068'
p4154
sg7
g4146
sg9
V14514774.xml
p4155
sa(dp4156
g3
VSTD-Prantera-2002a
p4157
sg5
S'PMC1773351'
p4158
sg7
VCD004826 v. 5.0 Probiotics for maintenance of remission in Crohn's disease.rm5
p4159
sg9
V12171964.xml
p4160
sa(dp4161
g3
VSTD-Schultz-2004
p4162
sg5
S'PMC394324'
p4163
sg7
g4159
sg9
V15113451.xml
p4164
sa(dp4165
g3
VSTD-Schwandner-2011
p4166
sg5
S'PMC3196995'
p4167
sg7
VCD002111 v. 8.0 Biofeedback andor sphincter exercises for the treatment of faecal incontinence in adults.rm5
p4168
sg9
V22013492.xml
p4169
sa(dp4170
g3
VSTD-Callaway-2010
p4171
sg5
S'PMC2890340'
p4172
sg7
VCD009021 v. 2.0 Exercise for pregnant women for preventing gestational diabetes mellitus.rm5
p4173
sg9
V20357374.xml
p4174
sa(dp4175
g3
VSTD-Strandberg-1995
p4176
sg5
S'PMC484055'
p4177
sg7
VMR000009 v. 8.2 Outcomes of patients who participate in randomized controlled trials compared to similar patients re.rm5
p4178
sg9
V7488463.xml
p4179
sa(dp4180
g3
VSTD-Mahon-1996
p4181
sg5
S'PMC2350863'
p4182
sg7
g4178
sg9
V8616414.xml
p4183
sa(dp4184
g3
VSTD-Dahan-1986
p4185
sg5
S'PMC1341050'
p4186
sg7
g4178
sg9
V3089521.xml
p4187
sa(dp4188
g3
VSTD-Chilvers-2001a
p4189
sg5
S'PMC30555'
p4190
sg7
g4178
sg9
V11282864.xml
p4191
sa(dp4192
g3
VSTD-Chilvers-2001b
p4193
sg5
S'PMC30555'
p4194
sg7
g4178
sg9
V11282864.xml
p4195
sa(dp4196
g3
VSTD-Henshaw-1993a
p4197
sg5
S'PMC1678709'
p4198
sg7
g4178
sg9
V8401094.xml
p4199
sa(dp4200
g3
VSTD-Henshaw-1993b
p4201
sg5
S'PMC1678709'
p4202
sg7
g4178
sg9
V8401094.xml
p4203
sa(dp4204
g3
VSTD-Bradshaw-1975
p4205
sg5
S'PMC1083241'
p4206
sg7
VCD000248 v. 6.0 Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or tr.rm5
p4207
sg9
V1159434.xml
p4208
sa(dp4209
g3
VSTD-Vermeulen-1993
p4210
sg5
S'PMC1014761'
p4211
sg7
VCD001797 v. 7.0 Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.rm5
p4212
sg9
V8429321.xml
p4213
sa(dp4214
g3
VSTD-Kumana-2003
p4215
sg5
S'PMC1884301'
p4216
sg7
VCD003598 v. 8.0 Antihypertensive treatment for kidney transplant recipients.rm5
p4217
sg9
V14616428.xml
p4218
sa(dp4219
g3
VSTD-Benders-2006
p4220
sg5
S'PMC2672696'
p4221
sg7
VCD006817 v. 4.0 Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encepha.rm5
p4222
sg9
V16428356.xml
p4223
sa(dp4224
g3
VSTD-Phelan-2011
p4225
sg5
S'PMC3057546'
p4226
sg7
VCD007145 v. 2.0 Interventions for preventing excessive weight gain during pregnancy.rm5
p4227
sg9
V21310836.xml
p4228
sa(dp4229
g3
VSTD-Callaway-2010
p4230
sg5
S'PMC2890340'
p4231
sg7
g4227
sg9
V20357374.xml
p4232
sa(dp4233
g3
VSTD-Rhodes-2010
p4234
sg5
S'PMC2980957'
p4235
sg7
g4227
sg9
V20962162.xml
p4236
sa(dp4237
g3
VSTD-Korpi_x002d_Hyovalti-2011
p4238
sg5
S'PMC3078095'
p4239
sg7
g4227
sg9
V21429234.xml
p4240
sa(dp4241
g3
VSTD-Moses-2009
p4242
sg5
S'PMC2681032'
p4243
sg7
g4227
sg9
V19279301.xml
p4244
sa(dp4245
g3
VSTD-Luoto-2011
p4246
sg5
S'PMC3096610'
p4247
sg7
g4227
sg9
V21610860.xml
p4248
sa(dp4249
g3
VSTD-Dodd-2006
p4250
sg5
S'PMC1388124'
p4251
sg7
VCD001338 v. 7.0 Oral misoprostol for induction of labour.rm5
p4252
sg9
V16455695.xml
p4253
sa(dp4254
g3
VSTD-Ott-1998
p4255
sg5
S'PMC3015252'
p4256
sg7
VCD007821 v. 2.0 Heated CO2 with or without humidification for minimally invasive abdominal surgery.rm5
p4257
sg9
V10036122.xml
p4258
sa(dp4259
g3
VSTD-Taylor--1977
p4260
sg5
S'PMC1631450'
p4261
sg7
VCD000247 v. 11.0 Antibiotics for the common cold and acute purulent rhinitis.rm5
p4262
sg9
V329949.xml
p4263
sa(dp4264
g3
VSTD-Wu-2002
p4265
sg5
S'PMC1447358'
p4266
sg7
VCD005030 v. 9.0 Interventions for prevention of drug use by young people delivered in non-school settings.rm5
p4267
sg9
V12453815.xml
p4268
sa(dp4269
g3
VSTD-Biglan-2000
p4270
sg5
S'PMC1748303'
p4271
sg7
g4267
sg9
V10691755.xml
p4272
sa(dp4273
g3
VSTD-Flay-2004
p4274
sg5
S'PMC2386246'
p4275
sg7
g4267
sg9
V15066879.xml
p4276
sa(dp4277
g3
VSTD-Wiberg_x002d_Itzel-2008
p4278
sg5
S'PMC2413392'
p4279
sg7
VCD006174 v. 4.0 Intrapartum fetal scalp lactate sampling for fetal assessment in the presence of a non-reassuring fe.rm5
p4280
sg9
V18503103.xml
p4281
sa(dp4282
g3
VSTD-Pachowsky-2011
p4283
sg5
S'PMC3311811'
p4284
sg7
VCD009261 v. 4.0 Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention.rm5
p4285
sg9
V21761149.xml
p4286
sa(dp4287
g3
VSTD-Llanos-2006
p4288
sg5
S'PMC1856589'
p4289
sg7
g4285
sg9
V17060762.xml
p4290
sa(dp4291
g3
VSTD-Kiss-2004
p4292
sg5
S'PMC509340'
p4293
sg7
VCD006178 v. 6.0 Antenatal lower genital tract infection screening and treatment programs for preventing preterm deli.rm5
p4294
sg9
V15294856.xml
p4295
sa(dp4296
g3
VSTD-Garbutt-2012
p4297
sg5
S'PMC3667493'
p4298
sg7
VCD006089 v. 8.1 Antibiotics for clinically diagnosed acute rhinosinusitis in adults.rm5
p4299
sg9
V22337680.xml
p4300
sa(dp4301
g3
VSTD-Stalman-1997
p4302
sg5
S'PMC1410064'
p4303
sg7
g4299
sg9
V9463979.xml
p4304
sa(dp4305
g3
VSTD-Scott-2002
p4306
sg5
S'PMC1784606'
p4307
sg7
VCD004946 v. 4.0 Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) rec.rm5
p4308
sg9
V12530483.xml
p4309
sa(dp4310
g3
VSTD-Aronstam-1977
p4311
sg5
S'PMC476643'
p4312
sg7
VCD003429 v. 9.0 Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people .rm5
p4313
sg9
V320230.xml
p4314
sa(dp4315
g3
VSTD-Boogaerts-2003
p4316
sg5
S'PMC2376376'
p4317
sg7
VCD007303 v. 3.2 Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient d.rm5
p4318
sg9
V12671693.xml
p4319
sa(dp4320
g3
VSTD-Wilkinson-2006
p4321
sg5
S'PMC2361228'
p4322
sg7
g4318
sg9
V16570051.xml
p4323
sa(dp4324
g3
VSTD-Moore-1991
p4325
sg5
S'PMC1014522'
p4326
sg7
VCD003633 v. 3.0 Botulinum toxin type A therapy for cervical dystonia.rm5
p4327
sg9
V1955900.xml
p4328
sa(dp4329
g3
VSTD-Blackie-1990
p4330
sg5
S'PMC488163'
p4331
sg7
g4327
sg9
V2213040.xml
p4332
sa(dp4333
g3
VSTD-Lindor-2009
p4334
sg5
S'PMC2758780'
p4335
sg7
VCD003626 v. 6.0 Bile acids for primary sclerosing cholangitis.rm5
p4336
sg9
V19585548.xml
p4337
sa(dp4338
g3
VSTD-Weitoft-2003
p4339
sg5
S'PMC1754327'
p4340
sg7
VCD002824 v. 5.0 Intra-articular steroids and splintsrest for children with juvenile idiopathic arthritis and adults.rm5
p4341
sg9
V12972485.xml
p4342
sa(dp4343
g3
VSTD-Ros-2001
p4344
sg5
S'PMC1422133'
p4345
sg7
VCD006229 v. 2.2 Laparoscopic versus small-incision cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
p4346
sg9
V11729380.xml
p4347
sa(dp4348
g3
VSTD-Floyd-2007
p4349
sg5
S'PMC2888541'
p4350
sg7
VCD007249 v. 3.0 Theory-based interventions for contraception.rm5
p4351
sg9
V17218187.xml
p4352
sa(dp4353
g3
VSTD-Ingersoll-2005
p4354
sg5
S'PMC2875062'
p4355
sg7
g4351
sg9
V16183466.xml
p4356
sa(dp4357
g3
VSTD-Barnet-2009
p4358
sg5
S'PMC2746510'
p4359
sg7
g4351
sg9
V19752472.xml
p4360
sa(dp4361
g3
VSTD-Kirby-2010
p4362
sg5
S'PMC3153424'
p4363
sg7
g4351
sg9
V21126301.xml
p4364
sa(dp4365
g3
VSTD-Peipert-2008
p4366
sg5
S'PMC2535847'
p4367
sg7
g4351
sg9
V18395692.xml
p4368
sa(dp4369
g3
VSTD-Coyle-2001
p4370
sg5
S'PMC1913682'
p4371
sg7
g4351
sg9
V11889277.xml
p4372
sa(dp4373
g3
VSTD-Wight-2002
p4374
sg5
S'PMC115856'
p4375
sg7
g4351
sg9
V12065268.xml
p4376
sa(dp4377
g3
VSTD-Gabriel-1977
p4378
sg5
S'PMC1653741'
p4379
sg7
VCD004804 v. 6.0 Interventions for improving adherence to treatment in patients with high blood pressure in ambulator.rm5
p4380
sg9
V911007.xml
p4381
sa(dp4382
g3
VSTD-Johnson-1978
p4383
sg5
S'PMC1819059'
p4384
sg7
g4380
sg9
V369673.xml
p4385
sa(dp4386
g3
VSTD-Asplund-1984
p4387
sg5
S'PMC1463452'
p4388
sg7
g4380
sg9
V6375710.xml
p4389
sa(dp4390
g3
VSTD-Goodman-2006
p4391
sg5
S'PMC2670780'
p4392
sg7
VCD003401 v. 6.0 Combined spinal-epidural versus epidural analgesia in labour.rm5
p4393
sg9
V19095858.xml
p4394
sa(dp4395
g3
VSTD-Klaber-Moffet-2005
p4396
sg5
S'PMC543869'
p4397
sg7
VCD005106 v. 9.0 Patient education for neck pain.rm5
p4398
sg9
V15585539.xml
p4399
sa(dp4400
g3
VSTD-Sherman-2009
p4401
sg5
S'PMC2664516'
p4402
sg7
g4398
sg9
V19333174.xml
p4403
sa(dp4404
g3
VSTD-Seymour-1996
p4405
sg5
S'PMC2042618'
p4406
sg7
VCD007355 v. 6.0 Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults.rm5
p4407
sg9
V8799525.xml
p4408
sa(dp4409
g3
VSTD-Rathbun-2012
p4410
sg5
S'PMC3343207'
p4411
sg7
VCD004982 v. 8.0 Treatment for superficial thrombophlebitis of the leg.rm5
p4412
sg9
V22360152.xml
p4413
sa(dp4414
g3
VSTD-Gorecka-1997
p4415
sg5
S'PMC1758616'
p4416
sg7
VCD001744 v. 10.0 Domiciliary oxygen for chronic obstructive pulmonary disease.rm5
p4417
sg9
V9337824.xml
p4418
sa(dp4419
g3
VSTD-Humphrey-1996
p4420
sg5
S'PMC2486738'
p4421
sg7
VCD007480 v. 2.0 Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age.rm5
p4422
sg9
V7867131.xml
p4423
sa(dp4424
g3
VSTD-Benn-2008
p4425
sg5
S'PMC2432170'
p4426
sg7
g4422
sg9
V18558641.xml
p4427
sa(dp4428
g3
VSTD-Benn-2010
p4429
sg5
S'PMC2835853'
p4430
sg7
g4422
sg9
V20215360.xml
p4431
sa(dp4432
g3
VSTD-Owen-2009
p4433
sg5
S'PMC2768604'
p4434
sg7
VCD008991 v. 2.0 Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy.rm5
p4435
sg9
V19788970.xml
p4436
sa(dp4437
g3
VSTD-Takwale-2003
p4438
sg5
S'PMC292992'
p4439
sg7
VCD004416 v. 6.0 Oral evening primrose oil and borage oil for eczema.rm5
p4440
sg9
V14670885.xml
p4441
sa(dp4442
g3
VSTD-Hederos-1996
p4443
sg5
S'PMC1511801'
p4444
sg7
g4440
sg9
V9014601.xml
p4445
sa(dp4446
g3
VSTD-Zwart-2003
p4447
sg5
S'PMC286321'
p4448
sg7
VCD000023 v. 20.0 Antibiotics for sore throat.rm5
p4449
sg9
V14656841.xml
p4450
sa(dp4451
g3
VSTD-Little-1997
p4452
sg5
S'PMC2126131'
p4453
sg7
g4449
sg9
V9116551.xml
p4454
sa(dp4455
g3
VSTD-Landsman-1951
p4456
sg5
S'PMC2068130'
p4457
sg7
g4449
sg9
V14821407.xml
p4458
sa(dp4459
g3
VSTD-Petersen-1997
p4460
sg5
S'PMC1497066'
p4461
sg7
g4449
sg9
V9051558.xml
p4462
sa(dp4463
g3
VSTD-Howe-1997
p4464
sg5
S'PMC1313000'
p4465
sg7
g4449
sg9
V9219402.xml
p4466
sa(dp4467
g3
VSTD-MacDonald-1951
p4468
sg5
S'PMC2068133'
p4469
sg7
g4449
sg9
V14821406.xml
p4470
sa(dp4471
g3
VSTD-Dagnelie-1996
p4472
sg5
S'PMC1239783'
p4473
sg7
g4449
sg9
V8945796.xml
p4474
sa(dp4475
g3
VSTD-Moorthy-2004b
p4476
sg5
S'PMC524376'
p4477
sg7
VCD006198 v. 3.0 Vaccines for preventing malaria (pre-erythrocytic).rm5
p4478
sg9
V15526058.xml
p4479
sa(dp4480
g3
VSTD-Gomez_x002d_Jimenez-1993
p4481
sg5
S'PMC188024'
p4482
sg7
VCD002232 v. 8.9 Antibiotics for spontaneous bacterial peritonitis in cirrhotic patients.rm5
p4483
sg9
V8215267.xml
p4484
sa(dp4485
g3
VSTD-P_x00e9_rez_x002d_B_x00e1_rcena-2008
p4486
sg5
S'PMC2575601'
p4487
sg7
VCD000033 v. 9.12 Barbiturates for acute traumatic brain injury.rm5
p4488
sg9
V18759980.xml
p4489
sa(dp4490
g3
VSTD-P_x002d_Hilton_x002d_Jones_x0028_D_x0029_
p4491
sg5
S'PMC1083170'
p4492
sg7
VCD001790 v. 7.0 Posture and fluids for preventing post-dural puncture headache.rm5
p4493
sg9
V7131001.xml
p4494
sa(dp4495
g3
VSTD-Kirby-2010
p4496
sg5
S'PMC3153424'
p4497
sg7
VCD004317 v. 8.0 Strategies to improve adherence and acceptability of hormonal methods of contraception.rm5
p4498
sg9
V21126301.xml
p4499
sa(dp4500
g3
VSTD-Toll-2010a
p4501
sg5
S'PMC3771701'
p4502
sg7
VCD003086 v. 10.2 Opioid antagonists for smoking cessation.rm5
p4503
sg9
V20542391.xml
p4504
sa(dp4505
g3
VSTD-Dundee-1986
p4506
sg5
S'PMC1341376'
p4507
sg7
VCD003281 v. 6.0 Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting.rm5
p4508
sg9
V3092933.xml
p4509
sa(dp4510
g3
VSTD-Barsoum-1990
p4511
sg5
S'PMC1292503'
p4512
sg7
g4508
sg9
V2181138.xml
p4513
sa(dp4514
g3
VSTD-Ko-2009
p4515
sg5
S'PMC2650992'
p4516
sg7
VCD009557 v. 2.0 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and a.rm5
p4517
sg9
V19270819.xml
p4518
sa(dp4519
g3
VSTD-Lennox-2001
p4520
sg5
S'PMC32255'
p4521
sg7
VCD004492 v. 9.0 Stage-based interventions for smoking cessation.rm5
p4522
sg9
V11397745.xml
p4523
sa(dp4524
g3
VSTD-Prochaska-2008
p4525
sg5
S'PMC3384542'
p4526
sg7
g4522
sg9
V18155287.xml
p4527
sa(dp4528
g3
VSTD-Meyer-2008
p4529
sg5
S'PMC2253708'
p4530
sg7
g4522
sg9
V17995993.xml
p4531
sa(dp4532
g3
VSTD-Prokhorov-2008
p4533
sg5
S'PMC2365030'
p4534
sg7
g4522
sg9
V18280668.xml
p4535
sa(dp4536
g3
VSTD-Young-2008
p4537
sg5
S'PMC2268921'
p4538
sg7
g4522
sg9
V18304363.xml
p4539
sa(dp4540
g3
VSTD-Stoltzfus-2001
p4541
sg5
S'PMC60982'
p4542
sg7
VCD000371 v. 15.4 Deworming drugs for soil-transmitted intestinal worms in children effects on nutritional indicators.rm5
p4543
sg9
V11744561.xml
p4544
sa(dp4545
g3
VSTD-Awasthi-2008-_x0028_Cluster_x0029_
p4546
sg5
S'PMC2291568'
p4547
sg7
g4543
sg9
V18414647.xml
p4548
sa(dp4549
g3
VSTD-Alderman-2006-_x0028_Cluster_x0029_
p4550
sg5
S'PMC1502184'
p4551
sg7
g4543
sg9
V16790460.xml
p4552
sa(dp4553
g3
VSTD-Kirwan-2010
p4554
sg5
S'PMC3161357'
p4555
sg7
g4543
sg9
V20858280.xml
p4556
sa(dp4557
g3
VSTD-Willett-1979
p4558
sg5
S'PMC1619153'
p4559
sg7
g4543
sg9
V384815.xml
p4560
sa(dp4561
g3
VSTD-Baram-1996
p4562
sg5
S'PMC3100715'
p4563
sg7
VCD001770 v. 17.10 Treatment of infantile spasms.rm5
p4564
sg9
V8604274.xml
p4565
sa(dp4566
g3
VSTD-WACS-2007
p4567
sg5
S'PMC2034519'
p4568
sg7
VCD004183 v. 10.0 Antioxidant supplements for preventing gastrointestinal cancers.rm5
p4569
sg9
V17698683.xml
p4570
sa(dp4571
g3
VSTD-Chu-2004
p4572
sg5
S'PMC3181213'
p4573
sg7
VCD008186 v. 2.0 Water-based exercises for improving activities of daily living after stroke.rm5
p4574
sg9
V15179638.xml
p4575
sa(dp4576
g3
VSTD-van-der-Molen-1997
p4577
sg5
S'PMC1758577'
p4578
sg7
VCD006923 v. 6.0 Regular treatment with formoterol for chronic asthma serious adverse events.rm5
p4579
sg9
V9227720.xml
p4580
sa(dp4581
g3
VSTD-Chalela-2007
p4582
sg5
S'PMC1859855'
p4583
sg7
VCD007424 v. 2.0 Magnetic resonance imaging versus computed tomography for detection of acute vascular lesions in pat.rm5
p4584
sg9
V17258669.xml
p4585
sa(dp4586
g3
VSTD-Rashiq-1986
p4587
sg5
S'PMC1339971'
p4588
sg7
VCD005185 v. 6.2 Thiazide diuretics and the risk of hip fracture.rm5
p4589
sg9
V3083912.xml
p4590
sa(dp4591
g3
VSTD-Atroshi-2006
p4592
sg5
S'PMC1482334'
p4593
sg7
VCD003905 v. 8.0 Surgical treatment options for carpal tunnel syndrome.rm5
p4594
sg9
V16777857.xml
p4595
sa(dp4596
g3
VSTD-Yip-2002
p4597
sg5
S'PMC3620974'
p4598
sg7
VCD000168 v. 10.0 Pre-operative traction for hip fractures in adults.rm5
p4599
sg9
V12466869.xml
p4600
sa(dp4601
g3
VSTD-Bogner-2008
p4602
sg5
S'PMC2478504'
p4603
sg7
VCD006560 v. 4.0 Interventions for improving outcomes in patients with multimorbidity in primary care and community s.rm5
p4604
sg9
V18626028.xml
p4605
sa(dp4606
g3
VSTD-Hogg-2009
p4607
sg5
S'PMC2793206'
p4608
sg7
g4604
sg9
V20008582.xml
p4609
sa(dp4610
g3
VSTD-Fung-1991
p4611
sg5
S'PMC2950613'
p4612
sg7
VCD005161 v. 6.0 Cyclosporin versus tacrolimus for liver transplanted patients.rm5
p4613
sg9
V1721333.xml
p4614
sa(dp4615
g3
VSTD-Narvekar-2010
p4616
sg5
S'PMC2890904'
p4617
sg7
VCD009517 v. 2.6 Endometrial injury in women undergoing assisted reproductive techniques.rm5
p4618
sg9
V20607003.xml
p4619
sa(dp4620
g3
VSTD-Tang-2006
p4621
sg5
S'PMC1448972'
p4622
sg7
VCD005080 v. 3.0 Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction af.rm5
p4623
sg9
V16552194.xml
p4624
sa(dp4625
g3
VSTD-Vrijiland-2002
p4626
sg5
S'PMC1422414'
p4627
sg7
g4623
sg9
V11807358.xml
p4628
sa(dp4629
g3
VSTD-Shim-2012
p4630
sg5
S'PMC3260973'
p4631
sg7
VCD007253 v. 5.13 Interventions for smoking cessation and reduction in individuals with schizophrenia.rm5
p4632
sg9
V22048460.xml
p4633
sa(dp4634
g3
VSTD-_x005e_Horst-2005
p4635
sg5
S'PMC2424122'
p4636
sg7
g4632
sg9
V18568115.xml
p4637
sa(dp4638
g3
VSTD-Weinberger-2008
p4639
sg5
S'PMC3675443'
p4640
sg7
g4632
sg9
V18344743.xml
p4641
sa(dp4642
g3
VSTD-_x002a_George-2008
p4643
sg5
S'PMC2693008'
p4644
sg7
g4632
sg9
V18096137.xml
p4645
sa(dp4646
g3
VSTD-_x002b_Tidey-2011
p4647
sg5
S'PMC3685403'
p4648
sg7
g4632
sg9
V21475970.xml
p4649
sa(dp4650
g3
VSTD-Kelly-2008
p4651
sg5
S'PMC2547986'
p4652
sg7
g4632
sg9
V18550339.xml
p4653
sa(dp4654
g3
VSTD-_x002a_Weiner-2011
p4655
sg5
S'PMC3691956'
p4656
sg7
g4632
sg9
V21376537.xml
p4657
sa(dp4658
g3
VSTD-Hong-2011
p4659
sg5
S'PMC3618988'
p4660
sg7
g4632
sg9
V21810630.xml
p4661
sa(dp4662
g3
VSTD-Subhedar-1997
p4663
sg5
S'PMC1720712'
p4664
sg7
VCD000509 v. 11.0 Inhaled nitric oxide for respiratory failure in preterm infants.rm5
p4665
sg9
V9462187.xml
p4666
sa(dp4667
g3
VSTD-Ziegler-2010
p4668
sg5
S'PMC2845038'
p4669
sg7
VCD009318 v. 2.0 Lacosamide for neuropathic pain and fibromyalgia in adults.rm5
p4670
sg9
V20067958.xml
p4671
sa(dp4672
g3
VSTD-DICE-1994
p4673
sg5
S'PMC2540045'
p4674
sg7
VCD004910 v. 4.0 Effectiveness of shared care across the interface between primary and specialty care in chronic dise.rm5
p4675
sg9
V8180540.xml
p4676
sa(dp4677
g3
VSTD-McGhee-1994
p4678
sg5
S'PMC1239016'
p4679
sg7
g4675
sg9
V7748631.xml
p4680
sa(dp4681
g3
VSTD-Llewelyn_x002d_Jones-1999
p4682
sg5
S'PMC28220'
p4683
sg7
g4675
sg9
V10480824.xml
p4684
sa(dp4685
g3
VSTD-Byng-2004
p4686
sg5
S'PMC1314850'
p4687
sg7
g4675
sg9
V15113492.xml
p4688
sa(dp4689
g3
VSTD-Qu-2007
p4690
sg5
S'PMC1810361'
p4691
sg7
VCD009232 v. 2.0 Acupuncture or acupressure for pain management in labour.rm5
p4692
sg9
V17342250.xml
p4693
sa(dp4694
g3
VSTD-Kariminia-2004
p4695
sg5
S'PMC351839'
p4696
sg7
VCD001063 v. 5.0 Hands and knees posture in late pregnancy or labour for fetal malposition (lateral or posterior).rm5
p4697
sg9
V14744821.xml
p4698
sa(dp4699
g3
VSTD-Sulke-1992
p4700
sg5
S'PMC1024703'
p4701
sg7
VCD003710 v. 6.0 Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricul.rm5
p4702
sg9
V1739528.xml
p4703
sa(dp4704
g3
VSTD-Mitsuoka
p4705
sg5
S'PMC1216582'
p4706
sg7
g4702
sg9
V3056477.xml
p4707
sa(dp4708
g3
VSTD-Boon
p4709
sg5
S'PMC1277244'
p4710
sg7
g4702
sg9
V3304370.xml
p4711
sa(dp4712
g3
VSTD-Hargreaves
p4713
sg5
S'PMC484046'
p4714
sg7
g4702
sg9
V7488454.xml
p4715
sa(dp4716
g3
VSTD-Kenny
p4717
sg5
S'PMC1236894'
p4718
sg7
g4702
sg9
V3790382.xml
p4719
sa(dp4720
g3
VSTD-Oldroyd
p4721
sg5
S'PMC1024577'
p4722
sg7
g4702
sg9
V1827588.xml
p4723
sa(dp4724
g3
VSTD-Perrins
p4725
sg5
S'PMC481382'
p4726
sg7
g4702
sg9
V6349666.xml
p4727
sa(dp4728
g3
VSTD-Morisky-2001
p4729
sg5
S'PMC1497389'
p4730
sg7
VCD004808 v. 6.2 Contracts between patients and healthcare practitioners for improving patients' adherence to treatme.rm5
p4731
sg9
V12196616.xml
p4732
sa(dp4733
g3
VSTD-Aragona-1975
p4734
sg5
S'PMC1311852'
p4735
sg7
g4731
sg9
V1184491.xml
p4736
sa(dp4737
g3
VSTD-Campbell_x002d_Brown-1987
p4738
sg5
S'PMC1246728'
p4739
sg7
VCD007855 v. 2.0 Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy.rm5
p4740
sg9
V3113538.xml
p4741
sa(dp4742
g3
VSTD-Creed_x002d_UK_x002d_1996
p4743
sg5
S'PMC2126667'
p4744
sg7
VCD004026 v. 6.0 Day hospital versus admission for acute psychiatric disorders.rm5
p4745
sg9
V9161310.xml
p4746
sa(dp4747
g3
VSTD-Cochrane-1990
p4748
sg5
S'PMC462468'
p4749
sg7
VCD001116 v. 9.2 Physical training for asthma.rm5
p4750
sg9
V2116678.xml
p4751
sa(dp4752
g3
VSTD-Matsumoto-1999
p4753
sg5
S'PMC1745437'
p4754
sg7
g4750
sg9
V10325893.xml
p4755
sa(dp4756
g3
VSTD-Macdonald-1992
p4757
sg5
S'PMC1590483'
p4758
sg7
VCD001819 v. 6.0 Continuous nasogastric milk feeding versus intermittent bolus milk feeding for premature infants les.rm5
p4759
sg9
V1586185.xml
p4760
sa(dp4761
g3
VSTD-Bouzari-2011
p4762
sg5
S'PMC3217057'
p4763
sg7
VCD009997 v. 1.0 Intermittent oral iron supplementation during pregnancy.rm5
p4764
sg9
V22026956.xml
p4765
sa(dp4766
g3
VSTD-Yekta-2011
p4767
sg5
S'PMC3233526'
p4768
sg7
g4764
sg9
V22162919.xml
p4769
sa(dp4770
g3
VSTD-Boscoe-1983
p4771
sg5
S'PMC1549862'
p4772
sg7
VCD005566 v. 4.0 Prophylactic corticosteroids for cardiopulmonary bypass in adults.rm5
p4773
sg9
V6416575.xml
p4774
sa(dp4775
g3
VSTD-Starobin-2007
p4776
sg5
S'PMC1892551'
p4777
sg7
g4773
sg9
V17547746.xml
p4778
sa(dp4779
g3
VSTD-Maartense-2004a
p4780
sg5
S'PMC1356514'
p4781
sg7
VCD006267 v. 3.3 Open versus laparoscopic (assisted) ileo pouch anal anastomosis for ulcerative colitis and familial .rm5
p4782
sg9
V15570204.xml
p4783
sa(dp4784
g3
VSTD-Larson-2006
p4785
sg5
S'PMC1570559'
p4786
sg7
g4782
sg9
V16633002.xml
p4787
sa(dp4788
g3
VSTD-Brown-2007
p4789
sg5
S'PMC2213513'
p4790
sg7
VCD000031 v. 17.0 Antidepressants for smoking cessation.rm5
p4791
sg9
V17577801.xml
p4792
sa(dp4793
g3
VSTD-Aveyard-2008
p4794
sg5
S'PMC2405820'
p4795
sg7
g4791
sg9
V18441375.xml
p4796
sa(dp4797
g3
VSTD-George-2008
p4798
sg5
S'PMC2693008'
p4799
sg7
g4791
sg9
V18096137.xml
p4800
sa(dp4801
g3
VSTD-Grant-2007
p4802
sg5
S'PMC2064868'
p4803
sg7
g4791
sg9
V17889314.xml
p4804
sa(dp4805
g3
VSTD-Piper-2007
p4806
sg5
S'PMC3030120'
p4807
sg7
g4791
sg9
V17763111.xml
p4808
sa(dp4809
g3
VSTD-Niaura-2002
p4810
sg5
S'PMC1852538'
p4811
sg7
g4791
sg9
V12182272.xml
p4812
sa(dp4813
g3
VSTD-Holt-2005
p4814
sg5
S'PMC1747282'
p4815
sg7
g4791
sg9
V15681499.xml
p4816
sa(dp4817
g3
VSTD-Tan-2008
p4818
sg5
S'PMC2780654'
p4819
sg7
VCD006761 v. 5.0 Conventional versus LigaSure hemorrhoidectomy for patients with symptomatic Hemorrhoids.rm5
p4820
sg9
V18545884.xml
p4821
sa(dp4822
g3
VSTD-de-Lalla-2001
p4823
sg5
S'PMC90429'
p4824
sg7
VCD006810 v. 4.2 Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections.rm5
p4825
sg9
V11257020.xml
p4826
sa(dp4827
g3
VSTD-Wamalwa-2009
p4828
sg5
S'PMC2708138'
p4829
sg7
VCD009513 v. 1.0 Interventions to improve adherence to antiretroviral therapy in children with HIV infection.rm5
p4830
sg9
V19549342.xml
p4831
sa(dp4832
g3
VSTD-Bolam-1998
p4833
sg5
S'PMC28481'
p4834
sg7
VCD010038 v. 2.2 Face to face interventions for informing or educating parents about early childhood vaccination.rm5
p4835
sg9
V9549449.xml
p4836
sa(dp4837
g3
VSTD-Usman-2011
p4838
sg5
S'PMC3763701'
p4839
sg7
g4835
sg9
V21159080.xml
p4840
sa(dp4841
g3
VSTD-Steiner-2001
p4842
sg5
S'PMC26560'
p4843
sg7
VCD002214 v. 6.0 Effectiveness of intermediate care in nursing-led in-patient units.rm5
p4844
sg9
V11222419.xml
p4845
sa(dp4846
g3
VSTD-Patel-2009
p4847
sg5
S'PMC2684117'
p4848
sg7
VCD005436 v. 5.0 Oral zinc for treating diarrhoea in children.rm5
p4849
sg9
V19416499.xml
p4850
sa(dp4851
g3
VSTD-Roy-1997
p4852
sg5
S'PMC1717301'
p4853
sg7
g4849
sg9
V9370894.xml
p4854
sa(dp4855
g3
VSTD-Patel-2009a-_x0028_zinc_x0029_
p4856
sg5
S'PMC2684117'
p4857
sg7
g4849
sg9
V19416499.xml
p4858
sa(dp4859
g3
VSTD-Patel-2009b-_x0028_zinc_x002b_copper_x0029_
p4860
sg5
S'PMC2684117'
p4861
sg7
g4849
sg9
V19416499.xml
p4862
sa(dp4863
g3
VSTD-d-SGCTG-1986
p4864
sg5
S'PMC1977737'
p4865
sg7
VCD001418 v. 8.0 Chemotherapy for advanced ovarian cancer.rm5
p4866
sg9
V1739629.xml
p4867
sa(dp4868
g3
VSTD-Stenson-1998
p4869
sg5
S'PMC1720861'
p4870
sg7
VCD001815 v. 6.6 Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.rm5
p4871
sg9
V10194995.xml
p4872
sa(dp4873
g3
VSTD-Ng-PC-2001
p4874
sg5
S'PMC1721258'
p4875
sg7
g4871
sg9
V11320044.xml
p4876
sa(dp4877
g3
VSTD-Louis-2009
p4878
sg5
S'PMC2826448'
p4879
sg7
VCD008535 v. 2.0 Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease evidence from observati.rm5
p4880
sg9
V19696520.xml
p4881
sa(dp4882
g3
VSTD-Simon-2010
p4883
sg5
S'PMC2939261'
p4884
sg7
g4880
sg9
V20669249.xml
p4885
sa(dp4886
g3
VSTD-Ritz-2010
p4887
sg5
S'PMC2917467'
p4888
sg7
g4880
sg9
V20437557.xml
p4889
sa(dp4890
g3
VSTD-Ton-2007
p4891
sg5
S'PMC1893113'
p4892
sg7
g4880
sg9
V17055323.xml
p4893
sa(dp4894
g3
VSTD-Slama-1990
p4895
sg5
S'PMC1663307'
p4896
sg7
VCD000165 v. 14.0 Physician advice for smoking cessation.rm5
p4897
sg9
V2202445.xml
p4898
sa(dp4899
g3
VSTD-Marshall-1985
p4900
sg5
S'PMC1415622'
p4901
sg7
g4897
sg9
V3922510.xml
p4902
sa(dp4903
g3
VSTD-Lang-2000
p4904
sg5
S'PMC1731676'
p4905
sg7
g4897
sg9
V10814655.xml
p4906
sa(dp4907
g3
VSTD-Rose-78_x002d_92
p4908
sg5
S'PMC1060968'
p4909
sg7
g4897
sg9
V370171.xml
p4910
sa(dp4911
g3
VSTD-Janz-1987
p4912
sg5
S'PMC1647206'
p4913
sg7
g4897
sg9
V3592033.xml
p4914
sa(dp4915
g3
VSTD-Meyer-2008
p4916
sg5
S'PMC2253708'
p4917
sg7
g4897
sg9
V17995993.xml
p4918
sa(dp4919
g3
VSTD-BTS-1990a
p4920
sg5
S'PMC462779'
p4921
sg7
g4897
sg9
V2256010.xml
p4922
sa(dp4923
g3
VSTD-Richmond-1986
p4924
sg5
S'PMC1339727'
p4925
sg7
g4897
sg9
V3082450.xml
p4926
sa(dp4927
g3
VSTD-Jamrozik-1984
p4928
sg5
S'PMC1441184'
p4929
sg7
g4897
sg9
V6426618.xml
p4930
sa(dp4931
g3
VSTD-Unrod-2007
p4932
sg5
S'PMC1829425'
p4933
sg7
g4897
sg9
V17372796.xml
p4934
sa(dp4935
g3
VSTD-Stewart-1982
p4936
sg5
S'PMC1863274'
p4937
sg7
g4897
sg9
V7074505.xml
p4938
sa(dp4939
g3
VSTD-Wilson-1982
p4940
sg5
S'PMC1862918'
p4941
sg7
g4897
sg9
V7037143.xml
p4942
sa(dp4943
g3
VSTD-BTS-1990b
p4944
sg5
S'PMC462779'
p4945
sg7
g4897
sg9
V2256010.xml
p4946
sa(dp4947
g3
VSTD-Russell-1983
p4948
sg5
S'PMC1549849'
p4949
sg7
g4897
sg9
V6416593.xml
p4950
sa(dp4951
g3
VSTD-Lalit-2004
p4952
sg5
S'PMC2950952'
p4953
sg7
VCD006534 v. 4.0 Citalopram versus other anti-depressive agents for depression.rm5
p4954
sg9
V21206792.xml
p4955
sa(dp4956
g3
VSTD-Ekberg-1994
p4957
sg5
S'PMC1128125'
p4958
sg7
VCD002194 v. 8.1 Multidisciplinary biopsychosocial rehabilitation for neck and shoulder pain among working age adults.rm5
p4959
sg9
V7849868.xml
p4960
sa(dp4961
g3
VSTD-Windbichler-2000
p4962
sg5
S'PMC2363351'
p4963
sg7
VCD009620 v. 2.0 Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.rm5
p4964
sg9
V10735496.xml
p4965
sa(dp4966
g3
VSTD-Hall-2004
p4967
sg5
S'PMC2364769'
p4968
sg7
g4964
sg9
V15305182.xml
p4969
sa(dp4970
g3
VSTD-Ridsdale-1999
p4971
sg5
S'PMC1313394'
p4972
sg7
VCD006244 v. 6.0 Care delivery and self-management strategies for adults with epilepsy.rm5
p4973
sg9
V10736906.xml
p4974
sa(dp4975
g3
VSTD-Thapar-2002
p4976
sg5
S'PMC1314230'
p4977
sg7
g4973
sg9
V11885833.xml
p4978
sa(dp4979
g3
VSTD-Ridsdale-1997
p4980
sg5
S'PMC2125629'
p4981
sg7
g4973
sg9
V9006472.xml
p4982
sa(dp4983
g3
VSTD-Kalilani-2007
p4984
sg5
S'PMC2048661'
p4985
sg7
VCD004912 v. 5.0 Drugs for treating uncomplicated malaria in pregnant women.rm5
p4986
sg9
V18000538.xml
p4987
sa(dp4988
g3
VSTD-Coulibaly-2006
p4989
sg5
S'PMC1533839'
p4990
sg7
g4986
sg9
V16776817.xml
p4991
sa(dp4992
g3
VSTD-Newschaffer-1998b
p4993
sg5
S'PMC3456288'
p4994
sg7
VCD004348 v. 4.0 Setting and organization of care for persons living with HIVAIDS.rm5
p4995
sg9
V9663974.xml
p4996
sa(dp4997
g3
VSTD-Smith-1996
p4998
sg5
S'PMC2350105'
p4999
sg7
g4995
sg9
V8601114.xml
p5000
sa(dp5001
g3
VSTD-Turner-1998
p5002
sg5
S'PMC1496898'
p5003
sg7
g4995
sg9
V9462490.xml
p5004
sa(dp5005
g3
VSTD-Keitz-2001
p5006
sg5
S'PMC1495270'
p5007
sg7
g4995
sg9
V11556937.xml
p5008
sa(dp5009
g3
VSTD-Hendrickse-1965
p5010
sg5
S'PMC1944076'
p5011
sg7
VCD003954 v. 4.0 Diazepam for treating tetanus.rm5
p5012
sg9
V5917405.xml
p5013
sa(dp5014
g3
VSTD-Sehgal-1994
p5015
sg5
S'PMC2607653'
p5016
sg7
VCD000144 v. 6.0 Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.rm5
p5017
sg9
V8151722.xml
p5018
sa(dp5019
g3
VSTD-Park-2001
p5020
sg5
S'PMC1422079'
p5021
sg7
VCD005059 v. 7.0 Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery.rm5
p5022
sg9
V11573049.xml
p5023
sa(dp5024
g3
VSTD-Hawthorne-1992
p5025
sg5
S'PMC1882467'
p5026
sg7
VCD000478 v. 6.0 Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.rm5
p5027
sg9
V1638191.xml
p5028
sa(dp5029
g3
VSTD-Jewell-1974
p5030
sg5
S'PMC1612983'
p5031
sg7
g5027
sg9
V4441827.xml
p5032
sa(dp5033
g3
VSTD-Szegedi-2005
p5034
sg5
S'PMC552808'
p5035
sg7
VCD000448 v. 10.0 St John's wort for major depression.rm5
p5036
sg9
V15708844.xml
p5037
sa(dp5038
g3
VSTD-Woelk-2000
p5039
sg5
S'PMC27467'
p5040
sg7
g5036
sg9
V10968813.xml
p5041
sa(dp5042
g3
VSTD-van-Gurp-2002
p5043
sg5
S'PMC2214056'
p5044
sg7
g5036
sg9
V12053635.xml
p5045
sa(dp5046
g3
VSTD-Kasper-2006
p5047
sg5
S'PMC1538611'
p5048
sg7
g5036
sg9
V16796730.xml
p5049
sa(dp5050
g3
VSTD-Philipp-1999
p5051
sg5
S'PMC28296'
p5052
sg7
g5036
sg9
V10591711.xml
p5053
sa(dp5054
g3
VSTD-UKPDS-39
p5055
sg5
S'PMC28660'
p5056
sg7
VCD001841 v. 7.0 First-line drugs for hypertension.rm5
p5057
sg9
V9732338.xml
p5058
sa(dp5059
g3
VSTD-Sooch-1965
p5060
sg5
S'PMC2555234'
p5061
sg7
VCD003819 v. 4.2 Iodine supplementation for preventing iodine deficiency disorders in children.rm5
p5062
sg9
V14315706.xml
p5063
sa(dp5064
g3
VSTD-Stutchfield-2005
p5065
sg5
S'PMC1226243'
p5066
sg7
VCD006614 v. 4.0 Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at te.rm5
p5067
sg9
V16115831.xml
p5068
sa(dp5069
g3
VSTD-Woody-2008
p5070
sg5
S'PMC2610690'
p5071
sg7
VCD006749 v. 4.2 Detoxification treatments for opiate dependent adolescents.rm5
p5072
sg9
V18984887.xml
p5073
sa(dp5074
g3
VSTD-Chamberlain-1984
p5075
sg5
S'PMC2494468'
p5076
sg7
VCD002929 v. 10.0 Disposable surgical face masks for preventing surgical wound infection in clean surgery.rm5
p5077
sg9
V6391343.xml
p5078
sa(dp5079
g3
VSTD-Predel-2004
p5080
sg5
S'PMC1724805'
p5081
sg7
VCD007402 v. 4.0 Topical NSAIDs for acute pain in adults.rm5
p5082
sg9
V15155436.xml
p5083
sa(dp5084
g3
VSTD-Campbell-1994
p5085
sg5
S'PMC1342427'
p5086
sg7
g5082
sg9
V7804585.xml
p5087
sa(dp5088
g3
VSTD-Weller-1980
p5089
sg5
S'PMC471218'
p5090
sg7
VCD007168 v. 3.0 Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.rm5
p5091
sg9
V6767295.xml
p5092
sa(dp5093
g3
VSTD-Nyman-1983
p5094
sg5
S'PMC1040004'
p5095
sg7
VCD005137 v. 5.0 Interventions for unilateral and bilateral refractive amblyopia.rm5
p5096
sg9
V6337623.xml
p5097
sa(dp5098
g3
VSTD-Clarke-2003
p5099
sg5
S'PMC286242'
p5100
sg7
g5096
sg9
V14644966.xml
p5101
sa(dp5102
g3
VSTD-Stewart-2007a
p5103
sg5
S'PMC2001048'
p5104
sg7
g5096
sg9
V17855283.xml
p5105
sa(dp5106
g3
VSTD-PEDIG-2006a
p5107
sg5
S'PMC1609192'
p5108
sg7
g5096
sg9
V16751033.xml
p5109
sa(dp5110
g3
VSTD-PEDIG-2008
p5111
sg5
S'PMC2615691'
p5112
sg7
g5096
sg9
V18789533.xml
p5113
sa(dp5114
g3
VSTD-Brown-2003
p5115
sg5
S'PMC1766133'
p5116
sg7
VCD003289 v. 8.0 Tobacco cessation interventions for young people.rm5
p5117
sg9
V14645934.xml
p5118
sa(dp5119
g3
VSTD-Horn-2007
p5120
sg5
S'PMC1832131'
p5121
sg7
g5117
sg9
V17173716.xml
p5122
sa(dp5123
g3
VSTD-Peterson-2009
p5124
sg5
S'PMC2765261'
p5125
sg7
g5117
sg9
V19822836.xml
p5126
sa(dp5127
g3
VSTD-Robinson-2003
p5128
sg5
S'PMC1766134'
p5129
sg7
g5117
sg9
V14645937.xml
p5130
sa(dp5131
g3
VSTD-Yung-1998
p5132
sg5
S'PMC1717748'
p5133
sg7
VCD001276 v. 9.0 Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronc.rm5
p5134
sg9
V10193252.xml
p5135
sa(dp5136
g3
VSTD-Abdalla-2004
p5137
sg5
S'PMC1356290'
p5138
sg7
VCD006317 v. 4.0 Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.rm5
p5139
sg9
V15166961.xml
p5140
sa(dp5141
g3
VSTD-McKay-2009
p5142
sg5
S'PMC2817867'
p5143
sg7
g5139
sg9
V20148084.xml
p5144
sa(dp5145
g3
VSTD-Kim-2011
p5146
sg5
S'PMC3204557'
p5147
sg7
g5139
sg9
V22066097.xml
p5148
sa(dp5149
g3
VSTD-USA-2005
p5150
sg5
S'PMC3070486'
p5151
sg7
VCD007388 v. 4.0 Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.rm5
p5152
sg9
V18293201.xml
p5153
sa(dp5154
g3
VSTD-Peeters-1996
p5155
sg5
S'PMC1010292'
p5156
sg7
VCD000332 v. 9.0 Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.rm5
p5157
sg9
V8984939.xml
p5158
sa(dp5159
g3
VSTD-Webb-1985
p5160
sg5
S'PMC1777652'
p5161
sg7
VCD004873 v. 9.0 Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.rm5
p5162
sg9
V3907510.xml
p5163
sa(dp5164
g3
VSTD-Gajdos-2010
p5165
sg5
S'PMC2946956'
p5166
sg7
g5162
sg9
V20927359.xml
p5167
sa(dp5168
g3
VSTD-Elden-2005
p5169
sg5
S'PMC555879'
p5170
sg7
VCD001139 v. 5.0 Interventions for preventing and treating pelvic and back pain in pregnancy.rm5
p5171
sg9
V15778231.xml
p5172
sa(dp5173
g3
VSTD-Meier-2003
p5174
sg5
S'PMC1069018'
p5175
sg7
VCD004736 v. 7.0 Daily oral iron supplementation during pregnancy.rm5
p5176
sg9
V15931282.xml
p5177
sa(dp5178
g3
VSTD-Zeng-2008-_x0028_C_x0029_
p5179
sg5
S'PMC2577799'
p5180
sg7
g5176
sg9
V18996930.xml
p5181
sa(dp5182
g3
VSTD-Chanarin-1971
p5183
sg5
S'PMC1795515'
p5184
sg7
g5176
sg9
V5551272.xml
p5185
sa(dp5186
g3
VSTD-Christian-2003-_x0028_C_x0029_
p5187
sg5
S'PMC151518'
p5188
sg7
g5176
sg9
V12637400.xml
p5189
sa(dp5190
g3
VSTD-Chanarin-1965
p5191
sg5
S'PMC2165857'
p5192
sg7
g5176
sg9
V14238675.xml
p5193
sa(dp5194
g3
VSTD-Lofdahl-1999
p5195
sg5
S'PMC28156'
p5196
sg7
VCD003133 v. 10.0 Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.rm5
p5197
sg9
V10398629.xml
p5198
sa(dp5199
g3
VSTD-Price-2003
p5200
sg5
S'PMC1746596'
p5201
sg7
g5197
sg9
V12612295.xml
p5202
sa(dp5203
g3
VSTD-Vaquerizo-2003
p5204
sg5
S'PMC1746619'
p5205
sg7
g5197
sg9
V12612294.xml
p5206
sa(dp5207
g3
VSTD-Walma-1997
p5208
sg5
S'PMC2127314'
p5209
sg7
VCD003838 v. 8.2 Diuretics for heart failure.rm5
p5210
sg9
V9284668.xml
p5211
sa(dp5212
g3
VSTD-Resick-2002
p5213
sg5
S'PMC2977927'
p5214
sg7
VCD003388 v. 13.0 Psychological treatment of post-traumatic stress disorder (PTSD).rm5
p5215
sg9
V12182270.xml
p5216
sa(dp5217
g3
VSTD-Resick-2002b
p5218
sg5
S'PMC2977927'
p5219
sg7
g5215
sg9
V12182270.xml
p5220
sa(dp5221
g3
VSTD-Faglia-2010
p5222
sg5
S'PMC2890332'
p5223
sg7
VCD002302 v. 5.0 Pressure-relieving interventions for treating diabetic foot ulcers.rm5
p5224
sg9
V20357377.xml
p5225
sa(dp5226
g3
VSTD-McClure-2000
p5227
sg5
S'PMC1721038'
p5228
sg7
VCD000504 v. 6.0 Early trophic feeding versus enteral fasting for very preterm or very low birth weight infants.rm5
p5229
sg9
V10634838.xml
p5230
sa(dp5231
g3
VSTD-van-Elburg-2004
p5232
sg5
S'PMC1721703'
p5233
sg7
g5229
sg9
V15210658.xml
p5234
sa(dp5235
g3
VSTD-Hill-2001
p5236
sg5
S'PMC1753835'
p5237
sg7
VCD003688 v. 7.0 Patient education for adults with rheumatoid arthritis.rm5
p5238
sg9
V11502614.xml
p5239
sa(dp5240
g3
VSTD-Berry-2007
p5241
sg5
S'PMC1945054'
p5242
sg7
VCD001872 v. 6.15 Interventions for treating obesity in children.rm5
p5243
sg9
V17481469.xml
p5244
sa(dp5245
g3
VSTD-Jiang-2005
p5246
sg5
S'PMC1720215'
p5247
sg7
g5243
sg9
V16188958.xml
p5248
sa(dp5249
g3
VSTD-Schwingshandl-1999
p5250
sg5
S'PMC1718135'
p5251
sg7
g5243
sg9
V10519718.xml
p5252
sa(dp5253
g3
VSTD-Epstein-2008a
p5254
sg5
S'PMC2408744'
p5255
sg7
g5243
sg9
V18239639.xml
p5256
sa(dp5257
g3
VSTD-Karbwang-1994
p5258
sg5
S'PMC2486514'
p5259
sg7
VCD004531 v. 5.0 Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria.rm5
p5260
sg9
V8131255.xml
p5261
sa(dp5262
g3
VSTD-Watters-1997
p5263
sg5
S'PMC1191041'
p5264
sg7
VCD006832 v. 2.2 Interventions for preventing critical illness polyneuropathy and critical illness myopathy.rm5
p5265
sg9
V9339943.xml
p5266
sa(dp5267
g3
VSTD-MRC-LU11
p5268
sg5
S'PMC2074683'
p5269
sg7
VCD002142 v. 13.0 Postoperative radiotherapy for non-small cell lung cancer.rm5
p5270
sg9
V8761382.xml
p5271
sa(dp5272
g3
VSTD-Furrie-2005
p5273
sg5
S'PMC1774839'
p5274
sg7
VCD005573 v. 4.0 Probiotics for induction of remission in ulcerative colitis.rm5
p5275
sg9
V15647189.xml
p5276
sa(dp5277
g3
VSTD-Venning-2000
p5278
sg5
S'PMC27348'
p5279
sg7
VCD001271 v. 4.4 Substitution of doctors by nurses in primary care.rm5
p5280
sg9
V10764367.xml
p5281
sa(dp5282
g3
VSTD-Kinnersley-2000
p5283
sg5
S'PMC27347'
p5284
sg7
g5280
sg9
V10764366.xml
p5285
sa(dp5286
g3
VSTD-Moher-2001
p5287
sg5
S'PMC32168'
p5288
sg7
g5280
sg9
V11387182.xml
p5289
sa(dp5290
g3
VSTD-Shum-2000
p5291
sg5
S'PMC27346'
p5292
sg7
g5280
sg9
V10764365.xml
p5293
sa(dp5294
g3
VSTD-Lattimer-1998
p5295
sg5
S'PMC28690'
p5296
sg7
g5280
sg9
V9774295.xml
p5297
sa(dp5298
g3
VSTD-Flynn-1974
p5299
sg5
S'PMC1775498'
p5300
sg7
g5280
sg9
V4829073.xml
p5301
sa(dp5302
g3
VSTD-McIntosh-1997
p5303
sg5
S'PMC2255191'
p5304
sg7
g5280
sg9
V9386883.xml
p5305
sa(dp5306
g3
VSTD-Eke-1983
p5307
sg5
S'PMC1628291'
p5308
sg7
VCD008327 v. 1.0 Interventions for bone disease in children with chronic kidney disease.rm5
p5309
sg9
V6357106.xml
p5310
sa(dp5311
g3
VSTD-Mak-1985
p5312
sg5
S'PMC1417527'
p5313
sg7
g5309
sg9
V3928054.xml
p5314
sa(dp5315
g3
VSTD-Faithfull-2001
p5316
sg5
S'PMC2364007'
p5317
sg7
VCD006953 v. 3.6 Psychosocial interventions for reducing fatigue during cancer treatment in adults.rm5
p5318
sg9
V11747326.xml
p5319
sa(dp5320
g3
VSTD-de-Vries-2007a
p5321
sg5
S'PMC1913177'
p5322
sg7
VCD006438 v. 4.0 Open surgical procedures for incisional hernias.rm5
p5323
sg9
V17372669.xml
p5324
sa(dp5325
g3
VSTD-Burger-2004
p5326
sg5
S'PMC1356459'
p5327
sg7
g5323
sg9
V15383785.xml
p5328
sa(dp5329
g3
VSTD-Amadori-2005
p5330
sg5
S'PMC1895135'
p5331
sg7
VCD008238 v. 3.0 Colony-stimulating factors for prevention and treatment of infectious complications in patients with.rm5
p5332
sg9
V15761020.xml
p5333
sa(dp5334
g3
VSTD-Sekhavat-2012
p5335
sg5
S'PMC3598277'
p5336
sg7
VCD009243 v. 3.0 Antispasmodics for labour.rm5
p5337
sg9
V23515202.xml
p5338
sa(dp5339
g3
VSTD-Wallace-1988
p5340
sg5
S'PMC1834369'
p5341
sg7
VCD004148 v. 10.0 Effectiveness of brief alcohol interventions in primary care populations.rm5
p5342
sg9
V3052668.xml
p5343
sa(dp5344
g3
VSTD-Heather-1987
p5345
sg5
S'PMC1711039'
p5346
sg7
g5342
sg9
V3448228.xml
p5347
sa(dp5348
g3
VSTD-McIntosh-1997
p5349
sg5
S'PMC2255191'
p5350
sg7
g5342
sg9
V9386883.xml
p5351
sa(dp5352
g3
VSTD-Gentillelo-1999
p5353
sg5
S'PMC1420896'
p5354
sg7
g5342
sg9
V10522717.xml
p5355
sa(dp5356
g3
VSTD-Horita-2007
p5357
sg5
S'PMC2409178'
p5358
sg7
VCD003962 v. 6.0 Non-immunosuppressive treatment for IgA nephropathy.rm5
p5359
sg9
V17497466.xml
p5360
sa(dp5361
g3
VSTD-Lask-1979
p5362
sg5
S'PMC1545376'
p5363
sg7
VCD000089 v. 11.0 Family therapy for asthma in children.rm5
p5364
sg9
V373642.xml
p5365
sa(dp5366
g3
VSTD-Mariette-1997
p5367
sg5
S'PMC2169620'
p5368
sg7
VCD002827 v. 10.0 Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropat.rm5
p5369
sg9
V9221964.xml
p5370
sa(dp5371
g3
VSTD-Mariette-2000
p5372
sg5
S'PMC1737051'
p5373
sg7
g5369
sg9
V10960293.xml
p5374
sa(dp5375
g3
VSTD-Oksenhendler-1995
p5376
sg5
S'PMC486020'
p5377
sg7
g5369
sg9
V7673949.xml
p5378
sa(dp5379
g3
VSTD-Soltanian-2010
p5380
sg5
S'PMC3302710'
p5381
sg7
VCD010538 v. 2.0 Topical herbal therapies for treating osteoarthritis.rm5
p5382
sg9
V22427772.xml
p5383
sa(dp5384
g3
VSTD-Randall-2000
p5385
sg5
S'PMC1298033'
p5386
sg7
g5382
sg9
V10911825.xml
p5387
sa(dp5388
g3
VSTD-Lahat-2000
p5389
sg5
S'PMC27427'
p5390
sg7
VCD001905 v. 10.0 Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in childr.rm5
p5391
sg9
V10884257.xml
p5392
sa(dp5393
g3
VSTD-Perez-1993
p5394
sg5
S'PMC1374020'
p5395
sg7
VCD000345 v. 7.0 Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for .rm5
p5396
sg9
V8314497.xml
p5397
sa(dp5398
g3
VSTD-Holland-1988
p5399
sg5
S'PMC1386569'
p5400
sg7
VCD002067 v. 10.0 Single dose oral aspirin for acute postoperative pain in adults.rm5
p5401
sg9
V3190996.xml
p5402
sa(dp5403
g3
VSTD-Seymour-1992
p5404
sg5
S'PMC1381328'
p5405
sg7
g5401
sg9
V1576068.xml
p5406
sa(dp5407
g3
VSTD-Nelson-1985
p5408
sg5
S'PMC2148530'
p5409
sg7
g5401
sg9
V2934008.xml
p5410
sa(dp5411
g3
VSTD-Parkhouse-1969
p5412
sg5
S'PMC1946013'
p5413
sg7
g5401
sg9
V4891424.xml
p5414
sa(dp5415
g3
VSTD-Sydney
p5416
sg5
S'PMC1736543'
p5417
sg7
VCD006564 v. 4.0 Dopamine agonist therapy in early Parkinson's disease.rm5
p5418
sg9
V10449550.xml
p5419
sa(dp5420
g3
VSTD-Grunfeld
p5421
sg5
S'PMC2351993'
p5422
sg7
VCD001768 v. 9.0 Follow-up strategies for women treated for early breast cancer.rm5
p5423
sg9
V8811760.xml
p5424
sa(dp5425
g3
VSTD-Lagro_x002d_Janssen-1991
p5426
sg5
S'PMC1371786'
p5427
sg7
VCD005654 v. 4.0 Pelvic floor muscle training versus no treatment or inactive control treatments for urinary incont.rm5
p5428
sg9
V1807303.xml
p5429
sa(dp5430
g3
VSTD-B_x00f8_-1999
p5431
sg5
S'PMC27740'
p5432
sg7
g5428
sg9
V10024253.xml
p5433
sa(dp5434
g3
VSTD-Castro-2008
p5435
sg5
S'PMC2664121'
p5436
sg7
g5428
sg9
V18719756.xml
p5437
sa(dp5438
g3
VSTD-Klopper-1962
p5439
sg5
S'PMC1926558'
p5440
sg7
VCD003393 v. 6.0 Oestrogens alone or with amniotomy for cervical ripening or induction of labour.rm5
p5441
sg9
V14033615.xml
p5442
sa(dp5443
g3
VSTD-Tromans-1981
p5444
sg5
S'PMC1504503'
p5445
sg7
g5441
sg9
V6781613.xml
p5446
sa(dp5447
g3
VSTD-Bowen-2007
p5448
sg5
S'PMC2639555'
p5449
sg7
VCD006483 v. 3.8 Interactive computer-based interventions for sexual health promotion.rm5
p5450
sg9
V16849391.xml
p5451
sa(dp5452
g3
VSTD-Di-Noia-2004
p5453
sg5
S'PMC1524876'
p5454
sg7
g5450
sg9
V15193576.xml
p5455
sa(dp5456
g3
VSTD-SELECT-2009
p5457
sg5
S'PMC3682779'
p5458
sg7
VCD005195 v. 9.0 Selenium for preventing cancer.rm5
p5459
sg9
V19066370.xml
p5460
sa(dp5461
g3
VSTD-Epplein-2009
p5462
sg5
S'PMC2755047'
p5463
sg7
g5459
sg9
V19531680.xml
p5464
sa(dp5465
g3
VSTD-Peters-2007
p5466
sg5
S'PMC1839923'
p5467
sg7
g5459
sg9
V17209198.xml
p5468
sa(dp5469
g3
VSTD-Michaud-2005
p5470
sg5
S'PMC2361644'
p5471
sg7
g5459
sg9
V16175184.xml
p5472
sa(dp5473
g3
VSTD-Dong-2008
p5474
sg5
S'PMC2366201'
p5475
sg7
g5459
sg9
V18444134.xml
p5476
sa(dp5477
g3
VSTD-Peters-2008
p5478
sg5
S'PMC2729504'
p5479
sg7
g5459
sg9
V19687417.xml
p5480
sa(dp5481
g3
VSTD-Ringstad-1988
p5482
sg5
S'PMC1141475'
p5483
sg7
g5459
sg9
V3366933.xml
p5484
sa(dp5485
g3
VSTD-Jones-1996
p5486
sg5
S'PMC2353074'
p5487
sg7
VCD002902 v. 9.0 Psychological interventions for coronary heart disease.rm5
p5488
sg9
V8978226.xml
p5489
sa(dp5490
g3
VSTD-McLaughlin-2005
p5491
sg5
S'PMC1490273'
p5492
sg7
g5488
sg9
V16423095.xml
p5493
sa(dp5494
g3
VSTD-aa-Rudenko-1996a
p5495
sg5
S'PMC2486837'
p5496
sg7
VCD004879 v. 9.0 Vaccines for preventing influenza in healthy children.rm5
p5497
sg9
V8653819.xml
p5498
sa(dp5499
g3
VSTD-ba-Kissling-2011
p5500
sg5
S'PMC3216983'
p5501
sg7
g5497
sg9
V22110695.xml
p5502
sa(dp5503
g3
VSTD-ba-Valenciano-2011
p5504
sg5
S'PMC3019108'
p5505
sg7
g5497
sg9
V21379316.xml
p5506
sa(dp5507
g3
VSTD-ba-Eisenberg-2008a
p5508
sg5
S'PMC3695734'
p5509
sg7
g5497
sg9
V18977968.xml
p5510
sa(dp5511
g3
VSTD-ba-Eisenberg-2008b
p5512
sg5
S'PMC3695734'
p5513
sg7
g5497
sg9
V18977968.xml
p5514
sa(dp5515
g3
VSTD-ab-Mallory-2010
p5516
sg5
S'PMC2966412'
p5517
sg7
g5497
sg9
V21060780.xml
p5518
sa(dp5519
g3
VSTD-AMCT_x002d_010--2005
p5520
sg5
S'PMC1895225'
p5521
sg7
VCD005419 v. 4.0 Interventions for previously untreated patients with AIDS-associated Non-Hodgkins Lymphoma.rm5
p5522
sg9
V15914552.xml
p5523
sa(dp5524
g3
VSTD-Macaulay-1988
p5525
sg5
S'PMC1245577'
p5526
sg7
VCD003193 v. 6.2 Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrom.rm5
p5527
sg9
V3103764.xml
p5528
sa(dp5529
g3
VSTD-Song-2006
p5530
sg5
S'PMC2721929'
p5531
sg7
g5527
sg9
V17179687.xml
p5532
sa(dp5533
g3
VSTD-Chancellor-2008
p5534
sg5
S'PMC2325270'
p5535
sg7
g5527
sg9
V18324952.xml
p5536
sa(dp5537
g3
VSTD-Burgio-2008
p5538
sg5
S'PMC3201984'
p5539
sg7
g5527
sg9
V18678843.xml
p5540
sa(dp5541
g3
VSTD-Kim-2001
p5542
sg5
S'PMC3349651'
p5543
sg7
VCD003316 v. 6.0 Physical fitness training for stroke patients.rm5
p5544
sg9
V17903837.xml
p5545
sa(dp5546
g3
VSTD-Sanderson-1987
p5547
sg5
S'PMC1778272'
p5548
sg7
VCD003873 v. 5.0 Interventions for growth failure in childhood Crohn's disease.rm5
p5549
sg9
V3548602.xml
p5550
sa(dp5551
g3
VSTD-Seymour-1996
p5552
sg5
S'PMC2042618'
p5553
sg7
VCD004602 v. 6.3 Single dose oral paracetamol (acetaminophen) for postoperative pain in adults.rm5
p5554
sg9
V8799525.xml
p5555
sa(dp5556
g3
VSTD-Cooper-1986
p5557
sg5
S'PMC2175476'
p5558
sg7
g5554
sg9
V3461725.xml
p5559
sa(dp5560
g3
VSTD-Bautmans-2005
p5561
sg5
S'PMC1368976'
p5562
sg7
VCD004294 v. 6.3 Physical rehabilitation for older people in long-term care.rm5
p5563
sg9
V16372905.xml
p5564
sa(dp5565
g3
VSTD-Kerse-2008
p5566
sg5
S'PMC2565754'
p5567
sg7
g5563
sg9
V18845605.xml
p5568
sa(dp5569
g3
VSTD-Sackley-2009
p5570
sg5
S'PMC2736373'
p5571
sg7
g5563
sg9
V19723707.xml
p5572
sa(dp5573
g3
VSTD-Makita-2006
p5574
sg5
S'PMC2723343'
p5575
sg7
g5563
sg9
V21432349.xml
p5576
sa(dp5577
g3
VSTD-Tappen-2000
p5578
sg5
S'PMC1950269'
p5579
sg7
g5563
sg9
V11186596.xml
p5580
sa(dp5581
g3
VSTD-Chin-A-Paw-2004
p5582
sg5
S'PMC471553'
p5583
sg7
g5563
sg9
V15233841.xml
p5584
sa(dp5585
g3
VSTD-Tappen-1994
p5586
sg5
S'PMC1952655'
p5587
sg7
g5563
sg9
V8184127.xml
p5588
sa(dp5589
g3
VSTD-Mattar-2005
p5590
sg5
S'PMC1402345'
p5591
sg7
VCD007340 v. 3.0 Bariatric surgery for non-alcoholic steatohepatitis in obese patients.rm5
p5592
sg9
V16192822.xml
p5593
sa(dp5594
g3
VSTD-Chittenden-1997
p5595
sg5
S'PMC1722170'
p5596
sg7
VCD006291 v. 4.0 Sub-Tenon's anaesthesia versus topical anaesthesia for cataract surgery.rm5
p5597
sg9
V9215056.xml
p5598
sa(dp5599
g3
VSTD-R_x00fc_schen-2005
p5600
sg5
S'PMC1772574'
p5601
sg7
g5597
sg9
V15722306.xml
p5602
sa(dp5603
g3
VSTD-Gebbia-1996
p5604
sg5
S'PMC2074540'
p5605
sg7
VCD004310 v. 8.0 Megestrol acetate for treatment of anorexia-cachexia syndrome.rm5
p5606
sg9
V8664133.xml
p5607
sa(dp5608
g3
VSTD-Field-1966
p5609
sg5
S'PMC1843176'
p5610
sg7
VCD005189 v. 11.0 Antibiotics for bronchiolitis in children.rm5
p5611
sg9
V5323069.xml
p5612
sa(dp5613
g3
VSTD-Nilforoushzadeh-2007
p5614
sg5
S'PMC1891315'
p5615
sg7
VCD005083 v. 7.0 Honey as a topical treatment for wounds.rm5
p5616
sg9
V17466071.xml
p5617
sa(dp5618
g3
VSTD-Baghel-2009
p5619
sg5
S'PMC2845359'
p5620
sg7
g5616
sg9
V20368852.xml
p5621
sa(dp5622
g3
VSTD-Richens-1994
p5623
sg5
S'PMC1072969'
p5624
sg7
VCD001030 v. 11.2 Carbamazepine versus valproate monotherapy for epilepsy.rm5
p5625
sg9
V8006647.xml
p5626
sa(dp5627
g3
VSTD-Callaghan-1985
p5628
sg5
S'PMC1028404'
p5629
sg7
g5625
sg9
V3928820.xml
p5630
sa(dp5631
g3
VSTD-Heller-1995
p5632
sg5
S'PMC1073267'
p5633
sg7
g5625
sg9
V7823066.xml
p5634
sa(dp5635
g3
VSTD-Wang-1996
p5636
sg5
S'PMC472613'
p5637
sg7
VCD001146 v. 8.0 Early ( 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.rm5
p5638
sg9
V8984701.xml
p5639
sa(dp5640
g3
VSTD-Subhedar-1997
p5641
sg5
S'PMC1720712'
p5642
sg7
g5638
sg9
V9462187.xml
p5643
sa(dp5644
g3
VSTD-Shinwell-1996
p5645
sg5
S'PMC2528319'
p5646
sg7
g5638
sg9
V8653433.xml
p5647
sa(dp5648
g3
VSTD-Elmes-1957
p5649
sg5
S'PMC1963159'
p5650
sg7
VCD010257 v. 1.2 Antibiotics for exacerbations of chronic obstructive pulmonary disease.rm5
p5651
sg9
V13479695.xml
p5652
sa(dp5653
g3
VSTD-Sachs-1995
p5654
sg5
S'PMC474649'
p5655
sg7
g5651
sg9
V7570411.xml
p5656
sa(dp5657
g3
VSTD-Pines-1968
p5658
sg5
S'PMC1991661'
p5659
sg7
g5651
sg9
V4872151.xml
p5660
sa(dp5661
g3
VSTD-McCaul-1984
p5662
sg5
S'PMC1307916'
p5663
sg7
VCD005031 v. 13.0 Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxificat.rm5
p5664
sg9
V6725168.xml
p5665
sa(dp5666
g3
VSTD-Campbell-2009
p5667
sg5
S'PMC2779725'
p5668
sg7
g5664
sg9
V19586142.xml
p5669
sa(dp5670
g3
VSTD-Schmidt-1975
p5671
sg5
S'PMC492284'
p5672
sg7
VCD001332 v. 6.0 Anti-spasticity agents for multiple sclerosis.rm5
p5673
sg9
V778344.xml
p5674
sa(dp5675
g3
VSTD-a01-MRC-LU02
p5676
sg5
S'PMC1977284'
p5677
sg7
VCD002139 v. 10.0 Chemotherapy for non-small cell lung cancer.rm5
p5678
sg9
V3907687.xml
p5679
sa(dp5680
g3
VSTD-c11-Gwent-1
p5681
sg5
S'PMC471474'
p5682
sg7
g5678
sg9
V7281085.xml
p5683
sa(dp5684
g3
VSTD-d04-RLW-8351
p5685
sg5
S'PMC1971367'
p5686
sg7
g5678
sg9
V1691921.xml
p5687
sa(dp5688
g3
VSTD-d06-Southampton
p5689
sg5
S'PMC1971367'
p5690
sg7
g5678
sg9
V1691921.xml
p5691
sa(dp5692
g3
VSTD-Macdonald-1954
p5693
sg5
S'PMC2011610'
p5694
sg7
VCD001167 v. 5.2 Antimicrobials for treating symptomatic non-typhoidal Salmonella infection.rm5
p5695
sg9
V13159368.xml
p5696
sa(dp5697
g3
VSTD-Pugh-1989
p5698
sg5
S'PMC1216711'
p5699
sg7
VCD002901 v. 10.0 Digitalis for treatment of heart failure in patients in sinus rhythm.rm5
p5700
sg9
V2503017.xml
p5701
sa(dp5702
g3
VSTD-Bye-1980
p5703
sg5
S'PMC1713673'
p5704
sg7
VCD004976 v. 8.5 Oral antihistamine-decongestant-analgesic combinations for the common cold.rm5
p5705
sg9
V6996784.xml
p5706
sa(dp5707
g3
VSTD-Sperber-1989
p5708
sg5
S'PMC1807791'
p5709
sg7
g5705
sg9
V2557947.xml
p5710
sa(dp5711
g3
VSTD-Motzer_x0028_1_x0029_-2010
p5712
sg5
S'PMC3646307'
p5713
sg7
VCD006017 v. 4.4 Targeted therapy for advanced renal cell carcinoma.rm5
p5714
sg9
V19487381.xml
p5715
sa(dp5716
g3
VSTD-Rini-2010
p5717
sg5
S'PMC2651074'
p5718
sg7
g5714
sg9
V18936475.xml
p5719
sa(dp5720
g3
VSTD-Yang-2003
p5721
sg5
S'PMC2275324'
p5722
sg7
g5714
sg9
V12890841.xml
p5723
sa(dp5724
g3
VSTD-Pinion-1994
p5725
sg5
S'PMC2541307'
p5726
sg7
VCD000329 v. 7.0 Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding.rm5
p5727
sg9
V7772106.xml
p5728
sa(dp5729
g3
VSTD-Gannon-1991
p5730
sg5
S'PMC1671634'
p5731
sg7
g5727
sg9
V1760601.xml
p5732
sa(dp5733
g3
VSTD-Rosenfeldt-2011
p5734
sg5
S'PMC3063826'
p5735
sg7
VCD010118 v. 2.0 Preoperative physical therapy for elective cardiac surgery patients.rm5
p5736
sg9
V21385466.xml
p5737
sa(dp5738
g3
VSTD-Daniell-2006
p5739
sg5
S'PMC1857014'
p5740
sg7
VCD009078 v. 3.2 Topical cyclosporine for atopic keratoconjunctivitis.rm5
p5741
sg9
V16547328.xml
p5742
sa(dp5743
g3
VSTD-Thompson-1999
p5744
sg5
S'PMC1230704'
p5745
sg7
VCD003286 v. 4.0 Specialist nurses in diabetes mellitus.rm5
p5746
sg9
V10551191.xml
p5747
sa(dp5748
g3
VSTD-Garc_x00ed_a_x002d_Toro-2001-c
p5749
sg5
S'PMC1763496'
p5750
sg7
VCD003493 v. 10.0 Transcranial magnetic stimulation for treating depression.rm5
p5751
sg9
V11561046.xml
p5752
sa(dp5753
g3
VSTD-Sargent-2009a
p5754
sg5
S'PMC3719160'
p5755
sg7
VCD003439 v. 6.5 Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours.rm5
p5756
sg9
V19413793.xml
p5757
sa(dp5758
g3
VSTD-Gilpin-2007
p5759
sg5
S'PMC1931446'
p5760
sg7
g5756
sg9
V17600271.xml
p5761
sa(dp5762
g3
VSTD-While-1996
p5763
sg5
S'PMC2351819'
p5764
sg7
g5756
sg9
V8761227.xml
p5765
sa(dp5766
g3
VSTD-Biener-2000
p5767
sg5
S'PMC1446173'
p5768
sg7
g5756
sg9
V10705860.xml
p5769
sa(dp5770
g3
VSTD-Henriksen-2010
p5771
sg5
S'PMC3046636'
p5772
sg7
g5756
sg9
V20643725.xml
p5773
sa(dp5774
g3
VSTD-Sargent-2009b
p5775
sg5
S'PMC2707779'
p5776
sg7
g5756
sg9
V18948391.xml
p5777
sa(dp5778
g3
VSTD-Ward-2002
p5779
sg5
S'PMC117136'
p5780
sg7
VCD006375 v. 4.6 Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women.rm5
p5781
sg9
V12114234.xml
p5782
sa(dp5783
g3
VSTD-Tibbutt-1974
p5784
sg5
S'PMC1633603'
p5785
sg7
VCD004437 v. 6.0 Thrombolytic therapy for pulmonary embolism.rm5
p5786
sg9
V4594580.xml
p5787
sa(dp5788
g3
VSTD-Kylmala-1997
p5789
sg5
S'PMC2228066'
p5790
sg7
VCD002068 v. 9.0 Bisphosphonates for the relief of pain secondary to bone metastases.rm5
p5791
sg9
V9328156.xml
p5792
sa(dp5793
g3
VSTD-Morice-2007
p5794
sg5
S'PMC2228375'
p5795
sg7
VCD006924 v. 4.0 Regular treatment with formoterol and inhaled steroids for chronic asthma serious adverse events.rm5
p5796
sg9
V17887990.xml
p5797
sa(dp5798
g3
VSTD-Price-2002
p5799
sg5
S'PMC1746437'
p5800
sg7
g5796
sg9
V12200524.xml
p5801
sa(dp5802
g3
VSTD-Hawthorne-1992
p5803
sg5
S'PMC1379405'
p5804
sg7
VCD006443 v. 3.0 Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis.rm5
p5805
sg9
V1353742.xml
p5806
sa(dp5807
g3
VSTD-Lindenmuth-1989
p5808
sg5
S'PMC2190635'
p5809
sg7
VCD007440 v. 6.0 Single dose oral diflunisal for acute postoperative pain in adults.rm5
p5810
sg9
V2490035.xml
p5811
sa(dp5812
g3
VSTD-Chaowagul-2005
p5813
sg5
S'PMC1251512'
p5814
sg7
VCD001263 v. 8.2 Interventions for treating melioidosis.rm5
p5815
sg9
V16189075.xml
p5816
sa(dp5817
g3
VSTD-Sookpranee-1992
p5818
sg5
S'PMC189245'
p5819
sg7
g5815
sg9
V1590682.xml
p5820
sa(dp5821
g3
VSTD-Trinder-2006
p5822
sg5
S'PMC1471967'
p5823
sg7
VCD007223 v. 4.0 Medical treatments for incomplete miscarriage.rm5
p5824
sg9
V16707509.xml
p5825
sa(dp5826
g3
VSTD-Richards-2002
p5827
sg5
S'PMC135495'
p5828
sg7
VCD004180 v. 5.0 Telephone consultation and triage effects on health care use and patient satisfaction.rm5
p5829
sg9
V12446539.xml
p5830
sa(dp5831
g3
VSTD-Jiwa-2002
p5832
sg5
S'PMC1314295'
p5833
sg7
g5829
sg9
V12014537.xml
p5834
sa(dp5835
g3
VSTD-McKinstry-2002
p5836
sg5
S'PMC1314272'
p5837
sg7
g5829
sg9
V11942448.xml
p5838
sa(dp5839
g3
VSTD-Thompson-1999
p5840
sg5
S'PMC28285'
p5841
sg7
g5829
sg9
V10574857.xml
p5842
sa(dp5843
g3
VSTD-Lattimer-1998
p5844
sg5
S'PMC28690'
p5845
sg7
g5829
sg9
V9774295.xml
p5846
sa(dp5847
g3
VSTD-Majumdar-2008
p5848
sg5
S'PMC2244663'
p5849
sg7
VCD006094 v. 3.0 Interventions for improving the appropriate use of imaging in people with musculoskeletal conditions.rm5
p5850
sg9
V18299546.xml
p5851
sa(dp5852
g3
VSTD-Hollingworth-2002
p5853
sg5
S'PMC1314323'
p5854
sg7
g5850
sg9
V12051212.xml
p5855
sa(dp5856
g3
VSTD-Oakeshott-1994
p5857
sg5
S'PMC1238864'
p5858
sg7
g5850
sg9
V8204331.xml
p5859
sa(dp5860
g3
VSTD-Dey-2004
p5861
sg5
S'PMC1314775'
p5862
sg7
g5850
sg9
V14965404.xml
p5863
sa(dp5864
g3
VSTD-Schectman-2003
p5865
sg5
S'PMC1494929'
p5866
sg7
g5850
sg9
V14521638.xml
p5867
sa(dp5868
g3
VSTD-Solomon-2007a
p5869
sg5
S'PMC1824772'
p5870
sg7
g5850
sg9
V17356969.xml
p5871
sa(dp5872
g3
VSTD-Lafata-2007
p5873
sg5
S'PMC1824751'
p5874
sg7
g5850
sg9
V17356966.xml
p5875
sa(dp5876
g3
VSTD-Pavord-2007
p5877
sg5
S'PMC2174463'
p5878
sg7
VCD003137 v. 10.0 Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chron.rm5
p5879
sg9
V17897478.xml
p5880
sa(dp5881
g3
VSTD-Bjermer-2003
p5882
sg5
S'PMC218809'
p5883
sg7
g5879
sg9
V14563743.xml
p5884
sa(dp5885
g3
VSTD-Lemanske-2010
p5886
sg5
S'PMC2989902'
p5887
sg7
g5879
sg9
V20197425.xml
p5888
sa(dp5889
g3
VSTD-Nikolaizik-2008
p5890
sg5
S'PMC2679548'
p5891
sg7
VCD001021 v. 12.0 Inhaled antibiotics for long-term therapy in cystic fibrosis.rm5
p5892
sg9
V18716688.xml
p5893
sa(dp5894
g3
VSTD-McCoy-2008
p5895
sg5
S'PMC2577727'
p5896
sg7
g5892
sg9
V18658109.xml
p5897
sa(dp5898
g3
VSTD-Gardner-2008
p5899
sg5
S'PMC2748261'
p5900
sg7
VCD006888 v. 4.0 Ginkgo biloba for intermittent claudication.rm5
p5901
sg9
V18628657.xml
p5902
sa(dp5903
g3
VSTD-Mortimore-1998
p5904
sg5
S'PMC1745186'
p5905
sg7
VCD005308 v. 8.0 Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea.rm5
p5906
sg9
V9741373.xml
p5907
sa(dp5908
g3
VSTD-Chen-2008
p5909
sg5
S'PMC2170466'
p5910
sg7
VCD007458 v. 2.3 Mobile phone messaging reminders for attendance at healthcare appointments.rm5
p5911
sg9
V18196610.xml
p5912
sa(dp5913
g3
VSTD-Renner-2001
p5914
sg5
S'PMC1745899'
p5915
sg7
VCD008037 v. 5.0 Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.rm5
p5916
sg9
V11120904.xml
p5917
sa(dp5918
g3
VSTD-van-Woensel-2003
p5919
sg5
S'PMC1746666'
p5920
sg7
VCD007720 v. 6.3 Corticosteroids for pneumonia.rm5
p5921
sg9
V12728156.xml
p5922
sa(dp5923
g3
VSTD-McHardy-1972
p5924
sg5
S'PMC1786783'
p5925
sg7
g5921
sg9
V4404939.xml
p5926
sa(dp5927
g3
VSTD-Ling-2005
p5928
sg5
S'PMC1480367'
p5929
sg7
VCD002025 v. 13.0 Buprenorphine for the management of opioid withdrawal.rm5
p5930
sg9
V16042639.xml
p5931
sa(dp5932
g3
VSTD-Petticrew-1999
p5933
sg5
S'PMC1756922'
p5934
sg7
VMR000005 v. 6.0 Full publication of results initially presented in abstracts.rm5
p5935
sg9
V10492742.xml
p5936
sa(dp5937
g3
VSTD-Riordan-2000
p5938
sg5
S'PMC1718573'
p5939
sg7
g5935
sg9
V11087295.xml
p5940
sa(dp5941
g3
VSTD-Sanders-2001
p5942
sg5
S'PMC1728360'
p5943
sg7
g5935
sg9
V11444234.xml
p5944
sa(dp5945
g3
VSTD-Timmer-2002
p5946
sg5
S'PMC115863'
p5947
sg7
g5935
sg9
V11978183.xml
p5948
sa(dp5949
g3
VSTD-Aloia-2005
p5950
sg5
S'PMC1464166'
p5951
sg7
VCD007470 v. 4.2 Vitamin D supplementation for prevention of mortality in adults.rm5
p5952
sg9
V16043680.xml
p5953
sa(dp5954
g3
VSTD-Campbell-2005
p5955
sg5
S'PMC1246082'
p5956
sg7
g5952
sg9
V16183652.xml
p5957
sa(dp5958
g3
VSTD-Trivedi-2003
p5959
sg5
S'PMC150177'
p5960
sg7
g5952
sg9
V12609940.xml
p5961
sa(dp5962
g3
VSTD-Porthouse-2005
p5963
sg5
S'PMC557150'
p5964
sg7
g5952
sg9
V15860827.xml
p5965
sa(dp5966
g3
VSTD-Chel-2008
p5967
sg5
S'PMC2277446'
p5968
sg7
g5952
sg9
V17874029.xml
p5969
sa(dp5970
g3
VSTD-Sato-1999a
p5971
sg5
S'PMC1736147'
p5972
sg7
g5952
sg9
V9886454.xml
p5973
sa(dp5974
g3
VSTD-Turner-1987
p5975
sg5
S'PMC1247354'
p5976
sg7
VCD000389 v. 7.0 Mass media interventions effects on health services utilisation.rm5
p5977
sg9
V3117190.xml
p5978
sa(dp5979
g3
VSTD-Rachmilewitz-1989
p5980
sg5
S'PMC1835436'
p5981
sg7
VCD000543 v. 11.18 Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p5982
sg9
V2563951.xml
p5983
sa(dp5984
g3
VSTD-Riley-1988
p5985
sg5
S'PMC1433642'
p5986
sg7
g5982
sg9
V2899536.xml
p5987
sa(dp5988
g3
VSTD-Ito-2010
p5989
sg5
S'PMC2972638'
p5990
sg7
g5982
sg9
V20049950.xml
p5991
sa(dp5992
g3
VSTD-Rao-1989
p5993
sg5
S'PMC1434223'
p5994
sg7
g5982
sg9
V2567266.xml
p5995
sa(dp5996
g3
VSTD-Hanauer-2007
p5997
sg5
S'PMC2658575'
p5998
sg7
g5982
sg9
V18080055.xml
p5999
sa(dp6000
g3
VSTD-Kruis-2009
p6001
sg5
S'PMC3269751'
p6002
sg7
g5982
sg9
V18832520.xml
p6003
sa(dp6004
g3
VSTD-Feurle-1989
p6005
sg5
S'PMC1434384'
p6006
sg7
g5982
sg9
V2684804.xml
p6007
sa(dp6008
g3
VSTD-Hetherington-1986
p6009
sg5
S'PMC1339208'
p6010
sg7
VCD004137 v. 8.0 Nonsteroidal anti-inflammatory drugs (NSAIDS) versus opioids for acute renal colic.rm5
p6011
sg9
V3081085.xml
p6012
sa(dp6013
g3
VSTD-Thompson-1989
p6014
sg5
S'PMC1838035'
p6015
sg7
g6011
sg9
V2513026.xml
p6016
sa(dp6017
g3
VSTD-Bolam-1998
p6018
sg5
S'PMC28481'
p6019
sg7
VCD004068 v. 5.0 Postnatal parental education for optimizing infant general health and parent-infant relationships.rm5
p6020
sg9
V9549449.xml
p6021
sa(dp6022
g3
VSTD-Goetter-2005
p6023
sg5
S'PMC1595267'
p6024
sg7
g6020
sg9
V17273449.xml
p6025
sa(dp6026
g3
VSTD-Browning-1983
p6027
sg5
S'PMC1549550'
p6028
sg7
VCD005608 v. 2.0 Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eard.rm5
p6029
sg9
V6412934.xml
p6030
sa(dp6031
g3
VSTD-Ho-2002b
p6032
sg5
S'PMC1422548'
p6033
sg7
VCD006040 v. 3.0 Reconstructive Techniques After Rectal Resection for Rectal Cancer.rm5
p6034
sg9
V12131085.xml
p6035
sa(dp6036
g3
VSTD-Hallbook-1996
p6037
sg5
S'PMC1235247'
p6038
sg7
g6034
sg9
V8678619.xml
p6039
sa(dp6040
g3
VSTD-Machado-2003
p6041
sg5
S'PMC1422690'
p6042
sg7
g6034
sg9
V12894014.xml
p6043
sa(dp6044
g3
VSTD-Smellie-1996
p6045
sg5
S'PMC1511665'
p6046
sg7
VCD002117 v. 7.0 Tricyclic and related drugs for nocturnal enuresis in children.rm5
p6047
sg9
V8813873.xml
p6048
sa(dp6049
g3
VSTD-Alderton-1970_x0023_
p6050
sg5
S'PMC1930205'
p6051
sg7
g6047
sg9
V4911961.xml
p6052
sa(dp6053
g3
VSTD-Netley-1984
p6054
sg5
S'PMC1483635'
p6055
sg7
g6047
sg9
V6478342.xml
p6056
sa(dp6057
g3
VSTD-McKendry-1975
p6058
sg5
S'PMC1956570'
p6059
sg7
g6047
sg9
V1192312.xml
p6060
sa(dp6061
g3
VSTD-Hodes-1973
p6062
sg5
S'PMC2157147'
p6063
sg7
g6047
sg9
V4753483.xml
p6064
sa(dp6065
g3
VSTD-Bui-2002
p6066
sg5
S'PMC2007405'
p6067
sg7
VCD003877 v. 6.0 Sedation of children undergoing dental treatment.rm5
p6068
sg9
V12779109.xml
p6069
sa(dp6070
g3
VSTD-Abrams-1993
p6071
sg5
S'PMC2148744'
p6072
sg7
g6068
sg9
V7645790.xml
p6073
sa(dp6074
g3
VSTD-Roelofse-1998
p6075
sg5
S'PMC2148942'
p6076
sg7
g6068
sg9
V9790003.xml
p6077
sa(dp6078
g3
VSTD-Lam-2005
p6079
sg5
S'PMC2527044'
p6080
sg7
g6068
sg9
V16048152.xml
p6081
sa(dp6082
g3
VSTD-Kiderman-2005
p6083
sg5
S'PMC1463093'
p6084
sg7
VCD008268 v. 4.0 Corticosteroids as standalone or add-on treatment for sore throat.rm5
p6085
sg9
V15808038.xml
p6086
sa(dp6087
g3
VSTD-Cao-2009
p6088
sg5
S'PMC2726958'
p6089
sg7
VCD006536 v. 5.0 Stem cell treatment for acute myocardial infarction.rm5
p6090
sg9
V19508995.xml
p6091
sa(dp6092
g3
VSTD-Roncalli-2010
p6093
sg5
S'PMC3386167'
p6094
sg7
g6090
sg9
V21127322.xml
p6095
sa(dp6096
g3
VSTD-Traverse-2010
p6097
sg5
S'PMC2939727'
p6098
sg7
g6090
sg9
V20826249.xml
p6099
sa(dp6100
g3
VSTD-Ge-2006
p6101
sg5
S'PMC1861266'
p6102
sg7
g6090
sg9
V16775089.xml
p6103
sa(dp6104
g3
VSTD-Cuervo-2006
p6105
sg5
S'PMC1468428'
p6106
sg7
VCD000330 v. 12.0 Enemas during labour.rm5
p6107
sg9
V16545140.xml
p6108
sa(dp6109
g3
VSTD-Potter-2008
p6110
sg5
S'PMC2745056'
p6111
sg7
VCD010119 v. 2.0 Integration of HIVAIDS services with maternal neonatal and child health nutrition and family pla.rm5
p6112
sg9
V17984757.xml
p6113
sa(dp6114
g3
VSTD-Bahwere-2008
p6115
sg5
S'PMC2536666'
p6116
sg7
g6112
sg9
V18671876.xml
p6117
sa(dp6118
g3
VSTD-Gillespie-2009
p6119
sg5
S'PMC2770289'
p6120
sg7
g6112
sg9
V20072773.xml
p6121
sa(dp6122
g3
VSTD-Downey-2009
p6123
sg5
S'PMC2858762'
p6124
sg7
VCD007544 v. 2.0 Spiritual and religious interventions for well-being of adults in the terminal phase of disease.rm5
p6125
sg9
V19678461.xml
p6126
sa(dp6127
g3
VSTD-Mabin-1995
p6128
sg5
S'PMC1511267'
p6129
sg7
VCD005203 v. 4.0 Dietary exclusions for established atopic eczema.rm5
p6130
sg9
V7492155.xml
p6131
sa(dp6132
g3
VSTD-Cant-1986
p6133
sg5
S'PMC1341170'
p6134
sg7
g6130
sg9
V3089466.xml
p6135
sa(dp6136
g3
VSTD-Tieffenberg-2000
p6137
sg5
S'PMC3456130'
p6138
sg7
VCD006245 v. 7.0 Care delivery and self-management strategies for children with epilepsy.rm5
p6139
sg9
V10856009.xml
p6140
sa(dp6141
g3
VSTD-Zwick-2009
p6142
sg5
S'PMC2745452'
p6143
sg7
VCD008602 v. 3.2 Interventions for congenital talipes equinovarus (clubfoot).rm5
p6144
sg9
V19350335.xml
p6145
sa(dp6146
g3
VSTD-Rijal-2010
p6147
sg5
S'PMC2856397'
p6148
sg7
g6144
sg9
V20419009.xml
p6149
sa(dp6150
g3
VSTD-Sud-2008
p6151
sg5
S'PMC2323422'
p6152
sg7
g6144
sg9
V17323092.xml
p6153
sa(dp6154
g3
VSTD-Lago-1998
p6155
sg5
S'PMC1720853'
p6156
sg7
VCD004212 v. 6.0 Opioids for neonates receiving mechanical ventilation.rm5
p6157
sg9
V10194990.xml
p6158
sa(dp6159
g3
VSTD-Saarenmaa-1996
p6160
sg5
S'PMC1061172'
p6161
sg7
g6157
sg9
V8949692.xml
p6162
sa(dp6163
g3
VSTD-Lillemoe-1993
p6164
sg5
S'PMC1242819'
p6165
sg7
VCD007519 v. 3.0 Celiac plexus block for pancreatic cancer pain in adults.rm5
p6166
sg9
V7683868.xml
p6167
sa(dp6168
g3
VSTD-Lidwell-1971
p6169
sg5
S'PMC2130854'
p6170
sg7
VCD005315 v. 3.3 Sensory environment on health-related outcomes of hospital patients.rm5
p6171
sg9
V5291743.xml
p6172
sa(dp6173
g3
VSTD-Kotwal-1998
p6174
sg5
S'PMC2362603'
p6175
sg7
g6171
sg9
V18493472.xml
p6176
sa(dp6177
g3
VSTD-Nixon-2006
p6178
sg5
S'PMC1479635'
p6179
sg7
VCD009490 v. 1.0 Support surfaces for treating pressure ulcers.rm5
p6180
sg9
V16740528.xml
p6181
sa(dp6182
g3
VSTD-Jones-1996
p6183
sg5
S'PMC1010319'
p6184
sg7
VCD005328 v. 4.0 Intraarticular corticosteroid for treatment of osteoarthritis of the knee.rm5
p6185
sg9
V8976640.xml
p6186
sa(dp6187
g3
VSTD-Wright-1960
p6188
sg5
S'PMC1007152'
p6189
sg7
g6185
sg9
V13786828.xml
p6190
sa(dp6191
g3
VSTD-Gaffney-1995
p6192
sg5
S'PMC1005598'
p6193
sg7
g6185
sg9
V7794044.xml
p6194
sa(dp6195
g3
VSTD-Hoghton-1996
p6196
sg5
S'PMC1239579'
p6197
sg7
VCD007296 v. 2.0 Early versus Delayed Refeeding for Children with Acute Diarrhoea.rm5
p6198
sg9
V8731625.xml
p6199
sa(dp6200
g3
VSTD-Conway-1989
p6201
sg5
S'PMC1791816'
p6202
sg7
g6198
sg9
V2647038.xml
p6203
sa(dp6204
g3
VSTD-Khin_x002d_Maung_x002d_U-1985
p6205
sg5
S'PMC1417304'
p6206
sg7
g6198
sg9
V3918683.xml
p6207
sa(dp6208
g3
VSTD-Hawkins-2009
p6209
sg5
S'PMC2740999'
p6210
sg7
VCD009307 v. 1.0 Universal multi-component prevention programs for alcohol misuse in young people.rm5
p6211
sg9
V19736331.xml
p6212
sa(dp6213
g3
VSTD-Spoth-2007
p6214
sg5
S'PMC2869212'
p6215
sg7
g6211
sg9
V17478265.xml
p6216
sa(dp6217
g3
VSTD-Perry-1996
p6218
sg5
S'PMC1380436'
p6219
sg7
g6211
sg9
V8669519.xml
p6220
sa(dp6221
g3
VSTD-Schinke-2004
p6222
sg5
S'PMC2795165'
p6223
sg7
g6211
sg9
V15376818.xml
p6224
sa(dp6225
g3
VSTD-Kabir-1986
p6226
sg5
S'PMC180459'
p6227
sg7
VCD006784 v. 5.0 Antibiotic therapy for Shigella dysentery.rm5
p6228
sg9
V3518625.xml
p6229
sa(dp6230
g3
VSTD-Gotuzzo-1989
p6231
sg5
S'PMC176069'
p6232
sg7
g6228
sg9
V2675757.xml
p6233
sa(dp6234
g3
VSTD-Haltalin-1973
p6235
sg5
S'PMC1648332'
p6236
sg7
g6228
sg9
V4574641.xml
p6237
sa(dp6238
g3
VSTD-Schwartz-2009
p6239
sg5
S'PMC2744567'
p6240
sg7
VCD003917 v. 10.0 Cardioprotective interventions for cancer patients receiving anthracyclines.rm5
p6241
sg9
V19584400.xml
p6242
sa(dp6243
g3
VSTD-Schinke-2009b
p6244
sg5
S'PMC2783411'
p6245
sg7
VCD009308 v. 1.0 Universal family-based prevention programs for alcohol misuse in young people.rm5
p6246
sg9
V19682490.xml
p6247
sa(dp6248
g3
VSTD-Schinke-2009c
p6249
sg5
S'PMC2741484'
p6250
sg7
g6246
sg9
V19632053.xml
p6251
sa(dp6252
g3
VSTD-Preclik-1999
p6253
sg5
S'PMC28241'
p6254
sg7
VCD005571 v. 7.0 Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy.rm5
p6255
sg9
V10506041.xml
p6256
sa(dp6257
g3
VSTD-Conway-2007
p6258
sg5
S'PMC2084134'
p6259
sg7
VCD004827 v. 6.3 Probiotics for the prevention of pediatric antibiotic-associated diarrhea.rm5
p6260
sg9
V18252070.xml
p6261
sa(dp6262
g3
VSTD-Baker-1998T96
p6263
sg5
S'PMC1496989'
p6264
sg7
VCD003941 v. 8.0 Patient reminder and recall systems to improve immunization rates.rm5
p6265
sg9
V9686713.xml
p6266
sa(dp6267
g3
VSTD-Stehr_x002d_Green1993T10
p6268
sg5
S'PMC1403403'
p6269
sg7
g6265
sg9
V8341774.xml
p6270
sa(dp6271
g3
VSTD-Young1980T63
p6272
sg5
S'PMC1619400'
p6273
sg7
g6265
sg9
V7361966.xml
p6274
sa(dp6275
g3
VSTD-Hull2002T511
p6276
sg5
S'PMC1314410'
p6277
sg7
g6265
sg9
V12236273.xml
p6278
sa(dp6279
g3
VSTD-Rosser1992T47
p6280
sg5
S'PMC1488617'
p6281
sg7
g6265
sg9
V1544078.xml
p6282
sa(dp6283
g3
VSTD-Rosser1991T61
p6284
sg5
S'PMC1335900'
p6285
sg7
g6265
sg9
V1913409.xml
p6286
sa(dp6287
g3
VSTD-Mullooly1987T67
p6288
sg5
S'PMC1647052'
p6289
sg7
g6265
sg9
V3565663.xml
p6290
sa(dp6291
g3
VSTD-McDowell1986T46
p6292
sg5
S'PMC1488617'
p6293
sg7
g6265
sg9
V1544078.xml
p6294
sa(dp6295
g3
VSTD-Hogg1998T101
p6296
sg5
S'PMC2277568'
p6297
sg7
g6265
sg9
V9481466.xml
p6298
sa(dp6299
g3
VSTD-Lukasik1987T85
p6300
sg5
S'PMC2218648'
p6301
sg7
g6265
sg9
V21263970.xml
p6302
sa(dp6303
g3
VSTD-WACS-2007Low
p6304
sg5
S'PMC2034519'
p6305
sg7
VCD007176 v. 7.4 Antioxidant supplements for prevention of mortality in healthy participants and patients with variou.rm5
p6306
sg9
V17698683.xml
p6307
sa(dp6308
g3
VSTD-PHS-2008Low
p6309
sg5
S'PMC2586922'
p6310
sg7
g6306
sg9
V18997197.xml
p6311
sa(dp6312
g3
VSTD-SELECT-2009Low
p6313
sg5
S'PMC3682779'
p6314
sg7
g6306
sg9
V19066370.xml
p6315
sa(dp6316
g3
VSTD-MAVIS-2005-Low
p6317
sg5
S'PMC1183131'
p6318
sg7
g6306
sg9
V16081445.xml
p6319
sa(dp6320
g3
VSTD-Meydani-2004Low
p6321
sg5
S'PMC2377357'
p6322
sg7
g6306
sg9
V15315997.xml
p6323
sa(dp6324
g3
VSTD-Choung-2008
p6325
sg5
S'PMC2671765'
p6326
sg7
VCD009163 v. 2.5 Antibiotics for otitis media with effusion in children.rm5
p6327
sg9
V19434268.xml
p6328
sa(dp6329
g3
VSTD-Figved-2009
p6330
sg5
S'PMC2866935'
p6331
sg7
VCD001706 v. 9.0 Arthroplasties (with and without bone cement) for proximal femoral fractures in adults.rm5
p6332
sg9
V19130162.xml
p6333
sa(dp6334
g3
VSTD-Mouzopoulos-2008
p6335
sg5
S'PMC2323425'
p6336
sg7
g6332
sg9
V17431621.xml
p6337
sa(dp6338
g3
VSTD-Huh-2009
p6339
sg5
S'PMC2688140'
p6340
sg7
VCD009098 v. 3.0 High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult pat.rm5
p6341
sg9
V19239703.xml
p6342
sa(dp6343
g3
VSTD-Clark-2000a
p6344
sg5
S'PMC1753277'
p6345
sg7
VCD006717 v. 3.0 Patellar taping for patellofemoral pain syndrome in adults.rm5
p6346
sg9
V10976083.xml
p6347
sa(dp6348
g3
VSTD-Mattick-2002a
p6349
sg5
S'PMC1725943'
p6350
sg7
VCD003326 v. 9.0 Tissue adhesives for traumatic lacerations in children and adults.rm5
p6351
sg9
V12204985.xml
p6352
sa(dp6353
g3
VSTD-Littlejohns-1991
p6354
sg5
S'PMC463273'
p6355
sg7
VCD002990 v. 11.0 Self-management education for patients with chronic obstructive pulmonary disease.rm5
p6356
sg9
V1926024.xml
p6357
sa(dp6358
g3
VSTD-Cockcroft-1987
p6359
sg5
S'PMC1245234'
p6360
sg7
g6356
sg9
V3101821.xml
p6361
sa(dp6362
g3
VSTD-Bollen-2005
p6363
sg5
S'PMC1269459'
p6364
sg7
VCD004085 v. 5.2 High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and ac.rm5
p6365
sg9
V16137357.xml
p6366
sa(dp6367
g3
VSTD-Dyhr-2003
p6368
sg5
S'PMC154111'
p6369
sg7
VCD006667 v. 5.0 Recruitment manoeuvres for adults with acute lung injury receiving mechanical ventilation.rm5
p6370
sg9
V12617741.xml
p6371
sa(dp6372
g3
VSTD-Harkins-1964
p6373
sg5
S'PMC1927374'
p6374
sg7
VCD009223 v. 3.0 Non-opioid drugs for pain management in labour.rm5
p6375
sg9
V14180526.xml
p6376
sa(dp6377
g3
VSTD-Makvandi-2011
p6378
sg5
S'PMC3081214'
p6379
sg7
g6375
sg9
V21495198.xml
p6380
sa(dp6381
g3
VSTD-Meijer-1999
p6382
sg5
S'PMC1745367'
p6383
sg7
VCD003534 v. 9.2 Fluticasone at different doses for chronic asthma in adults and children.rm5
p6384
sg9
V10491451.xml
p6385
sa(dp6386
g3
VSTD-Verona-2003
p6387
sg5
S'PMC1763114'
p6388
sg7
g6384
sg9
V12765916.xml
p6389
sa(dp6390
g3
VSTD-Vichinsky-2007
p6391
sg5
S'PMC1974786'
p6392
sg7
VCD007477 v. 5.0 Deferasirox for managing transfusional iron overload in people with sickle cell disease.rm5
p6393
sg9
V17233848.xml
p6394
sa(dp6395
g3
VSTD-Ellickson-2003
p6396
sg5
S'PMC1448059'
p6397
sg7
VCD003020 v. 9.0 School-based prevention for illicit drugs' use.rm5
p6398
sg9
V14600049.xml
p6399
sa(dp6400
g3
VSTD-WISDOM-2007
p6401
sg5
S'PMC1939792'
p6402
sg7
VCD002229 v. 11.6 Hormone therapy for preventing cardiovascular disease in post-menopausal women.rm5
p6403
sg9
V17626056.xml
p6404
sa(dp6405
g3
VSTD-_x0031_200-SE-Pimenta-2009
p6406
sg5
S'PMC2771382'
p6407
sg7
VCD004022 v. 8.7 Effects of low sodium diet versus high sodium diet on blood pressure renin aldosterone catecholam.rm5
p6408
sg9
V19620517.xml
p6409
sa(dp6410
g3
VSTD-_x0031_107-SE-MacFadyen-1994
p6411
sg5
S'PMC1364776'
p6412
sg7
g6408
sg9
V7833222.xml
p6413
sa(dp6414
g3
VSTD-_x0031_035-SE-Watt-1985-b
p6415
sg5
S'PMC1418187'
p6416
sg7
g6408
sg9
V3933736.xml
p6417
sa(dp6418
g3
VSTD-_x0031_024-P-Erwteman-1984
p6419
sg5
S'PMC1442440'
p6420
sg7
g6408
sg9
V6432119.xml
p6421
sa(dp6422
g3
VSTD-_x0031_034-SE-Watt-1985
p6423
sg5
S'PMC1418187'
p6424
sg7
g6408
sg9
V3933736.xml
p6425
sa(dp6426
g3
VSTD-_x0031_199-P-Meland-2009
p6427
sg5
S'PMC3410469'
p6428
sg7
g6408
sg9
V19140039.xml
p6429
sa(dp6430
g3
VSTD-Mantovani-2010a
p6431
sg5
S'PMC3227938'
p6432
sg7
VCD008664 v. 2.0 Thalidomide for managing cancer cachexia.rm5
p6433
sg9
V20156909.xml
p6434
sa(dp6435
g3
VSTD-Gordon-2005
p6436
sg5
S'PMC1774430'
p6437
sg7
g6433
sg9
V15753541.xml
p6438
sa(dp6439
g3
VSTD-Varney-1991
p6440
sg5
S'PMC1668945'
p6441
sg7
VCD001936 v. 4.0 Allergen injection immunotherapy for seasonal allergic rhinitis.rm5
p6442
sg9
V1998791.xml
p6443
sa(dp6444
g3
VSTD-Bafna-2011
p6445
sg5
S'PMC3146157'
p6446
sg7
VCD004087 v. 4.8 Pharmacological agents for preventing morbidity associated with the haemodynamic response to trachea.rm5
p6447
sg9
V21804705.xml
p6448
sa(dp6449
g3
VSTD-Montazeri-2011
p6450
sg5
S'PMC3252769'
p6451
sg7
g6447
sg9
V22247722.xml
p6452
sa(dp6453
g3
VSTD-Fujisaka-2011
p6454
sg5
S'PMC3241560'
p6455
sg7
VCD003407 v. 13.2 Erythropoietin or darbepoetin for patients with cancer.rm5
p6456
sg9
V21959870.xml
p6457
sa(dp6458
g3
VSTD-Thatcher-1999b
p6459
sg5
S'PMC2362337'
p6460
sg7
g6456
sg9
V10408844.xml
p6461
sa(dp6462
g3
VSTD-Thatcher-1999a
p6463
sg5
S'PMC2362337'
p6464
sg7
g6456
sg9
V10408844.xml
p6465
sa(dp6466
g3
VSTD-Boogaerts-2003
p6467
sg5
S'PMC2376376'
p6468
sg7
g6456
sg9
V12671693.xml
p6469
sa(dp6470
g3
VSTD-Smith-2003b
p6471
sg5
S'PMC2741110'
p6472
sg7
g6456
sg9
V12799626.xml
p6473
sa(dp6474
g3
VSTD-Smith-2003c
p6475
sg5
S'PMC2741110'
p6476
sg7
g6456
sg9
V12799626.xml
p6477
sa(dp6478
g3
VSTD-Smith-2003a
p6479
sg5
S'PMC2741110'
p6480
sg7
g6456
sg9
V12799626.xml
p6481
sa(dp6482
g3
VSTD-Thomas-2008
p6483
sg5
S'PMC2350198'
p6484
sg7
g6456
sg9
V18037478.xml
p6485
sa(dp6486
g3
VSTD-Wilkinson-2006
p6487
sg5
S'PMC2361228'
p6488
sg7
g6456
sg9
V16570051.xml
p6489
sa(dp6490
g3
VSTD-Pronzato-2010
p6491
sg5
S'PMC3228044'
p6492
sg7
g6456
sg9
V20798194.xml
p6493
sa(dp6494
g3
VSTD-Sweeney-1998
p6495
sg5
S'PMC2150364'
p6496
sg7
g6456
sg9
V9667681.xml
p6497
sa(dp6498
g3
VSTD-Thatcher-1999
p6499
sg5
S'PMC2362337'
p6500
sg7
g6456
sg9
V10408844.xml
p6501
sa(dp6502
g3
VSTD-Smith-2003
p6503
sg5
S'PMC2741110'
p6504
sg7
g6456
sg9
V12799626.xml
p6505
sa(dp6506
g3
VSTD-Ghalaut-2007
p6507
sg5
S'PMC3453121'
p6508
sg7
VCD005197 v. 7.0 Anti-pseudomonal beta-lactams for the initial empirical treatment of febrile neutropenia comparis.rm5
p6509
sg9
V23100925.xml
p6510
sa(dp6511
g3
VSTD-Liang-1990
p6512
sg5
S'PMC175977'
p6513
sg7
g6509
sg9
V2201252.xml
p6514
sa(dp6515
g3
VSTD-Underwood-2004
p6516
sg5
S'PMC3471981'
p6517
sg7
VCD003978 v. 7.0 Prescription of prosthetic ankle-foot mechanisms after lower limb amputation.rm5
p6518
sg9
V15234485.xml
p6519
sa(dp6520
g3
VSTD-Kitajima-1997
p6521
sg5
S'PMC1720633'
p6522
sg7
VCD005496 v. 6.0 Probiotics for prevention of necrotizing enterocolitis in preterm infants.rm5
p6523
sg9
V9135288.xml
p6524
sa(dp6525
g3
VSTD-Mohan-2006
p6526
sg5
S'PMC1698302'
p6527
sg7
g6523
sg9
V16971641.xml
p6528
sa(dp6529
g3
VSTD-Millar-1993
p6530
sg5
S'PMC1029589'
p6531
sg7
g6523
sg9
V8285750.xml
p6532
sa(dp6533
g3
VSTD-Currie-2002
p6534
sg5
S'PMC1746197'
p6535
sg7
VCD005309 v. 8.0 Fluticasone versus 'extrafine' HFA-beclomethasone dipropionate for chronic asthma in adults and chil.rm5
p6536
sg9
V12324672.xml
p6537
sa(dp6538
g3
VSTD-Mannel-2011
p6539
sg5
S'PMC3110746'
p6540
sg7
VCD007414 v. 5.6 Maintenance chemotherapy for ovarian cancer.rm5
p6541
sg9
V21529904.xml
p6542
sa(dp6543
g3
VSTD-Britton-1985
p6544
sg5
S'PMC1416077'
p6545
sg7
VCD006338 v. 9.2 Chest physiotherapy for pneumonia in adults.rm5
p6546
sg9
V3924221.xml
p6547
sa(dp6548
g3
VSTD-Galloway-2005
p6549
sg5
S'PMC1087493'
p6550
sg7
VCD006140 v. 5.0 Sustained-Release Naltrexone For Opioid Dependence.rm5
p6551
sg9
V15804355.xml
p6552
sa(dp6553
g3
VSTD-Hulse-2005
p6554
sg5
S'PMC1646626'
p6555
sg7
g6551
sg9
V15899557.xml
p6556
sa(dp6557
g3
VSTD-Keystone-2009
p6558
sg5
S'PMC2674549'
p6559
sg7
VCD008341 v. 2.0 Golimumab for rheumatoid arthritis.rm5
p6560
sg9
V19066176.xml
p6561
sa(dp6562
g3
VSTD-Jun-2006
p6563
sg5
S'PMC2722000'
p6564
sg7
VCD002907 v. 8.2 Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding.rm5
p6565
sg9
V17043424.xml
p6566
sa(dp6567
g3
VSTD-Hallman-1986
p6568
sg5
S'PMC1778095'
p6569
sg7
VCD000366 v. 8.0 Inositol for respiratory distress syndrome in preterm infants.rm5
p6570
sg9
V3539028.xml
p6571
sa(dp6572
g3
VSTD-Lakhani-1984
p6573
sg5
S'PMC1628817'
p6574
sg7
VCD002099 v. 4.0 Nursing record systems effects on nursing practice and healthcare outcomes.rm5
p6575
sg9
V6508341.xml
p6576
sa(dp6577
g3
VSTD-Mutrie-2002
p6578
sg5
S'PMC1732165'
p6579
sg7
VCD005575 v. 6.2 Organisational travel plans for improving health.rm5
p6580
sg9
V12011193.xml
p6581
sa(dp6582
g3
VSTD-McKee-2007
p6583
sg5
S'PMC2703799'
p6584
sg7
g6580
sg9
V17699538.xml
p6585
sa(dp6586
g3
VSTD-Rowland-2003
p6587
sg5
S'PMC1719287'
p6588
sg7
g6580
sg9
V12495948.xml
p6589
sa(dp6590
g3
VSTD-Mendoza-2009
p6591
sg5
S'PMC2680829'
p6592
sg7
g6580
sg9
V19413910.xml
p6593
sa(dp6594
g3
VSTD-Di-Bisceglie-2008
p6595
sg5
S'PMC2606037'
p6596
sg7
VCD003617 v. 6.55 Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.rm5
p6597
sg9
V19052125.xml
p6598
sa(dp6599
g3
VSTD-Lai-1987
p6600
sg5
S'PMC1248243'
p6601
sg7
VCD003965 v. 11.0 Immunosuppressive agents for treating IgA nephropathy.rm5
p6602
sg9
V3120928.xml
p6603
sa(dp6604
g3
VSTD-Gombocz-2007
p6605
sg5
S'PMC2206488'
p6606
sg7
VCD001319 v. 13.0 Colloid solutions for fluid resuscitation.rm5
p6607
sg9
V17697359.xml
p6608
sa(dp6609
g3
VSTD-Akech-2006
p6610
sg5
S'PMC1569382'
p6611
sg7
g6607
sg9
V16998584.xml
p6612
sa(dp6613
g3
VSTD-Gold-1990
p6614
sg5
S'PMC1358036'
p6615
sg7
g6607
sg9
V1690974.xml
p6616
sa(dp6617
g3
VSTD-England-1996
p6618
sg5
S'PMC2350357'
p6619
sg7
VCD000934 v. 8.0 Alternative versus standard packages of antenatal care for low-risk pregnancy.rm5
p6620
sg9
V8595286.xml
p6621
sa(dp6622
g3
VSTD-Berlauk-1991
p6623
sg5
S'PMC1358649'
p6624
sg7
VCD003408 v. 10.4 Pulmonary artery catheters for adult patients in intensive care.rm5
p6625
sg9
V1929610.xml
p6626
sa(dp6627
g3
VSTD-Bender-1997
p6628
sg5
S'PMC1191013'
p6629
sg7
g6625
sg9
V9339929.xml
p6630
sa(dp6631
g3
VSTD-Chawarski-2011
p6632
sg5
S'PMC3076517'
p6633
sg7
VCD004147 v. 10.0 Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alon.rm5
p6634
sg9
V21159452.xml
p6635
sa(dp6636
g3
VSTD-Epstein-2009
p6637
sg5
S'PMC2943844'
p6638
sg7
g6634
sg9
V19101098.xml
p6639
sa(dp6640
g3
VSTD-Bickel-2008
p6641
sg5
S'PMC2746734'
p6642
sg7
g6634
sg9
V18489017.xml
p6643
sa(dp6644
g3
VSTD-Chopra-2009
p6645
sg5
S'PMC2852314'
p6646
sg7
g6634
sg9
V19653788.xml
p6647
sa(dp6648
g3
VSTD-Ghitza-2008
p6649
sg5
S'PMC2271179'
p6650
sg7
g6634
sg9
V18068905.xml
p6651
sa(dp6652
g3
VSTD-Luthar-2000
p6653
sg5
S'PMC2190295'
p6654
sg7
g6634
sg9
V17241493.xml
p6655
sa(dp6656
g3
VSTD-Neufeld-2008
p6657
sg5
S'PMC2193670'
p6658
sg7
g6634
sg9
V17574801.xml
p6659
sa(dp6660
g3
VSTD-Daniels-1996
p6661
sg5
S'PMC2528339'
p6662
sg7
VCD003312 v. 4.0 Selenium supplementation to prevent short-term morbidity in preterm neonates.rm5
p6663
sg9
V8777677.xml
p6664
sa(dp6665
g3
VSTD-GAL_x002d_INT_x002d_2-Rockwood
p6666
sg5
S'PMC1737604'
p6667
sg7
VCD001747 v. 11.0 Galantamine for Alzheimer's disease and mild cognitive impairment.rm5
p6668
sg9
V11606667.xml
p6669
sa(dp6670
g3
VSTD-Sherwood-1983
p6671
sg5
S'PMC1650873'
p6672
sg7
VCD006855 v. 3.0 Personal assistance for older adults (65) without dementia.rm5
p6673
sg9
V6405641.xml
p6674
sa(dp6675
g3
VSTD-Carlson-2007
p6676
sg5
S'PMC1955332'
p6677
sg7
g6673
sg9
V17244293.xml
p6678
sa(dp6679
g3
VSTD-Feldman-1996
p6680
sg5
S'PMC1070133'
p6681
sg7
g6673
sg9
V8885860.xml
p6682
sa(dp6683
g3
VSTD-ATBC-1998
p6684
sg5
S'PMC1756731'
p6685
sg7
VCD004567 v. 5.0 Antioxidant vitamin supplementation for preventing and slowing the progression of age-related catara.rm5
p6686
sg9
V9799882.xml
p6687
sa(dp6688
g3
VSTD-APC-2006
p6689
sg5
S'PMC1857154'
p6690
sg7
g6686
sg9
V16556618.xml
p6691
sa(dp6692
g3
VSTD-PHS-II-2010
p6693
sg5
S'PMC3051399'
p6694
sg7
g6686
sg9
V21060040.xml
p6695
sa(dp6696
g3
VSTD-Graham-2002
p6697
sg5
S'PMC111106'
p6698
sg7
VCD005215 v. 6.0 Interventions for preventing unintended pregnancies among adolescents.rm5
p6699
sg9
V12016180.xml
p6700
sa(dp6701
g3
VSTD-Henderson-2007
p6702
sg5
S'PMC1779834'
p6703
sg7
g6699
sg9
V17118950.xml
p6704
sa(dp6705
g3
VSTD-Coyle-2004
p6706
sg5
S'PMC1448347'
p6707
sg7
g6699
sg9
V15117710.xml
p6708
sa(dp6709
g3
VSTD-Dilorio-2007
p6710
sg5
S'PMC1874204'
p6711
sg7
g6699
sg9
V17463382.xml
p6712
sa(dp6713
g3
VSTD-Villarruel-2006
p6714
sg5
S'PMC3034476'
p6715
sg7
g6699
sg9
V16894074.xml
p6716
sa(dp6717
g3
VSTD-Walker-2006
p6718
sg5
S'PMC1463960'
p6719
sg7
g6699
sg9
V16682420.xml
p6720
sa(dp6721
g3
VSTD-Wight-2002
p6722
sg5
S'PMC115856'
p6723
sg7
g6699
sg9
V12065268.xml
p6724
sa(dp6725
g3
VSTD-Bent-2011
p6726
sg5
S'PMC3076562'
p6727
sg7
VCD007992 v. 3.0 Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).rm5
p6728
sg9
V20683766.xml
p6729
sa(dp6730
g3
VSTD-Creinin-2006
p6731
sg5
S'PMC2853373'
p6732
sg7
VCD001324 v. 10.0 Interventions for emergency contraception.rm5
p6733
sg9
V17077229.xml
p6734
sa(dp6735
g3
VSTD-Webb-1992
p6736
sg5
S'PMC1883543'
p6737
sg7
g6733
sg9
V1458074.xml
p6738
sa(dp6739
g3
VSTD-Giardiello-2002
p6740
sg5
S'PMC2225537'
p6741
sg7
VCD004079 v. 5.0 Non steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and car.rm5
p6742
sg9
V11932472.xml
p6743
sa(dp6744
g3
VSTD-Berg-2009
p6745
sg5
S'PMC2899375'
p6746
sg7
VCD008326 v. 5.0 Total disc replacement for chronic back pain in the presence of disc degeneration.rm5
p6747
sg9
V19506919.xml
p6748
sa(dp6749
g3
VSTD-Hellum-2011
p6750
sg5
S'PMC3100911'
p6751
sg7
g6747
sg9
V21596740.xml
p6752
sa(dp6753
g3
VSTD-Dew-1983a
p6754
sg5
S'PMC1548114'
p6755
sg7
VCD000544 v. 11.0 Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.rm5
p6756
sg9
V6134565.xml
p6757
sa(dp6758
g3
VSTD-Ito-2010
p6759
sg5
S'PMC2972641'
p6760
sg7
g6756
sg9
V20049949.xml
p6761
sa(dp6762
g3
VSTD-Kane-2008a
p6763
sg5
S'PMC2770408'
p6764
sg7
g6756
sg9
V19920971.xml
p6765
sa(dp6766
g3
VSTD-Kamm-2008
p6767
sg5
S'PMC2564831'
p6768
sg7
g6756
sg9
V18272546.xml
p6769
sa(dp6770
g3
VSTD-Travis-1994
p6771
sg5
S'PMC1375708'
p6772
sg7
g6756
sg9
V7959238.xml
p6773
sa(dp6774
g3
VSTD-Kiilerich-1992
p6775
sg5
S'PMC1373939'
p6776
sg7
g6756
sg9
V1347280.xml
p6777
sa(dp6778
g3
VSTD-Kruis-2001
p6779
sg5
S'PMC1728533'
p6780
sg7
g6756
sg9
V11709512.xml
p6781
sa(dp6782
g3
VSTD-Ireland-1988
p6783
sg5
S'PMC1433723'
p6784
sg7
g6756
sg9
V2898422.xml
p6785
sa(dp6786
g3
VSTD-Green-2010
p6787
sg5
S'PMC2890859'
p6788
sg7
VCD009774 v. 2.0 Parent-mediated early intervention for young children with autism spectrum disorders (ASD).rm5
p6789
sg9
V20494434.xml
p6790
sa(dp6791
g3
VSTD-Siller-2012
p6792
sg5
S'PMC3511916'
p6793
sg7
g6789
sg9
V22825926.xml
p6794
sa(dp6795
g3
VSTD-Kasari-2010
p6796
sg5
S'PMC2922697'
p6797
sg7
g6789
sg9
V20145986.xml
p6798
sa(dp6799
g3
VSTD-Bech-2007
p6800
sg5
S'PMC1804137'
p6801
sg7
VCD006965 v. 6.0 Effects of restricted caffeine intake by mother on fetal neonatal and pregnancy outcome.rm5
p6802
sg9
V17259189.xml
p6803
sa(dp6804
g3
VSTD-Johnson-1985
p6805
sg5
S'PMC1418227'
p6806
sg7
VCD002286 v. 7.3 Feverfew for preventing migraine.rm5
p6807
sg9
V3929876.xml
p6808
sa(dp6809
g3
VSTD-Sindrup-1990b
p6810
sg5
S'PMC1368167'
p6811
sg7
VCD005454 v. 11.0 Antidepressants for neuropathic pain.rm5
p6812
sg9
V2271367.xml
p6813
sa(dp6814
g3
VSTD-Hampf-1989
p6815
sg5
S'PMC2148641'
p6816
sg7
g6812
sg9
V2574958.xml
p6817
sa(dp6818
g3
VSTD-Feinmann-1984
p6819
sg5
S'PMC1444752'
p6820
sg7
g6812
sg9
V6419955.xml
p6821
sa(dp6822
g3
VSTD-McCleane-2000a
p6823
sg5
S'PMC2015036'
p6824
sg7
g6812
sg9
V10848721.xml
p6825
sa(dp6826
g3
VSTD-Shepperd-1998
p6827
sg5
S'PMC28578'
p6828
sg7
VCD004957 v. 4.0 Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chron.rm5
p6829
sg9
V9624068.xml
p6830
sa(dp6831
g3
VSTD-Jaffe-1983
p6832
sg5
S'PMC481332'
p6833
sg7
VCD006743 v. 5.0 Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients .rm5
p6834
sg9
V6404289.xml
p6835
sa(dp6836
g3
VSTD-Hargreaves-1992
p6837
sg5
S'PMC1025134'
p6838
sg7
g6834
sg9
V1449918.xml
p6839
sa(dp6840
g3
VSTD-Norris-1980
p6841
sg5
S'PMC482762'
p6842
sg7
g6834
sg9
V7426142.xml
p6843
sa(dp6844
g3
VSTD-Self-1983
p6845
sg5
S'PMC1874805'
p6846
sg7
VCD008416 v. 2.2 Multimedia educational interventions for consumers about prescribed and over-the-counter medications.rm5
p6847
sg9
V6848154.xml
p6848
sa(dp6849
g3
VSTD-Schwarz-2008a
p6850
sg5
S'PMC2517895'
p6851
sg7
g6847
sg9
V18398664.xml
p6852
sa(dp6853
g3
VSTD-Emond-2002
p6854
sg5
S'PMC1719107'
p6855
sg7
VCD006020 v. 6.0 Parenting interventions for the prevention of unintentional injuries in childhood.rm5
p6856
sg9
V11861228.xml
p6857
sa(dp6858
g3
VSTD-Johnson-1993
p6859
sg5
S'PMC1677859'
p6860
sg7
g6856
sg9
V8518642.xml
p6861
sa(dp6862
g3
VSTD-Barlow-2007
p6863
sg5
S'PMC2083433'
p6864
sg7
g6856
sg9
V17068074.xml
p6865
sa(dp6866
g3
VSTD-McCormack-1983
p6867
sg5
S'PMC2494372'
p6868
sg7
VCD006003 v. 6.2 Routine abdominal drainage for uncomplicated open cholecystectomy.rm5
p6869
sg9
V6614773.xml
p6870
sa(dp6871
g3
VSTD-Salam-1984
p6872
sg5
S'PMC2492550'
p6873
sg7
g6869
sg9
V6721407.xml
p6874
sa(dp6875
g3
VSTD-Fraser-1982
p6876
sg5
S'PMC2493965'
p6877
sg7
g6869
sg9
V7081917.xml
p6878
sa(dp6879
g3
VSTD-O_x0027_Kane-2008
p6880
sg5
S'PMC2394643'
p6881
sg7
VCD005060 v. 6.0 Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.rm5
p6882
sg9
V18420662.xml
p6883
sa(dp6884
g3
VSTD-DiGEM-trial-2007
p6885
sg5
S'PMC1925177'
p6886
sg7
g6882
sg9
V17591623.xml
p6887
sa(dp6888
g3
VSTD-Henderson-1986
p6889
sg5
S'PMC1341513'
p6890
sg7
VCD004640 v. 11.0 Magnesium supplementation for the management of primary hypertension in adults.rm5
p6891
sg9
V3092972.xml
p6892
sa(dp6893
g3
VSTD-McKinney-1989
p6894
sg5
S'PMC1837927'
p6895
sg7
VCD003338 v. 9.0 Conservative treatments for whiplash.rm5
p6896
sg9
V2511939.xml
p6897
sa(dp6898
g3
VSTD-Schnabel-2004
p6899
sg5
S'PMC1726332'
p6900
sg7
g6896
sg9
V15107368.xml
p6901
sa(dp6902
g3
VSTD-Mealy-1986
p6903
sg5
S'PMC1339641'
p6904
sg7
g6896
sg9
V3081211.xml
p6905
sa(dp6906
g3
VSTD-Kumar-2011
p6907
sg5
S'PMC3116809'
p6908
sg7
VCD000323 v. 8.1 Interventions for dysphagia and nutritional support in acute and subacute stroke.rm5
p6909
sg9
V21441148.xml
p6910
sa(dp6911
g3
VSTD-Norton-1996
p6912
sg5
S'PMC2349687'
p6913
sg7
g6909
sg9
V8555849.xml
p6914
sa(dp6915
g3
VSTD-Coope-1981
p6916
sg5
S'PMC1971963'
p6917
sg7
VCD002978 v. 3.0 Oral oestrogen and combined oestrogenprogestogen therapy versus placebo for hot flushes.rm5
p6918
sg9
V6268783.xml
p6919
sa(dp6920
g3
VSTD-Coope-1975
p6921
sg5
S'PMC1674796'
p6922
sg7
g6918
sg9
V172181.xml
p6923
sa(dp6924
g3
VSTD-Sesay-2011
p6925
sg5
S'PMC3024263'
p6926
sg7
VCD003756 v. 6.2 Intermittent preventive treatment for malaria in children living in areas with seasonal transmission.rm5
p6927
sg9
V21214940.xml
p6928
sa(dp6929
g3
VSTD-Konate-2011
p6930
sg5
S'PMC3032552'
p6931
sg7
g6927
sg9
V21304925.xml
p6932
sa(dp6933
g3
VSTD-Kweku-2008
p6934
sg5
S'PMC2602973'
p6935
sg7
g6927
sg9
V19098989.xml
p6936
sa(dp6937
g3
VSTD-Dicko-2011
p6938
sg5
S'PMC3032550'
p6939
sg7
g6927
sg9
V21304923.xml
p6940
sa(dp6941
g3
VSTD-Dicko-2008
p6942
sg5
S'PMC2500037'
p6943
sg7
g6927
sg9
V18611271.xml
p6944
sa(dp6945
g3
VSTD-Kari-1993
p6946
sg5
S'PMC1029304'
p6947
sg7
VCD001144 v. 7.0 Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preter.rm5
p6948
sg9
V8323356.xml
p6949
sa(dp6950
g3
VSTD-Sandrini-2007
p6951
sg5
S'PMC1974802'
p6952
sg7
VCD008615 v. 3.2 Sumatriptan (oral route of administration) for acute migraine attacks in adults.rm5
p6953
sg9
V17627707.xml
p6954
sa(dp6955
g3
VSTD-Tfelt_x002d_Hansen-2006
p6956
sg5
S'PMC3452229'
p6957
sg7
g6953
sg9
V17164991.xml
p6958
sa(dp6959
g3
VSTD-Bacon-1981b
p6960
sg5
S'PMC1627392'
p6961
sg7
VCD003031 v. 7.0 Prophylactic drug management for febrile seizures in children.rm5
p6962
sg9
V7305427.xml
p6963
sa(dp6964
g3
VSTD-Knudsen-1985b
p6965
sg5
S'PMC1777614'
p6966
sg7
g6962
sg9
V3907504.xml
p6967
sa(dp6968
g3
VSTD-Knudsen-1996
p6969
sg5
S'PMC1511589'
p6970
sg7
g6962
sg9
V8660037.xml
p6971
sa(dp6972
g3
VSTD-Heckmatt-1976
p6973
sg5
S'PMC1639342'
p6974
sg7
g6962
sg9
V1260273.xml
p6975
sa(dp6976
g3
VSTD-Ngwane-1980
p6977
sg5
S'PMC1626746'
p6978
sg7
g6962
sg9
V6770760.xml
p6979
sa(dp6980
g3
VSTD-Calis-2000
p6981
sg5
S'PMC1752990'
p6982
sg7
VCD007427 v. 2.0 Physical tests for shoulder impingements and local lesions of bursa tendon or labrum that may accom.rm5
p6983
sg9
V10627426.xml
p6984
sa(dp6985
g3
VSTD-Naredo--2002
p6986
sg5
S'PMC1754006'
p6987
sg7
g6983
sg9
V11796399.xml
p6988
sa(dp6989
g3
VSTD-Figueras-2007
p6990
sg5
S'PMC1877032'
p6991
sg7
VCD004171 v. 5.11 Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.rm5
p6992
sg9
V17414601.xml
p6993
sa(dp6994
g3
VSTD-Oniki-2003
p6995
sg5
S'PMC150371'
p6996
sg7
VCD001175 v. 6.7 Computer-generated reminders delivered on paper to healthcare professionals; effects on professional.rm5
p6997
sg9
V12595407.xml
p6998
sa(dp6999
g3
VSTD-McAlister-2009
p7000
sg5
S'PMC2789127'
p7001
sg7
g6997
sg9
V19933787.xml
p7002
sa(dp7003
g3
VSTD-Nilasena-1995
p7004
sg5
S'PMC2579172'
p7005
sg7
g6997
sg9
V8563365.xml
p7006
sa(dp7007
g3
VSTD-Rossi-1997
p7008
sg5
S'PMC1497186'
p7009
sg7
g6997
sg9
V9383135.xml
p7010
sa(dp7011
g3
VSTD-Rosser-1991
p7012
sg5
S'PMC1335900'
p7013
sg7
g6997
sg9
V1913409.xml
p7014
sa(dp7015
g3
VSTD-Wolter-2002
p7016
sg5
S'PMC1746273'
p7017
sg7
VCD002203 v. 10.0 Macrolide antibiotics for cystic fibrosis.rm5
p7018
sg9
V11867823.xml
p7019
sa(dp7020
g3
VSTD-Clement-2006
p7021
sg5
S'PMC2104771'
p7022
sg7
g7018
sg9
V16809416.xml
p7023
sa(dp7024
g3
VSTD-Choi-2008
p7025
sg5
S'PMC2636470'
p7026
sg7
VCD001035 v. 8.0 Interventions for encouraging sexual behaviours intended to prevent cervical cancer.rm5
p7027
sg9
V18703460.xml
p7028
sa(dp7029
g3
VSTD-Morrison_x002d_Beedy-2005
p7030
sg5
S'PMC2430924'
p7031
sg7
g7027
sg9
V15625713.xml
p7032
sa(dp7033
g3
VSTD-Kershaw-2009
p7034
sg5
S'PMC2759789'
p7035
sg7
g7027
sg9
V19762662.xml
p7036
sa(dp7037
g3
VSTD-Jaworski-2001
p7038
sg5
S'PMC2423731'
p7039
sg7
g7027
sg9
V11728891.xml
p7040
sa(dp7041
g3
VSTD-Peipert-2008
p7042
sg5
S'PMC2535847'
p7043
sg7
g7027
sg9
V18395692.xml
p7044
sa(dp7045
g3
VSTD-Thio-B-2000
p7046
sg5
S'PMC1745622'
p7047
sg7
VCD003570 v. 5.0 Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis.rm5
p7048
sg9
V10992533.xml
p7049
sa(dp7050
g3
VSTD-Thio-A-2000
p7051
sg5
S'PMC1745622'
p7052
sg7
g7048
sg9
V10992533.xml
p7053
sa(dp7054
g3
VSTD-Thio-C-2000
p7055
sg5
S'PMC1745622'
p7056
sg7
g7048
sg9
V10992533.xml
p7057
sa(dp7058
g3
VSTD-McKee-1991
p7059
sg5
S'PMC1368499'
p7060
sg7
VCD007124 v. 5.0 Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.rm5
p7061
sg9
V1888646.xml
p7062
sa(dp7063
g3
VSTD-Khawaja-1992
p7064
sg5
S'PMC1881859'
p7065
sg7
VCD006213 v. 9.0 Healing by primary versus secondary intention after surgical treatment for pilonidal sinus.rm5
p7066
sg9
V1606429.xml
p7067
sa(dp7068
g3
VSTD-Jatakanon-1999
p7069
sg5
S'PMC1745406'
p7070
sg7
VCD004109 v. 4.0 High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and c.rm5
p7071
sg9
V10325913.xml
p7072
sa(dp7073
g3
VSTD-Lorentzson-1990
p7074
sg5
S'PMC462715'
p7075
sg7
g7071
sg9
V1978947.xml
p7076
sa(dp7077
g3
VSTD-Holloway-1989
p7078
sg5
S'PMC1026946'
p7079
sg7
VCD003557 v. 8.2 Antibiotics and antiseptics for venous leg ulcers.rm5
p7080
sg9
V2669345.xml
p7081
sa(dp7082
g3
VSTD-Ormiston-1985
p7083
sg5
S'PMC1416577'
p7084
sg7
g7080
sg9
V3926169.xml
p7085
sa(dp7086
g3
VSTD-Greene-1983
p7087
sg5
S'PMC1549780'
p7088
sg7
VCD003816 v. 4.9 'Human' insulin versus animal insulin in people with diabetes mellitus.rm5
p7089
sg9
V6416510.xml
p7090
sa(dp7091
g3
VSTD-Maran-1993
p7092
sg5
S'PMC1676615'
p7093
sg7
g7089
sg9
V8443479.xml
p7094
sa(dp7095
g3
VSTD-Mann-1983
p7096
sg5
S'PMC1549785'
p7097
sg7
g7089
sg9
V6416511.xml
p7098
sa(dp7099
g3
VSTD-Egger-1991
p7100
sg5
S'PMC1671054'
p7101
sg7
g7089
sg9
V1932903.xml
p7102
sa(dp7103
g3
VSTD-Fossey-2006
p7104
sg5
S'PMC1420717'
p7105
sg7
VCD008634 v. 2.0 Psychosocial interventions for reducing antipsychotic medication in care home residents.rm5
p7106
sg9
V16543297.xml
p7107
sa(dp7108
g3
VSTD-Duoll-1997
p7109
sg5
S'PMC2127557'
p7110
sg7
VCD001107 v. 3.0 Inhaled steroids for episodic viral wheeze of childhood.rm5
p7111
sg9
V9353508.xml
p7112
sa(dp7113
g3
VSTD-Connett--1993
p7114
sg5
S'PMC1029187'
p7115
sg7
g7111
sg9
V8435016.xml
p7116
sa(dp7117
g3
VSTD-Wilson-1995
p7118
sg5
S'PMC1511243'
p7119
sg7
g7111
sg9
V7763063.xml
p7120
sa(dp7121
g3
VSTD-Wilson-1990
p7122
sg5
S'PMC1792186'
p7123
sg7
g7111
sg9
V2189367.xml
p7124
sa(dp7125
g3
VSTD-Wallin-1977
p7126
sg5
S'PMC1045406'
p7127
sg7
VCD006562 v. 3.0 5-FU for genital warts in non-immunocompromised individuals.rm5
p7128
sg9
V922458.xml
p7129
sa(dp7130
g3
VSTD-Cryz-1993
p7131
sg5
S'PMC302854'
p7132
sg7
VCD001261 v. 5.0 Vaccines for preventing typhoid fever.rm5
p7133
sg9
V8432597.xml
p7134
sa(dp7135
g3
VSTD-Wahdan-1980a
p7136
sg5
S'PMC2395909'
p7137
sg7
g7133
sg9
V6998594.xml
p7138
sa(dp7139
g3
VSTD-Yang-2001
p7140
sg5
S'PMC2566475'
p7141
sg7
g7133
sg9
V11477965.xml
p7142
sa(dp7143
g3
VSTD-Wahdan-1980b
p7144
sg5
S'PMC2395909'
p7145
sg7
g7133
sg9
V6998594.xml
p7146
sa(dp7147
g3
VSTD-Liu-2004
p7148
sg5
S'PMC1356212'
p7149
sg7
VCD006232 v. 5.2 Routine abdominal drainage for uncomplicated liver resection.rm5
p7150
sg9
V14745327.xml
p7151
sa(dp7152
g3
VSTD-Szewczyk-2010
p7153
sg5
S'PMC3298351'
p7154
sg7
VCD000265 v. 15.0 Compression for venous leg ulcers.rm5
p7155
sg9
V22419941.xml
p7156
sa(dp7157
g3
VSTD-Morrell-1998
p7158
sg5
S'PMC28546'
p7159
sg7
g7155
sg9
V9582132.xml
p7160
sa(dp7161
g3
VSTD-Scriven-1998
p7162
sg5
S'PMC2503021'
p7163
sg7
g7155
sg9
V9682649.xml
p7164
sa(dp7165
g3
VSTD-Roland-1989
p7166
sg5
S'PMC1711929'
p7167
sg7
VCD004057 v. 9.0 Individual patient education for low back pain.rm5
p7168
sg9
V2556518.xml
p7169
sa(dp7170
g3
VSTD-Jellema-2005
p7171
sg5
S'PMC558614'
p7172
sg7
g7168
sg9
V15967762.xml
p7173
sa(dp7174
g3
VSTD-Frost-2004
p7175
sg5
S'PMC518892'
p7176
sg7
g7168
sg9
V15377573.xml
p7177
sa(dp7178
g3
VSTD-Rapha_x00eb_l-2001
p7179
sg5
S'PMC1737513'
p7180
sg7
VCD002063 v. 10.0 Intravenous immunoglobulin for Guillain-Barr syndrome.rm5
p7181
sg9
V11459901.xml
p7182
sa(dp7183
g3
VSTD-El_x002d_Bayoumi-2011
p7184
sg5
S'PMC3387601'
p7185
sg7
g7181
sg9
V21745374.xml
p7186
sa(dp7187
g3
VSTD-Arm-1988
p7188
sg5
S'PMC1020747'
p7189
sg7
VCD001283 v. 11.1 Dietary marine fatty acids (fish oil) for asthma in adults and children.rm5
p7190
sg9
V3353893.xml
p7191
sa(dp7192
g3
VSTD-Petry-2008
p7193
sg5
S'PMC2738749'
p7194
sg7
VCD008937 v. 2.4 Psychological therapies for pathological and problem gambling.rm5
p7195
sg9
V18377127.xml
p7196
sa(dp7197
g3
VSTD-Grant-2009
p7198
sg5
S'PMC2801822'
p7199
sg7
g7195
sg9
V19721120.xml
p7200
sa(dp7201
g3
VSTD-Carlbring-2010
p7202
sg5
S'PMC2882846'
p7203
sg7
g7195
sg9
V19967577.xml
p7204
sa(dp7205
g3
VSTD-Petry-2009
p7206
sg5
S'PMC2758481'
p7207
sg7
g7195
sg9
V19686527.xml
p7208
sa(dp7209
g3
VSTD-Tebutt-2003
p7210
sg5
S'PMC1773619'
p7211
sg7
VCD008997 v. 2.0 Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable Stag.rm5
p7212
sg9
V12631671.xml
p7213
sa(dp7214
g3
VSTD-PATAF
p7215
sg5
S'PMC28250'
p7216
sg7
VCD006186 v. 4.0 Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular .rm5
p7217
sg9
V10514159.xml
p7218
sa(dp7219
g3
VSTD-Chapman-2000
p7220
sg5
S'PMC27395'
p7221
sg7
VCD004726 v. 4.3 Education of children and adolescents for the prevention of dog bite injuries.rm5
p7222
sg9
V10834894.xml
p7223
sa(dp7224
g3
VSTD-Hawthorne-1997
p7225
sg5
S'PMC1313005'
p7226
sg7
VCD005268 v. 2.2 Individual patient education for people with type 2 diabetes mellitus.rm5
p7227
sg9
V9219407.xml
p7228
sa(dp7229
g3
VSTD-Santos-2010-_x0028_preD_x002f_Dial_x0029_
p7230
sg5
S'PMC2893059'
p7231
sg7
VCD003264 v. 11.0 Growth hormone for children with chronic kidney disease.rm5
p7232
sg9
V20522533.xml
p7233
sa(dp7234
g3
VSTD-Maxwell-1998a-_x0028_TP_x0029_
p7235
sg5
S'PMC1717762'
p7236
sg7
g7232
sg9
V10210991.xml
p7237
sa(dp7238
g3
VSTD-Maxwell-1998b-_x0028_TP_x0029_
p7239
sg5
S'PMC1717762'
p7240
sg7
g7232
sg9
V10210991.xml
p7241
sa(dp7242
g3
VSTD-Holford-1976
p7243
sg5
S'PMC1689300'
p7244
sg7
VCD001484 v. 9.0 Elastic compression stockings for prevention of deep vein thrombosis.rm5
p7245
sg9
V788855.xml
p7246
sa(dp7247
g3
VSTD-Trivedi-2003
p7248
sg5
S'PMC150177'
p7249
sg7
VCD000227 v. 9.0 Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-men.rm5
p7250
sg9
V12609940.xml
p7251
sa(dp7252
g3
VSTD-Porthouse-2005
p7253
sg5
S'PMC557150'
p7254
sg7
g7250
sg9
V15860827.xml
p7255
sa(dp7256
g3
VSTD-Sato-1999a
p7257
sg5
S'PMC1736147'
p7258
sg7
g7250
sg9
V9886454.xml
p7259
sa(dp7260
g3
VSTD-Melchart-2005
p7261
sg5
S'PMC1184247'
p7262
sg7
VCD007587 v. 3.0 Acupuncture for tension-type headache.rm5
p7263
sg9
V16055451.xml
p7264
sa(dp7265
g3
VSTD-Endres-2007
p7266
sg5
S'PMC3476149'
p7267
sg7
g7263
sg9
V17955168.xml
p7268
sa(dp7269
g3
VSTD-MacDonald-2006b
p7270
sg5
S'PMC2082836'
p7271
sg7
VCD004731 v. 9.0 Protein substitute for children and adults with phenylketonuria.rm5
p7272
sg9
V16547085.xml
p7273
sa(dp7274
g3
VSTD-Litt-2010
p7275
sg5
S'PMC2939176'
p7276
sg7
VCD008456 v. 2.0 Psychosocial interventions for the management of chronic orofacial pain.rm5
p7277
sg9
V20655662.xml
p7278
sa(dp7279
g3
VSTD-Katz-2010
p7280
sg5
S'PMC2884332'
p7281
sg7
VCD007991 v. 2.16 Zinc supplementation for mental and motor development in children.rm5
p7282
sg9
V20484548.xml
p7283
sa(dp7284
g3
VSTD-Kuhn-2008
p7285
sg5
S'PMC2577610'
p7286
sg7
VCD006734 v. 4.0 Interventions for preventing late postnatal mother-to-child transmission of HIV.rm5
p7287
sg9
V18525036.xml
p7288
sa(dp7289
g3
VSTD-Watts-1994
p7290
sg5
S'PMC2366143'
p7291
sg7
VCD000246 v. 8.0 Prophylactic antibiotics for inhibiting preterm labour with intact membranes.rm5
p7292
sg9
V18472878.xml
p7293
sa(dp7294
g3
VSTD-Hibbard-1998
p7295
sg5
S'PMC1784771'
p7296
sg7
VCD001233 v. 8.0 Mechanical methods for induction of labour.rm5
p7297
sg9
V9678143.xml
p7298
sa(dp7299
g3
VSTD-Laing-1986
p7300
sg5
S'PMC1777578'
p7301
sg7
VCD003487 v. 5.2 Transpyloric versus gastric tube feeding for preterm infants.rm5
p7302
sg9
V3082297.xml
p7303
sa(dp7304
g3
VSTD-Macdonald-1992
p7305
sg5
S'PMC1590483'
p7306
sg7
g7302
sg9
V1586185.xml
p7307
sa(dp7308
g3
VSTD-Whitfield-1982
p7309
sg5
S'PMC1627713'
p7310
sg7
g7302
sg9
V6810764.xml
p7311
sa(dp7312
g3
VSTD-Webster-2010a
p7313
sg5
S'PMC2958861'
p7314
sg7
VCD007393 v. 4.0 Topical capsaicin (high concentration) for chronic neuropathic pain in adults.rm5
p7315
sg9
V20937130.xml
p7316
sa(dp7317
g3
VSTD-Farrokhi-2010
p7318
sg5
S'PMC2989232'
p7319
sg7
VCD009073 v. 2.0 Pedicle screw fixation for traumatic fractures of the thoracic and lumbar spine.rm5
p7320
sg9
V20495932.xml
p7321
sa(dp7322
g3
VSTD-Daniel-1972
p7323
sg5
S'PMC1215343'
p7324
sg7
VCD002898 v. 10.0 Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratiti.rm5
p7325
sg9
V5079408.xml
p7326
sa(dp7327
g3
VSTD-Hung-1984
p7328
sg5
S'PMC1040361'
p7329
sg7
g7325
sg9
V6372855.xml
p7330
sa(dp7331
g3
VSTD-Colin-2007a
p7332
sg5
S'PMC2704535'
p7333
sg7
g7325
sg9
V19668521.xml
p7334
sa(dp7335
g3
VSTD-Colin-2007b
p7336
sg5
S'PMC2704535'
p7337
sg7
g7325
sg9
V19668521.xml
p7338
sa(dp7339
g3
VSTD-de-Koning-1982
p7340
sg5
S'PMC1039837'
p7341
sg7
g7325
sg9
V6179534.xml
p7342
sa(dp7343
g3
VSTD-MacKenzie-1964
p7344
sg5
S'PMC505953'
p7345
sg7
g7325
sg9
V14193681.xml
p7346
sa(dp7347
g3
VSTD-Laibson-1977
p7348
sg5
S'PMC1311553'
p7349
sg7
g7325
sg9
V418546.xml
p7350
sa(dp7351
g3
VSTD-Coster-1980
p7352
sg5
S'PMC1043812'
p7353
sg7
g7325
sg9
V7000170.xml
p7354
sa(dp7355
g3
VSTD-Yeakley-1981
p7356
sg5
S'PMC1312181'
p7357
sg7
g7325
sg9
V7043864.xml
p7358
sa(dp7359
g3
VSTD-Luntz-1963
p7360
sg5
S'PMC505831'
p7361
sg7
g7325
sg9
V14189714.xml
p7362
sa(dp7363
g3
VSTD-La-Lau-1982
p7364
sg5
S'PMC1039836'
p7365
sg7
g7325
sg9
V6809036.xml
p7366
sa(dp7367
g3
VSTD-Coster-1979
p7368
sg5
S'PMC1043501'
p7369
sg7
g7325
sg9
V111704.xml
p7370
sa(dp7371
g3
VSTD-Collum-1980
p7372
sg5
S'PMC1043813'
p7373
sg7
g7325
sg9
V7000171.xml
p7374
sa(dp7375
g3
VSTD-Power-1991
p7376
sg5
S'PMC1042518'
p7377
sg7
g7325
sg9
V1751456.xml
p7378
sa(dp7379
g3
VSTD-Collum-1985
p7380
sg5
S'PMC1040757'
p7381
sg7
g7325
sg9
V3904820.xml
p7382
sa(dp7383
g3
VSTD-Collum-1986
p7384
sg5
S'PMC1041036'
p7385
sg7
g7325
sg9
V3521717.xml
p7386
sa(dp7387
g3
VSTD-Van-Bijsterveld-1989
p7388
sg5
S'PMC1041826'
p7389
sg7
g7325
sg9
V2669938.xml
p7390
sa(dp7391
g3
VSTD-Young-1982
p7392
sg5
S'PMC1039800'
p7393
sg7
g7325
sg9
V7044411.xml
p7394
sa(dp7395
g3
VSTD-Van-Bijsterveld-1980
p7396
sg5
S'PMC1039344'
p7397
sg7
g7325
sg9
V6766733.xml
p7398
sa(dp7399
g3
VSTD-Schachter-1980
p7400
sg5
S'PMC490494'
p7401
sg7
VCD003724 v. 6.0 Antidepressant drugs for narcolepsy.rm5
p7402
sg9
V6766990.xml
p7403
sa(dp7404
g3
VSTD-Mitler-1990
p7405
sg5
S'PMC2254143'
p7406
sg7
g7402
sg9
V1968069.xml
p7407
sa(dp7408
g3
VSTD-van-Rensen-1999
p7409
sg5
S'PMC1763792'
p7410
sg7
VCD003135 v. 7.0 Fluticasone versus placebo for chronic asthma in adults and children.rm5
p7411
sg9
V10212103.xml
p7412
sa(dp7413
g3
VSTD-Phillips-2004
p7414
sg5
S'PMC1758859'
p7415
sg7
g7411
sg9
V14694242.xml
p7416
sa(dp7417
g3
VSTD-Jayaram-2005
p7418
sg5
S'PMC1747311'
p7419
sg7
g7411
sg9
V15681495.xml
p7420
sa(dp7421
g3
VSTD-Faul-1998
p7422
sg5
S'PMC1745308'
p7423
sg7
g7411
sg9
V10319057.xml
p7424
sa(dp7425
g3
VSTD-Sovij_x00e4_rvi-2003
p7426
sg5
S'PMC1746689'
p7427
sg7
g7411
sg9
V12775860.xml
p7428
sa(dp7429
g3
VSTD-Ward-2001
p7430
sg5
S'PMC1746305'
p7431
sg7
g7411
sg9
V11923548.xml
p7432
sa(dp7433
g3
VSTD-Albrecht-2004
p7434
sg5
S'PMC2395315'
p7435
sg7
VCD005247 v. 4.0 Chemotherapy for hormone-refractory prostate cancer.rm5
p7436
sg9
V14710214.xml
p7437
sa(dp7438
g3
VSTD-Francini-1993
p7439
sg5
S'PMC1968505'
p7440
sg7
g7436
sg9
V8512828.xml
p7441
sa(dp7442
g3
VSTD-Fan-2009
p7443
sg5
S'PMC2781155'
p7444
sg7
VCD006023 v. 6.0 Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.rm5
p7445
sg9
V19666658.xml
p7446
sa(dp7447
g3
VSTD-Cheng-2008
p7448
sg5
S'PMC2440276'
p7449
sg7
g7445
sg9
V18385391.xml
p7450
sa(dp7451
g3
VSTD-McIntyre-2009
p7452
sg5
S'PMC2637599'
p7453
sg7
g7445
sg9
V19158369.xml
p7454
sa(dp7455
g3
VSTD-Ferreira-2008
p7456
sg5
S'PMC2396748'
p7457
sg7
g7445
sg9
V18199805.xml
p7458
sa(dp7459
g3
VSTD-FORESEE-Study-2008
p7460
sg5
S'PMC2518797'
p7461
sg7
g7445
sg9
V18579668.xml
p7462
sa(dp7463
g3
VSTD-Sprague-2009a
p7464
sg5
S'PMC2615694'
p7465
sg7
g7445
sg9
V19056618.xml
p7466
sa(dp7467
g3
VSTD-Tzanakis-2008
p7468
sg5
S'PMC2268719'
p7469
sg7
g7445
sg9
V18193489.xml
p7470
sa(dp7471
g3
VSTD-Bolden-1972
p7472
sg5
S'PMC2156555'
p7473
sg7
VCD004402 v. 10.4 Steroids for symptom control in infectious mononucleosis.rm5
p7474
sg9
V4556193.xml
p7475
sa(dp7476
g3
VSTD-Mynors_x002d_Wallis-1995
p7477
sg5
S'PMC2548821'
p7478
sg7
VCD003494 v. 11.0 Psychosocial interventions by general practitioners.rm5
p7479
sg9
V7873952.xml
p7480
sa(dp7481
g3
VSTD-Mynors_x002d_Wallis-2000
p7482
sg5
S'PMC27250'
p7483
sg7
g7479
sg9
V10617523.xml
p7484
sa(dp7485
g3
VSTD-McIntosh-1997
p7486
sg5
S'PMC2255191'
p7487
sg7
g7479
sg9
V9386883.xml
p7488
sa(dp7489
g3
VSTD-Clark-2000
p7490
sg5
S'PMC1753277'
p7491
sg7
VCD003472 v. 4.0 Exercise therapy for patellofemoral pain syndrome.rm5
p7492
sg9
V10976083.xml
p7493
sa(dp7494
g3
VSTD-Hayward-1976
p7495
sg5
S'PMC1045214'
p7496
sg7
VCD000218 v. 8.0 Interventions for treating trichomoniasis in women.rm5
p7497
sg9
V769913.xml
p7498
sa(dp7499
g3
VSTD-Lean-1972
p7500
sg5
S'PMC1044856'
p7501
sg7
g7497
sg9
V4348437.xml
p7502
sa(dp7503
g3
VSTD-Notowicz-1977
p7504
sg5
S'PMC1045370'
p7505
sg7
g7497
sg9
V322823.xml
p7506
sa(dp7507
g3
VSTD-Evans-1971
p7508
sg5
S'PMC1799017'
p7509
sg7
g7497
sg9
V4939601.xml
p7510
sa(dp7511
g3
VSTD-McClean-1972
p7512
sg5
S'PMC1048274'
p7513
sg7
g7497
sg9
V5015963.xml
p7514
sa(dp7515
g3
VSTD-Wigfield-1975
p7516
sg5
S'PMC1045112'
p7517
sg7
g7497
sg9
V1092425.xml
p7518
sa(dp7519
g3
VSTD-Roy-1975
p7520
sg5
S'PMC1046566'
p7521
sg7
g7497
sg9
V1098732.xml
p7522
sa(dp7523
g3
VSTD-Grootendorst-2007
p7524
sg5
S'PMC2094292'
p7525
sg7
VCD002309 v. 5.4 Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.rm5
p7526
sg9
V17573446.xml
p7527
sa(dp7528
g3
VSTD-Brubaker-2008
p7529
sg5
S'PMC2614233'
p7530
sg7
VCD004014 v. 8.0 Surgical management of pelvic organ prolapse in women.rm5
p7531
sg9
V18591307.xml
p7532
sa(dp7533
g3
VSTD-Dietz-2010
p7534
sg5
S'PMC2808513'
p7535
sg7
g7531
sg9
V19834635.xml
p7536
sa(dp7537
g3
VSTD-Sung-2012
p7538
sg5
S'PMC3244827'
p7539
sg7
g7531
sg9
V22183220.xml
p7540
sa(dp7541
g3
VSTD-Carey-2009
p7542
sg5
S'PMC2774153'
p7543
sg7
g7531
sg9
V19583714.xml
p7544
sa(dp7545
g3
VSTD-Wei-2011
p7546
sg5
S'PMC3433843'
p7547
sg7
g7531
sg9
V22716974.xml
p7548
sa(dp7549
g3
VSTD-Freeman--2008
p7550
sg5
S'PMC2820297'
p7551
sg7
VCD004856 v. 6.0 Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adol.rm5
p7552
sg9
V18356758.xml
p7553
sa(dp7554
g3
VSTD-Foley-2003
p7555
sg5
S'PMC1754378'
p7556
sg7
VCD005523 v. 4.0 Aquatic exercise for the treatment of knee and hip osteoarthritis.rm5
p7557
sg9
V14644853.xml
p7558
sa(dp7559
g3
VSTD-Katzenstein-2009
p7560
sg5
S'PMC2795100'
p7561
sg7
VCD009219 v. 3.0 Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.rm5
p7562
sg9
V19813275.xml
p7563
sa(dp7564
g3
VSTD-LaGrone-2012
p7565
sg5
S'PMC3238461'
p7566
sg7
VCD009584 v. 2.0 Specially formulated foods for treating children with moderate acute malnutrition in low- and middle.rm5
p7567
sg9
V22170366.xml
p7568
sa(dp7569
g3
VSTD-Matilsky-2009
p7570
sg5
S'PMC3151028'
p7571
sg7
g7567
sg9
V19225128.xml
p7572
sa(dp7573
g3
VSTD-Philipp_x0028_100_x0029_
p7574
sg5
S'PMC28296'
p7575
sg7
VCD003197 v. 8.0 Low dosage tricyclic antidepressants for depression.rm5
p7576
sg9
V10591711.xml
p7577
sa(dp7578
g3
VSTD-Blashki_x0028_75_x0026_150_x0029_
p7579
sg5
S'PMC1795147'
p7580
sg7
g7576
sg9
V4923928.xml
p7581
sa(dp7582
g3
VSTD-Tan_x0028_70_x0029_
p7583
sg5
S'PMC1364731'
p7584
sg7
g7576
sg9
V8018452.xml
p7585
sa(dp7586
g3
VSTD-Feary-2009a
p7587
sg5
S'PMC2728895'
p7588
sg7
VCD009238 v. 3.0 Helminth therapy (worms) for allergic rhinitis.rm5
p7589
sg9
V19400893.xml
p7590
sa(dp7591
g3
VSTD-Cornelissen-1992
p7592
sg5
S'PMC1793939'
p7593
sg7
VCD002776 v. 4.0 Prophylactic vitamin K for vitamin K deficiency bleeding in neonates.rm5
p7594
sg9
V1444522.xml
p7595
sa(dp7596
g3
VSTD-Greer-1998
p7597
sg5
S'PMC1717721'
p7598
sg7
g7594
sg9
V9875038.xml
p7599
sa(dp7600
g3
VSTD-Choudari-1994
p7601
sg5
S'PMC1374741'
p7602
sg7
VCD005584 v. 5.0 Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleed.rm5
p7603
sg9
V8200551.xml
p7604
sa(dp7605
g3
VSTD-Lin-1999
p7606
sg5
S'PMC1727515'
p7607
sg7
g7603
sg9
V10205211.xml
p7608
sa(dp7609
g3
VSTD-Lin-1993
p7610
sg5
S'PMC1375450'
p7611
sg7
g7603
sg9
V8406150.xml
p7612
sa(dp7613
g3
VSTD-Loizou-1991
p7614
sg5
S'PMC1379366'
p7615
sg7
g7603
sg9
V1955161.xml
p7616
sa(dp7617
g3
VSTD-Chung-1997
p7618
sg5
S'PMC2126544'
p7619
sg7
g7603
sg9
V9158465.xml
p7620
sa(dp7621
g3
VSTD-Gyr-1996
p7622
sg5
S'PMC1383318'
p7623
sg7
VCD002798 v. 11.0 Benzodiazepine receptor antagonists for hepatic encephalopathy.rm5
p7624
sg9
V8977350.xml
p7625
sa(dp7626
g3
VSTD-Neuberger-1985
p7627
sg5
S'PMC1432420'
p7628
sg7
VCD004789 v. 7.0 D-penicillamine for primary biliary cirrhosis.rm5
p7629
sg9
V3881323.xml
p7630
sa(dp7631
g3
VSTD-Van-Gurp-2002
p7632
sg5
S'PMC2214056'
p7633
sg7
VCD006117 v. 10.0 Sertraline versus other antidepressive agents for depression.rm5
p7634
sg9
V12053635.xml
p7635
sa(dp7636
g3
VSTD-Stehl-2009
p7637
sg5
S'PMC2734126'
p7638
sg7
VCD009660 v. 2.0 Psychological interventions for parents of children and adolescents with chronic illness.rm5
p7639
sg9
V19091806.xml
p7640
sa(dp7641
g3
VSTD-Barakat-2010
p7642
sg5
S'PMC2950888'
p7643
sg7
g7639
sg9
V20686425.xml
p7644
sa(dp7645
g3
VSTD-Levy-2010
p7646
sg5
S'PMC2887246'
p7647
sg7
g7639
sg9
V20216531.xml
p7648
sa(dp7649
g3
VSTD-Lehmkuhl-2010
p7650
sg5
S'PMC2825642'
p7651
sg7
g7639
sg9
V20167185.xml
p7652
sa(dp7653
g3
VSTD-Kashikar_x002d_Zuck-2012
p7654
sg5
S'PMC3690664'
p7655
sg7
g7639
sg9
V22108765.xml
p7656
sa(dp7657
g3
VSTD-Askins-2009
p7658
sg5
S'PMC2684487'
p7659
sg7
g7639
sg9
V19091804.xml
p7660
sa(dp7661
g3
VSTD-Ambrosino-2008
p7662
sg5
S'PMC2936820'
p7663
sg7
g7639
sg9
V18540868.xml
p7664
sa(dp7665
g3
VSTD-Wade-2011
p7666
sg5
S'PMC3387908'
p7667
sg7
g7639
sg9
V21890828.xml
p7668
sa(dp7669
g3
VSTD-Grey-2011
p7670
sg5
S'PMC3134246'
p7671
sg7
g7639
sg9
V21522034.xml
p7672
sa(dp7673
g3
VSTD-Lask-1979
p7674
sg5
S'PMC1545376'
p7675
sg7
g7639
sg9
V373642.xml
p7676
sa(dp7677
g3
VSTD-Palermo-2009
p7678
sg5
S'PMC2760656'
p7679
sg7
g7639
sg9
V19695776.xml
p7680
sa(dp7681
g3
VSTD-Widman-2002
p7682
sg5
S'PMC3620860'
p7683
sg7
VCD006836 v. 4.0 Bone grafts and bone substitutes for treating distal radial fractures in adults.rm5
p7684
sg9
V11954842.xml
p7685
sa(dp7686
g3
VSTD-Appleby-1997
p7687
sg5
S'PMC2126383'
p7688
sg7
VCD002018 v. 6.0 Antidepressant treatment for post-natal depression.rm5
p7689
sg9
V9099116.xml
p7690
sa(dp7691
g3
VSTD-MacKenzie-2001
p7692
sg5
S'PMC55924'
p7693
sg7
VCD006373 v. 3.0 Interventions for treating functional dysphonia in adults.rm5
p7694
sg9
V11566828.xml
p7695
sa(dp7696
g3
VSTD-Dormuth-2004
p7697
sg5
S'PMC526331'
p7698
sg7
VCD004398 v. 10.0 Printed educational materials effects on professional practice and healthcare outcomes.rm5
p7699
sg9
V15505268.xml
p7700
sa(dp7701
g3
VSTD-Perria-2007
p7702
sg5
S'PMC1904445'
p7703
sg7
g7699
sg9
V17547760.xml
p7704
sa(dp7705
g3
VSTD-Black-2002
p7706
sg5
S'PMC1743616'
p7707
sg7
g7699
sg9
V12448802.xml
p7708
sa(dp7709
g3
VSTD-Kabir-2007
p7710
sg5
S'PMC2000662'
p7711
sg7
g7699
sg9
V17610535.xml
p7712
sa(dp7713
g3
VSTD-Mason-2001
p7714
sg5
S'PMC59683'
p7715
sg7
g7699
sg9
V11701573.xml
p7716
sa(dp7717
g3
VSTD-Oakeshott-1994
p7718
sg5
S'PMC1238864'
p7719
sg7
g7699
sg9
V8204331.xml
p7720
sa(dp7721
g3
VSTD-Crane-2004
p7722
sg5
S'PMC1726258'
p7723
sg7
VCD005351 v. 3.2 Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema.rm5
p7724
sg9
V14988338.xml
p7725
sa(dp7726
g3
VSTD-Kirwan-2006
p7727
sg5
S'PMC1633773'
p7728
sg7
VCD003433 v. 7.0 Beta radiation for glaucoma surgery.rm5
p7729
sg9
V17023435.xml
p7730
sa(dp7731
g3
VSTD-Carey-2005
p7732
sg5
S'PMC547907'
p7733
sg7
VCD008141 v. 2.3 Second-generation antipsychotics for obsessive compulsive disorder.rm5
p7734
sg9
V15667657.xml
p7735
sa(dp7736
g3
VSTD-Banani-1994
p7737
sg5
S'PMC1030063'
p7738
sg7
VCD008300 v. 2.2 Treating BCG-induced disease in children.rm5
p7739
sg9
V7826118.xml
p7740
sa(dp7741
g3
VSTD-Norrkoping
p7742
sg5
S'PMC3069219'
p7743
sg7
VCD004720 v. 8.0 Screening for prostate cancer.rm5
p7744
sg9
V21454449.xml
p7745
sa(dp7746
g3
VSTD-PLCO
p7747
sg5
S'PMC3260132'
p7748
sg7
g7744
sg9
V22228146.xml
p7749
sa(dp7750
g3
VSTD-Bonduelle-1991
p7751
sg5
S'PMC2399106'
p7752
sg7
VCD001016 v. 5.0 Cyclical progestogens for heavy menstrual bleeding.rm5
p7753
sg9
V1835005.xml
p7754
sa(dp7755
g3
VSTD-Liang-1990
p7756
sg5
S'PMC171559'
p7757
sg7
VCD005590 v. 5.0 Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.rm5
p7758
sg9
V2327768.xml
p7759
sa(dp7760
g3
VSTD-Van-de-Putte-2004
p7761
sg5
S'PMC1755008'
p7762
sg7
VCD005113 v. 5.0 Adalimumab for treating rheumatoid arthritis.rm5
p7763
sg9
V15082480.xml
p7764
sa(dp7765
g3
VSTD-Yasuda-2001
p7766
sg5
S'PMC1728521'
p7767
sg7
VCD004890 v. 7.0 Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct .rm5
p7768
sg9
V11600473.xml
p7769
sa(dp7770
g3
VSTD-Vlavianos-2003
p7771
sg5
S'PMC1773772'
p7772
sg7
g7768
sg9
V12865276.xml
p7773
sa(dp7774
g3
VSTD-Oria-2007
p7775
sg5
S'PMC1867927'
p7776
sg7
VCD009779 v. 2.0 Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative mana.rm5
p7777
sg9
V17197959.xml
p7778
sa(dp7779
g3
VSTD-Montoya-1994
p7780
sg5
S'PMC2633654'
p7781
sg7
VCD006754 v. 5.0 Anticonvulsants for cocaine dependence.rm5
p7782
sg9
V7555621.xml
p7783
sa(dp7784
g3
VSTD-Beales-1972
p7785
sg5
S'PMC1788331'
p7786
sg7
VCD008886 v. 2.0 Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis ankylosing .rm5
p7787
sg9
V4555545.xml
p7788
sa(dp7789
g3
VSTD-Grennan-1979
p7790
sg5
S'PMC1429811'
p7791
sg7
g7787
sg9
V389264.xml
p7792
sa(dp7793
g3
VSTD-Sperryn-1973
p7794
sg5
S'PMC1006067'
p7795
sg7
g7787
sg9
V4571392.xml
p7796
sa(dp7797
g3
VSTD-Harvey-1998
p7798
sg5
S'PMC1410004'
p7799
sg7
VCD001025 v. 14.0 Counselling for mental health and psychosocial problems in primary care.rm5
p7800
sg9
V9624744.xml
p7801
sa(dp7802
g3
VSTD-Chilvers-2001
p7803
sg5
S'PMC30555'
p7804
sg7
g7800
sg9
V11282864.xml
p7805
sa(dp7806
g3
VSTD-Bennett-1982
p7807
sg5
S'PMC1352659'
p7808
sg7
VCD003348 v. 9.0 Patient controlled opioid analgesia versus conventional opioid analgesia for postoperative pain.rm5
p7809
sg9
V7082061.xml
p7810
sa(dp7811
g3
VSTD-Rosen-1998
p7812
sg5
S'PMC3015270'
p7813
sg7
g7809
sg9
V9876706.xml
p7814
sa(dp7815
g3
VSTD-Lantz-1995
p7816
sg5
S'PMC1615506'
p7817
sg7
VCD002943 v. 6.0 Strategies for increasing the participation of women in community breast cancer screening.rm5
p7818
sg9
V7646664.xml
p7819
sa(dp7820
g3
VSTD-Lerman-1992
p7821
sg5
S'PMC1694134'
p7822
sg7
g7818
sg9
V1566953.xml
p7823
sa(dp7824
g3
VSTD-Sutton-1994
p7825
sg5
S'PMC1059897'
p7826
sg7
g7818
sg9
V8138773.xml
p7827
sa(dp7828
g3
VSTD-Sung-1992
p7829
sg5
S'PMC1403667'
p7830
sg7
g7818
sg9
V1641433.xml
p7831
sa(dp7832
g3
VSTD-Atri-1997
p7833
sg5
S'PMC2127854'
p7834
sg7
g7818
sg9
V9402779.xml
p7835
sa(dp7836
g3
VSTD-Janz-1997
p7837
sg5
S'PMC1381136'
p7838
sg7
g7818
sg9
V9357355.xml
p7839
sa(dp7840
g3
VSTD-Barbanel-2003
p7841
sg5
S'PMC1746491'
p7842
sg7
VCD007717 v. 3.0 Telehealthcare for asthma.rm5
p7843
sg9
V14514935.xml
p7844
sa(dp7845
g3
VSTD-Willems-2007a
p7846
sg5
S'PMC2000864'
p7847
sg7
g7843
sg9
V17662113.xml
p7848
sa(dp7849
g3
VSTD-Pinnock-2003
p7850
sg5
S'PMC150181'
p7851
sg7
g7843
sg9
V12609944.xml
p7852
sa(dp7853
g3
VSTD-Pinnock-2005
p7854
sg5
S'PMC1463186'
p7855
sg7
g7843
sg9
V15720933.xml
p7856
sa(dp7857
g3
VSTD-Pinnock-2007
p7858
sg5
S'PMC2151786'
p7859
sg7
g7843
sg9
V17761059.xml
p7860
sa(dp7861
g3
VSTD-Gruffydd_x002d_Jones-2005
p7862
sg5
S'PMC1570530'
p7863
sg7
g7843
sg9
V16378560.xml
p7864
sa(dp7865
g3
VSTD-Herndon-1990
p7866
sg5
S'PMC1358272'
p7867
sg7
VCD008990 v. 2.0 Recombinant human growth hormone for treating burns and donor sites.rm5
p7868
sg9
V2121109.xml
p7869
sa(dp7870
g3
VSTD-Gilpin-1994
p7871
sg5
S'PMC1234282'
p7872
sg7
g7868
sg9
V8024354.xml
p7873
sa(dp7874
g3
VSTD-Przkora-2006
p7875
sg5
S'PMC1479605'
p7876
sg7
g7868
sg9
V16772783.xml
p7877
sa(dp7878
g3
VSTD-Bastow-1983
p7879
sg5
S'PMC1549800'
p7880
sg7
VCD001880 v. 10.0 Nutritional supplementation for hip fracture aftercare in older people.rm5
p7881
sg9
V6416514.xml
p7882
sa(dp7883
g3
VSTD-De-Santis-2009
p7884
sg5
S'PMC2792956'
p7885
sg7
VCD008976 v. 2.0 Gemcitabine for unresectable locally advanced or metastatic bladder cancer.rm5
p7886
sg9
V19786668.xml
p7887
sa(dp7888
g3
VSTD-Johnston-1969
p7889
sg5
S'PMC1629696'
p7890
sg7
VCD004105 v. 5.0 Prophylactic antibiotic therapy for chronic bronchitis.rm5
p7891
sg9
V4899454.xml
p7892
sa(dp7893
g3
VSTD-Kruis-2004
p7894
sg5
S'PMC1774300'
p7895
sg7
VCD007443 v. 2.0 Probiotics for maintenance of remission in ulcerative colitis.rm5
p7896
sg9
V15479682.xml
p7897
sa(dp7898
g3
VSTD-Sadighi-2006
p7899
sg5
S'PMC1693922'
p7900
sg7
VCD004064 v. 10.0 Chemotherapy for advanced gastric cancer.rm5
p7901
sg9
V17147808.xml
p7902
sa(dp7903
g3
VSTD-Moehler-2005
p7904
sg5
S'PMC2361806'
p7905
sg7
g7901
sg9
V15942629.xml
p7906
sa(dp7907
g3
VSTD-Pyrh_x00f6_nen-1995
p7908
sg5
S'PMC2033628'
p7909
sg7
g7901
sg9
V7533517.xml
p7910
sa(dp7911
g3
VSTD-de-Benedictis-1994b
p7912
sg5
S'PMC2365597'
p7913
sg7
VCD002731 v. 6.0 Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction.rm5
p7914
sg9
V18475602.xml
p7915
sa(dp7916
g3
VSTD-Ly-2009
p7917
sg5
S'PMC2686207'
p7918
sg7
VCD000320 v. 14.0 Interventions for treating scabies.rm5
p7919
sg9
V19565120.xml
p7920
sa(dp7921
g3
VSTD-Bachewar-2009
p7922
sg5
S'PMC2825021'
p7923
sg7
g7919
sg9
V20177574.xml
p7924
sa(dp7925
g3
VSTD-Lambert-2000
p7926
sg5
S'PMC2503543'
p7927
sg7
VCD005538 v. 8.0 Diclofenac for acute pain in children.rm5
p7928
sg9
V10743430.xml
p7929
sa(dp7930
g3
VSTD-Davies-1999
p7931
sg5
S'PMC1717983'
p7932
sg7
VCD004231 v. 6.0 Inhaled corticosteroids for non-specific chronic cough in children.rm5
p7933
sg9
V10373132.xml
p7934
sa(dp7935
g3
VSTD-Woody-2008
p7936
sg5
S'PMC2610690'
p7937
sg7
VCD007210 v. 2.2 Maintenance treatments for opiate dependent adolescent.rm5
p7938
sg9
V18984887.xml
p7939
sa(dp7940
g3
VSTD-Eckstein-1999
p7941
sg5
S'PMC1723028'
p7942
sg7
VCD003171 v. 6.0 Surgical interventions for bilateral congenital cataract.rm5
p7943
sg9
V10216048.xml
p7944
sa(dp7945
g3
VSTD-Popelut-2010
p7946
sg5
S'PMC2858083'
p7947
sg7
VMR000033 v. 3.0 Industry sponsorship and research outcome.rm5
p7948
sg9
V20422000.xml
p7949
sa(dp7950
g3
VSTD-Booth-2008
p7951
sg5
S'PMC2651075'
p7952
sg7
g7948
sg9
V18955452.xml
p7953
sa(dp7954
g3
VSTD-Bero-2007
p7955
sg5
S'PMC1885451'
p7956
sg7
g7948
sg9
V17550302.xml
p7957
sa(dp7958
g3
VSTD-Clifford-2002
p7959
sg5
S'PMC126226'
p7960
sg7
g7948
sg9
V12213183.xml
p7961
sa(dp7962
g3
VSTD-Kemmeren-2001
p7963
sg5
S'PMC34722'
p7964
sg7
g7948
sg9
V11463678.xml
p7965
sa(dp7966
g3
VSTD-Bourgeois-2010
p7967
sg5
S'PMC3374868'
p7968
sg7
g7948
sg9
V20679560.xml
p7969
sa(dp7970
g3
VSTD-Jefferson-2009
p7971
sg5
S'PMC2643439'
p7972
sg7
g7948
sg9
V19213766.xml
p7973
sa(dp7974
g3
VSTD-Rasmussen-2009
p7975
sg5
S'PMC2811705'
p7976
sg7
g7948
sg9
V20015404.xml
p7977
sa(dp7978
g3
VSTD-Bhandari-2004
p7979
sg5
S'PMC332713'
p7980
sg7
g7948
sg9
V14970094.xml
p7981
sa(dp7982
g3
VSTD-Kjaergard-2002
p7983
sg5
S'PMC117638'
p7984
sg7
g7948
sg9
V12153921.xml
p7985
sa(dp7986
g3
VSTD-Rattinger-2009
p7987
sg5
S'PMC2688752'
p7988
sg7
g7948
sg9
V19503811.xml
p7989
sa(dp7990
g3
VSTD-Chard-2000
p7991
sg5
S'PMC1753176'
p7992
sg7
g7948
sg9
V10834855.xml
p7993
sa(dp7994
g3
VSTD-Ekeberg-2009
p7995
sg5
S'PMC2769057'
p7996
sg7
VCD009147 v. 2.0 Image-guided versus blind glucocorticoid injection for shoulder pain.rm5
p7997
sg9
V19168537.xml
p7998
sa(dp7999
g3
VSTD-Xiao-2008
p8000
sg5
S'PMC2447617'
p8001
sg7
VCD008409 v. 3.3 Progesterone for acute traumatic brain injury.rm5
p8002
sg9
V18447940.xml
p8003
sa(dp8004
g3
VSTD-Siebert-2009
p8005
sg5
S'PMC2682185'
p8006
sg7
VCD003053 v. 10.2 Insulin-sensitising drugs (metformin rosiglitazone pioglitazone D-chiro-inositol) for women with .rm5
p8007
sg9
V19396538.xml
p8008
sa(dp8009
g3
VSTD-Moll-2006
p8010
sg5
S'PMC1482338'
p8011
sg7
g8007
sg9
V16769748.xml
p8012
sa(dp8013
g3
VSTD-Sturrock-2002
p8014
sg5
S'PMC1874363'
p8015
sg7
g8007
sg9
V11994052.xml
p8016
sa(dp8017
g3
VSTD-Ladson-2011
p8018
sg5
S'PMC3073705'
p8019
sg7
g8007
sg9
V21193187.xml
p8020
sa(dp8021
g3
VSTD-Legro-2007
p8022
sg5
S'PMC2515084'
p8023
sg7
g8007
sg9
V18505764.xml
p8024
sa(dp8025
g3
VSTD-Barakat-2010
p8026
sg5
S'PMC2950888'
p8027
sg7
VCD003968 v. 11.0 Psychological therapies for the management of chronic and recurrent pain in children and adolescents.rm5
p8028
sg9
V20686425.xml
p8029
sa(dp8030
g3
VSTD-Levy-2010
p8031
sg5
S'PMC2887246'
p8032
sg7
g8028
sg9
V20216531.xml
p8033
sa(dp8034
g3
VSTD-Kashikar_x002d_Zuck-2012
p8035
sg5
S'PMC3690664'
p8036
sg7
g8028
sg9
V22108765.xml
p8037
sa(dp8038
g3
VSTD-Palermo-2009
p8039
sg5
S'PMC2760656'
p8040
sg7
g8028
sg9
V19695776.xml
p8041
sa(dp8042
g3
VSTD-Greally-1994
p8043
sg5
S'PMC1029909'
p8044
sg7
VCD000407 v. 19.0 Oral steroids for long-term use in cystic fibrosis.rm5
p8045
sg9
V8067791.xml
p8046
sa(dp8047
g3
VSTD-van-de-Vusse-2004
p8048
sg5
S'PMC523854'
p8049
sg7
VCD007938 v. 4.0 Gabapentin for chronic neuropathic pain and fibromyalgia in adults.rm5
p8050
sg9
V15453912.xml
p8051
sa(dp8052
g3
VSTD-Gorson-1999
p8053
sg5
S'PMC1736215'
p8054
sg7
g8050
sg9
V10071116.xml
p8055
sa(dp8056
g3
VSTD-Lillemoe-1999
p8057
sg5
S'PMC1420877'
p8058
sg7
VCD008533 v. 4.0 Prophylactic gastrojejunostomy for unresectable periampullary carcinoma.rm5
p8059
sg9
V10493479.xml
p8060
sa(dp8061
g3
VSTD-Van-Heek-2003
p8062
sg5
S'PMC1356171'
p8063
sg7
g8059
sg9
V14631226.xml
p8064
sa(dp8065
g3
VSTD-Rashidi-2011
p8066
sg5
S'PMC3446117'
p8067
sg7
VCD009415 v. 2.0 Zinc supplements for treating thalassaemia and sickle cell disease.rm5
p8068
sg9
V23056757.xml
p8069
sa(dp8070
g3
VSTD-Ulrich-2007
p8071
sg5
S'PMC2493058'
p8072
sg7
VCD004415 v. 4.4 Interventions for actinic keratoses.rm5
p8073
sg9
V18067628.xml
p8074
sa(dp8075
g3
VSTD-Perrett-2007
p8076
sg5
S'PMC2423222'
p8077
sg7
g8073
sg9
V17223873.xml
p8078
sa(dp8079
g3
VSTD-Kakkar-1969
p8080
sg5
S'PMC1982488'
p8081
sg7
VCD002783 v. 7.0 Thrombolysis for acute deep vein thrombosis.rm5
p8082
sg9
V5774077.xml
p8083
sa(dp8084
g3
VSTD-Fowler-2005
p8085
sg5
S'PMC1739638'
p8086
sg7
VCD009427 v. 2.0 Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis.rm5
p8087
sg9
V15834030.xml
p8088
sa(dp8089
g3
VSTD-Chudry-1987
p8090
sg5
S'PMC1778341'
p8091
sg7
VCD001183 v. 10.0 Nedocromil sodium for preventing exercise-induced bronchoconstriction.rm5
p8092
sg9
V3036020.xml
p8093
sa(dp8094
g3
VSTD-De-Benedictis-1994b
p8095
sg5
S'PMC2365597'
p8096
sg7
g8092
sg9
V18475602.xml
p8097
sa(dp8098
g3
VSTD-Keulemans-1998
p8099
sg5
S'PMC1191590'
p8100
sg7
VCD006798 v. 3.4 Day-case versus overnight stay for laparoscopic cholecystectomy.rm5
p8101
sg9
V9860471.xml
p8102
sa(dp8103
g3
VSTD-O_x0027_Donnell-2003
p8104
sg5
S'PMC214016'
p8105
sg7
VCD000011 v. 8.4 Interventions for enhancing medication adherence.rm5
p8106
sg9
V14551096.xml
p8107
sa(dp8108
g3
VSTD-Kemp-1996
p8109
sg5
S'PMC2350295'
p8110
sg7
g8106
sg9
V8611831.xml
p8111
sa(dp8112
g3
VSTD-Johnson-1978
p8113
sg5
S'PMC1819059'
p8114
sg7
g8106
sg9
V369673.xml
p8115
sa(dp8116
g3
VSTD-Peveler-1999
p8117
sg5
S'PMC28214'
p8118
sg7
g8106
sg9
V10473477.xml
p8119
sa(dp8120
g3
VSTD-Brus-1998
p8121
sg5
S'PMC1752549'
p8122
sg7
g8106
sg9
V9640129.xml
p8123
sa(dp8124
g3
VSTD-Sadik-2005
p8125
sg5
S'PMC1884928'
p8126
sg7
g8106
sg9
V16042672.xml
p8127
sa(dp8128
g3
VSTD-Al_x002d_Eidan-2002
p8129
sg5
S'PMC1874294'
p8130
sg7
g8106
sg9
V11851640.xml
p8131
sa(dp8132
g3
VSTD-Stevens-2002
p8133
sg5
S'PMC1071673'
p8134
sg7
g8106
sg9
V11897728.xml
p8135
sa(dp8136
g3
VSTD-Hill-2001
p8137
sg5
S'PMC1753835'
p8138
sg7
g8106
sg9
V11502614.xml
p8139
sa(dp8140
g3
VSTD-Gajdos-1993
p8141
sg5
S'PMC489815'
p8142
sg7
VCD005224 v. 4.0 Immunosuppressive agents for myasthenia gravis.rm5
p8143
sg9
V8229026.xml
p8144
sa(dp8145
g3
VSTD-Stoller-2011
p8146
sg5
S'PMC3139980'
p8147
sg7
VCD004003 v. 7.3 Environmental sanitary interventions for preventing active trachoma.rm5
p8148
sg9
V21785663.xml
p8149
sa(dp8150
g3
VSTD-Ickovics-2007a
p8151
sg5
S'PMC2276878'
p8152
sg7
VCD007622 v. 2.0 Group versus conventional antenatal care for women.rm5
p8153
sg9
V17666608.xml
p8154
sa(dp8155
g3
VSTD-Healthy-Choices-2009
p8156
sg5
S'PMC3282587'
p8157
sg7
VCD009748 v. 3.5 Motivational interviewing for improving outcomes in youth living with HIV.rm5
p8158
sg9
V21783053.xml
p8159
sa(dp8160
g3
VSTD-A_x003a_-Rigaud-1991
p8161
sg5
S'PMC1379249'
p8162
sg7
VCD000542 v. 8.0 Enteral nutritional therapy for induction of remission in Crohn's disease.rm5
p8163
sg9
V1773955.xml
p8164
sa(dp8165
g3
VSTD-A_x003a_-Leiper-2001
p8166
sg5
S'PMC1728544'
p8167
sg7
g8163
sg9
V11709513.xml
p8168
sa(dp8169
g3
VSTD-A_x003a_-Mansfield-1995
p8170
sg5
S'PMC1382354'
p8171
sg7
g8163
sg9
V7890238.xml
p8172
sa(dp8173
g3
VSTD-B_x003a_-Gonzalez_x002d_Huix-_x0027_93
p8174
sg5
S'PMC1374261'
p8175
sg7
g8163
sg9
V8314510.xml
p8176
sa(dp8177
g3
VSTD-A_x003a_-Raouf-1991
p8178
sg5
S'PMC1378894'
p8179
sg7
g8163
sg9
V1905672.xml
p8180
sa(dp8181
g3
VSTD-A_x003a_-Gassull-2002
p8182
sg5
S'PMC1773299'
p8183
sg7
g8163
sg9
V12117873.xml
p8184
sa(dp8185
g3
VSTD-A_x003a_-Royall-1994
p8186
sg5
S'PMC1374879'
p8187
sg7
g8163
sg9
V8020806.xml
p8188
sa(dp8189
g3
VSTD-Nealon-1993
p8190
sg5
S'PMC1242821'
p8191
sg7
VCD007884 v. 2.12 Endoscopic or surgical intervention for painful obstructive chronic pancreatitis.rm5
p8192
sg9
V8489308.xml
p8193
sa(dp8194
g3
VSTD-Brown-2002
p8195
sg5
S'PMC2134805'
p8196
sg7
VCD006424 v. 2.0 Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups.rm5
p8197
sg9
V11815493.xml
p8198
sa(dp8199
g3
VSTD-Hawthorne-1997
p8200
sg5
S'PMC1313005'
p8201
sg7
g8197
sg9
V9219407.xml
p8202
sa(dp8203
g3
VSTD-Baradaran-2006
p8204
sg5
S'PMC1489930'
p8205
sg7
g8197
sg9
V16709243.xml
p8206
sa(dp8207
g3
VSTD-Osborne-2011
p8208
sg5
S'PMC3068058'
p8209
sg7
VCD007102 v. 5.2 First-line chemotherapy in low-risk gestational trophoblastic neoplasia.rm5
p8210
sg9
V21263100.xml
p8211
sa(dp8212
g3
VSTD-Allegrante-2007
p8213
sg5
S'PMC2504100'
p8214
sg7
VCD007624 v. 3.0 Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture .rm5
p8215
sg9
V18751772.xml
p8216
sa(dp8217
g3
VSTD-Kaste-1976
p8218
sg5
S'PMC1690349'
p8219
sg7
VCD000103 v. 4.0 Haemodilution for acute ischaemic stroke.rm5
p8220
sg9
V795498.xml
p8221
sa(dp8222
g3
VSTD-Bonderup-2003
p8223
sg5
S'PMC1774966'
p8224
sg7
VCD003575 v. 14.0 Interventions for treating collagenous colitis.rm5
p8225
sg9
V12524408.xml
p8226
sa(dp8227
g3
VSTD-Ramos-1996
p8228
sg5
S'PMC2352260'
p8229
sg7
VCD001329 v. 7.0 Lactational amenorrhea for family planning.rm5
p8230
sg9
V8876092.xml
p8231
sa(dp8232
g3
VSTD-Shearman-1963
p8233
sg5
S'PMC2123785'
p8234
sg7
VCD003511 v. 8.0 Progestogen for preventing miscarriage.rm5
p8235
sg9
V13977012.xml
p8236
sa(dp8237
g3
VSTD-Gray-1991
p8238
sg5
S'PMC1972556'
p8239
sg7
VCD005390 v. 4.0 Adjuvant Therapy for completely resected Stage II Colon Cancer.rm5
p8240
sg9
V2069842.xml
p8241
sa(dp8242
g3
VSTD-Vaillant-2000
p8243
sg5
S'PMC1421018'
p8244
sg7
g8240
sg9
V10749603.xml
p8245
sa(dp8246
g3
VSTD-Taal-2001
p8247
sg5
S'PMC2363941'
p8248
sg7
g8240
sg9
V11720425.xml
p8249
sa(dp8250
g3
VSTD-Henderson-2004-a
p8251
sg5
S'PMC478218'
p8252
sg7
VCD005963 v. 8.0 Advance treatment directives for people with severe mental illness.rm5
p8253
sg9
V15240438.xml
p8254
sa(dp8255
g3
VSTD-EORTC-40954-2010
p8256
sg5
S'PMC3020693'
p8257
sg7
VCD008107 v. 2.0 Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomac.rm5
p8258
sg9
V21060024.xml
p8259
sa(dp8260
g3
VSTD-Gehrman-2009
p8261
sg5
S'PMC2630117'
p8262
sg7
VCD003802 v. 9.0 Melatonin for the treatment of dementia.rm5
p8263
sg9
V19155748.xml
p8264
sa(dp8265
g3
VSTD-Nyamathi-2010
p8266
sg5
S'PMC3383096'
p8267
sg7
VCD009269 v. 2.2 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit d.rm5
p8268
sg9
V19836904.xml
p8269
sa(dp8270
g3
VSTD-Mikamo-_x0028_1_x0029_-1995
p8271
sg5
S'PMC2364408'
p8272
sg7
VCD002845 v. 6.0 Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal.rm5
p8273
sg9
V18475414.xml
p8274
sa(dp8275
g3
VSTD-Seidman-2005
p8276
sg5
S'PMC1784583'
p8277
sg7
g8273
sg9
V16338779.xml
p8278
sa(dp8279
g3
VSTD-Stein-1993
p8280
sg5
S'PMC187610'
p8281
sg7
g8273
sg9
V8381643.xml
p8282
sa(dp8283
g3
VSTD-Tobin-1992
p8284
sg5
S'PMC1194795'
p8285
sg7
g8273
sg9
V1312506.xml
p8286
sa(dp8287
g3
VSTD-Boag-1991
p8288
sg5
S'PMC1194678'
p8289
sg7
g8273
sg9
V2071126.xml
p8290
sa(dp8291
g3
VSTD-Mikamo-_x0028_2_x0029_-1995
p8292
sg5
S'PMC2364408'
p8293
sg7
g8273
sg9
V18475414.xml
p8294
sa(dp8295
g3
VSTD-Zoumboulakis-1973
p8296
sg5
S'PMC1647791'
p8297
sg7
VCD003257 v. 9.0 Symptomatic treatment of the cough in whooping cough.rm5
p8298
sg9
V4568265.xml
p8299
sa(dp8300
g3
VSTD-Menon-2007
p8301
sg5
S'PMC2636008'
p8302
sg7
VCD001430 v. 10.0 Corticosteroids for treating optic neuritis.rm5
p8303
sg9
V17699944.xml
p8304
sa(dp8305
g3
VSTD-Luabeya-2007
p8306
sg5
S'PMC1891438'
p8307
sg7
VCD008563 v. 2.0 Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.rm5
p8308
sg9
V17593956.xml
p8309
sa(dp8310
g3
VSTD-Coutsoudis-1995
p8311
sg5
S'PMC1615817'
p8312
sg7
g8308
sg9
V7625499.xml
p8313
sa(dp8314
g3
VSTD-Sovani-2008
p8315
sg5
S'PMC2148237'
p8316
sg7
VCD007313 v. 5.0 Combination formoterol and budesonide as maintenance and reliever therapy versus current best practi.rm5
p8317
sg9
V18186995.xml
p8318
sa(dp8319
g3
VSTD-Blockey-1954
p8320
sg5
S'PMC2085434'
p8321
sg7
VCD006189 v. 2.0 Oral steroids for adhesive capsulitis.rm5
p8322
sg9
V13160496.xml
p8323
sa(dp8324
g3
VSTD-Buchbinder-2004
p8325
sg5
S'PMC1754804'
p8326
sg7
g8322
sg9
V15479896.xml
p8327
sa(dp8328
g3
VSTD-Saha-2007
p8329
sg5
S'PMC1924983'
p8330
sg7
VCD003094 v. 9.0 Treatments for iron-deficiency anaemia in pregnancy.rm5
p8331
sg9
V17435611.xml
p8332
sa(dp8333
g3
VSTD-Byrnes-2000
p8334
sg5
S'PMC1745864'
p8335
sg7
VCD003901 v. 5.0 Regular treatment with long acting beta agonists versus daily regular treatment with short acting be.rm5
p8336
sg9
V10950898.xml
p8337
sa(dp8338
g3
VSTD-Lundback-1993
p8339
sg5
S'PMC464292'
p8340
sg7
g8336
sg9
V8493629.xml
p8341
sa(dp8342
g3
VSTD-Castle-1993
p8343
sg5
S'PMC1676982'
p8344
sg7
g8336
sg9
V8098238.xml
p8345
sa(dp8346
g3
VSTD-Taylor-1998
p8347
sg5
S'PMC1745306'
p8348
sg7
g8336
sg9
V10319056.xml
p8349
sa(dp8350
g3
VSTD-Ng-2006
p8351
sg5
S'PMC1964052'
p8352
sg7
VCD005391 v. 4.6 Workload and surgeons specialty for outcome after colorectal cancer surgery.rm5
p8353
sg9
V16551415.xml
p8354
sa(dp8355
g3
VSTD-Harmon-1999
p8356
sg5
S'PMC1420885'
p8357
sg7
g8353
sg9
V10493487.xml
p8358
sa(dp8359
g3
VSTD-Urbach-2004
p8360
sg5
S'PMC381322'
p8361
sg7
g8353
sg9
V15020356.xml
p8362
sa(dp8363
g3
VSTD-Schrag-2002
p8364
sg5
S'PMC1422616'
p8365
sg7
g8353
sg9
V12409664.xml
p8366
sa(dp8367
g3
VSTD-Rogers-2006
p8368
sg5
S'PMC1856632'
p8369
sg7
g8353
sg9
V17122626.xml
p8370
sa(dp8371
g3
VSTD-Akpinarli-1999
p8372
sg5
S'PMC1717973'
p8373
sg7
VCD007949 v. 2.2 Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.rm5
p8374
sg9
V10373134.xml
p8375
sa(dp8376
g3
VSTD-Dolan-2006
p8377
sg5
S'PMC3205443'
p8378
sg7
VCD005417 v. 3.0 Home-based care for reducing morbidity and mortality in people infected with HIVAIDS.rm5
p8379
sg9
V16772251.xml
p8380
sa(dp8381
g3
VSTD-Baker-1997
p8382
sg5
S'PMC1055438'
p8383
sg7
VCD000259 v. 11.2 Audit and feedback effects on professional practice and healthcare outcomes.rm5
p8384
sg9
V10166596.xml
p8385
sa(dp8386
g3
VSTD-Lagerl_x00f8_v-2000
p8387
sg5
S'PMC1743532'
p8388
sg7
g8384
sg9
V10980076.xml
p8389
sa(dp8390
g3
VSTD-Van-den-Hombergh-1999
p8391
sg5
S'PMC2483655'
p8392
sg7
g8384
sg9
V10847872.xml
p8393
sa(dp8394
g3
VSTD-O_x0027_Connor-2009
p8395
sg5
S'PMC2699722'
p8396
sg7
g8384
sg9
V19366977.xml
p8397
sa(dp8398
g3
VSTD-Thomas-2007
p8399
sg5
S'PMC2219846'
p8400
sg7
g8384
sg9
V17973175.xml
p8401
sa(dp8402
g3
VSTD-Baker-2003A
p8403
sg5
S'PMC1314570'
p8404
sg7
g8384
sg9
V12879828.xml
p8405
sa(dp8406
g3
VSTD-Schneider-2008
p8407
sg5
S'PMC2440309'
p8408
sg7
g8384
sg9
V18093108.xml
p8409
sa(dp8410
g3
VSTD-Eltayeb-2005
p8411
sg5
S'PMC1745049'
p8412
sg7
g8384
sg9
V16199745.xml
p8413
sa(dp8414
g3
VSTD-Svetkey-2009
p8415
sg5
S'PMC2784648'
p8416
sg7
g8384
sg9
V19920081.xml
p8417
sa(dp8418
g3
VSTD-Moher-2001
p8419
sg5
S'PMC32168'
p8420
sg7
g8384
sg9
V11387182.xml
p8421
sa(dp8422
g3
VSTD-Laskshminarayan-2010
p8423
sg5
S'PMC2875128'
p8424
sg7
g8384
sg9
V20479363.xml
p8425
sa(dp8426
g3
VSTD-McConnell-1982
p8427
sg5
S'PMC1274191'
p8428
sg7
g8384
sg9
V6891147.xml
p8429
sa(dp8430
g3
VSTD-Hux-1999
p8431
sg5
S'PMC1230539'
p8432
sg7
g8384
sg9
V10478162.xml
p8433
sa(dp8434
g3
VSTD-Pimlott-2003
p8435
sg5
S'PMC151988'
p8436
sg7
g8384
sg9
V12668540.xml
p8437
sa(dp8438
g3
VSTD-Schectman-2003
p8439
sg5
S'PMC1494929'
p8440
sg7
g8384
sg9
V14521638.xml
p8441
sa(dp8442
g3
VSTD-Mitchell-2005
p8443
sg5
S'PMC1463214'
p8444
sg7
g8384
sg9
V15720929.xml
p8445
sa(dp8446
g3
VSTD-Hillman-1998
p8447
sg5
S'PMC1508575'
p8448
sg7
g8384
sg9
V9807540.xml
p8449
sa(dp8450
g3
VSTD-Siriwardena-2002
p8451
sg5
S'PMC1314414'
p8452
sg7
g8384
sg9
V12236277.xml
p8453
sa(dp8454
g3
VSTD-Verstappen-2004
p8455
sg5
S'PMC1466745'
p8456
sg7
g8384
sg9
V15576543.xml
p8457
sa(dp8458
g3
VSTD-Buntinx-1993
p8459
sg5
S'PMC1372391'
p8460
sg7
g8384
sg9
V8347386.xml
p8461
sa(dp8462
g3
VSTD-Fairbrother-1999
p8463
sg5
S'PMC1508536'
p8464
sg7
g8384
sg9
V9949744.xml
p8465
sa(dp8466
g3
VSTD-Frijiling-2003
p8467
sg5
S'PMC1743704'
p8468
sg7
g8384
sg9
V12792007.xml
p8469
sa(dp8470
g3
VSTD-Wadland-2007
p8471
sg5
S'PMC1838696'
p8472
sg7
g8384
sg9
V17389537.xml
p8473
sa(dp8474
g3
VSTD-Kinsinger-1998
p8475
sg5
S'PMC1497003'
p8476
sg7
g8384
sg9
V9734786.xml
p8477
sa(dp8478
g3
VSTD-Vingerhoets-2001
p8479
sg5
S'PMC1743447'
p8480
sg7
g8384
sg9
V11743151.xml
p8481
sa(dp8482
g3
VSTD-Foster-2007
p8483
sg5
S'PMC1868738'
p8484
sg7
g8384
sg9
V17456241.xml
p8485
sa(dp8486
g3
VSTD-O_x0027_Connell-1999
p8487
sg5
S'PMC27749'
p8488
sg7
g8384
sg9
V10024260.xml
p8489
sa(dp8490
g3
VSTD-McAlister-1986
p8491
sg5
S'PMC1341518'
p8492
sg7
g8384
sg9
V3092976.xml
p8493
sa(dp8494
g3
VSTD-Mayer-1998
p8495
sg5
S'PMC1508276'
p8496
sg7
g8384
sg9
V9663162.xml
p8497
sa(dp8498
g3
VSTD-Herrin-2006
p8499
sg5
S'PMC1426180'
p8500
sg7
g8384
sg9
V16609732.xml
p8501
sa(dp8502
g3
VSTD-McCartney-1997
p8503
sg5
S'PMC2127027'
p8504
sg7
g8384
sg9
V9233326.xml
p8505
sa(dp8506
g3
VSTD-Hemminki-2008
p8507
sg5
S'PMC2442595'
p8508
sg7
VCD005528 v. 4.0 Non-clinical interventions for reducing unnecessary caesarean section.rm5
p8509
sg9
V18547413.xml
p8510
sa(dp8511
g3
VSTD-Montgomery-2007
p8512
sg5
S'PMC1895676'
p8513
sg7
g8509
sg9
V17540908.xml
p8514
sa(dp8515
g3
VSTD-Hurst-1998
p8516
sg5
S'PMC3455419'
p8517
sg7
VCD001894 v. 12.0 Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm in.rm5
p8518
sg9
V9513842.xml
p8519
sa(dp8520
g3
VSTD-Baruffi-2000
p8521
sg5
S'PMC3455458'
p8522
sg7
g8518
sg9
V11212860.xml
p8523
sa(dp8524
g3
VSTD-Kutlu-2010
p8525
sg5
S'PMC2941589'
p8526
sg7
g8518
sg9
V20467801.xml
p8527
sa(dp8528
g3
VSTD-Isik-2000
p8529
sg5
S'PMC3455664'
p8530
sg7
g8518
sg9
V10911572.xml
p8531
sa(dp8532
g3
VSTD-Montini-2003
p8533
sg5
S'PMC1955287'
p8534
sg7
VCD003772 v. 12.0 Antibiotics for acute pyelonephritis in children.rm5
p8535
sg9
V17611232.xml
p8536
sa(dp8537
g3
VSTD-Benador-2001
p8538
sg5
S'PMC1718672'
p8539
sg7
g8535
sg9
V11207174.xml
p8540
sa(dp8541
g3
VSTD-Vigano-1992
p8542
sg5
S'PMC191611'
p8543
sg7
g8535
sg9
V1510446.xml
p8544
sa(dp8545
g3
VSTD-Rouse-2008
p8546
sg5
S'PMC2803083'
p8547
sg7
VCD004661 v. 7.0 Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.rm5
p8548
sg9
V18753646.xml
p8549
sa(dp8550
g3
VSTD-Mann-1982
p8551
sg5
S'PMC459250'
p8552
sg7
VCD003535 v. 10.0 Anticholinergic therapy for chronic asthma in children over two years of age.rm5
p8553
sg9
V6461943.xml
p8554
sa(dp8555
g3
VSTD-Sly-1987
p8556
sg5
S'PMC460756'
p8557
sg7
g8553
sg9
V2958950.xml
p8558
sa(dp8559
g3
VSTD-Langford-1983
p8560
sg5
S'PMC1628912'
p8561
sg7
VCD001399 v. 15.0 Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.rm5
p8562
sg9
V6441523.xml
p8563
sa(dp8564
g3
VSTD-D_x00f6_ring-2007
p8565
sg5
S'PMC1904125'
p8566
sg7
g8562
sg9
V17585011.xml
p8567
sa(dp8568
g3
VSTD-Kneyber-2009
p8569
sg5
S'PMC2717432'
p8570
sg7
VCD006915 v. 5.0 Heliox inhalation therapy for bronchiolitis in infants.rm5
p8571
sg9
V19450268.xml
p8572
sa(dp8573
g3
VSTD-Carbon-1992
p8574
sg5
S'PMC189443'
p8575
sg7
VCD004418 v. 13.0 Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized a.rm5
p8576
sg9
V1323954.xml
p8577
sa(dp8578
g3
VSTD-Mooney-2007-b
p8579
sg5
S'PMC2693095'
p8580
sg7
VCD003352 v. 8.0 Dopamine agonists for the treatment of cocaine dependence.rm5
p8581
sg9
V17134849.xml
p8582
sa(dp8583
g3
VSTD-Schmitz-2010
p8584
sg5
S'PMC3164487'
p8585
sg7
g8581
sg9
V20545388.xml
p8586
sa(dp8587
g3
VSTD-Mooney-2007-a
p8588
sg5
S'PMC2693095'
p8589
sg7
g8581
sg9
V17134849.xml
p8590
sa(dp8591
g3
VSTD-Schmitz-2008
p8592
sg5
S'PMC2293271'
p8593
sg7
g8581
sg9
V18164144.xml
p8594
sa(dp8595
g3
VSTD-Man-2004
p8596
sg5
S'PMC529363'
p8597
sg7
VCD005305 v. 4.0 Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.rm5
p8598
sg9
V15504763.xml
p8599
sa(dp8600
g3
VSTD-Burger-1987
p8601
sg5
S'PMC1246001'
p8602
sg7
VCD004509 v. 6.0 Testosterone for peri and postmenopausal women.rm5
p8603
sg9
V3107663.xml
p8604
sa(dp8605
g3
VSTD-Chan-1993
p8606
sg5
S'PMC1029305'
p8607
sg7
VCD000143 v. 10.0 Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in p.rm5
p8608
sg9
V8323357.xml
p8609
sa(dp8610
g3
VSTD-So-1995
p8611
sg5
S'PMC2528452'
p8612
sg7
g8608
sg9
V7796237.xml
p8613
sa(dp8614
g3
VSTD-Davis-1998
p8615
sg5
S'PMC1720820'
p8616
sg7
g8608
sg9
V9797626.xml
p8617
sa(dp8618
g3
VSTD-Razavi-2002
p8619
sg5
S'PMC2364281'
p8620
sg7
VCD003751 v. 5.0 Communication skills training for healthcare professionals working with people who have cancer.rm5
p8621
sg9
V12085247.xml
p8622
sa(dp8623
g3
VSTD-Tulsky-2011
p8624
sg5
S'PMC3368370'
p8625
sg7
g8621
sg9
V22041948.xml
p8626
sa(dp8627
g3
VSTD-Lienard-2010
p8628
sg5
S'PMC2906741'
p8629
sg7
g8621
sg9
V20628395.xml
p8630
sa(dp8631
g3
VSTD-Stewart-2007
p8632
sg5
S'PMC2000315'
p8633
sg7
g8621
sg9
V17893379.xml
p8634
sa(dp8635
g3
VSTD-Alberts-2004
p8636
sg5
S'PMC3579584'
p8637
sg7
VCD004433 v. 5.0 Constraint-induced movement therapy for upper extremities in stroke patients.rm5
p8638
sg9
V15537995.xml
p8639
sa(dp8640
g3
VSTD-Elsinga-2006
p8641
sg5
S'PMC1552064'
p8642
sg7
VCD007536 v. 2.0 Routine pre-pregnancy health promotion for improving pregnancy outcomes.rm5
p8643
sg9
V16824233.xml
p8644
sa(dp8645
g3
VSTD-Floyd-2007
p8646
sg5
S'PMC2888541'
p8647
sg7
g8643
sg9
V17218187.xml
p8648
sa(dp8649
g3
VSTD-Lumley-2006
p8650
sg5
S'PMC1712341'
p8651
sg7
g8643
sg9
V17156466.xml
p8652
sa(dp8653
g3
VSTD-Reis-Neto-2002
p8654
sg5
S'PMC3043413'
p8655
sg7
VCD005200 v. 3.0 Laparoscopic versus open total mesorectal excision for rectal cancer.rm5
p8656
sg9
V12113422.xml
p8657
sa(dp8658
g3
VSTD-Leung-2000-a
p8659
sg5
S'PMC1421025'
p8660
sg7
g8656
sg9
V10749610.xml
p8661
sa(dp8662
g3
VSTD-Morino-2003
p8663
sg5
S'PMC1514324'
p8664
sg7
g8656
sg9
V12616116.xml
p8665
sa(dp8666
g3
VSTD-BRAIN-2009
p8667
sg5
S'PMC2794266'
p8668
sg7
VCD006686 v. 7.0 Bradykinin beta-2 receptor antagonists for acute traumatic brain injury.rm5
p8669
sg9
V19958521.xml
p8670
sa(dp8671
g3
VSTD-Wiles-2001
p8672
sg5
S'PMC1737210'
p8673
sg7
VCD003980 v. 7.0 Exercise therapy for multiple sclerosis.rm5
p8674
sg9
V11160464.xml
p8675
sa(dp8676
g3
VSTD-Riccardi-1994
p8677
sg5
S'PMC2033710'
p8678
sg7
VCD004023 v. 8.0 Early versus deferred treatment for early stage multiple myeloma.rm5
p8679
sg9
V7981078.xml
p8680
sa(dp8681
g3
VSTD-Riccardi-2000
p8682
sg5
S'PMC2374495'
p8683
sg7
g8679
sg9
V10755397.xml
p8684
sa(dp8685
g3
VSTD-Morell-1992
p8686
sg5
S'PMC463918'
p8687
sg7
VCD001740 v. 7.0 Corticosteroids for acute severe asthma in hospitalised patients.rm5
p8688
sg9
V1412113.xml
p8689
sa(dp8690
g3
VSTD-Bowler-1992
p8691
sg5
S'PMC463917'
p8692
sg7
g8688
sg9
V1412112.xml
p8693
sa(dp8694
g3
VSTD-Bow-1984
p8695
sg5
S'PMC1875734'
p8696
sg7
VCD005339 v. 4.0 Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunct.rm5
p8697
sg9
V6697270.xml
p8698
sa(dp8699
g3
VSTD-Gogate-2003
p8700
sg5
S'PMC1771720'
p8701
sg7
VCD008811 v. 2.0 Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus extrac.rm5
p8702
sg9
V12770957.xml
p8703
sa(dp8704
g3
VSTD-Richards-2002
p8705
sg5
S'PMC117444'
p8706
sg7
VCD003786 v. 7.0 Exercise for treating fibromyalgia syndrome.rm5
p8707
sg9
V12142304.xml
p8708
sa(dp8709
g3
VSTD-Hakkinen-2001
p8710
sg5
S'PMC1753355'
p8711
sg7
g8707
sg9
V11114277.xml
p8712
sa(dp8713
g3
VSTD-Cedraschi-2004
p8714
sg5
S'PMC1754921'
p8715
sg7
g8707
sg9
V14962965.xml
p8716
sa(dp8717
g3
VSTD-Richards-2003
p8718
sg5
S'PMC1314708'
p8719
sg7
VCD000532 v. 5.0 On-site mental health workers delivering psychological therapy and psychosocial interventions to pat.rm5
p8720
sg9
V14601351.xml
p8721
sa(dp8722
g3
VSTD-Baker-1996
p8723
sg5
S'PMC1410018'
p8724
sg7
g8720
sg9
V9624745.xml
p8725
sa(dp8726
g3
VSTD-Blakey-1986
p8727
sg5
S'PMC1960439'
p8728
sg7
g8720
sg9
V3746764.xml
p8729
sa(dp8730
g3
VSTD-Benson-1988
p8731
sg5
S'PMC1711670'
p8732
sg7
g8720
sg9
V3267741.xml
p8733
sa(dp8734
g3
VSTD-Robson-1984
p8735
sg5
S'PMC1441852'
p8736
sg7
g8720
sg9
V6428555.xml
p8737
sa(dp8738
g3
VSTD-Earll-1982
p8739
sg5
S'PMC1970973'
p8740
sg7
g8720
sg9
V7086742.xml
p8741
sa(dp8742
g3
VSTD-Lester-2007
p8743
sg5
S'PMC2042545'
p8744
sg7
g8720
sg9
V17359606.xml
p8745
sa(dp8746
g3
VSTD-Harvey-1998
p8747
sg5
S'PMC1410004'
p8748
sg7
g8720
sg9
V9624744.xml
p8749
sa(dp8750
g3
VSTD-King-2000b
p8751
sg5
S'PMC27543'
p8752
sg7
g8720
sg9
V11099285.xml
p8753
sa(dp8754
g3
VSTD-King-2000a
p8755
sg5
S'PMC27543'
p8756
sg7
g8720
sg9
V11099285.xml
p8757
sa(dp8758
g3
VSTD-Ritchie-1979
p8759
sg5
S'PMC1597979'
p8760
sg7
VCD003460 v. 9.0 Bulking agents antispasmodics and antidepressants for the treatment of irritable bowel syndrome.rm5
p8761
sg9
V32949.xml
p8762
sa(dp8763
g3
VSTD-Lucey-1987
p8764
sg5
S'PMC1432984'
p8765
sg7
g8761
sg9
V3030904.xml
p8766
sa(dp8767
g3
VSTD-Prior-1987
p8768
sg5
S'PMC1433676'
p8769
sg7
g8761
sg9
V3322956.xml
p8770
sa(dp8771
g3
VSTD-Tack-2006a
p8772
sg5
S'PMC1856276'
p8773
sg7
g8761
sg9
V16401691.xml
p8774
sa(dp8775
g3
VSTD-Dobrilla-1990
p8776
sg5
S'PMC1378284'
p8777
sg7
g8761
sg9
V2182401.xml
p8778
sa(dp8779
g3
VSTD-Duvan-2006
p8780
sg5
S'PMC3455434'
p8781
sg7
VCD005996 v. 5.0 Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.rm5
p8782
sg9
V16518579.xml
p8783
sa(dp8784
g3
VSTD-Lee-2004
p8785
sg5
S'PMC1884548'
p8786
sg7
VCD007031 v. 3.0 Ciclesonide versus other inhaled steroids for chronic asthma in children and adults.rm5
p8787
sg9
V15206989.xml
p8788
sa(dp8789
g3
VSTD-Nicolle-1993
p8790
sg5
S'PMC187709'
p8791
sg7
VCD003597 v. 6.0 Quinolones for uncomplicated acute cystitis in women.rm5
p8792
sg9
V8384818.xml
p8793
sa(dp8794
g3
VSTD-Jardin-1995
p8795
sg5
S'PMC162511'
p8796
sg7
g8792
sg9
V7695309.xml
p8797
sa(dp8798
g3
VSTD-McEwan-1990
p8799
sg5
S'PMC1371072'
p8800
sg7
VCD001054 v. 10.4 Community screening for visual impairment in the elderly.rm5
p8801
sg9
V2112022.xml
p8802
sa(dp8803
g3
VSTD-Smeeth-2003
p8804
sg5
S'PMC261660'
p8805
sg7
g8801
sg9
V14593039.xml
p8806
sa(dp8807
g3
VSTD-Wagner-1994
p8808
sg5
S'PMC1615188'
p8809
sg7
g8801
sg9
V7977921.xml
p8810
sa(dp8811
g3
VSTD-Vetter-1992
p8812
sg5
S'PMC1882829'
p8813
sg7
g8801
sg9
V1392755.xml
p8814
sa(dp8815
g3
VSTD-Vetter-1984
p8816
sg5
S'PMC1444201'
p8817
sg7
g8801
sg9
V6229314.xml
p8818
sa(dp8819
g3
VSTD-Van-Rossum-1993
p8820
sg5
S'PMC1678489'
p8821
sg7
g8801
sg9
V8343668.xml
p8822
sa(dp8823
g3
VSTD-Schlagenhauf-2003a
p8824
sg5
S'PMC261741'
p8825
sg7
VCD006491 v. 5.0 Drugs for preventing malaria in travellers.rm5
p8826
sg9
V14604928.xml
p8827
sa(dp8828
g3
VSTD-REACT_x002d_UK
p8829
sg5
S'PMC1432213'
p8830
sg7
VCD007906 v. 4.0 Intensive case management for severe mental illness.rm5
p8831
sg9
V16543298.xml
p8832
sa(dp8833
g3
VSTD-Shern_x002d_USA1
p8834
sg5
S'PMC1446423'
p8835
sg7
g8831
sg9
V11111259.xml
p8836
sa(dp8837
g3
VSTD-Salkever_x002d_SCarolina
p8838
sg5
S'PMC1089024'
p8839
sg7
g8831
sg9
V10357291.xml
p8840
sa(dp8841
g3
VSTD-Denis-1978
p8842
sg5
S'PMC1412181'
p8843
sg7
VCD003628 v. 6.0 Artificial and bioartificial support systems for liver failure.rm5
p8844
sg9
V710967.xml
p8845
sa(dp8846
g3
VSTD-Fraser-S-1993
p8847
sg5
S'PMC1968186'
p8848
sg7
VCD003372 v. 8.0 Single agent versus combination chemotherapy for metastatic breast cancer.rm5
p8849
sg9
V8431375.xml
p8850
sa(dp8851
g3
VSTD-Rubens-RD-1975
p8852
sg5
S'PMC2025018'
p8853
sg7
g8849
sg9
V766800.xml
p8854
sa(dp8855
g3
VSTD-Khoury-1986
p8856
sg5
S'PMC2498441'
p8857
sg7
VCD004647 v. 3.0 Ileostomy or colostomy for temporary decompression of colorectal anastomosis.rm5
p8858
sg9
V3566123.xml
p8859
sa(dp8860
g3
VSTD-Western-Canada-1968
p8861
sg5
S'PMC1946029'
p8862
sg7
VCD000021 v. 6.0 Anti-D administration after childbirth for preventing Rhesus alloimmunisation.rm5
p8863
sg9
V4977545.xml
p8864
sa(dp8865
g3
VSTD-Netherlands-1968
p8866
sg5
S'PMC1912672'
p8867
sg7
g8863
sg9
V4177613.xml
p8868
sa(dp8869
g3
VSTD-Matthiessen-2007
p8870
sg5
S'PMC1933561'
p8871
sg7
VCD006878 v. 3.0 Covering ileo- or colostomy in anterior resection for rectal carcinoma.rm5
p8872
sg9
V17667498.xml
p8873
sa(dp8874
g3
VSTD-Harstad_x002c_-Norway
p8875
sg5
S'PMC1730374'
p8876
sg7
VCD004445 v. 8.0 The 'WHO Safe Communities' model for the prevention of injury in whole populations.rm5
p8877
sg9
V9788086.xml
p8878
sa(dp8879
g3
VSTD-Lidkoping_x002c_-Sweden
p8880
sg5
S'PMC1067586'
p8881
sg7
g8877
sg9
V9346020.xml
p8882
sa(dp8883
g3
VSTD-Shire-of-Bulla_x002c_-Australia
p8884
sg5
S'PMC1730817'
p8885
sg7
g8877
sg9
V11928967.xml
p8886
sa(dp8887
g3
VSTD-Collins-2004
p8888
sg5
S'PMC487729'
p8889
sg7
VCD005092 v. 3.0 Cup feeding versus other forms of supplemental enteral feeding for newborn infants unable to fully b.rm5
p8890
sg9
V15208209.xml
p8891
sa(dp8892
g3
VSTD-LEAD_x002d_3-2006
p8893
sg5
S'PMC3084519'
p8894
sg7
VCD009008 v. 2.6 Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.rm5
p8895
sg9
V21205128.xml
p8896
sa(dp8897
g3
VSTD-Alvarsson-2010
p8898
sg5
S'PMC3061612'
p8899
sg7
g8895
sg9
V21409314.xml
p8900
sa(dp8901
g3
VSTD-Quinn-N
p8902
sg5
S'PMC1027949'
p8903
sg7
VCD006456 v. 3.0 Therapeutic interventions for symptomatic treatment in Huntington's disease.rm5
p8904
sg9
V6236286.xml
p8905
sa(dp8906
g3
VSTD-van-Vugt-J
p8907
sg5
S'PMC2169648'
p8908
sg7
g8904
sg9
V9221965.xml
p8909
sa(dp8910
g3
VSTD-Flach-1998
p8911
sg5
S'PMC1298410'
p8912
sg7
VCD004239 v. 5.2 Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surger.rm5
p8913
sg9
V10360304.xml
p8914
sa(dp8915
g3
VSTD-Sun-2008
p8916
sg5
S'PMC2784033'
p8917
sg7
VCD009113 v. 1.0 Universal school-based prevention programs for alcohol misuse in young people.rm5
p8918
sg9
V18675294.xml
p8919
sa(dp8920
g3
VSTD-Kellam-2008
p8921
sg5
S'PMC2512256'
p8922
sg7
g8918
sg9
V18343607.xml
p8923
sa(dp8924
g3
VSTD-Johnson-2009
p8925
sg5
S'PMC3735174'
p8926
sg7
g8918
sg9
V19440837.xml
p8927
sa(dp8928
g3
VSTD-Werch-2008
p8929
sg5
S'PMC2898909'
p8930
sg7
g8918
sg9
V19004157.xml
p8931
sa(dp8932
g3
VSTD-Ellickson-2003
p8933
sg5
S'PMC1448059'
p8934
sg7
g8918
sg9
V14600049.xml
p8935
sa(dp8936
g3
VSTD-Werch-2010
p8937
sg5
S'PMC2845326'
p8938
sg7
g8918
sg9
V20307126.xml
p8939
sa(dp8940
g3
VSTD-Bond-2004
p8941
sg5
S'PMC1732649'
p8942
sg7
g8918
sg9
V15547059.xml
p8943
sa(dp8944
g3
VSTD-Britt-1998
p8945
sg5
S'PMC1730419'
p8946
sg7
VCD003985 v. 8.0 Non-legislative interventions for the promotion of cycle helmet wearing by children.rm5
p8947
sg9
V9887419.xml
p8948
sa(dp8949
g3
VSTD-Kendrick-2004
p8950
sg5
S'PMC1719862'
p8951
sg7
g8947
sg9
V15033841.xml
p8952
sa(dp8953
g3
VSTD-Hendrickson-1998
p8954
sg5
S'PMC1730341'
p8955
sg7
g8947
sg9
V9666367.xml
p8956
sa(dp8957
g3
VSTD-Cushman-1991b
p8958
sg5
S'PMC1405730'
p8959
sg7
g8947
sg9
V1853997.xml
p8960
sa(dp8961
g3
VSTD-Macarthur-1998
p8962
sg5
S'PMC1730356'
p8963
sg7
g8947
sg9
V9666365.xml
p8964
sa(dp8965
g3
VSTD-Farley-1996
p8966
sg5
S'PMC1380359'
p8967
sg7
g8947
sg9
V8561241.xml
p8968
sa(dp8969
g3
VSTD-Kim-1997
p8970
sg5
S'PMC1067762'
p8971
sg7
g8947
sg9
V9113846.xml
p8972
sa(dp8973
g3
VSTD-Wright-1995
p8974
sg5
S'PMC1067557'
p8975
sg7
g8947
sg9
V9346001.xml
p8976
sa(dp8977
g3
VSTD-Azeredo-2003
p8978
sg5
S'PMC1731011'
p8979
sg7
g8947
sg9
V12966021.xml
p8980
sa(dp8981
g3
VSTD-Lee-2000
p8982
sg5
S'PMC1730614'
p8983
sg7
g8947
sg9
V10875675.xml
p8984
sa(dp8985
g3
VSTD-Law-1987
p8986
sg5
S'PMC2428199'
p8987
sg7
VCD003091 v. 5.2 Dressings for the prevention of surgical site infection.rm5
p8988
sg9
V3671224.xml
p8989
sa(dp8990
g3
VSTD-Ali_x002d_Melkkila-1993
p8991
sg5
S'PMC504652'
p8992
sg7
VCD004083 v. 5.0 Peribulbar versus retrobulbar anaesthesia for cataract surgery.rm5
p8993
sg9
V8110669.xml
p8994
sa(dp8995
g3
VSTD-Bourbeau-1998
p8996
sg5
S'PMC1745246'
p8997
sg7
VCD002991 v. 7.0 Inhaled corticosteroids for stable chronic obstructive pulmonary disease.rm5
p8998
sg9
V9713447.xml
p8999
sa(dp9000
g3
VSTD-Auffarth-1991
p9001
sg5
S'PMC1020969'
p9002
sg7
g8998
sg9
V2068695.xml
p9003
sa(dp9004
g3
VSTD-Calverley-2008
p9005
sg5
S'PMC2644301'
p9006
sg7
g8998
sg9
V19014549.xml
p9007
sa(dp9008
g3
VSTD-Weir-1990a
p9009
sg5
S'PMC462320'
p9010
sg7
g8998
sg9
V2180105.xml
p9011
sa(dp9012
g3
VSTD-Bourbeau-2007
p9013
sg5
S'PMC2117108'
p9014
sg7
g8998
sg9
V17557771.xml
p9015
sa(dp9016
g3
VSTD-Verhoeven-2002
p9017
sg5
S'PMC1746396'
p9018
sg7
g8998
sg9
V12149529.xml
p9019
sa(dp9020
g3
VSTD-Schermer-2009
p9021
sg5
S'PMC2793071'
p9022
sg7
g8998
sg9
V20037682.xml
p9023
sa(dp9024
g3
VSTD-Wempe-1992
p9025
sg5
S'PMC463924'
p9026
sg7
g8998
sg9
V1412119.xml
p9027
sa(dp9028
g3
VSTD-Burge-2000
p9029
sg5
S'PMC27372'
p9030
sg7
g8998
sg9
V10807619.xml
p9031
sa(dp9032
g3
VSTD-van-Grunsven-1999
p9033
sg5
S'PMC1745350'
p9034
sg7
g8998
sg9
V10343624.xml
p9035
sa(dp9036
g3
VSTD-Brightling-2005
p9037
sg5
S'PMC1747331'
p9038
sg7
g8998
sg9
V15741434.xml
p9039
sa(dp9040
g3
VSTD-Colacone-1990
p9041
sg5
S'PMC462648'
p9042
sg7
VCD001112 v. 8.3 Caffeine for asthma.rm5
p9043
sg9
V2205947.xml
p9044
sa(dp9045
g3
VSTD-Halm-2009
p9046
sg5
S'PMC2690844'
p9047
sg7
VCD005199 v. 7.0 Transverse verses midline incisions for abdominal surgery.rm5
p9048
sg9
V19259615.xml
p9049
sa(dp9050
g3
VSTD-Midazolam-2003_x002c_-BZ
p9051
sg5
S'PMC200800'
p9052
sg7
VCD003079 v. 8.0 Benzodiazepines for psychosis-induced aggression or agitation.rm5
p9053
sg9
V14512476.xml
p9054
sa(dp9055
g3
VSTD-Rotheram_x002d_Borus-2004
p9056
sg5
S'PMC2843590'
p9057
sg7
VCD009189 v. 2.43 Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection.rm5
p9058
sg9
V15385902.xml
p9059
sa(dp9060
g3
VSTD-Kalichman-2011
p9061
sg5
S'PMC3085946'
p9062
sg7
g9058
sg9
V21457056.xml
p9063
sa(dp9064
g3
VSTD-Yoon-1993
p9065
sg5
S'PMC464888'
p9066
sg7
VCD003000 v. 9.0 Education interventions for adults who attend the emergency room for acute asthma.rm5
p9067
sg9
V8296253.xml
p9068
sa(dp9069
g3
VSTD-Osman-2002
p9070
sg5
S'PMC1746210'
p9071
sg7
g9067
sg9
V12324673.xml
p9072
sa(dp9073
g3
VSTD-Krudsood-2010
p9074
sg5
S'PMC2912575'
p9075
sg7
VCD002151 v. 7.0 Antipyretic measures for treating fever in malaria.rm5
p9076
sg9
V20595477.xml
p9077
sa(dp9078
g3
VSTD-Matsegui-2008
p9079
sg5
S'PMC2409363'
p9080
sg7
g9076
sg9
V18503714.xml
p9081
sa(dp9082
g3
VSTD-Kofoed-2011
p9083
sg5
S'PMC3123603'
p9084
sg7
g9076
sg9
V21631932.xml
p9085
sa(dp9086
g3
VSTD-Champlin-2007
p9087
sg5
S'PMC1885491'
p9088
sg7
VCD009159 v. 2.0 Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogenei.rm5
p9089
sg9
V17272503.xml
p9090
sa(dp9091
g3
VSTD-Thomas-2003
p9092
sg5
S'PMC1746567'
p9093
sg7
VCD001277 v. 10.0 Breathing exercises for asthma.rm5
p9094
sg9
V12554890.xml
p9095
sa(dp9096
g3
VSTD-Lichtenstein-2000
p9097
sg5
S'PMC1748368'
p9098
sg7
VCD001118 v. 10.0 Self-help interventions for smoking cessation.rm5
p9099
sg9
V10982577.xml
p9100
sa(dp9101
g3
VSTD-Etter-2004
p9102
sg5
S'PMC1763345'
p9103
sg7
g9099
sg9
V15365111.xml
p9104
sa(dp9105
g3
VSTD-Campbell-1986
p9106
sg5
S'PMC1020629'
p9107
sg7
g9099
sg9
V3529480.xml
p9108
sa(dp9109
g3
VSTD-Lennox-2001
p9110
sg5
S'PMC32255'
p9111
sg7
g9099
sg9
V11397745.xml
p9112
sa(dp9113
g3
VSTD-Janz-1987
p9114
sg5
S'PMC1647206'
p9115
sg7
g9099
sg9
V3592033.xml
p9116
sa(dp9117
g3
VSTD-Meyer-2008
p9118
sg5
S'PMC2253708'
p9119
sg7
g9099
sg9
V17995993.xml
p9120
sa(dp9121
g3
VSTD-Orleans-2000
p9122
sg5
S'PMC1766256'
p9123
sg7
g9099
sg9
V10688938.xml
p9124
sa(dp9125
g3
VSTD-Davis-1984
p9126
sg5
S'PMC1652036'
p9127
sg7
g9099
sg9
V6437257.xml
p9128
sa(dp9129
g3
VSTD-Hansen-1999
p9130
sg5
S'PMC1752793'
p9131
sg7
VCD006356 v. 4.0 Effects of glucocorticoids on radiological progression in rheumatoid arthritis.rm5
p9132
sg9
V10531077.xml
p9133
sa(dp9134
g3
VSTD-Choy-2005
p9135
sg5
S'PMC1755652'
p9136
sg7
g9132
sg9
V15760929.xml
p9137
sa(dp9138
g3
VSTD-Capell-2004
p9139
sg5
S'PMC1755058'
p9140
sg7
g9132
sg9
V15194574.xml
p9141
sa(dp9142
g3
VSTD-Empire-1955
p9143
sg5
S'PMC1006832'
p9144
sg7
g9132
sg9
V13275875.xml
p9145
sa(dp9146
g3
VSTD-Donskov_x0028_ii_x0029_-2005
p9147
sg5
S'PMC2361635'
p9148
sg7
VCD001425 v. 6.0 Immunotherapy for advanced renal cell cancer.rm5
p9149
sg9
V16136045.xml
p9150
sa(dp9151
g3
VSTD-Jayson-1998
p9152
sg5
S'PMC2063040'
p9153
sg7
g9149
sg9
V9703284.xml
p9154
sa(dp9155
g3
VSTD-DeMulder-1995
p9156
sg5
S'PMC2033601'
p9157
sg7
g9149
sg9
V7841054.xml
p9158
sa(dp9159
g3
VSTD-Donskov_x0028_i_x0029_-2005
p9160
sg5
S'PMC2361635'
p9161
sg7
g9149
sg9
V16136045.xml
p9162
sa(dp9163
g3
VSTD-Henriksson-1998
p9164
sg5
S'PMC2150170'
p9165
sg7
g9149
sg9
V9579838.xml
p9166
sa(dp9167
g3
VSTD-Yang-2003_x0028_ii_x0029_
p9168
sg5
S'PMC2275327'
p9169
sg7
g9149
sg9
V12915604.xml
p9170
sa(dp9171
g3
VSTD-Yang-2003_x0028_i_x0029_
p9172
sg5
S'PMC2275327'
p9173
sg7
g9149
sg9
V12915604.xml
p9174
sa(dp9175
g3
VSTD-Atzpodien-2001
p9176
sg5
S'PMC2375150'
p9177
sg7
g9149
sg9
V11710825.xml
p9178
sa(dp9179
g3
VSTD-Brooner-1998
p9180
sg5
S'PMC1307735'
p9181
sg7
VCD004145 v. 10.0 Oral substitution treatment of injecting opioid users for prevention of HIV infection.rm5
p9182
sg9
V9722818.xml
p9183
sa(dp9184
g3
VSTD-Willner_x002d_Reid-2008
p9185
sg5
S'PMC2600879'
p9186
sg7
g9182
sg9
V17931826.xml
p9187
sa(dp9188
g3
VSTD-Thiede-2000
p9189
sg5
S'PMC3456044'
p9190
sg7
g9182
sg9
V10976608.xml
p9191
sa(dp9192
g3
VSTD-Callaghan-1985
p9193
sg5
S'PMC1028404'
p9194
sg7
VCD001911 v. 10.0 Carbamazepine versus phenytoin monotherapy for epilepsy.rm5
p9195
sg9
V3928820.xml
p9196
sa(dp9197
g3
VSTD-Heller-1995
p9198
sg5
S'PMC1073267'
p9199
sg7
g9195
sg9
V7823066.xml
p9200
sa(dp9201
g3
VSTD-Glasgow-Trial-1988
p9202
sg5
S'PMC1041614'
p9203
sg7
VCD004399 v. 6.1 Medical versus surgical interventions for open angle glaucoma.rm5
p9204
sg9
V3067743.xml
p9205
sa(dp9206
g3
VSTD-Lucas-1992
p9207
sg5
S'PMC1793654'
p9208
sg7
VCD004696 v. 6.0 Nutrient-enriched formula versus standard term formula for preterm infants following hospital discha.rm5
p9209
sg9
V1575558.xml
p9210
sa(dp9211
g3
VSTD-Thomas-2001
p9212
sg5
S'PMC1760980'
p9213
sg7
VCD003087 v. 9.0 Double gloving to reduce surgical cross-infection.rm5
p9214
sg9
V11423598.xml
p9215
sa(dp9216
g3
VSTD-Wilson-1996
p9217
sg5
S'PMC2502654'
p9218
sg7
g9214
sg9
V8659967.xml
p9219
sa(dp9220
g3
VSTD-Huf-2007
p9221
sg5
S'PMC2043463'
p9222
sg7
VCD009377 v. 2.3 Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).rm5
p9223
sg9
V17954515.xml
p9224
sa(dp9225
g3
VSTD-Huijgens-1999
p9226
sg5
S'PMC1023076'
p9227
sg7
VCD003807 v. 5.2 Interventions for preventing oral candidiasis for patients with cancer receiving treatment.rm5
p9228
sg9
V10560360.xml
p9229
sa(dp9230
g3
VSTD-Nathan-1991
p9231
sg5
S'PMC2499492'
p9232
sg7
VCD004929 v. 5.0 Prophylactic nasogastric decompression after abdominal surgery.rm5
p9233
sg9
V1929130.xml
p9234
sa(dp9235
g3
VSTD-Cheadle-1985
p9236
sg5
S'PMC1250919'
p9237
sg7
g9233
sg9
V4037908.xml
p9238
sa(dp9239
g3
VSTD-Wolff-1989
p9240
sg5
S'PMC1494121'
p9241
sg7
g9233
sg9
V2658880.xml
p9242
sa(dp9243
g3
VSTD-Hurlstone-2004
p9244
sg5
S'PMC1773964'
p9245
sg7
VCD006439 v. 4.0 Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum.rm5
p9246
sg9
V14960519.xml
p9247
sa(dp9248
g3
VSTD-Stoffel-2008
p9249
sg5
S'PMC2701380'
p9250
sg7
g9246
sg9
V19139000.xml
p9251
sa(dp9252
g3
VSTD-Reissman-1995
p9253
sg5
S'PMC1234758'
p9254
sg7
VCD004080 v. 7.0 Early enteral nutrition within 24h of colorectal surgery versus later commencement of feeding for po.rm5
p9255
sg9
V7618972.xml
p9256
sa(dp9257
g3
VSTD-Watters-1997
p9258
sg5
S'PMC1191041'
p9259
sg7
g9255
sg9
V9339943.xml
p9260
sa(dp9261
g3
VSTD-Beier_x002d_Holgersen-1996
p9262
sg5
S'PMC1383455'
p9263
sg7
g9255
sg9
V9038665.xml
p9264
sa(dp9265
g3
VSTD-Heslin-1997
p9266
sg5
S'PMC1191079'
p9267
sg7
g9255
sg9
V9351723.xml
p9268
sa(dp9269
g3
VSTD-Whittaker-2011
p9270
sg5
S'PMC3221331'
p9271
sg7
VCD006611 v. 4.4 Mobile phone-based interventions for smoking cessation.rm5
p9272
sg9
V21371991.xml
p9273
sa(dp9274
g3
VSTD-Rodgers-2005
p9275
sg5
S'PMC1748056'
p9276
sg7
g9272
sg9
V16046689.xml
p9277
sa(dp9278
g3
VSTD-Free-2011
p9279
sg5
S'PMC3143315'
p9280
sg7
g9272
sg9
V21722952.xml
p9281
sa(dp9282
g3
VSTD-Wolthers-1991
p9283
sg5
S'PMC1670402'
p9284
sg7
VCD003271 v. 5.0 Budesonide at different doses for chronic asthma.rm5
p9285
sg9
V1878641.xml
p9286
sa(dp9287
g3
VSTD-Oddy-1999
p9288
sg5
S'PMC314207'
p9289
sg7
VCD003517 v. 5.0 Optimal duration of exclusive breastfeeding.rm5
p9290
sg9
V10496824.xml
p9291
sa(dp9292
g3
VSTD-Savilahti-1987a
p9293
sg5
S'PMC1778320'
p9294
sg7
g9290
sg9
V3566318.xml
p9295
sa(dp9296
g3
VSTD-COMPASS
p9297
sg5
S'PMC1920547'
p9298
sg7
VCD004106 v. 9.0 Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for c.rm5
p9299
sg9
V17362472.xml
p9300
sa(dp9301
g3
VSTD-McMurdo-2009
p9302
sg5
S'PMC2639265'
p9303
sg7
VCD001321 v. 17.0 Cranberries for preventing urinary tract infections.rm5
p9304
sg9
V19042940.xml
p9305
sa(dp9306
g3
VSTD-Barbosa_x002d_Cesnik-2011
p9307
sg5
S'PMC3060891'
p9308
sg7
g9304
sg9
V21148516.xml
p9309
sa(dp9310
g3
VSTD-Kontiokari-2001
p9311
sg5
S'PMC33514'
p9312
sg7
g9304
sg9
V11431298.xml
p9313
sa(dp9314
g3
VSTD-Lichtenstein-2000
p9315
sg5
S'PMC1748368'
p9316
sg7
VCD002850 v. 9.0 Telephone counselling for smoking cessation.rm5
p9317
sg9
V10982577.xml
p9318
sa(dp9319
g3
VSTD-Reid-1999
p9320
sg5
S'PMC1230362'
p9321
sg7
g9317
sg9
V10373999.xml
p9322
sa(dp9323
g3
VSTD-McBride-1999b
p9324
sg5
S'PMC1508743'
p9325
sg7
g9317
sg9
V10224982.xml
p9326
sa(dp9327
g3
VSTD-Lando-1997
p9328
sg5
S'PMC1381132'
p9329
sg7
g9317
sg9
V9357351.xml
p9330
sa(dp9331
g3
VSTD-Lando-1992
p9332
sg5
S'PMC1694411'
p9333
sg7
g9317
sg9
V1536333.xml
p9334
sa(dp9335
g3
VSTD-Hollis-2007
p9336
sg5
S'PMC2598511'
p9337
sg7
g9317
sg9
V18048633.xml
p9338
sa(dp9339
g3
VSTD-Ossip_x002d_Klein-1997
p9340
sg5
S'PMC1759567'
p9341
sg7
g9317
sg9
V9396102.xml
p9342
sa(dp9343
g3
VSTD-Rabius-2007
p9344
sg5
S'PMC2598518'
p9345
sg7
g9317
sg9
V18048636.xml
p9346
sa(dp9347
g3
VSTD-Hennrikus-2002
p9348
sg5
S'PMC1447056'
p9349
sg7
g9317
sg9
V11818305.xml
p9350
sa(dp9351
g3
VSTD-Holmes_x002d_Rovner-2008
p9352
sg5
S'PMC2517997'
p9353
sg7
g9317
sg9
V18618189.xml
p9354
sa(dp9355
g3
VSTD-Young-2008
p9356
sg5
S'PMC2268921'
p9357
sg7
g9317
sg9
V18304363.xml
p9358
sa(dp9359
g3
VSTD-Joyce-2008
p9360
sg5
S'PMC2614005'
p9361
sg7
g9317
sg9
V18783459.xml
p9362
sa(dp9363
g3
VSTD-Bonny-2009
p9364
sg5
S'PMC2749597'
p9365
sg7
VCD008815 v. 3.0 Progestin-only contraceptives effects on weight.rm5
p9366
sg9
V19766950.xml
p9367
sa(dp9368
g3
VSTD-Grootendorst-2005
p9369
sg5
S'PMC1361214'
p9370
sg7
VCD008654 v. 1.0 Pharmaceutical policies effects of restrictions on reimbursement.rm5
p9371
sg9
V16174135.xml
p9372
sa(dp9373
g3
VSTD-Bursey-2000
p9374
sg5
S'PMC1231278'
p9375
sg7
g9371
sg9
V10750472.xml
p9376
sa(dp9377
g3
VSTD-Fretheim-2007
p9378
sg5
S'PMC1904466'
p9379
sg7
g9371
sg9
V17622192.xml
p9380
sa(dp9381
g3
VSTD-Sakshaug-2007
p9382
sg5
S'PMC2048565'
p9383
sg7
g9371
sg9
V17441934.xml
p9384
sa(dp9385
g3
VSTD-COMTI-_x0028_E_x0029__x003a_-UK_x002f_Irish
p9386
sg5
S'PMC1738605'
p9387
sg7
VCD007166 v. 3.0 Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinsons disea.rm5
p9388
sg9
V12876237.xml
p9389
sa(dp9390
g3
VSTD-DA-_x0028_Pr_x0029__x003a_-Aust_x002f_Germ
p9391
sg5
S'PMC1736320'
p9392
sg7
g9388
sg9
V10201413.xml
p9393
sa(dp9394
g3
VSTD-COMTI-_x0028_T_x0029__x003a_-Europe
p9395
sg5
S'PMC2169755'
p9396
sg7
g9388
sg9
V9343116.xml
p9397
sa(dp9398
g3
VSTD-Lee-2007
p9399
sg5
S'PMC2206510'
p9400
sg7
VCD001000 v. 12.0 Corticosteroids for the prevention and treatment of post-extubation stridor in neonates children an.rm5
p9401
sg9
V17705879.xml
p9402
sa(dp9403
g3
VSTD-Levy-1983
p9404
sg5
S'PMC1028443'
p9405
sg7
VCD001015 v. 10.0 Lecithin for dementia and cognitive impairment.rm5
p9406
sg9
V3897460.xml
p9407
sa(dp9408
g3
VSTD-Ebbert-2009
p9409
sg5
S'PMC2784490'
p9410
sg7
VCD004306 v. 9.0 Interventions for smokeless tobacco use cessation.rm5
p9411
sg9
V19880578.xml
p9412
sa(dp9413
g3
VSTD-Walsh-1999
p9414
sg5
S'PMC1508522'
p9415
sg7
g9411
sg9
V9949754.xml
p9416
sa(dp9417
g3
VSTD-Fagerstrom-2010
p9418
sg5
S'PMC2997603'
p9419
sg7
g9411
sg9
V21134997.xml
p9420
sa(dp9421
g3
VSTD-Walsh-2010
p9422
sg5
S'PMC2902861'
p9423
sg7
g9411
sg9
V20439384.xml
p9424
sa(dp9425
g3
VSTD-Ebbert-2010a
p9426
sg5
S'PMC2850207'
p9427
sg7
g9411
sg9
V20060229.xml
p9428
sa(dp9429
g3
VSTD-Stevens-1995
p9430
sg5
S'PMC1615327'
p9431
sg7
g9411
sg9
V7856783.xml
p9432
sa(dp9433
g3
VSTD-Stotts-2003
p9434
sg5
S'PMC1766135'
p9435
sg7
g9411
sg9
V14645935.xml
p9436
sa(dp9437
g3
VSTD-Dale-2007
p9438
sg5
S'PMC1994655'
p9439
sg7
g9411
sg9
V17353101.xml
p9440
sa(dp9441
g3
VSTD-Davies-1977
p9442
sg5
S'PMC1544654'
p9443
sg7
VCD002971 v. 6.0 Formula milk versus donor breast milk for feeding preterm or low birth weight infants.rm5
p9444
sg9
V558739.xml
p9445
sa(dp9446
g3
VSTD-Lucas-1984b
p9447
sg5
S'PMC1628628'
p9448
sg7
g9444
sg9
V6476868.xml
p9449
sa(dp9450
g3
VSTD-Lucas-1984a
p9451
sg5
S'PMC1628628'
p9452
sg7
g9444
sg9
V6476868.xml
p9453
sa(dp9454
g3
VSTD-White-2007
p9455
sg5
S'PMC1831486'
p9456
sg7
VCD000009 v. 11.0 Acupuncture and related interventions for smoking cessation.rm5
p9457
sg9
V17359519.xml
p9458
sa(dp9459
g3
VSTD-Waite-1998
p9460
sg5
S'PMC1313196'
p9461
sg7
g9457
sg9
V10024707.xml
p9462
sa(dp9463
g3
VSTD-Bier-2002
p9464
sg5
S'PMC1447300'
p9465
sg7
g9457
sg9
V12356614.xml
p9466
sa(dp9467
g3
VSTD-Clavel-1985
p9468
sg5
S'PMC1418170'
p9469
sg7
g9457
sg9
V3933739.xml
p9470
sa(dp9471
g3
VSTD-Wickizer-2004
p9472
sg5
S'PMC1360996'
p9473
sg7
VCD006251 v. 7.0 Interventions to prevent injuries in construction workers.rm5
p9474
sg9
V14965079.xml
p9475
sa(dp9476
g3
VSTD-Scott-1968
p9477
sg5
S'PMC2019943'
p9478
sg7
VCD001532 v. 11.0 Interventions for primary vesicoureteric reflux.rm5
p9479
sg9
V5652710.xml
p9480
sa(dp9481
g3
VSTD-Muscle-Study-Group-2011
p9482
sg5
S'PMC3170432'
p9483
sg7
VCD003643 v. 10.0 Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.rm5
p9484
sg9
V21688301.xml
p9485
sa(dp9486
g3
VSTD-Geisser-2005a
p9487
sg5
S'PMC1360691'
p9488
sg7
VCD001929 v. 11.0 Massage for low-back pain.rm5
p9489
sg9
V16215330.xml
p9490
sa(dp9491
g3
VSTD-Preyde-2000
p9492
sg5
S'PMC1231369'
p9493
sg7
g9489
sg9
V10906914.xml
p9494
sa(dp9495
g3
VSTD-de-Wilde-1983
p9496
sg5
S'PMC1427657'
p9497
sg7
VCD006114 v. 6.0 Fluvoxamine versus other anti-depressive agents for depression.rm5
p9498
sg9
V6407503.xml
p9499
sa(dp9500
g3
VSTD-Itil-1983
p9501
sg5
S'PMC1427663'
p9502
sg7
g9498
sg9
V6407504.xml
p9503
sa(dp9504
g3
VSTD-Dick-1983
p9505
sg5
S'PMC1427654'
p9506
sg7
g9498
sg9
V6407502.xml
p9507
sa(dp9508
g3
VSTD-Bonham-1963
p9509
sg5
S'PMC1873904'
p9510
sg7
VCD001808 v. 9.0 Prophylactic oxytocin for the third stage of labour.rm5
p9511
sg9
V14066183.xml
p9512
sa(dp9513
g3
VSTD-Symon-1995
p9514
sg5
S'PMC1510964'
p9515
sg7
VCD003017 v. 5.2 Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) .rm5
p9516
sg9
V7717738.xml
p9517
sa(dp9518
g3
VSTD-Chiarelli-2002
p9519
sg5
S'PMC113274'
p9520
sg7
VCD007471 v. 3.0 Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in ante.rm5
p9521
sg9
V12028976.xml
p9522
sa(dp9523
g3
VSTD-Bolam-1998
p9524
sg5
S'PMC28481'
p9525
sg7
VCD001863 v. 8.0 Education for contraceptive use by women after childbirth.rm5
p9526
sg9
V9549449.xml
p9527
sa(dp9528
g3
VSTD-Barnet-2009
p9529
sg5
S'PMC2746510'
p9530
sg7
g9526
sg9
V19752472.xml
p9531
sa(dp9532
g3
VSTD-Luabeya-2007
p9533
sg5
S'PMC1891438'
p9534
sg7
VCD005978 v. 9.0 Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months.rm5
p9535
sg9
V17593956.xml
p9536
sa(dp9537
g3
VSTD-Bhandari-2002b
p9538
sg5
S'PMC115208'
p9539
sg7
g9535
sg9
V12052800.xml
p9540
sa(dp9541
g3
VSTD-Bhandari-2002a
p9542
sg5
S'PMC115208'
p9543
sg7
g9535
sg9
V12052800.xml
p9544
sa(dp9545
g3
VSTD-Stern-1997
p9546
sg5
S'PMC2127436'
p9547
sg7
VMR000006 v. 5.0 Publication bias in clinical trials due to statistical significance or direction of trial results.rm5
p9548
sg9
V9310565.xml
p9549
sa(dp9550
g3
VSTD-Bardy-1998
p9551
sg5
S'PMC1873669'
p9552
sg7
g9548
sg9
V9723823.xml
p9553
sa(dp9554
g3
VSTD-Mohide-1996
p9555
sg5
S'PMC2074537'
p9556
sg7
VCD008273 v. 3.0 Information interventions for orienting patients and their carers to cancer care facilities.rm5
p9557
sg9
V8664135.xml
p9558
sa(dp9559
g3
VSTD-Heller-1995
p9560
sg5
S'PMC1073267'
p9561
sg7
VCD001904 v. 9.4 Carbamazepine versus phenobarbitone monotherapy for epilepsy.rm5
p9562
sg9
V7823066.xml
p9563
sa(dp9564
g3
VSTD-Desai-1998
p9565
sg5
S'PMC2170369'
p9566
sg7
VCD004583 v. 3.0 Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage.rm5
p9567
sg9
V9810966.xml
p9568
sa(dp9569
g3
VSTD-Poustie-2006
p9570
sg5
S'PMC1403226'
p9571
sg7
VCD000406 v. 16.0 Oral calorie supplements for cystic fibrosis.rm5
p9572
sg9
V16467348.xml
p9573
sa(dp9574
g3
VSTD-Smith-1989
p9575
sg5
S'PMC172506'
p9576
sg7
VCD001364 v. 16.0 Zinc for the common cold.rm5
p9577
sg9
V2665639.xml
p9578
sa(dp9579
g3
VSTD-Farr-1987a
p9580
sg5
S'PMC174900'
p9581
sg7
g9577
sg9
V2820298.xml
p9582
sa(dp9583
g3
VSTD-Douglas-1987
p9584
sg5
S'PMC174915'
p9585
sg7
g9577
sg9
V3307620.xml
p9586
sa(dp9587
g3
VSTD-Christiansen-1973a
p9588
sg5
S'PMC1587877'
p9589
sg7
VCD004304 v. 5.1 Vitamins for epilepsy.rm5
p9590
sg9
V4776883.xml
p9591
sa(dp9592
g3
VSTD-Grant-1970
p9593
sg5
S'PMC1820248'
p9594
sg7
g9590
sg9
V4922754.xml
p9595
sa(dp9596
g3
VSTD-van-der-Ende-1988
p9597
sg5
S'PMC1834851'
p9598
sg7
VCD003255 v. 10.0 Condom effectiveness in reducing heterosexual HIV transmission.rm5
p9599
sg9
V3143442.xml
p9600
sa(dp9601
g3
VSTD-Allen-1992
p9602
sg5
S'PMC1881972'
p9603
sg7
g9599
sg9
V1628088.xml
p9604
sa(dp9605
g3
VSTD-Hemsell-1993
p9606
sg5
S'PMC2364680'
p9607
sg7
VCD005987 v. 5.0 Scalpel versus electrosurgery for abdominal incisions.rm5
p9608
sg9
V18476202.xml
p9609
sa(dp9610
g3
VSTD-Woodland-1981
p9611
sg5
S'PMC1000728'
p9612
sg7
VCD001461 v. 6.0 Azathioprine for treating rheumatoid arthritis.rm5
p9613
sg9
V7020612.xml
p9614
sa(dp9615
g3
VSTD-Parving-1989
p9616
sg5
S'PMC1837371'
p9617
sg7
VCD006257 v. 7.0 Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the .rm5
p9618
sg9
V2507061.xml
p9619
sa(dp9620
g3
VSTD-DIABHYCAR-2004
p9621
sg5
S'PMC351842'
p9622
sg7
g9618
sg9
V14960504.xml
p9623
sa(dp9624
g3
VSTD-Marre-1987
p9625
sg5
S'PMC1246608'
p9626
sg7
g9618
sg9
V3038254.xml
p9627
sa(dp9628
g3
VSTD-Guyer-1989
p9629
sg5
S'PMC1349806'
p9630
sg7
VCD004335 v. 11.0 Community-based interventions for the prevention of burns and scalds in children.rm5
p9631
sg9
V2817165.xml
p9632
sa(dp9633
g3
VSTD-MacKay-1982
p9634
sg5
S'PMC1649800'
p9635
sg7
g9631
sg9
V7058964.xml
p9636
sa(dp9637
g3
VSTD-Hawkey-2001
p9638
sg5
S'PMC1728427'
p9639
sg7
VCD006640 v. 4.12 Tranexamic acid for upper gastrointestinal bleeding.rm5
p9640
sg9
V11511559.xml
p9641
sa(dp9642
g3
VSTD-Biggs-1976
p9643
sg5
S'PMC1411285'
p9644
sg7
g9640
sg9
V789186.xml
p9645
sa(dp9646
g3
VSTD-Holstein-1987
p9647
sg5
S'PMC1245035'
p9648
sg7
g9640
sg9
V3101804.xml
p9649
sa(dp9650
g3
VSTD-Seymour-2002
p9651
sg5
S'PMC1422600'
p9652
sg7
VCD006575 v. 2.0 Virtual reality training for surgical trainees in laparoscopic surgery.rm5
p9653
sg9
V12368674.xml
p9654
sa(dp9655
g3
VSTD-Leykin-2008
p9656
sg5
S'PMC2615351'
p9657
sg7
VCD007126 v. 5.0 Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain.rm5
p9658
sg9
V18581586.xml
p9659
sa(dp9660
g3
VSTD-Williams-1969
p9661
sg5
S'PMC1984002'
p9662
sg7
VCD000490 v. 6.2 Antibiotics for asymptomatic bacteriuria in pregnancy.rm5
p9663
sg9
V5792611.xml
p9664
sa(dp9665
g3
VSTD-Solomon-1991
p9666
sg5
S'PMC1671261'
p9667
sg7
VCD005508 v. 3.0 Beta blockers for peripheral arterial disease.rm5
p9668
sg9
V1747577.xml
p9669
sa(dp9670
g3
VSTD-Lepantalo-1984a
p9671
sg5
S'PMC1463567'
p9672
sg7
g9668
sg9
V6378235.xml
p9673
sa(dp9674
g3
VSTD-Henry-1983
p9675
sg5
S'PMC1628387'
p9676
sg7
VCD001266 v. 7.0 Bronchodilators for bronchiolitis.rm5
p9677
sg9
V6228197.xml
p9678
sa(dp9679
g3
VSTD-Totapally-2002
p9680
sg5
S'PMC111183'
p9681
sg7
g9677
sg9
V11983043.xml
p9682
sa(dp9683
g3
VSTD-Wang-1992
p9684
sg5
S'PMC1793648'
p9685
sg7
g9677
sg9
V1533504.xml
p9686
sa(dp9687
g3
VSTD-Ho-1991
p9688
sg5
S'PMC1793026'
p9689
sg7
g9677
sg9
V1929514.xml
p9690
sa(dp9691
g3
VSTD-Watkins-1997
p9692
sg5
S'PMC163662'
p9693
sg7
VCD004406 v. 8.4 Different antibiotic treatments for group A streptococcal pharyngitis.rm5
p9694
sg9
V8980757.xml
p9695
sa(dp9696
g3
VSTD-Djulbegovic-2008
p9697
sg5
S'PMC2773511'
p9698
sg7
VMR000024 v. 5.0 New treatments compared to established treatments in randomized trials.rm5
p9699
sg9
V18362256.xml
p9700
sa(dp9701
g3
VSTD-Dent-2011
p9702
sg5
S'PMC3113983'
p9703
sg7
g9699
sg9
V21542934.xml
p9704
sa(dp9705
g3
VSTD-Smith-2003
p9706
sg5
S'PMC2741110'
p9707
sg7
VCD006704 v. 7.2 Drug therapy for the management of cancer-related fatigue.rm5
p9708
sg9
V12799626.xml
p9709
sa(dp9710
g3
VSTD-Boogaerts-2003
p9711
sg5
S'PMC2376376'
p9712
sg7
g9708
sg9
V12671693.xml
p9713
sa(dp9714
g3
VSTD-Thatcher-1999
p9715
sg5
S'PMC2362337'
p9716
sg7
g9708
sg9
V10408844.xml
p9717
sa(dp9718
g3
VSTD-Wilkinson-2006
p9719
sg5
S'PMC2361228'
p9720
sg7
g9708
sg9
V16570051.xml
p9721
sa(dp9722
g3
VSTD-Levy-1998
p9723
sg5
S'PMC1307738'
p9724
sg7
VCD002843 v. 5.0 Strategies for partner notification for sexually transmitted diseases.rm5
p9725
sg9
V9722821.xml
p9726
sa(dp9727
g3
VSTD-Andersen-et-al_x002c_-1998
p9728
sg5
S'PMC2665537'
p9729
sg7
g9725
sg9
V9487169.xml
p9730
sa(dp9731
g3
VSTD-Montesinos_x002c_-1990
p9732
sg5
S'PMC1286239'
p9733
sg7
g9725
sg9
V2249964.xml
p9734
sa(dp9735
g3
VSTD-Jones-1969
p9736
sg5
S'PMC1984038'
p9737
sg7
VCD009351 v. 2.0 Inhaled analgesia for pain management in labour.rm5
p9738
sg9
V4895338.xml
p9739
sa(dp9740
g3
VSTD-Garrod-2000
p9741
sg5
S'PMC1745814'
p9742
sg7
VCD005372 v. 5.0 Oxygen therapy during exercise training in chronic obstructive pulmonary disease.rm5
p9743
sg9
V10856310.xml
p9744
sa(dp9745
g3
VSTD-Howe-1983
p9746
sg5
S'PMC1973006'
p9747
sg7
VCD001878 v. 6.0 Non-invasive physical treatments for chronicrecurrent headache.rm5
p9748
sg9
V6355460.xml
p9749
sa(dp9750
g3
VSTD-Tsang-2005
p9751
sg5
S'PMC1747352'
p9752
sg7
VCD000996 v. 6.0 Inhaled steroids for bronchiectasis.rm5
p9753
sg9
V15741443.xml
p9754
sa(dp9755
g3
VSTD-Wright-2011
p9756
sg5
S'PMC3223774'
p9757
sg7
VCD003409 v. 19.0 Methadone at tapered doses for the management of opioid withdrawal.rm5
p9758
sg9
V22137413.xml
p9759
sa(dp9760
g3
VSTD-Madlung_x002d_Kratzer-2009
p9761
sg5
S'PMC2773536'
p9762
sg7
g9758
sg9
V19686525.xml
p9763
sa(dp9764
g3
VSTD-Scotland-1990
p9765
sg5
S'PMC1663720'
p9766
sg7
VCD002863 v. 7.0 Oral beta-blockers for mild to moderate hypertension during pregnancy.rm5
p9767
sg9
V2242456.xml
p9768
sa(dp9769
g3
VSTD-England-1983
p9770
sg5
S'PMC1548251'
p9771
sg7
g9767
sg9
V6407638.xml
p9772
sa(dp9773
g3
VSTD-Probert-2003
p9774
sg5
S'PMC1773722'
p9775
sg7
VCD005112 v. 5.0 Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.rm5
p9776
sg9
V12801957.xml
p9777
sa(dp9778
g3
VSTD-Hayward-2006
p9779
sg5
S'PMC1702427'
p9780
sg7
VCD005187 v. 7.0 Influenza vaccination for healthcare workers who work with the elderly.rm5
p9781
sg9
V17142257.xml
p9782
sa(dp9783
g3
VSTD-Bramwell-2006c
p9784
sg5
S'PMC1526944'
p9785
sg7
VCD006776 v. 6.0 Using alternative statistical formats for presenting risks and risk reductions.rm5
p9786
sg9
V16840441.xml
p9787
sa(dp9788
g3
VSTD-Bucher-1994
p9789
sg5
S'PMC2541000'
p9790
sg7
g9786
sg9
V7950558.xml
p9791
sa(dp9792
g3
VSTD-Misselbrook-2001
p9793
sg5
S'PMC1313976'
p9794
sg7
g9786
sg9
V11458479.xml
p9795
sa(dp9796
g3
VSTD-Adily-2004
p9797
sg5
S'PMC1732789'
p9798
sg7
g9786
sg9
V15143111.xml
p9799
sa(dp9800
g3
VSTD-Sheridan-2003
p9801
sg5
S'PMC1494938'
p9802
sg7
g9786
sg9
V14687273.xml
p9803
sa(dp9804
g3
VSTD-Carling-2009
p9805
sg5
S'PMC2724738'
p9806
sg7
g9786
sg9
V19707575.xml
p9807
sa(dp9808
g3
VSTD-Carling-2008
p9809
sg5
S'PMC2585274'
p9810
sg7
g9786
sg9
V19030110.xml
p9811
sa(dp9812
g3
VSTD-Nikolajevic_x002d_S-1999
p9813
sg5
S'PMC1496748'
p9814
sg7
g9786
sg9
V10571703.xml
p9815
sa(dp9816
g3
VSTD-Fahey-1995
p9817
sg5
S'PMC2551363'
p9818
sg7
g9786
sg9
V7580661.xml
p9819
sa(dp9820
g3
VSTD-Bramwell-2006d
p9821
sg5
S'PMC1526944'
p9822
sg7
g9786
sg9
V16840441.xml
p9823
sa(dp9824
g3
VSTD-Bramwell-2006b
p9825
sg5
S'PMC1526944'
p9826
sg7
g9786
sg9
V16840441.xml
p9827
sa(dp9828
g3
VSTD-Bramwell-2006a
p9829
sg5
S'PMC1526944'
p9830
sg7
g9786
sg9
V16840441.xml
p9831
sa(dp9832
g3
VSTD-Cranney-1996
p9833
sg5
S'PMC1239820'
p9834
sg7
g9786
sg9
V8978112.xml
p9835
sa(dp9836
g3
VSTD-O_x0027_Connor-2007
p9837
sg5
S'PMC1781394'
p9838
sg7
VCD004228 v. 4.0 Psychological andor educational interventions for reducing alcohol consumption in pregnant women an.rm5
p9839
sg9
V17194863.xml
p9840
sa(dp9841
g3
VSTD-Sharafi-2010
p9842
sg5
S'PMC3446002'
p9843
sg7
VCD009017 v. 2.0 Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.rm5
p9844
sg9
V23056681.xml
p9845
sa(dp9846
g3
VSTD-Lorente-2006
p9847
sg5
S'PMC1750976'
p9848
sg7
VCD004711 v. 6.0 Heated humidification versus heat and moisture exchangers for ventilated adults and children.rm5
p9849
sg9
V16884530.xml
p9850
sa(dp9851
g3
VSTD-NSABP-B_x002d_24-Trial-2011
p9852
sg5
S'PMC3107729'
p9853
sg7
VCD007847 v. 2.0 Postoperative tamoxifen for ductal carcinoma in situ.rm5
p9854
sg9
V21398619.xml
p9855
sa(dp9856
g3
VSTD-UK-ANZ-Trial-2011
p9857
sg5
S'PMC3018565'
p9858
sg7
g9854
sg9
V21145284.xml
p9859
sa(dp9860
g3
VSTD-Attar-1999
p9861
sg5
S'PMC1727381'
p9862
sg7
VCD007570 v. 4.0 Lactulose versus Polyethylene Glycol for Chronic Constipation.rm5
p9863
sg9
V9895382.xml
p9864
sa(dp9865
g3
VSTD-Voskuijl-2004
p9866
sg5
S'PMC1774276'
p9867
sg7
g9863
sg9
V15479678.xml
p9868
sa(dp9869
g3
VSTD-Robinson-1997
p9870
sg5
S'PMC1758438'
p9871
sg7
VCD001506 v. 10.0 Nebulised hypertonic saline for cystic fibrosis.rm5
p9872
sg9
V9404379.xml
p9873
sa(dp9874
g3
VSTD-Weller-1980
p9875
sg5
S'PMC471218'
p9876
sg7
g9872
sg9
V6767295.xml
p9877
sa(dp9878
g3
VSTD-Ray-2001
p9879
sg5
S'PMC3455875'
p9880
sg7
VCD005272 v. 4.0 Behavioral interventions to reduce the transmission of HIV infection among sex workers and their cli.rm5
p9881
sg9
V11796805.xml
p9882
sa(dp9883
g3
VSTD-Basu-2004
p9884
sg5
S'PMC2826108'
p9885
sg7
g9881
sg9
V15213569.xml
p9886
sa(dp9887
g3
VSTD-Li-2006
p9888
sg5
S'PMC1933388'
p9889
sg7
g9881
sg9
V17067252.xml
p9890
sa(dp9891
g3
VSTD-Hoke-2007
p9892
sg5
S'PMC2598714'
p9893
sg7
g9881
sg9
V17591662.xml
p9894
sa(dp9895
g3
VSTD-Chiao-2009
p9896
sg5
S'PMC3103188'
p9897
sg7
g9881
sg9
V18543095.xml
p9898
sa(dp9899
g3
VSTD-Feldblum-2005
p9900
sg5
S'PMC1764680'
p9901
sg7
g9881
sg9
V15800098.xml
p9902
sa(dp9903
g3
VSTD-Swendeman-2009
p9904
sg5
S'PMC2824563'
p9905
sg7
g9881
sg9
V19716639.xml
p9906
sa(dp9907
g3
VSTD-Patterson-2008
p9908
sg5
S'PMC2633868'
p9909
sg7
g9881
sg9
V18799768.xml
p9910
sa(dp9911
g3
VSTD-Hayes-1976
p9912
sg5
S'PMC483116'
p9913
sg7
VCD003836 v. 6.0 Bed rest for acute uncomplicated myocardial infarction.rm5
p9914
sg9
V971383.xml
p9915
sa(dp9916
g3
VSTD-West-1979
p9917
sg5
S'PMC482171'
p9918
sg7
g9914
sg9
V389259.xml
p9919
sa(dp9920
g3
VSTD-Banaszewska-2009
p9921
sg5
S'PMC2795658'
p9922
sg7
VCD008565 v. 3.2 Statins for women with polycystic ovary syndrome not actively trying to conceive.rm5
p9923
sg9
V19890022.xml
p9924
sa(dp9925
g3
VSTD-Ogata-2006
p9926
sg5
S'PMC1860021'
p9927
sg7
VCD007216 v. 1.0 Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis.rm5
p9928
sg9
V16484504.xml
p9929
sa(dp9930
g3
VSTD-Park-1998
p9931
sg5
S'PMC3619600'
p9932
sg7
VCD000093 v. 9.0 Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsula.rm5
p9933
sg9
V9728307.xml
p9934
sa(dp9935
g3
VSTD-Stringer-2007
p9936
sg5
S'PMC2730754'
p9937
sg7
VCD007043 v. 4.0 Copper containing intra-uterine devices versus depot progestogens for contraception.rm5
p9938
sg9
V17689627.xml
p9939
sa(dp9940
g3
VSTD-Perry-1999
p9941
sg5
S'PMC27688'
p9942
sg7
VCD004854 v. 6.0 Interventions for helping people recognise early signs of recurrence in bipolar disorder.rm5
p9943
sg9
V9888904.xml
p9944
sa(dp9945
g3
VSTD-Chadha-1983
p9946
sg5
S'PMC1428071'
p9947
sg7
VCD007187 v. 3.0 Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.rm5
p9948
sg9
V6357258.xml
p9949
sa(dp9950
g3
VSTD-Weinberger-1982
p9951
sg5
S'PMC1427520'
p9952
sg7
g9948
sg9
V6753893.xml
p9953
sa(dp9954
g3
VSTD-Kayanakis-1987
p9955
sg5
S'PMC1386051'
p9956
sg7
g9948
sg9
V3555588.xml
p9957
sa(dp9958
g3
VSTD-Wolf-2000
p9959
sg5
S'PMC1495322'
p9960
sg7
VCD001431 v. 9.0 Decision aids for people facing health treatment or screening decisions.rm5
p9961
sg9
V10632830.xml
p9962
sa(dp9963
g3
VSTD-McBride-2002
p9964
sg5
S'PMC1447199'
p9965
sg7
g9961
sg9
V12084693.xml
p9966
sa(dp9967
g3
VSTD-Krist-2007
p9968
sg5
S'PMC1838687'
p9969
sg7
g9961
sg9
V17389534.xml
p9970
sa(dp9971
g3
VSTD-Frosch-2003
p9972
sg5
S'PMC1494924'
p9973
sg7
g9961
sg9
V14521639.xml
p9974
sa(dp9975
g3
VSTD-Vodermaier-2009
p9976
sg5
S'PMC2653746'
p9977
sg7
g9961
sg9
V19209172.xml
p9978
sa(dp9979
g3
VSTD-McAlister-2005
p9980
sg5
S'PMC1188186'
p9981
sg7
g9961
sg9
V16129870.xml
p9982
sa(dp9983
g3
VSTD-Sheridan-2006
p9984
sg5
S'PMC1626460'
p9985
sg7
g9961
sg9
V17005051.xml
p9986
sa(dp9987
g3
VSTD-Montgomery-2003
p9988
sg5
S'PMC1314618'
p9989
sg7
g9961
sg9
V12939889.xml
p9990
sa(dp9991
g3
VSTD-Montgomery-2007
p9992
sg5
S'PMC1895676'
p9993
sg7
g9961
sg9
V17540908.xml
p9994
sa(dp9995
g3
VSTD-Green-2004
p9996
sg5
S'PMC1237120'
p9997
sg7
g9961
sg9
V15280342.xml
p9998
sa(dp9999
g3
VSTD-Volk-2008
p10000
sg5
S'PMC2867348'
p10001
sg7
g9961
sg9
V18760888.xml
p10002
sa(dp10003
g3
VSTD-Murray-2001b
p10004
sg5
S'PMC48137'
p10005
sg7
g9961
sg9
V11532844.xml
p10006
sa(dp10007
g3
VSTD-Murray-2001a
p10008
sg5
S'PMC48138'
p10009
sg7
g9961
sg9
V11532845.xml
p10010
sa(dp10011
g3
VSTD-Dodin-2001
p10012
sg5
S'PMC2018543'
p10013
sg7
g9961
sg9
V11561335.xml
p10014
sa(dp10015
g3
VSTD-Schwartz-2009
p10016
sg5
S'PMC3580845'
p10017
sg7
g9961
sg9
V19210013.xml
p10018
sa(dp10019
g3
VSTD-Morgan-2000
p10020
sg5
S'PMC1495608'
p10021
sg7
g9961
sg9
V11089711.xml
p10022
sa(dp10023
g3
VSTD-Myers-2005a
p10024
sg5
S'PMC2576013'
p10025
sg7
g9961
sg9
V16173330.xml
p10026
sa(dp10027
g3
VSTD-Thomson-2007
p10028
sg5
S'PMC1781432'
p10029
sg7
g9961
sg9
V17214891.xml
p10030
sa(dp10031
g3
VSTD-Kendrick-2001
p10032
sg5
S'PMC1763305'
p10033
sg7
VMR000013 v. 10.0 Strategies to improve recruitment to randomised controlled trials.rm5
p10034
sg9
V11604444.xml
p10035
sa(dp10036
g3
VSTD-Bentley-2004
p10037
sg5
S'PMC1733848'
p10038
sg7
g10034
sg9
V15173366.xml
p10039
sa(dp10040
g3
VSTD-Simes-1986
p10041
sg5
S'PMC1341916'
p10042
sg7
g10034
sg9
V3094776.xml
p10043
sa(dp10044
g3
VSTD-Welton-1999
p10045
sg5
S'PMC27847'
p10046
sg7
g10034
sg9
V10213724.xml
p10047
sa(dp10048
g3
VSTD-Weinfurt-2008b
p10049
sg5
S'PMC2908285'
p10050
sg7
g10034
sg9
V18946893.xml
p10051
sa(dp10052
g3
VSTD-Weinfurt-2008a
p10053
sg5
S'PMC2517900'
p10054
sg7
g10034
sg9
V18386101.xml
p10055
sa(dp10056
g3
VSTD-Trevena-2006
p10057
sg5
S'PMC2563378'
p10058
sg7
g10034
sg9
V16877628.xml
p10059
sa(dp10060
g3
VSTD-Jeste-2009
p10061
sg5
S'PMC2696362'
p10062
sg7
g10034
sg9
V18245061.xml
p10063
sa(dp10064
g3
VSTD-Hutchison-2007
p10065
sg5
S'PMC2360384'
p10066
sg7
g10034
sg9
V17848908.xml
p10067
sa(dp10068
g3
VSTD-Slichter-2010
p10069
sg5
S'PMC2951321'
p10070
sg7
VCD004269 v. 10.6 Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorde.rm5
p10071
sg9
V20164484.xml
p10072
sa(dp10073
g3
VSTD-RESOLVE
p10074
sg5
S'PMC2963502'
p10075
sg7
VCD007419 v. 4.0 Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular .rm5
p10076
sg9
V20980427.xml
p10077
sa(dp10078
g3
VSTD-Lundgren-1989
p10079
sg5
S'PMC1493950'
p10080
sg7
VCD000990 v. 8.6 Exercise for intermittent claudication.rm5
p10081
sg9
V2647051.xml
p10082
sa(dp10083
g3
VSTD-Greenfield-1975b
p10084
sg5
S'PMC1129908'
p10085
sg7
VCD000349 v. 4.2 Guidelines in professions allied to medicine.rm5
p10086
sg9
V128907.xml
p10087
sa(dp10088
g3
VSTD-Dixon-1992
p10089
sg5
S'PMC1977824'
p10090
sg7
VCD002747 v. 11.0 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.rm5
p10091
sg9
V1503915.xml
p10092
sa(dp10093
g3
VSTD-Zeloni-2002
p10094
sg5
S'PMC1737996'
p10095
sg7
VCD003586 v. 5.0 Cognitive rehabilitation for spatial neglect following stroke.rm5
p10096
sg9
V12122183.xml
p10097
sa(dp10098
g3
VSTD-Caldwell-1979
p10099
sg5
S'PMC1397199'
p10100
sg7
VCD002045 v. 9.1 Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients.rm5
p10101
sg9
V36048.xml
p10102
sa(dp10103
g3
VSTD-Cole-2002
p10104
sg5
S'PMC126506'
p10105
sg7
VCD006632 v. 5.0 Clinical pathways effects on professional practice patient outcomes length of stay and hospital c.rm5
p10106
sg9
V12389836.xml
p10107
sa(dp10108
g3
VSTD-Brattebo-2002
p10109
sg5
S'PMC1123333'
p10110
sg7
g10106
sg9
V12052813.xml
p10111
sa(dp10112
g3
VSTD-Brookfield-2009
p10113
sg5
S'PMC2612742'
p10114
sg7
VCD007945 v. 3.0 Centralisation of services for gynaecological cancer.rm5
p10115
sg9
V19125205.xml
p10116
sa(dp10117
g3
VSTD-Stockton-2000
p10118
sg5
S'PMC2363169'
p10119
sg7
g10115
sg9
V10638991.xml
p10120
sa(dp10121
g3
VSTD-Carling-2010
p10122
sg5
S'PMC2830888'
p10123
sg7
VCD006777 v. 3.0 Framing of health information messages.rm5
p10124
sg9
V20209127.xml
p10125
sa(dp10126
g3
VSTD-Mann-2004
p10127
sg5
S'PMC2575807'
p10128
sg7
g10124
sg9
V15099176.xml
p10129
sa(dp10130
g3
VSTD-Lerman-1992
p10131
sg5
S'PMC1694134'
p10132
sg7
g10124
sg9
V1566953.xml
p10133
sa(dp10134
g3
VSTD-Lewis-2003
p10135
sg5
S'PMC1494949'
p10136
sg7
g10124
sg9
V14687272.xml
p10137
sa(dp10138
g3
VSTD-Schlickau-2005a
p10139
sg5
S'PMC1595264'
p10140
sg7
VCD006425 v. 5.3 Antenatal breastfeeding education for increasing breastfeeding duration.rm5
p10141
sg9
V17273450.xml
p10142
sa(dp10143
g3
VSTD-MacArthur-2009
p10144
sg5
S'PMC2636685'
p10145
sg7
g10141
sg9
V19181730.xml
p10146
sa(dp10147
g3
VSTD-Efstathopoulos-2007
p10148
sg5
S'PMC2267541'
p10149
sg7
VCD004961 v. 5.0 Intramedullary nails for extracapsular hip fractures in adults.rm5
p10150
sg9
V16736148.xml
p10151
sa(dp10152
g3
VSTD-Herrera-2002
p10153
sg5
S'PMC3620972'
p10154
sg7
g10150
sg9
V12466870.xml
p10155
sa(dp10156
g3
VSTD-Foley_x002d_Nolan-1997
p10157
sg5
S'PMC1721990'
p10158
sg7
VCD006460 v. 6.0 Conventional occlusion versus pharmacologic penalization for amblyopia.rm5
p10159
sg9
V9135409.xml
p10160
sa(dp10161
g3
VSTD-PEDIG-2002
p10162
sg5
S'PMC2614923'
p10163
sg7
g10159
sg9
V17502505.xml
p10164
sa(dp10165
g3
VSTD-Watt-1985-_x0028_LL_x0029_
p10166
sg5
S'PMC1418187'
p10167
sg7
VCD004937 v. 6.12 Effect of longer-term modest salt reduction on blood pressure.rm5
p10168
sg9
V3933736.xml
p10169
sa(dp10170
g3
VSTD-Erwteman-1984
p10171
sg5
S'PMC1442440'
p10172
sg7
g10168
sg9
V6432119.xml
p10173
sa(dp10174
g3
VSTD-Watt-1985-_x0028_HH_x0029_
p10175
sg5
S'PMC1418187'
p10176
sg7
g10168
sg9
V3933736.xml
p10177
sa(dp10178
g3
VSTD-Schaad-2000
p10179
sg5
S'PMC89839'
p10180
sg7
VCD001753 v. 11.0 Vaccines for preventing influenza in people with cystic fibrosis.rm5
p10181
sg9
V10770746.xml
p10182
sa(dp10183
g3
VSTD-Girgis-1999-EGY
p10184
sg5
S'PMC89293'
p10185
sg7
VCD004530 v. 8.0 Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).rm5
p10186
sg9
V10348767.xml
p10187
sa(dp10188
g3
VSTD-Vinh-1996-VNM
p10189
sg5
S'PMC163238'
p10190
sg7
g10186
sg9
V8849259.xml
p10191
sa(dp10192
g3
VSTD-Gasem-2003-IDN
p10193
sg5
S'PMC153327'
p10194
sg7
g10186
sg9
V12709347.xml
p10195
sa(dp10196
g3
VSTD-Arjyal-2011
p10197
sg5
S'PMC3108101'
p10198
sg7
g10186
sg9
V21531174.xml
p10199
sa(dp10200
g3
VSTD-Unal-1996-TUR
p10201
sg5
S'PMC163645'
p10202
sg7
g10186
sg9
V9124864.xml
p10203
sa(dp10204
g3
VSTD-Parry-2007-VNM
p10205
sg5
S'PMC1803150'
p10206
sg7
g10186
sg9
V17145784.xml
p10207
sa(dp10208
g3
VSTD-Pandit-2007-NPL
p10209
sg5
S'PMC1891439'
p10210
sg7
g10186
sg9
V17593957.xml
p10211
sa(dp10212
g3
VSTD-Chinh-2000-VNM
p10213
sg5
S'PMC89974'
p10214
sg7
g10186
sg9
V10858343.xml
p10215
sa(dp10216
g3
VSTD-Dolecek-2008-VNM
p10217
sg5
S'PMC2374894'
p10218
sg7
g10186
sg9
V18493312.xml
p10219
sa(dp10220
g3
VSTD-Smith-1994-VNM
p10221
sg5
S'PMC284627'
p10222
sg7
g10186
sg9
V7986000.xml
p10223
sa(dp10224
g3
VSTD-Nasrallah-2010
p10225
sg5
S'PMC3055301'
p10226
sg7
VCD008296 v. 3.2 Paliperidone palmitate for schizophrenia.rm5
p10227
sg9
V20555312.xml
p10228
sa(dp10229
g3
VSTD-McLeod-2001
p10230
sg5
S'PMC1421263'
p10231
sg7
VCD009447 v. 2.0 Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in p.rm5
p10232
sg9
V11224634.xml
p10233
sa(dp10234
g3
VSTD-Goodall-1981
p10235
sg5
S'PMC471453'
p10236
sg7
VCD001496 v. 4.0 Gastro-oesophageal reflux treatment for asthma in adults and children.rm5
p10237
sg9
V7022737.xml
p10238
sa(dp10239
g3
VSTD-Ford-1994
p10240
sg5
S'PMC2397596'
p10241
sg7
g10237
sg9
V8016006.xml
p10242
sa(dp10243
g3
VSTD-McVey-2000
p10244
sg5
S'PMC1748378'
p10245
sg7
VCD004704 v. 8.0 Mass media interventions for smoking cessation in adults.rm5
p10246
sg9
V10982571.xml
p10247
sa(dp10248
g3
VSTD-Jenkins-1997
p10249
sg5
S'PMC1380945'
p10250
sg7
g10246
sg9
V9224191.xml
p10251
sa(dp10252
g3
VSTD-Lima-2010
p10253
sg5
S'PMC2830290'
p10254
sg7
VCD008524 v. 4.0 Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 year.rm5
p10255
sg9
V20038852.xml
p10256
sa(dp10257
g3
VSTD-Daulaire-1992
p10258
sg5
S'PMC1881470'
p10259
sg7
g10255
sg9
V1739794.xml
p10260
sa(dp10261
g3
VSTD-Rahman-2001
p10262
sg5
S'PMC37318'
p10263
sg7
g10255
sg9
V11498488.xml
p10264
sa(dp10265
g3
VSTD-Pant-1996
p10266
sg5
S'PMC2486860'
p10267
sg7
g10255
sg9
V9002334.xml
p10268
sa(dp10269
g3
VSTD-Chang-1987
p10270
sg5
S'PMC1493315'
p10271
sg7
VCD007823 v. 3.0 Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable.rm5
p10272
sg9
V2961314.xml
p10273
sa(dp10274
g3
VSTD-Thunander-2010
p10275
sg5
S'PMC3022338'
p10276
sg7
VCD006165 v. 5.0 Interventions for latent autoimmune diabetes (LADA) in adults.rm5
p10277
sg9
V21088056.xml
p10278
sa(dp10279
g3
VSTD-Roze-1993
p10280
sg5
S'PMC1029401'
p10281
sg7
VCD001242 v. 4.0 Dopamine versus dobutamine for hypotensive preterm infants.rm5
p10282
sg9
V8346957.xml
p10283
sa(dp10284
g3
VSTD-Manche-2011
p10285
sg5
S'PMC3259671'
p10286
sg7
VCD005135 v. 5.2 Laser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopia.rm5
p10287
sg9
V22253488.xml
p10288
sa(dp10289
g3
VSTD-Hatch-2011
p10290
sg5
S'PMC3090298'
p10291
sg7
g10287
sg9
V21573091.xml
p10292
sa(dp10293
g3
VSTD-Minnis-2001
p10294
sg5
S'PMC1718714'
p10295
sg7
VCD003760 v. 8.3 Behavioural and cognitive behavioural training interventions for assisting foster carers in the mana.rm5
p10296
sg9
V11259226.xml
p10297
sa(dp10298
g3
VSTD-Eddleston-2009
p10299
sg5
S'PMC2696321'
p10300
sg7
VCD005085 v. 4.0 Oximes for acute organophosphate pesticide poisoning.rm5
p10301
sg9
V19564902.xml
p10302
sa(dp10303
g3
VSTD-Woodcock-1984
p10304
sg5
S'PMC1444358'
p10305
sg7
VCD003833 v. 10.0 Omega-3 fatty acids for intermittent claudication.rm5
p10306
sg9
V6320945.xml
p10307
sa(dp10308
g3
VSTD-Gold-1990
p10309
sg5
S'PMC1358036'
p10310
sg7
VCD000991 v. 5.0 Intravenous fluids for abdominal aortic surgery.rm5
p10311
sg9
V1690974.xml
p10312
sa(dp10313
g3
VSTD-Ghosh-1994
p10314
sg5
S'PMC1375266'
p10315
sg7
VCD003043 v. 5.0 Ursodeoxycholic acid andor antibiotics for prevention of biliary stent occlusion.rm5
p10316
sg9
V7829015.xml
p10317
sa(dp10318
g3
VSTD-Cupples-1994
p10319
sg5
S'PMC2541257'
p10320
sg7
VCD008895 v. 2.2 Patient education in the management of coronary heart disease.rm5
p10321
sg9
V7950723.xml
p10322
sa(dp10323
g3
VSTD-Clark-2009
p10324
sg5
S'PMC3331992'
p10325
sg7
g10321
sg9
V18084052.xml
p10326
sa(dp10327
g3
VSTD-Muniyappa-2008
p10328
sg5
S'PMC2969165'
p10329
sg7
VCD008893 v. 3.1 Effect of cocoa on blood pressure.rm5
p10330
sg9
V19064532.xml
p10331
sa(dp10332
g3
VSTD-Ried-2009
p10333
sg5
S'PMC2712451'
p10334
sg7
g10330
sg9
V19583878.xml
p10335
sa(dp10336
g3
VSTD-Fraga-2005
p10337
sg5
S'PMC2270716'
p10338
sg7
g10330
sg9
V15712594.xml
p10339
sa(dp10340
g3
VSTD-Friedlaender-2001
p10341
sg5
S'PMC1425155'
p10342
sg7
VCD006950 v. 3.0 Bone morphogenetic protein (BMP) for fracture healing in adults.rm5
p10343
sg9
V11314793.xml
p10344
sa(dp10345
g3
VSTD-Hutchings-2007a
p10346
sg5
S'PMC1839187'
p10347
sg7
VCD008225 v. 2.6 Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct probl.rm5
p10348
sg9
V17350966.xml
p10349
sa(dp10350
g3
VSTD-Scott-2001a
p10351
sg5
S'PMC35270'
p10352
sg7
g10348
sg9
V11473908.xml
p10353
sa(dp10354
g3
VSTD-Telner-2010
p10355
sg5
S'PMC2939136'
p10356
sg7
VCD006411 v. 7.2 Educational games for health professionals.rm5
p10357
sg9
V20841574.xml
p10358
sa(dp10359
g3
VSTD-GESICA-2005-_x0028_DIAL_x0029_
p10360
sg5
S'PMC1188105'
p10361
sg7
VCD007228 v. 4.0 Structured telephone support or telemonitoring programmes for patients with chronic heart failure.rm5
p10362
sg9
V16061499.xml
p10363
sa(dp10364
g3
VSTD-DeWalt-2006
p10365
sg5
S'PMC1475568'
p10366
sg7
g10362
sg9
V16533388.xml
p10367
sa(dp10368
g3
VSTD-Ytterstad-1996
p10369
sg5
S'PMC1060349'
p10370
sg7
VCD004441 v. 8.0 Population-based interventions for the prevention of fall-related injuries in older people.rm5
p10371
sg9
V8944864.xml
p10372
sa(dp10373
g3
VSTD-Malotte-1998
p10374
sg5
S'PMC1508952'
p10375
sg7
VCD007952 v. 2.6 Material incentives and enablers in the management of tuberculosis.rm5
p10376
sg9
V9585747.xml
p10377
sa(dp10378
g3
VSTD-Martins-2009
p10379
sg5
S'PMC2767482'
p10380
sg7
g10376
sg9
V19858174.xml
p10381
sa(dp10382
g3
VSTD-Morisky-2001
p10383
sg5
S'PMC1497389'
p10384
sg7
g10376
sg9
V12196616.xml
p10385
sa(dp10386
g3
VSTD-Bell-2005
p10387
sg5
S'PMC2866196'
p10388
sg7
VCD000512 v. 4.0 Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity a.rm5
p10389
sg9
V15930233.xml
p10390
sa(dp10391
g3
VSTD-Slesnick-2007_x002f_08
p10392
sg5
S'PMC2430633'
p10393
sg7
VCD009823 v. 3.0 Interventions for promoting reintegration and reducing harmful behaviour and lifestyles in street-co.rm5
p10394
sg9
V17940861.xml
p10395
sa(dp10396
g3
VSTD-Slesnick-2009-EBFT
p10397
sg5
S'PMC2697451'
p10398
sg7
g10394
sg9
V19522781.xml
p10399
sa(dp10400
g3
VSTD-Slesnick-2005
p10401
sg5
S'PMC1933523'
p10402
sg7
g10394
sg9
V15878048.xml
p10403
sa(dp10404
g3
VSTD-Milburn-2012
p10405
sg5
S'PMC3313467'
p10406
sg7
g10394
sg9
V22443839.xml
p10407
sa(dp10408
g3
VSTD-Tischler-2002
p10409
sg5
S'PMC1719131'
p10410
sg7
g10394
sg9
V11861229.xml
p10411
sa(dp10412
g3
VSTD-Slesnick-2009-FFT
p10413
sg5
S'PMC2697451'
p10414
sg7
g10394
sg9
V19522781.xml
p10415
sa(dp10416
g3
VSTD-Fearon-2003
p10417
sg5
S'PMC1773823'
p10418
sg7
VCD004597 v. 8.0 Eicosapentaenoic acid (EPA an omega-3 fatty acid from fish oils) for the treatment of cancer cachex.rm5
p10419
sg9
V12970142.xml
p10420
sa(dp10421
g3
VSTD-Poovorawan-1997
p10422
sg5
S'PMC1720659'
p10423
sg7
VCD004790 v. 4.0 Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers.rm5
p10424
sg9
V9279183.xml
p10425
sa(dp10426
g3
VSTD-Cockayne-2011
p10427
sg5
S'PMC3109952'
p10428
sg7
VCD001781 v. 10.0 Topical treatments for cutaneous warts.rm5
p10429
sg9
V21652750.xml
p10430
sa(dp10431
g3
VSTD-Fuchs-2004
p10432
sg5
S'PMC2703213'
p10433
sg7
g10429
sg9
V19675691.xml
p10434
sa(dp10435
g3
VSTD-Steele-1988a
p10436
sg5
S'PMC1711371'
p10437
sg7
g10429
sg9
V3255811.xml
p10438
sa(dp10439
g3
VSTD-Bruggink-2010
p10440
sg5
S'PMC2952009'
p10441
sg7
g10429
sg9
V20837684.xml
p10442
sa(dp10443
g3
VSTD-Meyer-1977
p10444
sg5
S'PMC1605575'
p10445
sg7
VCD005411 v. 3.2 Systemic interventions for recurrent aphthous stomatitis (mouth ulcers).rm5
p10446
sg9
V321087.xml
p10447
sa(dp10448
g3
VSTD-Kerigan-1977
p10449
sg5
S'PMC1879363'
p10450
sg7
VCD002738 v. 5.0 Beclomethasone versus placebo for chronic asthma.rm5
p10451
sg9
V851928.xml
p10452
sa(dp10453
g3
VSTD-Chan-1993
p10454
sg5
S'PMC1029424'
p10455
sg7
g10451
sg9
V8024293.xml
p10456
sa(dp10457
g3
VSTD-Cameron-1973
p10458
sg5
S'PMC1587268'
p10459
sg7
g10451
sg9
V4357135.xml
p10460
sa(dp10461
g3
VSTD-TXT-Group
p10462
sg5
S'PMC2408916'
p10463
sg7
VCD003366 v. 9.0 Taxane containing regimens for metastatic breast cancer.rm5
p10464
sg9
V12439707.xml
p10465
sa(dp10466
g3
VSTD-Talbot
p10467
sg5
S'PMC2375384'
p10468
sg7
g10464
sg9
V11986765.xml
p10469
sa(dp10470
g3
VSTD-McCaughey-1994
p10471
sg5
S'PMC1029971'
p10472
sg7
VCD004440 v. 3.0 Recombinant growth hormone for idiopathic short stature in children and adolescents.rm5
p10473
sg9
V7979491.xml
p10474
sa(dp10475
g3
VSTD-Kamp-2002
p10476
sg5
S'PMC1719235'
p10477
sg7
g10473
sg9
V12193430.xml
p10478
sa(dp10479
g3
VSTD-Miller-1982
p10480
sg5
S'PMC1649895'
p10481
sg7
VCD002246 v. 6.0 Interventions for promoting smoke alarm ownership and function.rm5
p10482
sg9
V7065320.xml
p10483
sa(dp10484
g3
VSTD-Clamp-1998
p10485
sg5
S'PMC28560'
p10486
sg7
g10482
sg9
V9596598.xml
p10487
sa(dp10488
g3
VSTD-Project-Burn-1979
p10489
sg5
S'PMC1649807'
p10490
sg7
g10482
sg9
V7058963.xml
p10491
sa(dp10492
g3
VSTD-Schwarz-1993
p10493
sg5
S'PMC1694716'
p10494
sg7
g10482
sg9
V8484447.xml
p10495
sa(dp10496
g3
VSTD-DiGuiseppi-2002
p10497
sg5
S'PMC131023'
p10498
sg7
g10482
sg9
V12411355.xml
p10499
sa(dp10500
g3
VSTD-Johnston-2000
p10501
sg5
S'PMC1730673'
p10502
sg7
g10482
sg9
V11144634.xml
p10503
sa(dp10504
g3
VSTD-Kendrick-1999
p10505
sg5
S'PMC27827'
p10506
sg7
g10482
sg9
V10195971.xml
p10507
sa(dp10508
g3
VSTD-Watson-2005
p10509
sg5
S'PMC544992'
p10510
sg7
g10482
sg9
V15604156.xml
p10511
sa(dp10512
g3
VSTD-SCIPP-1989
p10513
sg5
S'PMC1349806'
p10514
sg7
g10482
sg9
V2817165.xml
p10515
sa(dp10516
g3
VSTD-Spaulding-1976
p10517
sg5
S'PMC1957107'
p10518
sg7
VCD004099 v. 4.0 Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabet.rm5
p10519
sg9
V1268789.xml
p10520
sa(dp10521
g3
VSTD-Skopnik-1992
p10522
sg5
S'PMC1590339'
p10523
sg7
VCD005091 v. 4.0 One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or prov.rm5
p10524
sg9
V1346956.xml
p10525
sa(dp10526
g3
VSTD-Lindbaek-1996a
p10527
sg5
S'PMC2351776'
p10528
sg7
VCD000243 v. 10.0 Antibiotics for acute maxillary sinusitis.rm5
p10529
sg9
V8760738.xml
p10530
sa(dp10531
g3
VSTD-Lindbaek-1996b
p10532
sg5
S'PMC2351776'
p10533
sg7
g10529
sg9
V8760738.xml
p10534
sa(dp10535
g3
VSTD-Henry-2003
p10536
sg5
S'PMC182642'
p10537
sg7
g10529
sg9
V12936972.xml
p10538
sa(dp10539
g3
VSTD-Gwaltney-1997
p10540
sg5
S'PMC163951'
p10541
sg7
g10529
sg9
V9210677.xml
p10542
sa(dp10543
g3
VSTD-Ferguson-1997
p10544
sg5
S'PMC1758547'
p10545
sg7
VCD001106 v. 7.0 Continuous positive airways pressure for obstructive sleep apnoea in adults.rm5
p10546
sg9
V9196520.xml
p10547
sa(dp10548
g3
VSTD-Engleman-1998
p10549
sg5
S'PMC1745223'
p10550
sg7
g10546
sg9
V9708223.xml
p10551
sa(dp10552
g3
VSTD-Marshall-2005
p10553
sg5
S'PMC1758913'
p10554
sg7
g10546
sg9
V15860720.xml
p10555
sa(dp10556
g3
VSTD-Engleman-1997
p10557
sg5
S'PMC1758499'
p10558
sg7
g10546
sg9
V9059469.xml
p10559
sa(dp10560
g3
VSTD-Sugawara-2006
p10561
sg5
S'PMC1856608'
p10562
sg7
VCD006933 v. 3.2 Methods of decreasing infection to improve outcomes after liver resections.rm5
p10563
sg9
V17060763.xml
p10564
sa(dp10565
g3
VSTD-Wiezer-2000
p10566
sg5
S'PMC1421132'
p10567
sg7
g10563
sg9
V10903599.xml
p10568
sa(dp10569
g3
VSTD-Davies-1997
p10570
sg5
S'PMC1758567'
p10571
sg7
VCD002312 v. 5.0 Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneu.rm5
p10572
sg9
V9176531.xml
p10573
sa(dp10574
g3
VSTD-Zuckerman-1997
p10575
sg5
S'PMC2125835'
p10576
sg7
VCD000100 v. 6.0 Vaccines for preventing hepatitis B in health-care workers.rm5
p10577
sg9
V9040320.xml
p10578
sa(dp10579
g3
VSTD-Powell-2001
p10580
sg5
S'PMC26565'
p10581
sg7
VCD003200 v. 7.0 Exercise therapy for chronic fatigue syndrome.rm5
p10582
sg9
V11179154.xml
p10583
sa(dp10584
g3
VSTD-Fulcher-1997
p10585
sg5
S'PMC2126868'
p10586
sg7
g10582
sg9
V9180065.xml
p10587
sa(dp10588
g3
VSTD-Dragone-2002
p10589
sg5
S'PMC3307387'
p10590
sg7
VCD002969 v. 6.0 Interventions for improving communication with children and adolescents about their cancer.rm5
p10591
sg9
V11932129.xml
p10592
sa(dp10593
g3
VSTD-Lindell-2008
p10594
sg5
S'PMC2649916'
p10595
sg7
VCD007407 v. 4.2 Psychological therapies for the management of chronic pain (excluding headache) in adults.rm5
p10596
sg9
V19116007.xml
p10597
sa(dp10598
g3
VSTD-Litt-2009
p10599
sg5
S'PMC2735598'
p10600
sg7
g10596
sg9
V19553018.xml
p10601
sa(dp10602
g3
VSTD-Ersek-2008
p10603
sg5
S'PMC2536565'
p10604
sg7
g10596
sg9
V18086516.xml
p10605
sa(dp10606
g3
VSTD-Toouli-2000
p10607
sg5
S'PMC1727795'
p10608
sg7
VCD001509 v. 6.0 Sphincterotomy for biliary sphincter of Oddi dysfunction.rm5
p10609
sg9
V10601063.xml
p10610
sa(dp10611
g3
VSTD-Pathak-2003
p10612
sg5
S'PMC1721575'
p10613
sg7
VCD003665 v. 7.0 Vitamin E supplementation for prevention of morbidity and mortality in preterm infants.rm5
p10614
sg9
V12819167.xml
p10615
sa(dp10616
g3
VSTD-Chiswick-1983
p10617
sg5
S'PMC1548339'
p10618
sg7
g10614
sg9
V6407714.xml
p10619
sa(dp10620
g3
VSTD-Kotwal-1998
p10621
sg5
S'PMC2362603'
p10622
sg7
VCD004843 v. 10.2 Music for pain relief.rm5
p10623
sg9
V18493472.xml
p10624
sa(dp10625
g3
VSTD-Angus-1996
p10626
sg5
S'PMC472663'
p10627
sg7
VCD000223 v. 7.0 Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease.rm5
p10628
sg9
V8977608.xml
p10629
sa(dp10630
g3
VSTD-Founds-2006
p10631
sg5
S'PMC3628770'
p10632
sg7
VCD000051 v. 10.0 Cephalic version by postural management for breech presentation.rm5
p10633
sg9
V16814225.xml
p10634
sa(dp10635
g3
VSTD-Leve-2005
p10636
sg5
S'PMC1904478'
p10637
sg7
VCD005649 v. 3.3 Treatment Foster Care for improving outcomes in children and young people.rm5
p10638
sg9
V16392991.xml
p10639
sa(dp10640
g3
VSTD-Hermiz-2002
p10641
sg5
S'PMC130059'
p10642
sg7
VCD005623 v. 7.0 Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-maligna.rm5
p10643
sg9
V12399344.xml
p10644
sa(dp10645
g3
VSTD-Neder-2002
p10646
sg5
S'PMC1746295'
p10647
sg7
g10643
sg9
V11923552.xml
p10648
sa(dp10649
g3
VSTD-Bourjeily_x002d_Habr-2002
p10650
sg5
S'PMC1758803'
p10651
sg7
g10643
sg9
V12454299.xml
p10652
sa(dp10653
g3
VSTD-Bredin-1999
p10654
sg5
S'PMC27809'
p10655
sg7
g10643
sg9
V10102851.xml
p10656
sa(dp10657
g3
VSTD-Moore-2002
p10658
sg5
S'PMC133453'
p10659
sg7
g10643
sg9
V12433764.xml
p10660
sa(dp10661
g3
VSTD-Hutchings-2007
p10662
sg5
S'PMC1839187'
p10663
sg7
VCD003680 v. 13.6 Group-based parent-training programmes for improving emotional and behavioural adjustment in childre.rm5
p10664
sg9
V17350966.xml
p10665
sa(dp10666
g3
VSTD-Rennard-2009
p10667
sg5
S'PMC3580134'
p10668
sg7
VCD006829 v. 8.0 Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonis.rm5
p10669
sg9
V19368417.xml
p10670
sa(dp10671
g3
VSTD-Van-Hees-1981
p10672
sg5
S'PMC1419240'
p10673
sg7
VCD008870 v. 2.0 Aminosalicylates for induction of remission or response in Crohn's disease.rm5
p10674
sg9
V6114023.xml
p10675
sa(dp10676
g3
VSTD-Marshall-2002
p10677
sg5
S'PMC116151'
p10678
sg7
VCD005979 v. 5.0 Pharmaceutical policies effects of reference pricing other pricing and purchasing policies.rm5
p10679
sg9
V12126319.xml
p10680
sa(dp10681
g3
VSTD-Schneeweiss-2002
p10682
sg5
S'PMC99452'
p10683
sg7
g10679
sg9
V11944760.xml
p10684
sa(dp10685
g3
VSTD-White-2005
p10686
sg5
S'PMC1153728'
p10687
sg7
VCD007394 v. 2.0 Galactomannan detection for invasive aspergillosis in immunocompromized patients.rm5
p10688
sg9
V15872239.xml
p10689
sa(dp10690
g3
VSTD-Pazos-2005
p10691
sg5
S'PMC540165'
p10692
sg7
g10688
sg9
V15634986.xml
p10693
sa(dp10694
g3
VSTD-Challier-2004
p10695
sg5
S'PMC344496'
p10696
sg7
g10688
sg9
V14766869.xml
p10697
sa(dp10698
g3
VSTD-Kawazu-2004
p10699
sg5
S'PMC427860'
p10700
sg7
g10688
sg9
V15184460.xml
p10701
sa(dp10702
g3
VSTD-Pinel-2003
p10703
sg5
S'PMC154675'
p10704
sg7
g10688
sg9
V12734275.xml
p10705
sa(dp10706
g3
VSTD-Verweij-1995
p10707
sg5
S'PMC228662'
p10708
sg7
g10688
sg9
V8586691.xml
p10709
sa(dp10710
g3
VSTD-Williamson-2000
p10711
sg5
S'PMC1731188'
p10712
sg7
g10688
sg9
V10889818.xml
p10713
sa(dp10714
g3
VSTD-Wilson-1980
p10715
sg5
S'PMC471402'
p10716
sg7
VCD001495 v. 7.0 Short-acting beta2-agonists for stable chronic obstructive pulmonary disease.rm5
p10717
sg9
V7013150.xml
p10718
sa(dp10719
g3
VSTD-Tandon-1990
p10720
sg5
S'PMC463088'
p10721
sg7
g10717
sg9
V2038732.xml
p10722
sa(dp10723
g3
VSTD-Jaeschke-1991
p10724
sg5
S'PMC1452523'
p10725
sg7
g10717
sg9
V1984814.xml
p10726
sa(dp10727
g3
VSTD-Carbajal-2003
p10728
sg5
S'PMC139493'
p10729
sg7
VCD004950 v. 5.0 Breastfeeding or breast milk for procedural pain in neonates.rm5
p10730
sg9
V12511452.xml
p10731
sa(dp10732
g3
VSTD-Aranda-2006
p10733
sg5
S'PMC2360523'
p10734
sg7
VCD004253 v. 10.0 Psychological interventions for women with metastatic breast cancer.rm5
p10735
sg9
V16967054.xml
p10736
sa(dp10737
g3
VSTD-Low-2010
p10738
sg5
S'PMC3128513'
p10739
sg7
g10735
sg9
V20658835.xml
p10740
sa(dp10741
g3
VSTD-Bayne_x002d_Smith-2004
p10742
sg5
S'PMC1448490'
p10743
sg7
VCD007651 v. 3.0 School-based physical activity programs for promoting physical activity and fitness in children and .rm5
p10744
sg9
V15333311.xml
p10745
sa(dp10746
g3
VSTD-Dorgo-2009
p10747
sg5
S'PMC2907740'
p10748
sg7
g10744
sg9
V19826296.xml
p10749
sa(dp10750
g3
VSTD-Wilson-2011
p10751
sg5
S'PMC3417297'
p10752
sg7
g10744
sg9
V21534677.xml
p10753
sa(dp10754
g3
VSTD-Jones-2008
p10755
sg5
S'PMC2556688'
p10756
sg7
g10744
sg9
V18718012.xml
p10757
sa(dp10758
g3
VSTD-Kriemler-2010
p10759
sg5
S'PMC2827713'
p10760
sg7
g10744
sg9
V20179126.xml
p10761
sa(dp10762
g3
VSTD-Gentile-2009
p10763
sg5
S'PMC2758893'
p10764
sg7
g10744
sg9
V19765270.xml
p10765
sa(dp10766
g3
VSTD-Neumark_x002d_Sztainer-2009
p10767
sg5
S'PMC2682640'
p10768
sg7
g10744
sg9
V18622011.xml
p10769
sa(dp10770
g3
VSTD-Donnelly-2009
p10771
sg5
S'PMC2766439'
p10772
sg7
g10744
sg9
V19665037.xml
p10773
sa(dp10774
g3
VSTD-Ewart-1998
p10775
sg5
S'PMC1508242'
p10776
sg7
g10744
sg9
V9618627.xml
p10777
sa(dp10778
g3
VSTD-Neumark_x002d_Sztainer-2010
p10779
sg5
S'PMC2978965'
p10780
sg7
g10744
sg9
V20965379.xml
p10781
sa(dp10782
g3
VSTD-Webber-2008
p10783
sg5
S'PMC2275165'
p10784
sg7
g10744
sg9
V18312804.xml
p10785
sa(dp10786
g3
VSTD-Trevino-2004
p10787
sg5
S'PMC1364479'
p10788
sg7
g10744
sg9
V15351759.xml
p10789
sa(dp10790
g3
VSTD-Lepcha-2002
p10791
sg5
S'PMC3450470'
p10792
sg7
VCD006286 v. 4.2 Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoida.rm5
p10793
sg9
V23119911.xml
p10794
sa(dp10795
g3
VSTD-Woodcock-1981
p10796
sg5
S'PMC1506180'
p10797
sg7
VCD007354 v. 7.0 Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in.rm5
p10798
sg9
V6788319.xml
p10799
sa(dp10800
g3
VSTD-Poikolainen-2008
p10801
sg5
S'PMC2265283'
p10802
sg7
VCD008358 v. 3.0 Magnesium for alcohol withdrawal.rm5
p10803
sg9
V18218147.xml
p10804
sa(dp10805
g3
VSTD-Steiner-2003
p10806
sg5
S'PMC1746806'
p10807
sg7
VCD000998 v. 11.0 Nutritional supplementation for stable chronic obstructive pulmonary disease.rm5
p10808
sg9
V12947128.xml
p10809
sa(dp10810
g3
VSTD-GLANCE-2009
p10811
sg5
S'PMC2821836'
p10812
sg7
VCD007621 v. 5.0 Natalizumab for relapsing remitting multiple sclerosis.rm5
p10813
sg9
V19255407.xml
p10814
sa(dp10815
g3
VSTD-Tucker-1984
p10816
sg5
S'PMC1443331'
p10817
sg7
VCD001730 v. 5.0 Medical day hospital care for the elderly versus alternative forms of care.rm5
p10818
sg9
V6437487.xml
p10819
sa(dp10820
g3
VSTD-Eagle-1991
p10821
sg5
S'PMC1453052'
p10822
sg7
g10818
sg9
V1998929.xml
p10823
sa(dp10824
g3
VSTD-Hogan-2001
p10825
sg5
S'PMC81411'
p10826
sg7
VCD003600 v. 10.6 Modification of the home environment for the reduction of injuries.rm5
p10827
sg9
V11563205.xml
p10828
sa(dp10829
g3
VSTD-Shaw-2003
p10830
sg5
S'PMC139930'
p10831
sg7
g10827
sg9
V12521968.xml
p10832
sa(dp10833
g3
VSTD-Campbell-2005
p10834
sg5
S'PMC1246082'
p10835
sg7
g10827
sg9
V16183652.xml
p10836
sa(dp10837
g3
VSTD-Clamp-1998
p10838
sg5
S'PMC28560'
p10839
sg7
g10827
sg9
V9596598.xml
p10840
sa(dp10841
g3
VSTD-Day-2002
p10842
sg5
S'PMC117228'
p10843
sg7
g10827
sg9
V12130606.xml
p10844
sa(dp10845
g3
VSTD-Kendrick-1999
p10846
sg5
S'PMC27827'
p10847
sg7
g10827
sg9
V10195971.xml
p10848
sa(dp10849
g3
VSTD-King-2005
p10850
sg5
S'PMC1730192'
p10851
sg7
g10827
sg9
V15805440.xml
p10852
sa(dp10853
g3
VSTD-Hendrickson-2005
p10854
sg5
S'PMC1730268'
p10855
sg7
g10827
sg9
V16203842.xml
p10856
sa(dp10857
g3
VSTD-Watson-2005
p10858
sg5
S'PMC544992'
p10859
sg7
g10827
sg9
V15604156.xml
p10860
sa(dp10861
g3
VSTD-Vetter-1992
p10862
sg5
S'PMC1882829'
p10863
sg7
g10827
sg9
V1392755.xml
p10864
sa(dp10865
g3
VSTD-Van-Haastregt-2000b
p10866
sg5
S'PMC27508'
p10867
sg7
g10827
sg9
V11039967.xml
p10868
sa(dp10869
g3
VSTD-Davies-2002
p10870
sg5
S'PMC121963'
p10871
sg7
VCD005470 v. 5.0 Tailored interventions to overcome identified barriers to change effects on professional practice a.rm5
p10872
sg9
V12240812.xml
p10873
sa(dp10874
g3
VSTD-Schouten-2007
p10875
sg5
S'PMC2653154'
p10876
sg7
g10872
sg9
V17403764.xml
p10877
sa(dp10878
g3
VSTD-Fretheim-2006
p10879
sg5
S'PMC1472695'
p10880
sg7
g10872
sg9
V16737346.xml
p10881
sa(dp10882
g3
VSTD-Baker-2001
p10883
sg5
S'PMC1314102'
p10884
sg7
g10872
sg9
V11593835.xml
p10885
sa(dp10886
g3
VSTD-Flottorp-2002
p10887
sg5
S'PMC117890'
p10888
sg7
g10872
sg9
V12183309.xml
p10889
sa(dp10890
g3
VSTD-Hux-1999
p10891
sg5
S'PMC1230539'
p10892
sg7
g10872
sg9
V10478162.xml
p10893
sa(dp10894
g3
VSTD-Langham-2002
p10895
sg5
S'PMC1316085'
p10896
sg7
g10872
sg9
V12392122.xml
p10897
sa(dp10898
g3
VSTD-Kamps-2003
p10899
sg5
S'PMC1746504'
p10900
sg7
VCD009296 v. 2.3 Nurse versus physician-led care for the management of asthma.rm5
p10901
sg9
V14586050.xml
p10902
sa(dp10903
g3
VSTD-Klerman-2001
p10904
sg5
S'PMC1446489'
p10905
sg7
VCD002869 v. 6.0 Individual or group antenatal education for childbirth or parenthood or both.rm5
p10906
sg9
V11189800.xml
p10907
sa(dp10908
g3
VSTD-Shepperd-1998
p10909
sg5
S'PMC28578'
p10910
sg7
VCD000356 v. 8.0 Hospital at home early discharge.rm5
p10911
sg9
V9624068.xml
p10912
sa(dp10913
g3
VSTD-Ojoo-2002
p10914
sg5
S'PMC1746235'
p10915
sg7
g10911
sg9
V11828049.xml
p10916
sa(dp10917
g3
VSTD-Cotton-2002
p10918
sg5
S'PMC1745631'
p10919
sg7
g10911
sg9
V11050257.xml
p10920
sa(dp10921
g3
VSTD-Skwarska-2000
p10922
sg5
S'PMC1745644'
p10923
sg7
g10911
sg9
V11050258.xml
p10924
sa(dp10925
g3
VSTD-Adler-1978
p10926
sg5
S'PMC1060932'
p10927
sg7
g10911
sg9
V98548.xml
p10928
sa(dp10929
g3
VSTD-Richards-1998
p10930
sg5
S'PMC28581'
p10931
sg7
g10911
sg9
V9624074.xml
p10932
sa(dp10933
g3
VSTD-Booth-2004
p10934
sg5
S'PMC1768555'
p10935
sg7
g10911
sg9
V15486143.xml
p10936
sa(dp10937
g3
VSTD-Rudd-1997
p10938
sg5
S'PMC2127677'
p10939
sg7
g10911
sg9
V9366727.xml
p10940
sa(dp10941
g3
VSTD-Pop_x002d_Eleches-2011
p10942
sg5
S'PMC3718389'
p10943
sg7
VCD009756 v. 2.0 Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV i.rm5
p10944
sg9
V21252632.xml
p10945
sa(dp10946
g3
VSTD-Cameron-2001
p10947
sg5
S'PMC2363881'
p10948
sg7
VCD008955 v. 2.2 Interferon alpha for the adjuvant treatment of cutaneous melanoma.rm5
p10949
sg9
V11379605.xml
p10950
sa(dp10951
g3
VSTD-Hawking-1967
p10952
sg5
S'PMC2554262'
p10953
sg7
VCD003758 v. 5.0 Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis.rm5
p10954
sg9
V5301383.xml
p10955
sa(dp10956
g3
VSTD-Davis-1969
p10957
sg5
S'PMC2427415'
p10958
sg7
g10954
sg9
V5308697.xml
p10959
sa(dp10960
g3
VSTD-Rapaport-2006
p10961
sg5
S'PMC2788739'
p10962
sg7
VCD008121 v. 3.0 Second-generation antipsychotics for major depressive disorder and dysthymia.rm5
p10963
sg9
V17928573.xml
p10964
sa(dp10965
g3
VSTD-Keitner-2009
p10966
sg5
S'PMC3685867'
p10967
sg7
g10963
sg9
V18586273.xml
p10968
sa(dp10969
g3
VSTD-Elavsky-2009
p10970
sg5
S'PMC2728615'
p10971
sg7
VCD006108 v. 9.0 Exercise for vasomotor menopausal symptoms.rm5
p10972
sg9
V19169167.xml
p10973
sa(dp10974
g3
VSTD-Keiser-2005
p10975
sg5
S'PMC548524'
p10976
sg7
VCD008270 v. 2.5 Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.rm5
p10977
sg9
V15647105.xml
p10978
sa(dp10979
g3
VSTD-Nilasena-1995
p10980
sg5
S'PMC2579172'
p10981
sg7
VCD001481 v. 5.0 Interventions to improve the management of diabetes mellitus in primary care outpatient and communi.rm5
p10982
sg9
V8563365.xml
p10983
sa(dp10984
g3
VSTD-Naji-1994
p10985
sg5
S'PMC2540045'
p10986
sg7
g10982
sg9
V8180540.xml
p10987
sa(dp10988
g3
VSTD-Kinmonth-1998
p10989
sg5
S'PMC28704'
p10990
sg7
g10982
sg9
V9794859.xml
p10991
sa(dp10992
g3
VSTD-Feder-1995
p10993
sg5
S'PMC2543702'
p10994
sg7
g10982
sg9
V8520339.xml
p10995
sa(dp10996
g3
VSTD-Chow-2000
p10997
sg5
S'PMC95987'
p10998
sg7
VCD005360 v. 8.0 Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery.rm5
p10999
sg9
V11063500.xml
p11000
sa(dp11001
g3
VSTD-Veldt-2003
p11002
sg5
S'PMC222984'
p11003
sg7
VCD005527 v. 5.4 Ribavirin monotherapy for chronic hepatitis C.rm5
p11004
sg9
V12948399.xml
p11005
sa(dp11006
g3
VSTD-Khakoo-1998
p11007
sg5
S'PMC1873804'
p11008
sg7
g11004
sg9
V9862245.xml
p11009
sa(dp11010
g3
VSTD-Ramhamdany-1989
p11011
sg5
S'PMC1434178'
p11012
sg7
VCD004931 v. 5.0 Intragastric balloon for obesity.rm5
p11013
sg9
V2767500.xml
p11014
sa(dp11015
g3
VSTD-McClure-1994
p11016
sg5
S'PMC1029715'
p11017
sg7
VCD003235 v. 7.0 Emergency interventions for hyperkalaemia.rm5
p11018
sg9
V8129434.xml
p11019
sa(dp11020
g3
VSTD-Hawkins-2009
p11021
sg5
S'PMC2740999'
p11022
sg7
VCD001291 v. 9.0 Community interventions for preventing smoking in young people.rm5
p11023
sg9
V19736331.xml
p11024
sa(dp11025
g3
VSTD-Biglan-2000
p11026
sg5
S'PMC1748303'
p11027
sg7
g11023
sg9
V10691755.xml
p11028
sa(dp11029
g3
VSTD-Perry-2008
p11030
sg5
S'PMC2667859'
p11031
sg7
g11023
sg9
V19299670.xml
p11032
sa(dp11033
g3
VSTD-Vartiainen-1998
p11034
sg5
S'PMC1508381'
p11035
sg7
g11023
sg9
V9584038.xml
p11036
sa(dp11037
g3
VSTD-Klein-2009
p11038
sg5
S'PMC2741406'
p11039
sg7
g11023
sg9
V19103639.xml
p11040
sa(dp11041
g3
VSTD-Walkup-2008
p11042
sg5
S'PMC2702984'
p11043
sg7
VCD005170 v. 7.2 Pharmacotherapy for anxiety disorders in children and adolescents.rm5
p11044
sg9
V18974308.xml
p11045
sa(dp11046
g3
VSTD-Bo-2007
p11047
sg5
S'PMC2219825'
p11048
sg7
VCD003054 v. 5.3 Exercise or exercise and diet for preventing type 2 diabetes mellitus.rm5
p11049
sg9
V17922167.xml
p11050
sa(dp11051
g3
VSTD-DPP-2002
p11052
sg5
S'PMC1370926'
p11053
sg7
g11049
sg9
V11832527.xml
p11054
sa(dp11055
g3
VSTD-Beenen-1999
p11056
sg5
S'PMC1736591'
p11057
sg7
VCD007286 v. 3.0 Antiepileptic drugs as prophylaxis for post-craniotomy seizures.rm5
p11058
sg9
V10486394.xml
p11059
sa(dp11060
g3
VSTD-Foy-1992
p11061
sg5
S'PMC1015096'
p11062
sg7
g11058
sg9
V1402964.xml
p11063
sa(dp11064
g3
VSTD-Calderon-2008
p11065
sg5
S'PMC2242423'
p11066
sg7
VCD009414 v. 2.1 Interventions for preventing or reducing domestic violence against pregnant women.rm5
p11067
sg9
V18201643.xml
p11068
sa(dp11069
g3
VSTD-Zlotnick-2011
p11070
sg5
S'PMC3042850'
p11071
sg7
g11067
sg9
V21153559.xml
p11072
sa(dp11073
g3
VSTD-Cripe-2010
p11074
sg5
S'PMC3741342'
p11075
sg7
g11067
sg9
V20145196.xml
p11076
sa(dp11077
g3
VSTD-Kiely-2010
p11078
sg5
S'PMC2917915'
p11079
sg7
g11067
sg9
V20093899.xml
p11080
sa(dp11081
g3
VSTD-O_x0027_Sullivan-2009
p11082
sg5
S'PMC2660391'
p11083
sg7
VCD003930 v. 8.0 Restricting oral fluid and food intake during labour.rm5
p11084
sg9
V19318702.xml
p11085
sa(dp11086
g3
VSTD-Bouchard-2008
p11087
sg5
S'PMC2592568'
p11088
sg7
VCD003602 v. 6.0 Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion.rm5
p11089
sg9
V19057729.xml
p11090
sa(dp11091
g3
VSTD-Hopper-1984
p11092
sg5
S'PMC1651641'
p11093
sg7
VCD003638 v. 4.0 Interventions for improving adherence to treatment recommendations in people with type 2 diabetes me.rm5
p11094
sg9
V6721016.xml
p11095
sa(dp11096
g3
VSTD-Admani-1978
p11097
sg5
S'PMC1608980'
p11098
sg7
VCD005478 v. 3.0 Naftidrofuryl for acute stroke.rm5
p11099
sg9
V367511.xml
p11100
sa(dp11101
g3
VSTD-Tisdall-1951
p11102
sg5
S'PMC1821925'
p11103
sg7
VCD004676 v. 8.0 School feeding for improving the physical and psychosocial health of disadvantaged students.rm5
p11104
sg9
V14839578.xml
p11105
sa(dp11106
g3
VSTD-Baker-1980-_x0028_-boys_x0029_
p11107
sg5
S'PMC1052036'
p11108
sg7
g11104
sg9
V6892711.xml
p11109
sa(dp11110
g3
VSTD-Baker-total-1980
p11111
sg5
S'PMC1052036'
p11112
sg7
g11104
sg9
V6892711.xml
p11113
sa(dp11114
g3
VSTD-Baker-girls-1980
p11115
sg5
S'PMC1052036'
p11116
sg7
g11104
sg9
V6892711.xml
p11117
sa(dp11118
g3
VSTD-Bonnar-1996
p11119
sg5
S'PMC2352023'
p11120
sg7
VCD000249 v. 7.2 Antifibrinolytics for heavy menstrual bleeding.rm5
p11121
sg9
V8806245.xml
p11122
sa(dp11123
g3
VSTD-Callender-1970
p11124
sg5
S'PMC1819762'
p11125
sg7
g11121
sg9
V4919554.xml
p11126
sa(dp11127
g3
VSTD-von-Brevern-2006
p11128
sg5
S'PMC2077628'
p11129
sg7
VCD003162 v. 8.0 The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo.rm5
p11130
sg9
V16549410.xml
p11131
sa(dp11132
g3
VSTD-Sinclair-1997
p11133
sg5
S'PMC2127619'
p11134
sg7
VCD003004 v. 7.0 Perioperative fluid volume optimization following proximal femoral fracture.rm5
p11135
sg9
V9361539.xml
p11136
sa(dp11137
g3
VSTD-Van-Vugt-1998a
p11138
sg5
S'PMC105468'
p11139
sg7
VCD005965 v. 3.0 Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria.rm5
p11140
sg9
V9449273.xml
p11141
sa(dp11142
g3
VSTD-Beattie-2000
p11143
sg5
S'PMC1756438'
p11144
sg7
VCD002008 v. 10.0 Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adul.rm5
p11145
sg9
V10807893.xml
p11146
sa(dp11147
g3
VSTD-Chandra-1985
p11148
sg5
S'PMC1416637'
p11149
sg7
g11145
sg9
V3929906.xml
p11150
sa(dp11151
g3
VSTD-Carson-2011
p11152
sg5
S'PMC3268062'
p11153
sg7
VCD002042 v. 8.0 Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.rm5
p11154
sg9
V22168590.xml
p11155
sa(dp11156
g3
VSTD-Bao--2008
p11157
sg5
S'PMC2551567'
p11158
sg7
VCD002922 v. 9.2 Treatment for lupus nephritis.rm5
p11159
sg9
V18596121.xml
p11160
sa(dp11161
g3
VSTD-Clark-1981
p11162
sg5
S'PMC1862250'
p11163
sg7
g11159
sg9
V7272867.xml
p11164
sa(dp11165
g3
VSTD-MAINTAIN-Nephritis-Study
p11166
sg5
S'PMC3002764'
p11167
sg7
g11159
sg9
V20833738.xml
p11168
sa(dp11169
g3
VSTD-Yee-2004
p11170
sg5
S'PMC1755006'
p11171
sg7
g11159
sg9
V15082482.xml
p11172
sa(dp11173
g3
VSTD-Appel-2009
p11174
sg5
S'PMC2678035'
p11175
sg7
g11159
sg9
V19369404.xml
p11176
sa(dp11177
g3
VSTD-Bonduelle-1991
p11178
sg5
S'PMC2399106'
p11179
sg7
VCD001017 v. 5.2 Danazol for heavy menstrual bleeding.rm5
p11180
sg9
V1835005.xml
p11181
sa(dp11182
g3
VSTD-Carter-1989
p11183
sg5
S'PMC2249529'
p11184
sg7
VCD006171 v. 3.1 Prenatal education for congenital toxoplasmosis.rm5
p11185
sg9
V2606162.xml
p11186
sa(dp11187
g3
VSTD-Zar-2007
p11188
sg5
S'PMC1779846'
p11189
sg7
VCD006418 v. 3.0 Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.rm5
p11190
sg9
V17085459.xml
p11191
sa(dp11192
g3
VSTD-Shapiro-1991
p11193
sg5
S'PMC3035844'
p11194
sg7
VCD003961 v. 9.0 Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.rm5
p11195
sg9
V1721361.xml
p11196
sa(dp11197
g3
VSTD-Bourgeois-2010
p11198
sg5
S'PMC3374868'
p11199
sg7
VMR000031 v. 2.3 Comparison of protocols and registry entries to published reports for randomised controlled trials.rm5
p11200
sg9
V20679560.xml
p11201
sa(dp11202
g3
VSTD-Charles-2009
p11203
sg5
S'PMC2680945'
p11204
sg7
g11200
sg9
V19435763.xml
p11205
sa(dp11206
g3
VSTD-Soares-2004
p11207
sg5
S'PMC313900'
p11208
sg7
g11200
sg9
V14703540.xml
p11209
sa(dp11210
g3
VSTD-Chan-2004b
p11211
sg5
S'PMC517858'
p11212
sg7
g11200
sg9
V15451835.xml
p11213
sa(dp11214
g3
VSTD-Ewart-2009
p11215
sg5
S'PMC2775624'
p11216
sg7
g11200
sg9
V19901314.xml
p11217
sa(dp11218
g3
VSTD-Thomson-1979
p11219
sg5
S'PMC2383381'
p11220
sg7
VCD003519 v. 6.0 Early skin-to-skin contact for mothers and their healthy newborn infants.rm5
p11221
sg9
V21297814.xml
p11222
sa(dp11223
g3
VSTD-Morris-1992
p11224
sg5
S'PMC1029623'
p11225
sg7
VCD003967 v. 11.0 Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.rm5
p11226
sg9
V8257180.xml
p11227
sa(dp11228
g3
VSTD-Amir-1997b
p11229
sg5
S'PMC2126953'
p11230
sg7
VCD006700 v. 2.0 Acyclovir for treating primary herpetic gingivostomatitis.rm5
p11231
sg9
V9224082.xml
p11232
sa(dp11233
g3
VSTD-Neuhaus-2009
p11234
sg5
S'PMC2634726'
p11235
sg7
VCD007464 v. 3.2 Chemotherapy for brain metastases from small cell lung cancer.rm5
p11236
sg9
V19127261.xml
p11237
sa(dp11238
g3
VSTD-Johnston-1993
p11239
sg5
S'PMC1677411'
p11240
sg7
VCD004935 v. 9.0 Relaxation therapies for the management of primary hypertension in adults.rm5
p11241
sg9
V8490471.xml
p11242
sa(dp11243
g3
VSTD-Blanchard-1979
p11244
sg5
S'PMC1311352'
p11245
sg7
g11241
sg9
V468751.xml
p11246
sa(dp11247
g3
VSTD-van-Montfrans-1990
p11248
sg5
S'PMC1662994'
p11249
sg7
g11241
sg9
V2196946.xml
p11250
sa(dp11251
g3
VSTD-Patel-1988
p11252
sg5
S'PMC2544650'
p11253
sg7
g11241
sg9
V3122919.xml
p11254
sa(dp11255
g3
VSTD-Candy-1995
p11256
sg5
S'PMC1382873'
p11257
sg7
VCD000545 v. 10.6 Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.rm5
p11258
sg9
V8549944.xml
p11259
sa(dp11260
g3
VSTD-Jones-2006
p11261
sg5
S'PMC1856426'
p11262
sg7
VCD004101 v. 7.11 Psychological interventions for symptomatic management of non-specific chest pain in patients with n.rm5
p11263
sg9
V16627548.xml
p11264
sa(dp11265
g3
VSTD-MAM-01-GOCSI
p11266
sg5
S'PMC2362097'
p11267
sg7
VCD004562 v. 7.0 LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.rm5
p11268
sg9
V15668708.xml
p11269
sa(dp11270
g3
VSTD-Guinea_x002d_Bissau-2005
p11271
sg5
S'PMC1239973'
p11272
sg7
VCD000494 v. 11.0 Prostaglandins for preventing postpartum haemorrhage.rm5
p11273
sg9
V16195287.xml
p11274
sa(dp11275
g3
VSTD-Pakistan-2011
p11276
sg5
S'PMC3041931'
p11277
sg7
g11273
sg9
V21176086.xml
p11278
sa(dp11279
g3
VSTD-Tibet-2009
p11280
sg5
S'PMC2791828'
p11281
sg7
g11273
sg9
V19249659.xml
p11282
sa(dp11283
g3
VSTD-Challenor-1991
p11284
sg5
S'PMC1368337'
p11285
sg7
VCD006687 v. 4.0 Oral vasodilators for primary Raynaud's phenomenon.rm5
p11286
sg9
V2049258.xml
p11287
sa(dp11288
g3
VSTD-Peuskens-2007
p11289
sg5
S'PMC2860517'
p11290
sg7
VCD008016 v. 3.2 Maintenance treatment with antipsychotic drugs for schizophrenia.rm5
p11291
sg9
V20428302.xml
p11292
sa(dp11293
g3
VSTD-Chen-2010
p11294
sg5
S'PMC2924475'
p11295
sg7
g11291
sg9
V20724402.xml
p11296
sa(dp11297
g3
VSTD-Channabasavanna-1987
p11298
sg5
S'PMC3172444'
p11299
sg7
g11291
sg9
V21927264.xml
p11300
sa(dp11301
g3
VSTD-Leff-1971
p11302
sg5
S'PMC1798790'
p11303
sg7
g11291
sg9
V4936538.xml
p11304
sa(dp11305
g3
VSTD-Hirsch-1973
p11306
sg5
S'PMC1588639'
p11307
sg7
g11291
sg9
V4571196.xml
p11308
sa(dp11309
g3
VSTD-Tyrrell-1986
p11310
sg5
S'PMC1777841'
p11311
sg7
VCD002011 v. 8.0 Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.rm5
p11312
sg9
V3524474.xml
p11313
sa(dp11314
g3
VSTD-Olszewer-1990
p11315
sg5
S'PMC2626030'
p11316
sg7
VCD002785 v. 5.0 Chelation therapy for atherosclerotic cardiovascular disease.rm5
p11317
sg9
V2108254.xml
p11318
sa(dp11319
g3
VSTD-Pyrhonen-1997
p11320
sg5
S'PMC2223944'
p11321
sg7
VCD008926 v. 2.0 Toremifene versus tamoxifen for advanced breast cancer.rm5
p11322
sg9
V9231932.xml
p11323
sa(dp11324
g3
VSTD-Oryazgan-1992
p11325
sg5
S'PMC504238'
p11326
sg7
VCD001084 v. 6.0 Pharmacotherapy for Behcet's syndrome.rm5
p11327
sg9
V1390495.xml
p11328
sa(dp11329
g3
VSTD-Chirico-2009
p11330
sg5
S'PMC2687544'
p11331
sg7
VCD006602 v. 7.0 Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.rm5
p11332
sg9
V19490659.xml
p11333
sa(dp11334
g3
VSTD-Nuijten-2010
p11335
sg5
S'PMC2816247'
p11336
sg7
g11332
sg9
V19967425.xml
p11337
sa(dp11338
g3
VSTD-Roberts-2001
p11339
sg5
S'PMC2566389'
p11340
sg7
VCD004794 v. 3.0 Interventions to improve water quality for preventing diarrhoea.rm5
p11341
sg9
V11357205.xml
p11342
sa(dp11343
g3
VSTD-Kirchhoff-1985
p11344
sg5
S'PMC2129411'
p11345
sg7
g11341
sg9
V2985691.xml
p11346
sa(dp11347
g3
VSTD-Conroy-1999
p11348
sg5
S'PMC1718112'
p11349
sg7
g11341
sg9
V10490440.xml
p11350
sa(dp11351
g3
VSTD-Quick-1999
p11352
sg5
S'PMC2809591'
p11353
sg7
g11341
sg9
V10098789.xml
p11354
sa(dp11355
g3
VSTD-Chiller-2004
p11356
sg5
S'PMC2626515'
p11357
sg7
g11341
sg9
V16501712.xml
p11358
sa(dp11359
g3
VSTD-Colford-2002
p11360
sg5
S'PMC2730258'
p11361
sg7
g11341
sg9
V11749745.xml
p11362
sa(dp11363
g3
VSTD-vs-HLP-_x002d_-Purdon-2001
p11364
sg5
S'PMC1407745'
p11365
sg7
VCD007815 v. 2.124 Quetiapine versus typical antipsychotic medications for schizophrenia.rm5
p11366
sg9
V11291531.xml
p11367
sa(dp11368
g3
VSTD-Koning-2003
p11369
sg5
S'PMC64791'
p11370
sg7
VCD003261 v. 7.0 Interventions for impetigo.rm5
p11371
sg9
V11809642.xml
p11372
sa(dp11373
g3
VSTD-Goldfarb-1988
p11374
sg5
S'PMC176017'
p11375
sg7
g11371
sg9
V3149884.xml
p11376
sa(dp11377
g3
VSTD-Ginsburg-1978
p11378
sg5
S'PMC352342'
p11379
sg7
g11371
sg9
V666305.xml
p11380
sa(dp11381
g3
VSTD-Tack-1997
p11382
sg5
S'PMC163785'
p11383
sg7
g11371
sg9
V9087480.xml
p11384
sa(dp11385
g3
VSTD-Farley-2002b
p11386
sg5
S'PMC1464003'
p11387
sg7
VCD004538 v. 5.28 Public release of performance data in changing the behaviour of healthcare consumers professionals .rm5
p11388
sg9
V12236394.xml
p11389
sa(dp11390
g3
VSTD-Gardner-1988
p11391
sg5
S'PMC1349736'
p11392
sg7
VCD001256 v. 9.0 Interventions for preventing lower limb soft-tissue running injuries.rm5
p11393
sg9
V3056045.xml
p11394
sa(dp11395
g3
VSTD-Withnall-2006
p11396
sg5
S'PMC1325079'
p11397
sg7
g11393
sg9
V16388054.xml
p11398
sa(dp11399
g3
VSTD-Margrett-2006
p11400
sg5
S'PMC2856450'
p11401
sg7
VCD006220 v. 4.0 Cognition-based interventions for healthy older people and people with mild cognitive impairment.rm5
p11402
sg9
V16807197.xml
p11403
sa(dp11404
g3
VSTD-Ball-2002
p11405
sg5
S'PMC2916176'
p11406
sg7
g11402
sg9
V12425704.xml
p11407
sa(dp11408
g3
VSTD-Mahncke-2006
p11409
sg5
S'PMC1526649'
p11410
sg7
g11402
sg9
V16888038.xml
p11411
sa(dp11412
g3
VSTD-Koivunen-2004
p11413
sg5
S'PMC351838'
p11414
sg7
VCD007810 v. 5.0 Adenoidectomy for otitis media in children.rm5
p11415
sg9
V14769785.xml
p11416
sa(dp11417
g3
VSTD-Casselbrant-2009
p11418
sg5
S'PMC2787742'
p11419
sg7
g11415
sg9
V19819563.xml
p11420
sa(dp11421
g3
VSTD-Black-1990
p11422
sg5
S'PMC1663097'
p11423
sg7
g11415
sg9
V2196954.xml
p11424
sa(dp11425
g3
VSTD-Varma-2006
p11426
sg5
S'PMC1557355'
p11427
sg7
VCD006756 v. 4.0 Cesarean delivery for the prevention of anal incontinence.rm5
p11428
sg9
V16741640.xml
p11429
sa(dp11430
g3
VSTD-Eason-2002
p11431
sg5
S'PMC99311'
p11432
sg7
g11428
sg9
V11868640.xml
p11433
sa(dp11434
g3
VSTD-Kalra-2004
p11435
sg5
S'PMC406319'
p11436
sg7
VCD001919 v. 7.0 Information provision for stroke patients and their caregivers.rm5
p11437
sg9
V15130977.xml
p11438
sa(dp11439
g3
VSTD-Busuttil-1981-A
p11440
sg5
S'PMC1345331'
p11441
sg7
VCD001439 v. 11.0 Antibiotics versus placebo for prevention of postoperative infection after appendicectomy..rm5
p11442
sg9
V7025769.xml
p11443
sa(dp11444
g3
VSTD-Willis-1976
p11445
sg5
S'PMC1638715'
p11446
sg7
g11442
sg9
V764935.xml
p11447
sa(dp11448
g3
VSTD-Bauer-1989
p11449
sg5
S'PMC1493927'
p11450
sg7
g11442
sg9
V2647050.xml
p11451
sa(dp11452
g3
VSTD-Moskowitz-2011
p11453
sg5
S'PMC3479399'
p11454
sg7
VCD009528 v. 2.0 Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic f.rm5
p11455
sg9
V20963843.xml
p11456
sa(dp11457
g3
VSTD-Bierer-2009
p11458
sg5
S'PMC3086684'
p11459
sg7
VCD004868 v. 5.0 Late erythropoietin for preventing red blood cell transfusion in preterm andor low birth weight inf.rm5
p11460
sg9
V19635302.xml
p11461
sa(dp11462
g3
VSTD-Bechensteen-1993
p11463
sg5
S'PMC1029391'
p11464
sg7
g11460
sg9
V8346946.xml
p11465
sa(dp11466
g3
VSTD-Emmerson-1993
p11467
sg5
S'PMC1590386'
p11468
sg7
g11460
sg9
V8466265.xml
p11469
sa(dp11470
g3
VSTD-Griffiths-1997
p11471
sg5
S'PMC1720643'
p11472
sg7
g11460
sg9
V9175950.xml
p11473
sa(dp11474
g3
VSTD-Brown-2002
p11475
sg5
S'PMC2134805'
p11476
sg7
VCD003417 v. 4.2 Group based training for self-management strategies in people with type 2 diabetes mellitus.rm5
p11477
sg9
V11815493.xml
p11478
sa(dp11479
g3
VSTD-Namutangula-2007
p11480
sg5
S'PMC2147028'
p11481
sg7
VCD004615 v. 5.2 Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria.rm5
p11482
sg9
V17958887.xml
p11483
sa(dp11484
g3
VSTD-Seymour-1999
p11485
sg5
S'PMC2014251'
p11486
sg7
VCD001548 v. 10.0 Single dose oral ibuprofen for acute postoperative pain in adults.rm5
p11487
sg9
V10383546.xml
p11488
sa(dp11489
g3
VSTD-Medve-2001
p11490
sg5
S'PMC2007376'
p11491
sg7
g11487
sg9
V11724223.xml
p11492
sa(dp11493
g3
VSTD-Seymour-1991-_x0028_study-2_x0029_
p11494
sg5
S'PMC1368416'
p11495
sg7
g11487
sg9
V2015175.xml
p11496
sa(dp11497
g3
VSTD-Seymour-1991-_x0028_study-1_x0029_
p11498
sg5
S'PMC1368416'
p11499
sg7
g11487
sg9
V2015175.xml
p11500
sa(dp11501
g3
VSTD-DPP-2000
p11502
sg5
S'PMC1360735'
p11503
sg7
VCD005270 v. 1.2 Long-term non-pharmacological weight loss interventions for adults with prediabetes.rm5
p11504
sg9
V11092283.xml
p11505
sa(dp11506
g3
VSTD-DPP-2002a
p11507
sg5
S'PMC1282458'
p11508
sg7
g11504
sg9
V12453955.xml
p11509
sa(dp11510
g3
VSTD-Jarrett-1987
p11511
sg5
S'PMC1052600'
p11512
sg7
g11504
sg9
V3655634.xml
p11513
sa(dp11514
g3
VSTD-Singh-2008
p11515
sg5
S'PMC2676172'
p11516
sg7
VCD008226 v. 2.0 Lipid lowering efficacy of atorvastatin.rm5
p11517
sg9
V18638594.xml
p11518
sa(dp11519
g3
VSTD-Welder-2010
p11520
sg5
S'PMC2918453'
p11521
sg7
g11517
sg9
V20525997.xml
p11522
sa(dp11523
g3
VSTD-SToP-AF-2011
p11524
sg5
S'PMC3022954'
p11525
sg7
g11517
sg9
V20946227.xml
p11526
sa(dp11527
g3
VSTD-Rosenson-2009
p11528
sg5
S'PMC2681027'
p11529
sg7
g11517
sg9
V19265025.xml
p11530
sa(dp11531
g3
VSTD-Park-2010
p11532
sg5
S'PMC2829413'
p11533
sg7
g11517
sg9
V20195400.xml
p11534
sa(dp11535
g3
VSTD-Miramadi-2008
p11536
sg5
S'PMC2526235'
p11537
sg7
g11517
sg9
V18492126.xml
p11538
sa(dp11539
g3
VSTD-Koh-2010
p11540
sg5
S'PMC3016087'
p11541
sg7
g11517
sg9
V20298928.xml
p11542
sa(dp11543
g3
VSTD-Cho-2011
p11544
sg5
S'PMC3079135'
p11545
sg7
g11517
sg9
V21519514.xml
p11546
sa(dp11547
g3
VSTD-STRENGTH-2008
p11548
sg5
S'PMC2995295'
p11549
sg7
g11517
sg9
V20031551.xml
p11550
sa(dp11551
g3
VSTD-Kom-2007
p11552
sg5
S'PMC2000588'
p11553
sg7
g11517
sg9
V17214829.xml
p11554
sa(dp11555
g3
VSTD-Davidson-1988
p11556
sg5
S'PMC461601'
p11557
sg7
VCD004356 v. 6.0 Short-term ambulatory oxygen for chronic obstructive pulmonary disease.rm5
p11558
sg9
V3238640.xml
p11559
sa(dp11560
g3
VSTD-Leggett-1977
p11561
sg5
S'PMC1630967'
p11562
sg7
g11558
sg9
V871805.xml
p11563
sa(dp11564
g3
VSTD-Garrod-1999
p11565
sg5
S'PMC1745430'
p11566
sg7
g11558
sg9
V10325901.xml
p11567
sa(dp11568
g3
VSTD-Garrod-2000
p11569
sg5
S'PMC1745814'
p11570
sg7
g11558
sg9
V10856310.xml
p11571
sa(dp11572
g3
VSTD-Louie-2011
p11573
sg5
S'PMC3198285'
p11574
sg7
VCD009275 v. 2.0 Different types of dietary advice for women with gestational diabetes mellitus.rm5
p11575
sg9
V21900148.xml
p11576
sa(dp11577
g3
VSTD-Moses-2009
p11578
sg5
S'PMC2681032'
p11579
sg7
g11575
sg9
V19279301.xml
p11580
sa(dp11581
g3
VSTD-Bonnar-1996
p11582
sg5
S'PMC2352023'
p11583
sg7
VCD000400 v. 8.0 Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.rm5
p11584
sg9
V8806245.xml
p11585
sa(dp11586
g3
VSTD-Sanchez-2002
p11587
sg5
S'PMC1725780'
p11588
sg7
VCD003237 v. 7.2 Modes of administration of antibiotics for symptomatic severe urinary tract infections.rm5
p11589
sg9
V11777865.xml
p11590
sa(dp11591
g3
VSTD-Rabinowitz-2011
p11592
sg5
S'PMC3738059'
p11593
sg7
VCD006396 v. 4.0 Interventions to prevent occupational noise-induced hearing loss.rm5
p11594
sg9
V21193566.xml
p11595
sa(dp11596
g3
VSTD-Del-Giglio-2008
p11597
sg5
S'PMC2628928'
p11598
sg7
VCD007913 v. 2.0 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile n.rm5
p11599
sg9
V19014494.xml
p11600
sa(dp11601
g3
VSTD-Kinmonth-1992
p11602
sg5
S'PMC1883680'
p11603
sg7
VCD004264 v. 7.0 Physical methods versus drug placebo or no treatment for managing fever in children.rm5
p11604
sg9
V1463951.xml
p11605
sa(dp11606
g3
VSTD-Newman-1985
p11607
sg5
S'PMC1345783'
p11608
sg7
g11604
sg9
V3978484.xml
p11609
sa(dp11610
g3
VSTD-Sarsfield-1979
p11611
sg5
S'PMC1596085'
p11612
sg7
VCD003163 v. 6.0 Topical nasal steroids for intermittent and persistent allergic rhinitis in children.rm5
p11613
sg9
V380773.xml
p11614
sa(dp11615
g3
VSTD-Sarman-1989b
p11616
sg5
S'PMC1792015'
p11617
sg7
VCD003062 v. 5.0 Cot-nursing versus incubator care for preterm infants.rm5
p11618
sg9
V2730122.xml
p11619
sa(dp11620
g3
VSTD-Sarman-1989a
p11621
sg5
S'PMC1590066'
p11622
sg7
g11618
sg9
V2923482.xml
p11623
sa(dp11624
g3
VSTD-Kuyvenhoven-1997
p11625
sg5
S'PMC1312903'
p11626
sg7
VMR000021 v. 4.0 Incentives and disincentives to participation by clinicians in randomised controlled trials.rm5
p11627
sg9
V9101682.xml
p11628
sa(dp11629
g3
VSTD-Earp-1982
p11630
sg5
S'PMC1650178'
p11631
sg7
VCD005182 v. 7.0 Interventions used to improve control of blood pressure in patients with hypertension.rm5
p11632
sg9
V7114339.xml
p11633
sa(dp11634
g3
VSTD-Bogden-1998
p11635
sg5
S'PMC1497023'
p11636
sg7
g11632
sg9
V9824519.xml
p11637
sa(dp11638
g3
VSTD-McKinstry-2006
p11639
sg5
S'PMC1927092'
p11640
sg7
g11632
sg9
V17132351.xml
p11641
sa(dp11642
g3
VSTD-Johnson-1978
p11643
sg5
S'PMC1819059'
p11644
sg7
g11632
sg9
V369673.xml
p11645
sa(dp11646
g3
VSTD-Robson-1989
p11647
sg5
S'PMC1835698'
p11648
sg7
g11632
sg9
V2495053.xml
p11649
sa(dp11650
g3
VSTD-Midanik-1991
p11651
sg5
S'PMC1580210'
p11652
sg7
g11632
sg9
V1899945.xml
p11653
sa(dp11654
g3
VSTD-Krieger-1999
p11655
sg5
S'PMC1508657'
p11656
sg7
g11632
sg9
V10358675.xml
p11657
sa(dp11658
g3
VSTD-Tobe-2006
p11659
sg5
S'PMC1435956'
p11660
sg7
g11632
sg9
V16595786.xml
p11661
sa(dp11662
g3
VSTD-Watkins-1987
p11663
sg5
S'PMC1711180'
p11664
sg7
g11632
sg9
V3503941.xml
p11665
sa(dp11666
g3
VSTD-Montgomery-2000
p11667
sg5
S'PMC27312'
p11668
sg7
g11632
sg9
V10710578.xml
p11669
sa(dp11670
g3
VSTD-McAlister-1986
p11671
sg5
S'PMC1341518'
p11672
sg7
g11632
sg9
V3092976.xml
p11673
sa(dp11674
g3
VSTD-Morisky-1983
p11675
sg5
S'PMC1650522'
p11676
sg7
g11632
sg9
V6849473.xml
p11677
sa(dp11678
g3
VSTD-Hunt-2004
p11679
sg5
S'PMC1492526'
p11680
sg7
g11632
sg9
V15333056.xml
p11681
sa(dp11682
g3
VSTD-McManus-2005
p11683
sg5
S'PMC1199029'
p11684
sg7
g11632
sg9
V16115830.xml
p11685
sa(dp11686
g3
VSTD-van-der-Klink-2003
p11687
sg5
S'PMC1740545'
p11688
sg7
VCD006389 v. 3.0 Interventions to facilitate return to work in adults with adjustment disorders.rm5
p11689
sg9
V12771395.xml
p11690
sa(dp11691
g3
VSTD-Bakker-2007
p11692
sg5
S'PMC1885369'
p11693
sg7
g11689
sg9
V17549228.xml
p11694
sa(dp11695
g3
VSTD-Cogswell-1985
p11696
sg5
S'PMC1777416'
p11697
sg7
VCD002173 v. 10.0 Inhaled sodium cromoglycate for asthma in children.rm5
p11698
sg9
V3929698.xml
p11699
sa(dp11700
g3
VSTD-Henry-1984
p11701
sg5
S'PMC1628434'
p11702
sg7
g11698
sg9
V6230059.xml
p11703
sa(dp11704
g3
VSTD-Glass-1981
p11705
sg5
S'PMC1627266'
p11706
sg7
g11698
sg9
V6791596.xml
p11707
sa(dp11708
g3
VSTD-Hiller-1977
p11709
sg5
S'PMC1544812'
p11710
sg7
g11698
sg9
V413493.xml
p11711
sa(dp11712
g3
VSTD-Edmunds-1980
p11713
sg5
S'PMC1714307'
p11714
sg7
g11698
sg9
V6775752.xml
p11715
sa(dp11716
g3
VSTD-Furfaro-1994
p11717
sg5
S'PMC1030013'
p11718
sg7
g11698
sg9
V7979527.xml
p11719
sa(dp11720
g3
VSTD-Irnich-2001
p11721
sg5
S'PMC33515'
p11722
sg7
VCD004870 v. 7.2 Acupuncture for neck disorders.rm5
p11723
sg9
V11431299.xml
p11724
sa(dp11725
g3
VSTD-Sharp-2007
p11726
sg5
S'PMC3749812'
p11727
sg7
VCD006657 v. 4.0 Indoor residual spraying for preventing malaria.rm5
p11728
sg9
V17255227.xml
p11729
sa(dp11730
g3
VSTD-Sooch-1965
p11731
sg5
S'PMC2555234'
p11732
sg7
VCD003204 v. 5.0 Iodised salt for preventing iodine deficiency disorders.rm5
p11733
sg9
V14315706.xml
p11734
sa(dp11735
g3
VSTD-Oh-2010
p11736
sg5
S'PMC2826100'
p11737
sg7
VCD007566 v. 2.2 Exercise interventions on health-related quality of life for cancer survivors.rm5
p11738
sg9
V19880433.xml
p11739
sa(dp11740
g3
VSTD-Dodd-2010
p11741
sg5
S'PMC2891044'
p11742
sg7
g11738
sg9
V20467301.xml
p11743
sa(dp11744
g3
VSTD-Brown-2009
p11745
sg5
S'PMC3040070'
p11746
sg7
VCD001867 v. 11.0 Opioid antagonists for alcohol dependence.rm5
p11747
sg9
V19673746.xml
p11748
sa(dp11749
g3
VSTD-Pettinati-2008b
p11750
sg5
S'PMC2600888'
p11751
sg7
g11747
sg9
V17664051.xml
p11752
sa(dp11753
g3
VSTD-Pettinati-2008a
p11754
sg5
S'PMC2374760'
p11755
sg7
g11747
sg9
V18079068.xml
p11756
sa(dp11757
g3
VSTD-Schmitz-2009
p11758
sg5
S'PMC2907651'
p11759
sg7
g11747
sg9
V19874153.xml
p11760
sa(dp11761
g3
VSTD-Oslin-2005
p11762
sg5
S'PMC3172720'
p11763
sg7
g11747
sg9
V15956269.xml
p11764
sa(dp11765
g3
VSTD-O_x0027_Malley-2008
p11766
sg5
S'PMC2746027'
p11767
sg7
g11747
sg9
V18482155.xml
p11768
sa(dp11769
g3
VSTD-Krudsood-2003
p11770
sg5
S'PMC3123522'
p11771
sg7
VCD005564 v. 6.0 Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.rm5
p11772
sg9
V12971556.xml
p11773
sa(dp11774
g3
VSTD-Sutherland-2005
p11775
sg5
S'PMC1087200'
p11776
sg7
g11772
sg9
V15839740.xml
p11777
sa(dp11778
g3
VSTD-van-der-Schans-1991
p11779
sg5
S'PMC463090'
p11780
sg7
VCD003147 v. 6.0 Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.rm5
p11781
sg9
V2038733.xml
p11782
sa(dp11783
g3
VSTD-Tyrrell-1986
p11784
sg5
S'PMC1777841'
p11785
sg7
g11781
sg9
V3524474.xml
p11786
sa(dp11787
g3
VSTD-Hofmeyr-1986
p11788
sg5
S'PMC460551'
p11789
sg7
g11781
sg9
V3296295.xml
p11790
sa(dp11791
g3
VSTD-Petrie-1989
p11792
sg5
S'PMC1835985'
p11793
sg7
VCD001520 v. 11.0 Melatonin for the prevention and treatment of jet lag.rm5
p11794
sg9
V2496815.xml
p11795
sa(dp11796
g3
VSTD-Burge-1982
p11797
sg5
S'PMC459315'
p11798
sg7
VCD006308 v. 4.0 Workplace interventions for treatment of occupational asthma.rm5
p11799
sg9
V7112471.xml
p11800
sa(dp11801
g3
VSTD-Lin-1996
p11802
sg5
S'PMC1128593'
p11803
sg7
g11799
sg9
V9038799.xml
p11804
sa(dp11805
g3
VSTD-Ridgway-2007
p11806
sg5
S'PMC1964725'
p11807
sg7
VCD004287 v. 8.0 Tissue adhesives for closure of surgical incisions.rm5
p11808
sg9
V17394707.xml
p11809
sa(dp11810
g3
VSTD-Rietveld-2005
p11811
sg5
S'PMC1570507'
p11812
sg7
VCD001211 v. 13.2 Antibiotics versus placebo for acute bacterial conjunctivitis.rm5
p11813
sg9
V16378561.xml
p11814
sa(dp11815
g3
VSTD-Ciliberto-2005
p11816
sg5
S'PMC557886'
p11817
sg7
VCD008147 v. 2.0 Supplementary vitamin E selenium cysteine and riboflavin for preventing kwashiorkor in preschool c.rm5
p11818
sg9
V15851401.xml
p11819
sa(dp11820
g3
VSTD-Silverman-1982
p11821
sg5
S'PMC1352475'
p11822
sg7
VCD003611 v. 7.0 Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.rm5
p11823
sg9
V6979982.xml
p11824
sa(dp11825
g3
VSTD-Eslami-2005
p11826
sg5
S'PMC1502073'
p11827
sg7
g11823
sg9
V16943938.xml
p11828
sa(dp11829
g3
VSTD-Butler-1993
p11830
sg5
S'PMC1025229'
p11831
sg7
g11823
sg9
V8038000.xml
p11832
sa(dp11833
g3
VSTD-Chavan-2010
p11834
sg5
S'PMC3034455'
p11835
sg7
g11823
sg9
V21358799.xml
p11836
sa(dp11837
g3
VSTD-Ormerod-1984
p11838
sg5
S'PMC481561'
p11839
sg7
g11823
sg9
V6610435.xml
p11840
sa(dp11841
g3
VSTD-Irnich-2001
p11842
sg5
S'PMC33515'
p11843
sg7
VCD004871 v. 10.0 Massage for mechanical neck disorders.rm5
p11844
sg9
V11431299.xml
p11845
sa(dp11846
g3
VSTD-Briem-2007
p11847
sg5
S'PMC2565604'
p11848
sg7
g11844
sg9
V19066648.xml
p11849
sa(dp11850
g3
VSTD-Sherman-2009
p11851
sg5
S'PMC2664516'
p11852
sg7
g11844
sg9
V19333174.xml
p11853
sa(dp11854
g3
VSTD-Helitzer-2011
p11855
sg5
S'PMC3539754'
p11856
sg7
VCD002213 v. 7.5 Interprofessional education effects on professional practice and healthcare outcomes (update).rm5
p11857
sg9
V20219315.xml
p11858
sa(dp11859
g3
VSTD-Morey-2002
p11860
sg5
S'PMC1464040'
p11861
sg7
g11857
sg9
V12546286.xml
p11862
sa(dp11863
g3
VSTD-Taylor-2007
p11864
sg5
S'PMC2464938'
p11865
sg7
g11857
sg9
V17693668.xml
p11866
sa(dp11867
g3
VSTD-Bialosky-2009
p11868
sg5
S'PMC2864088'
p11869
sg7
VCD009899 v. 1.0 Exercise and mobilisation interventions for carpal tunnel syndrome.rm5
p11870
sg9
V19801812.xml
p11871
sa(dp11872
g3
VSTD-Barth-2011
p11873
sg5
S'PMC3109880'
p11874
sg7
VCD002277 v. 10.0 Intravenous immunoglobulin for myasthenia gravis.rm5
p11875
sg9
V21562253.xml
p11876
sa(dp11877
g3
VSTD-FACS-2010
p11878
sg5
S'PMC2886041'
p11879
sg7
VCD006870 v. 4.0 Statins for acute coronary syndrome.rm5
p11880
sg9
V20500832.xml
p11881
sa(dp11882
g3
VSTD-O_x0027_Donnell-2003
p11883
sg5
S'PMC214016'
p11884
sg7
VCD008712 v. 4.0 Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.rm5
p11885
sg9
V14551096.xml
p11886
sa(dp11887
g3
VSTD-Kemp-1998
p11888
sg5
S'PMC2350295'
p11889
sg7
g11885
sg9
V8611831.xml
p11890
sa(dp11891
g3
VSTD-DiFrancisco-2007
p11892
sg5
S'PMC2465144'
p11893
sg7
VCD002759 v. 7.0 Progressive resistance strength training for improving physical function in older adults.rm5
p11894
sg9
V17062657.xml
p11895
sa(dp11896
g3
VSTD-Jette-1999
p11897
sg5
S'PMC1508501'
p11898
sg7
g11894
sg9
V9987467.xml
p11899
sa(dp11900
g3
VSTD-Foley-2003
p11901
sg5
S'PMC1754378'
p11902
sg7
g11894
sg9
V14644853.xml
p11903
sa(dp11904
g3
VSTD-Rhodes-2000
p11905
sg5
S'PMC1724140'
p11906
sg7
g11894
sg9
V10690445.xml
p11907
sa(dp11908
g3
VSTD-Fatouros-2005
p11909
sg5
S'PMC1725040'
p11910
sg7
g11894
sg9
V16183776.xml
p11911
sa(dp11912
g3
VSTD-Simpson-1992
p11913
sg5
S'PMC463573'
p11914
sg7
g11894
sg9
V1549826.xml
p11915
sa(dp11916
g3
VSTD-Sims-2006
p11917
sg5
S'PMC1698486'
p11918
sg7
g11894
sg9
V17134517.xml
p11919
sa(dp11920
g3
VSTD-Kluger-2007
p11921
sg5
S'PMC2206502'
p11922
sg7
VCD007877 v. 2.0 Haemostatic drugs for traumatic brain injury.rm5
p11923
sg9
V17686152.xml
p11924
sa(dp11925
g3
VSTD-Lofberg-1996
p11926
sg5
S'PMC1383237'
p11927
sg7
VCD002913 v. 6.2 Budesonide for maintenance of remission in Crohn's disease.rm5
p11928
sg9
V8881815.xml
p11929
sa(dp11930
g3
VSTD-Cortot-2001
p11931
sg5
S'PMC1728198'
p11932
sg7
g11928
sg9
V11156638.xml
p11933
sa(dp11934
g3
VSTD-Gross-1998
p11935
sg5
S'PMC1727061'
p11936
sg7
g11928
sg9
V9616309.xml
p11937
sa(dp11938
g3
VSTD-Cashman-1961
p11939
sg5
S'PMC1953822'
p11940
sg7
VCD005993 v. 5.0 Procaine treatments for cognition and dementia.rm5
p11941
sg9
V13691281.xml
p11942
sa(dp11943
g3
VSTD-Rossi-1986-_x002d_-AHE
p11944
sg5
S'PMC1434629'
p11945
sg7
VCD001939 v. 8.0 Branched-chain amino acids for hepatic encephalopathy.rm5
p11946
sg9
V3539709.xml
p11947
sa(dp11948
g3
VSTD-Tyrrell-1989a
p11949
sg5
S'PMC1836535'
p11950
sg7
VCD001728 v. 13.0 Heated humidified air for the common cold.rm5
p11951
sg9
V2500196.xml
p11952
sa(dp11953
g3
VSTD-Tyrrell-1989b
p11954
sg5
S'PMC1836535'
p11955
sg7
g11951
sg9
V2500196.xml
p11956
sa(dp11957
g3
VSTD-Prabhu-1997
p11958
sg5
S'PMC1720662'
p11959
sg7
VCD001694 v. 8.0 Aerosolized diuretics for preterm infants with (or developing) chronic lung disease.rm5
p11960
sg9
V9279180.xml
p11961
sa(dp11962
g3
VSTD-Hindle-1972
p11963
sg5
S'PMC1518609'
p11964
sg7
VCD004252 v. 7.2 Muscle relaxants for non-specific low-back pain.rm5
p11965
sg9
V4262210.xml
p11966
sa(dp11967
g3
VSTD-Fleming-1995
p11968
sg5
S'PMC2271576'
p11969
sg7
VCD004876 v. 9.0 Vaccines for preventing influenza in the elderly.rm5
p11970
sg9
V8557090.xml
p11971
sa(dp11972
g3
VSTD-Puig_x002d_Barber_x00e0_-1997
p11973
sg5
S'PMC1060539'
p11974
sg7
g11970
sg9
V9425463.xml
p11975
sa(dp11976
g3
VSTD-Nicholson-1999
p11977
sg5
S'PMC2810733'
p11978
sg7
g11970
sg9
V10487646.xml
p11979
sa(dp11980
g3
VSTD-Ahmed-1997
p11981
sg5
S'PMC2808769'
p11982
sg7
g11970
sg9
V9042032.xml
p11983
sa(dp11984
g3
VSTD-Keitel-1996
p11985
sg5
S'PMC170397'
p11986
sg7
g11970
sg9
V8877126.xml
p11987
sa(dp11988
g3
VSTD-Govaert-1993
p11989
sg5
S'PMC1679213'
p11990
sg7
g11970
sg9
V8241913.xml
p11991
sa(dp11992
g3
VSTD-Mukerjee-1994
p11993
sg5
S'PMC1060042'
p11994
sg7
g11970
sg9
V7830018.xml
p11995
sa(dp11996
g3
VSTD-Horman-1986
p11997
sg5
S'PMC1646616'
p11998
sg7
g11970
sg9
V3963278.xml
p11999
sa(dp12000
g3
VSTD-Garry-2004
p12001
sg5
S'PMC314503'
p12002
sg7
VCD003677 v. 8.0 Surgical approach to hysterectomy for benign gynaecological disease.rm5
p12003
sg9
V14711749.xml
p12004
sa(dp12005
g3
VSTD-Warburton-2000
p12006
sg5
S'PMC1730594'
p12007
sg7
VCD005244 v. 9.2 Interventions in the alcohol server setting for preventing injuries.rm5
p12008
sg9
V10728540.xml
p12009
sa(dp12010
g3
VSTD-Howard_x002d_Pitney-1991
p12011
sg5
S'PMC1404951'
p12012
sg7
g12008
sg9
V1990858.xml
p12013
sa(dp12014
g3
VSTD-Russ-1987
p12015
sg5
S'PMC1647259'
p12016
sg7
g12008
sg9
V3605473.xml
p12017
sa(dp12018
g3
VSTD-Yu-2008
p12019
sg5
S'PMC2613766'
p12020
sg7
VCD002024 v. 15.2 Alpha2-adrenergic agonists for the management of opioid withdrawal.rm5
p12021
sg9
V18508207.xml
p12022
sa(dp12023
g3
VSTD-Pincus-a-2004
p12024
sg5
S'PMC1755088'
p12025
sg7
VCD004257 v. 6.0 Acetaminophen for osteoarthritis.rm5
p12026
sg9
V15082468.xml
p12027
sa(dp12028
g3
VSTD-Boureau-2004
p12029
sg5
S'PMC1755112'
p12030
sg7
g12026
sg9
V15308513.xml
p12031
sa(dp12032
g3
VSTD-Miceli_x002d_Richard-2004
p12033
sg5
S'PMC1755093'
p12034
sg7
g12026
sg9
V15249319.xml
p12035
sa(dp12036
g3
VSTD-Pincus-b-2004
p12037
sg5
S'PMC1755088'
p12038
sg7
g12026
sg9
V15082468.xml
p12039
sa(dp12040
g3
VSTD-Gibbons-2001
p12041
sg5
S'PMC3620829'
p12042
sg7
VCD007911 v. 2.0 Cryotherapy following total knee replacement.rm5
p12043
sg9
V11561502.xml
p12044
sa(dp12045
g3
VSTD-Poustie-2006
p12046
sg5
S'PMC1403226'
p12047
sg7
VCD001914 v. 8.0 Oral protein calorie supplementation for children with chronic disease.rm5
p12048
sg9
V16467348.xml
p12049
sa(dp12050
g3
VSTD-Dougados-1988
p12051
sg5
S'PMC1003464'
p12052
sg7
VCD001083 v. 7.0 Cyclosporine for treating rheumatoid arthritis.rm5
p12053
sg9
V3281603.xml
p12054
sa(dp12055
g3
VSTD-Dorward-1988
p12056
sg5
S'PMC1020749'
p12057
sg7
VCD001187 v. 9.0 House dust mite control measures for asthma.rm5
p12058
sg9
V3353895.xml
p12059
sa(dp12060
g3
VSTD-de-Vries-2007
p12061
sg5
S'PMC2042544'
p12062
sg7
g12058
sg9
V17359604.xml
p12063
sa(dp12064
g3
VSTD-Warner-1993
p12065
sg5
S'PMC464427'
p12066
sg7
g12058
sg9
V8511730.xml
p12067
sa(dp12068
g3
VSTD-Sheikh-2002
p12069
sg5
S'PMC116603'
p12070
sg7
g12058
sg9
V12079502.xml
p12071
sa(dp12072
g3
VSTD-Burr-1980A
p12073
sg5
S'PMC471322'
p12074
sg7
g12058
sg9
V7001667.xml
p12075
sa(dp12076
g3
VSTD-Burr-1980B
p12077
sg5
S'PMC471323'
p12078
sg7
g12058
sg9
V7001668.xml
p12079
sa(dp12080
g3
VSTD-Alfageme-2006
p12081
sg5
S'PMC2080738'
p12082
sg7
VCD001390 v. 7.0 Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmo.rm5
p12083
sg9
V16227328.xml
p12084
sa(dp12085
g3
VSTD-Leech-1987
p12086
sg5
S'PMC1492041'
p12087
sg7
g12083
sg9
V3545418.xml
p12088
sa(dp12089
g3
VSTD-Jadad-1993b
p12090
sg5
S'PMC1678459'
p12091
sg7
VMR000001 v. 5.0 Handsearching versus electronic searching to identify reports of randomized trials.rm5
p12092
sg9
V8343701.xml
p12093
sa(dp12094
g3
VSTD-Cullum-1997
p12095
sg5
S'PMC1055436'
p12096
sg7
g12092
sg9
V10166598.xml
p12097
sa(dp12098
g3
VSTD-von-Muhlen-2007
p12099
sg5
S'PMC2574781'
p12100
sg7
VCD006221 v. 4.0 Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people.rm5
p12101
sg9
V18482290.xml
p12102
sa(dp12103
g3
VSTD-Garrett-1998
p12104
sg5
S'PMC1717626'
p12105
sg7
VCD007524 v. 3.0 Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adul.rm5
p12106
sg9
V9771245.xml
p12107
sa(dp12108
g3
VSTD-Fitzgerald-2004
p12109
sg5
S'PMC1747069'
p12110
sg7
g12106
sg9
V15223858.xml
p12111
sa(dp12112
g3
VSTD-Lincoln-2002
p12113
sg5
S'PMC1737698'
p12114
sg7
VCD008754 v. 2.1 Memory Rehabilitation for people with multiple sclerosis.rm5
p12115
sg9
V11784832.xml
p12116
sa(dp12117
g3
VSTD-Sokal-2004
p12118
sg5
S'PMC406425'
p12119
sg7
VCD003991 v. 10.0 Vasectomy occlusion techniques for male sterilization.rm5
p12120
sg9
V15056388.xml
p12121
sa(dp12122
g3
VSTD-Ryu-2006
p12123
sg5
S'PMC3489408'
p12124
sg7
VCD004958 v. 8.0 Single or double-level anterior interbody fusion techniques for cervical degenerative disc disease.rm5
p12125
sg9
V15980998.xml
p12126
sa(dp12127
g3
VSTD-Zoega-2000
p12128
sg5
S'PMC3611372'
p12129
sg7
g12125
sg9
V10823430.xml
p12130
sa(dp12131
g3
VSTD-Stulik-2007
p12132
sg5
S'PMC2078301'
p12133
sg7
g12125
sg9
V17684777.xml
p12134
sa(dp12135
g3
VSTD-Lofgren-2010
p12136
sg5
S'PMC2899760'
p12137
sg7
g12125
sg9
V19763634.xml
p12138
sa(dp12139
g3
VSTD-Ruetten-2009
p12140
sg5
S'PMC2899164'
p12141
sg7
g12125
sg9
V19015851.xml
p12142
sa(dp12143
g3
VSTD-Dai-2008
p12144
sg5
S'PMC2367424'
p12145
sg7
g12125
sg9
V18301927.xml
p12146
sa(dp12147
g3
VSTD-Lind-2007
p12148
sg5
S'PMC2200784'
p12149
sg7
g12125
sg9
V17342510.xml
p12150
sa(dp12151
g3
VSTD-Hsu-2010
p12152
sg5
S'PMC2829694'
p12153
sg7
VCD007999 v. 2.52 Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding.rm5
p12154
sg9
V20233195.xml
p12155
sa(dp12156
g3
VSTD-Tsai-2009
p12157
sg5
S'PMC2675043'
p12158
sg7
g12154
sg9
V19523014.xml
p12159
sa(dp12160
g3
VSTD-Southampton
p12161
sg5
S'PMC1971367'
p12162
sg7
VCD007309 v. 5.0 Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cance.rm5
p12163
sg9
V1691921.xml
p12164
sa(dp12165
g3
VSTD-RLW-8351
p12166
sg5
S'PMC1971367'
p12167
sg7
g12163
sg9
V1691921.xml
p12168
sa(dp12169
g3
VSTD-BLT2
p12170
sg5
S'PMC1746842'
p12171
sg7
g12163
sg9
V15454647.xml
p12172
sa(dp12173
g3
VSTD-BLT1
p12174
sg5
S'PMC1746842'
p12175
sg7
g12163
sg9
V15454647.xml
p12176
sa(dp12177
g3
VSTD-Manchester-1
p12178
sg5
S'PMC2374661'
p12179
sg7
g12163
sg9
V10945489.xml
p12180
sa(dp12181
g3
VSTD-UK-BEAM-trial-2004
p12182
sg5
S'PMC535454'
p12183
sg7
VCD008112 v. 5.0 Spinal manipulative therapy for chronic low-back pain.rm5
p12184
sg9
V15556955.xml
p12185
sa(dp12186
g3
VSTD-Gudavalli-2006
p12187
sg5
S'PMC3233943'
p12188
sg7
g12184
sg9
V16341712.xml
p12189
sa(dp12190
g3
VSTD-Koes-1992
p12191
sg5
S'PMC1881307'
p12192
sg7
g12184
sg9
V1532760.xml
p12193
sa(dp12194
g3
VSTD-Charleston-1996
p12195
sg5
S'PMC2364502'
p12196
sg7
VCD002256 v. 9.0 Treatments for symptomatic urinary tract infections during pregnancy.rm5
p12197
sg9
V18476110.xml
p12198
sa(dp12199
g3
VSTD-Lim-2009
p12200
sg5
S'PMC2687520'
p12201
sg7
VCD008586 v. 2.0 Antiepileptic drugs for treating seizures in adults with brain tumours.rm5
p12202
sg9
V19169651.xml
p12203
sa(dp12204
g3
VSTD-Yamac-1995
p12205
sg5
S'PMC2398107'
p12206
sg7
VCD000026 v. 12.0 Routine versus selective antifungal administration for control of fungal infections in patients with.rm5
p12207
sg9
V7596933.xml
p12208
sa(dp12209
g3
VSTD-Lundgren-1989
p12210
sg5
S'PMC1493950'
p12211
sg7
VCD002000 v. 7.0 Bypass surgery for chronic lower limb ischaemia.rm5
p12212
sg9
V2647051.xml
p12213
sa(dp12214
g3
VSTD-Itoh-2008
p12215
sg5
S'PMC2268695'
p12216
sg7
VCD002823 v. 8.2 Transcutaneous electrostimulation for osteoarthritis of the knee.rm5
p12217
sg9
V18312661.xml
p12218
sa(dp12219
g3
VSTD-Charron_x002d_Prochownik-2008
p12220
sg5
S'PMC2453657'
p12221
sg7
VCD007776 v. 3.0 Preconception care for diabetic women for improving maternal and infant health.rm5
p12222
sg9
V18411239.xml
p12223
sa(dp12224
g3
VSTD-Sorenson-2008
p12225
sg5
S'PMC2617770'
p12226
sg7
VCD002064 v. 8.2 Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sc.rm5
p12227
sg9
V19029516.xml
p12228
sa(dp12229
g3
VSTD-Bootsma-1995
p12230
sg5
S'PMC475016'
p12231
sg7
VCD002310 v. 11.2 Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.rm5
p12232
sg9
V7491551.xml
p12233
sa(dp12234
g3
VSTD-Fitzgerald-1998
p12235
sg5
S'PMC1745293'
p12236
sg7
g12232
sg9
V9828851.xml
p12237
sa(dp12238
g3
VSTD-Currie-2002
p12239
sg5
S'PMC1746197'
p12240
sg7
g12232
sg9
V12324672.xml
p12241
sa(dp12242
g3
VSTD-Ringdal-1996
p12243
sg5
S'PMC2365805'
p12244
sg7
g12232
sg9
V18475734.xml
p12245
sa(dp12246
g3
VSTD-Harrison-2001
p12247
sg5
S'PMC1758787'
p12248
sg7
g12232
sg9
V11182010.xml
p12249
sa(dp12250
g3
VSTD-Fabbri-1993
p12251
sg5
S'PMC464708'
p12252
sg7
g12232
sg9
V8211872.xml
p12253
sa(dp12254
g3
VSTD-Phillips-2004
p12255
sg5
S'PMC1758859'
p12256
sg7
g12232
sg9
V14694242.xml
p12257
sa(dp12258
g3
VSTD-Hughes-1999b
p12259
sg5
S'PMC1745450'
p12260
sg7
g12232
sg9
V10325897.xml
p12261
sa(dp12262
g3
VSTD-Gustafsson-1993
p12263
sg5
S'PMC1029458'
p12264
sg7
g12232
sg9
V8215522.xml
p12265
sa(dp12266
g3
VSTD-Fonseca-2008
p12267
sg5
S'PMC2494667'
p12268
sg7
VCD009361 v. 2.2 Colesevelam for type 2 diabetes mellitus.rm5
p12269
sg9
V18458145.xml
p12270
sa(dp12271
g3
VSTD-Ruottinen-1996-_x0028_a_x0029_
p12272
sg5
S'PMC486187'
p12273
sg7
VCD004554 v. 4.0 Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.rm5
p12274
sg9
V8558148.xml
p12275
sa(dp12276
g3
VSTD-Brooks-UK_x002d_IRISH-2003
p12277
sg5
S'PMC1738605'
p12278
sg7
g12274
sg9
V12876237.xml
p12279
sa(dp12280
g3
VSTD-Baas-1997
p12281
sg5
S'PMC2169755'
p12282
sg7
g12274
sg9
V9343116.xml
p12283
sa(dp12284
g3
VSTD-Sakamoto-2007-_x0028_JFMTC15_x002d_1_x0029_
p12285
sg5
S'PMC2360162'
p12286
sg7
VCD004078 v. 4.0 Postoperative adjuvant chemotherapy in rectal cancer operated for cure..rm5
p12287
sg9
V17375049.xml
p12288
sa(dp12289
g3
VSTD-Taal-2001-_x0028_NACCP_x0029_
p12290
sg5
S'PMC2363941'
p12291
sg7
g12287
sg9
V11720425.xml
p12292
sa(dp12293
g3
VSTD-Nucci-1999
p12294
sg5
S'PMC89294'
p12295
sg7
VCD000969 v. 11.0 Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia.rm5
p12296
sg9
V10348768.xml
p12297
sa(dp12298
g3
VSTD-Nath-1999
p12299
sg5
S'PMC89289'
p12300
sg7
g12296
sg9
V10348763.xml
p12301
sa(dp12302
g3
VSTD-Pope-2008
p12303
sg5
S'PMC2632747'
p12304
sg7
VCD003318 v. 6.0 Strategies for integrating primary health services in low- and middle-income countries at the point .rm5
p12305
sg9
V18520677.xml
p12306
sa(dp12307
g3
VSTD-Leon-2010
p12308
sg5
S'PMC2825497'
p12309
sg7
g12305
sg9
V20205841.xml
p12310
sa(dp12311
g3
VSTD-Gregson-2007
p12312
sg5
S'PMC1831737'
p12313
sg7
g12305
sg9
V17388666.xml
p12314
sa(dp12315
g3
VSTD-Glasgow-2010
p12316
sg5
S'PMC2988142'
p12317
sg7
VCD008776 v. 2.0 Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus.rm5
p12318
sg9
V20714820.xml
p12319
sa(dp12320
g3
VSTD-Lorig-2010
p12321
sg5
S'PMC2875437'
p12322
sg7
g12318
sg9
V20299481.xml
p12323
sa(dp12324
g3
VSTD-Quinn-2011
p12325
sg5
S'PMC3161305'
p12326
sg7
g12318
sg9
V21788632.xml
p12327
sa(dp12328
g3
VSTD-Lim-2011
p12329
sg5
S'PMC3024339'
p12330
sg7
g12318
sg9
V21270188.xml
p12331
sa(dp12332
g3
VSTD-Walsh-1999
p12333
sg5
S'PMC1508522'
p12334
sg7
VCD005084 v. 6.0 Interventions for tobacco cessation in the dental setting.rm5
p12335
sg9
V9949754.xml
p12336
sa(dp12337
g3
VSTD-Stevens-1995
p12338
sg5
S'PMC1615327'
p12339
sg7
g12335
sg9
V7856783.xml
p12340
sa(dp12341
g3
VSTD-Gordon-2010b
p12342
sg5
S'PMC2882418'
p12343
sg7
g12335
sg9
V20466951.xml
p12344
sa(dp12345
g3
VSTD-Binnie-2007
p12346
sg5
S'PMC1871574'
p12347
sg7
g12335
sg9
V17475005.xml
p12348
sa(dp12349
g3
VSTD-Gordon-2010a
p12350
sg5
S'PMC3780769'
p12351
sg7
g12335
sg9
V20675426.xml
p12352
sa(dp12353
g3
VSTD-Nohlert-2009
p12354
sg5
S'PMC2685131'
p12355
sg7
g12335
sg9
V19405969.xml
p12356
sa(dp12357
g3
VSTD-Horan-2009
p12358
sg5
S'PMC2653055'
p12359
sg7
VCD005147 v. 6.0 Training to recognise the early signs of recurrence in schizophrenia.rm5
p12360
sg9
V18930378.xml
p12361
sa(dp12362
g3
VSTD-Levy-1996
p12363
sg5
S'PMC1090518'
p12364
sg7
VCD002316 v. 9.14 Inhaled steroids for acute asthma following emergency department discharge.rm5
p12365
sg9
V8958890.xml
p12366
sa(dp12367
g3
VSTD-Gentry-1990
p12368
sg5
S'PMC171517'
p12369
sg7
VCD004439 v. 5.0 Antibiotics for treating chronic osteomyelitis in adults.rm5
p12370
sg9
V2183710.xml
p12371
sa(dp12372
g3
VSTD-Gentry-1991
p12373
sg5
S'PMC245046'
p12374
sg7
g12370
sg9
V2039205.xml
p12375
sa(dp12376
g3
VSTD-Greenberg-2000
p12377
sg5
S'PMC89644'
p12378
sg7
g12370
sg9
V10602739.xml
p12379
sa(dp12380
g3
VSTD-Sheftel-1986
p12381
sg5
S'PMC180374'
p12382
sg7
g12370
sg9
V3524419.xml
p12383
sa(dp12384
g3
VSTD-Brown-2001
p12385
sg5
S'PMC1832078'
p12386
sg7
VCD001007 v. 8.0 Group behaviour therapy programmes for smoking cessation.rm5
p12387
sg9
V11495176.xml
p12388
sa(dp12389
g3
VSTD-Brown-2007
p12390
sg5
S'PMC2213513'
p12391
sg7
g12387
sg9
V17577801.xml
p12392
sa(dp12393
g3
VSTD-Lando-1990
p12394
sg5
S'PMC1404660'
p12395
sg7
g12387
sg9
V2327531.xml
p12396
sa(dp12397
g3
VSTD-DePaul-1987
p12398
sg5
S'PMC1350178'
p12399
sg7
g12387
sg9
V2782506.xml
p12400
sa(dp12401
g3
VSTD-Shapiro-2008
p12402
sg5
S'PMC2592683'
p12403
sg7
VCD007457 v. 2.0 Mobile phone messaging for preventive health care.rm5
p12404
sg9
V18984496.xml
p12405
sa(dp12406
g3
VSTD-Jack-2009
p12407
sg5
S'PMC2738592'
p12408
sg7
VCD000313 v. 7.9 Discharge planning from hospital to home.rm5
p12409
sg9
V19189907.xml
p12410
sa(dp12411
g3
VSTD-Moher-1992
p12412
sg5
S'PMC1488427'
p12413
sg7
g12409
sg9
V1737315.xml
p12414
sa(dp12415
g3
VSTD-Balaban-2008
p12416
sg5
S'PMC2517968'
p12417
sg7
g12409
sg9
V18452048.xml
p12418
sa(dp12419
g3
VSTD-Hassan-2001
p12420
sg5
S'PMC3455693'
p12421
sg7
VCD002249 v. 5.0 Clomiphene and anti-oestrogens for ovulation induction in PCOS.rm5
p12422
sg9
V11804430.xml
p12423
sa(dp12424
g3
VSTD-Rubenstein-1965
p12425
sg5
S'PMC2031530'
p12426
sg7
VCD007180 v. 3.0 Interventions to improve disposal of human excreta for preventing diarrhoea.rm5
p12427
sg9
V4982076.xml
p12428
sa(dp12429
g3
VSTD-Garrett-2008
p12430
sg5
S'PMC2870746'
p12431
sg7
g12427
sg9
V18205977.xml
p12432
sa(dp12433
g3
VSTD-McCabe-1957
p12434
sg5
S'PMC2031363'
p12435
sg7
g12427
sg9
V13465958.xml
p12436
sa(dp12437
g3
VSTD-van-Sprundel-2005
p12438
sg5
S'PMC2361560'
p12439
sg7
VCD002748 v. 9.2 Prophylactic mastectomy for the prevention of breast cancer.rm5
p12440
sg9
V16052221.xml
p12441
sa(dp12442
g3
VSTD-Hatcher-2001
p12443
sg5
S'PMC26594'
p12444
sg7
g12440
sg9
V11154619.xml
p12445
sa(dp12446
g3
VSTD-Horton-1978
p12447
sg5
S'PMC1397010'
p12448
sg7
g12440
sg9
V736655.xml
p12449
sa(dp12450
g3
VSTD-Jenkins-1997
p12451
sg5
S'PMC1380945'
p12452
sg7
VCD001745 v. 8.0 Community interventions for reducing smoking among adults.rm5
p12453
sg9
V9224191.xml
p12454
sa(dp12455
g3
VSTD-Fisher-1998
p12456
sg5
S'PMC1508568'
p12457
sg7
g12453
sg9
V9807532.xml
p12458
sa(dp12459
g3
VSTD-Secker_x002d_Walker-2000
p12460
sg5
S'PMC1446253'
p12461
sg7
g12453
sg9
V10846513.xml
p12462
sa(dp12463
g3
VSTD-Weinehall-1999
p12464
sg5
S'PMC1756863'
p12465
sg7
g12453
sg9
V10396552.xml
p12466
sa(dp12467
g3
VSTD-Lando-1995
p12468
sg5
S'PMC1615309'
p12469
sg7
g12453
sg9
V7856779.xml
p12470
sa(dp12471
g3
VSTD-Baxter-1997
p12472
sg5
S'PMC2127433'
p12473
sg7
g12453
sg9
V9302957.xml
p12474
sa(dp12475
g3
VSTD-Carleton-1995
p12476
sg5
S'PMC1615494'
p12477
sg7
g12453
sg9
V7762709.xml
p12478
sa(dp12479
g3
VSTD-O_x0027_Loughlin-1999
p12480
sg5
S'PMC1509008'
p12481
sg7
g12453
sg9
V10589309.xml
p12482
sa(dp12483
g3
VSTD-Brownson-1996
p12484
sg5
S'PMC1380329'
p12485
sg7
g12453
sg9
V8633737.xml
p12486
sa(dp12487
g3
VSTD-Tudor_x002d_Smith-1998
p12488
sg5
S'PMC28483'
p12489
sg7
g12453
sg9
V9549451.xml
p12490
sa(dp12491
g3
VSTD-Giamarellou-2000
p12492
sg5
S'PMC90190'
p12493
sg7
VCD003992 v. 6.0 Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.rm5
p12494
sg9
V11083625.xml
p12495
sa(dp12496
g3
VSTD-Jacobs-1968
p12497
sg5
S'PMC1986152'
p12498
sg7
VCD000396 v. 11.0 Non-steroidal anti-inflammatory drugs for low back pain.rm5
p12499
sg9
V4232743.xml
p12500
sa(dp12501
g3
VSTD-Berry-1982
p12502
sg5
S'PMC1000895'
p12503
sg7
g12499
sg9
V6462116.xml
p12504
sa(dp12505
g3
VSTD-Stenius-2000
p12506
sg5
S'PMC27319'
p12507
sg7
VCD004674 v. 4.0 Calorie controlled diet for chronic asthma.rm5
p12508
sg9
V10731173.xml
p12509
sa(dp12510
g3
VSTD-McEvoy-2010
p12511
sg5
S'PMC2878893'
p12512
sg7
VCD003935 v. 12.0 Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal h.rm5
p12513
sg9
V20227053.xml
p12514
sa(dp12515
g3
VSTD-Bowler-1995
p12516
sg5
S'PMC1511379'
p12517
sg7
VCD005087 v. 7.0 Sodium channel blockers for cystic fibrosis.rm5
p12518
sg9
V8554360.xml
p12519
sa(dp12520
g3
VSTD-Wysocki-2001
p12521
sg5
S'PMC90678'
p12522
sg7
VCD008481 v. 3.0 Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.rm5
p12523
sg9
V11502515.xml
p12524
sa(dp12525
g3
VSTD-Sakka-2007
p12526
sg5
S'PMC2043189'
p12527
sg7
g12523
sg9
V17620371.xml
p12528
sa(dp12529
g3
VSTD-van-Zanten-2007
p12530
sg5
S'PMC2000713'
p12531
sg7
g12523
sg9
V16869814.xml
p12532
sa(dp12533
g3
VSTD-Lau-2006
p12534
sg5
S'PMC1635208'
p12535
sg7
g12523
sg9
V16940077.xml
p12536
sa(dp12537
g3
VSTD-Angus-2000
p12538
sg5
S'PMC2014958'
p12539
sg7
g12523
sg9
V10792202.xml
p12540
sa(dp12541
g3
VSTD-Cucchiara-1987
p12542
sg5
S'PMC1778411'
p12543
sg7
VCD002300 v. 14.0 Cisapride treatment for gastro-oesophageal reflux in children.rm5
p12544
sg9
V3300570.xml
p12545
sa(dp12546
g3
VSTD-Greally-1992
p12547
sg5
S'PMC1793694'
p12548
sg7
g12544
sg9
V1599300.xml
p12549
sa(dp12550
g3
VSTD-Casley_x002d_Smith-1993_x0028_2_x0029_
p12551
sg5
S'PMC1679230'
p12552
sg7
VCD003140 v. 11.0 Benzo-pyrones for reducing and controlling lymphoedema of the limbs.rm5
p12553
sg9
V8251778.xml
p12554
sa(dp12555
g3
VSTD-Sartain-2001
p12556
sg5
S'PMC1763073'
p12557
sg7
VCD004383 v. 5.2 Specialist home-based nursing services for children with acute and chronic illnesses.rm5
p12558
sg9
V12390903.xml
p12559
sa(dp12560
g3
VSTD-Burch-2000
p12561
sg5
S'PMC1421072'
p12562
sg7
VCD005477 v. 5.0 Single layer versus double layer suture anastomosis of the gastrointestinal tract.rm5
p12563
sg9
V10816626.xml
p12564
sa(dp12565
g3
VSTD-Kitchener-2009
p12566
sg5
S'PMC2646126'
p12567
sg7
VCD007585 v. 2.0 Lymphadenectomy for the management of endometrial cancer.rm5
p12568
sg9
V19070889.xml
p12569
sa(dp12570
g3
VSTD-Stevinson-2003
p12571
sg5
S'PMC539394'
p12572
sg7
VCD004158 v. 5.0 Rehabilitation following carpal tunnel release.rm5
p12573
sg9
V12562974.xml
p12574
sa(dp12575
g3
VSTD-Goorney-1989
p12576
sg5
S'PMC1194323'
p12577
sg7
VCD001036 v. 9.0 Collection devices for obtaining cervical cytology samples.rm5
p12578
sg9
V2759604.xml
p12579
sa(dp12580
g3
VSTD-Szarewski-1990
p12581
sg5
S'PMC1194584'
p12582
sg7
g12578
sg9
V2265842.xml
p12583
sa(dp12584
g3
VSTD-Wolfendale-1987
p12585
sg5
S'PMC1245047'
p12586
sg7
g12578
sg9
V3101790.xml
p12587
sa(dp12588
g3
VSTD-Yeung-2009a
p12589
sg5
S'PMC2717194'
p12590
sg7
VCD005472 v. 6.2 Acupuncture for insomnia.rm5
p12591
sg9
V19725255.xml
p12592
sa(dp12593
g3
VSTD-Merenstein-2010
p12594
sg5
S'PMC2906750'
p12595
sg7
VCD006895 v. 4.0 Probiotics for preventing acute upper respiratory tract infections.rm5
p12596
sg9
V20485304.xml
p12597
sa(dp12598
g3
VSTD-West-2011
p12599
sg5
S'PMC3083335'
p12600
sg7
g12596
sg9
V21477383.xml
p12601
sa(dp12602
g3
VSTD-Garc_x00ed_a-2005
p12603
sg5
S'PMC1087340'
p12604
sg7
VCD008603 v. 3.0 Oral vaccines for preventing cholera.rm5
p12605
sg9
V15845509.xml
p12606
sa(dp12607
g3
VSTD-Migasena-1989a
p12608
sg5
S'PMC259791'
p12609
sg7
g12605
sg9
V2807523.xml
p12610
sa(dp12611
g3
VSTD-Lagos-1995
p12612
sg5
S'PMC173056'
p12613
sg7
g12605
sg9
V7822046.xml
p12614
sa(dp12615
g3
VSTD-Gotuzzo-1993
p12616
sg5
S'PMC281106'
p12617
sg7
g12605
sg9
V8359923.xml
p12618
sa(dp12619
g3
VSTD-Perry-1998
p12620
sg5
S'PMC2305629'
p12621
sg7
g12605
sg9
V9615498.xml
p12622
sa(dp12623
g3
VSTD-Cohen-2002
p12624
sg5
S'PMC127885'
p12625
sg7
g12605
sg9
V11895960.xml
p12626
sa(dp12627
g3
VSTD-Mahalanabis-2008
p12628
sg5
S'PMC2396289'
p12629
sg7
g12605
sg9
V18523643.xml
p12630
sa(dp12631
g3
VSTD-Tacket-1999
p12632
sg5
S'PMC97039'
p12633
sg7
g12605
sg9
V10569747.xml
p12634
sa(dp12635
g3
VSTD-Kotloff-1992
p12636
sg5
S'PMC257485'
p12637
sg7
g12605
sg9
V1398956.xml
p12638
sa(dp12639
g3
VSTD-Ben_x00ed_tez-1999
p12640
sg5
S'PMC96352'
p12641
sg7
g12605
sg9
V9916056.xml
p12642
sa(dp12643
g3
VSTD-Trach-2002
p12644
sg5
S'PMC2567633'
p12645
sg7
g12605
sg9
V11884967.xml
p12646
sa(dp12647
g3
VSTD-WHO-BISG-1996
p12648
sg5
S'PMC1380435'
p12649
sg7
VCD001857 v. 7.0 Interventions for preventing injuries in problem drinkers.rm5
p12650
sg9
V8669518.xml
p12651
sa(dp12652
g3
VSTD-Gentilello-1999
p12653
sg5
S'PMC1420896'
p12654
sg7
g12650
sg9
V10522717.xml
p12655
sa(dp12656
g3
VSTD-Algotar-200_x03bc_g-2010
p12657
sg5
S'PMC2913148'
p12658
sg7
VCD009671 v. 2.0 Selenium supplementation for the primary prevention of cardiovascular disease.rm5
p12659
sg9
V20670733.xml
p12660
sa(dp12661
g3
VSTD-Algotar-2010
p12662
sg5
S'PMC2913148'
p12663
sg7
g12659
sg9
V20670733.xml
p12664
sa(dp12665
g3
VSTD-Algotar-800_x03bc_g-2010
p12666
sg5
S'PMC2913148'
p12667
sg7
g12659
sg9
V20670733.xml
p12668
sa(dp12669
g3
VSTD-UK-PRECISE
p12670
sg5
S'PMC3446875'
p12671
sg7
g12659
sg9
V23028897.xml
p12672
sa(dp12673
g3
VSTD-Lincoln-2003
p12674
sg5
S'PMC1739598'
p12675
sg7
VCD001920 v. 5.0 Physiotherapy treatment approaches for the recovery of postural control and lower limb function foll.rm5
p12676
sg9
V15774435.xml
p12677
sa(dp12678
g3
VSTD-Wade-1992
p12679
sg5
S'PMC1881332'
p12680
sg7
g12676
sg9
V1559090.xml
p12681
sa(dp12682
g3
VSTD-Burnham-2004
p12683
sg5
S'PMC2585922'
p12684
sg7
VCD009094 v. 1.0 The impact of user fees on access to health services in low- and middle-income countries.rm5
p12685
sg9
V15112007.xml
p12686
sa(dp12687
g3
VSTD-Wilkinson-2001
p12688
sg5
S'PMC2566476'
p12689
sg7
g12685
sg9
V11477970.xml
p12690
sa(dp12691
g3
VSTD-Ridde-2003
p12692
sg5
S'PMC2572499'
p12693
sg7
g12685
sg9
V12973646.xml
p12694
sa(dp12695
g3
VSTD-Dershewitz-1977
p12696
sg5
S'PMC1653806'
p12697
sg7
VCD005014 v. 8.5 Home safety education and provision of safety equipment for injury prevention.rm5
p12698
sg9
V596497.xml
p12699
sa(dp12700
g3
VSTD-Phelan-2010
p12701
sg5
S'PMC3693223'
p12702
sg7
g12698
sg9
V21464382.xml
p12703
sa(dp12704
g3
VSTD-Schwarz-1993
p12705
sg5
S'PMC1694716'
p12706
sg7
g12698
sg9
V8484447.xml
p12707
sa(dp12708
g3
VSTD-Rowland-2002
p12709
sg5
S'PMC131024'
p12710
sg7
g12698
sg9
V12411356.xml
p12711
sa(dp12712
g3
VSTD-Mock-2003
p12713
sg5
S'PMC2572517'
p12714
sg7
g12698
sg9
V14576891.xml
p12715
sa(dp12716
g3
VSTD-Colver-1982
p12717
sg5
S'PMC1500158'
p12718
sg7
g12698
sg9
V6812798.xml
p12719
sa(dp12720
g3
VSTD-Coggan-2000
p12721
sg5
S'PMC1730604'
p12722
sg7
g12698
sg9
V10875670.xml
p12723
sa(dp12724
g3
VSTD-Watson-2005
p12725
sg5
S'PMC544992'
p12726
sg7
g12698
sg9
V15604156.xml
p12727
sa(dp12728
g3
VSTD-Nansel-2002
p12729
sg5
S'PMC2387242'
p12730
sg7
g12698
sg9
V11932115.xml
p12731
sa(dp12732
g3
VSTD-Kendrick-2007
p12733
sg5
S'PMC2610598'
p12734
sg7
g12698
sg9
V17446248.xml
p12735
sa(dp12736
g3
VSTD-Kendrick-2005
p12737
sg5
S'PMC1463224'
p12738
sg7
g12698
sg9
V16105365.xml
p12739
sa(dp12740
g3
VSTD-Nansel-2008
p12741
sg5
S'PMC2562892'
p12742
sg7
g12698
sg9
V17906313.xml
p12743
sa(dp12744
g3
VSTD-Miller-1982
p12745
sg5
S'PMC1649895'
p12746
sg7
g12698
sg9
V7065320.xml
p12747
sa(dp12748
g3
VSTD-Hendrickson-2002
p12749
sg5
S'PMC1730268'
p12750
sg7
g12698
sg9
V16203842.xml
p12751
sa(dp12752
g3
VSTD-Yorkston-2007
p12753
sg5
S'PMC2598383'
p12754
sg7
g12698
sg9
V17567977.xml
p12755
sa(dp12756
g3
VSTD-Schlesinger-1966
p12757
sg5
S'PMC1067824'
p12758
sg7
g12698
sg9
V9338837.xml
p12759
sa(dp12760
g3
VSTD-Emond-2002
p12761
sg5
S'PMC1719107'
p12762
sg7
g12698
sg9
V11861228.xml
p12763
sa(dp12764
g3
VSTD-DiGuiseppi-2002
p12765
sg5
S'PMC131023'
p12766
sg7
g12698
sg9
V12411355.xml
p12767
sa(dp12768
g3
VSTD-Kendrick-1999
p12769
sg5
S'PMC27827'
p12770
sg7
g12698
sg9
V10195971.xml
p12771
sa(dp12772
g3
VSTD-Ozanne_x002d_Smith-2002
p12773
sg5
S'PMC1730817'
p12774
sg7
g12698
sg9
V11928967.xml
p12775
sa(dp12776
g3
VSTD-Guyer-1989
p12777
sg5
S'PMC1349806'
p12778
sg7
g12698
sg9
V2817165.xml
p12779
sa(dp12780
g3
VSTD-McLoughlin-1982
p12781
sg5
S'PMC1649807'
p12782
sg7
g12698
sg9
V7058963.xml
p12783
sa(dp12784
g3
VSTD-Clamp-1998
p12785
sg5
S'PMC28560'
p12786
sg7
g12698
sg9
V9596598.xml
p12787
sa(dp12788
g3
VSTD-Svanstrom-1995
p12789
sg5
S'PMC1067586'
p12790
sg7
g12698
sg9
V9346020.xml
p12791
sa(dp12792
g3
VSTD-Hwang-2006
p12793
sg5
S'PMC2563473'
p12794
sg7
g12698
sg9
V17018679.xml
p12795
sa(dp12796
g3
VSTD-Lindqvist-1998a
p12797
sg5
S'PMC1730829'
p12798
sg7
g12698
sg9
V11928968.xml
p12799
sa(dp12800
g3
VSTD-Mackay-2002
p12801
sg5
S'PMC1649800'
p12802
sg7
g12698
sg9
V7058964.xml
p12803
sa(dp12804
g3
VSTD-Sznajder-2003
p12805
sg5
S'PMC1730977'
p12806
sg7
g12698
sg9
V12966017.xml
p12807
sa(dp12808
g3
VSTD-Johnston-2000
p12809
sg5
S'PMC1730673'
p12810
sg7
g12698
sg9
V11144634.xml
p12811
sa(dp12812
g3
VSTD-Leung-2000
p12813
sg5
S'PMC1421025'
p12814
sg7
VCD003145 v. 5.0 Short term benefits for laparoscopic colorectal resection.rm5
p12815
sg9
V10749610.xml
p12816
sa(dp12817
g3
VSTD-Braga-2002-b
p12818
sg5
S'PMC1422642'
p12819
sg7
g12815
sg9
V12454514.xml
p12820
sa(dp12821
g3
VSTD-Richter-2010
p12822
sg5
S'PMC2914312'
p12823
sg7
VCD001756 v. 10.0 Mechanical devices for urinary incontinence in women.rm5
p12824
sg9
V20177294.xml
p12825
sa(dp12826
g3
VSTD-Cattarelli-2006
p12827
sg5
S'PMC2672685'
p12828
sg7
VCD001454 v. 10.0 Diuretics for respiratory distress syndrome in preterm infants.rm5
p12829
sg9
V16204359.xml
p12830
sa(dp12831
g3
VSTD-ANRS-1265
p12832
sg5
S'PMC1262556'
p12833
sg7
VCD003362 v. 8.0 Male circumcision for prevention of heterosexual acquisition of HIV in men.rm5
p12834
sg9
V16231970.xml
p12835
sa(dp12836
g3
VSTD-SUPPORT-2010
p12837
sg5
S'PMC3071534'
p12838
sg7
VCD000510 v. 7.0 Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm inf.rm5
p12839
sg9
V20472939.xml
p12840
sa(dp12841
g3
VSTD-Winstanley-2011
p12842
sg5
S'PMC3078567'
p12843
sg7
VCD002950 v. 10.2 Antidepressants for cocaine dependence and problematic cocaine use.rm5
p12844
sg9
V21266301.xml
p12845
sa(dp12846
g3
VSTD-Man-1997
p12847
sg5
S'PMC1191142'
p12848
sg7
VCD007530 v. 1.7 Vascular occlusion for elective liver resections.rm5
p12849
sg9
V9409569.xml
p12850
sa(dp12851
g3
VSTD-Glasgow-2000
p12852
sg5
S'PMC27300'
p12853
sg7
VCD002925 v. 6.0 Therapy-based rehabilitation services for stroke patients at home.rm5
p12854
sg9
V10698876.xml
p12855
sa(dp12856
g3
VSTD-McMahon-1979
p12857
sg5
S'PMC1597073'
p12858
sg7
VCD000053 v. 6.6 Drugs for treating urinary schistosomiasis.rm5
p12859
sg9
V519476.xml
p12860
sa(dp12861
g3
VSTD-Pugh-1983
p12862
sg5
S'PMC1546776'
p12863
sg7
g12859
sg9
V6401550.xml
p12864
sa(dp12865
g3
VSTD-Schwartz-1982a
p12866
sg5
S'PMC1627732'
p12867
sg7
VCD004401 v. 9.2 Antibiotics for the prevention of acute and chronic suppurative otitis media in children.rm5
p12868
sg9
V7051984.xml
p12869
sa(dp12870
g3
VSTD-Dube-1981
p12871
sg5
S'PMC3012941'
p12872
sg7
VCD003834 v. 5.0 Lithium for schizophrenia.rm5
p12873
sg9
V22058537.xml
p12874
sa(dp12875
g3
VSTD-Kuna-2007
p12876
sg5
S'PMC1920547'
p12877
sg7
VCD007694 v. 5.0 Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmet.rm5
p12878
sg9
V17362472.xml
p12879
sa(dp12880
g3
VSTD-Maspero-2010
p12881
sg5
S'PMC2993043'
p12882
sg7
g12878
sg9
V20874458.xml
p12883
sa(dp12884
g3
VSTD-van-Balen-2003
p12885
sg5
S'PMC274056'
p12886
sg7
VCD004740 v. 3.0 Interventions for acute otitis externa.rm5
p12887
sg9
V14630756.xml
p12888
sa(dp12889
g3
VSTD-Podas-2007
p12890
sg5
S'PMC2805936'
p12891
sg7
VCD006400 v. 2.2 Dietary interventions for rheumatoid arthritis.rm5
p12892
sg9
V17308218.xml
p12893
sa(dp12894
g3
VSTD-Sk_x00f6_ldstam-2003
p12895
sg5
S'PMC1754463'
p12896
sg7
g12892
sg9
V12594104.xml
p12897
sa(dp12898
g3
VSTD-Renner-2001
p12899
sg5
S'PMC1745899'
p12900
sg7
VCD007020 v. 7.0 Antioxidant micronutrients for lung disease in cystic fibrosis.rm5
p12901
sg9
V11120904.xml
p12902
sa(dp12903
g3
VSTD-Cantello-1989
p12904
sg5
S'PMC1032022'
p12905
sg7
VCD006722 v. 3.0 Psychostimulants for depression.rm5
p12906
sg9
V2664088.xml
p12907
sa(dp12908
g3
VSTD-Hare-1962
p12909
sg5
S'PMC1959255'
p12910
sg7
g12906
sg9
V13904675.xml
p12911
sa(dp12912
g3
VSTD-Hare-1964
p12913
sg5
S'PMC1815021'
p12914
sg7
g12906
sg9
V14097430.xml
p12915
sa(dp12916
g3
VSTD-Robin-1958
p12917
sg5
S'PMC497294'
p12918
sg7
g12906
sg9
V13514499.xml
p12919
sa(dp12920
g3
VSTD-Ramphal-1992
p12921
sg5
S'PMC188836'
p12922
sg7
VCD003914 v. 9.0 Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients.rm5
p12923
sg9
V1510394.xml
p12924
sa(dp12925
g3
VSTD-Verhagen-1987
p12926
sg5
S'PMC174690'
p12927
sg7
g12923
sg9
V3551829.xml
p12928
sa(dp12929
g3
VSTD-De-Pauw-1985
p12930
sg5
S'PMC180337'
p12931
sg7
g12923
sg9
V3909956.xml
p12932
sa(dp12933
g3
VSTD-Novakova-1991
p12934
sg5
S'PMC245077'
p12935
sg7
g12923
sg9
V1829879.xml
p12936
sa(dp12937
g3
VSTD-Del-Favero-1987
p12938
sg5
S'PMC174882'
p12939
sg7
g12923
sg9
V2959198.xml
p12940
sa(dp12941
g3
VSTD-Kiely-2004
p12942
sg5
S'PMC1758841'
p12943
sg7
VCD003002 v. 9.4 Drug therapy for obstructive sleep apnoea in adults.rm5
p12944
sg9
V14694248.xml
p12945
sa(dp12946
g3
VSTD-Prasad-2010
p12947
sg5
S'PMC2894441'
p12948
sg7
g12944
sg9
V20614859.xml
p12949
sa(dp12950
g3
VSTD-Marshall-2008
p12951
sg5
S'PMC2442407'
p12952
sg7
g12944
sg9
V18548827.xml
p12953
sa(dp12954
g3
VSTD-Eckert-2011
p12955
sg5
S'PMC3415379'
p12956
sg7
g12944
sg9
V21269278.xml
p12957
sa(dp12958
g3
VSTD-Dorman-2008
p12959
sg5
S'PMC2666004'
p12960
sg7
VCD001886 v. 8.0 Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.rm5
p12961
sg9
V18427286.xml
p12962
sa(dp12963
g3
VSTD-Harley-2002
p12964
sg5
S'PMC3686948'
p12965
sg7
g12961
sg9
V12067170.xml
p12966
sa(dp12967
g3
VSTD-Penta-de-Peppo-1995
p12968
sg5
S'PMC325258'
p12969
sg7
g12961
sg9
V7580360.xml
p12970
sa(dp12971
g3
VSTD-Desai-2009
p12972
sg5
S'PMC2789288'
p12973
sg7
g12961
sg9
V19843776.xml
p12974
sa(dp12975
g3
VSTD-Berenholtz-2009
p12976
sg5
S'PMC2772136'
p12977
sg7
g12961
sg9
V19730217.xml
p12978
sa(dp12979
g3
VSTD-Jimenez-2007
p12980
sg5
S'PMC2246206'
p12981
sg7
g12961
sg9
V17988379.xml
p12982
sa(dp12983
g3
VSTD-Apostolakis-2008
p12984
sg5
S'PMC2287179'
p12985
sg7
g12961
sg9
V18361800.xml
p12986
sa(dp12987
g3
VSTD-Yamasaki-2004
p12988
sg5
S'PMC3474476'
p12989
sg7
g12961
sg9
V15224162.xml
p12990
sa(dp12991
g3
VSTD-Wu-2006
p12992
sg5
S'PMC1448924'
p12993
sg7
g12961
sg9
V16432349.xml
p12994
sa(dp12995
g3
VSTD-Hashimoto-2007
p12996
sg5
S'PMC1877080'
p12997
sg7
VCD007338 v. 3.0 Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver re.rm5
p12998
sg9
V17457160.xml
p12999
sa(dp13000
g3
VSTD-Peng-2011
p13001
sg5
S'PMC3177872'
p13002
sg7
VCD004323 v. 8.0 Quality of life after rectal resection for cancer with or without permanent colostomy..rm5
p13003
sg9
V21835046.xml
p13004
sa(dp13005
g3
VSTD-Schmidt-2010
p13006
sg5
S'PMC2840249'
p13007
sg7
g13003
sg9
V20300220.xml
p13008
sa(dp13009
g3
VSTD-Krouse-2009
p13010
sg5
S'PMC2754912'
p13011
sg7
g13003
sg9
V19720920.xml
p13012
sa(dp13013
g3
VSTD-Engel-2003
p13014
sg5
S'PMC1422675'
p13015
sg7
g13003
sg9
V12894013.xml
p13016
sa(dp13017
g3
VSTD-Allal-2000
p13018
sg5
S'PMC2363346'
p13019
sg7
g13003
sg9
V10735495.xml
p13020
sa(dp13021
g3
VSTD-Grumann-2001
p13022
sg5
S'PMC1421194'
p13023
sg7
g13003
sg9
V11176118.xml
p13024
sa(dp13025
g3
VSTD-Smith_x002d_Gagen-2009
p13026
sg5
S'PMC2911491'
p13027
sg7
g13003
sg9
V19862692.xml
p13028
sa(dp13029
g3
VSTD-Jenkins-1989
p13030
sg5
S'PMC461992'
p13031
sg7
VCD004466 v. 5.0 Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft.rm5
p13032
sg9
V2799743.xml
p13033
sa(dp13034
g3
VSTD-Stenius-Aarniaala-2000
p13035
sg5
S'PMC27319'
p13036
sg7
VCD009339 v. 2.0 Weight loss interventions for chronic asthma.rm5
p13037
sg9
V10731173.xml
p13038
sa(dp13039
g3
VSTD-Martinuzzi-2007
p13040
sg5
S'PMC2949319'
p13041
sg7
VCD003458 v. 7.0 Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).rm5
p13042
sg9
V17915574.xml
p13043
sa(dp13044
g3
VSTD-Femi_x002d_Pearse-1977
p13045
sg5
S'PMC1605098'
p13046
sg7
VCD010256 v. 1.14 Intravenous beta2-agonists versus intravenous aminophylline for acute asthma.rm5
p13047
sg9
V319876.xml
p13048
sa(dp13049
g3
VSTD-Roberts-2003
p13050
sg5
S'PMC1746646'
p13051
sg7
g13047
sg9
V12668792.xml
p13052
sa(dp13053
g3
VSTD-Williams-1975
p13054
sg5
S'PMC1675841'
p13055
sg7
g13047
sg9
V1106817.xml
p13056
sa(dp13057
g3
VSTD-Hambleton-1979
p13058
sg5
S'PMC1545558'
p13059
sg7
g13047
sg9
V383024.xml
p13060
sa(dp13061
g3
VSTD-SHIP-1999
p13062
sg5
S'PMC27782'
p13063
sg7
VCD006772 v. 4.0 Service organisation for the secondary prevention of ischaemic heart disease in primary care.rm5
p13064
sg9
V10074017.xml
p13065
sa(dp13066
g3
VSTD-Feder-1999
p13067
sg5
S'PMC27895'
p13068
sg7
g13064
sg9
V10356008.xml
p13069
sa(dp13070
g3
VSTD-Campbell-1998
p13071
sg5
S'PMC1728827'
p13072
sg7
g13064
sg9
V9930042.xml
p13073
sa(dp13074
g3
VSTD-Eccles-2002
p13075
sg5
S'PMC130060'
p13076
sg7
g13064
sg9
V12399345.xml
p13077
sa(dp13078
g3
VSTD-Kiessling-2002
p13079
sg5
S'PMC129638'
p13080
sg7
g13064
sg9
V12386042.xml
p13081
sa(dp13082
g3
VSTD-Moher-2001b-_x0028_nurse-led_x0029_
p13083
sg5
S'PMC32168'
p13084
sg7
g13064
sg9
V11387182.xml
p13085
sa(dp13086
g3
VSTD-Cupples-1994a
p13087
sg5
S'PMC2541257'
p13088
sg7
g13064
sg9
V7950723.xml
p13089
sa(dp13090
g3
VSTD-SPHERE
p13091
sg5
S'PMC2770592'
p13092
sg7
g13064
sg9
V19875426.xml
p13093
sa(dp13094
g3
VSTD-Moher-2001a-_x0028_GP-led_x0029_
p13095
sg5
S'PMC32168'
p13096
sg7
g13064
sg9
V11387182.xml
p13097
sa(dp13098
g3
VSTD-Campbell-1966
p13099
sg5
S'PMC496031'
p13100
sg7
VCD005451 v. 14.0 Carbamazepine for acute and chronic pain in adults.rm5
p13101
sg9
V5327969.xml
p13102
sa(dp13103
g3
VSTD-Knubben-2007
p13104
sg5
S'PMC2465130'
p13105
sg7
VCD004366 v. 11.2 Exercise for depression.rm5
p13106
sg9
V17062659.xml
p13107
sa(dp13108
g3
VSTD-Blumenthal-2007
p13109
sg5
S'PMC2702700'
p13110
sg7
g13106
sg9
V17846259.xml
p13111
sa(dp13112
g3
VSTD-Brenes-2007
p13113
sg5
S'PMC2885010'
p13114
sg7
g13106
sg9
V17164159.xml
p13115
sa(dp13116
g3
VSTD-Veale--1992
p13117
sg5
S'PMC1293641'
p13118
sg7
g13106
sg9
V1433121.xml
p13119
sa(dp13120
g3
VSTD-Williams-2008
p13121
sg5
S'PMC2475651'
p13122
sg7
g13106
sg9
V18297481.xml
p13123
sa(dp13124
g3
VSTD-Pilu-2007
p13125
sg5
S'PMC1976311'
p13126
sg7
g13106
sg9
V17620123.xml
p13127
sa(dp13128
g3
VSTD-Tartter-1992
p13129
sg5
S'PMC1242709'
p13130
sg7
VCD005033 v. 6.0 Perioperative blood transfusions and recurrence of colorectal cancer.rm5
p13131
sg9
V1466616.xml
p13132
sa(dp13133
g3
VSTD-Frankish-1985
p13134
sg5
S'PMC1415976'
p13135
sg7
g13131
sg9
V3924274.xml
p13136
sa(dp13137
g3
VSTD-Creasy-1987
p13138
sg5
S'PMC2498481'
p13139
sg7
g13131
sg9
V3605994.xml
p13140
sa(dp13141
g3
VSTD-Cheslyn_x002d_Curtis-1990
p13142
sg5
S'PMC2499079'
p13143
sg7
g13131
sg9
V2405765.xml
p13144
sa(dp13145
g3
VSTD-Pickard-1989
p13146
sg5
S'PMC1835889'
p13147
sg7
VCD000277 v. 7.0 Calcium antagonists for aneurysmal subarachnoid haemorrhage.rm5
p13148
sg9
V2496789.xml
p13149
sa(dp13150
g3
VSTD-Humphreys-2011
p13151
sg5
S'PMC3053017'
p13152
sg7
VCD007007 v. 3.0 Screening women for intimate partner violence in healthcare settings.rm5
p13153
sg9
V21185737.xml
p13154
sa(dp13155
g3
VSTD-Carroll-2005
p13156
sg5
S'PMC1180654'
p13157
sg7
g13153
sg9
V16076821.xml
p13158
sa(dp13159
g3
VSTD-Jensen-1990
p13160
sg5
S'PMC462778'
p13161
sg7
VCD000191 v. 8.2 Silver acetate for smoking cessation.rm5
p13162
sg9
V2256009.xml
p13163
sa(dp13164
g3
VSTD-Lam-2007
p13165
sg5
S'PMC2092459'
p13166
sg7
VCD004435 v. 8.2 Oral appliances for obstructive sleep apnoea.rm5
p13167
sg9
V17121868.xml
p13168
sa(dp13169
g3
VSTD-Dowell-2001
p13170
sg5
S'PMC1313951'
p13171
sg7
VCD004417 v. 13.0 Delayed antibiotics for respiratory infections.rm5
p13172
sg9
V11255901.xml
p13173
sa(dp13174
g3
VSTD-Little-1997
p13175
sg5
S'PMC2126131'
p13176
sg7
g13172
sg9
V9116551.xml
p13177
sa(dp13178
g3
VSTD-Little-2001
p13179
sg5
S'PMC26576'
p13180
sg7
g13172
sg9
V11159657.xml
p13181
sa(dp13182
g3
VSTD-Eime-2005
p13183
sg5
S'PMC1725311'
p13184
sg7
VCD006527 v. 4.2 Educational interventions for the prevention of eye injuries.rm5
p13185
sg9
V16118310.xml
p13186
sa(dp13187
g3
VSTD-McCulloch-1983
p13188
sg5
S'PMC1550062'
p13189
sg7
VCD008722 v. 2.0 Interventions to enhance adherence to dietary advice for preventing and managing chronic diseases in.rm5
p13190
sg9
V6423045.xml
p13191
sa(dp13192
g3
VSTD-Ell-2008
p13193
sg5
S'PMC2653113'
p13194
sg7
VCD006525 v. 5.0 Collaborative care for depression and anxiety problems.rm5
p13195
sg9
V18802161.xml
p13196
sa(dp13197
g3
VSTD-Chew_x002d_Graham-2007
p13198
sg5
S'PMC2047010'
p13199
sg7
g13195
sg9
V17504586.xml
p13200
sa(dp13201
g3
VSTD-Cole-2006
p13202
sg5
S'PMC1319344'
p13203
sg7
g13195
sg9
V16330624.xml
p13204
sa(dp13205
g3
VSTD-Chaney-2011
p13206
sg5
S'PMC3219630'
p13207
sg7
g13195
sg9
V22032247.xml
p13208
sa(dp13209
g3
VSTD-Simon-2011
p13210
sg5
S'PMC3138593'
p13211
sg7
g13195
sg9
V21384219.xml
p13212
sa(dp13213
g3
VSTD-Vera-2010
p13214
sg5
S'PMC2900833'
p13215
sg7
g13195
sg9
V20123819.xml
p13216
sa(dp13217
g3
VSTD-Ell-2007
p13218
sg5
S'PMC1986637'
p13219
sg7
g13195
sg9
V17804354.xml
p13220
sa(dp13221
g3
VSTD-Gjerdingen-2009
p13222
sg5
S'PMC2791714'
p13223
sg7
g13195
sg9
V19734392.xml
p13224
sa(dp13225
g3
VSTD-Hilty-2007
p13226
sg5
S'PMC2922348'
p13227
sg7
g13195
sg9
V20805900.xml
p13228
sa(dp13229
g3
VSTD-Hedrick-2003
p13230
sg5
S'PMC1494801'
p13231
sg7
g13195
sg9
V12534758.xml
p13232
sa(dp13233
g3
VSTD-Bogner-2010
p13234
sg5
S'PMC2858776'
p13235
sg7
g13195
sg9
V20040705.xml
p13236
sa(dp13237
g3
VSTD-Landis-2007
p13238
sg5
S'PMC1838423'
p13239
sg7
g13195
sg9
V17338822.xml
p13240
sa(dp13241
g3
VSTD-Piette-2011
p13242
sg5
S'PMC3117978'
p13243
sg7
g13195
sg9
V21478777.xml
p13244
sa(dp13245
g3
VSTD-Fortney-2007
p13246
sg5
S'PMC2305730'
p13247
sg7
g13195
sg9
V17492326.xml
p13248
sa(dp13249
g3
VSTD-Kroenke-2010
p13250
sg5
S'PMC3010214'
p13251
sg7
g13195
sg9
V20628129.xml
p13252
sa(dp13253
g3
VSTD-Simon-2000a
p13254
sg5
S'PMC27299'
p13255
sg7
g13195
sg9
V10688563.xml
p13256
sa(dp13257
g3
VSTD-Simon-2000b
p13258
sg5
S'PMC27299'
p13259
sg7
g13195
sg9
V10688563.xml
p13260
sa(dp13261
g3
VSTD-Rubenstein-2002
p13262
sg5
S'PMC1464007'
p13263
sg7
g13195
sg9
V12236381.xml
p13264
sa(dp13265
g3
VSTD-Dietrich-2004
p13266
sg5
S'PMC516659'
p13267
sg7
g13195
sg9
V15345600.xml
p13268
sa(dp13269
g3
VSTD-Mann-1998
p13270
sg5
S'PMC1409896'
p13271
sg7
g13195
sg9
V9604408.xml
p13272
sa(dp13273
g3
VSTD-Rollman-2009
p13274
sg5
S'PMC3010227'
p13275
sg7
g13195
sg9
V19918088.xml
p13276
sa(dp13277
g3
VSTD-Richards-2012
p13278
sg5
S'PMC2770465'
p13279
sg7
g13195
sg9
V19832996.xml
p13280
sa(dp13281
g3
VSTD-Roy_x002d_Byrne-2010
p13282
sg5
S'PMC2928714'
p13283
sg7
g13195
sg9
V20483968.xml
p13284
sa(dp13285
g3
VSTD-Rost-2001a
p13286
sg5
S'PMC130058'
p13287
sg7
g13195
sg9
V12399343.xml
p13288
sa(dp13289
g3
VSTD-Waitzkin-2011
p13290
sg5
S'PMC3051073'
p13291
sg7
g13195
sg9
V20882400.xml
p13292
sa(dp13293
g3
VSTD-McMahon-2007
p13294
sg5
S'PMC2169311'
p13295
sg7
g13195
sg9
V17976288.xml
p13296
sa(dp13297
g3
VSTD-Roy_x002d_Byrne-2005
p13298
sg5
S'PMC1237029'
p13299
sg7
g13195
sg9
V15753242.xml
p13300
sa(dp13301
g3
VSTD-Yeung-2010
p13302
sg5
S'PMC2978195'
p13303
sg7
g13195
sg9
V20966373.xml
p13304
sa(dp13305
g3
VSTD-Bogner-2008
p13306
sg5
S'PMC2478504'
p13307
sg7
g13195
sg9
V18626028.xml
p13308
sa(dp13309
g3
VSTD-Katon-2010
p13310
sg5
S'PMC3312811'
p13311
sg7
g13195
sg9
V21190455.xml
p13312
sa(dp13313
g3
VSTD-Ell-2010
p13314
sg5
S'PMC2845010'
p13315
sg7
g13195
sg9
V20097780.xml
p13316
sa(dp13317
g3
VSTD-Ross-2008
p13318
sg5
S'PMC2518035'
p13319
sg7
g13195
sg9
V18498013.xml
p13320
sa(dp13321
g3
VSTD-Ben_x002d_Dov-1983
p13322
sg5
S'PMC459615'
p13323
sg7
VCD002986 v. 10.0 Ionisers for chronic asthma.rm5
p13324
sg9
V6351332.xml
p13325
sa(dp13326
g3
VSTD-Lipin-1984
p13327
sg5
S'PMC1020511'
p13328
sg7
g13324
sg9
V6474386.xml
p13329
sa(dp13330
g3
VSTD-Nogrady-1983
p13331
sg5
S'PMC459697'
p13332
sg7
g13324
sg9
V6364442.xml
p13333
sa(dp13334
g3
VSTD-Warner-1993
p13335
sg5
S'PMC464427'
p13336
sg7
g13324
sg9
V8511730.xml
p13337
sa(dp13338
g3
VSTD-Grunewald-1994
p13339
sg5
S'PMC1073126'
p13340
sg7
VCD007302 v. 4.0 Vigabatrin for refractory partial epilepsy.rm5
p13341
sg9
V8089668.xml
p13342
sa(dp13343
g3
VSTD-B304
p13344
sg5
S'PMC2117538'
p13345
sg7
VCD001191 v. 16.4 Rivastigmine for Alzheimer's disease.rm5
p13346
sg9
V17353259.xml
p13347
sa(dp13348
g3
VSTD-Ballard-2005
p13349
sg5
S'PMC556156'
p13350
sg7
g13346
sg9
V15722369.xml
p13351
sa(dp13352
g3
VSTD-Saxena-2009
p13353
sg5
S'PMC2900101'
p13354
sg7
VCD009107 v. 4.0 Intracutaneous or subcutaneous sterile water injection compared with blinded controls for pain manag.rm5
p13355
sg9
V20640118.xml
p13356
sa(dp13357
g3
VSTD-Govaert-1993
p13358
sg5
S'PMC1679213'
p13359
sg7
VCD002733 v. 10.0 Influenza vaccine for patients with chronic obstructive pulmonary disease.rm5
p13360
sg9
V8241913.xml
p13361
sa(dp13362
g3
VSTD-Ginsberg-1999
p13363
sg5
S'PMC1230312'
p13364
sg7
VCD004177 v. 6.0 Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome.rm5
p13365
sg9
V10333832.xml
p13366
sa(dp13367
g3
VSTD-Schumer-1976
p13368
sg5
S'PMC1344393'
p13369
sg7
VCD002243 v. 5.2 Corticosteroids for treating severe sepsis and septic shock.rm5
p13370
sg9
V786190.xml
p13371
sa(dp13372
g3
VSTD-Yildiz-2002
p13373
sg5
S'PMC125315'
p13374
sg7
g13370
sg9
V12133187.xml
p13375
sa(dp13376
g3
VSTD-Burton-2010
p13377
sg5
S'PMC2882221'
p13378
sg7
VCD008422 v. 2.0 Vitamin D for the management of multiple sclerosis.rm5
p13379
sg9
V20427749.xml
p13380
sa(dp13381
g3
VSTD-Uludag-2009
p13382
sg5
S'PMC3015970'
p13383
sg7
VCD005265 v. 3.3 Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy.rm5
p13384
sg9
V19793473.xml
p13385
sa(dp13386
g3
VSTD-Harling-2000
p13387
sg5
S'PMC2503474'
p13388
sg7
g13384
sg9
V11103159.xml
p13389
sa(dp13390
g3
VSTD-Godfrey-1976
p13391
sg5
S'PMC470375'
p13392
sg7
VCD002307 v. 8.2 Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction.rm5
p13393
sg9
V821168.xml
p13394
sa(dp13395
g3
VSTD-Tullett-1982
p13396
sg5
S'PMC459417'
p13397
sg7
g13393
sg9
V6218645.xml
p13398
sa(dp13399
g3
VSTD-Neijens-1981a
p13400
sg5
S'PMC1020434'
p13401
sg7
g13393
sg9
V6797085.xml
p13402
sa(dp13403
g3
VSTD-TORDIA
p13404
sg5
S'PMC3257891'
p13405
sg7
VCD007504 v. 4.0 Interventions for preventing relapse and recurrence of a depressive disorder in children and adolesc.rm5
p13406
sg9
V20478877.xml
p13407
sa(dp13408
g3
VSTD-TADS
p13409
sg5
S'PMC2587406'
p13410
sg7
g13406
sg9
V18391133.xml
p13411
sa(dp13412
g3
VSTD-Emslie-2008
p13413
sg5
S'PMC2824429'
p13414
sg7
g13406
sg9
V18281410.xml
p13415
sa(dp13416
g3
VSTD-Kennard-2008
p13417
sg5
S'PMC2826176'
p13418
sg7
g13406
sg9
V18978634.xml
p13419
sa(dp13420
g3
VSTD-Hamdy-1995
p13421
sg5
S'PMC2548761'
p13422
sg7
VCD008175 v. 1.2 Vitamin D compounds for people with chronic kidney disease not requiring dialysis.rm5
p13423
sg9
V7677827.xml
p13424
sa(dp13425
g3
VSTD-Miller-2005
p13426
sg5
S'PMC1720314'
p13427
sg7
VCD004407 v. 8.2 Vaccines for measles mumps and rubella in children.rm5
p13428
sg9
V15723921.xml
p13429
sa(dp13430
g3
VSTD-Bremner-2005
p13431
sg5
S'PMC1720414'
p13432
sg7
g13428
sg9
V15908618.xml
p13433
sa(dp13434
g3
VSTD-Benjamin-1992
p13435
sg5
S'PMC1881909'
p13436
sg7
g13428
sg9
V1586818.xml
p13437
sa(dp13438
g3
VSTD-Schlegel-1999
p13439
sg5
S'PMC32261'
p13440
sg7
g13428
sg9
V10435956.xml
p13441
sa(dp13442
g3
VSTD-Mackenzie-2006
p13443
sg5
S'PMC1872063'
p13444
sg7
g13428
sg9
V16834879.xml
p13445
sa(dp13446
g3
VSTD-McKeever-2004
p13447
sg5
S'PMC1448377'
p13448
sg7
g13428
sg9
V15249303.xml
p13449
sa(dp13450
g3
VSTD-Freeman-1993
p13451
sg5
S'PMC1485961'
p13452
sg7
g13428
sg9
V8242506.xml
p13453
sa(dp13454
g3
VSTD-Black-2003
p13455
sg5
S'PMC1884189'
p13456
sg7
g13428
sg9
V12534647.xml
p13457
sa(dp13458
g3
VSTD-Seagroatt-2005
p13459
sg5
S'PMC557892'
p13460
sg7
g13428
sg9
V15837703.xml
p13461
sa(dp13462
g3
VSTD-Canada-2000
p13463
sg5
S'PMC1407745'
p13464
sg7
VCD000967 v. 13.0 Quetiapine for schizophrenia.rm5
p13465
sg9
V11291531.xml
p13466
sa(dp13467
g3
VSTD-Spittle-2009a
p13468
sg5
S'PMC2797495'
p13469
sg7
VCD005495 v. 5.2 Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive i.rm5
p13470
sg9
V19954550.xml
p13471
sa(dp13472
g3
VSTD-APIP-1998
p13473
sg5
S'PMC1720827'
p13474
sg7
g13470
sg9
V9797618.xml
p13475
sa(dp13476
g3
VSTD-Stansfeld-1975
p13477
sg5
S'PMC1673626'
p13478
sg7
VCD001534 v. 10.0 Long-term antibiotics for preventing recurrent urinary tract infection in children.rm5
p13479
sg9
V1095132.xml
p13480
sa(dp13481
g3
VSTD-Connett-1994
p13482
sg5
S'PMC1029734'
p13483
sg7
VCD002886 v. 4.0 Corticosteroids for hospitalised children with acute asthma.rm5
p13484
sg9
V8135557.xml
p13485
sa(dp13486
g3
VSTD-Karlen-1998a
p13487
sg5
S'PMC1727094'
p13488
sg7
VCD000279 v. 7.0 Strategies for detecting colon cancer andor dysplasia in patients with inflammatory bowel disease.rm5
p13489
sg9
V9659169.xml
p13490
sa(dp13491
g3
VSTD-Taniguchi-2009
p13492
sg5
S'PMC2688118'
p13493
sg7
VCD009235 v. 5.3 Automated versus non-automated weaning for reducing the duration of mechanical ventilation for criti.rm5
p13494
sg9
V19171056.xml
p13495
sa(dp13496
g3
VSTD-Isle-of-Wight-2003
p13497
sg5
S'PMC1746711'
p13498
sg7
VCD006480 v. 4.0 Mono and multifaceted inhalant andor food allergen reduction interventions for preventing asthma in.rm5
p13499
sg9
V12775858.xml
p13500
sa(dp13501
g3
VSTD-zLondon-Kingsbury-94
p13502
sg5
S'PMC2495782'
p13503
sg7
VCD003177 v. 5.0 Omega 3 fatty acids for prevention and treatment of cardiovascular disease.rm5
p13504
sg9
V4469034.xml
p13505
sa(dp13506
g3
VSTD-zFinnish-Miettinen
p13507
sg5
S'PMC1500325'
p13508
sg7
g13504
sg9
V6812744.xml
p13509
sa(dp13510
g3
VSTD-Hawthorne-1992
p13511
sg5
S'PMC1379405'
p13512
sg7
g13504
sg9
V1353742.xml
p13513
sa(dp13514
g3
VSTD-Houghton-2007
p13515
sg5
S'PMC1971055'
p13516
sg7
VCD005535 v. 3.0 Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticost.rm5
p13517
sg9
V17629923.xml
p13518
sa(dp13519
g3
VSTD-Koopmans-2006
p13520
sg5
S'PMC2104614'
p13521
sg7
g13517
sg9
V16449264.xml
p13522
sa(dp13523
g3
VSTD-Price-2002
p13524
sg5
S'PMC1746437'
p13525
sg7
g13517
sg9
V12200524.xml
p13526
sa(dp13527
g3
VSTD-van-der-Molen-1997
p13528
sg5
S'PMC1758577'
p13529
sg7
g13517
sg9
V9227720.xml
p13530
sa(dp13531
g3
VSTD-Akpinarli-1999
p13532
sg5
S'PMC1717973'
p13533
sg7
g13517
sg9
V10373134.xml
p13534
sa(dp13535
g3
VSTD-Morino-2005
p13536
sg5
S'PMC1409879'
p13537
sg7
VCD007886 v. 2.0 Energy source instruments for laparoscopic colectomy.rm5
p13538
sg9
V16327500.xml
p13539
sa(dp13540
g3
VSTD-Skowron-1966-A_x0026_B
p13541
sg5
S'PMC1936541'
p13542
sg7
VCD001955 v. 11.6 Glucocorticoids for croup.rm5
p13543
sg9
V5324105.xml
p13544
sa(dp13545
g3
VSTD-Husby-1993
p13546
sg5
S'PMC1793858'
p13547
sg7
g13543
sg9
V8466237.xml
p13548
sa(dp13549
g3
VSTD-Sparrow--2006
p13550
sg5
S'PMC2082835'
p13551
sg7
g13543
sg9
V16624882.xml
p13552
sa(dp13553
g3
VSTD-Godden-1997
p13554
sg5
S'PMC1717068'
p13555
sg7
g13543
sg9
V9068309.xml
p13556
sa(dp13557
g3
VSTD-Geelhoed-1996a
p13558
sg5
S'PMC2351559'
p13559
sg7
g13543
sg9
V8688774.xml
p13560
sa(dp13561
g3
VSTD-Skowron-1966a
p13562
sg5
S'PMC1936541'
p13563
sg7
g13543
sg9
V5324105.xml
p13564
sa(dp13565
g3
VSTD-Skowron-1966b
p13566
sg5
S'PMC1936541'
p13567
sg7
g13543
sg9
V5324105.xml
p13568
sa(dp13569
g3
VSTD-STOP-2-2005
p13570
sg5
S'PMC2867598'
p13571
sg7
VCD003146 v. 9.0 Blood transfusion for preventing stroke in people with sickle cell disease.rm5
p13572
sg9
V17243135.xml
p13573
sa(dp13574
g3
VSTD-Britt-1977
p13575
sg5
S'PMC351960'
p13576
sg7
VCD005428 v. 6.0 Antibiotic prophylaxis for short-term catheter bladder drainage in adults.rm5
p13577
sg9
V848927.xml
p13578
sa(dp13579
g3
VSTD-Davies-2000
p13580
sg5
S'PMC27532'
p13581
sg7
VCD007491 v. 5.2 Hospital at home admission avoidance.rm5
p13582
sg9
V11082090.xml
p13583
sa(dp13584
g3
VSTD-Wilson-1999
p13585
sg5
S'PMC28299'
p13586
sg7
g13582
sg9
V10591717.xml
p13587
sa(dp13588
g3
VSTD-Corwin-2005
p13589
sg5
S'PMC544431'
p13590
sg7
g13582
sg9
V15604157.xml
p13591
sa(dp13592
g3
VSTD-Campbell--1997
p13593
sg5
S'PMC2127698'
p13594
sg7
VCD004963 v. 6.0 Exercise for improving balance in older people.rm5
p13595
sg9
V9366737.xml
p13596
sa(dp13597
g3
VSTD-Spiro-1989
p13598
sg5
S'PMC2247136'
p13599
sg7
VCD001990 v. 12.0 Chemotherapy versus best supportive care for extensive small cell lung cancer.rm5
p13600
sg9
V2540788.xml
p13601
sa(dp13602
g3
VSTD-Malcolm-2006
p13603
sg5
S'PMC2605430'
p13604
sg7
VCD008862 v. 3.0 Repetitive transcranial magnetic stimulation for improving function after stroke.rm5
p13605
sg9
V17709994.xml
p13606
sa(dp13607
g3
VSTD-Magill-1995
p13608
sg5
S'PMC1239433'
p13609
sg7
VCD003415 v. 8.0 Progesterone for premenstrual syndrome.rm5
p13610
sg9
V8554838.xml
p13611
sa(dp13612
g3
VSTD-Byrne-2005
p13613
sg5
S'PMC1409868'
p13614
sg7
VCD006321 v. 3.0 Human growth hormone and glutamine for patients with short bowel syndrome.rm5
p13615
sg9
V16244538.xml
p13616
sa(dp13617
g3
VSTD-Elleg_x00e5_rd-1997
p13618
sg5
S'PMC1190610'
p13619
sg7
g13615
sg9
V8998124.xml
p13620
sa(dp13621
g3
VSTD-Szkudlarek-2000
p13622
sg5
S'PMC1727998'
p13623
sg7
g13615
sg9
V10896910.xml
p13624
sa(dp13625
g3
VSTD-Congeni-1984
p13626
sg5
S'PMC185431'
p13627
sg7
VCD001832 v. 9.0 Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningi.rm5
p13628
sg9
V6322681.xml
p13629
sa(dp13630
g3
VSTD-Bryan-1985
p13631
sg5
S'PMC180254'
p13632
sg7
g13628
sg9
V4073858.xml
p13633
sa(dp13634
g3
VSTD-Wintzen-2007
p13635
sg5
S'PMC1915648'
p13636
sg7
VCD003218 v. 9.0 Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.rm5
p13637
sg9
V17285226.xml
p13638
sa(dp13639
g3
VSTD-Koninckx-2008
p13640
sg5
S'PMC2517154'
p13641
sg7
VCD008088 v. 6.0 Anti-TNF- treatment for pelvic pain associated with endometriosis.rm5
p13642
sg9
V18556683.xml
p13643
sa(dp13644
g3
VSTD-Dondorp-2010
p13645
sg5
S'PMC3033534'
p13646
sg7
VCD005967 v. 9.3 Artesunate versus quinine for treating severe malaria.rm5
p13647
sg9
V21062666.xml
p13648
sa(dp13649
g3
VSTD-Glover-1974
p13650
sg5
S'PMC1009544'
p13651
sg7
VCD008880 v. 3.0 Spinal manipulative therapy for acute low-back pain.rm5
p13652
sg9
V4274488.xml
p13653
sa(dp13654
g3
VSTD-Seferlis-1998
p13655
sg5
S'PMC3611294'
p13656
sg7
g13652
sg9
V9883955.xml
p13657
sa(dp13658
g3
VSTD-Essen-1995
p13659
sg5
S'PMC1234752'
p13660
sg7
VCD006231 v. 2.0 Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis.rm5
p13661
sg9
V7618966.xml
p13662
sa(dp13663
g3
VSTD-Balasch-2001
p13664
sg5
S'PMC3455335'
p13665
sg7
VCD005070 v. 5.0 Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproducti.rm5
p13666
sg9
V11464575.xml
p13667
sa(dp13668
g3
VSTD-De-Jong-2008
p13669
sg5
S'PMC2194921'
p13670
sg7
VCD006378 v. 3.0 Aspirin steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseas.rm5
p13671
sg9
V18213383.xml
p13672
sa(dp13673
g3
VSTD-Amirabdollahian-2007
p13674
sg5
S'PMC1819386'
p13675
sg7
VCD006876 v. 4.0 Electromechanical and robot-assisted arm training for improving generic activities of daily living .rm5
p13676
sg9
V17309791.xml
p13677
sa(dp13678
g3
VSTD-Kahn-2006
p13679
sg5
S'PMC1550245'
p13680
sg7
g13676
sg9
V16790067.xml
p13681
sa(dp13682
g3
VSTD-Flynn-2009
p13683
sg5
S'PMC2730562'
p13684
sg7
VCD005493 v. 7.10 Botulinum toxin injections for adults with overactive bladder syndrome.rm5
p13685
sg9
V19375091.xml
p13686
sa(dp13687
g3
VSTD-Brubaker-2008
p13688
sg5
S'PMC2597793'
p13689
sg7
g13685
sg9
V18499184.xml
p13690
sa(dp13691
g3
VSTD-BHACAS-I-_x002b_II-2002
p13692
sg5
S'PMC2836483'
p13693
sg7
VCD007224 v. 3.0 Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease.rm5
p13694
sg9
V19185140.xml
p13695
sa(dp13696
g3
VSTD-Zamvar-2002
p13697
sg5
S'PMC136922'
p13698
sg7
g13694
sg9
V12458242.xml
p13699
sa(dp13700
g3
VSTD-Gasz-2004
p13701
sg5
S'PMC2716259'
p13702
sg7
g13694
sg9
V19641693.xml
p13703
sa(dp13704
g3
VSTD-Al_x002d_Ruzzeh-2006
p13705
sg5
S'PMC1476725'
p13706
sg7
g13694
sg9
V16740529.xml
p13707
sa(dp13708
g3
VSTD-RASS-Study-2002
p13709
sg5
S'PMC2978030'
p13710
sg7
VCD004136 v. 12.2 Antihypertensive agents for preventing diabetic kidney disease.rm5
p13711
sg9
V19571282.xml
p13712
sa(dp13713
g3
VSTD-ADVANCE-Study-2009
p13714
sg5
S'PMC2663832'
p13715
sg7
g13711
sg9
V19225038.xml
p13716
sa(dp13717
g3
VSTD-Cummings-2008
p13718
sg5
S'PMC3684062'
p13719
sg7
VCD008536 v. 3.3 Short and long term effects of tibolone in postmenopausal women.rm5
p13720
sg9
V18703472.xml
p13721
sa(dp13722
g3
VSTD-Murthy-1991
p13723
sg5
S'PMC2988295'
p13724
sg7
VCD007139 v. 3.0 Alprazolam for depression.rm5
p13725
sg9
V21897464.xml
p13726
sa(dp13727
g3
VSTD-Luengo-1994
p13728
sg5
S'PMC475269'
p13729
sg7
VCD001983 v. 7.0 Calcitonin for preventing and treating corticosteroid-induced osteoporosis.rm5
p13730
sg9
V7831624.xml
p13731
sa(dp13732
g3
VSTD-van-den-Berg-1995a
p13733
sg5
S'PMC486021'
p13734
sg7
VCD004429 v. 4.0 Intravenous immunoglobulin for multifocal motor neuropathy.rm5
p13735
sg9
V7673950.xml
p13736
sa(dp13737
g3
VSTD-Berlauk-1991
p13738
sg5
S'PMC1358649'
p13739
sg7
VCD004082 v. 11.0 Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.rm5
p13740
sg9
V1929610.xml
p13741
sa(dp13742
g3
VSTD-Jhanji-2010
p13743
sg5
S'PMC2945135'
p13744
sg7
g13740
sg9
V20698956.xml
p13745
sa(dp13746
g3
VSTD-Mckendry-2004
p13747
sg5
S'PMC498021'
p13748
sg7
g13740
sg9
V15242867.xml
p13749
sa(dp13750
g3
VSTD-Sinclair-1997
p13751
sg5
S'PMC2127619'
p13752
sg7
g13740
sg9
V9361539.xml
p13753
sa(dp13754
g3
VSTD-Wilson-1999
p13755
sg5
S'PMC27840'
p13756
sg7
g13740
sg9
V10213716.xml
p13757
sa(dp13758
g3
VSTD-Cecconi-2011
p13759
sg5
S'PMC3218998'
p13760
sg7
g13740
sg9
V21624138.xml
p13761
sa(dp13762
g3
VSTD-Pearse-2005
p13763
sg5
S'PMC1414018'
p13764
sg7
g13740
sg9
V16356219.xml
p13765
sa(dp13766
g3
VSTD-Bender-1997
p13767
sg5
S'PMC1191013'
p13768
sg7
g13740
sg9
V9339929.xml
p13769
sa(dp13770
g3
VSTD-Mayer-2010
p13771
sg5
S'PMC2875533'
p13772
sg7
g13740
sg9
V20156348.xml
p13773
sa(dp13774
g3
VSTD-PHS-I
p13775
sg5
S'PMC1821351'
p13776
sg7
VCD000253 v. 17.6 Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.rm5
p13777
sg9
V17353403.xml
p13778
sa(dp13779
g3
VSTD-PROSPECT-1996
p13780
sg5
S'PMC1335066'
p13781
sg7
VCD007091 v. 5.0 5-alpha-reductase inhibitors for prostate cancer prevention.rm5
p13782
sg9
V8911291.xml
p13783
sa(dp13784
g3
VSTD-Cote-1998
p13785
sg5
S'PMC2063039'
p13786
sg7
g13782
sg9
V9703292.xml
p13787
sa(dp13788
g3
VSTD-Kennedy-2005
p13789
sg5
S'PMC1188111'
p13790
sg7
VCD006442 v. 2.2 Psychological treatments for the management of irritable bowel syndrome.rm5
p13791
sg9
V16093252.xml
p13792
sa(dp13793
g3
VSTD-Sylvester-2010
p13794
sg5
S'PMC2889174'
p13795
sg7
VCD006885 v. 4.0 Intravesical Bacillus Calmette-Gurin versus epirubicin for Ta and T1 bladder cancer.rm5
p13796
sg9
V20034729.xml
p13797
sa(dp13798
g3
VSTD-Vroomen-2002-_x0028_prim-care_x0029_
p13799
sg5
S'PMC1737860'
p13800
sg7
VCD007431 v. 4.0 Physical examination for lumbar radiculopathy due to disc herniation in patients with low-back pain.rm5
p13801
sg9
V11971050.xml
p13802
sa(dp13803
g3
VSTD-Demircan-2002
p13804
sg5
S'PMC3610488'
p13805
sg7
g13801
sg9
V11931063.xml
p13806
sa(dp13807
g3
VSTD-Kerr-1988
p13808
sg5
S'PMC1031525'
p13809
sg7
g13801
sg9
V3346682.xml
p13810
sa(dp13811
g3
VSTD-Unrod-2007
p13812
sg5
S'PMC1829425'
p13813
sg7
VCD000214 v. 10.5 Training health professionals in smoking cessation.rm5
p13814
sg9
V17372796.xml
p13815
sa(dp13816
g3
VSTD-Cohen-_x0028_Doc_x0029_-1989
p13817
sg5
S'PMC1646917'
p13818
sg7
g13814
sg9
V3812837.xml
p13819
sa(dp13820
g3
VSTD-Gordon-2010
p13821
sg5
S'PMC2882418'
p13822
sg7
g13814
sg9
V20466951.xml
p13823
sa(dp13824
g3
VSTD-Sinclair-1998
p13825
sg5
S'PMC1763872'
p13826
sg7
g13814
sg9
V9825420.xml
p13827
sa(dp13828
g3
VSTD-Hymowitz-2007
p13829
sg5
S'PMC2258138'
p13830
sg7
g13814
sg9
V17707898.xml
p13831
sa(dp13832
g3
VSTD-Twardella-2007
p13833
sg5
S'PMC2598437'
p13834
sg7
g13814
sg9
V17297068.xml
p13835
sa(dp13836
g3
VSTD-Clifford-2002
p13837
sg5
S'PMC126226'
p13838
sg7
VMR000012 v. 6.2 Randomisation to protect against selection bias in healthcare trials.rm5
p13839
sg9
V12213183.xml
p13840
sa(dp13841
g3
VSTD-Leehey-2009
p13842
sg5
S'PMC2796994'
p13843
sg7
VCD003236 v. 7.0 Exercise training for adults with chronic kidney disease.rm5
p13844
sg9
V20003224.xml
p13845
sa(dp13846
g3
VSTD-Chen-2010
p13847
sg5
S'PMC2902890'
p13848
sg7
g13844
sg9
V20100734.xml
p13849
sa(dp13850
g3
VSTD-Noel-2009
p13851
sg5
S'PMC2689909'
p13852
sg7
VCD003897 v. 11.0 Interleukin 2 receptor antagonists for kidney transplant recipients.rm5
p13853
sg9
V19470677.xml
p13854
sa(dp13855
g3
VSTD-Ritchie-1992
p13856
sg5
S'PMC1881680'
p13857
sg7
VCD000531 v. 4.5 Target payments in primary care effects on professional practice and health care outcomes.rm5
p13858
sg9
V1392710.xml
p13859
sa(dp13860
g3
VSTD-Bookman-2004
p13861
sg5
S'PMC509045'
p13862
sg7
VCD007400 v. 4.0 Topical NSAIDs for chronic musculoskeletal pain in adults.rm5
p13863
sg9
V15313991.xml
p13864
sa(dp13865
g3
VSTD-Baer-2005
p13866
sg5
S'PMC1201146'
p13867
sg7
g13863
sg9
V16086839.xml
p13868
sa(dp13869
g3
VSTD-Roth-2004
p13870
sg5
S'PMC1955127'
p13871
sg7
g13863
sg9
V17363401.xml
p13872
sa(dp13873
g3
VSTD-Andersen-2004-_x0028_Nordic_x0029_
p13874
sg5
S'PMC1763573'
p13875
sg7
VCD005181 v. 8.2 Interferon beta for secondary progressive multiple sclerosis.rm5
p13876
sg9
V15090564.xml
p13877
sa(dp13878
g3
VSTD-Lazarus-2007
p13879
sg5
S'PMC1899291'
p13880
sg7
VCD002314 v. 5.0 Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent andor ch.rm5
p13881
sg9
V17204725.xml
p13882
sa(dp13883
g3
VSTD-Jayaram-2005
p13884
sg5
S'PMC1747311'
p13885
sg7
g13881
sg9
V15681495.xml
p13886
sa(dp13887
g3
VSTD-Ducharme-2005
p13888
sg5
S'PMC1167811'
p13889
sg7
VCD002752 v. 9.0 Clinical service organisation for heart failure.rm5
p13890
sg9
V15997043.xml
p13891
sa(dp13892
g3
VSTD-Cline-1998
p13893
sg5
S'PMC1728835'
p13894
sg7
g13890
sg9
V9930041.xml
p13895
sa(dp13896
g3
VSTD-Mejhert-2004
p13897
sg5
S'PMC1768467'
p13898
sg7
g13890
sg9
V15310688.xml
p13899
sa(dp13900
g3
VSTD-Blue-2001
p13901
sg5
S'PMC56888'
p13902
sg7
g13890
sg9
V11576977.xml
p13903
sa(dp13904
g3
VSTD-Holland-2007
p13905
sg5
S'PMC1877883'
p13906
sg7
g13890
sg9
V17452390.xml
p13907
sa(dp13908
g3
VSTD-Marigold-2005
p13909
sg5
S'PMC3226796'
p13910
sg7
VCD007513 v. 3.0 Circuit class therapy for improving mobility after stroke.rm5
p13911
sg9
V15743283.xml
p13912
sa(dp13913
g3
VSTD-Pang-2005
p13914
sg5
S'PMC3226792'
p13915
sg7
g13911
sg9
V16181164.xml
p13916
sa(dp13917
g3
VSTD-Stewart-2007
p13918
sg5
S'PMC3163239'
p13919
sg7
VCD003552 v. 9.0 Skin patch and vaginal ring versus combined oral contraceptives for contraception.rm5
p13920
sg9
V18082856.xml
p13921
sa(dp13922
g3
VSTD-Hughes-1992
p13923
sg5
S'PMC1069857'
p13924
sg7
VCD009231 v. 2.2 Hospital at home home-based end of life care.rm5
p13925
sg9
V1737710.xml
p13926
sa(dp13927
g3
VSTD-Cowett-1977
p13928
sg5
S'PMC2595562'
p13929
sg7
VCD004697 v. 6.0 Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery cathete.rm5
p13930
sg9
V602256.xml
p13931
sa(dp13932
g3
VSTD-Bard-1973
p13933
sg5
S'PMC1648593'
p13934
sg7
g13930
sg9
V4783004.xml
p13935
sa(dp13936
g3
VSTD-Stepnowsky-2007
p13937
sg5
S'PMC1874716'
p13938
sg7
VCD007736 v. 2.0 Educational supportive and behavioural interventions to improve usage of continuous positive airway.rm5
p13939
sg9
V17513285.xml
p13940
sa(dp13941
g3
VSTD-Swanson-2009
p13942
sg5
S'PMC2825726'
p13943
sg7
VCD008679 v. 2.0 Follow-up for improving psychological well being for women after a miscarriage.rm5
p13944
sg9
V19630553.xml
p13945
sa(dp13946
g3
VSTD-Vathenen-1991
p13947
sg5
S'PMC1021035'
p13948
sg7
VCD002739 v. 6.0 Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction.rm5
p13949
sg9
V1771604.xml
p13950
sa(dp13951
g3
VSTD-Schibler-2003
p13952
sg5
S'PMC1719415'
p13953
sg7
VCD008901 v. 2.0 Recombinant growth hormone therapy for cystic fibrosis in children and young adults.rm5
p13954
sg9
V14670773.xml
p13955
sa(dp13956
g3
VSTD-Halpern-2008
p13957
sg5
S'PMC2582655'
p13958
sg7
VCD007961 v. 2.0 Topical microbicides for prevention of sexually transmitted infections.rm5
p13959
sg9
V19023429.xml
p13960
sa(dp13961
g3
VSTD-Peterson-2007
p13962
sg5
S'PMC2129116'
p13963
sg7
g13959
sg9
V18091987.xml
p13964
sa(dp13965
g3
VSTD-Abdool-Karim-2011
p13966
sg5
S'PMC3083640'
p13967
sg7
g13959
sg9
V21330907.xml
p13968
sa(dp13969
g3
VSTD-Abdool-Karim-2010
p13970
sg5
S'PMC3001187'
p13971
sg7
g13959
sg9
V20643915.xml
p13972
sa(dp13973
g3
VSTD-McCormack-2010
p13974
sg5
S'PMC2956883'
p13975
sg7
g13959
sg9
V20851460.xml
p13976
sa(dp13977
g3
VSTD-Feldblum-2008
p13978
sg5
S'PMC2190795'
p13979
sg7
g13959
sg9
V18213382.xml
p13980
sa(dp13981
g3
VSTD-Ahmedzai-2004
p13982
sg5
S'PMC2409543'
p13983
sg7
VCD004769 v. 7.0 Oxygen therapy for dyspnoea in adults.rm5
p13984
sg9
V14735178.xml
p13985
sa(dp13986
g3
VSTD-Chua-1996
p13987
sg5
S'PMC484598'
p13988
sg7
g13984
sg9
V9014795.xml
p13989
sa(dp13990
g3
VSTD-Innes-2007
p13991
sg5
S'PMC2265270'
p13992
sg7
VCD003808 v. 6.0 Operative caries management in adults and children.rm5
p13993
sg9
V18096042.xml
p13994
sa(dp13995
g3
VSTD-Madge-1997
p13996
sg5
S'PMC1758505'
p13997
sg7
VCD000326 v. 6.0 Educational interventions for asthma in children.rm5
p13998
sg9
V9093336.xml
p13999
sa(dp14000
g3
VSTD-Mitchell-1986
p14001
sg5
S'PMC1778203'
p14002
sg7
g13998
sg9
V3545094.xml
p14003
sa(dp14004
g3
VSTD-McNabb-1985
p14005
sg5
S'PMC1646372'
p14006
sg7
g13998
sg9
V4037168.xml
p14007
sa(dp14008
g3
VSTD-Charlton-1994
p14009
sg5
S'PMC1029785'
p14010
sg7
g13998
sg9
V8185365.xml
p14011
sa(dp14012
g3
VSTD-Shields-1990
p14013
sg5
S'PMC1404528'
p14014
sg7
g13998
sg9
V2293801.xml
p14015
sa(dp14016
g3
VSTD-Resch-2000
p14017
sg5
S'PMC1297969'
p14018
sg7
VMR000016 v. 7.0 Editorial peer review for improving the quality of reports of biomedical studies.rm5
p14019
sg9
V10844878.xml
p14020
sa(dp14021
g3
VSTD-van-Rooyen-1999
p14022
sg5
S'PMC27670'
p14023
sg7
g14019
sg9
V9872878.xml
p14024
sa(dp14025
g3
VSTD-Weller-1996
p14026
sg5
S'PMC226156'
p14027
sg7
g14019
sg9
V8883984.xml
p14028
sa(dp14029
g3
VSTD-Schroter-2004
p14030
sg5
S'PMC381220'
p14031
sg7
g14019
sg9
V14996698.xml
p14032
sa(dp14033
g3
VSTD-Forfar-1958
p14034
sg5
S'PMC2027064'
p14035
sg7
VCD003670 v. 9.0 Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mor.rm5
p14036
sg9
V13489318.xml
p14037
sa(dp14038
g3
VSTD-Mitchell-1986-Europeans
p14039
sg5
S'PMC1778203'
p14040
sg7
VCD008469 v. 3.0 Home-based educational interventions for children with asthma.rm5
p14041
sg9
V3545094.xml
p14042
sa(dp14043
g3
VSTD-Mitchell-1986-Polynesians
p14044
sg5
S'PMC1778203'
p14045
sg7
g14041
sg9
V3545094.xml
p14046
sa(dp14047
g3
VSTD-Mitchell-1986
p14048
sg5
S'PMC1778203'
p14049
sg7
g14041
sg9
V3545094.xml
p14050
sa(dp14051
g3
VSTD-Butz-2006
p14052
sg5
S'PMC2269706'
p14053
sg7
g14041
sg9
V16754825.xml
p14054
sa(dp14055
g3
VSTD-Hurwitz-2002
p14056
sg5
S'PMC1447299'
p14057
sg7
VCD004251 v. 9.2 Electrotherapy for neck pain.rm5
p14058
sg9
V12356613.xml
p14059
sa(dp14060
g3
VSTD-Aggarwal-2006
p14061
sg5
S'PMC2564084'
p14062
sg7
VCD003898 v. 8.10 Inhaled magnesium sulfate in the treatment of acute asthma.rm5
p14063
sg9
V16627836.xml
p14064
sa(dp14065
g3
VSTD-Patriarca-1984
p14066
sg5
S'PMC179927'
p14067
sg7
VCD002745 v. 7.2 Amantadine and rimantadine for influenza A in children and the elderly.rm5
p14068
sg9
V6476812.xml
p14069
sa(dp14070
g3
VSTD-Monto-1995
p14071
sg5
S'PMC162919'
p14072
sg7
g14068
sg9
V8619572.xml
p14073
sa(dp14074
g3
VSTD-Pitt-1980
p14075
sg5
S'PMC1344917'
p14076
sg7
VCD003073 v. 7.0 Prevention of infection in arterial reconstruction.rm5
p14077
sg9
V6998390.xml
p14078
sa(dp14079
g3
VSTD-Hasselgren-1984
p14080
sg5
S'PMC1250399'
p14081
sg7
g14077
sg9
V6375599.xml
p14082
sa(dp14083
g3
VSTD-Earnshaw-1988
p14084
sg5
S'PMC2498719'
p14085
sg7
g14077
sg9
V3408172.xml
p14086
sa(dp14087
g3
VSTD-Kaiser-1978
p14088
sg5
S'PMC1396974'
p14089
sg7
g14077
sg9
V686894.xml
p14090
sa(dp14091
g3
VSTD-Chester-1983
p14092
sg5
S'PMC2494433'
p14093
sg7
g14077
sg9
V6638856.xml
p14094
sa(dp14095
g3
VSTD-Tan-1994
p14096
sg5
S'PMC1364731'
p14097
sg7
VCD007503 v. 3.0 Antidepressants for depression in physically ill people.rm5
p14098
sg9
V8018452.xml
p14099
sa(dp14100
g3
VSTD-Menza-2009
p14101
sg5
S'PMC2677475'
p14102
sg7
g14098
sg9
V19092112.xml
p14103
sa(dp14104
g3
VSTD-Menza-2009-_x0028_paroxetine_x0029_
p14105
sg5
S'PMC2677475'
p14106
sg7
g14098
sg9
V19092112.xml
p14107
sa(dp14108
g3
VSTD-Menza-2009_x0028_nortriptyline_x0029_
p14109
sg5
S'PMC2677475'
p14110
sg7
g14098
sg9
V19092112.xml
p14111
sa(dp14112
g3
VSTD-Londahl-2010
p14113
sg5
S'PMC2858204'
p14114
sg7
VCD004123 v. 9.2 Hyperbaric oxygen therapy for chronic wounds.rm5
p14115
sg9
V20427683.xml
p14116
sa(dp14117
g3
VSTD-De-La-Cal-2005
p14118
sg5
S'PMC1356980'
p14119
sg7
VCD008738 v. 2.0 Antibiotic prophylaxis for preventing burn wound infection.rm5
p14120
sg9
V15729064.xml
p14121
sa(dp14122
g3
VSTD-Mann-1986
p14123
sg5
S'PMC1342106'
p14124
sg7
VCD001814 v. 5.0 Developmental care for promoting development and preventing morbidity in preterm infants.rm5
p14125
sg9
V3096460.xml
p14126
sa(dp14127
g3
VSTD-Field_x002d_Fote-2011
p14128
sg5
S'PMC3017322'
p14129
sg7
VCD006676 v. 4.8 Locomotor training for walking after spinal cord injury.rm5
p14130
sg9
V21051593.xml
p14131
sa(dp14132
g3
VSTD-Alexeeva-2011
p14133
sg5
S'PMC3152808'
p14134
sg7
g14130
sg9
V21903010.xml
p14135
sa(dp14136
g3
VSTD-Nguyen-2008
p14137
sg5
S'PMC2483918'
p14138
sg7
VCD007718 v. 3.0 Telehealthcare for chronic obstructive pulmonary disease.rm5
p14139
sg9
V18417444.xml
p14140
sa(dp14141
g3
VSTD-Hartvigsen-2005
p14142
sg5
S'PMC1740861'
p14143
sg7
VCD005958 v. 6.6 Manual material handling advice and assistive devices for preventing and treating back pain in worke.rm5
p14144
sg9
V15613603.xml
p14145
sa(dp14146
g3
VSTD-Ballotta-2000
p14147
sg5
S'PMC1421116'
p14148
sg7
VCD001921 v. 4.0 Eversion versus conventional carotid endarterectomy for preventing stroke.rm5
p14149
sg9
V10862204.xml
p14150
sa(dp14151
g3
VSTD-Strauss-2008
p14152
sg5
S'PMC2883857'
p14153
sg7
VCD003248 v. 8.7 Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion .rm5
p14154
sg9
V18194383.xml
p14155
sa(dp14156
g3
VSTD-Kinmond-1993
p14157
sg5
S'PMC1676623'
p14158
sg7
g14154
sg9
V8443480.xml
p14159
sa(dp14160
g3
VSTD-Mercer-2006
p14161
sg5
S'PMC1564438'
p14162
sg7
g14154
sg9
V16585320.xml
p14163
sa(dp14164
g3
VSTD-Erie-County-1995
p14165
sg5
S'PMC1508243'
p14166
sg7
VCD001497 v. 6.0 Interventions for preventing tobacco sales to minors.rm5
p14167
sg9
V9618623.xml
p14168
sa(dp14169
g3
VSTD-Harlem-1993
p14170
sg5
S'PMC1508216'
p14171
sg7
g14167
sg9
V9618624.xml
p14172
sa(dp14173
g3
VSTD-California-1995
p14174
sg5
S'PMC1766282'
p14175
sg7
g14167
sg9
V10841587.xml
p14176
sa(dp14177
g3
VSTD-Chicago-1993
p14178
sg5
S'PMC1283996'
p14179
sg7
g14167
sg9
V8926225.xml
p14180
sa(dp14181
g3
VSTD-TPOP-1996
p14182
sg5
S'PMC1508321'
p14183
sg7
g14167
sg9
V9702146.xml
p14184
sa(dp14185
g3
VSTD-Everett-1990
p14186
sg5
S'PMC1403659'
p14187
sg7
g14167
sg9
V1594748.xml
p14188
sa(dp14189
g3
VSTD-St-Paul-1990
p14190
sg5
S'PMC1694336'
p14191
sg7
g14167
sg9
V1503160.xml
p14192
sa(dp14193
g3
VSTD-Sellwood-2007a
p14194
sg5
S'PMC2465319'
p14195
sg7
VCD008262 v. 2.2 Cold-water immersion (cryotherapy) for preventing and treating muscle soreness after exercise.rm5
p14196
sg9
V17261562.xml
p14197
sa(dp14198
g3
VSTD-Fok-1999
p14199
sg5
S'PMC1720936'
p14200
sg7
VCD001969 v. 6.4 Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated ve.rm5
p14201
sg9
V10212082.xml
p14202
sa(dp14203
g3
VSTD-Scheltinga-1991
p14204
sg5
S'PMC1358534'
p14205
sg7
VCD002920 v. 8.0 Nutrition support for bone marrow transplant patients.rm5
p14206
sg9
V1953094.xml
p14207
sa(dp14208
g3
VSTD-Gill-1993
p14209
sg5
S'PMC1029493'
p14210
sg7
VCD002056 v. 5.0 Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm inf.rm5
p14211
sg9
V8215566.xml
p14212
sa(dp14213
g3
VSTD-Bhasin-2000
p14214
sg5
S'PMC3173037'
p14215
sg7
VCD004248 v. 4.0 Progressive resistive exercise interventions for adults living with HIVAIDS.rm5
p14216
sg9
V10683055.xml
p14217
sa(dp14218
g3
VSTD-GICOG
p14219
sg5
S'PMC2360651'
p14220
sg7
VCD003175 v. 6.0 Adjuvant chemotherapy for endometrial cancer after hysterectomy.rm5
p14221
sg9
V16868539.xml
p14222
sa(dp14223
g3
VSTD-NSGO_x002c_-MaNGO-and-EORTC
p14224
sg5
S'PMC3552301'
p14225
sg7
g14221
sg9
V20619634.xml
p14226
sa(dp14227
g3
VSTD-MaNGO
p14228
sg5
S'PMC3552301'
p14229
sg7
g14221
sg9
V20619634.xml
p14230
sa(dp14231
g3
VSTD-Oosterhof-2006
p14232
sg5
S'PMC3476076'
p14233
sg7
VCD003222 v. 5.0 Transcutaneous electrical nerve stimulation (TENS) for chronic pain.rm5
p14234
sg9
V16897618.xml
p14235
sa(dp14236
g3
VSTD-Lewis-1984
p14237
sg5
S'PMC1001217'
p14238
sg7
g14234
sg9
V6364997.xml
p14239
sa(dp14240
g3
VSTD-Blum-2008
p14241
sg5
S'PMC3608469'
p14242
sg7
VCD005652 v. 5.0 Psychological therapies for people with borderline personality disorder.rm5
p14243
sg9
V18281407.xml
p14244
sa(dp14245
g3
VSTD-Davidson-2006
p14246
sg5
S'PMC1852259'
p14247
sg7
g14243
sg9
V17032158.xml
p14248
sa(dp14249
g3
VSTD-Carroll-2005
p14250
sg5
S'PMC1180654'
p14251
sg7
VCD005124 v. 4.0 Antenatal psychosocial assessment for reducing perinatal mental health morbidity.rm5
p14252
sg9
V16076821.xml
p14253
sa(dp14254
g3
VSTD-Ewer-1986
p14255
sg5
S'PMC1341848'
p14256
sg7
VCD002982 v. 9.0 Psychological interventions for adults with asthma.rm5
p14257
sg9
V3094804.xml
p14258
sa(dp14259
g3
VSTD-Steiner-2003
p14260
sg5
S'PMC1746806'
p14261
sg7
VCD003288 v. 6.0 Protein and energy supplementation in elderly people at risk from malnutrition.rm5
p14262
sg9
V12947128.xml
p14263
sa(dp14264
g3
VSTD-Rowland-1996
p14265
sg5
S'PMC1380358'
p14266
sg7
VCD004333 v. 6.0 Helmets for preventing injury in motorcycle riders.rm5
p14267
sg9
V8561240.xml
p14268
sa(dp14269
g3
VSTD-Murdock-1991
p14270
sg5
S'PMC1003016'
p14271
sg7
g14267
sg9
V1771873.xml
p14272
sa(dp14273
g3
VSTD-Luna-1981
p14274
sg5
S'PMC1273021'
p14275
sg7
g14267
sg9
V7281654.xml
p14276
sa(dp14277
g3
VSTD-Maitra-1993
p14278
sg5
S'PMC1285998'
p14279
sg7
VCD004574 v. 4.0 Interventions for treating mallet finger injuries.rm5
p14280
sg9
V8216604.xml
p14281
sa(dp14282
g3
VSTD-Aveyard-2007
p14283
sg5
S'PMC2094265'
p14284
sg7
VCD001292 v. 7.0 Individual behavioural counselling for smoking cessation.rm5
p14285
sg9
V17483139.xml
p14286
sa(dp14287
g3
VSTD-Glasgow-2000
p14288
sg5
S'PMC1446229'
p14289
sg7
g14285
sg9
V10800431.xml
p14290
sa(dp14291
g3
VSTD-Molyneux-2003
p14292
sg5
S'PMC1746718'
p14293
sg7
g14285
sg9
V12775857.xml
p14294
sa(dp14295
g3
VSTD-Bentley-1981
p14296
sg5
S'PMC1000652'
p14297
sg7
VCD003470 v. 3.0 Pharmacotherapy for patellofemoral pain syndrome.rm5
p14298
sg9
V7008711.xml
p14299
sa(dp14300
g3
VSTD-Hay-1995
p14301
sg5
S'PMC1235020'
p14302
sg7
VCD001543 v. 6.0 Shouldice technique versus other open techniques for inguinal hernia repair.rm5
p14303
sg9
V8526578.xml
p14304
sa(dp14305
g3
VSTD-Wiles-2001
p14306
sg5
S'PMC1737210'
p14307
sg7
VCD005029 v. 5.0 Treatment for ataxia in multiple sclerosis.rm5
p14308
sg9
V11160464.xml
p14309
sa(dp14310
g3
VSTD-T_x00f8_nnesen-1999a
p14311
sg5
S'PMC27867'
p14312
sg7
VCD008343 v. 3.0 Preoperative alcohol cessation prior to elective surgery.rm5
p14313
sg9
V10323814.xml
p14314
sa(dp14315
g3
VSTD-Saps-2009
p14316
sg5
S'PMC2827243'
p14317
sg7
VCD008013 v. 3.0 Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in.rm5
p14318
sg9
V19596010.xml
p14319
sa(dp14320
g3
VSTD-Anderson-1974f
p14321
sg5
S'PMC1947567'
p14322
sg7
VCD000980 v. 16.0 Vitamin C for preventing and treating the common cold.rm5
p14323
sg9
V4601508.xml
p14324
sa(dp14325
g3
VSTD-Anderson-1974e
p14326
sg5
S'PMC1947567'
p14327
sg7
g14323
sg9
V4601508.xml
p14328
sa(dp14329
g3
VSTD-Anderson-1974b
p14330
sg5
S'PMC1947567'
p14331
sg7
g14323
sg9
V4601508.xml
p14332
sa(dp14333
g3
VSTD-Anderson-1974c
p14334
sg5
S'PMC1947567'
p14335
sg7
g14323
sg9
V4601508.xml
p14336
sa(dp14337
g3
VSTD-Anderson-1974a
p14338
sg5
S'PMC1947567'
p14339
sg7
g14323
sg9
V4601508.xml
p14340
sa(dp14341
g3
VSTD-Anderson-1974d
p14342
sg5
S'PMC1947567'
p14343
sg7
g14323
sg9
V4601508.xml
p14344
sa(dp14345
g3
VSTD-Tyrrell-1977
p14346
sg5
S'PMC479021'
p14347
sg7
g14323
sg9
V338079.xml
p14348
sa(dp14349
g3
VSTD-Elwood-1976
p14350
sg5
S'PMC478963'
p14351
sg7
g14323
sg9
V788820.xml
p14352
sa(dp14353
g3
VSTD-Anderson-1975a
p14354
sg5
S'PMC1958969'
p14355
sg7
g14323
sg9
V1091343.xml
p14356
sa(dp14357
g3
VSTD-Anderson-1975b
p14358
sg5
S'PMC1958969'
p14359
sg7
g14323
sg9
V1091343.xml
p14360
sa(dp14361
g3
VSTD-Seferlis-1998
p14362
sg5
S'PMC3611294'
p14363
sg7
VCD000335 v. 14.0 Exercise therapy for treatment of non-specific low back pain.rm5
p14364
sg9
V9883955.xml
p14365
sa(dp14366
g3
VSTD-Frost-2004
p14367
sg5
S'PMC518892'
p14368
sg7
g14364
sg9
V15377573.xml
p14369
sa(dp14370
g3
VSTD-Moffett-1999
p14371
sg5
S'PMC28176'
p14372
sg7
g14364
sg9
V10426734.xml
p14373
sa(dp14374
g3
VSTD-Preyde-2000
p14375
sg5
S'PMC1231369'
p14376
sg7
g14364
sg9
V10906914.xml
p14377
sa(dp14378
g3
VSTD-Van-Koningsveld-2004
p14379
sg5
S'PMC2778673'
p14380
sg7
VCD001446 v. 14.0 Corticosteroids for Guillain-Barr syndrome.rm5
p14381
sg9
V17426908.xml
p14382
sa(dp14383
g3
VSTD-MacDonald-1983
p14384
sg5
S'PMC2494194'
p14385
sg7
VCD001351 v. 12.0 Acupuncture and dry-needling for low back pain.rm5
p14386
sg9
V6218776.xml
p14387
sa(dp14388
g3
VSTD-Kinmonth-1992
p14389
sg5
S'PMC1883680'
p14390
sg7
VCD003676 v. 7.0 Paracetamol versus placebo or physical methods for treating fever in children.rm5
p14391
sg9
V1463951.xml
p14392
sa(dp14393
g3
VSTD-Roberts-2003
p14394
sg5
S'PMC1693668'
p14395
sg7
VCD006398 v. 4.0 Interventions for preventing injuries in the agricultural industry.rm5
p14396
sg9
V14758405.xml
p14397
sa(dp14398
g3
VSTD-Lee-2004
p14399
sg5
S'PMC1448528'
p14400
sg7
g14396
sg9
V15451744.xml
p14401
sa(dp14402
g3
VSTD-Gadomski-2006
p14403
sg5
S'PMC1470549'
p14404
sg7
g14396
sg9
V16507741.xml
p14405
sa(dp14406
g3
VSTD-Cheetham-2001-_x0023_
p14407
sg5
S'PMC1760141'
p14408
sg7
VCD002116 v. 6.0 Drug treatment for faecal incontinence in adults.rm5
p14409
sg9
V11171825.xml
p14410
sa(dp14411
g3
VSTD-Arrowsmith-2000
p14412
sg5
S'PMC1718269'
p14413
sg7
VCD004236 v. 7.0 EMLA and Amethocaine for reduction of children's pain associated with needle insertion.rm5
p14414
sg9
V10735838.xml
p14415
sa(dp14416
g3
VSTD-Wang-1992
p14417
sg5
S'PMC1793648'
p14418
sg7
VCD001279 v. 9.0 Anticholinergic drugs for wheeze in children under the age of two years.rm5
p14419
sg9
V1533504.xml
p14420
sa(dp14421
g3
VSTD-Henry-1984
p14422
sg5
S'PMC1628434'
p14423
sg7
g14419
sg9
V6230059.xml
p14424
sa(dp14425
g3
VSTD-Firth-1969
p14426
sg5
S'PMC1982084'
p14427
sg7
VCD005937 v. 4.0 Treatments for suppression of lactation.rm5
p14428
sg9
V4883649.xml
p14429
sa(dp14430
g3
VSTD-Varga-1972
p14431
sg5
S'PMC1788467'
p14432
sg7
g14428
sg9
V4556543.xml
p14433
sa(dp14434
g3
VSTD-Yuen-1977
p14435
sg5
S'PMC1880136'
p14436
sg7
g14428
sg9
V334356.xml
p14437
sa(dp14438
g3
VSTD-Senior-1969
p14439
sg5
S'PMC1982066'
p14440
sg7
g14428
sg9
V4883650.xml
p14441
sa(dp14442
g3
VSTD-Worth-2009
p14443
sg5
S'PMC2720945'
p14444
sg7
VCD001287 v. 10.6 Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.rm5
p14445
sg9
V19624838.xml
p14446
sa(dp14447
g3
VSTD-McGavin-1985
p14448
sg5
S'PMC1020560'
p14449
sg7
g14445
sg9
V2866607.xml
p14450
sa(dp14451
g3
VSTD-Bateman-1978
p14452
sg5
S'PMC493239'
p14453
sg7
VCD001203 v. 4.0 Bromocriptine for levodopa-induced motor complications in Parkinson's disease.rm5
p14454
sg9
V366085.xml
p14455
sa(dp14456
g3
VSTD-Steptoe-1999
p14457
sg5
S'PMC28246'
p14458
sg7
VCD001188 v. 9.0 Nursing interventions for smoking cessation.rm5
p14459
sg9
V10514155.xml
p14460
sa(dp14461
g3
VSTD-Quist_x002d_Paulsen-2003
p14462
sg5
S'PMC286243'
p14463
sg7
g14459
sg9
V14644967.xml
p14464
sa(dp14465
g3
VSTD-OXCHECK-1994
p14466
sg5
S'PMC2539253'
p14467
sg7
g14459
sg9
V8124120.xml
p14468
sa(dp14469
g3
VSTD-Janz-1987
p14470
sg5
S'PMC1647206'
p14471
sg7
g14459
sg9
V3592033.xml
p14472
sa(dp14473
g3
VSTD-Lancaster-1999
p14474
sg5
S'PMC1313370'
p14475
sg7
g14459
sg9
V10343421.xml
p14476
sa(dp14477
g3
VSTD-Carlsson-1997
p14478
sg5
S'PMC484693'
p14479
sg7
g14459
sg9
V9093045.xml
p14480
sa(dp14481
g3
VSTD-Campbell-1998
p14482
sg5
S'PMC1728827'
p14483
sg7
g14459
sg9
V9930042.xml
p14484
sa(dp14485
g3
VSTD-Hajek-2002
p14486
sg5
S'PMC64504'
p14487
sg7
g14459
sg9
V11786452.xml
p14488
sa(dp14489
g3
VSTD-Sanders-1989a
p14490
sg5
S'PMC1711904'
p14491
sg7
g14459
sg9
V2556540.xml
p14492
sa(dp14493
g3
VSTD-Sanders-1989b
p14494
sg5
S'PMC1711904'
p14495
sg7
g14459
sg9
V2556540.xml
p14496
sa(dp14497
g3
VSTD-Lyon-1998
p14498
sg5
S'PMC1720741'
p14499
sg7
VCD003744 v. 3.0 Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for or.rm5
p14500
sg9
V9536833.xml
p14501
sa(dp14502
g3
VSTD-Moroni-1996
p14503
sg5
S'PMC2074576'
p14504
sg7
VCD007881 v. 3.0 Interventions for cough in cancer.rm5
p14505
sg9
V8688342.xml
p14506
sa(dp14507
g3
VSTD-Olafsdottir-2001
p14508
sg5
S'PMC1718650'
p14509
sg7
VCD004796 v. 6.0 Manipulative therapies for infantile colic.rm5
p14510
sg9
V11159288.xml
p14511
sa(dp14512
g3
VSTD-Rahman-2001
p14513
sg5
S'PMC37318'
p14514
sg7
VCD006090 v. 8.0 Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of a.rm5
p14515
sg9
V11498488.xml
p14516
sa(dp14517
g3
VSTD-Bhandari-1994
p14518
sg5
S'PMC2541323'
p14519
sg7
g14515
sg9
V7819847.xml
p14520
sa(dp14521
g3
VSTD-Ferley-1989
p14522
sg5
S'PMC1379831'
p14523
sg7
VCD001957 v. 16.0 Homeopathic Oscillococcinum for preventing and treating influenza and influenza-like illness.rm5
p14524
sg9
V2655683.xml
p14525
sa(dp14526
g3
VSTD-Maartense-2006
p14527
sg5
S'PMC1448907'
p14528
sg7
VCD006956 v. 3.2 Laparoscopic versus Open surgery for small bowel Crohn's disease.rm5
p14529
sg9
V16432345.xml
p14530
sa(dp14531
g3
VSTD-Webster-2008
p14532
sg5
S'PMC2483870'
p14533
sg7
VCD007798 v. 3.0 Clinically-indicated replacement versus routine replacement of peripheral venous catheters.rm5
p14534
sg9
V18614482.xml
p14535
sa(dp14536
g3
VSTD-Barker-2004
p14537
sg5
S'PMC1964197'
p14538
sg7
g14534
sg9
V15239872.xml
p14539
sa(dp14540
g3
VSTD-Rickard-2010
p14541
sg5
S'PMC2944158'
p14542
sg7
g14534
sg9
V20831782.xml
p14543
sa(dp14544
g3
VSTD-Canani-2007
p14545
sg5
S'PMC1949444'
p14546
sg7
VCD003048 v. 6.0 Probiotics for treating acute infectious diarrhoea.rm5
p14547
sg9
V17690340.xml
p14548
sa(dp14549
g3
VSTD-Henker-2007a
p14550
sg5
S'PMC1802727'
p14551
sg7
g14547
sg9
V17287932.xml
p14552
sa(dp14553
g3
VSTD-Docherty-1995
p14554
sg5
S'PMC1234951'
p14555
sg7
VCD004320 v. 5.0 Stapled versus handsewn methods for ileocolic anastomoses.rm5
p14556
sg9
V7857145.xml
p14557
sa(dp14558
g3
VSTD-Maguire-1980
p14559
sg5
S'PMC1714830'
p14560
sg7
VCD005634 v. 7.2 Specialist breast care nurses for supportive care of women with breast cancer.rm5
p14561
sg9
V7192170.xml
p14562
sa(dp14563
g3
VSTD-McArdle-1996
p14564
sg5
S'PMC2350687'
p14565
sg7
g14561
sg9
V8608288.xml
p14566
sa(dp14567
g3
VSTD-Delvaux-2004
p14568
sg5
S'PMC2395320'
p14569
sg7
VCD002892 v. 7.0 Preventing occupational stress in healthcare workers.rm5
p14570
sg9
V14710215.xml
p14571
sa(dp14572
g3
VSTD-Fox-1999
p14573
sg5
S'PMC1717884'
p14574
sg7
VCD008888 v. 2.0 Inhaled corticosteroids for subacute cough in children.rm5
p14575
sg9
V10086941.xml
p14576
sa(dp14577
g3
VSTD-Vic-1998
p14578
sg5
S'PMC1717599'
p14579
sg7
VCD002009 v. 13.0 Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.rm5
p14580
sg9
V9713009.xml
p14581
sa(dp14582
g3
VSTD-Calverley-2003
p14583
sg5
S'PMC1746483'
p14584
sg7
VCD002876 v. 8.0 Tiotropium for stable chronic obstructive pulmonary disease.rm5
p14585
sg9
V14514937.xml
p14586
sa(dp14587
g3
VSTD-Brusasco-2003
p14588
sg5
S'PMC1746668'
p14589
sg7
g14585
sg9
V12728159.xml
p14590
sa(dp14591
g3
VSTD-van-Noord-2000
p14592
sg5
S'PMC1745719'
p14593
sg7
g14585
sg9
V10722768.xml
p14594
sa(dp14595
g3
VSTD-Lindholm-2010
p14596
sg5
S'PMC3587763'
p14597
sg7
VCD008743 v. 2.8 Use of electronic health records to support smoking cessation.rm5
p14598
sg9
V21287886.xml
p14599
sa(dp14600
g3
VSTD-Koplan-2008
p14601
sg5
S'PMC2517966'
p14602
sg7
g14598
sg9
V18465176.xml
p14603
sa(dp14604
g3
VSTD-Linder-2009
p14605
sg5
S'PMC3005286'
p14606
sg7
g14598
sg9
V19398690.xml
p14607
sa(dp14608
g3
VSTD-Tehraninejad-2010
p14609
sg5
S'PMC3302709'
p14610
sg7
VCD002808 v. 6.0 Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary.rm5
p14611
sg9
V22427771.xml
p14612
sa(dp14613
g3
VSTD-Zeiger-2011
p14614
sg5
S'PMC3247621'
p14615
sg7
VCD009611 v. 3.0 Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.rm5
p14616
sg9
V22111718.xml
p14617
sa(dp14618
g3
VSTD-Turpeinen-2008
p14619
sg5
S'PMC2532957'
p14620
sg7
g14616
sg9
V17634183.xml
p14621
sa(dp14622
g3
VSTD-Shukla-1966
p14623
sg5
S'PMC506219'
p14624
sg7
VCD001860 v. 9.6 Antibiotics for trachoma.rm5
p14625
sg9
V4952467.xml
p14626
sa(dp14627
g3
VSTD-Darougar-1980
p14628
sg5
S'PMC1043672'
p14629
sg7
g14625
sg9
V6992856.xml
p14630
sa(dp14631
g3
VSTD-Cochereau-2007
p14632
sg5
S'PMC1954762'
p14633
sg7
g14625
sg9
V17005549.xml
p14634
sa(dp14635
g3
VSTD-Wade-1992
p14636
sg5
S'PMC1881332'
p14637
sg7
VCD005952 v. 3.0 Therapy-based rehabilitation services for patients living at home more than one year after stroke.rm5
p14638
sg9
V1559090.xml
p14639
sa(dp14640
g3
VSTD-CREST-2010
p14641
sg5
S'PMC2932446'
p14642
sg7
VCD000515 v. 6.2 Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis.rm5
p14643
sg9
V20505173.xml
p14644
sa(dp14645
g3
VSTD-ICSS-2010
p14646
sg5
S'PMC2849002'
p14647
sg7
g14643
sg9
V20189239.xml
p14648
sa(dp14649
g3
VSTD-Spiro-1983
p14650
sg5
S'PMC459595'
p14651
sg7
VCD001316 v. 8.0 Steroids radiotherapy chemotherapy and stents for superior vena caval obstruction in carcinoma of .rm5
p14652
sg9
V6310812.xml
p14653
sa(dp14654
g3
VSTD-Stock-1995
p14655
sg5
S'PMC475086'
p14656
sg7
g14652
sg9
V8553270.xml
p14657
sa(dp14658
g3
VSTD-Watkinson-1993
p14659
sg5
S'PMC464777'
p14660
sg7
g14652
sg9
V7694384.xml
p14661
sa(dp14662
g3
VSTD-Lenssen-2008
p14663
sg5
S'PMC2386789'
p14664
sg7
VCD004260 v. 8.0 Continuous passive motion following total knee arthroplasty in people with arthritis.rm5
p14665
sg9
V18442423.xml
p14666
sa(dp14667
g3
VSTD-Pacifico-1996
p14668
sg5
S'PMC163247'
p14669
sg7
VCD004872 v. 7.0 Short-term late-generation antibiotics versus longer term penicillin for acute streptococcal pharyng.rm5
p14670
sg9
V8849215.xml
p14671
sa(dp14672
g3
VSTD-Ward-2005
p14673
sg5
S'PMC1747266'
p14674
sg7
VCD001941 v. 5.0 Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and ches.rm5
p14675
sg9
V16299118.xml
p14676
sa(dp14677
g3
VSTD-Phimda-2007
p14678
sg5
S'PMC2043199'
p14679
sg7
VCD008264 v. 2.0 Antibiotics for leptospirosis.rm5
p14680
sg9
V17638700.xml
p14681
sa(dp14682
g3
VSTD-Juster-2007
p14683
sg5
S'PMC2040364'
p14684
sg7
VCD005992 v. 4.0 Legislative smoking bans for reducing secondhand smoke exposure smoking prevalence and tobacco cons.rm5
p14685
sg9
V17901438.xml
p14686
sa(dp14687
g3
VSTD-Mulcahy-2005
p14688
sg5
S'PMC1748138'
p14689
sg7
g14685
sg9
V16319361.xml
p14690
sa(dp14691
g3
VSTD-Fern_x00e1_ndez-2009
p14692
sg5
S'PMC2621339'
p14693
sg7
g14685
sg9
V19165321.xml
p14694
sa(dp14695
g3
VSTD-Farrelly-2005
p14696
sg5
S'PMC1748080'
p14697
sg7
g14685
sg9
V16046685.xml
p14698
sa(dp14699
g3
VSTD-Eagan-2006
p14700
sg5
S'PMC2564667'
p14701
sg7
g14685
sg9
V16728756.xml
p14702
sa(dp14703
g3
VSTD-Hyland-2009
p14704
sg5
S'PMC2720733'
p14705
sg7
g14685
sg9
V19151105.xml
p14706
sa(dp14707
g3
VSTD-Fong-2006
p14708
sg5
S'PMC2593063'
p14709
sg7
g14685
sg9
V16754947.xml
p14710
sa(dp14711
g3
VSTD-Sargent-2004
p14712
sg5
S'PMC404491'
p14713
sg7
g14685
sg9
V15066887.xml
p14714
sa(dp14715
g3
VSTD-Gal_x00e1_n-2007
p14716
sg5
S'PMC2034550'
p14717
sg7
g14685
sg9
V17760974.xml
p14718
sa(dp14719
g3
VSTD-Allwright-2005
p14720
sg5
S'PMC1283274'
p14721
sg7
g14685
sg9
V16230313.xml
p14722
sa(dp14723
g3
VSTD-Fernando-2007
p14724
sg5
S'PMC2598530'
p14725
sg7
g14685
sg9
V17652238.xml
p14726
sa(dp14727
g3
VSTD-Gilpin-2002
p14728
sg5
S'PMC1447162'
p14729
sg7
g14685
sg9
V11988448.xml
p14730
sa(dp14731
g3
VSTD-Akhtar-2007
p14732
sg5
S'PMC1976539'
p14733
sg7
g14685
sg9
V17827487.xml
p14734
sa(dp14735
g3
VSTD-Abrams-2006
p14736
sg5
S'PMC1470494'
p14737
sg7
g14685
sg9
V16380571.xml
p14738
sa(dp14739
g3
VSTD-Haw-2007
p14740
sg5
S'PMC1976488'
p14741
sg7
g14685
sg9
V17827485.xml
p14742
sa(dp14743
g3
VSTD-McCusker-1995
p14744
sg5
S'PMC1615635'
p14745
sg7
VCD005338 v. 5.0 Therapeutic communities for substance related disorder.rm5
p14746
sg9
V7573630.xml
p14747
sa(dp14748
g3
VSTD-McCusker-1997a
p14749
sg5
S'PMC1381126'
p14750
sg7
g14746
sg9
V9357345.xml
p14751
sa(dp14752
g3
VSTD-Warner-2010
p14753
sg5
S'PMC2806180'
p14754
sg7
VCD003449 v. 11.0 Treatment of vaginal bleeding irregularities induced by progestin only contraceptives.rm5
p14755
sg9
V19897857.xml
p14756
sa(dp14757
g3
VSTD-Weisberg-2009
p14758
sg5
S'PMC2710284'
p14759
sg7
g14755
sg9
V19369294.xml
p14760
sa(dp14761
g3
VSTD-Sinha-1997
p14762
sg5
S'PMC1720717'
p14763
sg7
VCD003666 v. 6.1 Volume-targeted versus pressure-limited ventilation in the neonate.rm5
p14764
sg9
V9462190.xml
p14765
sa(dp14766
g3
VSTD-Ramenghi-1999
p14767
sg5
S'PMC1720910'
p14768
sg7
VCD001069 v. 7.0 Sucrose for analgesia in newborn infants undergoing painful procedures.rm5
p14769
sg9
V10325795.xml
p14770
sa(dp14771
g3
VSTD-Ramenghi-1996a
p14772
sg5
S'PMC2528545'
p14773
sg7
g14769
sg9
V8777660.xml
p14774
sa(dp14775
g3
VSTD-Ramenghi-1996b
p14776
sg5
S'PMC2528524'
p14777
sg7
g14769
sg9
V8777661.xml
p14778
sa(dp14779
g3
VSTD-Rushforth-1993
p14780
sg5
S'PMC1029529'
p14781
sg7
g14769
sg9
V8215552.xml
p14782
sa(dp14783
g3
VSTD-Alsaedi-2009
p14784
sg5
S'PMC2813645'
p14785
sg7
g14769
sg9
V19448377.xml
p14786
sa(dp14787
g3
VSTD-Boyle-2006
p14788
sg5
S'PMC2672697'
p14789
sg7
g14769
sg9
V16428355.xml
p14790
sa(dp14791
g3
VSTD-Carbajal-1999
p14792
sg5
S'PMC28282'
p14793
sg7
g14769
sg9
V10574854.xml
p14794
sa(dp14795
g3
VSTD-Ogawa-2005
p14796
sg5
S'PMC1721952'
p14797
sg7
g14769
sg9
V15871991.xml
p14798
sa(dp14799
g3
VSTD-Slater-2010
p14800
sg5
S'PMC2958259'
p14801
sg7
g14769
sg9
V20817247.xml
p14802
sa(dp14803
g3
VSTD-Acharya-2004
p14804
sg5
S'PMC1721636'
p14805
sg7
g14769
sg9
V14711847.xml
p14806
sa(dp14807
g3
VSTD-Taddio-2008
p14808
sg5
S'PMC2464480'
p14809
sg7
g14769
sg9
V18591525.xml
p14810
sa(dp14811
g3
VSTD-Haouari-1995
p14812
sg5
S'PMC2549876'
p14813
sg7
g14769
sg9
V7787595.xml
p14814
sa(dp14815
g3
VSTD-Tonnel-2008
p14816
sg5
S'PMC2629970'
p14817
sg7
VCD009285 v. 4.0 Tiotropium versus placebo for chronic obstructive pulmonary disease.rm5
p14818
sg9
V18686739.xml
p14819
sa(dp14820
g3
VSTD-Bateman-2010b
p14821
sg5
S'PMC2921687'
p14822
sg7
g14818
sg9
V20714373.xml
p14823
sa(dp14824
g3
VSTD-Brusasco-2003
p14825
sg5
S'PMC1746668'
p14826
sg7
g14818
sg9
V12728159.xml
p14827
sa(dp14828
g3
VSTD-Chan-2007
p14829
sg5
S'PMC2677771'
p14830
sg7
g14818
sg9
V18060091.xml
p14831
sa(dp14832
g3
VSTD-Freeman-2007
p14833
sg5
S'PMC1913915'
p14834
sg7
g14818
sg9
V17605774.xml
p14835
sa(dp14836
g3
VSTD-Trooster-2011
p14837
sg5
S'PMC3078679'
p14838
sg7
g14818
sg9
V21503263.xml
p14839
sa(dp14840
g3
VSTD-Cooper-2010
p14841
sg5
S'PMC2981152'
p14842
sg7
g14818
sg9
V21103404.xml
p14843
sa(dp14844
g3
VSTD-Bauman-1991
p14845
sg5
S'PMC1405075'
p14846
sg7
VCD001006 v. 11.0 Mass media interventions for preventing smoking in young people.rm5
p14847
sg9
V2014859.xml
p14848
sa(dp14849
g3
VSTD-Flynn-2010
p14850
sg5
S'PMC2898197'
p14851
sg7
g14847
sg9
V20537841.xml
p14852
sa(dp14853
g3
VSTD-Poskitt-1987
p14854
sg5
S'PMC1245732'
p14855
sg7
VCD001737 v. 9.2 Skin grafting for venous leg ulcers.rm5
p14856
sg9
V3105681.xml
p14857
sa(dp14858
g3
VSTD-Atkinson-2007
p14859
sg5
S'PMC2094276'
p14860
sg7
VCD004874 v. 10.0 Antibiotics for community-acquired pneumonia in children.rm5
p14861
sg9
V17567657.xml
p14862
sa(dp14863
g3
VSTD-Keeley-1990
p14864
sg5
S'PMC2393134'
p14865
sg7
g14861
sg9
V2194687.xml
p14866
sa(dp14867
g3
VSTD-Asghar-2008
p14868
sg5
S'PMC2190277'
p14869
sg7
g14861
sg9
V18182412.xml
p14870
sa(dp14871
g3
VSTD-Roord-1996
p14872
sg5
S'PMC163618'
p14873
sg7
g14861
sg9
V9124837.xml
p14874
sa(dp14875
g3
VSTD-Hoffbrand-1988
p14876
sg5
S'PMC1033029'
p14877
sg7
VCD000094 v. 6.0 Gangliosides for acute ischaemic stroke.rm5
p14878
sg9
V3066849.xml
p14879
sa(dp14880
g3
VSTD-Rebello-2001
p14881
sg5
S'PMC30583'
p14882
sg7
VCD008054 v. 2.2 Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.rm5
p14883
sg9
V11302900.xml
p14884
sa(dp14885
g3
VSTD-Cattani-2009
p14886
sg5
S'PMC2786669'
p14887
sg7
g14883
sg9
V19828739.xml
p14888
sa(dp14889
g3
VSTD-Lytwyn-2000
p14890
sg5
S'PMC80165'
p14891
sg7
g14883
sg9
V11022584.xml
p14892
sa(dp14893
g3
VSTD-Choung-2008
p14894
sg5
S'PMC2671765'
p14895
sg7
VCD003423 v. 4.2 Antihistamines andor decongestants for otitis media with effusion (OME) in children.rm5
p14896
sg9
V19434268.xml
p14897
sa(dp14898
g3
VSTD-Leibovici-2001
p14899
sg5
S'PMC61047'
p14900
sg7
VCD000368 v. 12.0 Intercessory prayer for the alleviation of ill health.rm5
p14901
sg9
V11751349.xml
p14902
sa(dp14903
g3
VSTD-Staab-2006
p14904
sg5
S'PMC1444870'
p14905
sg7
VCD004054 v. 4.0 Psychological and educational interventions for atopic eczema in children.rm5
p14906
sg9
V16627509.xml
p14907
sa(dp14908
g3
VSTD-Kushner-2008
p14909
sg5
S'PMC2652083'
p14910
sg7
VCD008216 v. 3.0 Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomy.rm5
p14911
sg9
V18809603.xml
p14912
sa(dp14913
g3
VSTD-Bertuzzi-2003
p14914
sg5
S'PMC2394317'
p14915
sg7
g14911
sg9
V14520438.xml
p14916
sa(dp14917
g3
VSTD-Mitchell-1994
p14918
sg5
S'PMC1029751'
p14919
sg7
g14911
sg9
V7907853.xml
p14920
sa(dp14921
g3
VSTD-Gara-2010
p14922
sg5
S'PMC2946754'
p14923
sg7
VCD006589 v. 5.5 Oral iron supplements for children in malaria-endemic areas.rm5
p14924
sg9
V20889877.xml
p14925
sa(dp14926
g3
VSTD-Zlotkin-2003
p14927
sg5
S'PMC2572396'
p14928
sg7
g14924
sg9
V12756979.xml
p14929
sa(dp14930
g3
VSTD-Aggarwal-2005
p14931
sg5
S'PMC1720080'
p14932
sg7
g14924
sg9
V15613506.xml
p14933
sa(dp14934
g3
VSTD-Johnson-2008
p14935
sg5
S'PMC2327253'
p14936
sg7
VCD008066 v. 4.0 Transtheoretical model for dietary and physical exercise modification in weight loss management for .rm5
p14937
sg9
V18055007.xml
p14938
sa(dp14939
g3
VSTD-Steptoe-2001
p14940
sg5
S'PMC1446539'
p14941
sg7
g14937
sg9
V11211636.xml
p14942
sa(dp14943
g3
VSTD-Gibson-1992
p14944
sg5
S'PMC1285823'
p14945
sg7
VCD008643 v. 4.3 Red flags to screen for vertebral fracture in patients presenting with low-back pain.rm5
p14946
sg9
V1533126.xml
p14947
sa(dp14948
g3
VSTD-Leung-2006
p14949
sg5
S'PMC1804104'
p14950
sg7
VCD005457 v. 7.0 Carbetocin for preventing postpartum haemorrhage.rm5
p14951
sg9
V17176279.xml
p14952
sa(dp14953
g3
VSTD-Chauhan-1992
p14954
sg5
S'PMC1882360'
p14955
sg7
VCD008250 v. 2.0 Breathing exercises for chronic obstructive pulmonary disease.rm5
p14956
sg9
V1633520.xml
p14957
sa(dp14958
g3
VSTD-Donesky_x002d_Cuenco-2009
p14959
sg5
S'PMC3051406'
p14960
sg7
g14956
sg9
V19249998.xml
p14961
sa(dp14962
g3
VSTD-Zmora-2003
p14963
sg5
S'PMC1514315'
p14964
sg7
VCD001544 v. 8.0 Mechanical bowel preparation for elective colorectal surgery.rm5
p14965
sg9
V12616120.xml
p14966
sa(dp14967
g3
VSTD-Scabini-2010
p14968
sg5
S'PMC2873340'
p14969
sg7
g14965
sg9
V20433721.xml
p14970
sa(dp14971
g3
VSTD-Kirke-1992
p14972
sg5
S'PMC1793975'
p14973
sg7
VCD004073 v. 6.0 Vitamin supplementation for preventing miscarriage.rm5
p14974
sg9
V1489222.xml
p14975
sa(dp14976
g3
VSTD-Lefaucheur-2004
p14977
sg5
S'PMC1739005'
p14978
sg7
VCD008208 v. 4.0 Non-invasive brain stimulation techniques for chronic pain.rm5
p14979
sg9
V15026508.xml
p14980
sa(dp14981
g3
VSTD-Borckardt-2009
p14982
sg5
S'PMC2863136'
p14983
sg7
g14979
sg9
V19594842.xml
p14984
sa(dp14985
g3
VSTD-Jones-1982
p14986
sg5
S'PMC1627926'
p14987
sg7
VCD001072 v. 6.0 Continuous positive airway pressure versus theophylline for apnea in preterm infants.rm5
p14988
sg9
V6753769.xml
p14989
sa(dp14990
g3
VSTD-Aufenacker-2004
p14991
sg5
S'PMC1356511'
p14992
sg7
VCD003769 v. 9.0 Antibiotic prophylaxis for hernia repair..rm5
p14993
sg9
V15570201.xml
p14994
sa(dp14995
g3
VSTD-Yerdel-2001
p14996
sg5
S'PMC1421162'
p14997
sg7
g14993
sg9
V11141221.xml
p14998
sa(dp14999
g3
VSTD-Araki-2011
p15000
sg5
S'PMC3047641'
p15001
sg7
VCD008413 v. 2.0 Double-bundle versus single-bundle reconstruction for anterior cruciate ligament rupture in adults.rm5
p15002
sg9
V20734043.xml
p15003
sa(dp15004
g3
VSTD-Song-2009
p15005
sg5
S'PMC3740368'
p15006
sg7
g15002
sg9
V19509412.xml
p15007
sa(dp15008
g3
VSTD-Murray-2011
p15009
sg5
S'PMC3323493'
p15010
sg7
VCD008858 v. 2.0 Vaccines for preventing herpes zoster in older adults.rm5
p15011
sg9
V22048110.xml
p15012
sa(dp15013
g3
VSTD-Gilderman-2008
p15014
sg5
S'PMC2238040'
p15015
sg7
g15011
sg9
V18077611.xml
p15016
sa(dp15017
g3
VSTD-Baqui_x002d_CARE-INDIA-2008
p15018
sg5
S'PMC2649510'
p15019
sg7
VCD007754 v. 3.0 Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and.rm5
p15020
sg9
V18949217.xml
p15021
sa(dp15022
g3
VSTD-Syed-2006
p15023
sg5
S'PMC3001155'
p15024
sg7
g15020
sg9
V17591348.xml
p15025
sa(dp15026
g3
VSTD-Bhutta-2008
p15027
sg5
S'PMC2647462'
p15028
sg7
g15020
sg9
V18568274.xml
p15029
sa(dp15030
g3
VSTD-Bari-2006
p15031
sg5
S'PMC3001156'
p15032
sg7
g15020
sg9
V17591349.xml
p15033
sa(dp15034
g3
VSTD-Leech-1987
p15035
sg5
S'PMC1492041'
p15036
sg7
VCD000422 v. 8.0 Vaccines for preventing pneumococcal infection in adults.rm5
p15037
sg9
V3545418.xml
p15038
sa(dp15039
g3
VSTD-Alfageme-2006
p15040
sg5
S'PMC2080738'
p15041
sg7
g15037
sg9
V16227328.xml
p15042
sa(dp15043
g3
VSTD-Ferrari-2003-BRA
p15044
sg5
S'PMC2572425'
p15045
sg7
VCD000528 v. 8.4 Drugs for treating Schistosoma mansoni infection.rm5
p15046
sg9
V12764515.xml
p15047
sa(dp15048
g3
VSTD-Tweyongyere-2009-UGA
p15049
sg5
S'PMC2666740'
p15050
sg7
g15046
sg9
V19296834.xml
p15051
sa(dp15052
g3
VSTD-Omer-1978-SDN
p15053
sg5
S'PMC1606234'
p15054
sg7
g15046
sg9
V678831.xml
p15055
sa(dp15056
g3
VSTD-Olliaro-2011-TZA
p15057
sg5
S'PMC3114749'
p15058
sg7
g15046
sg9
V21695161.xml
p15059
sa(dp15060
g3
VSTD-Katz-1979b-BRA
p15061
sg5
S'PMC2395863'
p15062
sg7
g15046
sg9
V396054.xml
p15063
sa(dp15064
g3
VSTD-Olliaro-2011-MRT
p15065
sg5
S'PMC3114749'
p15066
sg7
g15046
sg9
V21695161.xml
p15067
sa(dp15068
g3
VSTD-Katz-1979a-BRA
p15069
sg5
S'PMC2395863'
p15070
sg7
g15046
sg9
V396054.xml
p15071
sa(dp15072
g3
VSTD-Olliaro-2011-BRA
p15073
sg5
S'PMC3114749'
p15074
sg7
g15046
sg9
V21695161.xml
p15075
sa(dp15076
g3
VSTD-Bergstrom-2009
p15077
sg5
S'PMC2759981'
p15078
sg7
VCD009514 v. 1.0 Relaxation techniques for pain management in labour.rm5
p15079
sg9
V19538406.xml
p15080
sa(dp15081
g3
VSTD-Lepantalo-1984
p15082
sg5
S'PMC1463567'
p15083
sg7
VCD003893 v. 8.0 Methyldopa for primary hypertension.rm5
p15084
sg9
V6378235.xml
p15085
sa(dp15086
g3
VSTD-Petrie-1976
p15087
sg5
S'PMC1687472'
p15088
sg7
g15084
sg9
V776350.xml
p15089
sa(dp15090
g3
VSTD-Fernandez-1980
p15091
sg5
S'PMC1704774'
p15092
sg7
g15084
sg9
V7020900.xml
p15093
sa(dp15094
g3
VSTD-Edwards-1999
p15095
sg5
S'PMC1745469'
p15096
sg7
VCD004108 v. 9.0 Nedocromil sodium for chronic asthma in children.rm5
p15097
sg9
V10092691.xml
p15098
sa(dp15099
g3
VSTD-Fiocchi-1994
p15100
sg5
S'PMC2365600'
p15101
sg7
g15097
sg9
V18475604.xml
p15102
sa(dp15103
g3
VSTD-Muirhead-2006
p15104
sg5
S'PMC1828262'
p15105
sg7
VCD004015 v. 6.3 Lay health workers in primary and community health care for maternal and child health and the manage.rm5
p15106
sg9
V16536959.xml
p15107
sa(dp15108
g3
VSTD-Kouyate-2008
p15109
sg5
S'PMC2287184'
p15110
sg7
g15106
sg9
V18364043.xml
p15111
sa(dp15112
g3
VSTD-Olds-2002
p15113
sg5
S'PMC1509014'
p15114
sg7
g15106
sg9
V10589314.xml
p15115
sa(dp15116
g3
VSTD-Graffy-2004
p15117
sg5
S'PMC313903'
p15118
sg7
g15106
sg9
V14703543.xml
p15119
sa(dp15120
g3
VSTD-Morisky-2001
p15121
sg5
S'PMC1497389'
p15122
sg7
g15106
sg9
V12196616.xml
p15123
sa(dp15124
g3
VSTD-Gadomski-2006
p15125
sg5
S'PMC1470549'
p15126
sg7
g15106
sg9
V16507741.xml
p15127
sa(dp15128
g3
VSTD-MacArthur-2009
p15129
sg5
S'PMC2636685'
p15130
sg7
g15106
sg9
V19181730.xml
p15131
sa(dp15132
g3
VSTD-Morrell-2000
p15133
sg5
S'PMC27472'
p15134
sg7
g15106
sg9
V10977833.xml
p15135
sa(dp15136
g3
VSTD-Schuler-2000
p15137
sg5
S'PMC3143381'
p15138
sg7
g15106
sg9
V10969426.xml
p15139
sa(dp15140
g3
VSTD-Bari-2006
p15141
sg5
S'PMC3001156'
p15142
sg7
g15106
sg9
V17591349.xml
p15143
sa(dp15144
g3
VSTD-Dennis-2009
p15145
sg5
S'PMC2628301'
p15146
sg7
g15106
sg9
V19147637.xml
p15147
sa(dp15148
g3
VSTD-Johnson-1993
p15149
sg5
S'PMC1677859'
p15150
sg7
g15106
sg9
V8518642.xml
p15151
sa(dp15152
g3
VSTD-Zaman-2008
p15153
sg5
S'PMC2740673'
p15154
sg7
g15106
sg9
V18686554.xml
p15155
sa(dp15156
g3
VSTD-Wang-2007
p15157
sg5
S'PMC2636406'
p15158
sg7
g15106
sg9
V18026625.xml
p15159
sa(dp15160
g3
VSTD-Colombo-1979
p15161
sg5
S'PMC1619135'
p15162
sg7
g15106
sg9
V434277.xml
p15163
sa(dp15164
g3
VSTD-Nottingham-2002
p15165
sg5
S'PMC1773232'
p15166
sg7
VCD001216 v. 8.0 Screening for colorectal cancer using the faecal occult blood test Hemoccult.rm5
p15167
sg9
V12010887.xml
p15168
sa(dp15169
g3
VSTD-Nottingham-1999
p15170
sg5
S'PMC1727686'
p15171
sg7
g15167
sg9
V10486370.xml
p15172
sa(dp15173
g3
VSTD-Funen-2002
p15174
sg5
S'PMC1773083'
p15175
sg7
g15167
sg9
V11772963.xml
p15176
sa(dp15177
g3
VSTD-Allen-2001
p15178
sg5
S'PMC1446631'
p15179
sg7
VCD002834 v. 7.0 Interventions targeted at women to encourage the uptake of cervical screening.rm5
p15180
sg9
V11291370.xml
p15181
sa(dp15182
g3
VSTD-Robson-1989
p15183
sg5
S'PMC1835698'
p15184
sg7
g15180
sg9
V2495053.xml
p15185
sa(dp15186
g3
VSTD-Adab-2003
p15187
sg5
S'PMC1732533'
p15188
sg7
g15180
sg9
V12883063.xml
p15189
sa(dp15190
g3
VSTD-Buehler-1997
p15191
sg5
S'PMC1227965'
p15192
sg7
g15180
sg9
V9294390.xml
p15193
sa(dp15194
g3
VSTD-McAvoy-1991
p15195
sg5
S'PMC1669184'
p15196
sg7
g15180
sg9
V1958248.xml
p15197
sa(dp15198
g3
VSTD-Taylor-2002
p15199
sg5
S'PMC1592333'
p15200
sg7
g15180
sg9
V11983755.xml
p15201
sa(dp15202
g3
VSTD-Lancaster-1992
p15203
sg5
S'PMC1059645'
p15204
sg7
g15180
sg9
V1479324.xml
p15205
sa(dp15206
g3
VSTD-Pierce-1989
p15207
sg5
S'PMC1837038'
p15208
sg7
g15180
sg9
V2504359.xml
p15209
sa(dp15210
g3
VSTD-Mock-2007
p15211
sg5
S'PMC1963308'
p15212
sg7
g15180
sg9
V17329652.xml
p15213
sa(dp15214
g3
VSTD-Wilson-1987
p15215
sg5
S'PMC1247036'
p15216
sg7
g15180
sg9
V3115368.xml
p15217
sa(dp15218
g3
VSTD-Aguado-95_x002d_Heart_x002f_GCV
p15219
sg5
S'PMC162800'
p15220
sg7
VCD005129 v. 8.0 Immunoglobulins vaccines or interferon for preventing cytomegalovirus disease in solid organ transp.rm5
p15221
sg9
V7492123.xml
p15222
sa(dp15223
g3
VSTD-Walsh-1997
p15224
sg5
S'PMC1380897'
p15225
sg7
VCD001055 v. 7.0 Interventions for promoting smoking cessation during pregnancy.rm5
p15226
sg9
V9240113.xml
p15227
sa(dp15228
g3
VSTD-Tappin-2005
p15229
sg5
S'PMC1184246'
p15230
sg7
g15226
sg9
V16096304.xml
p15231
sa(dp15232
g3
VSTD-Campbell-2006
p15233
sg5
S'PMC2563553'
p15234
sg7
g15226
sg9
V16565456.xml
p15235
sa(dp15236
g3
VSTD-Mayer-1990
p15237
sg5
S'PMC1404549'
p15238
sg7
g15226
sg9
V2293809.xml
p15239
sa(dp15240
g3
VSTD-McBride-1999
p15241
sg5
S'PMC1508743'
p15242
sg7
g15226
sg9
V10224982.xml
p15243
sa(dp15244
g3
VSTD-Bauman-1983
p15245
sg5
S'PMC1651063'
p15246
sg7
g15226
sg9
V6881407.xml
p15247
sa(dp15248
g3
VSTD-Cinciripini-2000
p15249
sg5
S'PMC1766306'
p15250
sg7
g15226
sg9
V10982910.xml
p15251
sa(dp15252
g3
VSTD-Donovan-1977
p15253
sg5
S'PMC478984'
p15254
sg7
g15226
sg9
V856371.xml
p15255
sa(dp15256
g3
VSTD-Donatelle-2000
p15257
sg5
S'PMC1766304'
p15258
sg7
g15226
sg9
V10982912.xml
p15259
sa(dp15260
g3
VSTD-Lawrence-2003
p15261
sg5
S'PMC1747729'
p15262
sg7
g15226
sg9
V12773727.xml
p15263
sa(dp15264
g3
VSTD-Strecher-2000
p15265
sg5
S'PMC1766311'
p15266
sg7
g15226
sg9
V10982916.xml
p15267
sa(dp15268
g3
VSTD-Kendrick-1995
p15269
sg5
S'PMC1615299'
p15270
sg7
g15226
sg9
V7856781.xml
p15271
sa(dp15272
g3
VSTD-Pollak-2007
p15273
sg5
S'PMC3602964'
p15274
sg7
g15226
sg9
V17888856.xml
p15275
sa(dp15276
g3
VSTD-Solomon-2000
p15277
sg5
S'PMC1766314'
p15278
sg7
g15226
sg9
V10982914.xml
p15279
sa(dp15280
g3
VSTD-Heil-2008
p15281
sg5
S'PMC2731575'
p15282
sg7
g15226
sg9
V18482424.xml
p15283
sa(dp15284
g3
VSTD-Windsor-1985
p15285
sg5
S'PMC1646449'
p15286
sg7
g15226
sg9
V4061709.xml
p15287
sa(dp15288
g3
VSTD-Ershoff-1989
p15289
sg5
S'PMC1349930'
p15290
sg7
g15226
sg9
V2913837.xml
p15291
sa(dp15292
g3
VSTD-Windsor-1993
p15293
sg5
S'PMC1694576'
p15294
sg7
g15226
sg9
V8427323.xml
p15295
sa(dp15296
g3
VSTD-Moore-2002
p15297
sg5
S'PMC138509'
p15298
sg7
g15226
sg9
V12480850.xml
p15299
sa(dp15300
g3
VSTD-Whalen-1997
p15301
sg5
S'PMC2860292'
p15302
sg7
VCD000171 v. 12.0 Treatment of latent tuberculosis infection in HIV infected persons.rm5
p15303
sg9
V17065029.xml
p15304
sa(dp15305
g3
VSTD-Rikkers-1987
p15306
sg5
S'PMC1493196'
p15307
sg7
VCD000553 v. 6.0 Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis.rm5
p15308
sg9
V3307653.xml
p15309
sa(dp15310
g3
VSTD-Spina-1990
p15311
sg5
S'PMC1357962'
p15312
sg7
g15308
sg9
V2405792.xml
p15313
sa(dp15314
g3
VSTD-Karatzas-2002
p15315
sg5
S'PMC153443'
p15316
sg7
VCD001090 v. 10.5 Intravenous immunoglobulin for treating sepsis severe sepsis and septic shock.rm5
p15317
sg9
V12512504.xml
p15318
sa(dp15319
g3
VSTD-Tugrul-2002
p15320
sg5
S'PMC125317'
p15321
sg7
g15317
sg9
V12225613.xml
p15322
sa(dp15323
g3
VSTD-Barratt-1973
p15324
sg5
S'PMC1648329'
p15325
sg7
VCD002290 v. 11.0 Non-corticosteroid treatment for nephrotic syndrome in children.rm5
p15326
sg9
V4574639.xml
p15327
sa(dp15328
g3
VSTD-Barratt-1970
p15329
sg5
S'PMC1648329'
p15330
sg7
g15326
sg9
V4574639.xml
p15331
sa(dp15332
g3
VSTD-Barratt-1977
p15333
sg5
S'PMC1544692'
p15334
sg7
g15326
sg9
V879831.xml
p15335
sa(dp15336
g3
VSTD-Ueda-1990
p15337
sg5
S'PMC1792340'
p15338
sg7
g15326
sg9
V2248508.xml
p15339
sa(dp15340
g3
VSTD-McCleane-2000
p15341
sg5
S'PMC2015036'
p15342
sg7
VCD008943 v. 3.0 Combination pharmacotherapy for the treatment of neuropathic pain in adults.rm5
p15343
sg9
V10848721.xml
p15344
sa(dp15345
g3
VSTD-Khoromi-2007
p15346
sg5
S'PMC1974876'
p15347
sg7
g15343
sg9
V17182183.xml
p15348
sa(dp15349
g3
VSTD-Barton-2011
p15350
sg5
S'PMC3338170'
p15351
sg7
g15343
sg9
V20496177.xml
p15352
sa(dp15353
g3
VSTD-DIAS-2-2008
p15354
sg5
S'PMC2730486'
p15355
sg7
VCD000213 v. 7.0 Thrombolysis for acute ischaemic stroke.rm5
p15356
sg9
V19097942.xml
p15357
sa(dp15358
g3
VSTD-Unger-2004-_x0028_FLAVOR_x0029_
p15359
sg5
S'PMC1448241'
p15360
sg7
VCD001293 v. 13.0 School-based programmes for preventing smoking.rm5
p15361
sg9
V14759940.xml
p15362
sa(dp15363
g3
VSTD-Nutbeam-1993-_x0028_FSE_x0029_
p15364
sg5
S'PMC1676653'
p15365
sg7
g15361
sg9
V8435601.xml
p15366
sa(dp15367
g3
VSTD-Sun-2008-_x0028_Cognitive_x0029_
p15368
sg5
S'PMC2784033'
p15369
sg7
g15361
sg9
V18675294.xml
p15370
sa(dp15371
g3
VSTD-Crone-2003
p15372
sg5
S'PMC1732562'
p15373
sg7
g15361
sg9
V12933772.xml
p15374
sa(dp15375
g3
VSTD-Biglan-2000
p15376
sg5
S'PMC1748303'
p15377
sg7
g15361
sg9
V10691755.xml
p15378
sa(dp15379
g3
VSTD-Kellam-1998-_x0028_GBG_x0029_
p15380
sg5
S'PMC1508467'
p15381
sg7
g15361
sg9
V9772850.xml
p15382
sa(dp15383
g3
VSTD-Rohrbach-2010a
p15384
sg5
S'PMC2939247'
p15385
sg7
g15361
sg9
V20655946.xml
p15386
sa(dp15387
g3
VSTD-Hecht-2008
p15388
sg5
S'PMC2892822'
p15389
sg7
g15361
sg9
V19157042.xml
p15390
sa(dp15391
g3
VSTD-Campbell-2008
p15392
sg5
S'PMC2387195'
p15393
sg7
g15361
sg9
V18468543.xml
p15394
sa(dp15395
g3
VSTD-Johnson-2009
p15396
sg5
S'PMC2681204'
p15397
sg7
g15361
sg9
V19440519.xml
p15398
sa(dp15399
g3
VSTD-Aveyard-1999
p15400
sg5
S'PMC28247'
p15401
sg7
g15361
sg9
V10514156.xml
p15402
sa(dp15403
g3
VSTD-Schinke-1986c
p15404
sg5
S'PMC1839926'
p15405
sg7
g15361
sg9
V3957152.xml
p15406
sa(dp15407
g3
VSTD-Perry-1996
p15408
sg5
S'PMC1380436'
p15409
sg7
g15361
sg9
V8669519.xml
p15410
sa(dp15411
g3
VSTD-Cameron-1999
p15412
sg5
S'PMC1509003'
p15413
sg7
g15361
sg9
V10589310.xml
p15414
sa(dp15415
g3
VSTD-Ellickson-2003
p15416
sg5
S'PMC1448059'
p15417
sg7
g15361
sg9
V14600049.xml
p15418
sa(dp15419
g3
VSTD-Schinke-1986a
p15420
sg5
S'PMC1477741'
p15421
sg7
g15361
sg9
V3090603.xml
p15422
sa(dp15423
g3
VSTD-Schinke-1985a
p15424
sg5
S'PMC1646189'
p15425
sg7
g15361
sg9
V4003636.xml
p15426
sa(dp15427
g3
VSTD-Noland-1998
p15428
sg5
S'PMC1509045'
p15429
sg7
g15361
sg9
V9842390.xml
p15430
sa(dp15431
g3
VSTD-Spoth-2007
p15432
sg5
S'PMC2848497'
p15433
sg7
g15361
sg9
V17605536.xml
p15434
sa(dp15435
g3
VSTD-Perry-2009
p15436
sg5
S'PMC2667859'
p15437
sg7
g15361
sg9
V19299670.xml
p15438
sa(dp15439
g3
VSTD-Lal-1972
p15440
sg5
S'PMC1785512'
p15441
sg7
VCD002160 v. 11.0 Inhaled versus oral steroids for adults with chronic asthma.rm5
p15442
sg9
V4558306.xml
p15443
sa(dp15444
g3
VSTD-Jenkins-1988
p15445
sg5
S'PMC461253'
p15446
sg7
g15442
sg9
V3194866.xml
p15447
sa(dp15448
g3
VSTD-Bosman-1994
p15449
sg5
S'PMC474084'
p15450
sg7
g15442
sg9
V8153939.xml
p15451
sa(dp15452
g3
VSTD-Kok-2006
p15453
sg5
S'PMC1523437'
p15454
sg7
VCD006124 v. 4.1 Laparoscopic versus open nephrectomy for live kidney donors.rm5
p15455
sg9
V16847014.xml
p15456
sa(dp15457
g3
VSTD-Wolff-2004
p15458
sg5
S'PMC1356474'
p15459
sg7
VCD004930 v. 6.0 Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal sur.rm5
p15460
sg9
V15383800.xml
p15461
sa(dp15462
g3
VSTD-Luft-2004
p15463
sg5
S'PMC2930817'
p15464
sg7
VCD006432 v. 3.0 Simultaneous bilateral training for improving arm function after stroke.rm5
p15465
sg9
V15494583.xml
p15466
sa(dp15467
g3
VSTD-Edwards-1996
p15468
sg5
S'PMC2364515'
p15469
sg7
VCD000054 v. 10.0 Interventions for treating genital chlamydia trachomatis infection in pregnancy.rm5
p15470
sg9
V18476121.xml
p15471
sa(dp15472
g3
VSTD-Martin-1997
p15473
sg5
S'PMC2364533'
p15474
sg7
g15470
sg9
V18476128.xml
p15475
sa(dp15476
g3
VSTD-Rosenn-1995
p15477
sg5
S'PMC2364446'
p15478
sg7
g15470
sg9
V18476049.xml
p15479
sa(dp15480
g3
VSTD-Turrentine-1995
p15481
sg5
S'PMC2364394'
p15482
sg7
g15470
sg9
V18475393.xml
p15483
sa(dp15484
g3
VSTD-Khanna-2005
p15485
sg5
S'PMC1156915'
p15486
sg7
VCD006099 v. 6.0 Wound drains following thyroid surgery.rm5
p15487
sg9
V15946379.xml
p15488
sa(dp15489
g3
VSTD-Shah-1997
p15490
sg5
S'PMC1720690'
p15491
sg7
VCD001452 v. 10.0 Venepuncture versus heel lance for blood sampling in term neonates.rm5
p15492
sg9
V9377140.xml
p15493
sa(dp15494
g3
VSTD-Ogawa-2005
p15495
sg5
S'PMC1721952'
p15496
sg7
g15492
sg9
V15871991.xml
p15497
sa(dp15498
g3
VSTD-Korpan-1997
p15499
sg5
S'PMC1190648'
p15500
sg7
VCD006039 v. 6.0 Resection versus no intervention or other surgical interventions for colorectal cancer liver metasta.rm5
p15501
sg9
V9065296.xml
p15502
sa(dp15503
g3
VSTD-Boldt-1996
p15504
sg5
S'PMC484507'
p15505
sg7
VCD004126 v. 5.3 Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing su.rm5
p15506
sg9
V8868976.xml
p15507
sa(dp15508
g3
VSTD-Smithuis-2010-MMR
p15509
sg5
S'PMC2947715'
p15510
sg7
VCD008492 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.rm5
p15511
sg9
V20832366.xml
p15512
sa(dp15513
g3
VSTD-Awab-2010-AFG
p15514
sg5
S'PMC2864284'
p15515
sg7
g15511
sg9
V20409302.xml
p15516
sa(dp15517
g3
VSTD-Krudsood-2007-THA
p15518
sg5
S'PMC2526312'
p15519
sg7
g15511
sg9
V17570973.xml
p15520
sa(dp15521
g3
VSTD-Hasugian-2007-IDN
p15522
sg5
S'PMC2532501'
p15523
sg7
g15511
sg9
V17366451.xml
p15524
sa(dp15525
g3
VSTD-Ratcliff-2007-IDN
p15526
sg5
S'PMC2532500'
p15527
sg7
g15511
sg9
V17336652.xml
p15528
sa(dp15529
g3
VSTD-Hutagalung-2005-THA
p15530
sg5
S'PMC1261533'
p15531
sg7
g15511
sg9
V16179089.xml
p15532
sa(dp15533
g3
VSTD-Poravuth-2010-ASIA
p15534
sg5
S'PMC3022577'
p15535
sg7
g15511
sg9
V21267072.xml
p15536
sa(dp15537
g3
VSTD-Bolliger-2000
p15538
sg5
S'PMC27447'
p15539
sg7
VCD005231 v. 5.0 Interventions to reduce harm from continued tobacco use.rm5
p15540
sg9
V10926587.xml
p15541
sa(dp15542
g3
VSTD-Hanson-2008
p15543
sg5
S'PMC2441529'
p15544
sg7
g15540
sg9
V18242008.xml
p15545
sa(dp15546
g3
VSTD-Kralikova-2009
p15547
sg5
S'PMC2792228'
p15548
sg7
g15540
sg9
V19943947.xml
p15549
sa(dp15550
g3
VSTD-Sanyal-2008
p15551
sg5
S'PMC3730280'
p15552
sg7
VCD005162 v. 6.0 Terlipressin for hepatorenal syndrome.rm5
p15553
sg9
V18471513.xml
p15554
sa(dp15555
g3
VSTD-Leisti-1978
p15556
sg5
S'PMC1603701'
p15557
sg7
VCD001533 v. 12.0 Corticosteroid therapy for nephrotic syndrome in children.rm5
p15558
sg9
V346147.xml
p15559
sa(dp15560
g3
VSTD-Imbasciali-1985
p15561
sg5
S'PMC1417455'
p15562
sg7
g15558
sg9
V3933645.xml
p15563
sa(dp15564
g3
VSTD-Tee-2010
p15565
sg5
S'PMC2923764'
p15566
sg7
VCD008211 v. 3.0 Transparent Cap Colonoscopy versus Standard Colonoscopy to Improve Caecal Intubation.rm5
p15567
sg9
V20712051.xml
p15568
sa(dp15569
g3
VSTD-Collins-2004
p15570
sg5
S'PMC487729'
p15571
sg7
VCD005252 v. 3.0 Avoidance of bottles during the establishment of breast feeds in preterm infants.rm5
p15572
sg9
V15208209.xml
p15573
sa(dp15574
g3
VSTD-Hennrikus-2002
p15575
sg5
S'PMC1447056'
p15576
sg7
VCD004307 v. 10.0 Competitions and incentives for smoking cessation.rm5
p15577
sg9
V11818305.xml
p15578
sa(dp15579
g3
VSTD-Gomel-1993
p15580
sg5
S'PMC1694995'
p15581
sg7
g15577
sg9
V8362997.xml
p15582
sa(dp15583
g3
VSTD-Klesges-1986
p15584
sg5
S'PMC1646475'
p15585
sg7
g15577
sg9
V3946702.xml
p15586
sa(dp15587
g3
VSTD-Tevyaw-2009
p15588
sg5
S'PMC2688604'
p15589
sg7
g15577
sg9
V19443788.xml
p15590
sa(dp15591
g3
VSTD-Bayley-1976
p15592
sg5
S'PMC2158317'
p15593
sg7
VCD008922 v. 2.0 Muscle relaxants for pain management in rheumatoid arthritis.rm5
p15594
sg9
V787518.xml
p15595
sa(dp15596
g3
VSTD-Thomas-2002
p15597
sg5
S'PMC128377'
p15598
sg7
VCD004376 v. 5.0 Exercise for osteoarthritis of the knee.rm5
p15599
sg9
V12364304.xml
p15600
sa(dp15601
g3
VSTD-O_x0027_Reilly-1999
p15602
sg5
S'PMC1752761'
p15603
sg7
g15599
sg9
V10343535.xml
p15604
sa(dp15605
g3
VSTD-Thorstensson-2005
p15606
sg5
S'PMC1187893'
p15607
sg7
g15599
sg9
V15924620.xml
p15608
sa(dp15609
g3
VSTD-Bennell-2005
p15610
sg5
S'PMC1755542'
p15611
sg7
g15599
sg9
V15897310.xml
p15612
sa(dp15613
g3
VSTD-Hay-2006
p15614
sg5
S'PMC1635605'
p15615
sg7
g15599
sg9
V17056608.xml
p15616
sa(dp15617
g3
VSTD-Walker-2012
p15618
sg5
S'PMC2773219'
p15619
sg7
VCD006655 v. 4.0 Laparoscopy versus laparotomy for the management of early stage endometrial cancer.rm5
p15620
sg9
V19805679.xml
p15621
sa(dp15622
g3
VSTD-Zorlu-2005
p15623
sg5
S'PMC3015649'
p15624
sg7
g15620
sg9
V16381364.xml
p15625
sa(dp15626
g3
VSTD-Misra-2007
p15627
sg5
S'PMC3476139'
p15628
sg7
VCD008039 v. 4.0 Ibuprofen with or without an antiemetic for acute migraine headaches in adults.rm5
p15629
sg9
V17563841.xml
p15630
sa(dp15631
g3
VSTD-Misra-2004
p15632
sg5
S'PMC1743152'
p15633
sg7
g15629
sg9
V15579612.xml
p15634
sa(dp15635
g3
VSTD-Li-2006
p15636
sg5
S'PMC1764949'
p15637
sg7
VCD007315 v. 2.0 Perioperative glycaemic control for diabetic patients undergoing surgery.rm5
p15638
sg9
V17215967.xml
p15639
sa(dp15640
g3
VSTD-Chan-2008
p15641
sg5
S'PMC2671976'
p15642
sg7
g15638
sg9
V19142552.xml
p15643
sa(dp15644
g3
VSTD-Sharples-2002
p15645
sg5
S'PMC1746394'
p15646
sg7
VCD004359 v. 6.0 Nurse specialist care for bronchiectasis.rm5
p15647
sg9
V12149523.xml
p15648
sa(dp15649
g3
VSTD-Rahman-1998
p15650
sg5
S'PMC1722716'
p15651
sg7
VCD004241 v. 6.6 Medical interventions for fungal keratitis.rm5
p15652
sg9
V9828778.xml
p15653
sa(dp15654
g3
VSTD-Prajna-2003
p15655
sg5
S'PMC1920780'
p15656
sg7
g15652
sg9
V14507756.xml
p15657
sa(dp15658
g3
VSTD-Mohan-1988
p15659
sg5
S'PMC1041404'
p15660
sg7
g15652
sg9
V3281706.xml
p15661
sa(dp15662
g3
VSTD-Prajna-2010
p15663
sg5
S'PMC3774126'
p15664
sg7
g15652
sg9
V20547942.xml
p15665
sa(dp15666
g3
VSTD-Campieri-1997
p15667
sg5
S'PMC1891473'
p15668
sg7
VCD000296 v. 6.0 Budesonide for induction of remission in Crohn's disease.rm5
p15669
sg9
V9301500.xml
p15670
sa(dp15671
g3
VSTD-Rennie-1991
p15672
sg5
S'PMC1590349'
p15673
sg7
VCD003480 v. 5.0 Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in prete.rm5
p15674
sg9
V1996894.xml
p15675
sa(dp15676
g3
VSTD-Holcroft-1986a
p15677
sg5
S'PMC1251120'
p15678
sg7
VCD004477 v. 7.0 Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome.rm5
p15679
sg9
V3516085.xml
p15680
sa(dp15681
g3
VSTD-Li-2008
p15682
sg5
S'PMC2597744'
p15683
sg7
VCD008651 v. 3.0 Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in .rm5
p15684
sg9
V19081791.xml
p15685
sa(dp15686
g3
VSTD-Goldbach_x002d_Mansky-2009
p15687
sg5
S'PMC2938780'
p15688
sg7
VCD002948 v. 5.0 Herbal therapy for treating rheumatoid arthritis.rm5
p15689
sg9
V19687490.xml
p15690
sa(dp15691
g3
VSTD-Pattrick-1989
p15692
sg5
S'PMC1003814'
p15693
sg7
g15689
sg9
V2673080.xml
p15694
sa(dp15695
g3
VSTD-Belch-1988
p15696
sg5
S'PMC1003460'
p15697
sg7
g15689
sg9
V2833184.xml
p15698
sa(dp15699
g3
VSTD-Mitchell-2009
p15700
sg5
S'PMC2864467'
p15701
sg7
VCD000262 v. 11.0 Antibiotics for treating bacterial vaginosis in pregnancy.rm5
p15702
sg9
V19951217.xml
p15703
sa(dp15704
g3
VSTD-Kiss-2004
p15705
sg5
S'PMC509340'
p15706
sg7
g15702
sg9
V15294856.xml
p15707
sa(dp15708
g3
VSTD-Wardle-2001
p15709
sg5
S'PMC1721189'
p15710
sg7
VCD000501 v. 10.0 Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthw.rm5
p15711
sg9
V11124916.xml
p15712
sa(dp15713
g3
VSTD-James-1983
p15714
sg5
S'PMC1438733'
p15715
sg7
VCD001206 v. 10.0 Pharmacotherapy for social anxiety disorder.rm5
p15716
sg9
V6834370.xml
p15717
sa(dp15718
g3
VSTD-Edan-1997
p15719
sg5
S'PMC486720'
p15720
sg7
VCD008933 v. 3.0 Immunomodulators and immunosuppressants for multiple sclerosis a network meta-analysis.rm5
p15721
sg9
V9048709.xml
p15722
sa(dp15723
g3
VSTD-Andersen-2004
p15724
sg5
S'PMC1763573'
p15725
sg7
g15721
sg9
V15090564.xml
p15726
sa(dp15727
g3
VSTD-Likosky-1991
p15728
sg5
S'PMC1014677'
p15729
sg7
g15721
sg9
V1783915.xml
p15730
sa(dp15731
g3
VSTD-ASSET_x002d_1
p15732
sg5
S'PMC2914575'
p15733
sg7
VCD004434 v. 8.2 Endothelin receptor antagonists for pulmonary arterial hypertension.rm5
p15734
sg9
V20175775.xml
p15735
sa(dp15736
g3
VSTD-Dammers-1999
p15737
sg5
S'PMC28242'
p15738
sg7
VCD001554 v. 8.0 Local corticosteroid injection for carpal tunnel syndrome.rm5
p15739
sg9
V10506042.xml
p15740
sa(dp15741
g3
VSTD-O_x0027_Gradaigh-2000
p15742
sg5
S'PMC1753030'
p15743
sg7
g15739
sg9
V11053073.xml
p15744
sa(dp15745
g3
VSTD-Wattchow-2006
p15746
sg5
S'PMC2361245'
p15747
sg7
VCD002200 v. 5.0 Follow-up strategies for patients treated for non-metastatic colorectal cancer.rm5
p15748
sg9
V16622437.xml
p15749
sa(dp15750
g3
VSTD-Upward-1988
p15751
sg5
S'PMC1386560'
p15752
sg7
VCD004185 v. 9.0 Fluoxetine versus other types of pharmacotherapy for depression.rm5
p15753
sg9
V3263876.xml
p15754
sa(dp15755
g3
VSTD-Lapierre-1997
p15756
sg5
S'PMC1188834'
p15757
sg7
g15753
sg9
V9074306.xml
p15758
sa(dp15759
g3
VSTD-Basu-2008a
p15760
sg5
S'PMC2701394'
p15761
sg7
VCD002967 v. 10.0 Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.rm5
p15762
sg9
V18769904.xml
p15763
sa(dp15764
g3
VSTD-Russell_x002d_Jones-2009
p15765
sg5
S'PMC2744824'
p15766
sg7
g15762
sg9
V19688338.xml
p15767
sa(dp15768
g3
VSTD-Hundal-2000
p15769
sg5
S'PMC2995498'
p15770
sg7
g15762
sg9
V11118008.xml
p15771
sa(dp15772
g3
VSTD-Clarke-1977
p15773
sg5
S'PMC1632725'
p15774
sg7
g15762
sg9
V589351.xml
p15775
sa(dp15776
g3
VSTD-Lingvay-2007
p15777
sg5
S'PMC1994788'
p15778
sg7
g15762
sg9
V17493545.xml
p15779
sa(dp15780
g3
VSTD-Home-2007
p15781
sg5
S'PMC1974817'
p15782
sg7
g15762
sg9
V17403121.xml
p15783
sa(dp15784
g3
VSTD-Phillips-2009
p15785
sg5
S'PMC2739702'
p15786
sg7
g15762
sg9
V19622782.xml
p15787
sa(dp15788
g3
VSTD-Gupta-2009
p15789
sg5
S'PMC2748337'
p15790
sg7
g15762
sg9
V19267711.xml
p15791
sa(dp15792
g3
VSTD-Vahatalo-2007
p15793
sg5
S'PMC3379773'
p15794
sg7
g15762
sg9
V17846932.xml
p15795
sa(dp15796
g3
VSTD-Rains-1989
p15797
sg5
S'PMC1292002'
p15798
sg7
g15762
sg9
V2647992.xml
p15799
sa(dp15800
g3
VSTD-Zinman-2009
p15801
sg5
S'PMC2699702'
p15802
sg7
g15762
sg9
V19289857.xml
p15803
sa(dp15804
g3
VSTD-List-2009
p15805
sg5
S'PMC2660449'
p15806
sg7
g15762
sg9
V19114612.xml
p15807
sa(dp15808
g3
VSTD-Nauck-2009b
p15809
sg5
S'PMC2699710'
p15810
sg7
g15762
sg9
V19366970.xml
p15811
sa(dp15812
g3
VSTD-Nauck-2009a
p15813
sg5
S'PMC2606836'
p15814
sg7
g15762
sg9
V18931095.xml
p15815
sa(dp15816
g3
VSTD-McBain-1988
p15817
sg5
S'PMC1141646'
p15818
sg7
g15762
sg9
V3192752.xml
p15819
sa(dp15820
g3
VSTD-Peacock-1984
p15821
sg5
S'PMC1442249'
p15822
sg7
g15762
sg9
V6428619.xml
p15823
sa(dp15824
g3
VSTD-Lord-1983
p15825
sg5
S'PMC1547150'
p15826
sg7
g15762
sg9
V6403102.xml
p15827
sa(dp15828
g3
VSTD-Oldaeus-1997
p15829
sg5
S'PMC1717242'
p15830
sg7
VCD003664 v. 5.0 Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.rm5
p15831
sg9
V9279143.xml
p15832
sa(dp15833
g3
VSTD-Masia_x002d_Warner-2011
p15834
sg5
S'PMC3128648'
p15835
sg7
VCD004690 v. 6.0 Cognitive behavioural therapy for anxiety disorders in children and adolescents.rm5
p15836
sg9
V21681863.xml
p15837
sa(dp15838
g3
VSTD-McNally-Keehn-2012
p15839
sg5
S'PMC3537891'
p15840
sg7
g15836
sg9
V22588377.xml
p15841
sa(dp15842
g3
VSTD-Melfsen-2011
p15843
sg5
S'PMC3058082'
p15844
sg7
g15836
sg9
V21356037.xml
p15845
sa(dp15846
g3
VSTD-White-2012
p15847
sg5
S'PMC3494811'
p15848
sg7
g15836
sg9
V22735897.xml
p15849
sa(dp15850
g3
VSTD-Walkup-2008
p15851
sg5
S'PMC2702984'
p15852
sg7
g15836
sg9
V18974308.xml
p15853
sa(dp15854
g3
VSTD-Schnoll-2010b
p15855
sg5
S'PMC2834192'
p15856
sg7
VCD000146 v. 19.3 Nicotine replacement therapy for smoking cessation.rm5
p15857
sg9
V20004065.xml
p15858
sa(dp15859
g3
VSTD-Schnoll-2010a
p15860
sg5
S'PMC3782858'
p15861
sg7
g15857
sg9
V20124230.xml
p15862
sa(dp15863
g3
VSTD-Hand-2002
p15864
sg5
S'PMC1746389'
p15865
sg7
g15857
sg9
V12149533.xml
p15866
sa(dp15867
g3
VSTD-Molyneux-2003
p15868
sg5
S'PMC1746718'
p15869
sg7
g15857
sg9
V12775857.xml
p15870
sa(dp15871
g3
VSTD-Pirie-1992
p15872
sg5
S'PMC1694323'
p15873
sg7
g15857
sg9
V1503165.xml
p15874
sa(dp15875
g3
VSTD-Blondal-1999
p15876
sg5
S'PMC27708'
p15877
sg7
g15857
sg9
V9924052.xml
p15878
sa(dp15879
g3
VSTD-Cooney-2009
p15880
sg5
S'PMC2753831'
p15881
sg7
g15857
sg9
V19549054.xml
p15882
sa(dp15883
g3
VSTD-Marshall-1985
p15884
sg5
S'PMC1415622'
p15885
sg7
g15857
sg9
V3922510.xml
p15886
sa(dp15887
g3
VSTD-T_x00f8_nnesen-2012
p15888
sg5
S'PMC3432241'
p15889
sg7
g15857
sg9
V22323576.xml
p15890
sa(dp15891
g3
VSTD-Ahluwalia-1998
p15892
sg5
S'PMC1496888'
p15893
sg7
g15857
sg9
V9462488.xml
p15894
sa(dp15895
g3
VSTD-Hughes-2010
p15896
sg5
S'PMC2930079'
p15897
sg7
g15857
sg9
V20537810.xml
p15898
sa(dp15899
g3
VSTD-Piper-2009
p15900
sg5
S'PMC2933113'
p15901
sg7
g15857
sg9
V19884613.xml
p15902
sa(dp15903
g3
VSTD-Oncken-2008
p15904
sg5
S'PMC2630492'
p15905
sg7
g15857
sg9
V18827129.xml
p15906
sa(dp15907
g3
VSTD-Gourlay-1995
p15908
sg5
S'PMC2550432'
p15909
sg7
g15857
sg9
V7640544.xml
p15910
sa(dp15911
g3
VSTD-ICRF-1994
p15912
sg5
S'PMC2540289'
p15913
sg7
g15857
sg9
V8019282.xml
p15914
sa(dp15915
g3
VSTD-Bolliger-2000a
p15916
sg5
S'PMC27447'
p15917
sg7
g15857
sg9
V10926587.xml
p15918
sa(dp15919
g3
VSTD-Smith-2009
p15920
sg5
S'PMC2891174'
p15921
sg7
g15857
sg9
V20008701.xml
p15922
sa(dp15923
g3
VSTD-Clavel-1985
p15924
sg5
S'PMC1418170'
p15925
sg7
g15857
sg9
V3933739.xml
p15926
sa(dp15927
g3
VSTD-Gariti-2009
p15928
sg5
S'PMC2778325'
p15929
sg7
g15857
sg9
V19339135.xml
p15930
sa(dp15931
g3
VSTD-Jamrozik-1984
p15932
sg5
S'PMC1442980'
p15933
sg7
g15857
sg9
V6434084.xml
p15934
sa(dp15935
g3
VSTD-Rose-2010
p15936
sg5
S'PMC2896464'
p15937
sg7
g15857
sg9
V20379614.xml
p15938
sa(dp15939
g3
VSTD-Piper-2007
p15940
sg5
S'PMC3030120'
p15941
sg7
g15857
sg9
V17763111.xml
p15942
sa(dp15943
g3
VSTD-Pollak-2007
p15944
sg5
S'PMC3602964'
p15945
sg7
g15857
sg9
V17888856.xml
p15946
sa(dp15947
g3
VSTD-Russell-1983
p15948
sg5
S'PMC1549849'
p15949
sg7
g15857
sg9
V6416593.xml
p15950
sa(dp15951
g3
VSTD-Hays-1999
p15952
sg5
S'PMC1508975'
p15953
sg7
g15857
sg9
V10553392.xml
p15954
sa(dp15955
g3
VSTD-Rosenstock-2008
p15956
sg5
S'PMC2235909'
p15957
sg7
VCD006383 v. 3.2 Insulin detemir versus insulin glargine for type 2 diabetes mellitus.rm5
p15958
sg9
V18204830.xml
p15959
sa(dp15960
g3
VSTD-Swinnen-2010a
p15961
sg5
S'PMC2875419'
p15962
sg7
g15958
sg9
V20200301.xml
p15963
sa(dp15964
g3
VSTD-Bradley-2002
p15965
sg5
S'PMC100764'
p15966
sg7
VCD007335 v. 3.0 Interventions to improve question formulation in professional practice and self-directed learning.rm5
p15967
sg9
V11999177.xml
p15968
sa(dp15969
g3
VSTD-WAFACS-2008
p15970
sg5
S'PMC2684623'
p15971
sg7
VCD006612 v. 4.0 Homocysteine-lowering interventions for preventing cardiovascular events.rm5
p15972
sg9
V18460663.xml
p15973
sa(dp15974
g3
VSTD-BVAIT-2009
p15975
sg5
S'PMC2701290'
p15976
sg7
g15972
sg9
V19118243.xml
p15977
sa(dp15978
g3
VSTD-Edan-1997
p15979
sg5
S'PMC486720'
p15980
sg7
VCD002127 v. 5.0 Mitoxantrone for multiple sclerosis.rm5
p15981
sg9
V9048709.xml
p15982
sa(dp15983
g3
VSTD-Westerbeek-2010
p15984
sg5
S'PMC2579424'
p15985
sg7
VCD006474 v. 4.0 Prebiotics in infants for prevention of allergy.rm5
p15986
sg9
V18947426.xml
p15987
sa(dp15988
g3
VSTD-Moro-2006
p15989
sg5
S'PMC2066015'
p15990
sg7
g15986
sg9
V16873437.xml
p15991
sa(dp15992
g3
VSTD-DuPont-1984
p15993
sg5
S'PMC284111'
p15994
sg7
VCD002242 v. 6.0 Antibiotic treatment for travellers' diarrhoea.rm5
p15995
sg9
V6385838.xml
p15996
sa(dp15997
g3
VSTD-Ericsson-1992
p15998
sg5
S'PMC245552'
p15999
sg7
g15995
sg9
V1482152.xml
p16000
sa(dp16001
g3
VSTD-Ericsson-1986
p16002
sg5
S'PMC180497'
p16003
sg7
g15995
sg9
V3524436.xml
p16004
sa(dp16005
g3
VSTD-Ertzeid-1999
p16006
sg5
S'PMC3455375'
p16007
sg7
VCD004378 v. 4.0 Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm .rm5
p16008
sg9
V10575581.xml
p16009
sa(dp16010
g3
VSTD-Griffin-1999
p16011
sg5
S'PMC1720946'
p16012
sg7
VCD005095 v. 5.0 Enteral iron supplementation in preterm and low birth weight infants.rm5
p16013
sg9
V10375362.xml
p16014
sa(dp16015
g3
VSTD-Coles-1954
p16016
sg5
S'PMC2011580'
p16017
sg7
g16013
sg9
V13149207.xml
p16018
sa(dp16019
g3
VSTD-Aggarwal-2005
p16020
sg5
S'PMC1720080'
p16021
sg7
g16013
sg9
V15613506.xml
p16022
sa(dp16023
g3
VSTD-Spitzyna-2007
p16024
sg5
S'PMC2651560'
p16025
sg7
VCD008388 v. 2.0 Interventions for visual field defects in patients with stroke.rm5
p16026
sg9
V17536049.xml
p16027
sa(dp16028
g3
VSTD-Evans-1974
p16029
sg5
S'PMC470171'
p16030
sg7
VCD005374 v. 3.0 Oral corticosteroids for stable chronic obstructive pulmonary disease.rm5
p16031
sg9
V4603999.xml
p16032
sa(dp16033
g3
VSTD-Mitchell-1986
p16034
sg5
S'PMC460405'
p16035
sg7
g16031
sg9
V3538487.xml
p16036
sa(dp16037
g3
VSTD-Weir-1993
p16038
sg5
S'PMC464423'
p16039
sg7
g16031
sg9
V8511727.xml
p16040
sa(dp16041
g3
VSTD-Weir-1990
p16042
sg5
S'PMC462320'
p16043
sg7
g16031
sg9
V2180105.xml
p16044
sa(dp16045
g3
VSTD-Wempe-1992
p16046
sg5
S'PMC463924'
p16047
sg7
g16031
sg9
V1412119.xml
p16048
sa(dp16049
g3
VSTD-Morris-2008
p16050
sg5
S'PMC2821221'
p16051
sg7
VCD007966 v. 2.19 Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.rm5
p16052
sg9
V18971491.xml
p16053
sa(dp16054
g3
VSTD-Jangaard-2007
p16055
sg5
S'PMC2532565'
p16056
sg7
g16052
sg9
V19043499.xml
p16057
sa(dp16058
g3
VSTD-Pontari-2010
p16059
sg5
S'PMC3767281'
p16060
sg7
VCD009063 v. 2.0 Pregabalin for chronic prostatitis.rm5
p16061
sg9
V20876412.xml
p16062
sa(dp16063
g3
VSTD-Tuck-1982
p16064
sg5
S'PMC1627664'
p16065
sg7
VCD000499 v. 6.0 Kinesthetic stimulation for treating apnea in preterm infants.rm5
p16066
sg9
V7092314.xml
p16067
sa(dp16068
g3
VSTD-Weber-2010
p16069
sg5
S'PMC2880820'
p16070
sg7
VCD009689 v. 2.0 Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment f.rm5
p16071
sg9
V20434603.xml
p16072
sa(dp16073
g3
VSTD-Emet-2004
p16074
sg5
S'PMC522835'
p16075
sg7
VCD006616 v. 3.2 N-acetylcysteine for sepsis and systemic inflammatory response in adults.rm5
p16076
sg9
V15312215.xml
p16077
sa(dp16078
g3
VSTD-Charunwatthana-2009
p16079
sg5
S'PMC2731834'
p16080
sg7
g16076
sg9
V19114891.xml
p16081
sa(dp16082
g3
VSTD-Keays-1991
p16083
sg5
S'PMC1671790'
p16084
sg7
g16076
sg9
V1954453.xml
p16085
sa(dp16086
g3
VSTD-Lee-2009
p16087
sg5
S'PMC3189485'
p16088
sg7
g16076
sg9
V19524577.xml
p16089
sa(dp16090
g3
VSTD-Bianchi-Porro-1993
p16091
sg5
S'PMC1374304'
p16092
sg7
VCD003840 v. 10.0 Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.rm5
p16093
sg9
V8491391.xml
p16094
sa(dp16095
g3
VSTD-Hosking-1992
p16096
sg5
S'PMC1882868'
p16097
sg7
g16093
sg9
V1392995.xml
p16098
sa(dp16099
g3
VSTD-Lam-1997
p16100
sg5
S'PMC1027226'
p16101
sg7
g16093
sg9
V9274470.xml
p16102
sa(dp16103
g3
VSTD-Axon-1997
p16104
sg5
S'PMC2126021'
p16105
sg7
g16093
sg9
V9055715.xml
p16106
sa(dp16107
g3
VSTD-Bardhan-1997
p16108
sg5
S'PMC1891448'
p16109
sg7
g16093
sg9
V9301496.xml
p16110
sa(dp16111
g3
VSTD-Lesurtel-2005
p16112
sg5
S'PMC1409877'
p16113
sg7
VCD006880 v. 2.4 Techniques for liver parenchymal transection in liver resection.rm5
p16114
sg9
V16327491.xml
p16115
sa(dp16116
g3
VSTD-Stendell_x002d_Hollis-2010
p16117
sg5
S'PMC2966548'
p16118
sg7
VCD009934 v. 2.0 Green and black tea for the primary prevention of cardiovascular disease.rm5
p16119
sg9
V20807303.xml
p16120
sa(dp16121
g3
VSTD-Shale-1987
p16122
sg5
S'PMC460599'
p16123
sg7
VCD001108 v. 9.0 Azoles for allergic bronchopulmonary aspergillosis associated with asthma.rm5
p16124
sg9
V3303424.xml
p16125
sa(dp16126
g3
VSTD-Tarshis-2001
p16127
sg5
S'PMC90654'
p16128
sg7
VCD004299 v. 3.0 Interventions for cellulitis and erysipelas.rm5
p16129
sg9
V11451697.xml
p16130
sa(dp16131
g3
VSTD-Weigelt-2005
p16132
sg5
S'PMC1140485'
p16133
sg7
g16129
sg9
V15917519.xml
p16134
sa(dp16135
g3
VSTD-Bernard-2002
p16136
sg5
S'PMC129632'
p16137
sg7
g16129
sg9
V12386036.xml
p16138
sa(dp16139
g3
VSTD-Leman-2005
p16140
sg5
S'PMC1726763'
p16141
sg7
g16129
sg9
V15843702.xml
p16142
sa(dp16143
g3
VSTD-_x0031_-Pirie-1992
p16144
sg5
S'PMC1694323'
p16145
sg7
VCD006219 v. 5.25 Interventions for preventing weight gain after smoking cessation.rm5
p16146
sg9
V1503165.xml
p16147
sa(dp16148
g3
VSTD-_x0031_-Hall-1992
p16149
sg5
S'PMC1694191'
p16150
sg7
g16146
sg9
V1585959.xml
p16151
sa(dp16152
g3
VSTD-_x0032_-NRT-Pirie-1992
p16153
sg5
S'PMC1694323'
p16154
sg7
g16146
sg9
V1503165.xml
p16155
sa(dp16156
g3
VSTD-_x0031_-Levine-2010
p16157
sg5
S'PMC3113531'
p16158
sg7
g16146
sg9
V20308641.xml
p16159
sa(dp16160
g3
VSTD-_x0032_-NRT-Pack-2008
p16161
sg5
S'PMC3174063'
p16162
sg7
g16146
sg9
V18777992.xml
p16163
sa(dp16164
g3
VSTD-_x0032_-NRT-Blondal-1999
p16165
sg5
S'PMC27708'
p16166
sg7
g16146
sg9
V9924052.xml
p16167
sa(dp16168
g3
VSTD-_x0031_-Danielsson-1999
p16169
sg5
S'PMC28202'
p16170
sg7
g16146
sg9
V10454403.xml
p16171
sa(dp16172
g3
VSTD-_x0032_-AD-Piper-2007
p16173
sg5
S'PMC3030120'
p16174
sg7
g16146
sg9
V17763111.xml
p16175
sa(dp16176
g3
VSTD-_x0031_-Toll-2010
p16177
sg5
S'PMC3771701'
p16178
sg7
g16146
sg9
V20542391.xml
p16179
sa(dp16180
g3
VSTD-_x0032_-NRT-Gourlay-1995
p16181
sg5
S'PMC2550432'
p16182
sg7
g16146
sg9
V7640544.xml
p16183
sa(dp16184
g3
VSTD-Feltelius-1986
p16185
sg5
S'PMC1001898'
p16186
sg7
VCD004800 v. 6.0 Sulfasalazine for ankylosing spondylitis.rm5
p16187
sg9
V2872857.xml
p16188
sa(dp16189
g3
VSTD-Dougados-1986
p16190
sg5
S'PMC1341708'
p16191
sg7
g16187
sg9
V2876744.xml
p16192
sa(dp16193
g3
VSTD-Kuijper-2009
p16194
sg5
S'PMC2758937'
p16195
sg7
VCD004250 v. 8.7 Exercises for mechanical neck disorders.rm5
p16196
sg9
V19812130.xml
p16197
sa(dp16198
g3
VSTD-Viljanen-2006
p16199
sg5
S'PMC188429'
p16200
sg7
g16196
sg9
V12946968.xml
p16201
sa(dp16202
g3
VSTD-Martel-2011
p16203
sg5
S'PMC3045999'
p16204
sg7
g16196
sg9
V21303529.xml
p16205
sa(dp16206
g3
VSTD-Kusalic-1993
p16207
sg5
S'PMC1188546'
p16208
sg7
VCD009138 v. 2.0 Amitriptyline versus placebo for major depressive disorder.rm5
p16209
sg9
V8297924.xml
p16210
sa(dp16211
g3
VSTD-Blashki-1971
p16212
sg5
S'PMC1795147'
p16213
sg7
g16209
sg9
V4923928.xml
p16214
sa(dp16215
g3
VSTD-Mynors_x002d_Wallis-1995
p16216
sg5
S'PMC2548821'
p16217
sg7
g16209
sg9
V7873952.xml
p16218
sa(dp16219
g3
VSTD-Str_x00f6_hlein-2009
p16220
sg5
S'PMC2644666'
p16221
sg7
VCD007287 v. 2.0 Antigen-specific active immunotherapy for ovarian cancer.rm5
p16222
sg9
V19216794.xml
p16223
sa(dp16224
g3
VSTD-Gulley-2008
p16225
sg5
S'PMC2673097'
p16226
sg7
g16222
sg9
V18483372.xml
p16227
sa(dp16228
g3
VSTD-Odunsi-2007
p16229
sg5
S'PMC1937553'
p16230
sg7
g16222
sg9
V17652518.xml
p16231
sa(dp16232
g3
VSTD-Gajdos-1993
p16233
sg5
S'PMC489815'
p16234
sg7
VCD002828 v. 9.0 Corticosteroids for myasthenia gravis.rm5
p16235
sg9
V8229026.xml
p16236
sa(dp16237
g3
VSTD-Van-Noord-1999
p16238
sg5
S'PMC1745431'
p16239
sg7
VCD005533 v. 3.0 Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in ad.rm5
p16240
sg9
V10325895.xml
p16241
sa(dp16242
g3
VSTD-Brooten-2001
p16243
sg5
S'PMC3544939'
p16244
sg7
VCD000198 v. 12.0 Support during pregnancy for women at increased risk of low birthweight babies.rm5
p16245
sg9
V11519238.xml
p16246
sa(dp16247
g3
VSTD-Klerman-2001
p16248
sg5
S'PMC1446489'
p16249
sg7
g16245
sg9
V11189800.xml
p16250
sa(dp16251
g3
VSTD-Buchbinder-2004
p16252
sg5
S'PMC1754915'
p16253
sg7
VCD007005 v. 2.0 Arthrographic distension for adhesive capsulitis (frozen shoulder).rm5
p16254
sg9
V14962967.xml
p16255
sa(dp16256
g3
VSTD-Manegold-2003
p16257
sg5
S'PMC2361263'
p16258
sg7
VCD002140 v. 7.0 Concurrent chemoradiotherapy in non-small cell lung cancer.rm5
p16259
sg9
V16641904.xml
p16260
sa(dp16261
g3
VSTD-Huskamp-2005
p16262
sg5
S'PMC1403292'
p16263
sg7
VCD007017 v. 4.2 Pharmaceutical policies effects of cap and co-payment on rational drug use.rm5
p16264
sg9
V15809411.xml
p16265
sa(dp16266
g3
VSTD-Kozyrskyj-2001
p16267
sg5
S'PMC81497'
p16268
sg7
g16264
sg9
V11599328.xml
p16269
sa(dp16270
g3
VSTD-Cromwell-1999
p16271
sg5
S'PMC1070338'
p16272
sg7
g16264
sg9
V10029499.xml
p16273
sa(dp16274
g3
VSTD-D_x0027_Ignazio-2005
p16275
sg5
S'PMC1251562'
p16276
sg7
VCD002109 v. 7.0 Antibiotics for community acquired pneumonia in adult outpatients.rm5
p16277
sg9
V16189077.xml
p16278
sa(dp16279
g3
VSTD-van-der-Kooi-2007
p16280
sg5
S'PMC2779375'
p16281
sg7
VCD003908 v. 8.0 Rehabilitation interventions for foot drop in neuromuscular disease.rm5
p16282
sg9
V17361345.xml
p16283
sa(dp16284
g3
VSTD-Siu-1998
p16285
sg5
S'PMC1720837'
p16286
sg7
VCD000405 v. 10.0 Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants.rm5
p16287
sg9
V9828735.xml
p16288
sa(dp16289
g3
VSTD-Gaffey-1988
p16290
sg5
S'PMC175945'
p16291
sg7
VCD008231 v. 3.0 Intranasal ipratropium bromide for the common cold.rm5
p16292
sg9
V2855297.xml
p16293
sa(dp16294
g3
VSTD-Dale-1999
p16295
sg5
S'PMC28239'
p16296
sg7
VCD001733 v. 13.0 Pentoxifylline for treating venous leg ulcers.rm5
p16297
sg9
V10506039.xml
p16298
sa(dp16299
g3
VSTD-Yu-1993
p16300
sg5
S'PMC1380136'
p16301
sg7
VCD000096 v. 7.0 Glycerol for acute stroke.rm5
p16302
sg9
V2310658.xml
p16303
sa(dp16304
g3
VSTD-Schwinn-2010
p16305
sg5
S'PMC2822104'
p16306
sg7
VCD009287 v. 2.0 Media campaigns for the prevention of illicit drug use in young people.rm5
p16307
sg9
V19728091.xml
p16308
sa(dp16309
g3
VSTD-Fishbein-2002
p16310
sg5
S'PMC1447050'
p16311
sg7
g16307
sg9
V11818299.xml
p16312
sa(dp16313
g3
VSTD-Lee-2010
p16314
sg5
S'PMC2891541'
p16315
sg7
g16307
sg9
V20565152.xml
p16316
sa(dp16317
g3
VSTD-Slater-2011
p16318
sg5
S'PMC3042048'
p16319
sg7
g16307
sg9
V21271357.xml
p16320
sa(dp16321
g3
VSTD-Palmgreen-2001
p16322
sg5
S'PMC1446528'
p16323
sg7
g16307
sg9
V11211642.xml
p16324
sa(dp16325
g3
VSTD-Fang-2010
p16326
sg5
S'PMC2964276'
p16327
sg7
g16307
sg9
V20970090.xml
p16328
sa(dp16329
g3
VSTD-Carpenter-2011
p16330
sg5
S'PMC3076395'
p16331
sg7
g16307
sg9
V21421952.xml
p16332
sa(dp16333
g3
VSTD-Alijani-2004
p16334
sg5
S'PMC1356238'
p16335
sg7
VCD006574 v. 4.0 Abdominal lift for laparoscopic cholecystectomy.rm5
p16336
sg9
V15075657.xml
p16337
sa(dp16338
g3
VSTD-Hopkins-1985
p16339
sg5
S'PMC1001603'
p16340
sg7
VCD000212 v. 7.0 Interventions for treating psoriatic arthritis.rm5
p16341
sg9
V3883917.xml
p16342
sa(dp16343
g3
VSTD-McKendry-1993
p16344
sg5
S'PMC1005197'
p16345
sg7
g16341
sg9
V8250615.xml
p16346
sa(dp16347
g3
VSTD-Khoo-2007
p16348
sg5
S'PMC1876970'
p16349
sg7
VCD007635 v. 2.0 Fast track surgery versus conventional recovery strategies for colorectal surgery.rm5
p16350
sg9
V17522511.xml
p16351
sa(dp16352
g3
VSTD-Gregson-2007
p16353
sg5
S'PMC1831737'
p16354
sg7
VCD001220 v. 8.2 Population-based biomedical sexually transmitted infection control interventions for reducing HIV in.rm5
p16355
sg9
V17388666.xml
p16356
sa(dp16357
g3
VSTD-Dale-1995
p16358
sg5
S'PMC2550494'
p16359
sg7
VCD002097 v. 6.15 Primary care professionals providing non-urgent care in hospital emergency departments.rm5
p16360
sg9
V7640592.xml
p16361
sa(dp16362
g3
VSTD-Murphy-1996
p16363
sg5
S'PMC2350641'
p16364
sg7
g16360
sg9
V8620132.xml
p16365
sa(dp16366
g3
VSTD-Gibney-1999
p16367
sg5
S'PMC1313317'
p16368
sg7
g16360
sg9
V10622016.xml
p16369
sa(dp16370
g3
VSTD-Echeverry-2009
p16371
sg5
S'PMC2782968'
p16372
sg7
VCD008381 v. 2.2 Psychological and pharmacological interventions for depression in patients with diabetes mellitus an.rm5
p16373
sg9
V19729522.xml
p16374
sa(dp16375
g3
VSTD-Paile_x002d_Hyv_x00e4_rinen-2007
p16376
sg5
S'PMC1914073'
p16377
sg7
g16373
sg9
V17570858.xml
p16378
sa(dp16379
g3
VSTD-Piette-2011
p16380
sg5
S'PMC3117978'
p16381
sg7
g16373
sg9
V21478777.xml
p16382
sa(dp16383
g3
VSTD-Paile_x002d_Hyv_x00e4_rinen-2003
p16384
sg5
S'PMC165418'
p16385
sg7
g16373
sg9
V12747810.xml
p16386
sa(dp16387
g3
VSTD-van-Bastelaar-2011
p16388
sg5
S'PMC3024341'
p16389
sg7
g16373
sg9
V21216855.xml
p16390
sa(dp16391
g3
VSTD-Adcock-1972
p16392
sg5
S'PMC1648034'
p16393
sg7
VCD004404 v. 9.0 Antibiotics for whooping cough (pertussis).rm5
p16394
sg9
V4336846.xml
p16395
sa(dp16396
g3
VSTD-Uhari-1996
p16397
sg5
S'PMC2352484'
p16398
sg7
VCD007095 v. 5.0 Xylitol for preventing acute otitis media in children up to 12 years of age.rm5
p16399
sg9
V8916749.xml
p16400
sa(dp16401
g3
VSTD-Dolan-2006
p16402
sg5
S'PMC3205443'
p16403
sg7
VCD001796 v. 8.0 Aerobic exercise interventions for adults living with HIVAIDS.rm5
p16404
sg9
V16772251.xml
p16405
sa(dp16406
g3
VSTD-Mutimura-2008a
p16407
sg5
S'PMC3167195'
p16408
sg7
g16404
sg9
V18320351.xml
p16409
sa(dp16410
g3
VSTD-Campbell-1991
p16411
sg5
S'PMC2448633'
p16412
sg7
VCD004125 v. 6.0 Drugs for preventing postoperative nausea and vomiting.rm5
p16413
sg9
V1853495.xml
p16414
sa(dp16415
g3
VSTD-Bisgaard-2003
p16416
sg5
S'PMC1356141'
p16417
sg7
g16413
sg9
V14578725.xml
p16418
sa(dp16419
g3
VSTD-Dundee-1975
p16420
sg5
S'PMC1402493'
p16421
sg7
g16413
sg9
V1234491.xml
p16422
sa(dp16423
g3
VSTD-Waldmann-1985
p16424
sg5
S'PMC1463742'
p16425
sg7
g16413
sg9
V3885984.xml
p16426
sa(dp16427
g3
VSTD-Dabbous-1998
p16428
sg5
S'PMC3015295'
p16429
sg7
g16413
sg9
V9876753.xml
p16430
sa(dp16431
g3
VSTD-Joris-2003
p16432
sg5
S'PMC1343506'
p16433
sg7
g16413
sg9
V14633758.xml
p16434
sa(dp16435
g3
VSTD-Usmani-2003
p16436
sg5
S'PMC3451062'
p16437
sg7
g16413
sg9
V23119952.xml
p16438
sa(dp16439
g3
VSTD-Apfel-2004
p16440
sg5
S'PMC1307533'
p16441
sg7
g16413
sg9
V15190136.xml
p16442
sa(dp16443
g3
VSTD-Fujii-2001e
p16444
sg5
S'PMC1724019'
p16445
sg7
g16413
sg9
V11371485.xml
p16446
sa(dp16447
g3
VSTD-Provenzano-2009-HD
p16448
sg5
S'PMC2637590'
p16449
sg7
VCD007857 v. 3.4 Parenteral versus oral iron therapy for adults and children with chronic kidney disease.rm5
p16450
sg9
V19176796.xml
p16451
sa(dp16452
g3
VSTD-Spinowitz-2008-CKD
p16453
sg5
S'PMC2488268'
p16454
sg7
g16450
sg9
V18525001.xml
p16455
sa(dp16456
g3
VSTD-Fisher-2008
p16457
sg5
S'PMC2989816'
p16458
sg7
VCD007830 v. 2.0 Treadmill training for patients with Parkinson's disease.rm5
p16459
sg9
V18534554.xml
p16460
sa(dp16461
g3
VSTD-KarbwangTHI92b
p16462
sg5
S'PMC2486535'
p16463
sg7
VCD000256 v. 10.0 Artemisinin derivatives for treating uncomplicated malaria.rm5
p16464
sg9
V8205643.xml
p16465
sa(dp16466
g3
VSTD-KarbwangTHI92a
p16467
sg5
S'PMC2486514'
p16468
sg7
g16464
sg9
V8131255.xml
p16469
sa(dp16470
g3
VSTD-AlinTAZ94
p16471
sg5
S'PMC2042621'
p16472
sg7
g16464
sg9
V8799526.xml
p16473
sa(dp16474
g3
VSTD-_x0030_13-Papanikolaou-2004
p16475
sg5
S'PMC524504'
p16476
sg7
VCD000941 v. 13.0 Vaginal misoprostol for cervical ripening and induction of labour.rm5
p16477
sg9
V15450119.xml
p16478
sa(dp16479
g3
VSTD-Finlay-1982
p16480
sg5
S'PMC1083128'
p16481
sg7
VCD004762 v. 9.0 Drug treatment for myotonia.rm5
p16482
sg9
V7045292.xml
p16483
sa(dp16484
g3
VSTD-Grant-1987
p16485
sg5
S'PMC1031492'
p16486
sg7
g16482
sg9
V3553433.xml
p16487
sa(dp16488
g3
VSTD-Schneider-2006
p16489
sg5
S'PMC1856122'
p16490
sg7
VCD005111 v. 5.0 Acupuncture for treatment of irritable bowel syndrome.rm5
p16491
sg9
V16150852.xml
p16492
sa(dp16493
g3
VSTD-Lembo-2009
p16494
sg5
S'PMC2694961'
p16495
sg7
g16491
sg9
V19455132.xml
p16496
sa(dp16497
g3
VSTD-Varshney-2011
p16498
sg5
S'PMC3060783'
p16499
sg7
VCD009014 v. 2.8 Allergen-specific oral immunotherapy for peanut allergy.rm5
p16500
sg9
V21377034.xml
p16501
sa(dp16502
g3
VSTD-Kueuk-2008
p16503
sg5
S'PMC2582075'
p16504
sg7
VCD000099 v. 7.0 Growth hormone for in vitro fertilization.rm5
p16505
sg9
V18392675.xml
p16506
sa(dp16507
g3
VSTD-Stephenson-2011
p16508
sg5
S'PMC3115412'
p16509
sg7
VCD006964 v. 5.0 Strategies for communicating contraceptive effectiveness.rm5
p16510
sg9
V21410332.xml
p16511
sa(dp16512
g3
VSTD-Vassar-1991
p16513
sg5
S'PMC1493198'
p16514
sg7
VCD000567 v. 15.0 Colloids versus crystalloids for fluid resuscitation in critically ill patients.rm5
p16515
sg9
V2443087.xml
p16516
sa(dp16517
g3
VSTD-Goodwin-1983
p16518
sg5
S'PMC1353023'
p16519
sg7
g16515
sg9
V6342554.xml
p16520
sa(dp16521
g3
VSTD-Shires-1983
p16522
sg5
S'PMC1353021'
p16523
sg7
g16515
sg9
V6847271.xml
p16524
sa(dp16525
g3
VSTD-Bulger-2011
p16526
sg5
S'PMC3232054'
p16527
sg7
g16515
sg9
V21178763.xml
p16528
sa(dp16529
g3
VSTD-Dick-1995
p16530
sg5
S'PMC1511304'
p16531
sg7
VCD007786 v. 3.0 Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in ch.rm5
p16532
sg9
V7492164.xml
p16533
sa(dp16534
g3
VSTD-Swann-1979
p16535
sg5
S'PMC1597274'
p16536
sg7
g16532
sg9
V519355.xml
p16537
sa(dp16538
g3
VSTD-Dalzell-1986
p16539
sg5
S'PMC1777777'
p16540
sg7
g16532
sg9
V3013104.xml
p16541
sa(dp16542
g3
VSTD-Perneger-1998
p16543
sg5
S'PMC28595'
p16544
sg7
VCD003410 v. 20.2 Heroin maintenance for chronic heroin-dependent individuals.rm5
p16545
sg9
V9651260.xml
p16546
sa(dp16547
g3
VSTD-RIOTT-2010
p16548
sg5
S'PMC1613238'
p16549
sg7
g16545
sg9
V17002810.xml
p16550
sa(dp16551
g3
VSTD-Lincoln-2002
p16552
sg5
S'PMC1737698'
p16553
sg7
VCD009131 v. 2.0 Neuropsychological rehabilitation for multiple sclerosis.rm5
p16554
sg9
V11784832.xml
p16555
sa(dp16556
g3
VSTD-Brownlee-1993
p16557
sg5
S'PMC1029492'
p16558
sg7
VCD005256 v. 2.0 Early introduction of lipids to parenterally-fed preterm infants.rm5
p16559
sg9
V8215565.xml
p16560
sa(dp16561
g3
VSTD-McElhinney-2000
p16562
sg5
S'PMC2449154'
p16563
sg7
VCD000006 v. 8.0 Absorbable suture materials for primary repair of episiotomy and second degree tears.rm5
p16564
sg9
V10881642.xml
p16565
sa(dp16566
g3
VSTD-Sacks-high-protein-2009
p16567
sg5
S'PMC2763382'
p16568
sg7
VCD002137 v. 8.2 Reduced or modified dietary fat for preventing cardiovascular disease.rm5
p16569
sg9
V19246357.xml
p16570
sa(dp16571
g3
VSTD-WHEL-2007
p16572
sg5
S'PMC2083253'
p16573
sg7
g16569
sg9
V17635889.xml
p16574
sa(dp16575
g3
VSTD-Sacks-low-protein-2009
p16576
sg5
S'PMC2763382'
p16577
sg7
g16569
sg9
V19246357.xml
p16578
sa(dp16579
g3
VSTD-Rivellese-1994
p16580
sg5
S'PMC2539301'
p16581
sg7
g16569
sg9
V8111257.xml
p16582
sa(dp16583
g3
VSTD-Strychar-2009
p16584
sg5
S'PMC2732152'
p16585
sg7
g16569
sg9
V19542011.xml
p16586
sa(dp16587
g3
VSTD-Carey-2006
p16588
sg5
S'PMC2442891'
p16589
sg7
VCD008063 v. 4.0 Motivational interviewing for substance abuse.rm5
p16590
sg9
V17032098.xml
p16591
sa(dp16592
g3
VSTD-Parsons-2009
p16593
sg5
S'PMC2666542'
p16594
sg7
g16590
sg9
V18077833.xml
p16595
sa(dp16596
g3
VSTD-Walters-2009
p16597
sg5
S'PMC2704891'
p16598
sg7
g16590
sg9
V19170454.xml
p16599
sa(dp16600
g3
VSTD-Schaus-2009
p16601
sg5
S'PMC2701092'
p16602
sg7
g16590
sg9
V19538921.xml
p16603
sa(dp16604
g3
VSTD-Bernstein-2009
p16605
sg5
S'PMC2910362'
p16606
sg7
g16590
sg9
V20053238.xml
p16607
sa(dp16608
g3
VSTD-Martin-2008
p16609
sg5
S'PMC2996851'
p16610
sg7
g16590
sg9
V17869051.xml
p16611
sa(dp16612
g3
VSTD-Walitzer-2008
p16613
sg5
S'PMC2802221'
p16614
sg7
g16590
sg9
V19207347.xml
p16615
sa(dp16616
g3
VSTD-Carroll-2006a
p16617
sg5
S'PMC2386852'
p16618
sg7
g16590
sg9
V16169159.xml
p16619
sa(dp16620
g3
VSTD-Carroll-2006b
p16621
sg5
S'PMC2148500'
p16622
sg7
g16590
sg9
V17032099.xml
p16623
sa(dp16624
g3
VSTD-Winhusen-2008
p16625
sg5
S'PMC2546520'
p16626
sg7
g16590
sg9
V18083322.xml
p16627
sa(dp16628
g3
VSTD-Carroll-2009
p16629
sg5
S'PMC2792592'
p16630
sg7
g16590
sg9
V19803579.xml
p16631
sa(dp16632
g3
VSTD-Ball-2007b
p16633
sg5
S'PMC2148493'
p16634
sg7
g16590
sg9
V17663610.xml
p16635
sa(dp16636
g3
VSTD-Morgenstern-2009
p16637
sg5
S'PMC2758623'
p16638
sg7
g16590
sg9
V19634958.xml
p16639
sa(dp16640
g3
VSTD-Stein-2010
p16641
sg5
S'PMC2858363'
p16642
sg7
g16590
sg9
V20402990.xml
p16643
sa(dp16644
g3
VSTD-Thush-2009
p16645
sg5
S'PMC3140345'
p16646
sg7
g16590
sg9
V19290699.xml
p16647
sa(dp16648
g3
VSTD-Borsari-2005
p16649
sg5
S'PMC2663045'
p16650
sg7
g16590
sg9
V16187809.xml
p16651
sa(dp16652
g3
VSTD-Walker-2006
p16653
sg5
S'PMC2587139'
p16654
sg7
g16590
sg9
V16822119.xml
p16655
sa(dp16656
g3
VSTD-UKATT-2005
p16657
sg5
S'PMC1200586'
p16658
sg7
g16590
sg9
V16150764.xml
p16659
sa(dp16660
g3
VSTD-Mastroleo-2010
p16661
sg5
S'PMC2937069'
p16662
sg7
g16590
sg9
V20673621.xml
p16663
sa(dp16664
g3
VSTD-Barnett-2007
p16665
sg5
S'PMC2000456'
p16666
sg7
g16590
sg9
V17707594.xml
p16667
sa(dp16668
g3
VSTD-Kadden-2007
p16669
sg5
S'PMC1903379'
p16670
sg7
g16590
sg9
V16996224.xml
p16671
sa(dp16672
g3
VSTD-Whipps-Cross-1998
p16673
sg5
S'PMC28600'
p16674
sg7
VCD001785 v. 10.0 Laparoscopic techniques versus open techniques for inguinal hernia repair.rm5
p16675
sg9
V9657784.xml
p16676
sa(dp16677
g3
VSTD-SCUR-1999
p16678
sg5
S'PMC1420865'
p16679
sg7
g16675
sg9
V10450737.xml
p16680
sa(dp16681
g3
VSTD-Oxford-1995
p16682
sg5
S'PMC2550988'
p16683
sg7
g16675
sg9
V7580639.xml
p16684
sa(dp16685
g3
VSTD-Jarvis-1980
p16686
sg5
S'PMC1714748'
p16687
sg7
VCD001308 v. 5.0 Bladder training for urinary incontinence in adults.rm5
p16688
sg9
V7002250.xml
p16689
sa(dp16690
g3
VSTD-Mynors_x002d_Wallis-1995
p16691
sg5
S'PMC2548821'
p16692
sg7
VCD007954 v. 1.2 Antidepressants versus placebo for depression in primary care.rm5
p16693
sg9
V7873952.xml
p16694
sa(dp16695
g3
VSTD-Blashki-_x0028_75mg_x0029_-1971
p16696
sg5
S'PMC1795147'
p16697
sg7
g16693
sg9
V4923928.xml
p16698
sa(dp16699
g3
VSTD-Blashki-_x0028_150-mg_x0029_-1971
p16700
sg5
S'PMC1795147'
p16701
sg7
g16693
sg9
V4923928.xml
p16702
sa(dp16703
g3
VSTD-Hollyman-1988
p16704
sg5
S'PMC1711591'
p16705
sg7
g16693
sg9
V3076905.xml
p16706
sa(dp16707
g3
VSTD-Philipp-1999
p16708
sg5
S'PMC28296'
p16709
sg7
g16693
sg9
V10591711.xml
p16710
sa(dp16711
g3
VSTD-Malt--1999
p16712
sg5
S'PMC34546'
p16713
sg7
g16693
sg9
V10221945.xml
p16714
sa(dp16715
g3
VSTD-Barrowman-2003
p16716
sg5
S'PMC212708'
p16717
sg7
VMR000023 v. 4.2 When and how to update systematic reviews.rm5
p16718
sg9
V12877755.xml
p16719
sa(dp16720
g3
VSTD-Ioannidis-2001
p16721
sg5
S'PMC14669'
p16722
sg7
g16718
sg9
V11158556.xml
p16723
sa(dp16724
g3
VSTD-Neuhaus-2009
p16725
sg5
S'PMC2634726'
p16726
sg7
VCD003869 v. 10.0 Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.rm5
p16727
sg9
V19127261.xml
p16728
sa(dp16729
g3
VSTD-Kocher-2011
p16730
sg5
S'PMC3058272'
p16731
sg7
g16727
sg9
V21041710.xml
p16732
sa(dp16733
g3
VSTD-McKay-2008
p16734
sg5
S'PMC2630830'
p16735
sg7
VCD002295 v. 9.0 Exercise interventions for smoking cessation.rm5
p16736
sg9
V19017582.xml
p16737
sa(dp16738
g3
VSTD-Ciccolo-2011
p16739
sg5
S'PMC3150692'
p16740
sg7
g16736
sg9
V21504883.xml
p16741
sa(dp16742
g3
VSTD-Kinnunen-2008
p16743
sg5
S'PMC3695732'
p16744
sg7
g16736
sg9
V18418791.xml
p16745
sa(dp16746
g3
VSTD-Rubidge-1970
p16747
sg5
S'PMC2020286'
p16748
sg7
VCD006085 v. 4.0 Antiamoebic drugs for treating amoebic colitis.rm5
p16749
sg9
V4315969.xml
p16750
sa(dp16751
g3
VSTD-Shabat-2005
p16752
sg5
S'PMC3489231'
p16753
sg7
VCD005275 v. 7.0 Insoles for prevention and treatment of back pain.rm5
p16754
sg9
V15668775.xml
p16755
sa(dp16756
g3
VSTD-Tattersfield-2001
p16757
sg5
S'PMC1746016'
p16758
sg7
VCD003537 v. 4.0 Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary d.rm5
p16759
sg9
V11254817.xml
p16760
sa(dp16761
g3
VSTD-Corney-1997
p16762
sg5
S'PMC1313103'
p16763
sg7
VCD006731 v. 6.0 Pharmaceutical policies effects of financial incentives for prescribers.rm5
p16764
sg9
V9406488.xml
p16765
sa(dp16766
g3
VSTD-Harris-1996
p16767
sg5
S'PMC2353056'
p16768
sg7
g16764
sg9
V8978232.xml
p16769
sa(dp16770
g3
VSTD-Wilson-1995
p16771
sg5
S'PMC2551250'
p16772
sg7
g16764
sg9
V7496289.xml
p16773
sa(dp16774
g3
VSTD-Kammerling-1996
p16775
sg5
S'PMC2351139'
p16776
sg7
g16764
sg9
V8646099.xml
p16777
sa(dp16778
g3
VSTD-Bradlow-1993
p16779
sg5
S'PMC1679320'
p16780
sg7
g16764
sg9
V8251847.xml
p16781
sa(dp16782
g3
VSTD-Kylmala-1997
p16783
sg5
S'PMC2228066'
p16784
sg7
VCD006250 v. 4.0 Bisphosphonates for advanced prostate cancer.rm5
p16785
sg9
V9328156.xml
p16786
sa(dp16787
g3
VSTD-Szigethy-2007
p16788
sg5
S'PMC2638168'
p16789
sg7
VCD006913 v. 5.0 Psychological interventions for treatment of inflammatory bowel disease.rm5
p16790
sg9
V18831071.xml
p16791
sa(dp16792
g3
VSTD-Kennedy-2004
p16793
sg5
S'PMC1774266'
p16794
sg7
g16790
sg9
V15479685.xml
p16795
sa(dp16796
g3
VSTD-Opiyo-2008
p16797
sg5
S'PMC2229665'
p16798
sg7
VCD007071 v. 4.0 In-service training for health professionals to improve care of the seriously ill newborn or child i.rm5
p16799
sg9
V18270586.xml
p16800
sa(dp16801
g3
VSTD-Majumdar-2008
p16802
sg5
S'PMC2244663'
p16803
sg7
VCD000125 v. 12.8 Local opinion leaders effects on professional practice and health care outcomes.rm5
p16804
sg9
V18299546.xml
p16805
sa(dp16806
g3
VSTD-McAlister-2009
p16807
sg5
S'PMC2789127'
p16808
sg7
g16804
sg9
V19933787.xml
p16809
sa(dp16810
g3
VSTD-Sculier-2001
p16811
sg5
S'PMC2363948'
p16812
sg7
VCD007107 v. 2.4 Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in ca.rm5
p16813
sg9
V11720426.xml
p16814
sa(dp16815
g3
VSTD-Waites-2006
p16816
sg5
S'PMC1864807'
p16817
sg7
VCD004012 v. 7.0 Washout policies in long-term indwelling urinary catheterisation in adults.rm5
p16818
sg9
V16859225.xml
p16819
sa(dp16820
g3
VSTD-Callaghan-1985
p16821
sg5
S'PMC1028404'
p16822
sg7
VCD001769 v. 12.0 Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic.rm5
p16823
sg9
V3928820.xml
p16824
sa(dp16825
g3
VSTD-Turnbull-1985
p16826
sg5
S'PMC1418605'
p16827
sg7
g16823
sg9
V3919805.xml
p16828
sa(dp16829
g3
VSTD-Heller-1995
p16830
sg5
S'PMC1073267'
p16831
sg7
g16823
sg9
V7823066.xml
p16832
sa(dp16833
g3
VSTD-LEADER-2002
p16834
sg5
S'PMC133451'
p16835
sg7
VCD003697 v. 5.0 Statins and fibrates for preventing melanoma.rm5
p16836
sg9
V12433762.xml
p16837
sa(dp16838
g3
VSTD-WHO-1973
p16839
sg5
S'PMC2481013'
p16840
sg7
g16836
sg9
V4578364.xml
p16841
sa(dp16842
g3
VSTD-Attard-1992
p16843
sg5
S'PMC1883284'
p16844
sg7
VCD005660 v. 5.0 Analgesia in patients with acute abdominal pain.rm5
p16845
sg9
V1393034.xml
p16846
sa(dp16847
g3
VSTD-Patki-1990
p16848
sg5
S'PMC1663843'
p16849
sg7
VCD004805 v. 12.0 Combined calcium magnesium and potassium supplementation for the management of primary hypertension.rm5
p16850
sg9
V2207419.xml
p16851
sa(dp16852
g3
VSTD-Geleijnse-1994
p16853
sg5
S'PMC2540967'
p16854
sg7
g16850
sg9
V7920126.xml
p16855
sa(dp16856
g3
VSTD-Vedder-2007
p16857
sg5
S'PMC1913555'
p16858
sg7
VCD006663 v. 7.0 Enzyme replacement therapy for Anderson-Fabry disease.rm5
p16859
sg9
V17622343.xml
p16860
sa(dp16861
g3
VSTD-Frihagen-2007
p16862
sg5
S'PMC2137068'
p16863
sg7
VCD001708 v. 10.0 Internal fixation versus arthroplasty for intracapsular proximal femoral fractures in adults.rm5
p16864
sg9
V18056740.xml
p16865
sa(dp16866
g3
VSTD-Mouzopoulos-2008
p16867
sg5
S'PMC2323425'
p16868
sg7
g16864
sg9
V17431621.xml
p16869
sa(dp16870
g3
VSTD-Walker-1987
p16871
sg5
S'PMC1246354'
p16872
sg7
VCD006771 v. 3.4 Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.rm5
p16873
sg9
V3109574.xml
p16874
sa(dp16875
g3
VSTD-Madge-1997
p16876
sg5
S'PMC1758505'
p16877
sg7
VCD001290 v. 7.0 Interventions for educating children who are at risk of asthma-related emergency department attendan.rm5
p16878
sg9
V9093336.xml
p16879
sa(dp16880
g3
VSTD-Mitchell-1986
p16881
sg5
S'PMC1778203'
p16882
sg7
g16878
sg9
V3545094.xml
p16883
sa(dp16884
g3
VSTD-McNabb-1985
p16885
sg5
S'PMC1646372'
p16886
sg7
g16878
sg9
V4037168.xml
p16887
sa(dp16888
g3
VSTD-Charlton-1994
p16889
sg5
S'PMC1029785'
p16890
sg7
g16878
sg9
V8185365.xml
p16891
sa(dp16892
g3
VSTD-Wesseldine-1999
p16893
sg5
S'PMC1717832'
p16894
sg7
g16878
sg9
V10325723.xml
p16895
sa(dp16896
g3
VSTD-Garrett-1994
p16897
sg5
S'PMC475232'
p16898
sg7
g16878
sg9
V7974314.xml
p16899
sa(dp16900
g3
VSTD-Butz-2006
p16901
sg5
S'PMC2269706'
p16902
sg7
g16878
sg9
V16754825.xml
p16903
sa(dp16904
g3
VSTD-Stevens-2002
p16905
sg5
S'PMC1746177'
p16906
sg7
g16878
sg9
V11809988.xml
p16907
sa(dp16908
g3
VSTD-Westlake-2009
p16909
sg5
S'PMC2708184'
p16910
sg7
VCD006185 v. 5.0 Electromechanical-assisted training for walking after stroke.rm5
p16911
sg9
V19523207.xml
p16912
sa(dp16913
g3
VSTD-Pritchard-1999
p16914
sg5
S'PMC1756872'
p16915
sg7
VCD000984 v. 10.0 Interventions to change the behaviour of health professionals and the organisation of care to promot.rm5
p16916
sg9
V10396539.xml
p16917
sa(dp16918
g3
VSTD-Moore-2003
p16919
sg5
S'PMC261745'
p16920
sg7
g16916
sg9
V14604931.xml
p16921
sa(dp16922
g3
VSTD-Ruger-2008
p16923
sg5
S'PMC2775431'
p16924
sg7
VCD003999 v. 6.23 Relapse prevention interventions for smoking cessation.rm5
p16925
sg9
V17854434.xml
p16926
sa(dp16927
g3
VSTD-McBride-1999
p16928
sg5
S'PMC1508743'
p16929
sg7
g16925
sg9
V10224982.xml
p16930
sa(dp16931
g3
VSTD-Lando-1996
p16932
sg5
S'PMC1380734'
p16933
sg7
g16925
sg9
V9003138.xml
p16934
sa(dp16935
g3
VSTD-Hajek-2002
p16936
sg5
S'PMC64504'
p16937
sg7
g16925
sg9
V11786452.xml
p16938
sa(dp16939
g3
VSTD-Ormiston-1988
p16940
sg5
S'PMC1416577'
p16941
sg7
VCD001103 v. 9.0 Dressings for healing venous leg ulcers.rm5
p16942
sg9
V3926169.xml
p16943
sa(dp16944
g3
VSTD-Prendiville-1988
p16945
sg5
S'PMC1834913'
p16946
sg7
VCD007412 v. 4.0 Active versus expectant management for women in the third stage of labour.rm5
p16947
sg9
V3144366.xml
p16948
sa(dp16949
g3
VSTD-Kreisman-1981
p16950
sg5
S'PMC471515'
p16951
sg7
VCD003269 v. 7.0 Anticholinergic agents for chronic asthma in adults.rm5
p16952
sg9
V6458919.xml
p16953
sa(dp16954
g3
VSTD-van-Schayck-1995
p16955
sg5
S'PMC1239228'
p16956
sg7
g16952
sg9
V7619569.xml
p16957
sa(dp16958
g3
VSTD-Bellia-1988
p16959
sg5
S'PMC2428919'
p16960
sg7
g16952
sg9
V3074291.xml
p16961
sa(dp16962
g3
VSTD-Taylor-1986
p16963
sg5
S'PMC460313'
p16964
sg7
g16952
sg9
V2943050.xml
p16965
sa(dp16966
g3
VSTD-van-Schayck-1991b
p16967
sg5
S'PMC463136'
p16968
sg7
g16952
sg9
V1829865.xml
p16969
sa(dp16970
g3
VSTD-Sherwood-1983
p16971
sg5
S'PMC1650873'
p16972
sg7
VCD006860 v. 3.0 Personal assistance for adults (19-64) with both physical and intellectual impairments.rm5
p16973
sg9
V6405641.xml
p16974
sa(dp16975
g3
VSTD-Carlson-2007
p16976
sg5
S'PMC1955332'
p16977
sg7
g16973
sg9
V17244293.xml
p16978
sa(dp16979
g3
VSTD-Rosenfeld-2008
p16980
sg5
S'PMC2631354'
p16981
sg7
VCD004157 v. 4.0 Treatment for cramps in amyotrophic lateral sclerosismotor neuron disease.rm5
p16982
sg9
V18608103.xml
p16983
sa(dp16984
g3
VSTD-Gerr-2005
p16985
sg5
S'PMC1741055'
p16986
sg7
VCD008570 v. 4.0 Ergonomic design and training for preventing work-related musculoskeletal disorders of the upper lim.rm5
p16987
sg9
V15961625.xml
p16988
sa(dp16989
g3
VSTD-Rempel-2006
p16990
sg5
S'PMC2092482'
p16991
sg7
g16987
sg9
V16621849.xml
p16992
sa(dp16993
g3
VSTD-Barennes-2006
p16994
sg5
S'PMC1458599'
p16995
sg7
VCD004009 v. 4.0 Intrarectal quinine versus intravenous or intramuscular quinine for treating Plasmodium falciparum m.rm5
p16996
sg9
V16675812.xml
p16997
sa(dp16998
g3
VSTD-Pussard-2004
p16999
sg5
S'PMC525409'
p17000
sg7
g16996
sg9
V15504872.xml
p17001
sa(dp17002
g3
VSTD-Barennes-1996a
p17003
sg5
S'PMC2042609'
p17004
sg7
g16996
sg9
V8735679.xml
p17005
sa(dp17006
g3
VSTD-Carlo-2010
p17007
sg5
S'PMC3565382'
p17008
sg7
VCD005460 v. 6.0 Traditional birth attendant training for improving health behaviours and pregnancy outcomes.rm5
p17009
sg9
V20164485.xml
p17010
sa(dp17011
g3
VSTD-Gill-2011
p17012
sg5
S'PMC3032994'
p17013
sg7
g17009
sg9
V21292711.xml
p17014
sa(dp17015
g3
VSTD-Mertens-1992
p17016
sg5
S'PMC191603'
p17017
sg7
VCD001954 v. 12.0 Azithromycin for acute lower respiratory tract infections.rm5
p17018
sg9
V1324645.xml
p17019
sa(dp17020
g3
VSTD-Patten-2009
p17021
sg5
S'PMC2670370'
p17022
sg7
VCD002928 v. 7.0 Enhancing partner support to improve smoking cessation.rm5
p17023
sg9
V19357315.xml
p17024
sa(dp17025
g3
VSTD-Malott-1984
p17026
sg5
S'PMC1307970'
p17027
sg7
g17023
sg9
V6441794.xml
p17028
sa(dp17029
g3
VSTD-Arathoon-2002
p17030
sg5
S'PMC127070'
p17031
sg7
VCD003940 v. 6.0 Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV inf.rm5
p17032
sg9
V11796357.xml
p17033
sa(dp17034
g3
VSTD-Nittayananta-2008
p17035
sg5
S'PMC3253386'
p17036
sg7
g17032
sg9
V18627504.xml
p17037
sa(dp17038
g3
VSTD-Chavanet-1992
p17039
sg5
S'PMC1883525'
p17040
sg7
g17032
sg9
V1458072.xml
p17041
sa(dp17042
g3
VSTD-Bedford_x002d_Russell-2001
p17043
sg5
S'PMC1721238'
p17044
sg7
VCD003066 v. 5.0 G-CSF and GM-CSF for treating or preventing neonatal infections.rm5
p17045
sg9
V11320043.xml
p17046
sa(dp17047
g3
VSTD-Greenwood-1978
p17048
sg5
S'PMC1604678'
p17049
sg7
VCD001093 v. 7.3 Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.rm5
p17050
sg9
V417754.xml
p17051
sa(dp17052
g3
VSTD-Wahdan-1973
p17053
sg5
S'PMC2483073'
p17054
sg7
g17050
sg9
V4206451.xml
p17055
sa(dp17056
g3
VSTD-Erwa-1973
p17057
sg5
S'PMC2481142'
p17058
sg7
g17050
sg9
V4211056.xml
p17059
sa(dp17060
g3
VSTD-Wahdan-1977
p17061
sg5
S'PMC2366720'
p17062
sg7
g17050
sg9
V413639.xml
p17063
sa(dp17064
g3
VSTD-Rindone-2000
p17065
sg5
S'PMC1070762'
p17066
sg7
VCD002946 v. 8.0 Glucosamine therapy for treating osteoarthritis.rm5
p17067
sg9
V10693368.xml
p17068
sa(dp17069
g3
VSTD-McManus-1998
p17070
sg5
S'PMC28735'
p17071
sg7
VMR000026 v. 2.3 Checking reference lists to find additional studies for systematic reviews.rm5
p17072
sg9
V9836655.xml
p17073
sa(dp17074
g3
VSTD-McNally-2004
p17075
sg5
S'PMC2080777'
p17076
sg7
g17072
sg9
V15318916.xml
p17077
sa(dp17078
g3
VSTD-Ogilvie-2005
p17079
sg5
S'PMC1733146'
p17080
sg7
g17072
sg9
V16100321.xml
p17081
sa(dp17082
g3
VSTD-Greenhalgh-2005
p17083
sg5
S'PMC1283190'
p17084
sg7
g17072
sg9
V16230312.xml
p17085
sa(dp17086
g3
VSTD-Mann-1986
p17087
sg5
S'PMC1342106'
p17088
sg7
VCD006982 v. 3.0 Cycled light in the intensive care unit for preterm and low birth weight infants.rm5
p17089
sg9
V3096460.xml
p17090
sa(dp17091
g3
VSTD-Howden_x002d_Chapman-2007
p17092
sg5
S'PMC1808149'
p17093
sg7
VCD007897 v. 2.2 Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract sym.rm5
p17094
sg9
V17324975.xml
p17095
sa(dp17096
g3
VSTD-Kercsmar-2006
p17097
sg5
S'PMC1626393'
p17098
sg7
g17094
sg9
V17035145.xml
p17099
sa(dp17100
g3
VSTD-Baker-1991
p17101
sg5
S'PMC1368470'
p17102
sg7
VCD002104 v. 10.0 Written information about individual medicines for consumers.rm5
p17103
sg9
V1888619.xml
p17104
sa(dp17105
g3
VSTD-Gibbs-1989
p17106
sg5
S'PMC1379799'
p17107
sg7
g17103
sg9
V2569323.xml
p17108
sa(dp17109
g3
VSTD-Bergus-2002
p17110
sg5
S'PMC1495093'
p17111
sg7
g17103
sg9
V12213142.xml
p17112
sa(dp17113
g3
VSTD-Little-1998
p17114
sg5
S'PMC28594'
p17115
sg7
g17103
sg9
V9641933.xml
p17116
sa(dp17117
g3
VSTD-Knapp-2004
p17118
sg5
S'PMC1743828'
p17119
sg7
g17103
sg9
V15175486.xml
p17120
sa(dp17121
g3
VSTD-Peveler-1999
p17122
sg5
S'PMC28214'
p17123
sg7
g17103
sg9
V10473477.xml
p17124
sa(dp17125
g3
VSTD-Clark-1972
p17126
sg5
S'PMC1530384'
p17127
sg7
g17103
sg9
V5046455.xml
p17128
sa(dp17129
g3
VSTD-Bradley-2002
p17130
sg5
S'PMC100764'
p17131
sg7
VCD006093 v. 5.0 Interventions for promoting information and communication technologies adoption in healthcare profes.rm5
p17132
sg9
V11999177.xml
p17133
sa(dp17134
g3
VSTD-Haynes-1991
p17135
sg5
S'PMC225582'
p17136
sg7
g17132
sg9
V1958910.xml
p17137
sa(dp17138
g3
VSTD-Cabell-2001
p17139
sg5
S'PMC1495306'
p17140
sg7
g17132
sg9
V11903763.xml
p17141
sa(dp17142
g3
VSTD-Haynes-2006
p17143
sg5
S'PMC1656957'
p17144
sg7
g17132
sg9
V16929034.xml
p17145
sa(dp17146
g3
VSTD-Katz-2003
p17147
sg5
S'PMC1494914'
p17148
sg7
g17132
sg9
V12950483.xml
p17149
sa(dp17150
g3
VSTD-Warburton-1987
p17151
sg5
S'PMC1386096'
p17152
sg7
VCD005044 v. 4.0 Quinine for muscle cramps.rm5
p17153
sg9
V3555580.xml
p17154
sa(dp17155
g3
VSTD-Woodfield-2005
p17156
sg5
S'PMC1463087'
p17157
sg7
g17153
sg9
V15808032.xml
p17158
sa(dp17159
g3
VSTD-Dunn-1993
p17160
sg5
S'PMC1372336'
p17161
sg7
g17153
sg9
V8323792.xml
p17162
sa(dp17163
g3
VSTD-Fung-1989
p17164
sg5
S'PMC1026949'
p17165
sg7
g17153
sg9
V2669346.xml
p17166
sa(dp17167
g3
VSTD-Glasgow-2000
p17168
sg5
S'PMC27300'
p17169
sg7
VCD003585 v. 5.0 Occupational therapy for patients with problems in activities of daily living after stroke.rm5
p17170
sg9
V10698876.xml
p17171
sa(dp17172
g3
VSTD-Arrieta-2003
p17173
sg5
S'PMC201139'
p17174
sg7
VCD001095 v. 14.0 Short-course antibiotics for acute otitis media.rm5
p17175
sg9
V14506028.xml
p17176
sa(dp17177
g3
VSTD-Dagan-2000b
p17178
sg5
S'PMC89626'
p17179
sg7
g17175
sg9
V10602721.xml
p17180
sa(dp17181
g3
VSTD-Arthur-2007
p17182
sg5
S'PMC2598642'
p17183
sg7
VCD001224 v. 5.0 Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countrie.rm5
p17184
sg9
V17991688.xml
p17185
sa(dp17186
g3
VSTD-Cremin-2010
p17187
sg5
S'PMC2865634'
p17188
sg7
g17184
sg9
V19623481.xml
p17189
sa(dp17190
g3
VSTD-de-Lacey-1985-RA
p17191
sg5
S'PMC1416756'
p17192
sg7
VMR000002 v. 7.0 Technical editing of research reports in biomedical journals.rm5
p17193
sg9
V3931753.xml
p17194
sa(dp17195
g3
VSTD-Taddio-1994
p17196
sg5
S'PMC1336964'
p17197
sg7
g17193
sg9
V8174031.xml
p17198
sa(dp17199
g3
VSTD-Aronsky-2005-RA
p17200
sg5
S'PMC551554'
p17201
sg7
g17193
sg9
V15561784.xml
p17202
sa(dp17203
g3
VSTD-Eichorn-1987-RA
p17204
sg5
S'PMC1647239'
p17205
sg7
g17193
sg9
V3079520.xml
p17206
sa(dp17207
g3
VSTD-Harbourt-1995
p17208
sg5
S'PMC226026'
p17209
sg7
g17193
sg9
V7599584.xml
p17210
sa(dp17211
g3
VSTD-VargasOrigel-2001-RA
p17212
sg5
S'PMC1719006'
p17213
sg7
g17193
sg9
V11719341.xml
p17214
sa(dp17215
g3
VSTD-Darrow-2008
p17216
sg5
S'PMC2376895'
p17217
sg7
VCD009337 v. 2.0 Social marketing interventions to increase HIVSTI testing uptake among men who have sex with men an.rm5
p17218
sg9
V18172146.xml
p17219
sa(dp17220
g3
VSTD-Grant-2009
p17221
sg5
S'PMC2799061'
p17222
sg7
VCD003720 v. 5.0 Timing of breast surgery in premenopausal breast cancer patients.rm5
p17223
sg9
V19487378.xml
p17224
sa(dp17225
g3
VSTD-Swoboda-2010
p17226
sg5
S'PMC2924376'
p17227
sg7
VCD006282 v. 4.0 Drug treatment for spinal muscular atrophy types II and III.rm5
p17228
sg9
V20808854.xml
p17229
sa(dp17230
g3
VSTD-Schiff-2008
p17231
sg5
S'PMC2564802'
p17232
sg7
VCD007277 v. 3.0 Abatacept for rheumatoid arthritis.rm5
p17233
sg9
V18055472.xml
p17234
sa(dp17235
g3
VSTD-Weinblatt-2007
p17236
sg5
S'PMC1798511'
p17237
sg7
g17233
sg9
V16935912.xml
p17238
sa(dp17239
g3
VSTD-Brett-1992
p17240
sg5
S'PMC1793633'
p17241
sg7
VCD002767 v. 12.0 Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis.rm5
p17242
sg9
V1417051.xml
p17243
sa(dp17244
g3
VSTD-Elborn-2000
p17245
sg5
S'PMC1745744'
p17246
sg7
g17242
sg9
V10770814.xml
p17247
sa(dp17248
g3
VSTD-Grove-1996
p17249
sg5
S'PMC472490'
p17250
sg7
VCD001104 v. 7.0 Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.rm5
p17251
sg9
V8882074.xml
p17252
sa(dp17253
g3
VSTD-Ulrik-1995
p17254
sg5
S'PMC474647'
p17255
sg7
g17251
sg9
V7570409.xml
p17256
sa(dp17257
g3
VSTD-Combe-2006
p17258
sg5
S'PMC2689524'
p17259
sg7
VCD004525 v. 6.51 Etanercept for the treatment of rheumatoid arthritis.rm5
p17260
sg9
V18794178.xml
p17261
sa(dp17262
g3
VSTD-Gardner-1988
p17263
sg5
S'PMC1349736'
p17264
sg7
VCD000450 v. 6.0 Interventions for preventing and treating stress fractures and stress reactions of bone of the lower.rm5
p17265
sg9
V3056045.xml
p17266
sa(dp17267
g3
VSTD-Pinter-1999
p17268
sg5
S'PMC1736320'
p17269
sg7
VCD002261 v. 4.2 Pramipexole for levodopa-induced complications in Parkinson's disease.rm5
p17270
sg9
V10201413.xml
p17271
sa(dp17272
g3
VSTD-MacDougall-1990
p17273
sg5
S'PMC1664403'
p17274
sg7
VCD006387 v. 3.0 Interventions for the treatment of oral cavity and oropharyngeal cancer radiotherapy.rm5
p17275
sg9
V2125513.xml
p17276
sa(dp17277
g3
VSTD-Johnson-1989
p17278
sg5
S'PMC461792'
p17279
sg7
VCD003134 v. 5.0 Non-steroid agents for idiopathic pulmonary fibrosis.rm5
p17280
sg9
V2669218.xml
p17281
sa(dp17282
g3
VSTD-Premawardhena-1999
p17283
sg5
S'PMC27835'
p17284
sg7
VCD002153 v. 4.0 Interventions for preventing reactions to snake antivenom.rm5
p17285
sg9
V10205101.xml
p17286
sa(dp17287
g3
VSTD-Fan-1999
p17288
sg5
S'PMC27887'
p17289
sg7
g17285
sg9
V10346769.xml
p17290
sa(dp17291
g3
VSTD-Ietswaart-2011
p17292
sg5
S'PMC3097892'
p17293
sg7
VCD008449 v. 2.0 Mirror therapy for improving motor function after stroke.rm5
p17294
sg9
V21515905.xml
p17295
sa(dp17296
g3
VSTD-Yun-2010
p17297
sg5
S'PMC3309215'
p17298
sg7
g17294
sg9
V22506139.xml
p17299
sa(dp17300
g3
VSTD-Viljanen-2003
p17301
sg5
S'PMC188429'
p17302
sg7
VCD005956 v. 3.0 Interventions to improve adherence to exercise for chronic musculoskeletal pain in adults.rm5
p17303
sg9
V12946968.xml
p17304
sa(dp17305
g3
VSTD-Hurley-2007
p17306
sg5
S'PMC2673355'
p17307
sg7
g17303
sg9
V17907147.xml
p17308
sa(dp17309
g3
VSTD-Nour-2006
p17310
sg5
S'PMC1525193'
p17311
sg7
g17303
sg9
V16734904.xml
p17312
sa(dp17313
g3
VSTD-Ersek-2004
p17314
sg5
S'PMC509247'
p17315
sg7
g17303
sg9
V15285783.xml
p17316
sa(dp17317
g3
VSTD-Smeets-2006
p17318
sg5
S'PMC1382224'
p17319
sg7
g17303
sg9
V16426449.xml
p17320
sa(dp17321
g3
VSTD-Latimer-1982
p17322
sg5
S'PMC1862216'
p17323
sg7
VCD002158 v. 6.0 Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agoni.rm5
p17324
sg9
V7139504.xml
p17325
sa(dp17326
g3
VSTD-Taggart-1995
p17327
sg5
S'PMC2550012'
p17328
sg7
g17324
sg9
V7795451.xml
p17329
sa(dp17330
g3
VSTD-Selroos-1994
p17331
sg5
S'PMC475329'
p17332
sg7
g17324
sg9
V7878558.xml
p17333
sa(dp17334
g3
VSTD-NCBRG-1981
p17335
sg5
S'PMC1627274'
p17336
sg7
VCD006943 v. 4.49 Interventions for covert bacteriuria in children.rm5
p17337
sg9
V7271298.xml
p17338
sa(dp17339
g3
VSTD-Van-Vliet-2005
p17340
sg5
S'PMC1739598'
p17341
sg7
VCD006073 v. 3.0 Repetitive task training for improving functional ability after stroke.rm5
p17342
sg9
V15774435.xml
p17343
sa(dp17344
g3
VSTD-Bland-1973
p17345
sg5
S'PMC1648558'
p17346
sg7
VCD001208 v. 12.2 Human albumin solution for resuscitation and volume expansion in critically ill patients.rm5
p17347
sg9
V4749684.xml
p17348
sa(dp17349
g3
VSTD-Goodwin-1983
p17350
sg5
S'PMC1353023'
p17351
sg7
g17347
sg9
V6342554.xml
p17352
sa(dp17353
g3
VSTD-So-1997
p17354
sg5
S'PMC1720603'
p17355
sg7
g17347
sg9
V9059186.xml
p17356
sa(dp17357
g3
VSTD-Browner-1994
p17358
sg5
S'PMC1022738'
p17359
sg7
VCD003030 v. 6.5 Continuing education meetings and workshops effects on professional practice and health care outcom.rm5
p17360
sg9
V7856157.xml
p17361
sa(dp17362
g3
VSTD-Moore-2003-b
p17363
sg5
S'PMC261745'
p17364
sg7
g17360
sg9
V14604931.xml
p17365
sa(dp17366
g3
VSTD-Moore-2003-a
p17367
sg5
S'PMC1314568'
p17368
sg7
g17360
sg9
V12879826.xml
p17369
sa(dp17370
g3
VSTD-Dolan1997
p17371
sg5
S'PMC1497157'
p17372
sg7
g17360
sg9
V9294786.xml
p17373
sa(dp17374
g3
VSTD-Forsetlund-2003
p17375
sg5
S'PMC153535'
p17376
sg7
g17360
sg9
V12694632.xml
p17377
sa(dp17378
g3
VSTD-Harmsen-2005
p17379
sg5
S'PMC1463156'
p17380
sg7
g17360
sg9
V15904552.xml
p17381
sa(dp17382
g3
VSTD-Dietrich-1992
p17383
sg5
S'PMC1881551'
p17384
sg7
g17360
sg9
V1571644.xml
p17385
sa(dp17386
g3
VSTD-Wilson-1992
p17387
sg5
S'PMC2145470'
p17388
sg7
g17360
sg9
V21221270.xml
p17389
sa(dp17390
g3
VSTD-Smeele-1999
p17391
sg5
S'PMC2483639'
p17392
sg7
g17360
sg9
V10557684.xml
p17393
sa(dp17394
g3
VSTD-Flottorp-2002
p17395
sg5
S'PMC117890'
p17396
sg7
g17360
sg9
V12183309.xml
p17397
sa(dp17398
g3
VSTD-Schectman-2003
p17399
sg5
S'PMC1494929'
p17400
sg7
g17360
sg9
V14521638.xml
p17401
sa(dp17402
g3
VSTD-Westphal-1995
p17403
sg5
S'PMC2486792'
p17404
sg7
g17360
sg9
V7554017.xml
p17405
sa(dp17406
g3
VSTD-Worrall-1999
p17407
sg5
S'PMC1232647'
p17408
sg7
g17360
sg9
V10420862.xml
p17409
sa(dp17410
g3
VSTD-Morrison-2001
p17411
sg5
S'PMC31924'
p17412
sg7
g17360
sg9
V11375232.xml
p17413
sa(dp17414
g3
VSTD-Lewin-2005
p17415
sg5
S'PMC2626204'
p17416
sg7
g17360
sg9
V15868015.xml
p17417
sa(dp17418
g3
VSTD-Welschen-2004
p17419
sg5
S'PMC514206'
p17420
sg7
g17360
sg9
V15297305.xml
p17421
sa(dp17422
g3
VSTD-Kerse-1999
p17423
sg5
S'PMC28221'
p17424
sg7
g17360
sg9
V10480825.xml
p17425
sa(dp17426
g3
VSTD-Simons-2001
p17427
sg5
S'PMC1314123'
p17428
sg7
g17360
sg9
V11677701.xml
p17429
sa(dp17430
g3
VSTD-King-2002
p17431
sg5
S'PMC102328'
p17432
sg7
g17360
sg9
V11964340.xml
p17433
sa(dp17434
g3
VSTD-Garcia-2003
p17435
sg5
S'PMC2572366'
p17436
sg7
g17360
sg9
V14758407.xml
p17437
sa(dp17438
g3
VSTD-Verstappen-2004
p17439
sg5
S'PMC1466745'
p17440
sg7
g17360
sg9
V15576543.xml
p17441
sa(dp17442
g3
VSTD-Kiessling-2002
p17443
sg5
S'PMC129638'
p17444
sg7
g17360
sg9
V12386042.xml
p17445
sa(dp17446
g3
VSTD-Chappell-2008
p17447
sg5
S'PMC2840539'
p17448
sg7
VCD010292 v. 3.0 Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.rm5
p17449
sg9
V20428412.xml
p17450
sa(dp17451
g3
VSTD-Baumslag-1970
p17452
sg5
S'PMC1700896'
p17453
sg7
VCD006896 v. 4.0 Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes.rm5
p17454
sg9
V5460838.xml
p17455
sa(dp17456
g3
VSTD-Trigg-1976
p17457
sg5
S'PMC2158056'
p17458
sg7
g17454
sg9
V1263177.xml
p17459
sa(dp17460
g3
VSTD-Rae-1970
p17461
sg5
S'PMC476777'
p17462
sg7
g17454
sg9
V5476865.xml
p17463
sa(dp17464
g3
VSTD-Chanarin-1965
p17465
sg5
S'PMC2165857'
p17466
sg7
g17454
sg9
V14238675.xml
p17467
sa(dp17468
g3
VSTD-Weaver-1994
p17469
sg5
S'PMC1029705'
p17470
sg7
VCD001912 v. 12.0 Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.rm5
p17471
sg9
V8129449.xml
p17472
sa(dp17473
g3
VSTD-Chatfield-1991
p17474
sg5
S'PMC1590363'
p17475
sg7
g17471
sg9
V1996888.xml
p17476
sa(dp17477
g3
VSTD-Gilchrist-1988
p17478
sg5
S'PMC1834849'
p17479
sg7
VCD007125 v. 3.0 Multidisciplinary rehabilitation for older people with hip fractures.rm5
p17480
sg9
V3143450.xml
p17481
sa(dp17482
g3
VSTD-Kennie-1988
p17483
sg5
S'PMC1834847'
p17484
sg7
g17480
sg9
V3143436.xml
p17485
sa(dp17486
g3
VSTD-Naglie-2002
p17487
sg5
S'PMC116636'
p17488
sg7
g17480
sg9
V12137074.xml
p17489
sa(dp17490
g3
VSTD-Rogahn-2000
p17491
sg5
S'PMC1721136'
p17492
sg7
VCD005253 v. 3.0 Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in pr.rm5
p17493
sg9
V10952698.xml
p17494
sa(dp17495
g3
VSTD-Hodges-1971
p17496
sg5
S'PMC472390'
p17497
sg7
VCD003270 v. 9.2 Azathioprine as an oral corticosteroid sparing agent for asthma.rm5
p17498
sg9
V4947381.xml
p17499
sa(dp17500
g3
VSTD-Hodges-1971a
p17501
sg5
S'PMC472390'
p17502
sg7
g17498
sg9
V4947381.xml
p17503
sa(dp17504
g3
VSTD-Schiffman-2007
p17505
sg5
S'PMC2278036'
p17506
sg7
VCD006385 v. 3.0 Arthroscopy for temporomandibular disorders.rm5
p17507
sg9
V17189464.xml
p17508
sa(dp17509
g3
VSTD-Agarwal-2004
p17510
sg5
S'PMC383371'
p17511
sg7
VCD005976 v. 9.2 Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in ch.rm5
p17512
sg9
V15070633.xml
p17513
sa(dp17514
g3
VSTD-Gordon-2005
p17515
sg5
S'PMC1449162'
p17516
sg7
VCD008194 v. 3.0 Outreach strategies for expanding health insurance coverage in children.rm5
p17517
sg9
V15671460.xml
p17518
sa(dp17519
g3
VSTD-Smithuis-2010
p17520
sg5
S'PMC2947715'
p17521
sg7
VCD008152 v. 2.4 Primaquine for reducing Plasmodium falciparum transmission.rm5
p17522
sg9
V20832366.xml
p17523
sa(dp17524
g3
VSTD-Kolaczinski-2012
p17525
sg5
S'PMC3269419'
p17526
sg7
g17522
sg9
V22303437.xml
p17527
sa(dp17528
g3
VSTD-El_x002d_Sayed-2007
p17529
sg5
S'PMC2111052'
p17530
sg7
g17522
sg9
V18074034.xml
p17531
sa(dp17532
g3
VSTD-Ledermann-2006
p17533
sg5
S'PMC1665467'
p17534
sg7
g17522
sg9
V17105658.xml
p17535
sa(dp17536
g3
VSTD-Pukrittayakamee-2004
p17537
sg5
S'PMC375327'
p17538
sg7
g17522
sg9
V15047537.xml
p17539
sa(dp17540
g3
VSTD-Shekalaghe-2007
p17541
sg5
S'PMC1995753'
p17542
sg7
g17522
sg9
V17925871.xml
p17543
sa(dp17544
g3
VSTD-Smith-1991
p17545
sg5
S'PMC463022'
p17546
sg7
VCD006849 v. 3.0 Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.rm5
p17547
sg9
V1851339.xml
p17548
sa(dp17549
g3
VSTD-Norton-1996
p17550
sg5
S'PMC2349687'
p17551
sg7
VCD008096 v. 4.0 Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing distu.rm5
p17552
sg9
V8555849.xml
p17553
sa(dp17554
g3
VSTD-Park-1992
p17555
sg5
S'PMC1882203'
p17556
sg7
g17552
sg9
V1628013.xml
p17557
sa(dp17558
g3
VSTD-Mistiaen-2009
p17559
sg5
S'PMC2924330'
p17560
sg7
VCD001735 v. 17.4 Support surfaces for pressure ulcer prevention.rm5
p17561
sg9
V20687915.xml
p17562
sa(dp17563
g3
VSTD-Sorensen-work_x002b_family
p17564
sg5
S'PMC1508509'
p17565
sg7
VCD002128 v. 7.0 Dietary advice for reducing cardiovascular risk.rm5
p17566
sg9
V9987465.xml
p17567
sa(dp17568
g3
VSTD-ENCORE
p17569
sg5
S'PMC3633078'
p17570
sg7
g17566
sg9
V20101007.xml
p17571
sa(dp17572
g3
VSTD-Sorensen-worksite
p17573
sg5
S'PMC1508509'
p17574
sg7
g17566
sg9
V9987465.xml
p17575
sa(dp17576
g3
VSTD-Little--2004
p17577
sg5
S'PMC403849'
p17578
sg7
g17566
sg9
V15082472.xml
p17579
sa(dp17580
g3
VSTD-Havas-1998
p17581
sg5
S'PMC1508288'
p17582
sg7
g17566
sg9
V9702141.xml
p17583
sa(dp17584
g3
VSTD-Beresford-1997
p17585
sg5
S'PMC1380841'
p17586
sg7
g17566
sg9
V9146440.xml
p17587
sa(dp17588
g3
VSTD-Baron-men-1990
p17589
sg5
S'PMC1371239'
p17590
sg7
g17566
sg9
V2115348.xml
p17591
sa(dp17592
g3
VSTD-Baron-women-1990
p17593
sg5
S'PMC1371239'
p17594
sg7
g17566
sg9
V2115348.xml
p17595
sa(dp17596
g3
VSTD-PITCH-2012
p17597
sg5
S'PMC3420230'
p17598
sg7
VCD000493 v. 8.0 Interventions for treating cholestasis in pregnancy.rm5
p17599
sg9
V22695903.xml
p17600
sa(dp17601
g3
VSTD-Campieri-1991b
p17602
sg5
S'PMC1378964'
p17603
sg7
VCD004115 v. 4.2 Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.rm5
p17604
sg9
V1885075.xml
p17605
sa(dp17606
g3
VSTD-Palmer-1981
p17607
sg5
S'PMC1505556'
p17608
sg7
g17604
sg9
V6113021.xml
p17609
sa(dp17610
g3
VSTD-Powell_x002d_Tuck-1986
p17611
sg5
S'PMC1339576'
p17612
sg7
g17604
sg9
V3081188.xml
p17613
sa(dp17614
g3
VSTD-Lee-1996
p17615
sg5
S'PMC1383028'
p17616
sg7
g17604
sg9
V8801202.xml
p17617
sa(dp17618
g3
VSTD-CLOTS-2009
p17619
sg5
S'PMC2692021'
p17620
sg7
VCD001922 v. 6.0 Physical methods for preventing deep vein thrombosis in stroke.rm5
p17621
sg9
V19477503.xml
p17622
sa(dp17623
g3
VSTD-Louie-2005
p17624
sg5
S'PMC3211537'
p17625
sg7
VCD002837 v. 10.0 Enteral versus parenteral nutrition for acute pancreatitis.rm5
p17626
sg9
V16149365.xml
p17627
sa(dp17628
g3
VSTD-Brown-2009
p17629
sg5
S'PMC2727938'
p17630
sg7
VCD007506 v. 6.0 Lifestyle changes in women with polycystic ovary syndrome.rm5
p17631
sg9
V19204602.xml
p17632
sa(dp17633
g3
VSTD-Hoeger-2008
p17634
sg5
S'PMC2582568'
p17635
sg7
g17631
sg9
V18728175.xml
p17636
sa(dp17637
g3
VSTD-PRoFESS-2008
p17638
sg5
S'PMC2714259'
p17639
sg7
VCD005449 v. 3.0 Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in typ.rm5
p17640
sg9
V18753638.xml
p17641
sa(dp17642
g3
VSTD-Huang-2005
p17643
sg5
S'PMC1357702'
p17644
sg7
VCD006745 v. 4.2 Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcino.rm5
p17645
sg9
V15973099.xml
p17646
sa(dp17647
g3
VSTD-Lin-2005
p17648
sg5
S'PMC1774888'
p17649
sg7
g17645
sg9
V16009687.xml
p17650
sa(dp17651
g3
VSTD-Harland-1999
p17652
sg5
S'PMC314213'
p17653
sg7
VCD003180 v. 8.0 Interventions for promoting physical activity.rm5
p17654
sg9
V10496829.xml
p17655
sa(dp17656
g3
VSTD-Stevens-1998
p17657
sg5
S'PMC1756094'
p17658
sg7
g17654
sg9
V9773174.xml
p17659
sa(dp17660
g3
VSTD-Reid-1979
p17661
sg5
S'PMC1618997'
p17662
sg7
g17654
sg9
V443500.xml
p17663
sa(dp17664
g3
VSTD-Stewart-2001
p17665
sg5
S'PMC1780022'
p17666
sg7
g17654
sg9
V11487597.xml
p17667
sa(dp17668
g3
VSTD-Lamb-2002
p17669
sg5
S'PMC1732126'
p17670
sg7
g17654
sg9
V11896130.xml
p17671
sa(dp17672
g3
VSTD-Smith-2000
p17673
sg5
S'PMC1724212'
p17674
sg7
g17654
sg9
V10953898.xml
p17675
sa(dp17676
g3
VSTD-Elley-2003
p17677
sg5
S'PMC153098'
p17678
sg7
g17654
sg9
V12689976.xml
p17679
sa(dp17680
g3
VSTD-Shortland-1998
p17681
sg5
S'PMC1720799'
p17682
sg7
VCD000950 v. 6.0 Carnitine supplementation of parenterally fed neonates.rm5
p17683
sg9
V9713029.xml
p17684
sa(dp17685
g3
VSTD-Mok-2007
p17686
sg5
S'PMC2656338'
p17687
sg7
VCD004744 v. 6.0 Rivastigmine for vascular cognitive impairment.rm5
p17688
sg9
V19300631.xml
p17689
sa(dp17690
g3
VSTD-Strunk-2008
p17691
sg5
S'PMC2647106'
p17692
sg7
VCD004249 v. 9.0 Manipulation or Mobilisation for Neck Pain.rm5
p17693
sg9
V19674713.xml
p17694
sa(dp17695
g3
VSTD-Howe-1983
p17696
sg5
S'PMC1973006'
p17697
sg7
g17693
sg9
V6355460.xml
p17698
sa(dp17699
g3
VSTD-Krauss-2008
p17700
sg5
S'PMC2565124'
p17701
sg7
g17693
sg9
V19119394.xml
p17702
sa(dp17703
g3
VSTD-Hurwitz-2002
p17704
sg5
S'PMC1447299'
p17705
sg7
g17693
sg9
V12356613.xml
p17706
sa(dp17707
g3
VSTD-Wade-1997
p17708
sg5
S'PMC486856'
p17709
sg7
VCD004170 v. 9.12 Multi-disciplinary rehabilitation for acquired brain injury in adults of working age.rm5
p17710
sg9
V9153604.xml
p17711
sa(dp17712
g3
VSTD-Smith-1981
p17713
sg5
S'PMC1504295'
p17714
sg7
g17710
sg9
V6780105.xml
p17715
sa(dp17716
g3
VSTD-Wade-1998
p17717
sg5
S'PMC2170203'
p17718
sg7
g17710
sg9
V9703167.xml
p17719
sa(dp17720
g3
VSTD-Powell-2002
p17721
sg5
S'PMC1737759'
p17722
sg7
g17710
sg9
V11796769.xml
p17723
sa(dp17724
g3
VSTD-Carlini-2012
p17725
sg5
S'PMC3438078'
p17726
sg7
VCD009187 v. 2.0 Interventions for recruiting smokers into cessation programmes.rm5
p17727
sg9
V22768793.xml
p17728
sa(dp17729
g3
VSTD-McClure-2009
p17730
sg5
S'PMC2889910'
p17731
sg7
g17727
sg9
V19524389.xml
p17732
sa(dp17733
g3
VSTD-Hennrikus-2002
p17734
sg5
S'PMC1447056'
p17735
sg7
g17727
sg9
V11818305.xml
p17736
sa(dp17737
g3
VSTD-McClure-2006
p17738
sg5
S'PMC2018826'
p17739
sg7
g17727
sg9
V16954124.xml
p17740
sa(dp17741
g3
VSTD-Lung-Health-Study
p17742
sg5
S'PMC1615316'
p17743
sg7
VCD008286 v. 3.0 Combined pharmacotherapy and behavioural interventions for smoking cessation.rm5
p17744
sg9
V7856782.xml
p17745
sa(dp17746
g3
VSTD-Cooney-2007
p17747
sg5
S'PMC2702144'
p17748
sg7
g17744
sg9
V18072840.xml
p17749
sa(dp17750
g3
VSTD-Binnie-2007
p17751
sg5
S'PMC1871574'
p17752
sg7
g17744
sg9
V17475005.xml
p17753
sa(dp17754
g3
VSTD-Wewers-2009
p17755
sg5
S'PMC2791896'
p17756
sg7
g17744
sg9
V19959695.xml
p17757
sa(dp17758
g3
VSTD-Rodriguez-2003
p17759
sg5
S'PMC1740534'
p17760
sg7
g17744
sg9
V12709522.xml
p17761
sa(dp17762
g3
VSTD-Hollis-2007
p17763
sg5
S'PMC2598511'
p17764
sg7
g17744
sg9
V18048633.xml
p17765
sa(dp17766
g3
VSTD-Schauffler-2001
p17767
sg5
S'PMC1747566'
p17768
sg7
g17744
sg9
V11387540.xml
p17769
sa(dp17770
g3
VSTD-Molyneux-2003
p17771
sg5
S'PMC1746718'
p17772
sg7
g17744
sg9
V12775857.xml
p17773
sa(dp17774
g3
VSTD-Hall-2006
p17775
sg5
S'PMC1586139'
p17776
sg7
g17744
sg9
V17008577.xml
p17777
sa(dp17778
g3
VSTD-_x00c5_gren-2011
p17779
sg5
S'PMC3233272'
p17780
sg7
VCD006133 v. 5.0 Steroidal contraceptives effect on carbohydrate metabolism in women without diabetes mellitus.rm5
p17781
sg9
V22066891.xml
p17782
sa(dp17783
g3
VSTD-Bennell-2010
p17784
sg5
S'PMC2830179'
p17785
sg7
VCD008618 v. 2.0 Exercise for improving outcomes after osteoporotic vertebral fracture.rm5
p17786
sg9
V20163739.xml
p17787
sa(dp17788
g3
VSTD-Morgan-2010
p17789
sg5
S'PMC3639680'
p17790
sg7
VCD003188 v. 15.3 Bisphosphonates in multiple myeloma a network meta-analysis.rm5
p17791
sg9
V21131037.xml
p17792
sa(dp17793
g3
VSTD-Ogilvie-2004
p17794
sg5
S'PMC1747869'
p17795
sg7
VMR000028 v. 2.4 How effects on health equity are assessed in systematic reviews of interventions.rm5
p17796
sg9
V15175527.xml
p17797
sa(dp17798
g3
VSTD-Jepson-2010
p17799
sg5
S'PMC2944371'
p17800
sg7
g17796
sg9
V20825660.xml
p17801
sa(dp17802
g3
VSTD-Bambra-2010
p17803
sg5
S'PMC2921286'
p17804
sg7
g17796
sg9
V19692738.xml
p17805
sa(dp17806
g3
VSTD-Darmstadt-2009
p17807
sg5
S'PMC2679412'
p17808
sg7
g17796
sg9
V19426469.xml
p17809
sa(dp17810
g3
VSTD-Main-2008
p17811
sg5
S'PMC2412872'
p17812
sg7
g17796
sg9
V18505545.xml
p17813
sa(dp17814
g3
VSTD-Yakoob-2009
p17815
sg5
S'PMC2679409'
p17816
sg7
g17796
sg9
V19426466.xml
p17817
sa(dp17818
g3
VSTD-Menezes-2009
p17819
sg5
S'PMC2679410'
p17820
sg7
g17796
sg9
V19426467.xml
p17821
sa(dp17822
g3
VSTD-Haws-2009
p17823
sg5
S'PMC2679411'
p17824
sg7
g17796
sg9
V19426468.xml
p17825
sa(dp17826
g3
VSTD-Shea-2009
p17827
sg5
S'PMC3226237'
p17828
sg7
g17796
sg9
V19828063.xml
p17829
sa(dp17830
g3
VSTD-Barros-2010
p17831
sg5
S'PMC2841444'
p17832
sg7
g17796
sg9
V20233384.xml
p17833
sa(dp17834
g3
VSTD-Lepore-_x0028_PE_x0029_-2003
p17835
sg5
S'PMC2593114'
p17836
sg7
VCD007569 v. 4.0 Interventions to enhance return-to-work for cancer patients.rm5
p17837
sg9
V14570527.xml
p17838
sa(dp17839
g3
VSTD-Lepore-_x0028_PE_x002b_discus_x0029_-2003
p17840
sg5
S'PMC2593114'
p17841
sg7
g17837
sg9
V14570527.xml
p17842
sa(dp17843
g3
VSTD-Kornblith-2009
p17844
sg5
S'PMC2773220'
p17845
sg7
g17837
sg9
V19805678.xml
p17846
sa(dp17847
g3
VSTD-Hollis-2007
p17848
sg5
S'PMC2598511'
p17849
sg7
VCD006936 v. 5.0 Motivational interviewing for smoking cessation.rm5
p17850
sg9
V18048633.xml
p17851
sa(dp17852
g3
VSTD-Soria-2006
p17853
sg5
S'PMC1920717'
p17854
sg7
g17850
sg9
V17007707.xml
p17855
sa(dp17856
g3
VSTD-Glasgow-2000
p17857
sg5
S'PMC1446229'
p17858
sg7
g17850
sg9
V10800431.xml
p17859
sa(dp17860
g3
VSTD-Nimmo-1979
p17861
sg5
S'PMC1597257'
p17862
sg7
VCD006332 v. 8.0 Mu-opioid antagonists for opioid-induced bowel dysfunction.rm5
p17863
sg9
V519357.xml
p17864
sa(dp17865
g3
VSTD-Wolff-2004
p17866
sg5
S'PMC1356474'
p17867
sg7
g17863
sg9
V15383800.xml
p17868
sa(dp17869
g3
VSTD-Collins-2008a
p17870
sg5
S'PMC2572211'
p17871
sg7
VCD008402 v. 2.0 Foot orthoses for patellofemoral pain in adults.rm5
p17872
sg9
V18952682.xml
p17873
sa(dp17874
g3
VSTD-Ballard-2007
p17875
sg5
S'PMC2556913'
p17876
sg7
VCD003531 v. 6.0 Pressure modification for improving usage of continuous positive airway pressure machines in adults .rm5
p17877
sg9
V18198804.xml
p17878
sa(dp17879
g3
VSTD-West-2006
p17880
sg5
S'PMC2080742'
p17881
sg7
g17877
sg9
V16254055.xml
p17882
sa(dp17883
g3
VSTD-Yeka-2007-UGA
p17884
sg5
S'PMC2405936'
p17885
sg7
VCD007483 v. 3.0 Artemisinin-based combination therapy for treating uncomplicated malaria.rm5
p17886
sg9
V18545692.xml
p17887
sa(dp17888
g3
VSTD-Van-den-Broek-2004-ZAR
p17889
sg5
S'PMC1697822'
p17890
sg7
g17886
sg9
V17125496.xml
p17891
sa(dp17892
g3
VSTD-Hasugian-2005-IDN
p17893
sg5
S'PMC2532501'
p17894
sg7
g17886
sg9
V17366451.xml
p17895
sa(dp17896
g3
VSTD-Yeka-2004-UGA
p17897
sg5
S'PMC1181876'
p17898
sg7
g17886
sg9
V16033307.xml
p17899
sa(dp17900
g3
VSTD-Faye-2003-SEN
p17901
sg5
S'PMC1919387'
p17902
sg7
g17886
sg9
V17570848.xml
p17903
sa(dp17904
g3
VSTD-Grande-2005-PER
p17905
sg5
S'PMC2040506'
p17906
sg7
g17886
sg9
V17971864.xml
p17907
sa(dp17908
g3
VSTD-Mukhtar-2005-SDN
p17909
sg5
S'PMC1940006'
p17910
sg7
g17886
sg9
V17631681.xml
p17911
sa(dp17912
g3
VSTD-Kobbe-2007-GHA
p17913
sg5
S'PMC2625364'
p17914
sg7
g17886
sg9
V19099594.xml
p17915
sa(dp17916
g3
VSTD-Kamya-2006-UGA
p17917
sg5
S'PMC1876597'
p17918
sg7
g17886
sg9
V17525792.xml
p17919
sa(dp17920
g3
VSTD-Mens-2007-KEN
p17921
sg5
S'PMC2600646'
p17922
sg7
g17886
sg9
V19017387.xml
p17923
sa(dp17924
g3
VSTD-Ratcliff-2005-IDN
p17925
sg5
S'PMC2532500'
p17926
sg7
g17886
sg9
V17336652.xml
p17927
sa(dp17928
g3
VSTD-Bonnet-2004-GIN
p17929
sg5
S'PMC1868032'
p17930
sg7
g17886
sg9
V17477865.xml
p17931
sa(dp17932
g3
VSTD-Bukirwa-2005-UGA
p17933
sg5
S'PMC1488893'
p17934
sg7
g17886
sg9
V16871329.xml
p17935
sa(dp17936
g3
VSTD-Hutagalung-2002-THA
p17937
sg5
S'PMC1261533'
p17938
sg7
g17886
sg9
V16179089.xml
p17939
sa(dp17940
g3
VSTD-Menard-2006-MDG
p17941
sg5
S'PMC1887535'
p17942
sg7
g17886
sg9
V17519010.xml
p17943
sa(dp17944
g3
VSTD-Owusu_x002d_Agyei-2006-GHA
p17945
sg5
S'PMC2430614'
p17946
sg7
g17886
sg9
V18575626.xml
p17947
sa(dp17948
g3
VSTD-Kayentao-2006-MLI
p17949
sg5
S'PMC2631542'
p17950
sg7
g17886
sg9
V19128455.xml
p17951
sa(dp17952
g3
VSTD-Patte-2007
p17953
sg5
S'PMC1852229'
p17954
sg7
VCD005198 v. 8.7 Therapeutic interventions for Burkitt lymphoma in children.rm5
p17955
sg9
V17132719.xml
p17956
sa(dp17957
g3
VSTD-Magrath-1976
p17958
sg5
S'PMC1639074'
p17959
sg7
g17955
sg9
V766905.xml
p17960
sa(dp17961
g3
VSTD-Candy-1995
p17962
sg5
S'PMC1382873'
p17963
sg7
VCD000067 v. 7.0 Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.rm5
p17964
sg9
V8549944.xml
p17965
sa(dp17966
g3
VSTD-Sangdee-2002-_x002a_
p17967
sg5
S'PMC102323'
p17968
sg7
VCD001977 v. 8.0 Acupuncture for peripheral joint osteoarthritis.rm5
p17969
sg9
V11914160.xml
p17970
sa(dp17971
g3
VSTD-Vas-2004
p17972
sg5
S'PMC529365'
p17973
sg7
g17969
sg9
V15494348.xml
p17974
sa(dp17975
g3
VSTD-Foster-2007
p17976
sg5
S'PMC1962890'
p17977
sg7
g17969
sg9
V17699546.xml
p17978
sa(dp17979
g3
VSTD-Sangdee-2002-_x002a__x002a_
p17980
sg5
S'PMC102323'
p17981
sg7
g17969
sg9
V11914160.xml
p17982
sa(dp17983
g3
VSTD-Silverberg-1976
p17984
sg5
S'PMC1878979'
p17985
sg7
VCD004293 v. 6.0 Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.rm5
p17986
sg9
V793706.xml
p17987
sa(dp17988
g3
VSTD-Schapel-1993
p17989
sg5
S'PMC1014998'
p17990
sg7
VCD001909 v. 12.0 Lamotrigine add-on for drug-resistant partial epilepsy.rm5
p17991
sg9
V8505632.xml
p17992
sa(dp17993
g3
VSTD-Albers-2005
p17994
sg5
S'PMC1357063'
p17995
sg7
VCD005947 v. 5.0 Glutamine supplementation for young infants with severe gastrointestinal disease.rm5
p17996
sg9
V15798461.xml
p17997
sa(dp17998
g3
VSTD-SST-2004-Group-N
p17999
sg5
S'PMC1256024'
p18000
sg7
VCD006931 v. 3.0 Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration.rm5
p18001
sg9
V15522362.xml
p18002
sa(dp18003
g3
VSTD-SST-2004-Group-B
p18004
sg5
S'PMC1256022'
p18005
sg7
g18001
sg9
V15522364.xml
p18006
sa(dp18007
g3
VSTD-Bates-1978
p18008
sg5
S'PMC1608620'
p18009
sg7
VCD004192 v. 8.0 Dietary interventions for multiple sclerosis.rm5
p18010
sg9
V363236.xml
p18011
sa(dp18012
g3
VSTD-Bates-1989
p18013
sg5
S'PMC1032650'
p18014
sg7
g18010
sg9
V2540285.xml
p18015
sa(dp18016
g3
VSTD-Millar-1973
p18017
sg5
S'PMC1588925'
p18018
sg7
g18010
sg9
V4571680.xml
p18019
sa(dp18020
g3
VSTD-Shen-2004
p18021
sg5
S'PMC397380'
p18022
sg7
VCD009594 v. 3.0 The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission.rm5
p18023
sg9
V15044693.xml
p18024
sa(dp18025
g3
VSTD-OPUS_x002d_Scandinavia
p18026
sg5
S'PMC1215551'
p18027
sg7
VCD004718 v. 7.0 Early intervention for psychosis.rm5
p18028
sg9
V16141449.xml
p18029
sa(dp18030
g3
VSTD-Alam-1993
p18031
sg5
S'PMC489825'
p18032
sg7
VCD006921 v. 4.0 Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.rm5
p18033
sg9
V8229035.xml
p18034
sa(dp18035
g3
VSTD-Dyer-2008
p18036
sg5
S'PMC2596972'
p18037
sg7
VCD007967 v. 3.0 Acetylcholinesterase inhibitors for schizophrenia.rm5
p18038
sg9
V18325740.xml
p18039
sa(dp18040
g3
VSTD-Smith-1978
p18041
sg5
S'PMC1412084'
p18042
sg7
VCD000301 v. 7.0 Corticosteroids for maintenance of remission in Crohn's disease.rm5
p18043
sg9
V355071.xml
p18044
sa(dp18045
g3
VSTD-Durbin-1976
p18046
sg5
S'PMC1545933'
p18047
sg7
VCD002271 v. 5.0 Continuous distending pressure for respiratory distress in preterm infants.rm5
p18048
sg9
V782375.xml
p18049
sa(dp18050
g3
VSTD-Assadi-2003
p18051
sg5
S'PMC293465'
p18052
sg7
VCD007775 v. 2.0 Pharmacological therapies for maintenance treatments of opium dependence.rm5
p18053
sg9
V14624703.xml
p18054
sa(dp18055
g3
VSTD-Jorge-2010
p18056
sg5
S'PMC3718472'
p18057
sg7
VCD008391 v. 2.0 Cognitive rehabilitation for executive dysfunction in adults with stroke or other adult non-progress.rm5
p18058
sg9
V20124118.xml
p18059
sa(dp18060
g3
VSTD-Check-1998
p18061
sg5
S'PMC3454856'
p18062
sg7
VCD004832 v. 7.2 Aspirin for in vitro fertilisation.rm5
p18063
sg9
V9866064.xml
p18064
sa(dp18065
g3
VSTD-Urman-2000
p18066
sg5
S'PMC3455451'
p18067
sg7
g18063
sg9
V11209540.xml
p18068
sa(dp18069
g3
VSTD-Duvan-2006
p18070
sg5
S'PMC3455434'
p18071
sg7
g18063
sg9
V16518579.xml
p18072
sa(dp18073
g3
VSTD-Jenkins-1997
p18074
sg5
S'PMC1891518'
p18075
sg7
VCD002233 v. 5.2 Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patien.rm5
p18076
sg9
V9391254.xml
p18077
sa(dp18078
g3
VSTD-Moylan-1988
p18079
sg5
S'PMC1493556'
p18080
sg7
VCD009228 v. 2.4 Helicopter emergency medical services for adults with major trauma.rm5
p18081
sg9
V3389935.xml
p18082
sa(dp18083
g3
VSTD-Mitchell-2007
p18084
sg5
S'PMC2384270'
p18085
sg7
g18081
sg9
V17550717.xml
p18086
sa(dp18087
g3
VSTD-Newgard-2010
p18088
sg5
S'PMC3008652'
p18089
sg7
g18081
sg9
V19783323.xml
p18090
sa(dp18091
g3
VSTD-Nicholl-1995
p18092
sg5
S'PMC2550277'
p18093
sg7
g18081
sg9
V7627033.xml
p18094
sa(dp18095
g3
VSTD-Palumbo-2010
p18096
sg5
S'PMC3021781'
p18097
sg7
VCD004772 v. 5.0 Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.rm5
p18098
sg9
V20942667.xml
p18099
sa(dp18100
g3
VSTD-Violari-2008
p18101
sg5
S'PMC2950021'
p18102
sg7
g18098
sg9
V19020325.xml
p18103
sa(dp18104
g3
VSTD-Cluett-2004
p18105
sg5
S'PMC338094'
p18106
sg7
VCD006794 v. 5.0 Early amniotomy and early oxytocin for prevention of or therapy for delay in first stage spontaneo.rm5
p18107
sg9
V14744822.xml
p18108
sa(dp18109
g3
VSTD-Nachum-2010
p18110
sg5
S'PMC2988803'
p18111
sg7
g18107
sg9
V21054896.xml
p18112
sa(dp18113
g3
VSTD-Li-1998a
p18114
sg5
S'PMC2305576'
p18115
sg7
VCD004614 v. 6.0 Unit-dose packaged drugs for treating malaria.rm5
p18116
sg9
V9763719.xml
p18117
sa(dp18118
g3
VSTD-Yeboah_x002d_Antwi-2001
p18119
sg5
S'PMC2566421'
p18120
sg7
g18116
sg9
V11417034.xml
p18121
sa(dp18122
g3
VSTD-Li-1998b
p18123
sg5
S'PMC2305576'
p18124
sg7
g18116
sg9
V9763719.xml
p18125
sa(dp18126
g3
VSTD-Glasgow-1984
p18127
sg5
S'PMC1443311'
p18128
sg7
VCD001451 v. 8.2 Routine ultrasound in late pregnancy (after 24 weeks' gestation).rm5
p18129
sg9
V6437476.xml
p18130
sa(dp18131
g3
VSTD-Peterborough-1987
p18132
sg5
S'PMC1246821'
p18133
sg7
g18129
sg9
V3113566.xml
p18134
sa(dp18135
g3
VSTD-ES-Barcelona
p18136
sg5
S'PMC1963295'
p18137
sg7
VCD004607 v. 10.0 Speed cameras for the prevention of road traffic injuries and deaths.rm5
p18138
sg9
V17666698.xml
p18139
sa(dp18140
g3
VSTD-GB-South-Wales
p18141
sg5
S'PMC1731028'
p18142
sg7
g18138
sg9
V14693888.xml
p18143
sa(dp18144
g3
VSTD-Arun-2008
p18145
sg5
S'PMC2772000'
p18146
sg7
VCD010398 v. 1.2 The effect of pharmacist-provided non-dispensing services on patient outcomes health service utilis.rm5
p18147
sg9
V19902034.xml
p18148
sa(dp18149
g3
VSTD-Zwarenstein-2007
p18150
sg5
S'PMC2200659'
p18151
sg7
g18147
sg9
V17892588.xml
p18152
sa(dp18153
g3
VSTD-Haworth-2001
p18154
sg5
S'PMC1746027'
p18155
sg7
VCD002010 v. 12.0 Bisphosphonates for osteoporosis in people with cystic fibrosis.rm5
p18156
sg9
V11254825.xml
p18157
sa(dp18158
g3
VSTD-Coskun-1998
p18159
sg5
S'PMC3454860'
p18160
sg7
VCD009391 v. 2.0 Brief co-incubation of sperm and oocytes for in vitro fertilization techniques.rm5
p18161
sg9
V9866069.xml
p18162
sa(dp18163
g3
VSTD-Lin-2000
p18164
sg5
S'PMC3455400'
p18165
sg7
g18161
sg9
V11042832.xml
p18166
sa(dp18167
g3
VSTD-Boone-2001
p18168
sg5
S'PMC3455812'
p18169
sg7
g18161
sg9
V11292990.xml
p18170
sa(dp18171
g3
VSTD-Sharieff-2006a
p18172
sg5
S'PMC2082848'
p18173
sg7
VCD008959 v. 3.5 Home fortification of foods with multiple micronutrient powders for health and nutrition in children.rm5
p18174
sg9
V16556612.xml
p18175
sa(dp18176
g3
VSTD-Straker-1966
p18177
sg5
S'PMC1935503'
p18178
sg7
VCD004186 v. 10.0 Amitriptyline for depression.rm5
p18179
sg9
V5328359.xml
p18180
sa(dp18181
g3
VSTD-Edwards-1996
p18182
sg5
S'PMC2042690'
p18183
sg7
g18179
sg9
V8904622.xml
p18184
sa(dp18185
g3
VSTD-Feighner-1983
p18186
sg5
S'PMC1427892'
p18187
sg7
g18179
sg9
V6337610.xml
p18188
sa(dp18189
g3
VSTD-Upward-1988
p18190
sg5
S'PMC1386560'
p18191
sg7
g18179
sg9
V3263876.xml
p18192
sa(dp18193
g3
VSTD-Grof-1977
p18194
sg5
S'PMC1429109'
p18195
sg7
g18179
sg9
V334227.xml
p18196
sa(dp18197
g3
VSTD-Quadri-1980
p18198
sg5
S'PMC3013310'
p18199
sg7
g18179
sg9
V22058460.xml
p18200
sa(dp18201
g3
VSTD-Avril-1997
p18202
sg5
S'PMC2223779'
p18203
sg7
VCD003412 v. 8.0 Interventions for basal cell carcinoma of the skin.rm5
p18204
sg9
V9218740.xml
p18205
sa(dp18206
g3
VSTD-Jolley-1990
p18207
sg5
S'PMC1663999'
p18208
sg7
VCD000307 v. 8.0 Depot fluphenazine decanoate and enanthate for schizophrenia.rm5
p18209
sg9
V2282421.xml
p18210
sa(dp18211
g3
VSTD-Marson-2007
p18212
sg5
S'PMC2080688'
p18213
sg7
VCD006453 v. 4.0 Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.rm5
p18214
sg9
V17382827.xml
p18215
sa(dp18216
g3
VSTD-Nafisi-2006
p18217
sg5
S'PMC1764008'
p18218
sg7
VCD000331 v. 10.2 Epidural versus non-epidural or no analgesia in labour.rm5
p18219
sg9
V17176461.xml
p18220
sa(dp18221
g3
VSTD-Benenson-1968a
p18222
sg5
S'PMC2554479'
p18223
sg7
VCD000974 v. 14.1 Vaccines for preventing cholera killed whole cell or other subunit vaccines (injected).rm5
p18224
sg9
V5302328.xml
p18225
sa(dp18226
g3
VSTD-Saroso-1978i
p18227
sg5
S'PMC2395651'
p18228
sg7
g18224
sg9
V365388.xml
p18229
sa(dp18230
g3
VSTD-PCC-1968
p18231
sg5
S'PMC2554519'
p18232
sg7
g18224
sg9
V5303665.xml
p18233
sa(dp18234
g3
VSTD-PCC-1973b
p18235
sg5
S'PMC2480948'
p18236
sg7
g18224
sg9
V4603994.xml
p18237
sa(dp18238
g3
VSTD-PCC-1973a_x002d_i
p18239
sg5
S'PMC2481072'
p18240
sg7
g18224
sg9
V4596491.xml
p18241
sa(dp18242
g3
VSTD-das-Gupta-1965b_x002d_i
p18243
sg5
S'PMC2554277'
p18244
sg7
g18224
sg9
V5301381.xml
p18245
sa(dp18246
g3
VSTD-Pal-1980
p18247
sg5
S'PMC2395994'
p18248
sg7
g18224
sg9
V7028299.xml
p18249
sa(dp18250
g3
VSTD-das-Gupta-1965a
p18251
sg5
S'PMC2554277'
p18252
sg7
g18224
sg9
V5301381.xml
p18253
sa(dp18254
g3
VSTD-Benenson-1968b_x002d_i
p18255
sg5
S'PMC2554494'
p18256
sg7
g18224
sg9
V5302329.xml
p18257
sa(dp18258
g3
VSTD-Burgasov-1976
p18259
sg5
S'PMC2366434'
p18260
sg7
g18224
sg9
V798636.xml
p18261
sa(dp18262
g3
VSTD-McCormack-1969
p18263
sg5
S'PMC2554602'
p18264
sg7
g18224
sg9
V5306540.xml
p18265
sa(dp18266
g3
VSTD-Azurin-1965i
p18267
sg5
S'PMC2555245'
p18268
sg7
g18224
sg9
V5294176.xml
p18269
sa(dp18270
g3
VSTD-Herfarth-2006
p18271
sg5
S'PMC1856424'
p18272
sg7
VCD006873 v. 3.0 Interventions for prevention of post-operative recurrence of Crohn's disease.rm5
p18273
sg9
V16966711.xml
p18274
sa(dp18275
g3
VSTD-Marteau-2006
p18276
sg5
S'PMC1856210'
p18277
sg7
g18273
sg9
V16377775.xml
p18278
sa(dp18279
g3
VSTD-Colombel-2001
p18280
sg5
S'PMC1728363'
p18281
sg7
g18273
sg9
V11413109.xml
p18282
sa(dp18283
g3
VSTD-Prantera-2002
p18284
sg5
S'PMC1773351'
p18285
sg7
g18273
sg9
V12171964.xml
p18286
sa(dp18287
g3
VSTD-Pollock-1989
p18288
sg5
S'PMC2498915'
p18289
sg7
VCD001181 v. 5.0 Antimicrobial prophylaxis for colorectal surgery.rm5
p18290
sg9
V2523210.xml
p18291
sa(dp18292
g3
VSTD-Sauven-1986
p18293
sg5
S'PMC1290230'
p18294
sg7
g18290
sg9
V2939239.xml
p18295
sa(dp18296
g3
VSTD-Kaiser-1983
p18297
sg5
S'PMC1353198'
p18298
sg7
g18290
sg9
V6354113.xml
p18299
sa(dp18300
g3
VSTD-Schoetz-1990
p18301
sg5
S'PMC1358059'
p18302
sg7
g18290
sg9
V2100983.xml
p18303
sa(dp18304
g3
VSTD-Bates-1992
p18305
sg5
S'PMC2399526'
p18306
sg7
g18290
sg9
V1461853.xml
p18307
sa(dp18308
g3
VSTD-Becker-1991
p18309
sg5
S'PMC1358335'
p18310
sg7
g18290
sg9
V1847796.xml
p18311
sa(dp18312
g3
VSTD-Lewis-2002
p18313
sg5
S'PMC3686946'
p18314
sg7
g18290
sg9
V12067168.xml
p18315
sa(dp18316
g3
VSTD-Bergman-1987
p18317
sg5
S'PMC1492867'
p18318
sg7
g18290
sg9
V3541803.xml
p18319
sa(dp18320
g3
VSTD-Hoffmann-1981
p18321
sg5
S'PMC1345075'
p18322
sg7
g18290
sg9
V7011223.xml
p18323
sa(dp18324
g3
VSTD-Rowe_x002d_Jones-1990
p18325
sg5
S'PMC1661869'
p18326
sg7
g18290
sg9
V2105115.xml
p18327
sa(dp18328
g3
VSTD-Robinson-1988
p18329
sg5
S'PMC1779094'
p18330
sg7
VCD003424 v. 10.0 Drug therapies for reducing gastric acidity in people with cystic fibrosis.rm5
p18331
sg9
V3140739.xml
p18332
sa(dp18333
g3
VSTD-Durie-1980
p18334
sg5
S'PMC1419526'
p18335
sg7
g18331
sg9
V7429342.xml
p18336
sa(dp18337
g3
VSTD-Siani-1987
p18338
sg5
S'PMC1246609'
p18339
sg7
VCD004641 v. 10.0 Potassium supplementation for the management of primary hypertension in adults.rm5
p18340
sg9
V3300841.xml
p18341
sa(dp18342
g3
VSTD-Zehnder-2010
p18343
sg5
S'PMC2841102'
p18344
sg7
VCD003380 v. 12.1 Psychological and educational interventions for preventing depression in children and adolescents.rm5
p18345
sg9
V20181120.xml
p18346
sa(dp18347
g3
VSTD-Stice-c2008
p18348
sg5
S'PMC2553682'
p18349
sg7
g18345
sg9
V18665688.xml
p18350
sa(dp18351
g3
VSTD-Stice-b2008
p18352
sg5
S'PMC2553682'
p18353
sg7
g18345
sg9
V18665688.xml
p18354
sa(dp18355
g3
VSTD-Stice-b2006
p18356
sg5
S'PMC2330269'
p18357
sg7
g18345
sg9
V17007812.xml
p18358
sa(dp18359
g3
VSTD-Stice-a2008
p18360
sg5
S'PMC2553682'
p18361
sg7
g18345
sg9
V18665688.xml
p18362
sa(dp18363
g3
VSTD-Barnet-2007
p18364
sg5
S'PMC1886481'
p18365
sg7
g18345
sg9
V17548850.xml
p18366
sa(dp18367
g3
VSTD-Bond-2004
p18368
sg5
S'PMC1732649'
p18369
sg7
g18345
sg9
V15547059.xml
p18370
sa(dp18371
g3
VSTD-Compas-2009
p18372
sg5
S'PMC2821830'
p18373
sg7
g18345
sg9
V19968378.xml
p18374
sa(dp18375
g3
VSTD-Stice-c2006
p18376
sg5
S'PMC2330269'
p18377
sg7
g18345
sg9
V17007812.xml
p18378
sa(dp18379
g3
VSTD-Stice-d2006
p18380
sg5
S'PMC2330269'
p18381
sg7
g18345
sg9
V17007812.xml
p18382
sa(dp18383
g3
VSTD-Stice-e2006
p18384
sg5
S'PMC2330269'
p18385
sg7
g18345
sg9
V17007812.xml
p18386
sa(dp18387
g3
VSTD-Stice-a2006
p18388
sg5
S'PMC2330269'
p18389
sg7
g18345
sg9
V17007812.xml
p18390
sa(dp18391
g3
VSTD-Garber-2009
p18392
sg5
S'PMC2737625'
p18393
sg7
g18345
sg9
V19491183.xml
p18394
sa(dp18395
g3
VSTD-Palermo-2009
p18396
sg5
S'PMC2760656'
p18397
sg7
g18345
sg9
V19695776.xml
p18398
sa(dp18399
g3
VSTD-TREC_x002d_Rio_x002d_II
p18400
sg5
S'PMC2043463'
p18401
sg7
VCD005146 v. 8.0 Haloperidol plus promethazine for psychosis-induced aggression.rm5
p18402
sg9
V17954515.xml
p18403
sa(dp18404
g3
VSTD-TREC_x002d_Rio_x002d_I
p18405
sg5
S'PMC200800'
p18406
sg7
g18402
sg9
V14512476.xml
p18407
sa(dp18408
g3
VSTD-TREC_x002d_Vellore_x002d_II
p18409
sg5
S'PMC2043469'
p18410
sg7
g18402
sg9
V17954514.xml
p18411
sa(dp18412
g3
VSTD-Wolfson-2007
p18413
sg5
S'PMC2752331'
p18414
sg7
VCD006812 v. 4.2 Adjuvant radiotherapy andor chemotherapy after surgery for uterine carcinosarcoma.rm5
p18415
sg9
V17822748.xml
p18416
sa(dp18417
g3
VSTD-Newell-1966
p18418
sg5
S'PMC2476295'
p18419
sg7
VCD002959 v. 9.0 Vaccines for women to prevent neonatal tetanus.rm5
p18420
sg9
V5338377.xml
p18421
sa(dp18422
g3
VSTD-Black-1980
p18423
sg5
S'PMC2396004'
p18424
sg7
g18420
sg9
V6971190.xml
p18425
sa(dp18426
g3
VSTD-UK-1989
p18427
sg5
S'PMC1837690'
p18428
sg7
VCD000230 v. 7.7 Zinc supplementation for improving pregnancy and infant outcome.rm5
p18429
sg9
V2510845.xml
p18430
sa(dp18431
g3
VSTD-Nepal-2003
p18432
sg5
S'PMC151518'
p18433
sg7
g18429
sg9
V12637400.xml
p18434
sa(dp18435
g3
VSTD-Pakistan-2005
p18436
sg5
S'PMC1721853'
p18437
sg7
g18429
sg9
V15724045.xml
p18438
sa(dp18439
g3
VSTD-Ghana-2009
p18440
sg5
S'PMC2928084'
p18441
sg7
g18429
sg9
V19902797.xml
p18442
sa(dp18443
g3
VSTD-Bogden-1997
p18444
sg5
S'PMC1497081'
p18445
sg7
VCD000336 v. 7.0 Effect of outpatient pharmacists'non-dispensing roleson patient outcomes and prescribing patterns.rm5
p18446
sg9
V9100140.xml
p18447
sa(dp18448
g3
VSTD-Bond-2000
p18449
sg5
S'PMC1313673'
p18450
sg7
g18446
sg9
V10897509.xml
p18451
sa(dp18452
g3
VSTD-Barbanel-2003
p18453
sg5
S'PMC1746491'
p18454
sg7
g18446
sg9
V14514935.xml
p18455
sa(dp18456
g3
VSTD-Ilett-2000
p18457
sg5
S'PMC2014897'
p18458
sg7
g18446
sg9
V10671912.xml
p18459
sa(dp18460
g3
VSTD-Sadik-2005
p18461
sg5
S'PMC1884928'
p18462
sg7
g18446
sg9
V16042672.xml
p18463
sa(dp18464
g3
VSTD-Freemantle-2002
p18465
sg5
S'PMC1314269'
p18466
sg7
g18446
sg9
V11942445.xml
p18467
sa(dp18468
g3
VSTD-Nathanson-2005
p18469
sg5
S'PMC1357723'
p18470
sg7
VCD003327 v. 5.0 Surgical versus endoscopic treatment of bile duct stones.rm5
p18471
sg9
V16041208.xml
p18472
sa(dp18473
g3
VSTD-Kapoor-1996
p18474
sg5
S'PMC2443081'
p18475
sg7
g18471
sg9
V8725454.xml
p18476
sa(dp18477
g3
VSTD-Neoptolemos-1987
p18478
sg5
S'PMC1245519'
p18479
sg7
g18471
sg9
V3103731.xml
p18480
sa(dp18481
g3
VSTD-Stain-1991
p18482
sg5
S'PMC1358591'
p18483
sg7
g18471
sg9
V2039294.xml
p18484
sa(dp18485
g3
VSTD-Martins--2004
p18486
sg5
S'PMC3455614'
p18487
sg7
VCD006107 v. 4.0 Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women.rm5
p18488
sg9
V15704516.xml
p18489
sa(dp18490
g3
VSTD-Li-2005
p18491
sg5
S'PMC3455385'
p18492
sg7
g18488
sg9
V15807215.xml
p18493
sa(dp18494
g3
VSTD-Horemans-2003
p18495
sg5
S'PMC1757426'
p18496
sg7
VCD007818 v. 4.3 Treatment for postpolio syndrome.rm5
p18497
sg9
V14638885.xml
p18498
sa(dp18499
g3
VSTD-FEIG-2008
p18500
sg5
S'PMC2684336'
p18501
sg7
VCD008652 v. 2.0 Pharmacotherapy for hyperuricemia in hypertensive patients.rm5
p18502
sg9
V18728266.xml
p18503
sa(dp18504
g3
VSTD-Wynn-2007
p18505
sg5
S'PMC2716219'
p18506
sg7
VCD006626 v. 4.0 Risperidone versus other atypical antipsychotics for schizophrenia.rm5
p18507
sg9
V17662577.xml
p18508
sa(dp18509
g3
VSTD-Devanand-ADAD--2012
p18510
sg5
S'PMC3490406'
p18511
sg7
VCD007726 v. 3.0 Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symp.rm5
p18512
sg9
V23075176.xml
p18513
sa(dp18514
g3
VSTD-Devanand-2011
p18515
sg5
S'PMC3685500'
p18516
sg7
g18512
sg9
V21845596.xml
p18517
sa(dp18518
g3
VSTD-Davis-2008
p18519
sg5
S'PMC2408888'
p18520
sg7
VCD008081 v. 2.0 Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinop.rm5
p18521
sg9
V18316700.xml
p18522
sa(dp18523
g3
VSTD-Sadda-2006
p18524
sg5
S'PMC1779509'
p18525
sg7
g18521
sg9
V16647123.xml
p18526
sa(dp18527
g3
VSTD-Hee-1998
p18528
sg5
S'PMC2923575'
p18529
sg7
g18521
sg9
V9479300.xml
p18530
sa(dp18531
g3
VSTD-Meade-1990
p18532
sg5
S'PMC1663160'
p18533
sg7
VCD005427 v. 6.0 Combined chiropractic interventions for low-back pain.rm5
p18534
sg9
V2143092.xml
p18535
sa(dp18536
g3
VSTD-Gudavalli-2006
p18537
sg5
S'PMC3233943'
p18538
sg7
g18534
sg9
V16341712.xml
p18539
sa(dp18540
g3
VSTD-Reacher-1990
p18541
sg5
S'PMC1042003'
p18542
sg7
VCD004008 v. 4.0 Interventions for trachoma trichiasis.rm5
p18543
sg9
V2178677.xml
p18544
sa(dp18545
g3
VSTD-Burton-2005
p18546
sg5
S'PMC1772881'
p18547
sg7
g18543
sg9
V16170117.xml
p18548
sa(dp18549
g3
VSTD-Nierop-1992
p18550
sg5
S'PMC463749'
p18551
sg7
VCD002985 v. 8.0 Gold as an oral corticosteroid sparing agent in stable asthma.rm5
p18552
sg9
V1609377.xml
p18553
sa(dp18554
g3
VSTD-Ward-1998
p18555
sg5
S'PMC1728578'
p18556
sg7
VCD004194 v. 7.0 Drugs and pacemakers for vasovagal carotid sinus and situational syncope.rm5
p18557
sg9
V9505918.xml
p18558
sa(dp18559
g3
VSTD-McIntosh-1997
p18560
sg5
S'PMC484800'
p18561
sg7
g18557
sg9
V9227301.xml
p18562
sa(dp18563
g3
VSTD-Biffi-1997
p18564
sg5
S'PMC484696'
p18565
sg7
g18557
sg9
V9093048.xml
p18566
sa(dp18567
g3
VSTD-Maclean-1990
p18568
sg5
S'PMC1380116'
p18569
sg7
VCD007185 v. 3.3 Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.rm5
p18570
sg9
V2183868.xml
p18571
sa(dp18572
g3
VSTD-Norris-1986
p18573
sg5
S'PMC1338973'
p18574
sg7
VCD000064 v. 8.0 Corticosteroids for acute ischaemic stroke.rm5
p18575
sg9
V3080050.xml
p18576
sa(dp18577
g3
VSTD-Dowling-2007
p18578
sg5
S'PMC2387134'
p18579
sg7
VCD003946 v. 10.0 Light therapy for managing cognitive sleep functional behavioural or psychiatric disturbances in.rm5
p18580
sg9
V17596638.xml
p18581
sa(dp18582
g3
VSTD-Dowling-2005b
p18583
sg5
S'PMC2387133'
p18584
sg7
g18580
sg9
V16035127.xml
p18585
sa(dp18586
g3
VSTD-Dowling-2008
p18587
sg5
S'PMC2642966'
p18588
sg7
g18580
sg9
V18070004.xml
p18589
sa(dp18590
g3
VSTD-Rai-1997
p18591
sg5
S'PMC2125731'
p18592
sg7
VCD002859 v. 7.0 Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.rm5
p18593
sg9
V9022487.xml
p18594
sa(dp18595
g3
VSTD-Netley-1984
p18596
sg5
S'PMC1483635'
p18597
sg7
VCD002911 v. 6.0 Alarm interventions for nocturnal enuresis in children.rm5
p18598
sg9
V6478342.xml
p18599
sa(dp18600
g3
VSTD-McKendry-1975
p18601
sg5
S'PMC1956570'
p18602
sg7
g18598
sg9
V1192312.xml
p18603
sa(dp18604
g3
VSTD-Wille-1986
p18605
sg5
S'PMC1777552'
p18606
sg7
g18598
sg9
V3513716.xml
p18607
sa(dp18608
g3
VSTD-Alho-2007
p18609
sg5
S'PMC1865439'
p18610
sg7
VCD001802 v. 6.0 Tonsillectomy or adeno-tonsillectomy versus non-surgical treatment for chronicrecurrent acute tonsi.rm5
p18611
sg9
V17347187.xml
p18612
sa(dp18613
g3
VSTD-van-Staaij-2004
p18614
sg5
S'PMC517640'
p18615
sg7
g18611
sg9
V15361407.xml
p18616
sa(dp18617
g3
VSTD-Shyu-2006
p18618
sg5
S'PMC1405861'
p18619
sg7
VCD005207 v. 9.0 Colony stimulating factors (including erythropoietin granulocyte colony stimulating factor and anal.rm5
p18620
sg9
V16517764.xml
p18621
sa(dp18622
g3
VSTD-Yip-2011
p18623
sg5
S'PMC3221969'
p18624
sg7
g18620
sg9
V21269484.xml
p18625
sa(dp18626
g3
VSTD-Ehrenreich-2002
p18627
sg5
S'PMC2040012'
p18628
sg7
g18620
sg9
V12435860.xml
p18629
sa(dp18630
g3
VSTD-Matsumoto-2002
p18631
sg5
S'PMC2375187'
p18632
sg7
VCD007814 v. 2.0 Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer.rm5
p18633
sg9
V11870500.xml
p18634
sa(dp18635
g3
VSTD-Dodson_x005f_P-1989
p18636
sg5
S'PMC1835532'
p18637
sg7
VCD006763 v. 3.0 Altered dietary salt intake for preventing and treating diabetic kidney disease.rm5
p18638
sg9
V2493869.xml
p18639
sa(dp18640
g3
VSTD-Dodson_x005f_X-1989
p18641
sg5
S'PMC1835532'
p18642
sg7
g18638
sg9
V2493869.xml
p18643
sa(dp18644
g3
VSTD-Gilles-2004
p18645
sg5
S'PMC2866634'
p18646
sg7
VCD002253 v. 7.0 Medical treatment for early fetal death (less than 24 weeks).rm5
p18647
sg9
V14981379.xml
p18648
sa(dp18649
g3
VSTD-Neiman-1985
p18650
sg5
S'PMC1028364'
p18651
sg7
VCD003057 v. 7.0 Hyperbaric oxygen therapy for multiple sclerosis.rm5
p18652
sg9
V3891920.xml
p18653
sa(dp18654
g3
VSTD-Wiles-1986
p18655
sg5
S'PMC1339347'
p18656
sg7
g18652
sg9
V3080173.xml
p18657
sa(dp18658
g3
VSTD-Barnes-1987
p18659
sg5
S'PMC1032548'
p18660
sg7
g18652
sg9
V3320274.xml
p18661
sa(dp18662
g3
VSTD-Cohen-2004
p18663
sg5
S'PMC1201422'
p18664
sg7
VCD001930 v. 8.4 Cognitive-behavioural interventions for children who have been sexually abused.rm5
p18665
sg9
V15187799.xml
p18666
sa(dp18667
g3
VSTD-LOTUS-Trial-2008
p18668
sg5
S'PMC2565581'
p18669
sg7
VCD003243 v. 6.0 Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.rm5
p18670
sg9
V18469091.xml
p18671
sa(dp18672
g3
VSTD-Keuter-1990
p18673
sg5
S'PMC1663772'
p18674
sg7
VCD004387 v. 6.0 Chlorproguanil-dapsone for treating uncomplicated malaria.rm5
p18675
sg9
V2207399.xml
p18676
sa(dp18677
g3
VSTD-Amukoye-1997
p18678
sg5
S'PMC164103'
p18679
sg7
g18675
sg9
V9333058.xml
p18680
sa(dp18681
g3
VSTD-Meyer-2003
p18682
sg5
S'PMC139934'
p18683
sg7
VCD001255 v. 14.0 Hip protectors for preventing hip fractures in older people.rm5
p18684
sg9
V12521969.xml
p18685
sa(dp18686
g3
VSTD-Cameron-2003
p18687
sg5
S'PMC1730958'
p18688
sg7
g18684
sg9
V12810740.xml
p18689
sa(dp18690
g3
VSTD-Gerotto-1999
p18691
sg5
S'PMC104248'
p18692
sg7
VCD005445 v. 6.4 Ribavirin plus interferon versus interferon for chronic hepatitis C.rm5
p18693
sg9
V10438811.xml
p18694
sa(dp18695
g3
VSTD-Khakoo-1998
p18696
sg5
S'PMC1873804'
p18697
sg7
g18693
sg9
V9862245.xml
p18698
sa(dp18699
g3
VSTD-Memmos-1981
p18700
sg5
S'PMC1505819'
p18701
sg7
VCD005633 v. 5.2 Vitamin D compounds for people with chronic kidney disease requiring dialysis.rm5
p18702
sg9
V6786673.xml
p18703
sa(dp18704
g3
VSTD-Johnson-1997
p18705
sg5
S'PMC1191122'
p18706
sg7
VCD008057 v. 3.0 Staples versus sutures for closing leg wounds after vein graft harvesting for coronary artery bypass.rm5
p18707
sg9
V9389394.xml
p18708
sa(dp18709
g3
VSTD-Angelini-1984
p18710
sg5
S'PMC459958'
p18711
sg7
g18707
sg9
V6096982.xml
p18712
sa(dp18713
g3
VSTD-Chick-1985
p18714
sg5
S'PMC1418284'
p18715
sg7
VCD005191 v. 8.0 Brief interventions for heavy alcohol users admitted to general hospital wards.rm5
p18716
sg9
V2858246.xml
p18717
sa(dp18718
g3
VSTD-Gentilello-1999
p18719
sg5
S'PMC1420896'
p18720
sg7
g18716
sg9
V10522717.xml
p18721
sa(dp18722
g3
VSTD-Cooke-2011
p18723
sg5
S'PMC3272376'
p18724
sg7
VCD008552 v. 2.0 Interventions for increasing fruit and vegetable consumption in children aged 5 years and under.rm5
p18725
sg9
V21191095.xml
p18726
sa(dp18727
g3
VSTD-Haire_x002d_Joshu-2008
p18728
sg5
S'PMC3607447'
p18729
sg7
g18725
sg9
V18486203.xml
p18730
sa(dp18731
g3
VSTD-Demark_x002d_Wahnefried-2006
p18732
sg5
S'PMC1532928'
p18733
sg7
VCD007730 v. 3.0 Multidimensional rehabilitation programmes for adult cancer survivors.rm5
p18734
sg9
V16849763.xml
p18735
sa(dp18736
g3
VSTD-Bernitz-2011
p18737
sg5
S'PMC3187863'
p18738
sg7
VCD000012 v. 10.0 Alternative versus conventional institutional settings for birth.rm5
p18739
sg9
V21749629.xml
p18740
sa(dp18741
g3
VSTD-Klein-1984
p18742
sg5
S'PMC1440352'
p18743
sg7
g18739
sg9
V6388776.xml
p18744
sa(dp18745
g3
VSTD-Hundley-1994
p18746
sg5
S'PMC2541316'
p18747
sg7
g18739
sg9
V7819846.xml
p18748
sa(dp18749
g3
VSTD-So-1997
p18750
sg5
S'PMC1720603'
p18751
sg7
VCD002055 v. 7.4 Early volume expansion for prevention of morbidity and mortality in very preterm infants.rm5
p18752
sg9
V9059186.xml
p18753
sa(dp18754
g3
VSTD-Beverley-1985
p18755
sg5
S'PMC1777434'
p18756
sg7
g18752
sg9
V3899020.xml
p18757
sa(dp18758
g3
VSTD-Emery-1992
p18759
sg5
S'PMC1590455'
p18760
sg7
g18752
sg9
V1444555.xml
p18761
sa(dp18762
g3
VSTD-Ehsanullah-1988
p18763
sg5
S'PMC1834765'
p18764
sg7
VCD002296 v. 13.0 Prevention of NSAID-induced gastroduodenal ulcers.rm5
p18765
sg9
V3142593.xml
p18766
sa(dp18767
g3
VSTD-Melo-Gomes-1993
p18768
sg5
S'PMC1005220'
p18769
sg7
g18765
sg9
V8311540.xml
p18770
sa(dp18771
g3
VSTD-Campbell-1982
p18772
sg5
S'PMC1308271'
p18773
sg7
VCD003466 v. 4.1 Speech and language therapy to improve the communication skills of children with cerebral palsy.rm5
p18774
sg9
V7118759.xml
p18775
sa(dp18776
g3
VSTD-Hurlbut-1982
p18777
sg5
S'PMC1308268'
p18778
sg7
g18774
sg9
V6181049.xml
p18779
sa(dp18780
g3
VSTD-Johnson-1993
p18781
sg5
S'PMC1677859'
p18782
sg7
VCD008131 v. 4.0 Home-based child development interventions for preschool children from socially disadvantaged famili.rm5
p18783
sg9
V8518642.xml
p18784
sa(dp18785
g3
VSTD-Turner-1987
p18786
sg5
S'PMC1247354'
p18787
sg7
VCD004775 v. 4.0 Mass media interventions for promoting HIV testing.rm5
p18788
sg9
V3117190.xml
p18789
sa(dp18790
g3
VSTD-Simpson-1998
p18791
sg5
S'PMC2665496'
p18792
sg7
g18788
sg9
V9472506.xml
p18793
sa(dp18794
g3
VSTD-Amaro-2001
p18795
sg5
S'PMC1497375'
p18796
sg7
g18788
sg9
V12196620.xml
p18797
sa(dp18798
g3
VSTD-Tran-2004
p18799
sg5
S'PMC1356476'
p18800
sg7
VCD006053 v. 7.0 Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whip.rm5
p18801
sg9
V15492552.xml
p18802
sa(dp18803
g3
VSTD-Perrett-2007
p18804
sg5
S'PMC2423222'
p18805
sg7
VCD007281 v. 2.0 Interventions for cutaneous Bowen's disease.rm5
p18806
sg9
V17223873.xml
p18807
sa(dp18808
g3
VSTD-Taylor-1988
p18809
sg5
S'PMC1041529'
p18810
sg7
VCD002219 v. 13.0 Ivermectin for onchocercal eye disease (river blindness).rm5
p18811
sg9
V3046657.xml
p18812
sa(dp18813
g3
VSTD-Scalambrino-1989
p18814
sg5
S'PMC1852268'
p18815
sg7
VCD001067 v. 9.0 Antibiotic regimens for endometritis after delivery.rm5
p18816
sg9
V12839630.xml
p18817
sa(dp18818
g3
VSTD-Chatwani-1997
p18819
sg5
S'PMC2364549'
p18820
sg7
g18816
sg9
V18476152.xml
p18821
sa(dp18822
g3
VSTD-Chatwani-1995
p18823
sg5
S'PMC2364413'
p18824
sg7
g18816
sg9
V18475417.xml
p18825
sa(dp18826
g3
VSTD-Blanco-1983
p18827
sg5
S'PMC185362'
p18828
sg7
g18816
sg9
V6360038.xml
p18829
sa(dp18830
g3
VSTD-Roy-2003
p18831
sg5
S'PMC1852268'
p18832
sg7
g18816
sg9
V12839630.xml
p18833
sa(dp18834
g3
VSTD-Knodel-1988
p18835
sg5
S'PMC172295'
p18836
sg7
g18816
sg9
V3415207.xml
p18837
sa(dp18838
g3
VSTD-Montgomery-2004
p18839
sg5
S'PMC1719807'
p18840
sg7
VCD002206 v. 9.2 Media-based behavioural treatments for behavioural problems in children.rm5
p18841
sg9
V14736626.xml
p18842
sa(dp18843
g3
VSTD-Forster-1996
p18844
sg5
S'PMC2351368'
p18845
sg7
VCD003689 v. 5.2 Interventions for preventing depression after stroke.rm5
p18846
sg9
V8664717.xml
p18847
sa(dp18848
g3
VSTD-Palomaki-1999
p18849
sg5
S'PMC1736281'
p18850
sg7
g18846
sg9
V10201422.xml
p18851
sa(dp18852
g3
VSTD-Fairbank-2005
p18853
sg5
S'PMC558090'
p18854
sg7
VCD002014 v. 8.0 Behavioural treatment for chronic low-back pain.rm5
p18855
sg9
V15911537.xml
p18856
sa(dp18857
g3
VSTD-van-der-Roer-2008
p18858
sg5
S'PMC2527421'
p18859
sg7
g18855
sg9
V18663487.xml
p18860
sa(dp18861
g3
VSTD-Heller-1995
p18862
sg5
S'PMC1073267'
p18863
sg7
VCD002217 v. 10.0 Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-c.rm5
p18864
sg9
V7823066.xml
p18865
sa(dp18866
g3
VSTD-John-1984
p18867
sg5
S'PMC1441216'
p18868
sg7
VCD003427 v. 12.0 Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.rm5
p18869
sg9
V6426646.xml
p18870
sa(dp18871
g3
VSTD-Fujimoto-2002
p18872
sg5
S'PMC3455835'
p18873
sg7
VCD009154 v. 5.0 Luteal phase support for assisted reproduction cycles.rm5
p18874
sg9
V12503886.xml
p18875
sa(dp18876
g3
VSTD-Hovell-2000
p18877
sg5
S'PMC27449'
p18878
sg7
VCD001746 v. 6.0 Family and carer smoking control programmes for reducing children's exposure to environmental tobacc.rm5
p18879
sg9
V10926589.xml
p18880
sa(dp18881
g3
VSTD-Conway-2004
p18882
sg5
S'PMC1747828'
p18883
sg7
g18879
sg9
V14985605.xml
p18884
sa(dp18885
g3
VSTD-Irvine-1999
p18886
sg5
S'PMC27890'
p18887
sg7
g18879
sg9
V10346773.xml
p18888
sa(dp18889
g3
VSTD-Krieger-2005
p18890
sg5
S'PMC1449237'
p18891
sg7
g18879
sg9
V15798126.xml
p18892
sa(dp18893
g3
VSTD-Wiggins-2005
p18894
sg5
S'PMC1733057'
p18895
sg7
g18879
sg9
V15767382.xml
p18896
sa(dp18897
g3
VSTD-Muir-2012
p18898
sg5
S'PMC3703932'
p18899
sg7
VCD006132 v. 5.2 Interventions for improving adherence to ocular hypotensive therapy.rm5
p18900
sg9
V22000272.xml
p18901
sa(dp18902
g3
VSTD-Gray-2011
p18903
sg5
S'PMC3299012'
p18904
sg7
g18900
sg9
V22094303.xml
p18905
sa(dp18906
g3
VSTD-I_x002d_SIGHT
p18907
sg5
S'PMC3593648'
p18908
sg7
g18900
sg9
V22688429.xml
p18909
sa(dp18910
g3
VSTD-Nakakura-2012
p18911
sg5
S'PMC3299559'
p18912
sg7
g18900
sg9
V22419858.xml
p18913
sa(dp18914
g3
VSTD-Sippel-1999
p18915
sg5
S'PMC1496767'
p18916
sg7
VCD004705 v. 7.2 Biomedical risk assessment as an aid for smoking cessation.rm5
p18917
sg9
V10571715.xml
p18918
sa(dp18919
g3
VSTD-Jamrozik-1984
p18920
sg5
S'PMC1441184'
p18921
sg7
g18917
sg9
V6426618.xml
p18922
sa(dp18923
g3
VSTD-Parkes-2008
p18924
sg5
S'PMC2267989'
p18925
sg7
g18917
sg9
V18326503.xml
p18926
sa(dp18927
g3
VSTD-McClure-2009
p18928
sg5
S'PMC2889910'
p18929
sg7
g18917
sg9
V19524389.xml
p18930
sa(dp18931
g3
VSTD-Sanders-1989
p18932
sg5
S'PMC1711904'
p18933
sg7
g18917
sg9
V2556540.xml
p18934
sa(dp18935
g3
VSTD-Mcleod-2001
p18936
sg5
S'PMC1421263'
p18937
sg7
VCD001217 v. 8.2 Heparins and mechanical methods for thromboprophylaxis in colorectal surgery.rm5
p18938
sg9
V11224634.xml
p18939
sa(dp18940
g3
VSTD-Yelnik-2007
p18941
sg5
S'PMC2117719'
p18942
sg7
VCD008271 v. 4.0 Botulinum toxin for shoulder pain.rm5
p18943
sg9
V17088333.xml
p18944
sa(dp18945
g3
VSTD-Mires-2001
p18946
sg5
S'PMC32308'
p18947
sg7
VCD005122 v. 10.0 Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for ass.rm5
p18948
sg9
V11408301.xml
p18949
sa(dp18950
g3
VSTD-John-1984
p18951
sg5
S'PMC1441216'
p18952
sg7
VCD003885 v. 9.2 Pneumococcal vaccines for sickle cell disease.rm5
p18953
sg9
V6426646.xml
p18954
sa(dp18955
g3
VSTD-UK_x002d_PDRG-_x0028_RR_x0029_-1998
p18956
sg5
S'PMC28519'
p18957
sg7
VCD004898 v. 5.0 Monoamine oxidase B inhibitors for early Parkinson's disease.rm5
p18958
sg9
V9583926.xml
p18959
sa(dp18960
g3
VSTD-Heimler-1992
p18961
sg5
S'PMC1793668'
p18962
sg7
VCD004951 v. 4.2 Body positioning for spontaneously breathing preterm infants with apnoea.rm5
p18963
sg9
V1575555.xml
p18964
sa(dp18965
g3
VSTD-Tack-2005
p18966
sg5
S'PMC1774790'
p18967
sg7
VCD003960 v. 7.0 Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.rm5
p18968
sg9
V16020489.xml
p18969
sa(dp18970
g3
VSTD-Kellow-2003
p18971
sg5
S'PMC1773630'
p18972
sg7
g18968
sg9
V12692051.xml
p18973
sa(dp18974
g3
VSTD-Thomson-2007
p18975
sg5
S'PMC2464985'
p18976
sg7
VCD008600 v. 2.2 Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrilla.rm5
p18977
sg9
V17545350.xml
p18978
sa(dp18979
g3
VSTD-McAlister-2005
p18980
sg5
S'PMC1188186'
p18981
sg7
g18977
sg9
V16129870.xml
p18982
sa(dp18983
g3
VSTD-Wang-2008
p18984
sg5
S'PMC2693759'
p18985
sg7
VCD003619 v. 6.0 Weight reduction for non-alcoholic fatty liver disease.rm5
p18986
sg9
V18330955.xml
p18987
sa(dp18988
g3
VSTD-Promrat-2010
p18989
sg5
S'PMC2799538'
p18990
sg7
g18986
sg9
V19827166.xml
p18991
sa(dp18992
g3
VSTD-Lazo-2010
p18993
sg5
S'PMC2945152'
p18994
sg7
g18986
sg9
V20664019.xml
p18995
sa(dp18996
g3
VSTD-Seideman-1993
p18997
sg5
S'PMC1005122'
p18998
sg7
VCD008872 v. 2.0 Safety of non-steroidal anti-inflammatory drugs including aspirin and paracetamol (acetaminophen) i.rm5
p18999
sg9
V8215627.xml
p19000
sa(dp19001
g3
VSTD-Fallis-2001
p19002
sg5
S'PMC3695182'
p19003
sg7
VCD004510 v. 4.2 Telephone follow-up initiated by a hospital-based health professional for postdischarge problems i.rm5
p19004
sg9
V11220797.xml
p19005
sa(dp19006
g3
VSTD-Phillips-2001
p19007
sg5
S'PMC1913671'
p19008
sg7
g19004
sg9
V11889278.xml
p19009
sa(dp19010
g3
VSTD-Coppin-2005
p19011
sg5
S'PMC1463088'
p19012
sg7
VCD008496 v. 2.0 Non-drug therapies for lower limb muscle cramps.rm5
p19013
sg9
V15808033.xml
p19014
sa(dp19015
g3
VSTD-Moorfields-1982
p19016
sg5
S'PMC1039921'
p19017
sg7
VCD004763 v. 4.0 Laser photocoagulation for neovascular age-related macular degeneration.rm5
p19018
sg9
V6184070.xml
p19019
sa(dp19020
g3
VSTD-Harms-2008
p19021
sg5
S'PMC2373885'
p19022
sg7
VCD008530 v. 2.0 Antibiotic therapy for preventing infections in patients with acute stroke.rm5
p19023
sg9
V18478129.xml
p19024
sa(dp19025
g3
VSTD-Flynn-1978
p19026
sg5
S'PMC1607519'
p19027
sg7
VCD003934 v. 3.0 Maternal positions and mobility during first stage labour.rm5
p19028
sg9
V698606.xml
p19029
sa(dp19030
g3
VSTD-Schooler-1997
p19031
sg5
S'PMC3330401'
p19032
sg7
VCD000088 v. 14.0 Family intervention for schizophrenia.rm5
p19033
sg9
V22700264.xml
p19034
sa(dp19035
g3
VSTD-Sandri-2004
p19036
sg5
S'PMC1721765'
p19037
sg7
VCD001243 v. 7.0 Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in ve.rm5
p19038
sg9
V15321956.xml
p19039
sa(dp19040
g3
VSTD-Carlson-2007
p19041
sg5
S'PMC1955332'
p19042
sg7
VCD006856 v. 2.5 Personal assistance for adults (19-64) with physical impairments.rm5
p19043
sg9
V17244293.xml
p19044
sa(dp19045
g3
VSTD-Mowat-1980
p19046
sg5
S'PMC1000462'
p19047
sg7
VCD003114 v. 7.0 Occupational therapy for rheumatoid arthritis.rm5
p19048
sg9
V7377854.xml
p19049
sa(dp19050
g3
VSTD-Begley-2008
p19051
sg5
S'PMC2443289'
p19052
sg7
VCD007496 v. 2.0 Male circumcision for prevention of homosexual acquisition of HIV in men.rm5
p19053
sg9
V18628946.xml
p19054
sa(dp19055
g3
VSTD-McDaid-2010
p19056
sg5
S'PMC3010905'
p19057
sg7
g19053
sg9
V20595141.xml
p19058
sa(dp19059
g3
VSTD-Templeton-2009-_x0028_CS_x0029_
p19060
sg5
S'PMC2784211'
p19061
sg7
g19053
sg9
V19911990.xml
p19062
sa(dp19063
g3
VSTD-Lane-2011
p19064
sg5
S'PMC2888758'
p19065
sg7
g19053
sg9
V19662523.xml
p19066
sa(dp19067
g3
VSTD-Templeton-2009-_x0028_P_x0029_
p19068
sg5
S'PMC2784211'
p19069
sg7
g19053
sg9
V19911990.xml
p19070
sa(dp19071
g3
VSTD-Skripak-2008
p19072
sg5
S'PMC3764488'
p19073
sg7
VCD009542 v. 2.5 Oral immunotherapy for milk allergy.rm5
p19074
sg9
V18951617.xml
p19075
sa(dp19076
g3
VSTD-Ventriculomegaly--90
p19077
sg5
S'PMC1590164'
p19078
sg7
VCD000216 v. 7.0 Repeated lumbar or ventricular punctures in newborns with intraventricular hemorrhage.rm5
p19079
sg9
V2407200.xml
p19080
sa(dp19081
g3
VSTD-David-1982
p19082
sg5
S'PMC491629'
p19083
sg7
VCD000425 v. 8.0 Speech and language therapy for aphasia following stroke.rm5
p19084
sg9
V6184453.xml
p19085
sa(dp19086
g3
VSTD-Meikle-1979
p19087
sg5
S'PMC1596055'
p19088
sg7
g19084
sg9
V466329.xml
p19089
sa(dp19090
g3
VSTD-Hall-2001-_x0028_Study-2_x0029_
p19091
sg5
S'PMC98234'
p19092
sg7
VCD009029 v. 2.2 Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.rm5
p19093
sg9
V11292698.xml
p19094
sa(dp19095
g3
VSTD-Hall-2001-_x0028_Study-3_x0029_
p19096
sg5
S'PMC98234'
p19097
sg7
g19093
sg9
V11292698.xml
p19098
sa(dp19099
g3
VSTD-Cohen-2000-_x0028_Study-2_x0029_
p19100
sg5
S'PMC98356'
p19101
sg7
g19093
sg9
V10899847.xml
p19102
sa(dp19103
g3
VSTD-Jertborn-2001
p19104
sg5
S'PMC96073'
p19105
sg7
g19093
sg9
V11238232.xml
p19106
sa(dp19107
g3
VSTD-Hall-2001-_x0028_Study-1_x0029_
p19108
sg5
S'PMC98234'
p19109
sg7
g19093
sg9
V11292698.xml
p19110
sa(dp19111
g3
VSTD-Cohen-2000-_x0028_Study-1_x0029_
p19112
sg5
S'PMC98356'
p19113
sg7
g19093
sg9
V10899847.xml
p19114
sa(dp19115
g3
VSTD-Swift-1994
p19116
sg5
S'PMC1374591'
p19117
sg7
VCD000299 v. 4.0 Anti-tuberculous therapy for maintenance of remission in Crohn's disease.rm5
p19118
sg9
V8150348.xml
p19119
sa(dp19120
g3
VSTD-Shaffer-1984
p19121
sg5
S'PMC1432256'
p19122
sg7
g19118
sg9
V6363219.xml
p19123
sa(dp19124
g3
VSTD-Rosenfeld-2008
p19125
sg5
S'PMC2631354'
p19126
sg7
VCD005225 v. 6.2 Creatine for amyotrophic lateral sclerosismotor neuron disease.rm5
p19127
sg9
V18608103.xml
p19128
sa(dp19129
g3
VSTD-Forney-2001
p19130
sg5
S'PMC88255'
p19131
sg7
VCD008122 v. 4.0 Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.rm5
p19132
sg9
V11474008.xml
p19133
sa(dp19134
g3
VSTD-Forney-2003
p19135
sg5
S'PMC156472'
p19136
sg7
g19132
sg9
V12791849.xml
p19137
sa(dp19138
g3
VSTD-Abeku-2008a
p19139
sg5
S'PMC2571107'
p19140
sg7
g19132
sg9
V18834523.xml
p19141
sa(dp19142
g3
VSTD-Abeku-2008b
p19143
sg5
S'PMC2571107'
p19144
sg7
g19132
sg9
V18834523.xml
p19145
sa(dp19146
g3
VSTD-Bell-2001b
p19147
sg5
S'PMC2566678'
p19148
sg7
g19132
sg9
V11693975.xml
p19149
sa(dp19150
g3
VSTD-Bell-2001a
p19151
sg5
S'PMC2566678'
p19152
sg7
g19132
sg9
V11693975.xml
p19153
sa(dp19154
g3
VSTD-Msellem-2009
p19155
sg5
S'PMC2667629'
p19156
sg7
g19132
sg9
V19399156.xml
p19157
sa(dp19158
g3
VSTD-Tjitra-1999
p19159
sg5
S'PMC85241'
p19160
sg7
g19132
sg9
V10405377.xml
p19161
sa(dp19162
g3
VSTD-Bharti-2008
p19163
sg5
S'PMC2478667'
p19164
sg7
g19132
sg9
V18620560.xml
p19165
sa(dp19166
g3
VSTD-Retting-Oxnard-2002
p19167
sg5
S'PMC1447335'
p19168
sg7
VCD003862 v. 8.0 Red-light cameras for the prevention of road traffic crashes.rm5
p19169
sg9
V12406815.xml
p19170
sa(dp19171
g3
VSTD-Muller-2001
p19172
sg5
S'PMC33513'
p19173
sg7
VCD006639 v. 6.0 Zinc supplements for preventing otitis media.rm5
p19174
sg9
V11431296.xml
p19175
sa(dp19176
g3
VSTD-Bhandari-2002
p19177
sg5
S'PMC115208'
p19178
sg7
g19174
sg9
V12052800.xml
p19179
sa(dp19180
g3
VSTD-Poche-1988
p19181
sg5
S'PMC1286121'
p19182
sg7
VCD004380 v. 4.0 School-based education programmes for the prevention of child sexual abuse.rm5
p19183
sg9
V3198545.xml
p19184
sa(dp19185
g3
VSTD-GRASP-2009
p19186
sg5
S'PMC2790382'
p19187
sg7
VCD005346 v. 8.0 Insulin for glycaemic control in acute ischaemic stroke.rm5
p19188
sg9
V19834016.xml
p19189
sa(dp19190
g3
VSTD-Arezzo-2008
p19191
sg5
S'PMC2565674'
p19192
sg7
VCD007076 v. 5.0 Pregabalin for acute and chronic pain in adults.rm5
p19193
sg9
V18796160.xml
p19194
sa(dp19195
g3
VSTD-Hillman-2005
p19196
sg5
S'PMC1237155'
p19197
sg7
VCD008685 v. 2.2 Optimal loading dose of warfarin for the initiation of oral anticoagulation.rm5
p19198
sg9
V16160068.xml
p19199
sa(dp19200
g3
VSTD-Ward-2002
p19201
sg5
S'PMC117136'
p19202
sg7
VCD002912 v. 13.3 Open retropubic colposuspension for urinary incontinence in women.rm5
p19203
sg9
V12114234.xml
p19204
sa(dp19205
g3
VSTD-Bakitas-2009
p19206
sg5
S'PMC3657724'
p19207
sg7
VCD007760 v. 3.0 Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illne.rm5
p19208
sg9
V19690306.xml
p19209
sa(dp19210
g3
VSTD-Zimmer-1985
p19211
sg5
S'PMC1645992'
p19212
sg7
g19208
sg9
V3966617.xml
p19213
sa(dp19214
g3
VSTD-McWhinney-1994
p19215
sg5
S'PMC2541867'
p19216
sg7
g19208
sg9
V7532501.xml
p19217
sa(dp19218
g3
VSTD-Hughes-1992
p19219
sg5
S'PMC1069857'
p19220
sg7
g19208
sg9
V1737710.xml
p19221
sa(dp19222
g3
VSTD-Grande-1999
p19223
sg5
S'PMC28293'
p19224
sg7
g19208
sg9
V10582932.xml
p19225
sa(dp19226
g3
VSTD-Altan_x002d_Yaycioglu-2005
p19227
sg5
S'PMC1884849'
p19228
sg7
VCD005429 v. 5.0 Which anticholinergic drug for overactive bladder symptoms in adults.rm5
p19229
sg9
V15842558.xml
p19230
sa(dp19231
g3
VSTD-Choo-2008
p19232
sg5
S'PMC2680337'
p19233
sg7
g19229
sg9
V19143854.xml
p19234
sa(dp19235
g3
VSTD-L-_x002d_-LEAD-1-Marre-2009
p19236
sg5
S'PMC2871176'
p19237
sg7
VCD006423 v. 4.0 Glucagon-like peptide analogues for type 2 diabetes mellitus.rm5
p19238
sg9
V19317822.xml
p19239
sa(dp19240
g3
VSTD-Lixi-_x002d_-Ratner-2010
p19241
sg5
S'PMC3068287'
p19242
sg7
g19238
sg9
V20722676.xml
p19243
sa(dp19244
g3
VSTD-T-_x002d_-Nauck-2009
p19245
sg5
S'PMC2699710'
p19246
sg7
g19238
sg9
V19366970.xml
p19247
sa(dp19248
g3
VSTD-A-_x002d_-Rosenstock-2009
p19249
sg5
S'PMC2752910'
p19250
sg7
g19238
sg9
V19592625.xml
p19251
sa(dp19252
g3
VSTD-L-_x002d_-LEAD-2-Nauck-2009
p19253
sg5
S'PMC2606836'
p19254
sg7
g19238
sg9
V18931095.xml
p19255
sa(dp19256
g3
VSTD-L-_x002d_-LEAD-5-Russell_x002d_J-2009
p19257
sg5
S'PMC2744824'
p19258
sg7
g19238
sg9
V19688338.xml
p19259
sa(dp19260
g3
VSTD-L-_x002d_-LEAD-4-Zinman-2009
p19261
sg5
S'PMC2699702'
p19262
sg7
g19238
sg9
V19289857.xml
p19263
sa(dp19264
g3
VSTD-T_x002d_-Ratner-2010
p19265
sg5
S'PMC2948428'
p19266
sg7
g19238
sg9
V20536952.xml
p19267
sa(dp19268
g3
VSTD-Cornelius-1996
p19269
sg5
S'PMC1342770'
p19270
sg7
VCD006581 v. 4.0 Adjusting the pH of lidocaine for reducing pain on injection.rm5
p19271
sg9
V8894861.xml
p19272
sa(dp19273
g3
VSTD-Moayyedi-1995
p19274
sg5
S'PMC474895'
p19275
sg7
VCD003900 v. 7.0 Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chron.rm5
p19276
sg9
V7570433.xml
p19277
sa(dp19278
g3
VSTD-Nakintu-2001
p19279
sg5
S'PMC2141556'
p19280
sg7
VCD004901 v. 5.0 Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for wome.rm5
p19281
sg9
V12789117.xml
p19282
sa(dp19283
g3
VSTD-UKPDS_x002d_39_x002d_1998
p19284
sg5
S'PMC28660'
p19285
sg7
VCD002003 v. 12.0 Beta-blockers for hypertension.rm5
p19286
sg9
V9732338.xml
p19287
sa(dp19288
g3
VSTD-Feste-2000
p19289
sg5
S'PMC3015351'
p19290
sg7
VCD006583 v. 5.0 Laparoscopic entry techniques.rm5
p19291
sg9
V10772522.xml
p19292
sa(dp19293
g3
VSTD-Venkatesh-2007
p19294
sg5
S'PMC3015718'
p19295
sg7
g19291
sg9
V17761080.xml
p19296
sa(dp19297
g3
VSTD-Carapeti-1999
p19298
sg5
S'PMC1727506'
p19299
sg7
VCD003431 v. 9.2 Non surgical therapy for anal fissure.rm5
p19300
sg9
V10205213.xml
p19301
sa(dp19302
g3
VSTD-Jensen-1987
p19303
sg5
S'PMC1290813'
p19304
sg7
g19300
sg9
V3039130.xml
p19305
sa(dp19306
g3
VSTD-Scholefield-2003
p19307
sg5
S'PMC1774963'
p19308
sg7
g19300
sg9
V12524411.xml
p19309
sa(dp19310
g3
VSTD-Kenny-2001
p19311
sg5
S'PMC1718983'
p19312
sg7
g19300
sg9
V11668104.xml
p19313
sa(dp19314
g3
VSTD-Patterson-2003
p19315
sg5
S'PMC1884398'
p19316
sg7
VCD003822 v. 7.0 Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension.rm5
p19317
sg9
V14651725.xml
p19318
sa(dp19319
g3
VSTD-Kinlock-2007
p19320
sg5
S'PMC2423344'
p19321
sg7
VCD002209 v. 11.0 Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.rm5
p19322
sg9
V17628351.xml
p19323
sa(dp19324
g3
VSTD-Gruber-2008
p19325
sg5
S'PMC2821580'
p19326
sg7
g19322
sg9
V18243585.xml
p19327
sa(dp19328
g3
VSTD-Bonnema-1998
p19329
sg5
S'PMC28526'
p19330
sg7
VCD007672 v. 2.3 Interventions to improve continuity of care in the follow-up of patients with cancer.rm5
p19331
sg9
V9554895.xml
p19332
sa(dp19333
g3
VSTD-Addington_x002d_Hall-1992
p19334
sg5
S'PMC1883850'
p19335
sg7
g19331
sg9
V1483075.xml
p19336
sa(dp19337
g3
VSTD-McWhinney-1994
p19338
sg5
S'PMC2541867'
p19339
sg7
g19331
sg9
V7532501.xml
p19340
sa(dp19341
g3
VSTD-Moore-2002
p19342
sg5
S'PMC133453'
p19343
sg7
g19331
sg9
V12433764.xml
p19344
sa(dp19345
g3
VSTD-Grunfeld-1996
p19346
sg5
S'PMC1313497'
p19347
sg7
g19331
sg9
V10756611.xml
p19348
sa(dp19349
g3
VSTD-Wells-2004
p19350
sg5
S'PMC2364768'
p19351
sg7
g19331
sg9
V15238983.xml
p19352
sa(dp19353
g3
VSTD-Hughes-1992
p19354
sg5
S'PMC1069857'
p19355
sg7
g19331
sg9
V1737710.xml
p19356
sa(dp19357
g3
VSTD-Williams-2001
p19358
sg5
S'PMC1743428'
p19359
sg7
g19331
sg9
V11533423.xml
p19360
sa(dp19361
g3
VSTD-King-2009
p19362
sg5
S'PMC2634705'
p19363
sg7
g19331
sg9
V19107130.xml
p19364
sa(dp19365
g3
VSTD-Drury-2000
p19366
sg5
S'PMC1313626'
p19367
sg7
g19331
sg9
V10750206.xml
p19368
sa(dp19369
g3
VSTD-Wattchow-2006
p19370
sg5
S'PMC2361245'
p19371
sg7
g19331
sg9
V16622437.xml
p19372
sa(dp19373
g3
VSTD-Hanks-2002
p19374
sg5
S'PMC2364271'
p19375
sg7
g19331
sg9
V12232756.xml
p19376
sa(dp19377
g3
VSTD-Poon-2007
p19378
sg5
S'PMC1959348'
p19379
sg7
VCD008914 v. 3.0 Stents for the prevention of pancreatic fistula following pancreaticoduodenectomy.rm5
p19380
sg9
V17717446.xml
p19381
sa(dp19382
g3
VSTD-Morisky-2001
p19383
sg5
S'PMC1497389'
p19384
sg7
VCD006591 v. 3.0 Patient education and counselling for promoting adherence to treatment for tuberculosis.rm5
p19385
sg9
V12196616.xml
p19386
sa(dp19387
g3
VSTD-Van-Horn-1991
p19388
sg5
S'PMC1404954'
p19389
sg7
VCD005051 v. 3.0 Wholegrain cereals for coronary heart disease.rm5
p19390
sg9
V1846723.xml
p19391
sa(dp19392
g3
VSTD-Hochreiter-2009
p19393
sg5
S'PMC2717450'
p19394
sg7
VCD007498 v. 3.5 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.rm5
p19395
sg9
V19493352.xml
p19396
sa(dp19397
g3
VSTD-Woods-1992
p19398
sg5
S'PMC483633'
p19399
sg7
VCD002755 v. 6.0 Intravenous magnesium for acute myocardial infarction.rm5
p19400
sg9
V8130021.xml
p19401
sa(dp19402
g3
VSTD-Appleby-1997
p19403
sg5
S'PMC2126383'
p19404
sg7
VCD006116 v. 4.0 Psychosocial and psychological interventions for treating postpartum depression.rm5
p19405
sg9
V9099116.xml
p19406
sa(dp19407
g3
VSTD-Brown-2001
p19408
sg5
S'PMC2375236'
p19409
sg7
VCD004565 v. 3.0 Interventions before consultations for helping patients address their information needs.rm5
p19410
sg9
V11720460.xml
p19411
sa(dp19412
g3
VSTD-Hornberger-1997
p19413
sg5
S'PMC1497170'
p19414
sg7
g19410
sg9
V9346455.xml
p19415
sa(dp19416
g3
VSTD-Brown-1999
p19417
sg5
S'PMC2363012'
p19418
sg7
g19410
sg9
V10390003.xml
p19419
sa(dp19420
g3
VSTD-Little-2004
p19421
sg5
S'PMC344265'
p19422
sg7
g19410
sg9
V14966078.xml
p19423
sa(dp19424
g3
VSTD-Finney-1990
p19425
sg5
S'PMC1286226'
p19426
sg7
g19410
sg9
V2373656.xml
p19427
sa(dp19428
g3
VSTD-Middleton-2006
p19429
sg5
S'PMC1471934'
p19430
sg7
g19410
sg9
V16707508.xml
p19431
sa(dp19432
g3
VSTD-Patra-1982
p19433
sg5
S'PMC1628063'
p19434
sg7
VCD006519 v. 3.0 Polymer-based oral rehydration solution for treating acute watery diarrhoea.rm5
p19435
sg9
V6758706.xml
p19436
sa(dp19437
g3
VSTD-Alam-1992
p19438
sg5
S'PMC1374078'
p19439
sg7
g19435
sg9
V1582603.xml
p19440
sa(dp19441
g3
VSTD-El_x002d_Mougi-1996
p19442
sg5
S'PMC2486870'
p19443
sg7
g19435
sg9
V9002327.xml
p19444
sa(dp19445
g3
VSTD-Islam-1994
p19446
sg5
S'PMC1029905'
p19447
sg7
g19435
sg9
V8067787.xml
p19448
sa(dp19449
g3
VSTD-Ramakrishna-2008
p19450
sg5
S'PMC2217593'
p19451
sg7
g19435
sg9
V18270575.xml
p19452
sa(dp19453
g3
VSTD-Molla-1985
p19454
sg5
S'PMC2536376'
p19455
sg7
g19435
sg9
V3910298.xml
p19456
sa(dp19457
g3
VSTD-Miskelly-1988
p19458
sg5
S'PMC1778829'
p19459
sg7
VCD003741 v. 7.0 Soy formula for prevention of allergy and food intolerance in infants.rm5
p19460
sg9
V3365008.xml
p19461
sa(dp19462
g3
VSTD-Mahmud-2001
p19463
sg5
S'PMC1728458'
p19464
sg7
VCD003715 v. 7.0 Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.rm5
p19465
sg9
V11559654.xml
p19466
sa(dp19467
g3
VSTD-Jones-1995
p19468
sg5
S'PMC474903'
p19469
sg7
VCD004107 v. 4.0 Options for self-management education for adults with asthma.rm5
p19470
sg9
V7570436.xml
p19471
sa(dp19472
g3
VSTD-Charlton-1990
p19473
sg5
S'PMC1664498'
p19474
sg7
g19470
sg9
V2148702.xml
p19475
sa(dp19476
g3
VSTD-Lahdensuo-1996
p19477
sg5
S'PMC2350456'
p19478
sg7
g19470
sg9
V8605463.xml
p19479
sa(dp19480
g3
VSTD-Grampian-1994
p19481
sg5
S'PMC2539575'
p19482
sg7
g19470
sg9
V8148679.xml
p19483
sa(dp19484
g3
VSTD-Matsumoto-1999
p19485
sg5
S'PMC1745437'
p19486
sg7
VCD009607 v. 2.2 Swimming training for asthma in children and adolescents aged 18 years and under.rm5
p19487
sg9
V10325893.xml
p19488
sa(dp19489
g3
VSTD-Malcolm-2002
p19490
sg5
S'PMC1495040'
p19491
sg7
VCD005063 v. 8.3 Benzodiazepines for alcohol withdrawal.rm5
p19492
sg9
V12047731.xml
p19493
sa(dp19494
g3
VSTD-Yardley-1998
p19495
sg5
S'PMC1410046'
p19496
sg7
VCD005397 v. 5.0 Vestibular rehabilitation for unilateral peripheral vestibular dysfunction.rm5
p19497
sg9
V9667087.xml
p19498
sa(dp19499
g3
VSTD-Christophersen-2002
p19500
sg5
S'PMC1874309'
p19501
sg7
VCD003328 v. 7.0 Interventions for paracetamol (acetaminophen) overdose.rm5
p19502
sg9
V11874395.xml
p19503
sa(dp19504
g3
VSTD-Gazzard-1974a
p19505
sg5
S'PMC1402556'
p19506
sg7
g19502
sg9
V22454960.xml
p19507
sa(dp19508
g3
VSTD-Underhill-1990
p19509
sg5
S'PMC1285692'
p19510
sg7
g19502
sg9
V1983801.xml
p19511
sa(dp19512
g3
VSTD-Gazzard-1975
p19513
sg5
S'PMC1411015'
p19514
sg7
g19502
sg9
V1102398.xml
p19515
sa(dp19516
g3
VSTD-Smith-1978
p19517
sg5
S'PMC1602895'
p19518
sg7
g19502
sg9
V623980.xml
p19519
sa(dp19520
g3
VSTD-Mutimer-1994
p19521
sg5
S'PMC1374884'
p19522
sg7
g19502
sg9
V8020810.xml
p19523
sa(dp19524
g3
VSTD-Yeates-2000
p19525
sg5
S'PMC2014891'
p19526
sg7
g19502
sg9
V10606832.xml
p19527
sa(dp19528
g3
VSTD-Susanna-2003
p19529
sg5
S'PMC1771784'
p19530
sg7
VCD004918 v. 4.0 Aqueous shunts for glaucoma.rm5
p19531
sg9
V12881343.xml
p19532
sa(dp19533
g3
VSTD-Jones-1981
p19534
sg5
S'PMC1627404'
p19535
sg7
VCD000373 v. 7.2 Kinesthetic stimulation for preventing apnea in preterm infants.rm5
p19536
sg9
V7030228.xml
p19537
sa(dp19538
g3
VSTD-McDonald-1993
p19539
sg5
S'PMC1679299'
p19540
sg7
VCD000201 v. 6.0 Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour.rm5
p19541
sg9
V8251842.xml
p19542
sa(dp19543
g3
VSTD-JUPITER-trial
p19544
sg5
S'PMC2710995'
p19545
sg7
VCD008203 v. 2.0 Statins for primary prevention of venous thromboembolism.rm5
p19546
sg9
V19329822.xml
p19547
sa(dp19548
g3
VSTD-Holt-2005
p19549
sg5
S'PMC1747282'
p19550
sg7
VCD009046 v. 2.5 Interventions for smoking cessation in Indigenous populations.rm5
p19551
sg9
V15681499.xml
p19552
sa(dp19553
g3
VSTD-Stewart-2007
p19554
sg5
S'PMC3163239'
p19555
sg7
VCD009805 v. 2.0 Hormonal and intrauterine methods for contraception for women aged 25 years and younger.rm5
p19556
sg9
V18082856.xml
p19557
sa(dp19558
g3
VSTD-Roberts-2001
p19559
sg5
S'PMC2015028'
p19560
sg7
VCD009095 v. 3.0 Interventions to optimise prescribing for older people in care homes.rm5
p19561
sg9
V11298072.xml
p19562
sa(dp19563
g3
VSTD-Juvenile-2009
p19564
sg5
S'PMC2945155'
p19565
sg7
VCD008101 v. 3.0 Continuous glucose monitoring systems for type 1 diabetes mellitus.rm5
p19566
sg9
V20696865.xml
p19567
sa(dp19568
g3
VSTD-Raccah-2009
p19569
sg5
S'PMC2782985'
p19570
sg7
g19566
sg9
V19767384.xml
p19571
sa(dp19572
g3
VSTD-Battelino-2011
p19573
sg5
S'PMC3064030'
p19574
sg7
g19566
sg9
V21335621.xml
p19575
sa(dp19576
g3
VSTD-Black-1990
p19577
sg5
S'PMC1663097'
p19578
sg7
VCD001801 v. 8.0 Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children.rm5
p19579
sg9
V2196954.xml
p19580
sa(dp19581
g3
VSTD-Edwards-1984
p19582
sg5
S'PMC1046385'
p19583
sg7
VCD004785 v. 9.0 Antibiotics for preventing meningococcal infections.rm5
p19584
sg9
V6440658.xml
p19585
sa(dp19586
g3
VSTD-Dworzack-1988
p19587
sg5
S'PMC175963'
p19588
sg7
g19584
sg9
V3252755.xml
p19589
sa(dp19590
g3
VSTD-Renkonen-1987
p19591
sg5
S'PMC284224'
p19592
sg7
g19584
sg9
V3113331.xml
p19593
sa(dp19594
g3
VSTD-Pugsley-1984
p19595
sg5
S'PMC185560'
p19596
sg7
g19584
sg9
V6732217.xml
p19597
sa(dp19598
g3
VSTD-Lorenz-1998
p19599
sg5
S'PMC1191593'
p19600
sg7
VCD003770 v. 6.0 Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer .rm5
p19601
sg9
V9860474.xml
p19602
sa(dp19603
g3
VSTD-Luckner-2006
p19604
sg5
S'PMC1550871'
p19605
sg7
VCD003709 v. 5.0 Vasopressors for hypotensive shock.rm5
p19606
sg9
V16542484.xml
p19607
sa(dp19608
g3
VSTD-Morelli-2009
p19609
sg5
S'PMC2750187'
p19610
sg7
g19606
sg9
V19664253.xml
p19611
sa(dp19612
g3
VSTD-Fraser-1993
p19613
sg5
S'PMC1968186'
p19614
sg7
VCD003367 v. 9.0 Antitumour antibiotic containing regimens for metastatic breast cancer.rm5
p19615
sg9
V8431375.xml
p19616
sa(dp19617
g3
VSTD-Brambilla-1976
p19618
sg5
S'PMC1639498'
p19619
sg7
g19615
sg9
V1260337.xml
p19620
sa(dp19621
g3
VSTD-Harper_x002d_Wynne-1999
p19622
sg5
S'PMC2362871'
p19623
sg7
g19615
sg9
V10496359.xml
p19624
sa(dp19625
g3
VSTD-Akova-1993
p19626
sg5
S'PMC188077'
p19627
sg7
VCD007179 v. 3.0 Antibiotics for treating human brucellosis.rm5
p19628
sg9
V8239591.xml
p19629
sa(dp19630
g3
VSTD-Karabay-2004
p19631
sg5
S'PMC459220'
p19632
sg7
g19628
sg9
V15214959.xml
p19633
sa(dp19634
g3
VSTD-McDevitt-1970
p19635
sg5
S'PMC1009044'
p19636
sg7
g19628
sg9
V4907514.xml
p19637
sa(dp19638
g3
VSTD-Colmenero-1994
p19639
sg5
S'PMC188288'
p19640
sg7
g19628
sg9
V7695265.xml
p19641
sa(dp19642
g3
VSTD-Crone-2003
p19643
sg5
S'PMC1732562'
p19644
sg7
VCD008645 v. 2.0 Incentives for preventing smoking in children and adolescents.rm5
p19645
sg9
V12933772.xml
p19646
sa(dp19647
g3
VSTD-Koopmans-2006
p19648
sg5
S'PMC2104614'
p19649
sg7
VCD006922 v. 4.0 Regular treatment with salmeterol and inhaled steroids for chronic asthma serious adverse events.rm5
p19650
sg9
V16449264.xml
p19651
sa(dp19652
g3
VSTD-Lumley-2006
p19653
sg5
S'PMC1479326'
p19654
sg7
VCD001134 v. 9.0 Psychosocial and psychological interventions for preventing postpartum depression.rm5
p19655
sg9
V16483383.xml
p19656
sa(dp19657
g3
VSTD-Small-2000
p19658
sg5
S'PMC27510'
p19659
sg7
g19655
sg9
V11053173.xml
p19660
sa(dp19661
g3
VSTD-Feinberg-2008
p19662
sg5
S'PMC3178882'
p19663
sg7
g19655
sg9
V18410212.xml
p19664
sa(dp19665
g3
VSTD-Ickovics-2011
p19666
sg5
S'PMC3311036'
p19667
sg7
g19655
sg9
V21318932.xml
p19668
sa(dp19669
g3
VSTD-Morrell-2000
p19670
sg5
S'PMC27472'
p19671
sg7
g19655
sg9
V10977833.xml
p19672
sa(dp19673
g3
VSTD-Dennis-2009
p19674
sg5
S'PMC2628301'
p19675
sg7
g19655
sg9
V19147637.xml
p19676
sa(dp19677
g3
VSTD-Pang-2005
p19678
sg5
S'PMC3226792'
p19679
sg7
VCD006075 v. 3.0 Overground physical therapy gait training for chronic stroke patients with mobility deficits.rm5
p19680
sg9
V16181164.xml
p19681
sa(dp19682
g3
VSTD-Wade-1992
p19683
sg5
S'PMC1881332'
p19684
sg7
g19680
sg9
V1559090.xml
p19685
sa(dp19686
g3
VSTD-King-1994
p19687
sg5
S'PMC3250832'
p19688
sg7
VCD004405 v. 7.0 Corticosteroids for acute bacterial meningitis.rm5
p19689
sg9
V22346503.xml
p19690
sa(dp19691
g3
VSTD-Qazi-1996
p19692
sg5
S'PMC1511808'
p19693
sg7
g19689
sg9
V9014599.xml
p19694
sa(dp19695
g3
VSTD-Oncken-2008
p19696
sg5
S'PMC2630492'
p19697
sg7
VCD010078 v. 1.0 Pharmacological interventions for promoting smoking cessation during pregnancy.rm5
p19698
sg9
V18827129.xml
p19699
sa(dp19700
g3
VSTD-Pollak-2007
p19701
sg5
S'PMC3602964'
p19702
sg7
g19698
sg9
V17888856.xml
p19703
sa(dp19704
g3
VSTD-Canada-1980b
p19705
sg5
S'PMC1336544'
p19706
sg7
VCD001877 v. 12.0 Screening for breast cancer with mammography.rm5
p19707
sg9
V1423088.xml
p19708
sa(dp19709
g3
VSTD-Canada-1980
p19710
sg5
S'PMC1226907'
p19711
sg7
g19707
sg9
V9012720.xml
p19712
sa(dp19713
g3
VSTD-UK-age-trial-1991
p19714
sg5
S'PMC2978129'
p19715
sg7
g19707
sg9
V20837718.xml
p19716
sa(dp19717
g3
VSTD-Edinburgh-1978
p19718
sg5
S'PMC1052787'
p19719
sg7
g19707
sg9
V2592888.xml
p19720
sa(dp19721
g3
VSTD-Levy-2003
p19722
sg5
S'PMC1719589'
p19723
sg7
VCD003495 v. 5.2 Intravenous secretin for autism spectrum disorders (ASD).rm5
p19724
sg9
V12876177.xml
p19725
sa(dp19726
g3
VSTD-Milligan-1987
p19727
sg5
S'PMC1031960'
p19728
sg7
VCD001331 v. 5.0 Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.rm5
p19729
sg9
V3295122.xml
p19730
sa(dp19731
g3
VSTD-Martin-1994-Liver
p19732
sg5
S'PMC2958671'
p19733
sg7
VCD003774 v. 13.0 Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.rm5
p19734
sg9
V7940710.xml
p19735
sa(dp19736
g3
VSTD-Young-2007
p19737
sg5
S'PMC2219885'
p19738
sg7
VCD008451 v. 2.4 The effect of financial incentives on the quality of health care provided by primary care physicians.rm5
p19739
sg9
V17443360.xml
p19740
sa(dp19741
g3
VSTD-Twardella-2007
p19742
sg5
S'PMC2598437'
p19743
sg7
g19739
sg9
V17297068.xml
p19744
sa(dp19745
g3
VSTD-Curley-2005
p19746
sg5
S'PMC1237036'
p19747
sg7
VCD003645 v. 10.0 Positioning for acute respiratory distress in hospitalised infants and children.rm5
p19748
sg9
V16014597.xml
p19749
sa(dp19750
g3
VSTD-Levene-1990
p19751
sg5
S'PMC1792134'
p19752
sg7
g19748
sg9
V2357093.xml
p19753
sa(dp19754
g3
VSTD-Gilbert-2008
p19755
sg5
S'PMC2292251'
p19756
sg7
VCD007844 v. 3.0 Behavioral interventions to promote condom use among women living with HIV.rm5
p19757
sg9
V18431475.xml
p19758
sa(dp19759
g3
VSTD-Cornman-2008
p19760
sg5
S'PMC2813056'
p19761
sg7
g19757
sg9
V18645518.xml
p19762
sa(dp19763
g3
VSTD-Pitt-1985
p19764
sg5
S'PMC1250755'
p19765
sg7
VCD005444 v. 6.4 Pre-operative biliary drainage for obstructive jaundice.rm5
p19766
sg9
V2986562.xml
p19767
sa(dp19768
g3
VSTD-Brandon-1985
p19769
sg5
S'PMC1444141'
p19770
sg7
VCD000076 v. 11.0 Electroconvulsive therapy for schizophrenia.rm5
p19771
sg9
V6418300.xml
p19772
sa(dp19773
g3
VSTD-Girish-2003
p19774
sg5
S'PMC2951534'
p19775
sg7
g19771
sg9
V21206808.xml
p19776
sa(dp19777
g3
VSTD-Agarwal-1985
p19778
sg5
S'PMC3011123'
p19779
sg7
g19771
sg9
V21927109.xml
p19780
sa(dp19781
g3
VSTD-Bagadia-1981
p19782
sg5
S'PMC3012902'
p19783
sg7
g19771
sg9
V22058556.xml
p19784
sa(dp19785
g3
VSTD-Janakiramiah-1981
p19786
sg5
S'PMC3012948'
p19787
sg7
g19771
sg9
V22058544.xml
p19788
sa(dp19789
g3
VSTD-Grant-2010
p19790
sg5
S'PMC3079639'
p19791
sg7
VCD007189 v. 4.9 Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.rm5
p19792
sg9
V21091279.xml
p19793
sa(dp19794
g3
VSTD-UK-1990
p19795
sg5
S'PMC1663720'
p19796
sg7
VCD002252 v. 8.0 Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.rm5
p19797
sg9
V2242456.xml
p19798
sa(dp19799
g3
VSTD-UK-1983a
p19800
sg5
S'PMC1548251'
p19801
sg7
g19797
sg9
V6407638.xml
p19802
sa(dp19803
g3
VSTD-Jordan-2003
p19804
sg5
S'PMC1241771'
p19805
sg7
VCD006047 v. 5.4 Household interventions for preventing domestic lead exposure in children.rm5
p19806
sg9
V14644671.xml
p19807
sa(dp19808
g3
VSTD-Farrell-1998
p19809
sg5
S'PMC1509060'
p19810
sg7
g19806
sg9
V9842383.xml
p19811
sa(dp19812
g3
VSTD-Campbell-2011
p19813
sg5
S'PMC3072906'
p19814
sg7
g19806
sg9
V21563715.xml
p19815
sa(dp19816
g3
VSTD-OCTAVE-1991
p19817
sg5
S'PMC1590232'
p19818
sg7
VCD000456 v. 7.0 Synchronized mechanical ventilation for respiratory support in newborn infants.rm5
p19819
sg9
V1863121.xml
p19820
sa(dp19821
g3
VSTD-Beresford-2000
p19822
sg5
S'PMC1721039'
p19823
sg7
g19819
sg9
V10634835.xml
p19824
sa(dp19825
g3
VSTD-Baumer-2000
p19826
sg5
S'PMC1721044'
p19827
sg7
g19819
sg9
V10634832.xml
p19828
sa(dp19829
g3
VSTD-Blazar-2006
p19830
sg5
S'PMC1895527'
p19831
sg7
VCD000978 v. 13.0 Interventions for preventing oral mucositis for patients with cancer receiving treatment.rm5
p19832
sg9
V16835378.xml
p19833
sa(dp19834
g3
VSTD-Symonds-1996
p19835
sg5
S'PMC2074575'
p19836
sg7
g19832
sg9
V8688343.xml
p19837
sa(dp19838
g3
VSTD-Stokman-2003
p19839
sg5
S'PMC2376383'
p19840
sg7
g19832
sg9
V12671696.xml
p19841
sa(dp19842
g3
VSTD-Jebb-1994
p19843
sg5
S'PMC2033386'
p19844
sg7
g19832
sg9
V7917930.xml
p19845
sa(dp19846
g3
VSTD-Bubley-1989
p19847
sg5
S'PMC284246'
p19848
sg7
g19832
sg9
V2669626.xml
p19849
sa(dp19850
g3
VSTD-Mills-1988
p19851
sg5
S'PMC2246575'
p19852
sg7
g19832
sg9
V3390377.xml
p19853
sa(dp19854
g3
VSTD-Hartmann-2001
p19855
sg5
S'PMC2363753'
p19856
sg7
g19832
sg9
V11161394.xml
p19857
sa(dp19858
g3
VSTD-Arad-1981
p19859
sg5
S'PMC1627396'
p19860
sg7
VCD001057 v. 6.0 Topical umbilical cord care at birth.rm5
p19861
sg9
V7030227.xml
p19862
sa(dp19863
g3
VSTD-Korpan-1997
p19864
sg5
S'PMC1190648'
p19865
sg7
VCD009058 v. 2.0 Cryotherapy for liver metastases.rm5
p19866
sg9
V9065296.xml
p19867
sa(dp19868
g3
VSTD-Sherwood-1987
p19869
sg5
S'PMC1041116'
p19870
sg7
VCD003919 v. 3.0 Laser trabeculoplasty for open angle glaucoma.rm5
p19871
sg9
V3828273.xml
p19872
sa(dp19873
g3
VSTD-Damji-1999
p19874
sg5
S'PMC1723059'
p19875
sg7
g19871
sg9
V10340983.xml
p19876
sa(dp19877
g3
VSTD-Croft-1986
p19878
sg5
S'PMC1960639'
p19879
sg7
VCD008274 v. 2.2 Long-term effects of weight-reducing diets in hypertensive patients.rm5
p19880
sg9
V3440987.xml
p19881
sa(dp19882
g3
VSTD-Khaodhiar-2007
p19883
sg5
S'PMC3207039'
p19884
sg7
VCD001395 v. 6.0 Phytoestrogens for vasomotor menopausal symptoms.rm5
p19885
sg9
V18257146.xml
p19886
sa(dp19887
g3
VSTD-Kavatha-2003
p19888
sg5
S'PMC149311'
p19889
sg7
VCD007182 v. 5.0 Antimicrobial agents for treating uncomplicated urinary tract infection in women.rm5
p19890
sg9
V12604518.xml
p19891
sa(dp19892
g3
VSTD-Hooton-1989
p19893
sg5
S'PMC172645'
p19894
sg7
g19890
sg9
V2802557.xml
p19895
sa(dp19896
g3
VSTD-Boyko-1990
p19897
sg5
S'PMC171664'
p19898
sg7
g19890
sg9
V2188590.xml
p19899
sa(dp19900
g3
VSTD-Goldstein-1985
p19901
sg5
S'PMC176290'
p19902
sg7
g19890
sg9
V3158277.xml
p19903
sa(dp19904
g3
VSTD-Ten-Centre-1987
p19905
sg5
S'PMC1590200'
p19906
sg7
VCD001079 v. 5.0 Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm inf.rm5
p19907
sg9
V2201266.xml
p19908
sa(dp19909
g3
VSTD-McGavin-1977
p19910
sg5
S'PMC470605'
p19911
sg7
VCD003793 v. 7.0 Pulmonary rehabilitation for chronic obstructive pulmonary disease.rm5
p19912
sg9
V882944.xml
p19913
sa(dp19914
g3
VSTD-Simpson-1992
p19915
sg5
S'PMC463573'
p19916
sg7
g19912
sg9
V1549826.xml
p19917
sa(dp19918
g3
VSTD-Cockcroft-1981
p19919
sg5
S'PMC471476'
p19920
sg7
g19912
sg9
V7025334.xml
p19921
sa(dp19922
g3
VSTD-Cornelius-2009
p19923
sg5
S'PMC2720419'
p19924
sg7
VCD008324 v. 3.0 Psychological therapies versus antidepressant medication alone and in combination for depression in.rm5
p19925
sg9
V19321268.xml
p19926
sa(dp19927
g3
VSTD-TASA-2009
p19928
sg5
S'PMC2891930'
p19929
sg7
g19925
sg9
V19730274.xml
p19930
sa(dp19931
g3
VSTD-ADAPT-2007
p19932
sg5
S'PMC1925185'
p19933
sg7
g19925
sg9
V17556431.xml
p19934
sa(dp19935
g3
VSTD-Fitzmaurice-2002
p19936
sg5
S'PMC1769803'
p19937
sg7
VCD003839 v. 7.8 Self-monitoring and self-management of oral anticoagulation.rm5
p19938
sg9
V12401823.xml
p19939
sa(dp19940
g3
VSTD-Fitzmaurice-2005
p19941
sg5
S'PMC1283185'
p19942
sg7
g19938
sg9
V16216821.xml
p19943
sa(dp19944
g3
VSTD-START-A-2008
p19945
sg5
S'PMC2323709'
p19946
sg7
VCD003860 v. 8.4 Fraction size in radiation treatment for breast conservation in early breast cancer.rm5
p19947
sg9
V18356109.xml
p19948
sa(dp19949
g3
VSTD-Newton-1978
p19950
sg5
S'PMC1608821'
p19951
sg7
VCD008328 v. 2.8 Airway clearance techniques for chronic obstructive pulmonary disease.rm5
p19952
sg9
V365289.xml
p19953
sa(dp19954
g3
VSTD-Vargas-2005
p19955
sg5
S'PMC1269449'
p19956
sg7
g19952
sg9
V16137351.xml
p19957
sa(dp19958
g3
VSTD-Aukland-1982
p19959
sg5
S'PMC497768'
p19960
sg7
VCD001272 v. 7.0 Antiplatelet agents for intermittent claudication.rm5
p19961
sg9
V7047575.xml
p19962
sa(dp19963
g3
VSTD-Bourjeily_x002d_Habr-2002
p19964
sg5
S'PMC1758803'
p19965
sg7
VCD009419 v. 2.0 Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.rm5
p19966
sg9
V12454299.xml
p19967
sa(dp19968
g3
VSTD-Neder-2002
p19969
sg5
S'PMC1746295'
p19970
sg7
g19966
sg9
V11923552.xml
p19971
sa(dp19972
g3
VSTD-N_x00e1_polis-2011
p19973
sg5
S'PMC3071998'
p19974
sg7
g19966
sg9
V21552662.xml
p19975
sa(dp19976
g3
VSTD-Murphy-1993
p19977
sg5
S'PMC1293006'
p19978
sg7
VCD001825 v. 6.0 Closed suction surgical wound drainage after orthopaedic surgery.rm5
p19979
sg9
V8371245.xml
p19980
sa(dp19981
g3
VSTD-Rowe-2009
p19982
sg5
S'PMC2667861'
p19983
sg7
VCD006413 v. 3.0 Managerial supervision to improve primary health care in low- and middle-income countries.rm5
p19984
sg9
V19299681.xml
p19985
sa(dp19986
g3
VSTD-Nilsson-2009
p19987
sg5
S'PMC2760502'
p19988
sg7
VCD005595 v. 3.0 Rehabilitation for ankle fractures in adults.rm5
p19989
sg9
V19781053.xml
p19990
sa(dp19991
g3
VSTD-Franke-2008
p19992
sg5
S'PMC2269030'
p19993
sg7
g19989
sg9
V17206496.xml
p19994
sa(dp19995
g3
VSTD-Durand-2003
p19996
sg5
S'PMC1314596'
p19997
sg7
VCD004191 v. 9.0 Self-help and guided self-help for eating disorders.rm5
p19998
sg9
V12830564.xml
p19999
sa(dp20000
g3
VSTD-Stone-1979
p20001
sg5
S'PMC1344502'
p20002
sg7
VCD002247 v. 13.0 Primary repair for penetrating colon injuries.rm5
p20003
sg9
V384941.xml
p20004
sa(dp20005
g3
VSTD-Chappius-1991
p20006
sg5
S'PMC1358480'
p20007
sg7
g20003
sg9
V2025069.xml
p20008
sa(dp20009
g3
VSTD-QALS-Study-Group-2009
p20010
sg5
S'PMC2854625'
p20011
sg7
VCD002829 v. 8.0 Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease.rm5
p20012
sg9
V19743457.xml
p20013
sa(dp20014
g3
VSTD-Millet-1982
p20015
sg5
S'PMC181819'
p20016
sg7
VCD001169 v. 14.0 Amantadine and rimantadine for influenza A in adults.rm5
p20017
sg9
V7044294.xml
p20018
sa(dp20019
g3
VSTD-Schapira-1971
p20020
sg5
S'PMC2156417'
p20021
sg7
g20017
sg9
V4947223.xml
p20022
sa(dp20023
g3
VSTD-Hayden-1981
p20024
sg5
S'PMC181399'
p20025
sg7
g20017
sg9
V7347558.xml
p20026
sa(dp20027
g3
VSTD-Nafta-1970
p20028
sg5
S'PMC2427540'
p20029
sg7
g20017
sg9
V5310209.xml
p20030
sa(dp20031
g3
VSTD-Hayden-1986
p20032
sg5
S'PMC176405'
p20033
sg7
g20017
sg9
V3521480.xml
p20034
sa(dp20035
g3
VSTD-Brady-1990
p20036
sg5
S'PMC171896'
p20037
sg7
g20017
sg9
V2285274.xml
p20038
sa(dp20039
g3
VSTD-Smorodintsev-1970
p20040
sg5
S'PMC2427564'
p20041
sg7
g20017
sg9
V5312248.xml
p20042
sa(dp20043
g3
VSTD-Oker_x002d_Blom-1970
p20044
sg5
S'PMC1701794'
p20045
sg7
g20017
sg9
V4919024.xml
p20046
sa(dp20047
g3
VSTD-Younkin-1983
p20048
sg5
S'PMC184704'
p20049
sg7
g20017
sg9
V6859836.xml
p20050
sa(dp20051
g3
VSTD-Hornick-1969d
p20052
sg5
S'PMC2427751'
p20053
sg7
g20017
sg9
V4908341.xml
p20054
sa(dp20055
g3
VSTD-Hornick-1969c
p20056
sg5
S'PMC2427751'
p20057
sg7
g20017
sg9
V4908341.xml
p20058
sa(dp20059
g3
VSTD-Hornick-1969b
p20060
sg5
S'PMC2427751'
p20061
sg7
g20017
sg9
V4908341.xml
p20062
sa(dp20063
g3
VSTD-Hornick-1969a
p20064
sg5
S'PMC2427751'
p20065
sg7
g20017
sg9
V4908341.xml
p20066
sa(dp20067
g3
VSTD-Belanger-2009
p20068
sg5
S'PMC2661342'
p20069
sg7
VCD007986 v. 4.0 Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children a.rm5
p20070
sg9
V19436468.xml
p20071
sa(dp20072
g3
VSTD-Koldsland-1993
p20073
sg5
S'PMC464703'
p20074
sg7
VCD002916 v. 9.0 Pleurodesis for malignant pleural effusions.rm5
p20075
sg9
V7692617.xml
p20076
sa(dp20077
g3
VSTD-Lo-1998
p20078
sg5
S'PMC1191296'
p20079
sg7
VCD005440 v. 9.0 Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis.rm5
p20080
sg9
V9563529.xml
p20081
sa(dp20082
g3
VSTD-PEDIG-2006
p20083
sg5
S'PMC1609192'
p20084
sg7
VCD006461 v. 5.0 Interventions for strabismic amblyopia.rm5
p20085
sg9
V16751033.xml
p20086
sa(dp20087
g3
VSTD-PEDIG-2008
p20088
sg5
S'PMC2615691'
p20089
sg7
g20085
sg9
V18789533.xml
p20090
sa(dp20091
g3
VSTD-Laurence-1981
p20092
sg5
S'PMC1505459'
p20093
sg7
VCD007950 v. 2.0 Effects and safety of periconceptional folate supplementation for preventing birth defects.rm5
p20094
sg9
V6786536.xml
p20095
sa(dp20096
g3
VSTD-Kirke-1992
p20097
sg5
S'PMC1793975'
p20098
sg7
g20094
sg9
V1489222.xml
p20099
sa(dp20100
g3
VSTD-Wahl-2008
p20101
sg5
S'PMC2573879'
p20102
sg7
VCD004974 v. 9.0 Immunostimulants for preventing respiratory tract infection in children.rm5
p20103
sg9
V18831749.xml
p20104
sa(dp20105
g3
VSTD-Liu-2000
p20106
sg5
S'PMC1447620'
p20107
sg7
VCD006061 v. 3.0 Whole grain foods for the prevention of type 2 diabetes mellitus.rm5
p20108
sg9
V10983198.xml
p20109
sa(dp20110
g3
VSTD-Petrowsky-2006
p20111
sg5
S'PMC1856627'
p20112
sg7
VCD007632 v. 1.2 Methods of vascular occlusion for elective liver resections.rm5
p20113
sg9
V17122617.xml
p20114
sa(dp20115
g3
VSTD-Figueras-2005
p20116
sg5
S'PMC1357061'
p20117
sg7
g20113
sg9
V15798459.xml
p20118
sa(dp20119
g3
VSTD-Belghiti-1996
p20120
sg5
S'PMC1235336'
p20121
sg7
g20113
sg9
V8757378.xml
p20122
sa(dp20123
g3
VSTD-Belghiti-1999
p20124
sg5
S'PMC1191702'
p20125
sg7
g20113
sg9
V10077049.xml
p20126
sa(dp20127
g3
VSTD-Mansour-2011
p20128
sg5
S'PMC3233274'
p20129
sg7
VCD004425 v. 10.0 Combined oral contraceptive pills for treatment of acne.rm5
p20130
sg9
V21995590.xml
p20131
sa(dp20132
g3
VSTD-Griffith-2009
p20133
sg5
S'PMC2761503'
p20134
sg7
VCD008465 v. 2.0 Exercise interventions on health-related quality of life for people with cancer during active treatm.rm5
p20135
sg9
V19637345.xml
p20136
sa(dp20137
g3
VSTD-Hwang-2008
p20138
sg5
S'PMC2615347'
p20139
sg7
g20135
sg9
V18581595.xml
p20140
sa(dp20141
g3
VSTD-Mustian-2009
p20142
sg5
S'PMC3034389'
p20143
sg7
g20135
sg9
V19831159.xml
p20144
sa(dp20145
g3
VSTD-Hacker-2011
p20146
sg5
S'PMC3085978'
p20147
sg7
g20135
sg9
V21116175.xml
p20148
sa(dp20149
g3
VSTD-Vadiraja-2009b
p20150
sg5
S'PMC2933732'
p20151
sg7
g20135
sg9
V20842268.xml
p20152
sa(dp20153
g3
VSTD-Mutrie-2007
p20154
sg5
S'PMC1819494'
p20155
sg7
g20135
sg9
V17307761.xml
p20156
sa(dp20157
g3
VSTD-Adamsen-2009
p20158
sg5
S'PMC2762035'
p20159
sg7
g20135
sg9
V19826172.xml
p20160
sa(dp20161
g3
VSTD-Oh-2010
p20162
sg5
S'PMC2826100'
p20163
sg7
g20135
sg9
V19880433.xml
p20164
sa(dp20165
g3
VSTD-Moudgil-2000
p20166
sg5
S'PMC1745690'
p20167
sg7
VCD006580 v. 4.0 Culture-specific programs for children and adults from minority groups who have asthma.rm5
p20168
sg9
V10679534.xml
p20169
sa(dp20170
g3
VSTD-Canino-2008
p20171
sg5
S'PMC3136215'
p20172
sg7
g20168
sg9
V18061648.xml
p20173
sa(dp20174
g3
VSTD-Rapp-2006
p20175
sg5
S'PMC1986793'
p20176
sg7
VCD006265 v. 6.0 Case management for persons with substance use disorders.rm5
p20177
sg9
V16616167.xml
p20178
sa(dp20179
g3
VSTD-Morgenstern-2006
p20180
sg5
S'PMC1751803'
p20181
sg7
g20177
sg9
V17018819.xml
p20182
sa(dp20183
g3
VSTD-Liu-2006
p20184
sg5
S'PMC3454905'
p20185
sg7
VCD003854 v. 7.0 Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples.rm5
p20186
sg9
V16496208.xml
p20187
sa(dp20188
g3
VSTD-Voerman-2007
p20189
sg5
S'PMC1915628'
p20190
sg7
VCD008160 v. 3.0 Workplace interventions for neck pain in workers.rm5
p20191
sg9
V17260162.xml
p20192
sa(dp20193
g3
VSTD-Barratt-1992
p20194
sg5
S'PMC1793542'
p20195
sg7
VCD004110 v. 6.0 Speech and language therapy interventions for children with primary speech and language delay or dis.rm5
p20196
sg9
V1739321.xml
p20197
sa(dp20198
g3
VSTD-Glogowska_x002c_-2000
p20199
sg5
S'PMC27499'
p20200
sg7
g20196
sg9
V11030677.xml
p20201
sa(dp20202
g3
VSTD-P_x00e4_rssinen-1989
p20203
sg5
S'PMC1041798'
p20204
sg7
VCD004916 v. 5.4 Interventions to slow progression of myopia in children.rm5
p20205
sg9
V2667638.xml
p20206
sa(dp20207
g3
VSTD-Hwang-2008
p20208
sg5
S'PMC2615347'
p20209
sg7
VCD005211 v. 6.0 Exercise interventions for upper-limb dysfunction due to breast cancer treatment.rm5
p20210
sg9
V18581595.xml
p20211
sa(dp20212
g3
VSTD-Champault-1984
p20213
sg5
S'PMC1463641'
p20214
sg7
VCD001423 v. 12.0 Serenoa repens for benign prostatic hyperplasia.rm5
p20215
sg9
V6207850.xml
p20216
sa(dp20217
g3
VSTD-Barry-2011
p20218
sg5
S'PMC3326341'
p20219
sg7
g20215
sg9
V21954478.xml
p20220
sa(dp20221
g3
VSTD-Carey-2005
p20222
sg5
S'PMC547907'
p20223
sg7
VCD005473 v. 3.0 Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.rm5
p20224
sg9
V15667657.xml
p20225
sa(dp20226
g3
VSTD-Macsai-2008
p20227
sg5
S'PMC2646454'
p20228
sg7
VCD005556 v. 3.3 Interventions for chronic blepharitis.rm5
p20229
sg9
V19277245.xml
p20230
sa(dp20231
g3
VSTD-Seal-1995
p20232
sg5
S'PMC505018'
p20233
sg7
g20229
sg9
V7880791.xml
p20234
sa(dp20235
g3
VSTD-Hyndiuk-1990
p20236
sg5
S'PMC171652'
p20237
sg7
g20229
sg9
V2344168.xml
p20238
sa(dp20239
g3
VSTD-More-1968
p20240
sg5
S'PMC506604'
p20241
sg7
g20229
sg9
V4872706.xml
p20242
sa(dp20243
g3
VSTD-Mandelbrot-2002
p20244
sg5
S'PMC1744488'
p20245
sg7
VCD003651 v. 7.0 Vaginal disinfection for preventing mother-to-child transmission of HIV infection.rm5
p20246
sg9
V12181464.xml
p20247
sa(dp20248
g3
VSTD-Mermelstein-2006
p20249
sg5
S'PMC2373262'
p20250
sg7
VCD007078 v. 6.0 Internet-based interventions for smoking cessation.rm5
p20251
sg9
V17491173.xml
p20252
sa(dp20253
g3
VSTD-Munoz-2006-Study-3
p20254
sg5
S'PMC150356'
p20255
sg7
g20251
sg9
V12509354.xml
p20256
sa(dp20257
g3
VSTD-Strecher-2008
p20258
sg5
S'PMC2697448'
p20259
sg7
g20251
sg9
V18407003.xml
p20260
sa(dp20261
g3
VSTD-Rabius-2008
p20262
sg5
S'PMC2630842'
p20263
sg7
g20251
sg9
V19033146.xml
p20264
sa(dp20265
g3
VSTD-Swartz-2006
p20266
sg5
S'PMC2563640'
p20267
sg7
g20251
sg9
V16436397.xml
p20268
sa(dp20269
g3
VSTD-Stoddard-2008
p20270
sg5
S'PMC2630832'
p20271
sg7
g20251
sg9
V19097974.xml
p20272
sa(dp20273
g3
VSTD-Etter-2005
p20274
sg5
S'PMC1550632'
p20275
sg7
g20251
sg9
V15829474.xml
p20276
sa(dp20277
g3
VSTD-Munoz-2009
p20278
sg5
S'PMC2725004'
p20279
sg7
g20251
sg9
V19640833.xml
p20280
sa(dp20281
g3
VSTD-McKay-2008
p20282
sg5
S'PMC2630830'
p20283
sg7
g20251
sg9
V19017582.xml
p20284
sa(dp20285
g3
VSTD-Brendryen-2008a
p20286
sg5
S'PMC2630841'
p20287
sg7
g20251
sg9
V19087949.xml
p20288
sa(dp20289
g3
VSTD-Meyer-2003
p20290
sg5
S'PMC1756013'
p20291
sg7
VCD004863 v. 6.0 Early erythropoietin for preventing red blood cell transfusion in preterm andor low birth weight in.rm5
p20292
sg9
V12496225.xml
p20293
sa(dp20294
g3
VSTD-Carnielli-1998
p20295
sg5
S'PMC1720813'
p20296
sg7
g20292
sg9
V9797624.xml
p20297
sa(dp20298
g3
VSTD-Pullar-1983
p20299
sg5
S'PMC1549364'
p20300
sg7
VCD000958 v. 7.0 Sulfasalazine for treating rheumatoid arthritis.rm5
p20301
sg9
V6138117.xml
p20302
sa(dp20303
g3
VSTD-Danis-1992
p20304
sg5
S'PMC1004800'
p20305
sg7
g20301
sg9
V1358037.xml
p20306
sa(dp20307
g3
VSTD-Wilding-1996
p20308
sg5
S'PMC472646'
p20309
sg7
VCD001285 v. 6.0 Inhaled short acting beta2-agonist use in chronic asthma regular versus as needed treatment.rm5
p20310
sg9
V8977598.xml
p20311
sa(dp20312
g3
VSTD-Taylor-1998
p20313
sg5
S'PMC1745306'
p20314
sg7
g20310
sg9
V10319056.xml
p20315
sa(dp20316
g3
VSTD-Hancox--1999a
p20317
sg5
S'PMC1745487'
p20318
sg7
g20310
sg9
V10335000.xml
p20319
sa(dp20320
g3
VSTD-Chavasse-2000
p20321
sg5
S'PMC1718341'
p20322
sg7
g20310
sg9
V10799426.xml
p20323
sa(dp20324
g3
VSTD-Hancox-1999b
p20325
sg5
S'PMC1745487'
p20326
sg7
g20310
sg9
V10335000.xml
p20327
sa(dp20328
g3
VSTD-Kim-2007
p20329
sg5
S'PMC1891405'
p20330
sg7
VCD002150 v. 6.0 Antibiotics for treating scrub typhus.rm5
p20331
sg9
V17404000.xml
p20332
sa(dp20333
g3
VSTD-Nickel-1996
p20334
sg5
S'PMC1335066'
p20335
sg7
VCD006015 v. 7.0 Finasteride for benign prostatic hyperplasia.rm5
p20336
sg9
V8911291.xml
p20337
sa(dp20338
g3
VSTD-Thompson-1990
p20339
sg5
S'PMC1405121'
p20340
sg7
VCD001855 v. 11.0 Helmets for preventing head and facial injuries in bicyclists.rm5
p20341
sg9
V2240332.xml
p20342
sa(dp20343
g3
VSTD-Thomas-1994
p20344
sg5
S'PMC2542522'
p20345
sg7
g20341
sg9
V8312768.xml
p20346
sa(dp20347
g3
VSTD-Maimaris-1994
p20348
sg5
S'PMC2540472'
p20349
sg7
g20341
sg9
V8019309.xml
p20350
sa(dp20351
g3
VSTD-Earley-2009
p20352
sg5
S'PMC2703581'
p20353
sg7
VCD007834 v. 2.0 Iron for restless legs syndrome.rm5
p20354
sg9
V18280205.xml
p20355
sa(dp20356
g3
VSTD-Nandi-2003
p20357
sg5
S'PMC1746761'
p20358
sg7
VCD006429 v. 3.0 Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease.rm5
p20359
sg9
V12885981.xml
p20360
sa(dp20361
g3
VSTD-Leach-1992
p20362
sg5
S'PMC464043'
p20363
sg7
g20359
sg9
V1481177.xml
p20364
sa(dp20365
g3
VSTD-Garrod-1999
p20366
sg5
S'PMC1745430'
p20367
sg7
g20359
sg9
V10325901.xml
p20368
sa(dp20369
g3
VSTD-Davidson-1988
p20370
sg5
S'PMC461601'
p20371
sg7
g20359
sg9
V3238640.xml
p20372
sa(dp20373
g3
VSTD-McKeon-1988a
p20374
sg5
S'PMC461095'
p20375
sg7
g20359
sg9
V3353874.xml
p20376
sa(dp20377
g3
VSTD-Killen-2000
p20378
sg5
S'PMC1745798'
p20379
sg7
g20359
sg9
V10856311.xml
p20380
sa(dp20381
g3
VSTD-Torre-et-al-1998
p20382
sg5
S'PMC105601'
p20383
sg7
VCD005420 v. 5.0 Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor set.rm5
p20384
sg9
V9624473.xml
p20385
sa(dp20386
g3
VSTD-Sprackling-1981
p20387
sg5
S'PMC1507336'
p20388
sg7
VCD000028 v. 14.0 Pharmacotherapy for hypertension in the elderly.rm5
p20389
sg9
V6794796.xml
p20390
sa(dp20391
g3
VSTD-Zainudin-1994
p20392
sg5
S'PMC1021158'
p20393
sg7
VCD002742 v. 7.4 Addition of intravenous aminophylline to inhaled beta2-agonists in adults with acute asthma.rm5
p20394
sg9
V8202885.xml
p20395
sa(dp20396
g3
VSTD-Cardozo-1986
p20397
sg5
S'PMC1341914'
p20398
sg7
VCD003101 v. 6.0 Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term.rm5
p20399
sg9
V3094775.xml
p20400
sa(dp20401
g3
VSTD-Harrison-1984
p20402
sg5
S'PMC1442189'
p20403
sg7
VCD000081 v. 8.2 Episiotomy for vaginal birth.rm5
p20404
sg9
V6428627.xml
p20405
sa(dp20406
g3
VSTD-Dodd-2010a
p20407
sg5
S'PMC2891044'
p20408
sg7
VCD006145 v. 6.0 Exercise for the management of cancer-related fatigue in adults.rm5
p20409
sg9
V20467301.xml
p20410
sa(dp20411
g3
VSTD-Hwang-2008
p20412
sg5
S'PMC2615347'
p20413
sg7
g20409
sg9
V18581595.xml
p20414
sa(dp20415
g3
VSTD-Mustian-2009
p20416
sg5
S'PMC3034389'
p20417
sg7
g20409
sg9
V19831159.xml
p20418
sa(dp20419
g3
VSTD-Dodd-2010b
p20420
sg5
S'PMC2891044'
p20421
sg7
g20409
sg9
V20467301.xml
p20422
sa(dp20423
g3
VSTD-Mutrie-2007
p20424
sg5
S'PMC1819494'
p20425
sg7
g20409
sg9
V17307761.xml
p20426
sa(dp20427
g3
VSTD-Adamsen-2009
p20428
sg5
S'PMC2762035'
p20429
sg7
g20409
sg9
V19826172.xml
p20430
sa(dp20431
g3
VSTD-Oh-2010
p20432
sg5
S'PMC2826100'
p20433
sg7
g20409
sg9
V19880433.xml
p20434
sa(dp20435
g3
VSTD-Wardrope-1985
p20436
sg5
S'PMC1285259'
p20437
sg7
VCD003320 v. 10.0 Anaesthesia for treating distal radial fracture in adults.rm5
p20438
sg9
V3893460.xml
p20439
sa(dp20440
g3
VSTD-Cobb-1985
p20441
sg5
S'PMC1418745'
p20442
sg7
g20438
sg9
V3935242.xml
p20443
sa(dp20444
g3
VSTD-McGlone-1988
p20445
sg5
S'PMC1285492'
p20446
sg7
g20438
sg9
V3408537.xml
p20447
sa(dp20448
g3
VSTD-Kendall-1997
p20449
sg5
S'PMC1342971'
p20450
sg7
g20438
sg9
V9413772.xml
p20451
sa(dp20452
g3
VSTD-London-1996
p20453
sg5
S'PMC1342769'
p20454
sg7
g20438
sg9
V8894860.xml
p20455
sa(dp20456
g3
VSTD-Lepere-2000
p20457
sg5
S'PMC3015374'
p20458
sg7
VCD004703 v. 6.0 Transabdominal pre-peritoneal (TAPP) vs totally extraperitoneal (TEP) laparoscopic techniques for in.rm5
p20459
sg9
V10917122.xml
p20460
sa(dp20461
g3
VSTD-Paradise-2005
p20462
sg5
S'PMC1201478'
p20463
sg7
VCD004163 v. 5.0 Identification of children in the first four years of life for early treatment for otitis media with.rm5
p20464
sg9
V16093466.xml
p20465
sa(dp20466
g3
VSTD-McHugh-1988
p20467
sg5
S'PMC1003442'
p20468
sg7
VCD000953 v. 7.0 Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis.rm5
p20469
sg9
V2449871.xml
p20470
sa(dp20471
g3
VSTD-Belch-1995
p20472
sg5
S'PMC1005556'
p20473
sg7
g20469
sg9
V7538285.xml
p20474
sa(dp20475
g3
VSTD-North-London-Study
p20476
sg5
S'PMC1629689'
p20477
sg7
VCD001991 v. 10.0 Screening for lung cancer.rm5
p20478
sg9
V5345935.xml
p20479
sa(dp20480
g3
VSTD-Clarke-1993
p20481
sg5
S'PMC1029426'
p20482
sg7
VCD002873 v. 6.0 Short acting beta2-agonists for recurrent wheeze in children under two years of age.rm5
p20483
sg9
V8024294.xml
p20484
sa(dp20485
g3
VSTD-Prendiville-1987a
p20486
sg5
S'PMC460631'
p20487
sg7
g20483
sg9
V2829374.xml
p20488
sa(dp20489
g3
VSTD-Chavasse-1999a
p20490
sg5
S'PMC1718341'
p20491
sg7
g20483
sg9
V10799426.xml
p20492
sa(dp20493
g3
VSTD-Dougados-1999
p20494
sg5
S'PMC1752864'
p20495
sg7
VCD008495 v. 1.2 Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying.rm5
p20496
sg9
V10364900.xml
p20497
sa(dp20498
g3
VSTD-Capell-2007
p20499
sg5
S'PMC1798490'
p20500
sg7
g20496
sg9
V16926184.xml
p20501
sa(dp20502
g3
VSTD-Augensen-1987
p20503
sg5
S'PMC1246355'
p20504
sg7
VCD004945 v. 7.0 Induction of labour for improving birth outcomes for women at or beyond term.rm5
p20505
sg9
V3109575.xml
p20506
sa(dp20507
g3
VSTD-Machiels-1990a
p20508
sg5
S'PMC296531'
p20509
sg7
VCD001186 v. 6.0 Injection allergen immunotherapy for asthma.rm5
p20510
sg9
V2318962.xml
p20511
sa(dp20512
g3
VSTD-Varney-1991
p20513
sg5
S'PMC1668945'
p20514
sg7
g20510
sg9
V1998791.xml
p20515
sa(dp20516
g3
VSTD-Hill-1982
p20517
sg5
S'PMC1495893'
p20518
sg7
g20510
sg9
V6800440.xml
p20519
sa(dp20520
g3
VSTD-Klaus-1986
p20521
sg5
S'PMC1341377'
p20522
sg7
VCD003766 v. 11.2 Continuous support for women during childbirth.rm5
p20523
sg9
V3092934.xml
p20524
sa(dp20525
g3
VSTD-Bruggemann-2007
p20526
sg5
S'PMC1936417'
p20527
sg7
g20523
sg9
V17612408.xml
p20528
sa(dp20529
g3
VSTD-Cascinu-1995
p20530
sg5
S'PMC2033463'
p20531
sg7
VCD003445 v. 8.0 Supportive care for patients with gastrointestinal cancer.rm5
p20532
sg9
V7819058.xml
p20533
sa(dp20534
g3
VSTD-Scheithauer-1993
p20535
sg5
S'PMC1677246'
p20536
sg7
g20532
sg9
V7683942.xml
p20537
sa(dp20538
g3
VSTD-Koivunen-2004
p20539
sg5
S'PMC351838'
p20540
sg7
VCD008282 v. 2.0 Adenoidectomy for recurrent or chronic nasal symptoms in children.rm5
p20541
sg9
V14769785.xml
p20542
sa(dp20543
g3
VSTD-Hollingworth-1983
p20544
sg5
S'PMC1549498'
p20545
sg7
VCD004016 v. 6.0 Corticosteroid injections for shoulder pain.rm5
p20546
sg9
V6416401.xml
p20547
sa(dp20548
g3
VSTD-van-der-Windt-1998
p20549
sg5
S'PMC28713'
p20550
sg7
g20546
sg9
V9804720.xml
p20551
sa(dp20552
g3
VSTD-Dacre-1989
p20553
sg5
S'PMC1003749'
p20554
sg7
g20546
sg9
V2712613.xml
p20555
sa(dp20556
g3
VSTD-Plafki-2000
p20557
sg5
S'PMC3619854'
p20558
sg7
g20546
sg9
V10774861.xml
p20559
sa(dp20560
g3
VSTD-Richardson-1975
p20561
sg5
S'PMC1864199'
p20562
sg7
g20546
sg9
V53845.xml
p20563
sa(dp20564
g3
VSTD-Bulgen-1984
p20565
sg5
S'PMC1001344'
p20566
sg7
g20546
sg9
V6742895.xml
p20567
sa(dp20568
g3
VSTD-Kikuchi-2006
p20569
sg5
S'PMC2360636'
p20570
sg7
VCD005004 v. 4.0 Green tea (Camellia sinensis) for the prevention of cancer.rm5
p20571
sg9
V16804523.xml
p20572
sa(dp20573
g3
VSTD-Hoshiyama-2002
p20574
sg5
S'PMC2364221'
p20575
sg7
g20571
sg9
V12177800.xml
p20576
sa(dp20577
g3
VSTD-Suzuki-2004
p20578
sg5
S'PMC2409667'
p20579
sg7
g20571
sg9
V15054454.xml
p20580
sa(dp20581
g3
VSTD-Inoue-2008
p20582
sg5
S'PMC2574755'
p20583
sg7
g20571
sg9
V18669903.xml
p20584
sa(dp20585
g3
VSTD-Key-1999
p20586
sg5
S'PMC2374337'
p20587
sg7
g20571
sg9
V10584890.xml
p20588
sa(dp20589
g3
VSTD-Li-2008
p20590
sg5
S'PMC2567088'
p20591
sg7
g20571
sg9
V18766189.xml
p20592
sa(dp20593
g3
VSTD-Chao-2008
p20594
sg5
S'PMC2483341'
p20595
sg7
VCD007275 v. 2.0 Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.rm5
p20596
sg9
V18317253.xml
p20597
sa(dp20598
g3
VSTD-Wright-2008
p20599
sg5
S'PMC2440307'
p20600
sg7
g20596
sg9
V18261131.xml
p20601
sa(dp20602
g3
VSTD-Zar-2007
p20603
sg5
S'PMC2083341'
p20604
sg7
VCD005536 v. 5.0 Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in childr.rm5
p20605
sg9
V16905564.xml
p20606
sa(dp20607
g3
VSTD-Sipatrigine-137_x002d_101
p20608
sg5
S'PMC2042617'
p20609
sg7
VCD001244 v. 4.0 Excitatory amino acid antagonists for acute stroke.rm5
p20610
sg9
V8799514.xml
p20611
sa(dp20612
g3
VSTD-Eaton-1999
p20613
sg5
S'PMC1508977'
p20614
sg7
VCD008366 v. 3.0 Community wide interventions for increasing physical activity.rm5
p20615
sg9
V10553400.xml
p20616
sa(dp20617
g3
VSTD-Sarrafzadegan-2009
p20618
sg5
S'PMC2649597'
p20619
sg7
g20615
sg9
V19197403.xml
p20620
sa(dp20621
g3
VSTD-O_x0027_Loughlin-1999
p20622
sg5
S'PMC1509008'
p20623
sg7
g20615
sg9
V10589309.xml
p20624
sa(dp20625
g3
VSTD-Evans-1981
p20626
sg5
S'PMC1505984'
p20627
sg7
VCD002885 v. 5.4 Oral xanthines as maintenance treatment for asthma in children.rm5
p20628
sg9
V6788244.xml
p20629
sa(dp20630
g3
VSTD-Glass-1981
p20631
sg5
S'PMC1627266'
p20632
sg7
g20628
sg9
V6791596.xml
p20633
sa(dp20634
g3
VSTD-Conway-1986
p20635
sg5
S'PMC1777982'
p20636
sg7
g20628
sg9
V3535686.xml
p20637
sa(dp20638
g3
VSTD-Edmunds-1980
p20639
sg5
S'PMC1714307'
p20640
sg7
g20628
sg9
V6775752.xml
p20641
sa(dp20642
g3
VSTD-Issenman-1993
p20643
sg5
S'PMC2379847'
p20644
sg7
VCD004390 v. 5.0 Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children.rm5
p20645
sg9
V8219860.xml
p20646
sa(dp20647
g3
VSTD-Mackenzie-1991
p20648
sg5
S'PMC1670684'
p20649
sg7
g20645
sg9
V1789830.xml
p20650
sa(dp20651
g3
VSTD-Sharifi-1985
p20652
sg5
S'PMC1777458'
p20653
sg7
g20645
sg9
V3901934.xml
p20654
sa(dp20655
g3
VSTD-Byrne-2003
p20656
sg5
S'PMC1719590'
p20657
sg7
VCD007639 v. 5.0 Nebuliser systems for drug delivery in cystic fibrosis.rm5
p20658
sg9
V12876172.xml
p20659
sa(dp20660
g3
VSTD-Thomas-1991
p20661
sg5
S'PMC463390'
p20662
sg7
g20658
sg9
V1750018.xml
p20663
sa(dp20664
g3
VSTD-Newman-1988
p20665
sg5
S'PMC461220'
p20666
sg7
g20658
sg9
V3406919.xml
p20667
sa(dp20668
g3
VSTD-Mazzella-2001
p20669
sg5
S'PMC1721298'
p20670
sg7
VCD002977 v. 6.0 Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP).rm5
p20671
sg9
V11517199.xml
p20672
sa(dp20673
g3
VSTD-Baharvand-2010
p20674
sg5
S'PMC3232086'
p20675
sg7
VCD001973 v. 9.0 Interventions for treating oral mucositis for patients with cancer receiving treatment.rm5
p20676
sg9
V22615593.xml
p20677
sa(dp20678
g3
VSTD-Osman-2010
p20679
sg5
S'PMC2922723'
p20680
sg7
VCD006842 v. 3.0 Oscillating devices for airway clearance in people with cystic fibrosis.rm5
p20681
sg9
V19703826.xml
p20682
sa(dp20683
g3
VSTD-Schwartz-2008
p20684
sg5
S'PMC2517895'
p20685
sg7
VCD005497 v. 7.0 Advance provision of emergency contraception for pregnancy prevention.rm5
p20686
sg9
V18398664.xml
p20687
sa(dp20688
g3
VSTD-Shapiro-2010
p20689
sg5
S'PMC2999916'
p20690
sg7
VCD005481 v. 4.4 Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.rm5
p20691
sg9
V20554983.xml
p20692
sa.